data_1f8h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1f8h _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.482 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.261 0.553 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -42.98 -28.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.417 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 23.8 t -101.73 139.2 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.91 . . . . 0.0 110.708 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.541 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.03 -177.3 0.64 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.49 -0.756 . . . . 0.0 109.748 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.7 Cg_endo -71.66 -32.63 11.6 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.711 1.374 . . . . 0.0 110.249 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 13.0 mm-40 -77.36 -31.78 54.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 109.784 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -77.44 -35.19 54.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -82.21 -18.47 42.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.638 0.732 . . . . 0.0 109.112 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -70.08 -40.15 75.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.61 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -73.51 -32.01 64.02 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.61 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -66.22 -36.58 83.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.56 -20.98 63.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.663 -0.648 . . . . 0.0 110.155 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.01 -38.73 24.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.971 . . . . 0.0 108.511 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.7 mt -75.79 -29.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.547 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -73.97 -36.41 64.58 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t70 -89.97 1.48 56.23 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.977 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -92.4 -3.47 55.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.922 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.604 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -109.63 -4.58 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 84.99 89.97 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.3 Cg_endo -72.42 148.7 49.07 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 124.503 1.791 . . . . 0.0 110.864 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 68.7 t -121.03 104.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.1 t30 58.88 20.41 8.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.805 . . . . 0.0 110.001 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 94.27 37.1 5.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 87.1 m-85 -150.29 149.22 29.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.164 -1.198 . . . . 0.0 111.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 15.0 mt -122.54 130.48 53.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -77.29 148.14 35.87 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.55 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -46.66 -25.55 2.25 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 9.0 t0 -63.02 -20.75 65.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.567 -0.961 . . . . 0.0 109.685 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 27.9 mttp -104.42 -32.38 9.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.552 HG13 ' CD1' ' A' ' 40' ' ' LEU . 92.3 t -83.5 -46.29 18.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.175 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.608 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 8.0 tttt -41.68 -49.91 9.91 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -67.69 -31.97 31.42 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.341 1.179 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -68.4 -34.58 66.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.622 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -86.3 -31.48 21.58 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.82 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 47.1 mt -71.02 -11.5 61.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.09 -10.36 53.07 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.169 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.511 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 87.7 p -79.17 7.92 6.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 110.473 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.64 9.53 5.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.066 -1.021 . . . . 0.0 109.939 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.521 HD11 ' CG2' ' A' ' 49' ' ' ILE . 15.2 mt -93.17 157.26 39.25 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.5 Cg_endo -74.72 167.86 26.13 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.857 1.451 . . . . 0.0 109.635 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.51 -7.4 6.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.941 -1.099 . . . . 0.0 109.142 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.51 -29.87 61.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.7 mm -85.62 -39.1 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.925 0.869 . . . . 0.0 108.898 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 13.1 mt -79.52 -28.77 41.33 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.08 -26.83 71.49 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.481 ' HD3' ' HG3' ' A' ' 88' ' ' MET . 28.0 ttm180 -101.43 -31.19 11.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.113 -0.64 . . . . 0.0 110.501 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 49' ' ' ILE . 18.7 t -70.63 -36.93 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 108.588 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CZ2' ' OD1' ' A' ' 58' ' ' ASP . 1.6 t-105 -63.44 -50.77 68.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.71 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.3 mm-40 -52.25 -57.7 8.91 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.11 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.546 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 3.4 mt -62.13 -19.28 62.87 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.141 -0.974 . . . . 0.0 108.646 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.542 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 7.5 t -85.9 -33.95 21.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -70.3 92.75 0.8 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 29.1 mm -75.31 -23.26 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 111.328 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -110.2 -9.54 14.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.884 -1.135 . . . . 0.0 110.948 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 50.7 m170 59.59 44.8 14.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.109 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 19.2 p-10 -106.74 9.31 31.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 109.989 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 80.05 24.77 59.06 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.2 mtp -152.17 161.4 42.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.183 -1.187 . . . . 0.0 110.373 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.542 ' CD2' ' OG ' ' A' ' 57' ' ' SER . 13.6 mt -116.84 103.12 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.723 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.575 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -69.26 173.23 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.067 -1.021 . . . . 0.0 110.021 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -50.07 -32.15 14.9 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.613 -0.679 . . . . 0.0 110.894 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 -30.38 20.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 36.2 mt-10 -79.16 -40.6 30.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 108.917 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.575 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.3 t80 -63.81 -24.45 67.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -70.17 -51.87 27.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.962 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.449 HG13 HD11 ' A' ' 76' ' ' LEU . 76.1 t -57.29 -25.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.547 -0.72 . . . . 0.0 110.359 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -89.07 -4.99 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 111.637 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmt -88.53 -44.16 10.88 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.862 -1.149 . . . . 0.0 110.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.527 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 4.5 p90 -77.71 -22.17 50.82 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.999 -1.081 . . . . 0.0 108.293 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 12.1 mt -74.63 -24.52 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.535 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 49.3 t -91.62 -40.96 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.586 -0.696 . . . . 0.0 110.123 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.508 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -71.91 -22.52 61.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.648 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.3 m -83.2 -20.76 34.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.818 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.519 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -80.62 -12.82 59.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.332 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.535 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.513 -0.742 . . . . 0.0 110.771 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.485 0.983 0 N-CA-C 110.588 -0.581 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 ' HD2' ' A' ' 87' ' ' PRO . 98.1 t -128.15 137.48 30.93 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 110.605 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.546 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 48.3 Cg_endo -84.41 175.43 7.2 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.869 1.457 . . . . 0.0 108.503 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.481 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 9.9 mtm -108.48 18.21 21.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.74 -1.225 . . . . 0.0 110.49 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 C--N 1.295 -1.772 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.355 -178.302 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.413 ' ND2' ' CD1' ' B' ' 111' ' ' PHE . 5.0 t-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.515 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -74.59 19.69 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.194 1.628 . . . . 0.0 112.35 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 24.5 m-85 -99.94 -61.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.511 -1.368 . . . . 0.0 108.69 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.414 ' HA ' HG13 ' A' ' 47' ' ' VAL . 27.1 mtm180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.222 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.597 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 16.0 t90 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.274 0.559 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.27 -27.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.597 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 42.0 t -96.6 145.3 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.539 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.4 mttm -112.52 -179.46 0.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.4 Cg_endo -67.56 -35.53 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.745 1.392 . . . . 0.0 110.199 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 6.2 pt-20 -71.21 -30.62 66.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 5.8 m-20 -83.63 -38.13 21.94 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.224 -0.923 . . . . 0.0 108.655 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 5.9 tptm -69.33 -17.65 63.73 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -78.74 -39.67 35.57 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.601 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.2 ptmm? -81.05 -22.85 38.98 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.601 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -76.93 -34.75 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.9 -19.63 60.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 0.0 110.31 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -83.6 -33.62 25.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.985 . . . . 0.0 108.451 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.475 ' CG2' HG11 ' A' ' 39' ' ' VAL . 22.2 mt -78.07 -31.39 16.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -71.84 -38.95 70.06 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.704 0.764 . . . . 0.0 109.034 179.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.55 -6.49 54.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.512 -0.742 . . . . 0.0 109.878 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.2 t -78.76 -7.51 57.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 0.0 108.909 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 25' ' ' SER . 10.6 mt -101.77 -54.34 2.75 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 m 137.97 98.51 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.16 148.3 39.18 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 O-C-N 123.977 1.514 . . . . 0.0 110.499 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -120.08 98.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.627 -0.67 . . . . 0.0 109.31 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 3.8 t30 60.37 14.86 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.726 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.458 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 107.03 32.88 3.38 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 84.9 m-85 -148.6 151.99 35.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.908 -1.348 . . . . 0.0 112.078 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 6.7 mt -120.31 143.18 48.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 33' ' ' GLY . 96.6 p -89.08 141.79 28.2 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.822 -1.174 . . . . 0.0 110.28 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.514 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.69 -25.96 0.99 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.0 t70 -65.83 -22.36 66.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.513 -0.993 . . . . 0.0 110.072 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HD2' HD23 ' A' ' 31' ' ' LEU . 7.7 mttp -97.81 -35.91 10.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.568 HG22 ' CD2' ' A' ' 70' ' ' PHE . 98.1 t -77.77 -42.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.514 0.673 . . . . 0.0 110.011 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.48 -53.82 5.31 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 110.915 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.1 Cg_endo -68.67 -33.9 20.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.542 1.285 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.475 HG11 ' CG2' ' A' ' 20' ' ' ILE . 2.5 t -63.55 -31.75 54.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.031 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 33.0 mt -88.43 -26.58 22.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 110.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.426 HD13 ' HG3' ' A' ' 37' ' ' LYS . 51.9 mt -73.8 -11.23 60.32 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.175 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -90.31 -3.19 57.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 91.9 p -84.34 13.98 4.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 110.09 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt 59.39 13.72 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.532 HD12 ' CB ' ' A' ' 80' ' ' ALA . 17.5 mt -100.16 156.87 34.78 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.905 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.6 Cg_endo -74.58 171.08 18.86 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.921 1.485 . . . . 0.0 109.868 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.4 -6.19 6.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.286 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.71 -31.15 59.54 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.537 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.6 mm -83.12 -40.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 122.017 0.913 . . . . 0.0 108.556 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 14.1 mt -76.7 -26.94 55.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.729 0.776 . . . . 0.0 108.959 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.8 -29.08 65.81 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 30.1 ttm180 -101.0 -28.3 12.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.886 -0.773 . . . . 0.0 109.934 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 77' ' ' VAL . 19.4 t -72.49 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.43 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.558 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.3 t-105 -65.82 -51.46 58.75 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.814 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.2 mm-40 -50.82 -60.53 2.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.406 -0.809 . . . . 0.0 109.991 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.536 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 2.6 mt -61.54 -15.93 43.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.498 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.515 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 9.2 t -92.24 -18.17 23.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.487 0.661 . . . . 0.0 109.235 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.1 t0 -90.83 82.11 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.514 -0.741 . . . . 0.0 110.322 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 12.1 mm -62.67 -24.12 34.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.604 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -104.24 -7.96 19.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 20.6 p80 38.35 51.92 1.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.567 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.2 p-10 -119.68 20.33 12.35 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.004 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.53 29.71 54.94 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.4 mtp -150.24 161.3 42.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -1.158 . . . . 0.0 111.087 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 14.0 mt -129.53 112.59 13.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 109.746 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 13.7 t0 -70.02 168.39 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.065 -1.022 . . . . 0.0 110.47 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.576 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -50.75 -41.08 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.872 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 46.4 t0 -81.01 -32.82 34.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 2.3 mt-10 -71.96 -50.21 30.82 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.873 0.844 . . . . 0.0 109.257 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.588 ' CD2' HD13 ' A' ' 31' ' ' LEU . 29.3 t80 -53.57 -22.83 9.15 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.83 -52.87 25.38 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.852 0.834 . . . . 0.0 109.77 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 76' ' ' LEU . 49.0 t -52.64 -24.61 6.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 110.394 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.515 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -89.67 -11.48 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 0.0 112.499 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 mmm -86.77 -47.11 9.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.392 -1.442 . . . . 0.0 110.435 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.534 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 1.9 p90 -73.38 -21.75 60.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 6.2 mt -74.55 -24.95 59.01 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 59.8 t -90.96 -42.46 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.466 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.6 m-85 -68.54 -19.09 64.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.619 -0.675 . . . . 0.0 110.21 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 16.1 m -84.65 -25.74 28.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.532 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -73.55 -17.44 61.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 108.698 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 43' ' ' SER . 1.1 mt . . . . . 0 C--N 1.305 -1.369 0 O-C-N 121.724 -0.61 . . . . 0.0 110.767 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.482 0.817 0 N-CA-C 110.244 -0.714 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.496 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 96.4 t -113.99 134.95 22.06 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.536 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.6 Cg_endo -84.69 -173.12 1.4 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.072 1.564 . . . . 0.0 109.02 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.544 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 29.6 mtm -111.55 10.14 21.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 109.872 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.887 -178.321 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.482 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.5 t-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.803 0.335 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.588 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -72.94 2.39 5.48 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.078 1.568 . . . . 0.0 111.483 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 4.4 m-85 -101.2 -47.97 4.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.853 -1.155 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.475 ' HG2' ' HA3' ' A' ' 51' ' ' GLY . 1.2 mmm180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.275 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.9 t90 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.16 0.505 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -40.93 -28.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.451 -0.78 . . . . 0.0 110.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 85.4 t -113.31 135.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 110.152 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -93.77 -179.69 1.07 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.349 -0.844 . . . . 0.0 109.995 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.13 -35.27 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.927 1.488 . . . . 0.0 110.02 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.6 -33.52 58.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 15.0 m-20 -76.96 -34.66 57.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 68' ' ' ASP . 1.5 tttt -76.79 -20.16 56.75 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.7 71.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.601 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -70.13 -21.23 63.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.601 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -80.21 -29.29 38.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.38 -20.14 57.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.718 -0.614 . . . . 0.0 109.804 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -81.57 -32.69 32.02 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.466 ' CD1' ' SD ' ' A' ' 74' ' ' MET . 63.8 mt -78.97 -33.0 15.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -67.78 -35.17 78.19 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -91.03 -5.44 55.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.461 -0.775 . . . . 0.0 110.324 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 87.3 p -78.95 -14.65 59.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 108.839 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' ' CB ' ' A' ' 25' ' ' SER . 11.6 mt -92.96 -55.07 3.48 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 t 142.8 92.92 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.478 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.7 Cg_endo -74.87 148.99 36.67 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 O-C-N 124.198 1.631 . . . . 0.0 110.88 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -125.38 103.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.5 t30 63.37 13.66 7.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.642 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 32.66 4.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.2 m-85 -146.5 148.79 32.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -1.166 . . . . 0.0 111.908 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.1 mt -113.83 158.51 20.93 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' ASP . 48.3 p -105.14 143.45 33.3 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.592 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.59 -25.1 0.49 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' SER . 61.4 t0 -71.32 -23.97 62.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.413 -1.051 . . . . 0.0 110.412 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 14.0 mttp -94.09 -35.61 12.48 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.071 -1.018 . . . . 0.0 108.417 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.526 ' CG1' HD13 ' A' ' 65' ' ' LEU . 87.5 t -78.16 -42.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.382 0.61 . . . . 0.0 110.384 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 14.8 tttt -40.03 -54.42 4.42 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 110.549 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -66.93 -33.85 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.406 1.214 . . . . 0.0 110.021 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -62.25 -35.2 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.818 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.651 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 30.3 mt -87.83 -30.02 20.52 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.705 -0.622 . . . . 0.0 110.063 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.49 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 67.2 mt -70.13 -13.95 62.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -91.36 -4.1 56.1 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.519 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -83.56 16.75 2.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.386 -0.821 . . . . 0.0 110.445 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.557 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.0 tttp 60.32 11.92 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.177 -0.952 . . . . 0.0 109.591 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.544 HD12 ' CG2' ' A' ' 49' ' ' ILE . 16.9 mt -99.19 153.39 37.81 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 110.566 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.0 Cg_endo -75.76 175.97 10.61 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 124.175 1.619 . . . . 0.0 109.271 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.488 HG13 ' O ' ' B' ' 111' ' ' PHE . 1.6 t -73.27 -3.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.6 m-20 -81.68 -30.44 32.64 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.246 -0.909 . . . . 0.0 109.285 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.569 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 5.3 mm -88.0 -39.23 12.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.558 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 23.6 mt -74.78 -27.67 60.42 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -74.58 -21.8 78.19 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.528 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.1 OUTLIER -99.99 -33.75 10.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.161 -0.611 . . . . 0.0 109.402 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' ILE . 18.6 t -69.22 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.592 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 4.4 t-105 -76.2 -55.38 5.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.557 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.8 mm-40 -52.02 -58.24 7.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.96 -1.088 . . . . 0.0 110.048 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 5.6 mt -59.29 -16.32 21.08 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.582 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.561 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 2.0 t -91.44 -40.25 11.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 109.713 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 54' ' ' TRP . 1.2 t0 -65.82 97.66 0.35 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.472 -0.767 . . . . 0.0 109.996 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.473 HG12 ' HG3' ' A' ' 69' ' ' GLU . 15.2 mm -72.22 -31.36 39.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.564 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 4.2 p30 -105.81 -9.64 17.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.801 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.564 ' CG ' ' C ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER 51.77 51.02 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.381 -0.825 . . . . 0.0 109.994 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 47.0 p-10 -111.09 20.83 17.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 75.11 32.81 55.73 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.6 mtp -150.69 161.34 42.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.248 . . . . 0.0 111.858 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.578 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 13.0 mt -132.27 99.73 4.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.606 -0.684 . . . . 0.0 109.293 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.2 p30 -71.49 160.41 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 110.468 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 66' ' ' ASP . 10.1 ptt-85 -34.9 -44.21 0.21 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.756 -0.59 . . . . 0.0 111.31 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.8 m-20 -77.64 -35.08 52.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.701 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -70.13 -48.41 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.81 0.814 . . . . 0.0 109.22 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 25.3 t80 -61.04 -14.17 21.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.19 -47.28 16.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.527 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.9 t -59.01 -29.62 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.077 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.561 ' HB1' ' CB ' ' A' ' 57' ' ' SER . . . -90.2 -2.37 58.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.63 -0.669 . . . . 0.0 111.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.595 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 10.0 mmt -88.08 -48.33 7.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.472 -1.392 . . . . 0.0 110.112 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.503 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -76.1 -24.18 54.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.503 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.6 mt -70.8 -26.45 63.32 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.552 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 8.6 t -91.09 -23.61 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.728 -0.607 . . . . 0.0 109.998 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.45 -26.31 28.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.599 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.29 -17.67 48.52 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.549 -0.72 . . . . 0.0 109.675 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.536 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -86.39 -8.68 57.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.374 -0.828 . . . . 0.0 109.145 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 81' ' ' LEU . 2.7 mt . . . . . 0 C--N 1.302 -1.458 0 CA-C-O 121.751 0.786 . . . . 0.0 108.959 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 N--CA 1.482 0.823 0 N-CA-C 110.063 -0.783 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 52' ' ' ARG . 59.9 t -138.18 125.56 13.58 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.52 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 53.2 Cg_endo -84.9 -175.95 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.926 1.488 . . . . 0.0 109.474 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.528 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 28.4 mtp -110.73 12.36 22.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 C--N 1.299 -1.625 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.772 -178.456 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 112' ' ' ARG . 10.6 t-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.01 0.434 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.606 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 52.2 Cg_endo -72.97 4.85 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.288 1.678 . . . . 0.0 111.686 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.651 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 4.1 m-85 -105.17 -69.42 0.82 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.793 -1.192 . . . . 0.0 109.007 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.515 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.566 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.251 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.597 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.4 t90 . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 121.287 0.565 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.07 -24.74 7.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.597 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 89.3 t -97.5 116.76 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.467 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.8 mttp -93.67 -177.81 0.75 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.496 -0.752 . . . . 0.0 109.633 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -67.63 -34.07 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.659 1.347 . . . . 0.0 110.048 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.43 -33.22 62.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.85 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.7 m-20 -81.55 -36.76 28.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.342 -0.849 . . . . 0.0 108.738 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -74.87 -15.17 60.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.93 -40.28 47.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.595 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.8 ptpt -75.34 -25.07 57.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -73.32 -36.02 66.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.83 -22.73 64.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.733 -0.604 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.24 -30.49 43.22 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.512 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 16.9 mt -82.8 -35.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.46 -36.59 68.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.5 t0 -87.03 -2.09 58.37 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.641 -0.662 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -86.48 -9.42 56.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 108.954 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.619 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.2 mt -102.96 -14.55 16.45 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.619 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.03 93.04 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -74.77 153.55 43.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.284 1.676 . . . . 0.0 111.068 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.1 t -120.92 105.86 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 65.04 12.64 8.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.218 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.71 33.83 5.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.575 ' CD1' ' OD1' ' A' ' 66' ' ' ASP . 76.9 m-85 -141.13 141.99 34.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.159 . . . . 0.0 111.882 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.8 mt -113.98 136.79 52.52 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 35' ' ' LYS . 3.3 p -83.5 146.01 28.61 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.77 -26.74 1.2 Allowed Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.433 ' N ' ' C ' ' A' ' 32' ' ' SER . 33.4 t0 -66.41 -26.22 67.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.579 -0.954 . . . . 0.0 109.991 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 6.1 mttp -92.26 -33.26 14.72 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG11 ' CD1' ' A' ' 40' ' ' LEU . 86.4 t -80.96 -47.12 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.415 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.585 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 20.6 tttm -39.67 -51.58 5.12 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 0.0 110.917 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -68.8 -34.39 18.4 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.355 1.187 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.601 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -62.84 -32.67 56.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.623 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 36.9 mt -90.62 -27.64 18.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.573 -0.704 . . . . 0.0 110.081 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.477 HD12 ' HE2' ' A' ' 37' ' ' LYS . 55.9 mt -74.77 -11.29 60.12 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.035 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -90.38 -9.21 48.47 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 110.185 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.3 p -78.39 5.98 9.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.1 tttt 69.23 9.02 7.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.935 . . . . 0.0 110.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.526 HD12 ' CG2' ' A' ' 49' ' ' ILE . 18.5 mt -93.82 157.25 38.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -75.68 171.89 17.35 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.251 1.658 . . . . 0.0 109.285 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.488 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.8 t -70.73 -4.76 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 109.189 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.17 -29.53 54.52 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 108.78 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.562 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 6.5 mm -87.89 -36.71 9.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.866 0.841 . . . . 0.0 108.755 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 13.4 mt -79.33 -26.72 42.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -72.52 -23.14 78.43 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.515 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 1.6 ttm105 -100.83 -32.49 10.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.972 -0.722 . . . . 0.0 109.723 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' A' ' 77' ' ' VAL . 12.9 t -68.91 -38.97 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.205 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.586 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 4.0 t-105 -67.49 -48.01 68.36 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.359 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.8 mm-40 -59.53 -58.28 9.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.154 -0.966 . . . . 0.0 109.848 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.555 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 5.6 mt -58.83 -17.39 23.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 108.483 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.557 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 10.2 t -88.25 -45.19 10.27 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.583 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -59.79 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.639 -0.663 . . . . 0.0 110.14 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.409 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 33.5 mm -67.98 -30.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 110.128 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.6 p30 -109.6 -15.67 14.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 9.9 m-70 62.02 41.17 11.39 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.406 -0.809 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.1 p-10 -93.13 3.9 54.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.989 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 89.03 23.01 36.39 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.4 mtp -152.79 162.1 41.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -1.168 . . . . 0.0 110.454 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' CD1' HG13 ' A' ' 36' ' ' VAL . 46.0 mt -119.4 112.33 19.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.422 -0.799 . . . . 0.0 109.502 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 30' ' ' PHE . 2.0 m-20 -69.39 159.22 33.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.283 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 19.7 ptt180 -41.52 -42.25 2.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 109.988 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.64 -34.69 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 66' ' ' ASP . 1.8 tt0 -69.35 -49.62 53.96 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.601 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 40.8 t80 -57.97 -19.8 33.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -70.56 -50.31 38.81 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.883 0.849 . . . . 0.0 109.587 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.461 ' O ' HD11 ' A' ' 76' ' ' LEU . 83.4 t -55.15 -24.87 15.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.458 0.647 . . . . 0.0 109.961 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -88.33 -10.46 49.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 111.972 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.59 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmm -84.58 -43.53 14.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 2.8 p90 -75.67 -22.88 56.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.645 -1.222 . . . . 0.0 107.751 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB3' HG21 ' A' ' 53' ' ' VAL . 5.0 mt -72.24 -22.16 61.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 53' ' ' VAL . 70.5 t -91.24 -44.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.765 -0.584 . . . . 0.0 109.513 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -65.14 -27.41 68.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.636 -0.665 . . . . 0.0 110.956 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -77.17 -20.47 55.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.99 -1.068 . . . . 0.0 108.722 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.524 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -87.48 -7.32 57.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.548 ' N ' HD23 ' A' ' 81' ' ' LEU . 3.2 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.399 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.484 0.941 0 N-CA-C 110.438 -0.639 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.8 t -132.32 127.41 20.79 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 110.753 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 48.5 Cg_endo -83.16 -179.54 4.44 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.905 1.476 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.515 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 4.0 mtt -104.32 10.38 35.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.798 -1.189 . . . . 0.0 109.847 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 C--N 1.297 -1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 112.115 -177.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.431 ' HA ' ' HD2' ' B' ' 110' ' ' PRO . 10.3 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.177 0.513 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.547 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 51.9 Cg_endo -71.01 6.16 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 121.887 1.725 . . . . 0.0 111.964 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.623 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 7.7 m-85 -99.88 -63.77 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.222 . . . . 0.0 108.992 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.54 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.4 t90 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.327 0.585 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.85 -27.75 3.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 0.0 109.935 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.54 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.4 t -92.14 122.64 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -80.33 176.01 4.22 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.192 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -70.08 -34.07 14.2 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.053 1.554 . . . . 0.0 109.788 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.2 pp20? -79.6 -22.59 43.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.421 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 m-20 -82.86 -38.49 22.89 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -73.81 -14.93 61.18 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.34 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.472 -0.768 . . . . 0.0 109.024 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.594 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.8 ptpt -72.97 -26.14 61.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.594 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -71.81 -35.2 69.87 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.81 -23.05 60.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.654 -0.654 . . . . 0.0 109.869 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.25 -32.19 38.34 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 66.7 mt -81.31 -31.9 11.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.543 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -73.26 -37.03 66.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.5 t70 -88.76 -1.49 58.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.658 -0.652 . . . . 0.0 110.119 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -4.15 57.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.21 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.5 mt -108.84 -8.66 15.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 87.04 95.0 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -72.09 148.56 50.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.314 1.691 . . . . 0.0 110.838 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 73.8 t -119.76 100.36 9.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 63.77 16.55 9.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 97.11 34.01 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.2 m-85 -149.48 147.41 28.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -1.191 . . . . 0.0 111.776 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.584 HD12 ' CE2' ' A' ' 70' ' ' PHE . 14.8 mt -116.63 134.45 54.81 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 34' ' ' ASP . 17.5 p -77.82 146.62 35.64 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.769 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.46 -27.19 1.18 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.454 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.3 m-20 -61.49 -25.42 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.869 . . . . 0.0 110.031 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 35.7 mttt -98.08 -32.19 11.74 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.111 -0.993 . . . . 0.0 108.338 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.582 HG23 ' CE2' ' A' ' 70' ' ' PHE . 97.9 t -83.54 -48.21 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.421 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.578 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 17.7 tttt -40.14 -53.56 5.02 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.49 -30.44 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.408 1.215 . . . . 0.0 109.703 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 2.2 t -68.81 -30.65 47.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 44.7 mt -88.79 -28.28 20.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.411 -0.806 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.411 HD11 ' HG3' ' A' ' 37' ' ' LYS . 44.3 mt -71.76 -11.25 60.73 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.014 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -90.08 -5.46 56.53 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.568 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.51 ' CB ' HG13 ' A' ' 77' ' ' VAL . 5.8 p -83.21 13.28 4.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.108 -0.995 . . . . 0.0 110.673 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 63.43 8.98 3.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.923 . . . . 0.0 110.676 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.549 HD11 ' CB ' ' A' ' 80' ' ' ALA . 15.2 mt -94.67 157.76 36.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 0.0 109.582 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.7 Cg_endo -75.28 173.66 14.13 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 124.023 1.538 . . . . 0.0 109.243 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.51 HG11 ' C ' ' B' ' 111' ' ' PHE . 3.0 t -74.45 -1.41 2.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.145 -0.972 . . . . 0.0 109.373 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -31.19 33.1 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.551 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 12.8 mm -83.02 -40.35 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.543 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 22.7 mt -73.84 -25.92 60.32 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.471 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -73.35 -25.28 73.31 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -100.86 -28.09 12.97 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.804 -0.821 . . . . 0.0 110.032 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 76' ' ' LEU . 17.0 t -72.58 -39.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.78 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 2.4 t-105 -65.09 -50.97 64.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.576 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 9.6 mm-40 -56.19 -53.84 52.39 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 89' ' ' SER . 18.3 mt -64.46 -12.7 46.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.532 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 1.9 t -94.97 -29.73 14.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 108.88 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 7.4 t0 -74.5 100.75 3.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.692 -0.63 . . . . 0.0 109.65 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.476 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.1 mm -80.44 -29.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -102.1 -18.56 15.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 4.8 m170 65.72 42.12 3.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.0 p30 -102.28 -3.74 26.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 95.12 25.87 13.52 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 5.1 mtp -152.56 161.25 42.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.245 . . . . 0.0 110.618 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.509 HD13 ' CG1' ' A' ' 36' ' ' VAL . 13.5 mt -119.78 102.12 8.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.667 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 5.1 p30 -71.57 167.47 19.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.56 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.7 ptt-85 -37.55 -46.04 0.8 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.0 111.854 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 80.7 m-20 -76.68 -37.21 56.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.075 -1.016 . . . . 0.0 110.665 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.497 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 44.9 mt-10 -71.85 -44.5 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CE2' HD12 ' A' ' 31' ' ' LEU . 11.6 t80 -60.51 -17.37 45.0 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -79.24 -45.79 19.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' LEU . 46.5 t -61.4 -25.97 38.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.476 0.655 . . . . 0.0 109.747 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.55 -8.23 50.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 111.258 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.566 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.7 mmt -83.24 -47.74 11.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -75.14 -28.73 60.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 6.7 mt -66.93 -28.67 68.48 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.532 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 41.0 t -91.38 -23.94 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.686 -0.634 . . . . 0.0 110.393 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -29.78 17.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.897 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.82 -15.65 44.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.65 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.549 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -81.42 -10.24 59.55 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.907 -1.121 . . . . 0.0 108.211 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.539 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 4.0 mt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.356 0.598 . . . . 0.0 110.273 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.484 0.923 0 N-CA-C 110.622 -0.568 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.469 HG21 ' CG2' ' A' ' 53' ' ' VAL . 59.0 t -113.56 146.71 35.99 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.241 -0.912 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 43.8 Cg_endo -86.97 -168.46 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.632 1.333 . . . . 0.0 109.472 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.425 ' HG3' ' C ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -124.88 15.21 8.6 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.004 -1.06 . . . . 0.0 111.361 -179.138 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.416 ' N ' HD21 ' A' ' 56' ' ' LEU . 29.8 t . . . . . 0 N--CA 1.495 1.801 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.565 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' B' ' 112' ' ' ARG . 6.0 t-20 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.54 ' HB2' ' CD ' ' A' ' 37' ' ' LYS . 50.6 Cg_endo -68.52 8.27 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.259 1.972 . . . . 0.0 112.573 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 2.0 m-85 -102.88 -67.49 0.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.545 -1.347 . . . . 0.0 108.577 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.5 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 2.0 mtt-85 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.121 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.2 t90 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.336 0.589 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -41.63 -32.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 110.298 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.634 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 69.9 t -102.99 136.92 33.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 109.598 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mtmt -88.42 175.09 4.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 110.24 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.5 Cg_endo -70.21 -34.37 13.19 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.975 1.513 . . . . 0.0 109.745 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -77.08 -22.44 52.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.743 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 3.1 m-20 -82.93 -36.78 24.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.81 . . . . 0.0 109.132 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.551 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -80.5 -24.51 39.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.78 91.12 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.583 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.0 ptpt -74.71 -28.67 60.9 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.4 m-30 -70.58 -36.71 73.72 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -63.8 -20.48 65.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.71 -0.619 . . . . 0.0 110.15 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.63 -36.1 33.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.452 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 47.8 mt -78.43 -31.43 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.48 -32.53 68.37 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -87.49 -5.61 58.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.579 -0.7 . . . . 0.0 109.859 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -85.46 -8.49 58.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 0.0 109.085 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 25' ' ' SER . 7.2 mt -100.4 -16.87 17.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.627 -0.671 . . . . 0.0 109.316 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.5 t 88.74 89.03 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 121.358 0.599 . . . . 0.0 109.877 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.7 Cg_endo -73.33 151.37 48.33 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.552 1.817 . . . . 0.0 110.854 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 55.9 t -121.3 104.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.89 18.09 11.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.439 -0.788 . . . . 0.0 109.413 -178.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.85 34.16 6.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.18 137.82 32.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 112.017 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 7.9 mt -110.3 158.5 18.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 35' ' ' LYS . 8.2 p -104.07 143.79 32.43 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.602 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.76 -25.78 0.65 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -70.85 -25.24 62.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.571 -0.958 . . . . 0.0 110.314 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 35.1 mttm -88.56 -36.01 16.6 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 40' ' ' LEU . 81.2 t -77.22 -41.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.08 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.51 -51.65 6.48 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.518 -0.739 . . . . 0.0 111.026 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.9 Cg_endo -70.62 -34.27 12.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.369 1.194 . . . . 0.0 109.878 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.565 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.51 -32.56 53.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.653 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 23.7 mt -90.56 -29.34 17.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.587 -0.696 . . . . 0.0 109.977 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.489 HD12 ' HE2' ' A' ' 37' ' ' LYS . 33.5 mt -69.75 -9.55 54.93 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -90.65 -8.68 49.37 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.565 -0.71 . . . . 0.0 111.173 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.535 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 84.5 p -82.18 15.36 2.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -0.976 . . . . 0.0 110.652 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.18 14.03 3.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -0.99 . . . . 0.0 110.197 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' CB ' ' A' ' 80' ' ' ALA . 17.5 mt -98.16 157.89 33.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.977 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.0 Cg_endo -74.88 166.71 28.67 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 124.067 1.562 . . . . 0.0 109.228 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 47' ' ' VAL . 13.9 t -68.26 -6.97 6.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -30.0 58.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.876 -1.14 . . . . 0.0 109.143 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.551 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.5 mm -83.81 -40.06 15.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 10.2 mt -71.02 -30.6 66.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' B' ' 109' ' ' ASN . . . -72.18 -26.22 72.73 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 2.3 ttm-85 -100.12 -28.41 13.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.825 -0.809 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.541 ' CG2' HG23 ' A' ' 86' ' ' VAL . 10.3 t -74.18 -34.7 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.602 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.1 t-105 -66.74 -53.05 37.4 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.131 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.6 mt-10 -48.65 -58.36 4.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 2.7 mt -62.65 -13.09 27.83 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.069 -1.053 . . . . 0.0 108.773 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -91.81 -42.72 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.255 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' TRP . 11.6 t0 -66.04 78.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.492 -0.755 . . . . 0.0 110.395 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.488 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 42.8 mm -51.47 -27.72 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.41 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.496 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 2.4 m-20 -102.84 -20.18 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.29 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.496 ' CD2' ' C ' ' A' ' 60' ' ' ASP . 9.1 m-70 59.89 47.1 10.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 33.4 p-10 -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.063 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.455 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 86.45 28.9 26.02 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.521 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.1 mtt -150.24 161.44 42.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 111.09 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.548 ' CD1' HG13 ' A' ' 36' ' ' VAL . 7.6 mt -130.99 109.72 10.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.842 . . . . 0.0 110.072 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 1.8 m-20 -69.8 159.34 33.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.981 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.583 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -41.21 -42.19 2.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.503 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 57.8 t0 -82.4 -33.3 28.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.5 tt0 -69.11 -50.46 47.89 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.171 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.572 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 57.3 t80 -55.93 -22.84 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -67.17 -48.67 67.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.455 -0.778 . . . . 0.0 110.055 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.579 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 76.9 t -58.27 -24.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.528 -0.732 . . . . 0.0 110.132 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -84.86 -13.36 51.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.246 -0.909 . . . . 0.0 112.166 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 9.2 mmm -85.92 -36.07 20.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.545 -1.347 . . . . 0.0 110.732 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.634 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 5.0 p90 -79.08 -26.3 43.02 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.611 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.8 mt -71.72 -22.33 61.65 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.562 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 72.6 t -90.82 -32.89 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.639 -0.663 . . . . 0.0 110.142 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -78.36 -23.24 47.02 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.441 -0.787 . . . . 0.0 110.045 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -83.02 -13.79 55.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.639 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.567 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -87.49 -14.18 41.09 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.189 -0.944 . . . . 0.0 109.125 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 9.6 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.602 -0.686 . . . . 0.0 110.844 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.484 0.953 0 N-CA-C 110.428 -0.643 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.541 HG23 ' CG2' ' A' ' 53' ' ' VAL . 84.8 t -115.07 122.18 33.86 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 111.024 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.533 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 51.1 Cg_endo -81.55 -167.09 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.964 1.507 . . . . 0.0 109.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.541 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 14.7 mtp -120.04 18.66 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.02 . . . . 0.0 110.338 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--N 1.295 -1.766 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.79 -177.247 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLY . 35.1 t-20 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.911 0.386 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.535 ' HD2' ' CE1' ' B' ' 111' ' ' PHE . 49.5 Cg_endo -69.54 3.04 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.32 1.695 . . . . 0.0 111.77 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.653 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -104.16 -62.92 1.25 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.776 -1.202 . . . . 0.0 108.903 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.168 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.586 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.7 t90 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.191 0.52 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.44 -26.36 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.293 -0.879 . . . . 0.0 110.207 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.593 HG22 ' CD2' ' A' ' 75' ' ' PHE . 76.4 t -102.7 137.97 28.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.45 -0.781 . . . . 0.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.501 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 5.5 mttt -110.71 176.04 1.67 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.411 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 39.6 Cg_endo -65.53 -38.13 26.66 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.94 1.495 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 12.4 pt-20 -67.94 -36.43 80.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.045 -1.035 . . . . 0.0 109.172 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -81.21 -37.8 28.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 10' ' ' LYS . 3.4 tttt -76.17 -17.05 59.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 11' ' ' PRO . . . -71.85 -40.87 68.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.598 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -75.69 -26.61 57.74 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -71.15 -34.32 70.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -21.67 64.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.662 -0.649 . . . . 0.0 110.265 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -80.6 -36.2 33.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.052 -1.03 . . . . 0.0 108.414 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 69.9 mt -76.94 -30.93 18.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.545 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.85 -39.66 63.83 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t70 -86.45 2.57 47.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.558 -0.714 . . . . 0.0 110.096 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 3.1 m -89.53 -11.5 42.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.329 -0.857 . . . . 0.0 109.333 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 25' ' ' SER . 6.4 mt -99.83 -15.14 18.51 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.608 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 t 86.01 81.68 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.299 0 CA-C-O 121.439 0.638 . . . . 0.0 109.674 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.545 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 44.6 Cg_endo -71.06 152.57 62.66 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.87 1.984 . . . . 0.0 111.103 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.1 t -118.92 117.22 53.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER 63.78 13.06 7.17 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.579 -178.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.51 34.1 8.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 23.1 m-85 -135.36 138.36 43.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -1.11 . . . . 0.0 111.647 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.596 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.1 mt -109.49 137.57 47.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 34' ' ' ASP . 3.9 p -85.06 142.28 29.67 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.105 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.31 -25.81 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . 32.8 t70 -69.18 -24.28 64.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.384 -1.069 . . . . 0.0 110.326 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 9.6 mttm -92.53 -35.35 13.64 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.018 -1.051 . . . . 0.0 108.17 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.572 HG23 ' CE2' ' A' ' 70' ' ' PHE . 96.3 t -75.32 -41.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.566 0.698 . . . . 0.0 110.403 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.79 -54.92 6.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 111.035 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.12 -32.48 34.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.443 1.233 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 3.3 t -63.84 -33.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.661 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 26.1 mt -89.92 -27.25 19.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 110.461 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.438 HD12 ' HG3' ' A' ' 37' ' ' LYS . 45.3 mt -68.26 -15.04 63.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -90.76 -2.45 57.8 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.708 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.469 ' HB2' HD13 ' A' ' 81' ' ' LEU . 79.6 p -82.65 12.67 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.591 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 63.57 10.55 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.536 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 16.8 mt -100.46 159.11 30.59 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.391 -0.818 . . . . 0.0 110.486 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.1 Cg_endo -76.39 171.77 17.47 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.113 1.586 . . . . 0.0 109.415 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 4.5 t -71.92 -3.49 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.526 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.45 -30.87 42.34 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.156 -0.965 . . . . 0.0 109.097 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.559 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.8 mm -84.1 -39.6 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 12.8 mt -72.2 -26.44 62.05 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.548 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -74.53 -26.54 67.43 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.109 -1.997 . . . . 0.0 108.109 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 86' ' ' VAL . 1.5 ttm180 -100.7 -25.47 14.13 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.92 -0.753 . . . . 0.0 110.215 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 77' ' ' VAL . 13.6 t -74.27 -36.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.917 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.79 -48.17 67.06 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.15 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.3 mm-40 -52.55 -58.18 7.58 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 110.089 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 3.5 mt -62.85 -17.57 61.64 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.481 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.523 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 30.1 t -86.08 -30.59 22.48 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.4 t0 -71.12 101.36 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.543 -0.723 . . . . 0.0 109.683 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.471 HG23 HD13 ' A' ' 59' ' ' ILE . 47.8 mm -75.63 -42.4 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.613 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 31.2 p30 -104.41 -4.69 22.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.062 -1.024 . . . . 0.0 111.044 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 38.0 m170 60.86 44.4 10.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.171 -0.955 . . . . 0.0 110.541 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 38.1 p30 -100.05 26.51 6.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.237 -0.914 . . . . 0.0 109.059 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 58.53 31.69 67.41 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.8 mtt -150.91 161.04 43.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -1.05 . . . . 0.0 110.357 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.579 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 16.0 mt -123.6 102.29 7.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.538 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -69.29 157.51 36.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 14.2 ptt180 -37.06 -39.39 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.676 . . . . 0.0 110.81 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -79.51 -35.0 40.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 109.928 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 14.5 mt-10 -75.4 -40.95 57.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 31' ' ' LEU . 27.0 t80 -62.62 -23.88 67.3 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.87 -44.79 63.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.465 -0.772 . . . . 0.0 110.13 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.439 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 85.7 t -64.28 -22.16 30.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.022 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.526 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -89.81 -5.66 56.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmt -87.94 -44.44 11.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.828 -1.17 . . . . 0.0 109.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CD2' HG22 ' A' ' 9' ' ' VAL . 2.3 p90 -75.55 -26.64 58.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 12.0 mt -67.53 -28.05 67.49 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.565 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 27.2 t -92.24 -60.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.411 0.624 . . . . 0.0 109.817 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -46.62 -27.33 1.12 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.536 -0.727 . . . . 0.0 111.391 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 56.9 m -81.61 -12.08 58.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 110.088 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.536 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -90.22 -12.53 37.78 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.392 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.4 mp . . . . . 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.516 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.484 0.965 0 N-CA-C 110.163 -0.745 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.5 t -113.3 119.25 42.49 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.532 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.556 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 50.6 Cg_endo -85.34 -168.99 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.924 1.486 . . . . 0.0 109.81 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.476 ' HE1' ' HG3' ' A' ' 52' ' ' ARG . 18.8 mtt -111.83 18.1 19.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.496 ' N ' HD22 ' A' ' 56' ' ' LEU . 3.0 m . . . . . 0 C--N 1.293 -1.87 0 C-N-CA 118.898 -1.121 . . . . 0.0 112.823 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.7 t-20 . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.5 Cg_endo -70.99 1.08 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.939 1.494 . . . . 0.0 112.015 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -105.67 -59.79 1.72 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.658 -1.276 . . . . 0.0 109.21 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.456 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.577 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.8 t90 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.351 0.596 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.26 -27.18 2.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.577 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 40.7 t -94.43 149.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.829 . . . . 0.0 110.312 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.552 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -104.24 170.22 6.35 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.511 -0.743 . . . . 0.0 109.731 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.15 -34.45 28.18 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.59 1.311 . . . . 0.0 109.926 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 2.1 pm0 -74.62 -25.67 59.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.917 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.507 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -81.37 -40.27 23.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 108.566 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -13.07 62.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.6 mtmt -84.54 -37.93 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 5.8 m-30 -64.22 -23.38 67.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.93 -23.66 26.88 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.816 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.2 34.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.523 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 23.7 mt -79.46 -32.04 14.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -72.79 -40.15 66.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 2.2 t70 -85.85 1.19 50.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.652 -0.655 . . . . 0.0 109.79 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.447 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -92.91 -4.94 51.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.086 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -107.32 -6.98 16.87 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 82.76 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.8 Cg_endo -73.07 149.94 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.08 1.569 . . . . 0.0 110.998 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 54.3 t -117.62 103.47 14.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 66.03 13.26 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.212 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 99.53 32.12 5.84 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 87.7 m-85 -143.09 153.91 43.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.271 . . . . 0.0 111.7 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.3 mt -119.78 137.15 54.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 17.7 p -80.8 142.58 33.58 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.051 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.566 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.66 -27.05 0.3 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -66.11 -27.28 67.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -1.023 . . . . 0.0 110.457 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 51.7 mttp -92.3 -33.24 14.7 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.041 -1.037 . . . . 0.0 108.299 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 40' ' ' LEU . 60.4 t -82.32 -45.07 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.7 tttt -43.96 -52.78 14.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.763 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.1 Cg_endo -65.51 -33.72 45.34 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.39 1.205 . . . . 0.0 109.48 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.533 HG22 HD12 ' A' ' 24' ' ' LEU . 2.1 t -64.56 -38.39 82.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.61 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 59.3 mt -81.98 -30.06 31.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 42.7 mt -73.43 -13.92 61.16 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -88.55 -8.97 53.87 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.929 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.549 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 4.3 p -80.07 9.46 5.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.254 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 67.34 12.93 9.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.529 HD12 ' CG2' ' A' ' 49' ' ' ILE . 17.0 mt -98.01 153.41 38.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 110.04 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.4 Cg_endo -75.01 171.84 17.54 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 123.994 1.523 . . . . 0.0 109.313 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.48 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.03 -6.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 109.467 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -77.53 -31.01 53.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.863 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.552 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.6 mm -85.32 -41.17 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 15.2 mt -73.71 -28.79 61.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.22 -23.61 74.78 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.2 ttm180 -101.06 -37.94 8.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.933 -0.745 . . . . 0.0 109.552 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.49 HG12 ' CG2' ' A' ' 77' ' ' VAL . 21.1 t -64.06 -39.79 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.631 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.566 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.6 t-105 -67.13 -51.38 54.72 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.463 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 56.1 mt-10 -53.24 -56.46 16.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -61.33 -15.15 32.95 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.536 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 16.1 m -93.59 -33.97 13.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.522 -0.737 . . . . 0.0 109.527 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -67.72 69.1 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.452 -0.78 . . . . 0.0 110.056 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.483 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -50.56 -30.33 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -106.71 -15.3 14.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.878 . . . . 0.0 109.889 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 93.1 m-70 57.31 45.72 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.362 -0.836 . . . . 0.0 111.66 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.6 p-10 -107.21 28.91 7.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.403 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 66.25 25.93 72.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 12.8 mtp -151.06 161.37 42.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 110.199 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.522 ' CD1' HG12 ' A' ' 36' ' ' VAL . 8.6 mt -122.03 110.31 15.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.863 . . . . 0.0 109.798 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.58 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 6.3 t0 -68.71 163.96 22.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.561 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -49.27 -30.38 7.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.182 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -86.83 -33.56 19.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 42.4 mt-10 -75.59 -43.79 46.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.5 t80 -54.39 -34.0 60.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -59.21 -57.29 13.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.57 0.7 . . . . 0.0 110.253 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 76' ' ' LEU . 44.9 t -52.23 -22.8 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -89.15 -10.22 48.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.3 mmm -89.41 -44.3 10.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.472 -1.393 . . . . 0.0 110.608 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 2.9 p90 -76.04 -19.4 58.67 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.466 ' HB3' HG23 ' A' ' 53' ' ' VAL . 6.2 mt -79.33 -25.5 42.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.549 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 17.6 t -91.11 -41.8 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.68 -25.67 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.423 -0.798 . . . . 0.0 110.266 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.2 m -80.1 -14.8 58.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.517 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -88.67 -10.09 49.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.143 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.567 ' N ' HD21 ' A' ' 81' ' ' LEU . 4.5 mt . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.482 0.851 0 N-CA-C 109.42 -1.031 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 31.2 t -128.49 121.32 21.25 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.957 -1.089 . . . . 0.0 111.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.505 ' O ' HD13 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -85.53 166.64 10.44 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.86 1.453 . . . . 0.0 109.086 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.55 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 6.6 mtp -90.36 14.25 13.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.921 -1.112 . . . . 0.0 110.477 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.298 -1.673 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.439 -179.039 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' B' ' 111' ' ' PHE . 27.1 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.709 0.29 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -76.41 12.57 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.488 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.61 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 9.8 m-85 -107.27 -61.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.798 -1.189 . . . . 0.0 109.08 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.056 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.575 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.5 t90 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -40.14 -27.97 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.34 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.575 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 25.5 t -97.98 126.17 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 109.757 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.8 mttp -82.12 173.66 7.27 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 110.45 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.2 Cg_endo -68.31 -33.96 22.49 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.091 1.574 . . . . 0.0 109.387 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.01 -18.95 48.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.546 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.82 -43.19 15.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.91 61.59 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.09 61.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.47 -23.52 50.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD2' ' HB2' ' A' ' 74' ' ' MET . 9.9 m-30 -74.98 -33.96 61.94 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.98 -22.27 63.16 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.734 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -78.23 -32.97 50.04 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.509 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 44.7 mt -81.55 -32.7 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.548 ' HB2' ' CG ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -73.36 -31.58 64.02 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.6 t0 -90.83 -3.22 57.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 71.6 p -87.84 -8.51 55.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.624 ' O ' ' CB ' ' A' ' 25' ' ' SER . 8.5 mt -98.81 -14.88 19.48 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.624 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 p 94.52 91.41 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.296 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.4 Cg_endo -72.73 147.27 44.63 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.194 1.628 . . . . 0.0 110.638 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 77.1 t -115.22 100.27 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 64.47 15.26 9.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 109.69 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.24 32.53 5.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 75.5 m-85 -145.63 148.75 33.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.17 . . . . 0.0 111.59 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 10.2 mt -115.0 159.03 21.26 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 35' ' ' LYS . 86.4 p -104.52 143.8 32.55 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.031 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.7 -25.32 0.86 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' SER . 1.6 t70 -71.67 -23.69 61.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.954 . . . . 0.0 110.354 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.3 mttp -92.36 -33.06 14.73 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.011 -1.055 . . . . 0.0 108.257 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.535 HG13 ' CD1' ' A' ' 40' ' ' LEU . 89.2 t -77.54 -38.42 26.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.296 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -42.54 -54.5 8.1 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -65.81 -32.62 45.88 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.622 1.327 . . . . 0.0 109.56 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.591 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.53 -31.97 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.654 ' CD1' ' CZ ' ' B' ' 111' ' ' PHE . 27.2 mt -92.91 -30.48 15.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.496 -0.753 . . . . 0.0 110.269 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 57.5 mt -72.39 -12.11 60.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -90.79 -9.63 45.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.417 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.52 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 92.2 p -81.32 11.0 4.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.363 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.59 14.75 9.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD11 ' CB ' ' A' ' 80' ' ' ALA . 14.4 mt -96.76 154.35 38.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.828 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.0 Cg_endo -75.38 169.26 22.81 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.939 1.494 . . . . 0.0 109.072 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.462 HG13 ' O ' ' B' ' 111' ' ' PHE . 2.1 t -69.87 -3.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.965 -1.085 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.63 -27.77 40.96 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.161 -0.962 . . . . 0.0 109.235 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.548 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.3 mm -87.81 -36.94 10.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 9.5 mt -76.23 -27.19 56.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -74.08 -25.84 70.19 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 1.7 ttm-85 -101.19 -31.19 11.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.048 -0.678 . . . . 0.0 110.242 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' ILE . 13.1 t -70.5 -34.27 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.044 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.623 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 5.1 t-105 -68.17 -56.78 7.51 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.262 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 3.4 mm-40 -43.17 -64.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.35 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 mt -55.6 -20.01 12.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.952 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 57.8 m -91.61 -19.84 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.479 -0.763 . . . . 0.0 109.403 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.9 t0 -96.1 86.19 4.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.512 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -91.05 -13.93 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.63 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 11.1 m-20 -92.36 -12.65 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 5.2 m170 56.8 47.11 18.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 110.648 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 21.9 p-10 -128.12 25.47 5.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.17 38.44 93.15 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.493 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 6.7 mtt -150.37 161.08 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -1.162 . . . . 0.0 111.981 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.596 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 13.9 mt -125.45 103.69 8.03 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.41 160.4 32.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.997 -1.065 . . . . 0.0 110.682 -179.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.437 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ptm180 -36.48 -44.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.774 -0.579 . . . . 0.0 111.392 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 t70 -79.53 -31.93 42.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.662 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.465 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 28.0 mt-10 -76.03 -45.38 34.69 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.079 -1.013 . . . . 0.0 109.134 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.6 t80 -58.19 -18.47 26.17 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.29 -45.82 37.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.444 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.78 -26.12 34.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 109.538 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.79 -5.61 55.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 111.193 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.596 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.2 mmt -84.43 -49.53 8.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.923 -1.111 . . . . 0.0 109.839 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.1 p90 -73.79 -28.26 61.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.593 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.1 mt -64.54 -28.23 69.5 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.527 ' CG2' ' CD2' ' A' ' 40' ' ' LEU . 45.8 t -91.25 -23.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.828 -0.545 . . . . 0.0 110.591 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.4 -23.22 23.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -0.972 . . . . 0.0 109.802 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.3 m -84.12 -12.85 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.537 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -87.86 -14.31 39.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.7 mt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.853 0.835 . . . . 0.0 109.188 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.48 0.729 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.508 ' CG1' HG22 ' A' ' 53' ' ' VAL . 95.7 t -111.91 129.09 24.56 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.2 -0.938 . . . . 0.0 110.015 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.541 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 46.6 Cg_endo -90.16 -161.73 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.763 1.402 . . . . 0.0 109.642 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.531 ' HG2' ' NH1' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -130.19 3.08 4.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.49 -0.756 . . . . 0.0 109.566 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--N 1.296 -1.723 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.597 -177.845 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.533 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.648 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 41.7 Cg_endo -72.38 -2.42 11.69 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.168 1.088 . . . . 0.0 109.922 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.654 ' CZ ' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.5 -66.72 0.99 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.911 -1.118 . . . . 0.0 108.792 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.261 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.573 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.271 0.558 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -47.74 -27.66 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 111.126 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 53.7 t -91.76 147.19 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 9.3 mttm -104.06 176.32 1.83 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.548 -0.72 . . . . 0.0 109.788 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.7 Cg_endo -67.89 -35.44 20.91 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.769 1.405 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.3 pt-20 -74.75 -29.08 61.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.519 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 35.3 m-20 -82.2 -33.14 29.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.296 -0.878 . . . . 0.0 109.07 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.461 ' O ' ' HD3' ' A' ' 14' ' ' LYS . 1.1 tmtt? -78.17 -13.21 59.95 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.199 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -79.29 -41.98 26.85 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.82 -26.2 61.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -73.32 -35.52 66.08 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.74 -23.56 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.831 -0.543 . . . . 0.0 109.765 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -79.14 -34.88 42.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.0 mt -79.35 -31.55 14.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.94 -36.71 59.26 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -90.4 3.98 52.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 0.0 109.609 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -91.9 -9.35 43.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 108.967 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.6 mt -104.8 -8.05 19.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 87.2 99.89 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.043 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 47.2 Cg_endo -70.68 146.72 55.25 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.453 1.765 . . . . 0.0 110.425 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.3 t -115.7 96.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.47 20.45 12.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 94.14 33.84 6.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 85.4 m-85 -150.24 145.69 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -1.191 . . . . 0.0 111.737 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.9 mt -112.8 149.22 33.36 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.518 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 24.8 p -99.22 144.86 27.86 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.182 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -40.96 -27.52 0.19 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.2 m-20 -65.38 -23.97 67.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -1.079 . . . . 0.0 110.407 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 25' ' ' SER . 69.8 mttt -99.22 -31.8 11.54 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.077 -1.014 . . . . 0.0 108.941 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.577 HG21 ' CE2' ' A' ' 70' ' ' PHE . 95.2 t -79.72 -42.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -42.0 -55.0 6.65 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.848 . . . . 0.0 110.868 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.84 -32.83 35.54 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.494 1.26 . . . . 0.0 109.866 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.489 ' CG2' HD22 ' A' ' 24' ' ' LEU . 3.6 t -65.22 -28.96 45.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 38.0 mt -92.95 -26.21 17.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.52 -0.737 . . . . 0.0 110.342 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 74.2 mt -73.5 -9.09 58.33 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.193 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.22 -4.13 57.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.944 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.576 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -84.65 10.38 11.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.1 -1.0 . . . . 0.0 110.283 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.9 OUTLIER 66.85 7.62 5.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 109.979 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 46' ' ' PRO . 13.9 mt -94.58 157.12 37.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.9 Cg_endo -77.0 176.4 10.18 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.079 1.568 . . . . 0.0 109.841 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.507 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.3 t -73.25 -4.44 5.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.14 -29.89 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.924 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.5 mm -86.37 -40.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 19.5 mt -76.3 -28.32 56.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -70.12 -25.16 75.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.535 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.3 ttm105 -101.46 -34.09 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.117 -0.637 . . . . 0.0 110.043 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' ILE . 24.5 t -67.37 -36.01 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.92 -1.113 . . . . 0.0 108.889 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.568 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.9 t-105 -66.82 -53.57 31.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.16 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 8.2 mt-10 -47.27 -58.04 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.126 -0.984 . . . . 0.0 110.396 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 87' ' ' PRO . 2.3 mt -63.04 -12.66 27.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.049 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 47.0 m -94.97 -40.43 9.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 61.9 t0 -84.36 70.84 10.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 110.01 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mt -61.04 -16.5 14.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 110.492 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 26.1 m-20 -91.98 -15.53 27.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.68 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 88.0 m-70 51.27 34.19 11.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.2 p-10 -103.03 4.68 37.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.993 . . . . 0.0 110.042 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.505 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 86.89 26.62 31.24 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.2 mmm -148.3 161.65 41.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.217 -1.167 . . . . 0.0 110.036 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 36' ' ' VAL . 12.1 mt -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.301 -0.874 . . . . 0.0 109.657 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.579 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 21.7 t0 -69.07 167.11 16.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.268 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 6.7 ptm180 -49.86 -39.23 38.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -35.49 38.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 109.448 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 57' ' ' SER . 40.3 mt-10 -72.56 -47.04 51.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 109.166 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.577 ' CE2' HG21 ' A' ' 36' ' ' VAL . 26.2 t80 -57.86 -26.79 62.55 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.491 -0.756 . . . . 0.0 109.028 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -68.47 -48.53 64.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.881 . . . . 0.0 110.115 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.443 ' O ' HD12 ' A' ' 76' ' ' LEU . 60.7 t -58.34 -22.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.688 -0.633 . . . . 0.0 109.847 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -88.5 -12.49 42.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.747 . . . . 0.0 111.96 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.7 mmm -85.6 -40.36 16.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.656 -1.277 . . . . 0.0 110.472 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.504 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.3 p90 -77.9 -25.19 48.34 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.788 -1.165 . . . . 0.0 107.894 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 4.6 mt -73.19 -20.13 60.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.544 0.688 . . . . 0.0 109.212 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.576 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 42.2 t -91.59 -49.82 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.849 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.565 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 3.4 m-85 -64.16 -41.07 97.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.471 -0.768 . . . . 0.0 110.711 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 59.9 m -80.67 -9.16 59.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.399 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 76' ' ' LEU . . . -92.97 -31.93 14.72 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.129 0.966 . . . . 0.0 109.136 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' CD2' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.591 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.638 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 N--CA 1.482 0.849 0 N-CA-C 110.458 -0.632 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 80.0 t -121.09 126.01 26.77 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.477 ' O ' HD13 ' A' ' 56' ' ' LEU . 48.9 Cg_endo -85.16 152.96 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.846 1.446 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.535 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 24.8 mtm -88.13 17.58 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--N 1.294 -1.81 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.836 -178.475 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.466 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 16.6 t-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.993 0.425 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.566 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 51.2 Cg_endo -71.62 5.54 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.165 1.613 . . . . 0.0 112.01 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 6.9 m-85 -101.66 -62.83 1.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.658 -1.276 . . . . 0.0 109.167 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.362 179.685 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.572 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.304 0.573 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.58 -28.06 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.97 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.7 t -97.42 152.6 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 110.045 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.0 mmmt -105.9 171.81 4.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.923 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.9 Cg_endo -67.61 -35.48 22.33 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.753 1.397 . . . . 0.0 109.46 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.21 -31.01 68.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -81.53 -33.72 31.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 10.9 tptp -74.76 -16.35 60.73 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.68 -38.65 47.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -78.52 -25.02 45.45 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.2 m-30 -75.33 -37.51 60.68 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 30.5 t70 -69.17 -18.58 63.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.653 -0.654 . . . . 0.0 109.655 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -83.08 -39.06 21.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 66.9 mt -75.14 -34.13 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -68.6 -41.17 79.96 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t70 -84.89 -0.64 54.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.587 -0.696 . . . . 0.0 109.905 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 36.7 t -86.49 -9.68 55.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.267 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.614 ' O ' ' CB ' ' A' ' 25' ' ' SER . 6.4 mt -100.75 -11.4 19.94 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.09 93.79 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 48.5 Cg_endo -74.25 151.06 43.07 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.385 1.729 . . . . 0.0 110.905 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -120.8 98.5 6.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 69.34 22.12 6.7 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.693 0.758 . . . . 0.0 109.207 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.85 37.43 7.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.559 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 71.9 m-85 -147.2 140.38 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -1.159 . . . . 0.0 111.766 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.6 mt -110.09 137.79 47.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.42 142.53 30.04 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.846 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.54 -25.87 0.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -70.01 -24.21 63.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.588 -0.948 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 39' ' ' VAL . 43.4 mttp -91.69 -35.12 14.36 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' CD1' ' A' ' 40' ' ' LEU . 90.8 t -79.68 -48.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.444 0.64 . . . . 0.0 110.296 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.6 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 9.0 tttp -38.94 -55.24 2.9 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.582 -0.699 . . . . 0.0 110.8 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.8 Cg_endo -66.18 -29.8 47.0 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.576 1.303 . . . . 0.0 110.025 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 24' ' ' LEU . 2.5 t -70.59 -31.74 47.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.522 -0.736 . . . . 0.0 109.07 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.64 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 32.9 mt -85.44 -28.63 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -0.822 . . . . 0.0 109.772 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 69.8 mt -69.63 -11.29 60.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.02 -5.01 57.09 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.556 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -81.97 14.52 2.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 110.144 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.73 15.34 1.56 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.812 -1.18 . . . . 0.0 109.847 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.572 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 14.0 mt -101.08 156.13 35.5 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.4 Cg_endo -73.61 160.74 43.54 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 123.803 1.422 . . . . 0.0 109.409 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 47' ' ' VAL . 38.2 t -63.26 -11.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.17 -0.957 . . . . 0.0 109.187 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -70.03 -29.73 66.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 108.815 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.547 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.1 mm -82.97 -42.47 17.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.961 0.886 . . . . 0.0 108.733 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.57 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 12.5 mt -71.72 -30.81 66.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.495 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -68.09 -25.05 74.59 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -101.82 -34.1 9.55 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.062 -0.669 . . . . 0.0 110.491 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.532 ' CG1' HG21 ' A' ' 77' ' ' VAL . 40.8 t -65.62 -38.13 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.156 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.4 t-105 -68.68 -50.73 48.73 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.462 -0.774 . . . . 0.0 110.412 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.0 mm-40 -51.04 -52.12 46.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.973 -1.079 . . . . 0.0 110.194 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 2.9 mt -64.69 -11.61 37.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.099 -1.0 . . . . 0.0 108.543 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.572 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 1.6 p -93.37 -46.7 7.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' CG ' ' HA ' ' A' ' 61' ' ' HIS . 3.5 t0 -59.56 78.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 110.308 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.514 HG22 HD13 ' A' ' 59' ' ' ILE . 43.8 mm -54.48 -27.1 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.24 -0.913 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 34.1 p30 -108.62 -13.66 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 85.1 m-70 58.63 47.33 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 10.9 p-10 -110.51 16.51 21.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.854 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 77.43 29.92 54.88 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.0 mtt -149.44 161.36 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -1.198 . . . . 0.0 110.636 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.537 ' CD2' ' OG ' ' A' ' 57' ' ' SER . 8.3 mt -127.84 107.0 9.49 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 5.0 t0 -69.58 162.61 27.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.583 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -46.63 -40.46 13.05 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.497 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 2.5 p30 -76.34 -42.04 46.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 109.856 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 30.8 mt-10 -66.27 -41.04 90.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.612 0.72 . . . . 0.0 109.059 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 47.1 t80 -63.49 -21.38 66.29 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 68' ' ' ASP . . . -71.93 -43.07 65.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.507 0.67 . . . . 0.0 109.689 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.29 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB1' ' CB ' ' A' ' 57' ' ' SER . . . -90.28 -2.13 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.483 -0.761 . . . . 0.0 111.176 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.56 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.8 mmt -88.39 -46.46 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 109.487 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 2.2 p90 -76.56 -19.1 58.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 53' ' ' VAL . 8.6 mt -77.13 -23.84 51.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.56 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 38.5 t -91.63 -46.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.654 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 1.4 m-85 -62.54 -28.89 70.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.536 -0.727 . . . . 0.0 111.514 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -82.26 -12.34 58.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.931 -1.106 . . . . 0.0 110.137 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.572 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -82.47 -19.62 38.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.733 0.778 . . . . 0.0 110.796 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 109.794 -0.887 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 76.0 t -110.78 119.62 45.73 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.135 -0.978 . . . . 0.0 110.63 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.508 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.8 Cg_endo -82.78 175.01 9.1 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.968 1.51 . . . . 0.0 109.009 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.487 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 2.6 mtm -99.14 12.89 34.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.502 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 18.5 m . . . . . 0 C--N 1.296 -1.745 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.398 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.45 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 14.7 t-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.567 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.0 Cg_endo -69.81 2.68 3.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.139 1.599 . . . . 0.0 111.913 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 2.4 m-85 -103.49 -54.89 2.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.703 -1.248 . . . . 0.0 109.371 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.319 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.474 ' CH2' ' HE2' ' A' ' 14' ' ' LYS . 11.2 t90 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.176 0.513 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.13 -26.97 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 110.826 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.69 146.57 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.1 mttt -99.17 169.98 7.47 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.614 -0.679 . . . . 0.0 109.785 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -66.57 -35.12 30.73 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.609 1.321 . . . . 0.0 109.609 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.669 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.4 m-20 -79.61 -41.51 26.9 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' HE2' ' CH2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -66.36 -16.16 63.85 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.736 0.779 . . . . 0.0 108.908 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.1 -37.91 57.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 3.1 mtmt -81.67 -40.32 23.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.4 m-30 -63.29 -23.61 67.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.3 t70 -85.54 -24.77 27.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.582 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.96 -32.4 39.9 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.574 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.0 mt -79.08 -35.24 17.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -70.06 -39.65 75.55 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.5 t0 -87.49 1.24 54.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 110.073 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 6.7 t -89.36 -7.03 56.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.0 109.069 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.618 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.6 mt -107.26 -13.06 15.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.39 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.6 Cg_endo -73.6 151.34 46.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.322 1.696 . . . . 0.0 110.975 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 48.4 t -116.58 115.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.0 t30 56.77 17.9 3.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 108.816 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 91.73 37.63 6.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 73.3 m-85 -149.7 138.11 20.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.111 -1.229 . . . . 0.0 112.449 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.3 mt -104.79 145.29 30.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.498 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 52.7 p -95.89 145.58 25.27 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 110.087 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -41.01 -27.57 0.2 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 79.1 m-20 -64.04 -26.17 68.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.386 -1.067 . . . . 0.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 49.3 mttm -96.84 -32.03 12.3 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.125 -0.984 . . . . 0.0 108.659 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG22 ' CE2' ' A' ' 70' ' ' PHE . 98.9 t -79.6 -43.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.551 -0.718 . . . . 0.0 110.73 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 15.2 tttt -43.18 -51.11 14.24 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 110.725 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -67.04 -32.02 35.63 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.213 1.112 . . . . 0.0 109.6 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.591 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.9 t -68.23 -29.94 46.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.636 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 50.5 mt -92.0 -32.34 15.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.491 -0.755 . . . . 0.0 110.867 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.535 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 22.9 mt -70.55 -14.0 62.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.062 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -90.39 -3.25 57.83 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.642 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.508 ' CB ' HG11 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.44 17.23 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.962 . . . . 0.0 110.299 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.87 11.77 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.658 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.576 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 18.9 mt -100.82 153.18 37.88 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.9 Cg_endo -76.53 173.68 14.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.036 1.545 . . . . 0.0 109.522 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 111' ' ' PHE . 2.1 t -73.09 -3.86 4.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.91 -1.119 . . . . 0.0 109.383 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -78.24 -29.79 48.36 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.563 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 11.1 mm -85.84 -39.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 15.4 mt -75.19 -29.05 60.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -67.41 -26.12 73.62 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -101.16 -35.09 9.43 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.005 -0.703 . . . . 0.0 109.85 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.529 ' CG1' HG23 ' A' ' 77' ' ' VAL . 41.3 t -64.57 -39.66 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.081 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -65.74 -52.79 48.25 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.067 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mm-40 -56.0 -58.66 6.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 5.0 mt -56.14 -19.22 12.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.913 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.53 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 13.5 t -91.93 -35.67 13.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.577 0.703 . . . . 0.0 109.683 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.566 ' OD2' ' CE2' ' A' ' 54' ' ' TRP . 1.6 t0 -65.56 95.54 0.22 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 110.157 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.536 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 10.5 mm -67.7 -32.01 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.46 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 2.4 p30 -112.2 -13.67 13.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 110.818 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.562 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 18.1 m-70 62.52 44.55 6.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.907 . . . . 0.0 110.472 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 64' ' ' MET . 57.4 p30 -95.98 5.87 50.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.527 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 85.31 22.76 50.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.527 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 4.0 mmm -148.47 161.55 41.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -1.144 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.6 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 13.8 mt -122.14 106.07 10.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.162 -0.961 . . . . 0.0 109.996 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.585 ' CB ' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -71.41 160.08 33.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.025 . . . . 0.0 110.232 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 25.7 ptt180 -39.66 -37.63 0.53 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.575 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 12.2 m-20 -83.07 -29.92 28.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -75.89 -47.93 23.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 20.6 t80 -61.71 -16.11 46.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.13 -50.21 13.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.395 -0.816 . . . . 0.0 109.842 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.461 ' O ' HD11 ' A' ' 76' ' ' LEU . 58.8 t -58.02 -28.73 34.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.523 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.53 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.15 -4.73 57.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 111.254 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.588 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 11.8 mmt -84.01 -47.6 10.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.979 -1.076 . . . . 0.0 110.121 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.574 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -75.08 -28.89 60.49 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.1 mt -67.1 -22.7 65.8 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 40' ' ' LEU . 49.4 t -91.5 -44.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.749 -0.594 . . . . 0.0 109.773 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.457 ' HA ' HD11 ' A' ' 81' ' ' LEU . 2.0 m-85 -70.93 -25.43 62.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.508 -0.745 . . . . 0.0 110.873 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 17.1 m -82.38 -21.44 35.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.966 -1.084 . . . . 0.0 109.286 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.576 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -77.69 -11.1 59.84 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 121.414 0.625 . . . . 0.0 110.568 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.485 1.001 0 N-CA-C 110.465 -0.629 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 53' ' ' VAL . 54.0 t -143.18 131.59 11.3 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.138 -0.976 . . . . 0.0 110.665 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.501 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.4 Cg_endo -89.45 -163.81 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.981 1.516 . . . . 0.0 109.51 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.467 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 -0.86 11.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.27 -0.894 . . . . 0.0 110.547 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.294 -1.827 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.176 -178.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.48 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 23.2 t-20 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.604 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.4 Cg_endo -72.35 1.39 6.17 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.843 1.443 . . . . 0.0 111.54 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 3.8 m-85 -101.19 -61.1 1.41 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.943 -1.098 . . . . 0.0 108.499 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.154 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.566 ' CH2' ' HG3' ' A' ' 14' ' ' LYS . 10.9 t90 . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.16 -25.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.505 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -96.31 146.98 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.951 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.8 mmtt -96.95 169.24 9.01 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.5 Cg_endo -69.95 -33.19 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.865 1.455 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.78 -27.38 31.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.496 -0.753 . . . . 0.0 109.548 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.59 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.1 m-20 -79.72 -30.46 40.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.566 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 2.9 tmtt? -81.9 -22.98 36.52 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.679 0.752 . . . . 0.0 109.112 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.56 85.46 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.9 -28.34 61.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -65.14 -36.14 83.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -22.39 64.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.673 -0.642 . . . . 0.0 109.847 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.69 -38.38 25.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 55.2 mt -76.09 -29.8 19.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' HB2' ' CD2' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -72.45 -39.36 67.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.495 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.8 t70 -87.19 2.09 51.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.306 0.574 . . . . 0.0 109.814 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -6.12 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.831 0.824 . . . . 0.0 109.178 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.607 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -107.07 -7.76 16.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.565 -0.709 . . . . 0.0 109.26 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.73 84.59 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.977 0 CA-C-O 121.269 0.556 . . . . 0.0 109.61 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 45.7 Cg_endo -74.58 150.4 40.3 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.536 1.808 . . . . 0.0 110.93 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.539 HG13 ' ND2' ' A' ' 28' ' ' ASN . 53.9 t -117.43 119.16 60.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.539 ' ND2' HG13 ' A' ' 27' ' ' VAL . 71.4 m-80 55.88 18.71 3.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.662 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.08 33.27 9.75 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 57.9 m-85 -137.73 137.25 38.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.854 -1.38 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.607 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.8 mt -108.5 138.22 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.458 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 20.8 p -86.0 144.37 27.64 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.177 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.603 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -45.64 -24.93 1.29 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 32' ' ' SER . 4.4 m-20 -70.95 -19.1 62.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.532 -0.981 . . . . 0.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 5.6 mttp -97.17 -34.97 10.93 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.579 HG23 ' CE1' ' A' ' 70' ' ' PHE . 98.0 t -77.35 -42.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.864 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.615 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.17 -53.98 6.17 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.576 -0.702 . . . . 0.0 110.729 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -68.39 -30.97 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.558 1.294 . . . . 0.0 110.078 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.496 ' CG2' HD13 ' A' ' 24' ' ' LEU . 2.6 t -66.38 -37.47 79.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.551 -0.718 . . . . 0.0 109.295 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 25.1 mt -83.01 -24.79 32.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.564 -0.71 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.11 -10.88 60.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.699 -0.801 . . . . 0.0 108.918 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -89.79 -7.12 55.12 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.523 -0.735 . . . . 0.0 110.224 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.467 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -78.07 7.82 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 0.0 110.284 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.91 10.78 7.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 109.358 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.578 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 16.1 mt -98.72 156.84 35.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.449 -0.782 . . . . 0.0 109.823 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.4 Cg_endo -75.98 172.1 16.9 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.121 1.59 . . . . 0.0 109.289 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.484 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.5 t -71.72 -5.03 5.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.967 -1.083 . . . . 0.0 108.951 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.34 -29.01 59.83 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.546 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.5 mm -87.4 -37.74 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.483 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 12.8 mt -79.39 -28.28 41.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.16 -24.99 75.6 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.533 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 6.7 ttm-85 -101.96 -33.78 9.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.109 -0.642 . . . . 0.0 110.014 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.522 ' CG2' HG23 ' A' ' 86' ' ' VAL . 8.7 t -70.9 -37.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.831 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.603 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.2 t-105 -63.64 -50.53 68.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.86 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.3 mt-10 -50.42 -55.1 17.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 109.925 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.51 -15.34 37.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 108.934 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.55 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 3.0 t -94.52 -41.47 9.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.537 -0.727 . . . . 0.0 109.513 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 t70 -75.92 95.02 3.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.617 -0.677 . . . . 0.0 110.72 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 3.7 mt -93.13 -16.2 7.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.13 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.7 m-20 -89.81 -5.04 57.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 109.552 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.5 p80 41.3 47.37 2.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.658 . . . . 0.0 110.941 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 28.3 p30 -129.05 26.4 5.49 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.218 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 59.37 42.12 97.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.471 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 2.6 mmt -149.35 161.22 42.49 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.318 -1.107 . . . . 0.0 111.514 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.535 HD11 ' CZ3' ' A' ' 54' ' ' TRP . 43.3 mt -137.65 107.09 6.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.648 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.0 p30 -76.58 161.58 28.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 110.454 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -34.55 -46.89 0.3 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.735 -0.603 . . . . 0.0 111.584 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.454 ' O ' ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -78.01 -37.66 46.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.226 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 57' ' ' SER . 12.7 tt0 -66.91 -44.44 80.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.632 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.581 ' CD1' HD12 ' A' ' 31' ' ' LEU . 37.7 t80 -60.46 -21.89 62.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.656 -0.652 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -75.16 -37.98 61.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 109.813 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 38.0 t -66.46 -26.66 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.684 0.754 . . . . 0.0 109.733 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.506 ' HB1' ' CB ' ' A' ' 57' ' ' SER . . . -90.39 -7.21 53.78 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 110.767 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.557 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.3 mmt -88.01 -47.45 8.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.922 -1.111 . . . . 0.0 110.256 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 2.2 p90 -75.98 -19.51 58.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.438 ' HB3' ' CG1' ' A' ' 53' ' ' VAL . 5.2 mt -74.27 -25.19 59.46 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.547 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 37.2 t -90.59 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.417 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.2 m-85 -45.53 -24.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.692 -0.63 . . . . 0.0 111.273 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.7 m -82.8 -18.84 39.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.964 -1.085 . . . . 0.0 110.009 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.578 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -86.43 -11.88 50.63 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.709 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.3 mp . . . . . 0 C--N 1.305 -1.362 0 CA-C-O 121.787 0.804 . . . . 0.0 108.871 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.485 1.029 0 N-CA-C 110.095 -0.771 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 53' ' ' VAL . 48.9 t -134.85 124.11 16.46 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.052 -1.03 . . . . 0.0 111.274 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.52 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 50.1 Cg_endo -85.06 174.31 7.34 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.919 1.484 . . . . 0.0 109.514 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.525 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 2.0 mtp -96.16 12.19 31.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 0.0 110.432 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.425 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 15.1 m . . . . . 0 C--N 1.296 -1.752 0 O-C-N 120.881 -1.137 . . . . 0.0 110.779 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.432 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 25.1 t-20 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.614 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.6 Cg_endo -74.17 7.59 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.866 1.456 . . . . 0.0 111.881 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 6.6 m-85 -107.14 -65.55 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.763 -1.21 . . . . 0.0 108.713 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.421 ' NH2' ' OE2' ' A' ' 55' ' ' GLU . 6.2 mtm180 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.289 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.0 t90 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 121.217 0.532 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.84 -26.16 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 43.9 t -101.19 151.03 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.237 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 31.5 mttt -111.67 169.37 6.4 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.324 -0.86 . . . . 0.0 109.792 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 37.5 Cg_endo -63.86 -35.26 57.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.616 1.324 . . . . 0.0 110.119 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -69.46 -30.03 67.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.387 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -82.35 -39.27 23.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.462 ' NZ ' ' OD1' ' A' ' 68' ' ' ASP . 14.8 tptm -72.28 -15.72 61.91 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.14 -39.65 54.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.03 -25.64 40.1 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.0 m-30 -72.27 -35.19 68.68 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.39 -20.23 62.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.837 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.89 -38.31 25.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.508 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 68.6 mt -76.2 -29.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -72.9 -36.68 67.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.5 t70 -90.45 0.86 57.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.728 -0.607 . . . . 0.0 110.186 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.0 t -88.77 -8.0 55.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.137 -0.977 . . . . 0.0 109.148 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.599 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.2 mt -106.76 -10.94 15.92 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 86.55 97.24 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.3 Cg_endo -74.02 149.69 42.09 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.214 1.639 . . . . 0.0 111.0 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 62.1 t -124.7 108.34 20.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 62.44 15.67 7.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.241 -179.035 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 92.51 38.04 5.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 81.5 m-85 -148.52 144.59 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 111.976 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.596 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.6 mt -112.14 131.13 55.63 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 1.6 m -80.23 147.04 31.4 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.582 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -44.94 -27.96 1.62 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 48.3 t0 -59.57 -25.37 64.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.89 . . . . 0.0 109.866 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 47.9 mttp -98.26 -36.42 10.03 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.573 ' CG1' ' CD1' ' A' ' 40' ' ' LEU . 95.1 t -77.17 -40.3 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.667 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -44.81 -50.51 24.97 Favored Pre-proline 0 N--CA 1.487 1.375 0 O-C-N 121.268 -0.895 . . . . 0.0 111.033 -178.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.2 Cg_endo -68.24 -33.25 24.83 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.089 1.047 . . . . 0.0 109.677 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.477 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.1 t -64.7 -35.94 76.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.612 -0.68 . . . . 0.0 109.705 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 17.8 mt -90.03 -30.67 17.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD11 ' CG ' ' A' ' 37' ' ' LYS . 53.8 mt -70.78 -10.69 60.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.874 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 1.2 t-20 -90.59 -9.94 45.21 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.444 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.477 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 83.5 p -80.58 11.25 3.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.871 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.04 11.21 4.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.944 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.538 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 13.3 mt -90.92 156.0 44.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.813 . . . . 0.0 109.663 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -76.62 169.28 22.11 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 O-C-N 123.907 1.478 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.552 HG13 ' CA ' ' B' ' 111' ' ' PHE . 42.1 t -70.6 -3.42 3.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.74 -32.97 35.46 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.57 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 14.3 mm -80.65 -42.42 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.65 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 14.3 mt -63.65 -32.03 73.38 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.075 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -72.25 -17.84 77.72 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -100.34 -31.28 11.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.843 -0.798 . . . . 0.0 110.138 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.56 ' CG1' HG21 ' A' ' 77' ' ' VAL . 32.3 t -75.87 -34.65 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.696 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.583 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 3.1 t-105 -70.82 -47.65 58.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.599 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' OE2' ' HB2' ' B' ' 109' ' ' ASN . 23.5 mm-40 -58.17 -57.25 13.69 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.019 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 5.8 mt -60.46 -16.53 37.34 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.354 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 73' ' ' ALA . 2.1 t -89.9 -34.52 16.04 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.661 0.743 . . . . 0.0 109.387 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.567 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -74.83 69.82 1.87 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.623 -0.673 . . . . 0.0 109.578 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 69' ' ' GLU . 42.2 mm -41.33 -32.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.493 -0.754 . . . . 0.0 110.406 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 3.0 p30 -108.38 -25.91 10.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 17.7 m-70 71.09 41.19 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 4.8 p-10 -90.69 -1.69 57.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 98.16 19.95 22.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtp -153.18 161.77 42.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -1.187 . . . . 0.0 110.341 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 36' ' ' VAL . 31.8 mt -118.73 107.79 14.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.099 -1.001 . . . . 0.0 110.662 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.76 165.07 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.04 . . . . 0.0 109.826 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -40.18 -43.53 1.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -78.44 -33.31 48.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.75 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 53.2 mt-10 -74.89 -42.95 56.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.45 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.553 ' CD2' HD12 ' A' ' 31' ' ' LEU . 36.7 t80 -63.12 -16.48 60.14 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.97 -44.36 22.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.462 ' O ' HD12 ' A' ' 76' ' ' LEU . 42.4 t -61.73 -26.42 39.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.708 0.766 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -89.55 -7.84 54.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.76 . . . . 0.0 111.187 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.559 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.5 mmt -84.95 -48.11 9.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.924 -1.11 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 3.6 p90 -75.33 -21.25 58.55 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.501 ' HB3' HG23 ' A' ' 53' ' ' VAL . 5.6 mt -76.37 -19.41 58.2 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 ' CG1' ' A' ' 53' ' ' VAL . 32.8 t -91.96 -41.86 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.569 -0.707 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -72.01 -22.54 61.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.837 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -81.58 -15.26 55.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.979 -1.075 . . . . 0.0 109.24 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.48 ' HB1' HG23 ' A' ' 86' ' ' VAL . . . -88.94 -10.89 46.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.459 -0.775 . . . . 0.0 109.077 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.9 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.787 . . . . 0.0 109.812 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.483 0.9 0 N-CA-C 109.652 -0.941 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG23 ' HB1' ' A' ' 80' ' ' ALA . 89.7 t -112.64 121.58 38.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.926 -1.109 . . . . 0.0 110.893 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 45.2 Cg_endo -90.13 -174.4 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.973 1.512 . . . . 0.0 109.289 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.475 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -117.76 10.29 13.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.073 -1.017 . . . . 0.0 110.295 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 C--N 1.293 -1.852 0 C-N-CA 119.246 -0.981 . . . . 0.0 111.66 -178.422 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' B' ' 112' ' ' ARG . 1.9 t-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.632 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.4 Cg_endo -71.49 -2.44 11.3 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.916 1.482 . . . . 0.0 111.028 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.65 ' CD2' ' HB3' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -116.16 -62.51 1.58 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.867 -1.146 . . . . 0.0 108.849 177.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.981 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.581 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.141 0.496 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -35.72 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.648 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 99.5 t -97.9 130.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.548 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -86.62 -179.13 1.29 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.729 -178.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.81 -36.3 8.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.014 1.534 . . . . 0.0 110.058 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.27 -22.78 57.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 51.6 m-20 -81.41 -36.94 28.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.062 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' CE ' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -73.78 -16.76 61.15 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.318 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -40.83 38.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.541 -0.724 . . . . 0.0 109.303 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.582 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.08 -26.69 60.52 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.8 m-30 -74.65 -32.06 62.14 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.07 -18.24 61.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.504 -0.748 . . . . 0.0 109.868 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -82.54 -36.67 26.11 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.542 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 12.3 mt -78.01 -28.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.556 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -76.36 -38.29 56.02 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.8 t70 -90.26 3.89 52.26 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.704 -0.623 . . . . 0.0 109.792 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -93.23 -3.48 53.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 108.631 178.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.24 -3.42 13.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 79.83 95.45 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 Cg_endo -71.37 152.33 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.308 1.688 . . . . 0.0 110.76 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 94.1 t -120.1 97.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 109.106 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 68.68 10.58 7.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.2 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 104.73 34.13 3.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 76.6 m-85 -150.89 149.88 30.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.468 -1.019 . . . . 0.0 111.886 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 18.1 mt -118.07 134.38 55.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -78.45 144.32 35.91 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.886 -1.125 . . . . 0.0 109.436 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -42.72 -28.33 0.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.0 m-20 -54.46 -25.14 23.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.44 -1.036 . . . . 0.0 109.506 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 1.1 mttp -104.38 -32.66 8.94 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.408 -0.807 . . . . 0.0 108.83 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.569 HG23 ' CE2' ' A' ' 70' ' ' PHE . 87.6 t -84.54 -44.76 17.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.683 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.6 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 15.4 tttt -43.99 -53.56 12.98 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 0.0 110.924 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.4 Cg_endo -67.19 -33.74 30.1 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.33 1.174 . . . . 0.0 109.467 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -63.38 -34.74 69.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.457 0.646 . . . . 0.0 109.389 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -85.92 -27.32 25.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 37' ' ' LYS . 58.0 mt -74.94 -10.89 59.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.225 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -89.56 -5.1 57.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.094 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.545 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.93 12.87 6.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.476 -0.765 . . . . 0.0 110.382 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 61.3 13.29 4.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.11 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.511 HD12 ' CB ' ' A' ' 80' ' ' ALA . 14.7 mt -97.91 154.53 37.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.663 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.61 172.34 16.4 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.071 1.564 . . . . 0.0 110.067 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.85 -6.04 6.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 109.072 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.63 -30.62 56.95 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.546 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.1 mm -88.02 -38.06 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 17.8 mt -77.17 -26.31 52.84 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.1 -27.38 72.09 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -101.47 -30.15 11.59 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 122.105 -0.644 . . . . 0.0 109.901 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 49' ' ' ILE . 22.3 t -71.25 -39.85 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.707 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 1.9 t-105 -64.27 -51.0 65.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.651 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.9 mm-40 -53.05 -57.54 10.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.322 -0.861 . . . . 0.0 109.847 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.418 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 13.8 mt -56.82 -21.07 26.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 108.94 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.506 ' CB ' HD21 ' A' ' 65' ' ' LEU . 69.7 m -89.48 -36.13 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 31.5 t0 -83.69 61.92 6.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.636 -0.665 . . . . 0.0 110.196 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.8 mt -59.5 -19.01 15.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.334 -0.853 . . . . 0.0 110.37 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 13.6 m-20 -91.74 -21.14 20.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.938 . . . . 0.0 109.637 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 2.2 m-70 61.27 33.74 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 110.745 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.43 -2.48 48.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.05 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 91.07 25.3 24.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.1 mtp -153.55 161.49 42.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.138 -1.213 . . . . 0.0 110.556 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 57' ' ' SER . 15.3 mt -117.84 110.84 18.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.324 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -70.99 172.39 9.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 110.562 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.556 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 3.5 ptp180 -51.15 -41.37 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.555 -0.715 . . . . 0.0 110.895 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.77 -36.31 37.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 57' ' ' SER . 45.8 mt-10 -72.13 -48.73 41.5 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.579 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 14.2 t80 -56.0 -26.27 47.91 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -67.75 -50.64 56.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 110.116 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.573 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 58.5 t -57.63 -22.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.744 . . . . 0.0 109.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.35 -5.34 56.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 111.425 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 3.5 mmm -89.98 -40.54 12.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.309 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.648 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 2.1 p90 -81.99 -22.77 36.38 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.848 -1.141 . . . . 0.0 108.339 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 4.4 mt -76.11 -23.33 54.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.545 ' CG1' ' OG ' ' A' ' 43' ' ' SER . 16.4 t -91.55 -47.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.533 -0.729 . . . . 0.0 109.722 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.57 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 m-85 -70.38 -35.29 73.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 110.417 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 75' ' ' PHE . 3.9 t -83.59 -8.6 59.28 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.511 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -92.18 -29.27 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.131 0.967 . . . . 0.0 109.208 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.57 ' CD2' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.655 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.759 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 N--CA 1.481 0.762 0 N-CA-C 110.283 -0.699 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.522 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 39.1 t -114.15 154.06 46.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 108.996 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.522 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 43.3 Cg_endo -86.13 -167.63 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.525 1.276 . . . . 0.0 109.877 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 mtt -122.25 11.12 10.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.02 -1.05 . . . . 0.0 111.541 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 120.677 -1.264 . . . . 0.0 111.609 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.982 0.42 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.496 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 46.0 Cg_endo -69.22 8.93 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.902 1.735 . . . . 0.0 112.344 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 13.5 m-85 -99.31 -49.74 4.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.505 -1.372 . . . . 0.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.939 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.554 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.7 t90 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.049 0.452 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.22 -27.61 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 109.741 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.554 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -95.56 130.79 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.794 . . . . 0.0 109.327 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -88.77 172.4 7.6 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.335 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -34.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.988 1.52 . . . . 0.0 109.946 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -78.33 -28.85 47.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.291 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.505 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 9.1 m-20 -81.05 -33.86 33.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.61 -17.92 57.31 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.177 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -37.48 61.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -76.91 -23.16 52.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 12.3 m-30 -77.55 -34.75 53.71 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.73 -20.2 62.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.893 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.04 33.4 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.484 ' CG2' HG12 ' A' ' 39' ' ' VAL . 73.5 mt -79.23 -30.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.562 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -72.79 -36.12 67.52 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 t70 -91.21 -3.23 57.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.447 -0.783 . . . . 0.0 110.034 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.9 t -82.17 -14.67 55.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 108.765 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 25' ' ' SER . 8.4 mt -94.09 -53.8 3.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 m 140.87 97.18 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.11 150.4 42.74 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 O-C-N 123.97 1.51 . . . . 0.0 110.643 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 84.4 t -119.8 84.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.316 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 72.73 3.96 4.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.563 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 123.31 29.46 1.2 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -149.89 151.76 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.277 . . . . 0.0 112.326 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.589 HD11 ' CE2' ' A' ' 70' ' ' PHE . 9.4 mt -120.47 154.16 35.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -98.14 141.49 31.0 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 120.754 -1.217 . . . . 0.0 109.715 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.594 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.79 -27.89 0.2 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.7 m-20 -67.63 -24.78 65.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.424 -1.045 . . . . 0.0 110.481 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 66.6 mttm -90.24 -36.75 14.55 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.584 HG23 ' CE2' ' A' ' 70' ' ' PHE . 93.3 t -72.76 -39.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.252 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -42.8 -54.95 7.94 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 111.264 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.7 Cg_endo -65.69 -30.64 50.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.699 1.368 . . . . 0.0 110.005 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.486 HG23 HD11 ' A' ' 24' ' ' LEU . 2.5 t -69.01 -28.71 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.51 -0.744 . . . . 0.0 109.064 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 27.1 mt -94.78 -31.49 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 0.0 110.176 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.0 mt -70.3 -9.93 57.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 27.2 p-10 -90.9 -7.69 51.46 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.993 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.556 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 p -81.4 14.13 2.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.716 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.81 10.71 5.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD13 ' CB ' ' A' ' 80' ' ' ALA . 14.3 mt -98.22 157.9 33.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.926 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.572 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.66 170.42 20.26 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.063 1.559 . . . . 0.0 109.569 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.515 HG12 ' O ' ' B' ' 111' ' ' PHE . 2.0 t -71.3 -3.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.125 -0.985 . . . . 0.0 109.37 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -78.14 -32.17 50.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.572 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.6 mm -81.67 -40.81 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -71.09 -30.79 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.528 ' CA ' ' OD1' ' B' ' 109' ' ' ASN . . . -67.68 -24.97 74.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -100.68 -35.06 9.61 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.906 -0.761 . . . . 0.0 109.868 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG1' ' CG2' ' A' ' 77' ' ' VAL . 23.8 t -65.87 -34.39 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.829 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.594 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.07 -55.03 10.53 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.43 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 1.7 mt-10 -48.0 -57.1 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.09 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 3.6 mt -63.32 -14.62 51.79 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.938 . . . . 0.0 108.96 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.516 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 11.0 t -93.09 -35.14 13.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' TRP . 22.5 t0 -74.84 99.94 3.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.718 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 14.6 mm -86.91 -23.82 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.24 -12.83 31.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 2.6 m170 55.61 47.66 20.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -0.944 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 42.8 p-10 -125.64 17.64 8.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.923 -1.111 . . . . 0.0 110.197 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 74.07 32.99 57.88 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.491 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.6 mtp -150.76 161.33 42.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -1.229 . . . . 0.0 111.071 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.508 ' CD2' ' OG ' ' A' ' 57' ' ' SER . 19.6 mt -133.15 107.31 8.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.544 -0.723 . . . . 0.0 109.432 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.62 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 32.9 p30 -78.73 175.13 10.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.75 -1.219 . . . . 0.0 110.378 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.46 -50.62 3.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 112.17 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 5.1 p-10 -72.55 -46.82 52.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.151 -0.968 . . . . 0.0 110.444 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 52.2 mt-10 -62.02 -54.67 38.25 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.533 -0.73 . . . . 0.0 109.229 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.589 ' CE2' HD11 ' A' ' 31' ' ' LEU . 12.2 t80 -49.83 -30.0 9.02 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -61.45 -55.54 30.15 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.79 0.805 . . . . 0.0 110.005 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 57' ' ' SER . 92.0 t -51.07 -28.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.488 0.661 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.98 -6.87 58.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 0.0 112.411 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.59 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.1 mmm -90.37 -43.36 10.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.268 -1.52 . . . . 0.0 110.569 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 2.2 p90 -76.05 -22.3 55.85 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.156 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.491 ' HB3' HG21 ' A' ' 53' ' ' VAL . 6.3 mt -72.61 -30.1 64.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.562 ' CG2' ' CG1' ' A' ' 53' ' ' VAL . 37.5 t -91.07 -21.79 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.742 -0.599 . . . . 0.0 110.106 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.16 -27.69 21.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.543 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 5.4 m -83.48 -14.44 52.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -0.789 . . . . 0.0 109.418 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.537 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . -82.66 -12.59 57.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.53 ' CD2' HD12 ' A' ' 45' ' ' LEU . 8.3 mt . . . . . 0 N--CA 1.487 1.423 0 O-C-N 121.734 -0.604 . . . . 0.0 110.482 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.483 0.857 0 N-CA-C 109.972 -0.818 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.534 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 90.4 t -127.79 119.2 21.27 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.85 -1.157 . . . . 0.0 111.51 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.8 Cg_endo -81.67 154.5 17.95 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.978 1.515 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.506 ' HG3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -85.04 18.06 2.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.607 -1.308 . . . . 0.0 110.582 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.289 -2.029 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.035 -179.243 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' CA ' ' A' ' 51' ' ' GLY . 5.9 t-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.936 0.398 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.608 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -73.78 11.56 1.09 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.243 1.654 . . . . 0.0 112.386 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 2.7 m-85 -110.73 -73.58 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.54 -1.35 . . . . 0.0 108.405 178.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.185 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.567 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.5 t90 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -39.55 -29.25 0.05 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.747 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.567 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 29.5 t -88.62 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.309 -0.87 . . . . 0.0 109.349 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.85 174.35 4.62 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.101 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.3 Cg_endo -70.59 -33.72 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.921 1.485 . . . . 0.0 109.584 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.13 -19.97 58.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.2 m-20 -85.33 -43.87 13.32 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.05 -20.56 66.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.69 . . . . 0.0 109.161 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.56 49.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.51 -24.58 45.71 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -73.69 -36.02 65.24 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.42 -20.82 60.64 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.919 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -82.82 -36.86 25.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.471 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 19.6 mt -76.04 -31.57 21.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -67.77 -38.27 83.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 15.4 t70 -91.29 -3.79 56.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.793 -0.567 . . . . 0.0 110.097 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -78.63 -15.6 58.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 108.92 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 25' ' ' SER . 11.9 mt -96.14 -52.44 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.668 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.2 t 136.51 99.05 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.0 Cg_endo -72.47 145.23 42.12 Favored 'Trans proline' 0 C--N 1.297 -2.18 0 O-C-N 124.184 1.623 . . . . 0.0 111.01 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 10.7 t -118.07 111.46 34.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 48.15 23.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.382 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.14 34.52 5.61 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 78.9 m-85 -150.99 146.67 26.38 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.183 -1.186 . . . . 0.0 112.397 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 7.7 mt -111.73 148.85 32.58 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.471 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -91.04 142.92 27.25 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.735 -1.228 . . . . 0.0 110.3 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.591 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.52 -25.37 0.81 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.5 m-20 -71.99 -21.88 61.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.967 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 29.2 mttm -93.12 -36.23 12.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 65' ' ' LEU . 64.1 t -79.01 -43.86 24.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.564 0.697 . . . . 0.0 109.863 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 15.7 tttt -41.01 -51.73 7.27 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.0 Cg_endo -67.61 -32.42 30.99 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.314 1.165 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 2.7 t -66.34 -31.91 55.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.561 -0.712 . . . . 0.0 109.089 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 33.9 mt -90.0 -29.85 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 110.075 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 58.8 mt -69.32 -15.36 63.31 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -90.72 -3.72 57.26 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.723 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 45' ' ' LEU . 83.8 p -81.37 12.56 3.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.816 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 2.9 ttmt 62.55 9.67 3.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.533 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 15.7 mt -100.55 153.22 37.86 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.6 Cg_endo -74.12 172.28 16.29 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.913 1.481 . . . . 0.0 109.734 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -70.2 -5.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.094 -1.004 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -78.11 -31.1 49.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 108.968 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.555 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.6 mm -85.17 -43.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 17.2 mt -70.24 -28.89 65.61 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.91 -25.99 74.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 8.8 ttm-85 -100.9 -31.06 11.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.876 -0.779 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 49' ' ' ILE . 7.4 t -69.82 -35.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.681 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.1 t-105 -69.08 -52.28 30.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.267 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 19.9 mm-40 -52.82 -54.27 36.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 110.111 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 3.6 mt -63.2 -13.26 35.37 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 108.612 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.542 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 3.9 m -96.18 -41.02 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.67 . . . . 0.0 110.601 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -69.54 82.3 0.41 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.239 -0.913 . . . . 0.0 110.615 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.529 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 33.4 mm -58.25 -21.7 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.144 -0.972 . . . . 0.0 108.939 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 1.9 m-20 -103.68 -9.91 18.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 0.0 109.818 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 29.8 p80 38.73 48.89 1.4 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.689 -0.632 . . . . 0.0 110.719 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 22.3 p-10 -117.01 12.26 14.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.325 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 88.11 28.76 22.15 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.8 mtt -150.75 161.59 42.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -1.21 . . . . 0.0 111.391 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.541 HD13 ' CG1' ' A' ' 36' ' ' VAL . 15.4 mt -135.73 110.41 8.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 1.1 t70 -72.94 172.64 10.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.547 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 4.2 ptm180 -51.24 -42.4 61.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 110.276 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 26.3 t0 -79.62 -35.2 39.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 7.9 tt0 -69.83 -52.38 25.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.723 0.773 . . . . 0.0 108.994 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.594 ' CD2' HD11 ' A' ' 31' ' ' LEU . 24.9 t80 -53.18 -26.59 17.79 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.94 -52.28 60.48 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.639 0.733 . . . . 0.0 109.917 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 57' ' ' SER . 89.9 t -54.22 -24.0 10.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.542 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -89.4 -7.71 54.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.293 -0.879 . . . . 0.0 112.129 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 mmm -90.22 -41.76 11.4 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.388 -1.445 . . . . 0.0 110.283 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.432 ' O ' ' SG ' ' A' ' 79' ' ' CYS . 2.5 p90 -78.44 -19.42 53.2 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.355 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HB3' HG22 ' A' ' 53' ' ' VAL . 6.9 mt -76.08 -26.15 56.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.559 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 20.7 t -91.36 -57.23 4.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.68 -0.637 . . . . 0.0 109.557 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -53.15 -20.26 3.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.361 -0.837 . . . . 0.0 110.578 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 7.8 m -83.96 -16.7 43.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.089 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -89.01 -11.52 44.0 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.203 -0.935 . . . . 0.0 109.383 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.3 mp . . . . . 0 C--N 1.304 -1.412 0 CA-C-O 121.663 0.744 . . . . 0.0 109.387 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 N--CA 1.482 0.805 0 N-CA-C 109.935 -0.833 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.465 HG12 HG21 ' A' ' 53' ' ' VAL . 20.7 t -112.56 119.81 42.54 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.074 -1.016 . . . . 0.0 110.584 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.477 ' O ' HD13 ' A' ' 56' ' ' LEU . 47.9 Cg_endo -84.62 -162.44 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 109.448 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.454 ' O ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.09 0.23 12.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 C--N 1.293 -1.88 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.434 -178.472 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.469 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 15.1 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.91 0.386 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.606 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -71.4 3.14 3.79 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.039 1.547 . . . . 0.0 111.573 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 8.4 m-85 -100.1 -45.83 5.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.862 -1.149 . . . . 0.0 109.561 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.219 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.572 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.6 t90 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.333 0.587 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -39.88 -27.66 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 110.277 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 88.4 t -107.29 138.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.26 -178.03 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.895 . . . . 0.0 110.089 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.8 Cg_endo -71.16 -36.23 7.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.791 1.416 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.59 -24.51 60.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.992 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.568 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 2.8 m-20 -83.26 -40.26 19.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.336 -0.853 . . . . 0.0 109.015 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -74.62 -21.56 59.39 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -71.43 -38.12 71.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.747 . . . . 0.0 109.248 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.582 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -78.19 -29.34 48.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 12.4 m-30 -71.09 -37.71 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 29.1 t0 -69.61 -18.06 63.58 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.818 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.0 -36.67 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.448 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 mt -78.38 -34.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -67.85 -36.83 81.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.5 t70 -87.5 -3.08 59.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.738 -0.601 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 -8.02 58.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 109.409 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.615 ' O ' ' CB ' ' A' ' 25' ' ' SER . 7.2 mt -102.17 -15.61 16.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 87.99 88.94 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.0 Cg_endo -75.94 150.78 34.65 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.563 1.823 . . . . 0.0 110.495 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 41.8 t -116.12 110.47 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.8 OUTLIER 65.42 13.79 9.05 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -177.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 93.58 32.55 7.62 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 26.3 m-85 -138.03 136.12 36.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.285 . . . . 0.0 112.358 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.3 mt -107.06 151.0 25.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' ASP . 15.9 p -100.58 147.78 25.55 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.989 -1.069 . . . . 0.0 109.774 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.48 -25.05 0.73 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . 46.7 m-20 -67.5 -22.34 65.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.458 -1.025 . . . . 0.0 110.672 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HE3' ' O ' ' A' ' 24' ' ' LEU . 2.9 mtpp -101.63 -34.72 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.914 -1.116 . . . . 0.0 108.398 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG13 ' CD1' ' A' ' 40' ' ' LEU . 92.3 t -78.18 -36.09 20.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.499 0.666 . . . . 0.0 109.692 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 1.8 tttp -44.78 -53.84 14.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 110.706 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.52 -30.34 29.17 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.566 1.298 . . . . 0.0 110.144 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.596 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 3.5 t -64.92 -28.43 44.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.369 0.604 . . . . 0.0 109.799 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 21.3 mt -94.52 -30.45 14.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 56.6 mt -69.26 -10.01 55.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 108.591 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -87.92 -6.25 58.15 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.241 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.53 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -84.96 18.3 2.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 110.242 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 19.33 1.62 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.644 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.519 HD13 ' CB ' ' A' ' 80' ' ' ALA . 15.5 mt -100.51 155.3 36.53 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 109.9 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -75.11 162.48 36.78 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.019 1.536 . . . . 0.0 109.442 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 9.1 t -67.25 -6.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -74.86 -31.24 61.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.521 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.3 mm -81.45 -43.12 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.62 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 9.5 mt -68.68 -32.54 72.44 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.465 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -68.25 -23.88 74.82 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.534 ' CG ' ' CG ' ' A' ' 88' ' ' MET . 3.9 ttm180 -101.67 -32.42 10.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.07 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 57' ' ' SER . 7.6 t -70.43 -40.23 77.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.124 -1.031 . . . . 0.0 108.574 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.566 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.6 t-105 -63.66 -50.86 67.62 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.76 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 13.0 mt-10 -47.22 -56.87 5.89 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.904 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.471 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 1.7 mt -64.54 -13.25 51.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.99 . . . . 0.0 108.919 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -88.48 -40.78 13.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.8 t0 -80.04 95.25 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.312 0.577 . . . . 0.0 110.221 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.32 -13.09 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.928 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.469 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 11.7 m-20 -99.67 -13.13 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.179 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 6.8 m-70 55.57 47.47 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.494 -0.754 . . . . 0.0 110.546 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 19.5 p-10 -126.09 29.66 5.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.51 38.45 93.61 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtt -150.19 160.8 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 111.823 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.485 HD23 ' CB ' ' A' ' 69' ' ' GLU . 5.7 mt -129.81 108.12 9.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.641 -0.662 . . . . 0.0 109.512 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -69.46 158.04 35.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.858 -1.151 . . . . 0.0 109.448 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.578 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 14.1 ptt180 -41.5 -42.43 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -73.27 -43.88 60.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 12.4 mt-10 -64.79 -51.48 62.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.596 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 33.5 t80 -49.63 -28.64 6.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.0 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -65.84 -45.06 83.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 110.185 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.523 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 71.6 t -63.74 -20.34 26.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 110.179 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -89.86 -6.63 55.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.461 -0.775 . . . . 0.0 111.002 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 10.2 mmm -90.44 -44.93 9.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.548 -1.345 . . . . 0.0 110.318 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.565 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 1.5 p90 -75.32 -26.38 58.61 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.027 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.479 ' CD2' HG11 ' A' ' 86' ' ' VAL . 6.7 mt -67.56 -28.54 67.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 24.0 t -91.0 -59.9 2.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.531 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 2.5 m-85 -48.52 -23.07 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.772 -0.58 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 23.0 m -82.93 -20.41 35.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.861 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . -82.26 -12.37 58.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 3.3 mp . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.415 -0.803 . . . . 0.0 110.17 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 N--CA 1.484 0.959 0 N-CA-C 109.985 -0.814 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' A' ' 53' ' ' VAL . 33.0 t -124.44 125.86 25.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.958 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.471 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 53.1 Cg_endo -87.71 164.03 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.932 1.491 . . . . 0.0 109.961 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.534 ' CG ' ' CG ' ' A' ' 52' ' ' ARG . 17.0 mtt -93.83 16.68 13.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.969 -1.082 . . . . 0.0 110.465 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.292 -1.911 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.549 -178.413 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.557 ' OD1' ' N ' ' B' ' 112' ' ' ARG . 11.6 t-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.679 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.6 Cg_endo -73.73 -3.15 13.27 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.85 1.448 . . . . 0.0 111.042 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.679 ' CE1' ' HG2' ' B' ' 110' ' ' PRO . 0.1 OUTLIER -113.82 -65.92 1.14 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.851 -1.156 . . . . 0.0 108.705 177.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.602 ' CG ' ' O ' ' B' ' 111' ' ' PHE . 2.1 ptt-85 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.273 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.512 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.6 t90 . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.64 -25.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.954 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.512 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 17.4 t -99.28 152.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.2 mttm -109.77 175.02 2.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.0 Cg_endo -68.35 -36.71 15.24 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.142 1.601 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -30.29 63.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.341 -0.849 . . . . 0.0 109.262 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -82.14 -38.8 24.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 12.6 tptp -70.84 -17.03 62.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.43 -40.98 49.15 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.93 -24.87 43.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.7 m-30 -73.45 -37.39 65.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -73.98 -20.29 60.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.925 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.51 -35.68 24.66 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.2 -0.938 . . . . 0.0 108.5 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.479 HG21 ' CE1' ' A' ' 70' ' ' PHE . 50.5 mt -77.22 -33.11 19.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -64.89 -37.87 89.06 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 t0 -90.53 -2.26 57.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 1.7 m -82.15 -9.93 59.35 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.309 -0.869 . . . . 0.0 108.948 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.625 ' O ' ' CB ' ' A' ' 25' ' ' SER . 13.1 mt -98.67 -53.89 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 150.62 84.33 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 55.8 Cg_endo -76.71 123.83 7.17 Favored 'Trans proline' 0 C--N 1.293 -2.357 0 O-C-N 124.307 1.688 . . . . 0.0 109.55 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN 0.251 2.2 p -119.48 121.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.723 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.026 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' ND2' ' CE2' ' A' ' 30' ' ' PHE . 10.0 t30 57.68 20.77 6.64 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 81.15 45.0 7.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.557 ' CE2' ' ND2' ' A' ' 28' ' ' ASN . 87.8 m-85 -151.87 158.79 43.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 112.452 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.603 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.7 mt -126.39 160.64 29.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' LYS . 1.4 p -106.88 146.78 30.57 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.682 -1.261 . . . . 0.0 110.532 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.597 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.65 -24.93 0.76 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.1 m-20 -75.85 -20.02 58.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.978 . . . . 0.0 110.618 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 11.7 mtmm -94.89 -35.2 12.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.976 -1.078 . . . . 0.0 108.141 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 HG22 ' CE2' ' A' ' 70' ' ' PHE . 96.8 t -78.01 -43.29 28.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.639 0.733 . . . . 0.0 109.764 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -40.83 -52.23 6.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 110.724 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.8 Cg_endo -67.03 -35.4 25.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.401 1.211 . . . . 0.0 109.65 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.53 ' CG2' HD21 ' A' ' 24' ' ' LEU . 2.2 t -61.5 -33.45 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.633 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 29.7 mt -88.97 -28.96 19.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.622 -0.674 . . . . 0.0 109.901 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.51 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 62.1 mt -71.95 -14.78 62.01 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -90.58 -3.74 57.35 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.118 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.511 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 37.7 m -81.75 11.44 4.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.2 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.14 11.72 4.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.707 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.539 HD12 ' CG2' ' A' ' 49' ' ' ILE . 16.2 mt -100.57 155.14 36.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.561 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.9 Cg_endo -75.27 170.13 21.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.046 1.551 . . . . 0.0 109.816 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.478 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -68.59 -7.3 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 120.952 -1.093 . . . . 0.0 109.045 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.34 -27.87 60.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.561 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.1 mm -88.38 -38.69 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.581 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 9.7 mt -77.28 -29.76 53.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.2 -25.66 75.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.549 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -102.22 -35.88 8.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.081 -0.658 . . . . 0.0 110.75 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.515 HG23 ' CG1' ' A' ' 86' ' ' VAL . 13.7 t -67.49 -37.72 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.819 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.597 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -64.11 -52.55 58.63 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.306 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 91.2 mt-10 -51.14 -58.79 5.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.388 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 3.2 mt -62.16 -13.98 32.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.98 . . . . 0.0 109.013 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.536 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 29.4 m -96.35 -26.73 15.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.717 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' TRP . 9.5 t0 -78.26 93.14 4.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' HG3' ' A' ' 69' ' ' GLU . 24.4 mm -73.12 -32.43 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 110.06 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 2.6 m-20 -95.62 -16.02 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.419 ' HA ' ' CG ' ' A' ' 58' ' ' ASP . 91.0 m-70 52.61 50.69 17.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.314 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 37.5 p-10 -125.0 36.87 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.5 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 58.19 33.01 68.47 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 6.6 mtt -150.54 160.66 43.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -1.091 . . . . 0.0 111.269 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.458 HD11 ' CG1' ' A' ' 36' ' ' VAL . 13.2 mt -132.28 110.49 10.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.222 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 10.7 t0 -70.13 167.62 17.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.946 -1.096 . . . . 0.0 110.372 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.3 ptm180 -45.61 -44.22 12.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.286 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.494 ' OD1' ' CZ2' ' A' ' 7' ' ' TRP . 11.7 t0 -78.19 -36.27 47.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.301 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -63.65 -52.47 60.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.938 0.875 . . . . 0.0 109.397 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.534 ' CD2' HD13 ' A' ' 31' ' ' LEU . 17.7 t80 -54.48 -20.37 7.53 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.533 0.682 . . . . 0.0 109.274 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -73.23 -46.27 51.2 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.7 t -59.94 -28.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.077 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.66 -4.67 57.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 5.6 mmt -87.43 -43.19 12.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.718 -1.239 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.468 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -77.77 -22.22 50.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.077 -1.014 . . . . 0.0 108.379 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.477 ' HB3' HG21 ' A' ' 53' ' ' VAL . 9.3 mt -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.566 HG23 ' CD2' ' A' ' 40' ' ' LEU . 41.3 t -91.7 -60.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.689 -0.632 . . . . 0.0 110.109 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.448 ' HA ' HD11 ' A' ' 81' ' ' LEU . 3.4 m-85 -55.97 -19.65 13.27 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.225 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 7.5 m -83.25 -16.69 45.4 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.019 -1.051 . . . . 0.0 109.581 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.508 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -85.78 -15.22 42.76 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.454 -0.779 . . . . 0.0 109.557 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.2 mp . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 121.643 0.735 . . . . 0.0 109.467 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.484 0.931 0 N-CA-C 109.969 -0.82 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.515 ' CG1' HG23 ' A' ' 53' ' ' VAL . 96.5 t -128.44 109.61 19.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.975 . . . . 0.0 110.793 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.517 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 46.4 Cg_endo -76.31 -169.95 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.988 1.52 . . . . 0.0 109.564 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.549 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -112.8 20.87 16.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.514 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.499 ' N ' HD21 ' A' ' 56' ' ' LEU . 74.8 m . . . . . 0 C--N 1.29 -2.0 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.102 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.43 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 7.6 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.029 0.442 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.486 ' HD2' ' CE1' ' B' ' 111' ' ' PHE . 48.5 Cg_endo -70.27 8.78 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.993 1.795 . . . . 0.0 112.176 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.633 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 15.3 m-85 -98.95 -45.04 6.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 109.854 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.449 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 13.1 t90 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -40.56 -28.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 62.8 t -94.02 165.45 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 12.6 mttt -119.55 172.65 4.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.3 Cg_endo -67.88 -35.46 20.93 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.005 1.529 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 6.4 pt-20 -72.64 -28.69 62.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.93 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.8 m-20 -81.17 -38.79 26.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 108.638 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppt? -68.56 -16.99 64.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -28.46 35.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -90.73 -35.62 14.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.7 m-30 -65.39 -28.56 69.35 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD2' ' HD2' ' A' ' 14' ' ' LYS . 9.6 m-20 -80.98 -24.09 38.27 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.662 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.37 -30.78 37.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.541 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 56.3 mt -80.78 -28.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -75.58 -35.8 60.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t70 -89.32 -3.06 58.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.758 -0.589 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -6.57 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.305 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.6 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.5 mt -106.5 -12.25 15.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 p 89.59 94.68 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.259 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -73.8 150.46 44.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.253 1.659 . . . . 0.0 110.871 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 71.9 t -123.9 110.27 25.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.3 t30 57.58 15.41 2.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.321 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.28 35.25 5.32 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 75.4 m-85 -150.56 143.2 24.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -1.205 . . . . 0.0 112.224 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.4 mt -109.56 134.46 51.89 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.489 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 1.7 m -78.37 142.56 37.57 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 118.939 -1.105 . . . . 0.0 109.942 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -43.48 -26.35 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 63.5 m-20 -67.55 -23.42 65.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 40.3 mttp -96.1 -33.18 12.18 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 40' ' ' LEU . 84.6 t -77.9 -38.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.641 0.734 . . . . 0.0 109.598 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.0 OUTLIER -43.15 -54.96 8.52 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.73 . . . . 0.0 111.137 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -67.79 -31.78 31.24 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.718 1.378 . . . . 0.0 109.926 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.578 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -64.27 -31.22 52.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.579 -0.701 . . . . 0.0 109.304 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 22.2 mt -94.34 -34.92 12.62 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.597 -0.689 . . . . 0.0 109.974 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.4 mt -67.91 -14.45 62.97 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 19.8 t30 -90.73 -4.91 56.35 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.525 ' OG ' HG11 ' A' ' 77' ' ' VAL . 5.7 m -84.97 18.65 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 0.0 110.431 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.9 tptt 60.23 13.5 3.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.05 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 81' ' ' LEU . 12.7 mt -100.22 152.13 37.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.92 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.576 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.8 Cg_endo -76.61 170.06 20.63 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.017 1.535 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 3.4 t -71.03 -4.53 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.757 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.8 -33.78 45.97 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.818 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.576 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 14.5 mm -79.32 -42.07 23.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 108.825 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 12.9 mt -68.35 -29.46 68.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.28 -24.69 73.57 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.51 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 5.5 ttm-85 -100.81 -32.59 10.62 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.685 -0.891 . . . . 0.0 110.265 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.545 ' CG1' HG22 ' A' ' 77' ' ' VAL . 24.6 t -68.77 -36.37 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.821 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.581 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.7 t-105 -69.59 -52.32 27.15 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.344 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 84.1 mt-10 -50.96 -57.38 8.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.095 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.51 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 3.1 mt -61.16 -14.36 24.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.128 -0.983 . . . . 0.0 108.834 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 15.5 t -97.0 -23.31 16.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.29 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 29.0 t0 -95.55 90.91 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.975 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.15 -15.45 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 110.164 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 8.0 m-20 -89.17 -17.25 29.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.479 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 11.8 m170 57.59 46.86 16.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.623 -0.673 . . . . 0.0 110.115 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 8.4 p30 -119.78 16.07 12.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.639 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.22 33.58 83.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 37.9 mtp -151.47 160.78 43.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.238 . . . . 0.0 110.635 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 12.6 mt -119.77 105.16 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.0 109.584 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -71.94 163.48 27.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.334 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -41.84 -39.84 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 111.108 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.466 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -79.71 -32.32 41.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.187 -0.946 . . . . 0.0 110.594 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' CG ' ' OD1' ' A' ' 66' ' ' ASP . 35.3 mt-10 -77.75 -39.24 44.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.108 -0.995 . . . . 0.0 109.021 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.579 ' CD2' HD11 ' A' ' 31' ' ' LEU . 20.9 t80 -62.35 -18.22 60.93 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 0.0 108.907 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.73 -44.34 28.09 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.797 0.808 . . . . 0.0 109.564 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.586 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 44.0 t -61.57 -30.43 48.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.607 0.717 . . . . 0.0 109.676 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 57' ' ' SER . . . -89.68 -2.81 58.38 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 110.82 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.5 mmt -83.62 -48.91 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.897 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 7.6 p90 -76.19 -23.74 54.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' HB3' HG22 ' A' ' 53' ' ' VAL . 5.7 mt -71.04 -24.45 62.35 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.545 HG22 ' CG1' ' A' ' 53' ' ' VAL . 45.7 t -91.68 -46.38 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.648 -0.658 . . . . 0.0 110.298 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -69.58 -26.42 64.45 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 110.865 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 16.1 t -81.43 -12.91 58.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.038 . . . . 0.0 109.385 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.53 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . -90.36 -10.54 43.63 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 109.023 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.4 mt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.739 0.781 . . . . 0.0 109.708 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 N--CA 1.479 0.639 0 N-CA-C 109.359 -1.054 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.47 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 91.6 t -116.73 126.69 27.31 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 110.562 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.466 ' O ' HD13 ' A' ' 56' ' ' LEU . 49.5 Cg_endo -84.42 -170.51 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.994 1.523 . . . . 0.0 108.913 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.485 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -118.48 13.25 13.46 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.954 -1.091 . . . . 0.0 110.242 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.411 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 3.6 m . . . . . 0 C--N 1.292 -1.921 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.245 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' B' ' 112' ' ' ARG . 2.5 t-20 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.665 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 42.3 Cg_endo -70.5 -3.73 13.08 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.812 1.428 . . . . 0.0 110.514 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.665 ' CE1' ' HG2' ' B' ' 110' ' ' PRO . 0.1 OUTLIER -111.95 -60.99 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.598 ' CG ' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.358 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.485 0.993 0 N-CA-C 110.56 -0.592 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.482 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -88.3 123.34 32.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.935 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -42.98 -28.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.417 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 23.8 t -101.73 139.2 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.91 . . . . 0.0 110.708 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.541 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.03 -177.3 0.64 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.49 -0.756 . . . . 0.0 109.748 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.7 Cg_endo -71.66 -32.63 11.6 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.711 1.374 . . . . 0.0 110.249 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 13.0 mm-40 -77.36 -31.78 54.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 109.784 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -77.44 -35.19 54.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -82.21 -18.47 42.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.638 0.732 . . . . 0.0 109.112 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -70.08 -40.15 75.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.61 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -73.51 -32.01 64.02 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.61 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -66.22 -36.58 83.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.56 -20.98 63.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.663 -0.648 . . . . 0.0 110.155 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.01 -38.73 24.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.971 . . . . 0.0 108.511 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.7 mt -75.79 -29.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.547 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -73.97 -36.41 64.58 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t70 -89.97 1.48 56.23 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.977 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -92.4 -3.47 55.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.922 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.604 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -109.63 -4.58 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 84.99 89.97 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.3 Cg_endo -72.42 148.7 49.07 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 124.503 1.791 . . . . 0.0 110.864 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 68.7 t -121.03 104.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.1 t30 58.88 20.41 8.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.805 . . . . 0.0 110.001 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 94.27 37.1 5.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 87.1 m-85 -150.29 149.22 29.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.164 -1.198 . . . . 0.0 111.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 15.0 mt -122.54 130.48 53.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -77.29 148.14 35.87 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.55 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -46.66 -25.55 2.25 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 9.0 t0 -63.02 -20.75 65.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.567 -0.961 . . . . 0.0 109.685 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 27.9 mttp -104.42 -32.38 9.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.552 HG13 ' CD1' ' A' ' 40' ' ' LEU . 92.3 t -83.5 -46.29 18.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.175 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.608 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 8.0 tttt -41.68 -49.91 9.91 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -67.69 -31.97 31.42 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.341 1.179 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -68.4 -34.58 66.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.622 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -86.3 -31.48 21.58 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.82 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 47.1 mt -71.02 -11.5 61.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.09 -10.36 53.07 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.169 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.511 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 87.7 p -79.17 7.92 6.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 110.473 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.64 9.53 5.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.066 -1.021 . . . . 0.0 109.939 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 HD11 ' CG2' ' A' ' 49' ' ' ILE . 15.2 mt -93.17 157.26 39.25 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.5 Cg_endo -74.72 167.86 26.13 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.857 1.451 . . . . 0.0 109.635 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.51 -7.4 6.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.941 -1.099 . . . . 0.0 109.142 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.51 -29.87 61.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.7 mm -85.62 -39.1 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.925 0.869 . . . . 0.0 108.898 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 13.1 mt -79.52 -28.77 41.33 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.08 -26.83 71.49 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.481 ' HD3' ' HG3' ' A' ' 88' ' ' MET . 28.0 ttm180 -101.43 -31.19 11.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.113 -0.64 . . . . 0.0 110.501 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 49' ' ' ILE . 18.7 t -70.63 -36.93 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 108.588 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CZ2' ' OD1' ' A' ' 58' ' ' ASP . 1.6 t-105 -63.44 -50.77 68.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.71 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.3 mm-40 -52.25 -57.7 8.91 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.11 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.4 mt -62.13 -19.28 62.87 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.141 -0.974 . . . . 0.0 108.646 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.542 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 7.5 t -85.9 -33.95 21.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -70.3 92.75 0.8 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 29.1 mm -75.31 -23.26 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 111.328 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -110.2 -9.54 14.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.884 -1.135 . . . . 0.0 110.948 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 50.7 m170 59.59 44.8 14.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.109 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 19.2 p-10 -106.74 9.31 31.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 109.989 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 80.05 24.77 59.06 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.2 mtp -152.17 161.4 42.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.183 -1.187 . . . . 0.0 110.373 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.542 ' CD2' ' OG ' ' A' ' 57' ' ' SER . 13.6 mt -116.84 103.12 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.723 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.575 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -69.26 173.23 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.067 -1.021 . . . . 0.0 110.021 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -50.07 -32.15 14.9 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.613 -0.679 . . . . 0.0 110.894 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 -30.38 20.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 36.2 mt-10 -79.16 -40.6 30.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 108.917 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.575 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.3 t80 -63.81 -24.45 67.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -70.17 -51.87 27.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.962 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.449 HG13 HD11 ' A' ' 76' ' ' LEU . 76.1 t -57.29 -25.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.547 -0.72 . . . . 0.0 110.359 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -89.07 -4.99 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 111.637 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmt -88.53 -44.16 10.88 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.862 -1.149 . . . . 0.0 110.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.62 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 4.5 p90 -77.71 -22.17 50.82 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.999 -1.081 . . . . 0.0 108.293 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 12.1 mt -74.63 -24.52 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.535 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 49.3 t -91.62 -40.96 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.586 -0.696 . . . . 0.0 110.123 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.508 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -71.91 -22.52 61.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.648 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' CA ' ' HB2' ' A' ' 83' ' ' LYS . 14.3 m -83.2 -20.76 34.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.818 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -80.62 -12.82 59.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.332 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.535 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -91.2 -41.13 11.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.513 -0.742 . . . . 0.0 110.771 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 4.0 tt0 -125.66 -9.15 6.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 111.768 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.525 ' HB2' ' CA ' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -110.47 -90.01 0.48 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.543 -1.348 . . . . 0.0 111.612 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.0 mt-10 -146.08 172.75 4.91 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.673 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 42.3 Cg_endo -67.65 -169.29 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.057 1.556 . . . . 0.0 110.588 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 ' HD2' ' A' ' 87' ' ' PRO . 98.1 t -128.15 137.48 30.93 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 110.605 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.546 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 48.3 Cg_endo -84.41 175.43 7.2 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.869 1.457 . . . . 0.0 108.503 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.481 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 9.9 mtm -108.48 18.21 21.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.74 -1.225 . . . . 0.0 110.49 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 74.8 m -112.88 99.51 7.94 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.355 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -47.16 104.97 0.44 Allowed Pre-proline 0 C--N 1.293 -1.863 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.494 178.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 43.5 Cg_endo -71.52 148.95 54.96 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.984 1.518 . . . . 0.0 110.54 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.45 -15.0 34.45 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.056 1.556 . . . . 0.0 110.554 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.441 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -84.57 -3.29 58.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.62 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -105.67 -8.58 17.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.338 -0.851 . . . . 0.0 110.086 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 99' ' ' LYS . 35.6 t -74.03 130.01 83.68 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.623 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.4 Cg_endo -71.41 174.78 10.35 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.9 1.474 . . . . 0.0 110.059 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.2 Cg_endo -71.91 -21.4 24.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.902 1.475 . . . . 0.0 110.842 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t -66.56 -15.77 63.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.879 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' HB3' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -97.34 8.52 44.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.89 . . . . 0.0 109.578 179.179 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.183 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.259 0.552 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' B' ' 109' ' ' ASN . 3.2 t -174.4 -166.24 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.226 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.413 ' ND2' ' CD1' ' B' ' 111' ' ' PHE . 5.0 t-20 46.57 88.84 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.903 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.515 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -74.59 19.69 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.194 1.628 . . . . 0.0 112.35 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.622 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 24.5 m-85 -99.94 -61.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.511 -1.368 . . . . 0.0 108.69 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.414 ' HA ' HG13 ' A' ' 47' ' ' VAL . 27.1 mtm180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.222 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 110.491 -0.619 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.597 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 16.0 t90 -80.2 126.15 30.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.933 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -43.27 -27.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.597 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 42.0 t -96.6 145.3 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.4 mttm -112.52 -179.46 0.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.4 Cg_endo -67.56 -35.53 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.745 1.392 . . . . 0.0 110.199 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 6.2 pt-20 -71.21 -30.62 66.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 5.8 m-20 -83.63 -38.13 21.94 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.224 -0.923 . . . . 0.0 108.655 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 5.9 tptm -69.33 -17.65 63.73 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -78.74 -39.67 35.57 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.601 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.2 ptmm? -81.05 -22.85 38.98 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.601 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -76.93 -34.75 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.9 -19.63 60.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 0.0 110.31 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -83.6 -33.62 25.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.985 . . . . 0.0 108.451 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.475 ' CG2' HG11 ' A' ' 39' ' ' VAL . 22.2 mt -78.07 -31.39 16.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -71.84 -38.95 70.06 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.704 0.764 . . . . 0.0 109.034 179.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.55 -6.49 54.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.512 -0.742 . . . . 0.0 109.878 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.2 t -78.76 -7.51 57.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 0.0 108.909 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 25' ' ' SER . 10.6 mt -101.77 -54.34 2.75 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 m 137.97 98.51 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.16 148.3 39.18 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 O-C-N 123.977 1.514 . . . . 0.0 110.499 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -120.08 98.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.627 -0.67 . . . . 0.0 109.31 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 3.8 t30 60.37 14.86 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.726 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.458 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 107.03 32.88 3.38 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 84.9 m-85 -148.6 151.99 35.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.908 -1.348 . . . . 0.0 112.078 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 6.7 mt -120.31 143.18 48.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 33' ' ' GLY . 96.6 p -89.08 141.79 28.2 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.822 -1.174 . . . . 0.0 110.28 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.514 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.69 -25.96 0.99 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.0 t70 -65.83 -22.36 66.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.513 -0.993 . . . . 0.0 110.072 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HD2' HD23 ' A' ' 31' ' ' LEU . 7.7 mttp -97.81 -35.91 10.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.568 HG22 ' CD2' ' A' ' 70' ' ' PHE . 98.1 t -77.77 -42.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.514 0.673 . . . . 0.0 110.011 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.48 -53.82 5.31 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 110.915 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.1 Cg_endo -68.67 -33.9 20.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.542 1.285 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.475 HG11 ' CG2' ' A' ' 20' ' ' ILE . 2.5 t -63.55 -31.75 54.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.031 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 33.0 mt -88.43 -26.58 22.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 110.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.426 HD13 ' HG3' ' A' ' 37' ' ' LYS . 51.9 mt -73.8 -11.23 60.32 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.175 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -90.31 -3.19 57.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 91.9 p -84.34 13.98 4.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 110.09 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt 59.39 13.72 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.532 HD12 ' CB ' ' A' ' 80' ' ' ALA . 17.5 mt -100.16 156.87 34.78 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.905 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.6 Cg_endo -74.58 171.08 18.86 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.921 1.485 . . . . 0.0 109.868 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.4 -6.19 6.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.286 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.71 -31.15 59.54 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.537 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.6 mm -83.12 -40.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 122.017 0.913 . . . . 0.0 108.556 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 14.1 mt -76.7 -26.94 55.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.729 0.776 . . . . 0.0 108.959 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.8 -29.08 65.81 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 30.1 ttm180 -101.0 -28.3 12.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.886 -0.773 . . . . 0.0 109.934 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 77' ' ' VAL . 19.4 t -72.49 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.43 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.558 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.3 t-105 -65.82 -51.46 58.75 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.814 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.2 mm-40 -50.82 -60.53 2.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.406 -0.809 . . . . 0.0 109.991 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.6 mt -61.54 -15.93 43.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.498 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.515 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 9.2 t -92.24 -18.17 23.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.487 0.661 . . . . 0.0 109.235 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.1 t0 -90.83 82.11 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.514 -0.741 . . . . 0.0 110.322 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 12.1 mm -62.67 -24.12 34.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.604 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -104.24 -7.96 19.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 20.6 p80 38.35 51.92 1.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.567 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.2 p-10 -119.68 20.33 12.35 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.004 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.53 29.71 54.94 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.4 mtp -150.24 161.3 42.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -1.158 . . . . 0.0 111.087 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 14.0 mt -129.53 112.59 13.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 109.746 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 13.7 t0 -70.02 168.39 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.065 -1.022 . . . . 0.0 110.47 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.576 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -50.75 -41.08 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.872 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 46.4 t0 -81.01 -32.82 34.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 2.3 mt-10 -71.96 -50.21 30.82 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.873 0.844 . . . . 0.0 109.257 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.588 ' CD2' HD13 ' A' ' 31' ' ' LEU . 29.3 t80 -53.57 -22.83 9.15 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.83 -52.87 25.38 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.852 0.834 . . . . 0.0 109.77 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.48 HG23 HD23 ' A' ' 94' ' ' LEU . 49.0 t -52.64 -24.61 6.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 110.394 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.515 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -89.67 -11.48 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 0.0 112.499 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 mmm -86.77 -47.11 9.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.392 -1.442 . . . . 0.0 110.435 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.546 ' CE1' HD21 ' A' ' 94' ' ' LEU . 1.9 p90 -73.38 -21.75 60.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 6.2 mt -74.55 -24.95 59.01 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 59.8 t -90.96 -42.46 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.466 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.6 m-85 -68.54 -19.09 64.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.619 -0.675 . . . . 0.0 110.21 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 16.1 m -84.65 -25.74 28.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.532 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -73.55 -17.44 61.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 108.698 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 43' ' ' SER . 1.1 mt -91.93 -41.21 10.71 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.724 -0.61 . . . . 0.0 110.767 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -121.49 -10.9 8.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.84 . . . . 0.0 111.778 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 79' ' ' CYS . 7.9 tttp -106.01 -85.11 0.5 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.553 -1.342 . . . . 0.0 110.932 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.525 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 2.8 mt-10 -161.8 179.6 1.26 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.94 -1.1 . . . . 0.0 109.947 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 39.7 Cg_endo -66.51 170.64 11.97 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.668 1.352 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.496 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 96.4 t -113.99 134.95 22.06 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.536 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.6 Cg_endo -84.69 -173.12 1.4 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.072 1.564 . . . . 0.0 109.02 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.544 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 29.6 mtm -111.55 10.14 21.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 109.872 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.452 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 19.6 m -108.12 101.19 10.44 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.887 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.591 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -50.69 106.46 0.65 Allowed Pre-proline 0 C--N 1.292 -1.893 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.512 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.515 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 41.6 Cg_endo -70.99 152.76 63.21 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.791 1.416 . . . . 0.0 110.728 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.62 -9.94 24.58 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.285 1.676 . . . . 0.0 111.397 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -84.73 -27.79 26.73 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 109.025 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.6 ' CD2' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -102.94 -12.09 17.75 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.849 0.833 . . . . 0.0 108.972 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 91' ' ' PRO . 47.8 t -87.38 137.21 32.62 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.924 -1.11 . . . . 0.0 110.781 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 46.1 Cg_endo -72.11 175.67 9.54 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.128 1.594 . . . . 0.0 109.985 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 41.6 Cg_endo -67.86 179.9 2.46 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.84 1.442 . . . . 0.0 110.529 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER 70.25 -53.91 0.63 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.311 -0.868 . . . . 0.0 110.08 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 100' ' ' ARG . 2.3 tptt -88.59 16.12 7.08 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 108.652 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.536 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 41.5 mmm-85 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.627 -0.671 . . . . 0.0 110.465 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.337 0.589 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 17.1 m -97.15 -27.43 14.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.482 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.5 t-20 -112.53 110.78 52.5 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.588 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -72.94 2.39 5.48 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.078 1.568 . . . . 0.0 111.483 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 4.4 m-85 -101.2 -47.97 4.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.853 -1.155 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.475 ' HG2' ' HA3' ' A' ' 51' ' ' GLY . 1.2 mmm180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.275 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 110.304 -0.691 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.9 t90 -52.42 134.39 34.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 109.668 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.545 ' CB ' HD21 ' A' ' 94' ' ' LEU . . . -40.93 -28.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.451 -0.78 . . . . 0.0 110.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 85.4 t -113.31 135.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 110.152 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -93.77 -179.69 1.07 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.349 -0.844 . . . . 0.0 109.995 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.13 -35.27 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.927 1.488 . . . . 0.0 110.02 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.6 -33.52 58.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 15.0 m-20 -76.96 -34.66 57.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 68' ' ' ASP . 1.5 tttt -76.79 -20.16 56.75 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.7 71.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.601 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -70.13 -21.23 63.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.601 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -80.21 -29.29 38.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.38 -20.14 57.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.718 -0.614 . . . . 0.0 109.804 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -81.57 -32.69 32.02 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.466 ' CD1' ' SD ' ' A' ' 74' ' ' MET . 63.8 mt -78.97 -33.0 15.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -67.78 -35.17 78.19 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -91.03 -5.44 55.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.461 -0.775 . . . . 0.0 110.324 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 87.3 p -78.95 -14.65 59.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 108.839 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' ' CB ' ' A' ' 25' ' ' SER . 11.6 mt -92.96 -55.07 3.48 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 t 142.8 92.92 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.478 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.7 Cg_endo -74.87 148.99 36.67 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 O-C-N 124.198 1.631 . . . . 0.0 110.88 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -125.38 103.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.5 t30 63.37 13.66 7.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.642 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 32.66 4.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.2 m-85 -146.5 148.79 32.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -1.166 . . . . 0.0 111.908 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.1 mt -113.83 158.51 20.93 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' ASP . 48.3 p -105.14 143.45 33.3 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.592 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.59 -25.1 0.49 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' SER . 61.4 t0 -71.32 -23.97 62.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.413 -1.051 . . . . 0.0 110.412 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 14.0 mttp -94.09 -35.61 12.48 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.071 -1.018 . . . . 0.0 108.417 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.526 ' CG1' HD13 ' A' ' 65' ' ' LEU . 87.5 t -78.16 -42.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.382 0.61 . . . . 0.0 110.384 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 14.8 tttt -40.03 -54.42 4.42 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 110.549 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -66.93 -33.85 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.406 1.214 . . . . 0.0 110.021 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -62.25 -35.2 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.818 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.651 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 30.3 mt -87.83 -30.02 20.52 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.705 -0.622 . . . . 0.0 110.063 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.49 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 67.2 mt -70.13 -13.95 62.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -91.36 -4.1 56.1 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.519 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -83.56 16.75 2.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.386 -0.821 . . . . 0.0 110.445 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.557 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.0 tttp 60.32 11.92 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.177 -0.952 . . . . 0.0 109.591 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.544 HD12 ' CG2' ' A' ' 49' ' ' ILE . 16.9 mt -99.19 153.39 37.81 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 110.566 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.0 Cg_endo -75.76 175.97 10.61 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 124.175 1.619 . . . . 0.0 109.271 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 HG13 ' O ' ' B' ' 111' ' ' PHE . 1.6 t -73.27 -3.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.6 m-20 -81.68 -30.44 32.64 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.246 -0.909 . . . . 0.0 109.285 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.569 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 5.3 mm -88.0 -39.23 12.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.558 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 23.6 mt -74.78 -27.67 60.42 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -74.58 -21.8 78.19 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 0.1 OUTLIER -99.99 -33.75 10.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.161 -0.611 . . . . 0.0 109.402 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 49' ' ' ILE . 18.6 t -69.22 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.592 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 4.4 t-105 -76.2 -55.38 5.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.557 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.8 mm-40 -52.02 -58.24 7.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.96 -1.088 . . . . 0.0 110.048 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 5.6 mt -59.29 -16.32 21.08 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.582 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.561 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 2.0 t -91.44 -40.25 11.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 109.713 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 54' ' ' TRP . 1.2 t0 -65.82 97.66 0.35 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.472 -0.767 . . . . 0.0 109.996 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' CG2' ' HD2' ' A' ' 99' ' ' LYS . 15.2 mm -72.22 -31.36 39.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.564 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 4.2 p30 -105.81 -9.64 17.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.801 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.564 ' CG ' ' C ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER 51.77 51.02 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.381 -0.825 . . . . 0.0 109.994 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 47.0 p-10 -111.09 20.83 17.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 75.11 32.81 55.73 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.6 mtp -150.69 161.34 42.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.248 . . . . 0.0 111.858 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.578 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 13.0 mt -132.27 99.73 4.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.606 -0.684 . . . . 0.0 109.293 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.2 p30 -71.49 160.41 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 110.468 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 66' ' ' ASP . 10.1 ptt-85 -34.9 -44.21 0.21 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.756 -0.59 . . . . 0.0 111.31 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.8 m-20 -77.64 -35.08 52.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.701 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -70.13 -48.41 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.81 0.814 . . . . 0.0 109.22 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 25.3 t80 -61.04 -14.17 21.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.19 -47.28 16.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.527 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.9 t -59.01 -29.62 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.077 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.561 ' HB1' ' CB ' ' A' ' 57' ' ' SER . . . -90.2 -2.37 58.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.63 -0.669 . . . . 0.0 111.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.595 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 10.0 mmt -88.08 -48.33 7.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.472 -1.392 . . . . 0.0 110.112 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.503 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -76.1 -24.18 54.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.503 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.6 mt -70.8 -26.45 63.32 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.552 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 8.6 t -91.09 -23.61 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.728 -0.607 . . . . 0.0 109.998 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.45 -26.31 28.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.599 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.1 m -81.29 -17.67 48.52 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.549 -0.72 . . . . 0.0 109.675 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.536 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -86.39 -8.68 57.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.374 -0.828 . . . . 0.0 109.145 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 81' ' ' LEU . 2.7 mt -90.33 -45.02 9.3 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.751 0.786 . . . . 0.0 108.959 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -71.49 -52.22 19.51 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.725 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 179.32 -30.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.255 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.4 mt-10 -65.48 110.33 4.24 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.174 -0.954 . . . . 0.0 111.074 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 44.0 Cg_endo -71.7 -170.92 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.832 1.438 . . . . 0.0 110.063 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 52' ' ' ARG . 59.9 t -138.18 125.56 13.58 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.52 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 53.2 Cg_endo -84.9 -175.95 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.926 1.488 . . . . 0.0 109.474 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.528 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 28.4 mtp -110.73 12.36 22.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 52.5 m -110.3 101.51 10.24 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.772 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -53.41 106.89 0.72 Allowed Pre-proline 0 C--N 1.29 -2.008 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.924 178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 46.9 Cg_endo -69.93 170.27 17.18 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.912 1.48 . . . . 0.0 109.909 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.58 -21.68 14.56 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.913 1.48 . . . . 0.0 111.272 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -82.24 4.96 21.52 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.078 -1.014 . . . . 0.0 109.249 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.547 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 2.1 mm? -114.29 9.72 17.03 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.423 -0.798 . . . . 0.0 110.944 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -124.13 107.99 30.14 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 0.0 110.831 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.82 168.49 24.7 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.976 1.514 . . . . 0.0 109.612 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 98' ' ' SER . 43.7 Cg_endo -71.03 175.13 9.59 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.755 1.397 . . . . 0.0 110.151 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 2.0 t 80.07 -33.6 0.13 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.828 -0.545 . . . . 0.0 110.121 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HD2' ' CG2' ' A' ' 59' ' ' ILE . 8.6 mmtt -88.73 0.7 56.21 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.023 -1.048 . . . . 0.0 108.632 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.04 179.722 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' B' ' 108' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.269 0.557 . . . . 0.0 110.199 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 61' ' ' HIS . 8.4 t -73.22 69.07 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.068 -1.02 . . . . 0.0 109.863 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 112' ' ' ARG . 10.6 t-20 -151.62 100.51 2.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.432 -0.793 . . . . 0.0 110.106 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.606 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 52.2 Cg_endo -72.97 4.85 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.288 1.678 . . . . 0.0 111.686 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.651 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 4.1 m-85 -105.17 -69.42 0.82 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.793 -1.192 . . . . 0.0 109.007 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.515 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.566 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.251 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 1.222 ' N ' ' HB3' ' B' ' 110' ' ' PRO 2.129 0.0 OUTLIER . . . . . 1 N--CA 28.865 1611.611 1 N-CA-C 11.458 -38.709 . . . . 0.0 11.458 . . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.597 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.4 t90 -89.53 121.03 31.35 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 109.919 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 93' ' ' ALA . . . -52.07 -24.74 7.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.597 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 89.3 t -97.5 116.76 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.467 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.547 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.8 mttp -93.67 -177.81 0.75 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.496 -0.752 . . . . 0.0 109.633 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -67.63 -34.07 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.659 1.347 . . . . 0.0 110.048 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.43 -33.22 62.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.85 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.7 m-20 -81.55 -36.76 28.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.342 -0.849 . . . . 0.0 108.738 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -74.87 -15.17 60.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.93 -40.28 47.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.595 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.8 ptpt -75.34 -25.07 57.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -73.32 -36.02 66.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.83 -22.73 64.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.733 -0.604 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.24 -30.49 43.22 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.512 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 16.9 mt -82.8 -35.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.46 -36.59 68.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.5 t0 -87.03 -2.09 58.37 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.641 -0.662 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -86.48 -9.42 56.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 108.954 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.619 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.2 mt -102.96 -14.55 16.45 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.619 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.03 93.04 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -74.77 153.55 43.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.284 1.676 . . . . 0.0 111.068 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.1 t -120.92 105.86 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.512 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 65.04 12.64 8.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.218 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.71 33.83 5.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.575 ' CD1' ' OD1' ' A' ' 66' ' ' ASP . 76.9 m-85 -141.13 141.99 34.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.159 . . . . 0.0 111.882 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.8 mt -113.98 136.79 52.52 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 35' ' ' LYS . 3.3 p -83.5 146.01 28.61 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.77 -26.74 1.2 Allowed Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.433 ' N ' ' C ' ' A' ' 32' ' ' SER . 33.4 t0 -66.41 -26.22 67.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.579 -0.954 . . . . 0.0 109.991 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 6.1 mttp -92.26 -33.26 14.72 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG11 ' CD1' ' A' ' 40' ' ' LEU . 86.4 t -80.96 -47.12 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.415 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.585 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 20.6 tttm -39.67 -51.58 5.12 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 0.0 110.917 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -68.8 -34.39 18.4 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.355 1.187 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.601 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -62.84 -32.67 56.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.623 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 36.9 mt -90.62 -27.64 18.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.573 -0.704 . . . . 0.0 110.081 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.477 HD12 ' HE2' ' A' ' 37' ' ' LYS . 55.9 mt -74.77 -11.29 60.12 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.035 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -90.38 -9.21 48.47 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 110.185 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.3 p -78.39 5.98 9.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.1 tttt 69.23 9.02 7.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.935 . . . . 0.0 110.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.526 HD12 ' CG2' ' A' ' 49' ' ' ILE . 18.5 mt -93.82 157.25 38.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -75.68 171.89 17.35 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.251 1.658 . . . . 0.0 109.285 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.8 t -70.73 -4.76 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 109.189 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.17 -29.53 54.52 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 108.78 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.562 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 6.5 mm -87.89 -36.71 9.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.866 0.841 . . . . 0.0 108.755 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 13.4 mt -79.33 -26.72 42.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -72.52 -23.14 78.43 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.515 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 1.6 ttm105 -100.83 -32.49 10.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.972 -0.722 . . . . 0.0 109.723 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' A' ' 77' ' ' VAL . 12.9 t -68.91 -38.97 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.205 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.586 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 4.0 t-105 -67.49 -48.01 68.36 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.359 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.8 mm-40 -59.53 -58.28 9.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.154 -0.966 . . . . 0.0 109.848 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 5.6 mt -58.83 -17.39 23.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 108.483 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.557 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 10.2 t -88.25 -45.19 10.27 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.583 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -59.79 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.639 -0.663 . . . . 0.0 110.14 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.409 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 33.5 mm -67.98 -30.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 110.128 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.6 p30 -109.6 -15.67 14.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 9.9 m-70 62.02 41.17 11.39 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.406 -0.809 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.1 p-10 -93.13 3.9 54.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.989 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 89.03 23.01 36.39 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.4 mtp -152.79 162.1 41.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -1.168 . . . . 0.0 110.454 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' CD1' HG13 ' A' ' 36' ' ' VAL . 46.0 mt -119.4 112.33 19.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.422 -0.799 . . . . 0.0 109.502 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 30' ' ' PHE . 2.0 m-20 -69.39 159.22 33.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.283 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 19.7 ptt180 -41.52 -42.25 2.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 109.988 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.64 -34.69 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 66' ' ' ASP . 1.8 tt0 -69.35 -49.62 53.96 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 40.8 t80 -57.97 -19.8 33.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -70.56 -50.31 38.81 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.883 0.849 . . . . 0.0 109.587 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 94' ' ' LEU . 83.4 t -55.15 -24.87 15.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.458 0.647 . . . . 0.0 109.961 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -88.33 -10.46 49.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 111.972 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.59 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmm -84.58 -43.53 14.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 2.8 p90 -75.67 -22.88 56.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.645 -1.222 . . . . 0.0 107.751 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB3' HG21 ' A' ' 53' ' ' VAL . 5.0 mt -72.24 -22.16 61.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 53' ' ' VAL . 70.5 t -91.24 -44.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.765 -0.584 . . . . 0.0 109.513 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -65.14 -27.41 68.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.636 -0.665 . . . . 0.0 110.956 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.0 OUTLIER -77.17 -20.47 55.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.99 -1.068 . . . . 0.0 108.722 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.524 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -87.48 -7.32 57.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 81' ' ' LEU . 3.2 mt -90.99 -39.8 12.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.399 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 1.8 mt-10 -69.17 -52.55 26.88 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.362 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER 176.26 -24.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.606 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -80.88 112.79 35.15 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.982 -1.073 . . . . 0.0 110.847 -178.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.53 -162.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.958 1.504 . . . . 0.0 110.438 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.8 t -132.32 127.41 20.79 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 110.753 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 48.5 Cg_endo -83.16 -179.54 4.44 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.905 1.476 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.515 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 4.0 mtt -104.32 10.38 35.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.798 -1.189 . . . . 0.0 109.847 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 90' ' ' LEU . 68.3 m -108.73 104.14 13.36 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 112.115 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 4.1 mt -44.97 106.08 0.51 Allowed Pre-proline 0 C--N 1.293 -1.858 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.927 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 40.3 Cg_endo -68.06 145.55 67.67 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.75 1.395 . . . . 0.0 110.998 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.57 -7.97 22.39 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.228 1.646 . . . . 0.0 110.826 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.557 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -97.95 24.39 7.03 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD12 ' CD2' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -154.11 -35.08 0.1 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.499 0.666 . . . . 0.0 109.649 -178.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 95' ' ' VAL . 2.8 p -74.9 135.7 73.98 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.265 -0.897 . . . . 0.0 110.41 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.32 157.2 45.83 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.015 1.534 . . . . 0.0 110.48 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.43 -2.17 10.85 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.172 1.617 . . . . 0.0 110.654 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.54 -19.28 62.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.133 -0.98 . . . . 0.0 109.806 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -96.93 10.9 37.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 109.49 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.311 -0.868 . . . . 0.0 110.259 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' B' ' 108' ' ' THR . 3.0 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' B' ' 107' ' ' SER . 39.7 p 43.97 -163.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.424 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' B' ' 108' ' ' THR . 10.3 t-20 62.35 96.98 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 110.118 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 1.222 ' HB3' ' N ' ' A' ' 6' ' ' PRO . 51.9 Cg_endo -71.01 6.16 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 121.887 1.725 . . . . 0.0 111.964 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.623 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 7.7 m-85 -99.88 -63.77 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.222 . . . . 0.0 108.992 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.481 0.785 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.54 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.4 t90 -98.81 124.95 44.03 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.158 -0.964 . . . . 0.0 110.26 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -48.85 -27.75 3.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 0.0 109.935 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.54 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.4 t -92.14 122.64 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.472 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -80.33 176.01 4.22 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.192 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -70.08 -34.07 14.2 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.053 1.554 . . . . 0.0 109.788 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.2 pp20? -79.6 -22.59 43.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.421 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 m-20 -82.86 -38.49 22.89 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -73.81 -14.93 61.18 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.34 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.472 -0.768 . . . . 0.0 109.024 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.594 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.8 ptpt -72.97 -26.14 61.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.594 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -71.81 -35.2 69.87 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.81 -23.05 60.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.654 -0.654 . . . . 0.0 109.869 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.25 -32.19 38.34 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 66.7 mt -81.31 -31.9 11.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.543 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -73.26 -37.03 66.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.5 t70 -88.76 -1.49 58.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.658 -0.652 . . . . 0.0 110.119 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -4.15 57.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.21 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.5 mt -108.84 -8.66 15.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 87.04 95.0 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -72.09 148.56 50.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.314 1.691 . . . . 0.0 110.838 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 73.8 t -119.76 100.36 9.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 63.77 16.55 9.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 97.11 34.01 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.2 m-85 -149.48 147.41 28.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -1.191 . . . . 0.0 111.776 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.584 HD12 ' CE2' ' A' ' 70' ' ' PHE . 14.8 mt -116.63 134.45 54.81 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 34' ' ' ASP . 17.5 p -77.82 146.62 35.64 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.769 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.46 -27.19 1.18 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.454 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.3 m-20 -61.49 -25.42 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.869 . . . . 0.0 110.031 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 35.7 mttt -98.08 -32.19 11.74 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.111 -0.993 . . . . 0.0 108.338 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.582 HG23 ' CE2' ' A' ' 70' ' ' PHE . 97.9 t -83.54 -48.21 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.421 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.578 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 17.7 tttt -40.14 -53.56 5.02 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.49 -30.44 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.408 1.215 . . . . 0.0 109.703 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 2.2 t -68.81 -30.65 47.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 44.7 mt -88.79 -28.28 20.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.411 -0.806 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.411 HD11 ' HG3' ' A' ' 37' ' ' LYS . 44.3 mt -71.76 -11.25 60.73 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.014 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -90.08 -5.46 56.53 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.568 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.51 ' CB ' HG13 ' A' ' 77' ' ' VAL . 5.8 p -83.21 13.28 4.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.108 -0.995 . . . . 0.0 110.673 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 63.43 8.98 3.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.923 . . . . 0.0 110.676 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.549 HD11 ' CB ' ' A' ' 80' ' ' ALA . 15.2 mt -94.67 157.76 36.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 0.0 109.582 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.7 Cg_endo -75.28 173.66 14.13 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 124.023 1.538 . . . . 0.0 109.243 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.51 HG11 ' C ' ' B' ' 111' ' ' PHE . 3.0 t -74.45 -1.41 2.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.145 -0.972 . . . . 0.0 109.373 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -31.19 33.1 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.551 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 12.8 mm -83.02 -40.35 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.543 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 22.7 mt -73.84 -25.92 60.32 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.471 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -73.35 -25.28 73.31 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -100.86 -28.09 12.97 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.804 -0.821 . . . . 0.0 110.032 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 76' ' ' LEU . 17.0 t -72.58 -39.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.78 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 2.4 t-105 -65.09 -50.97 64.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.576 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.493 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 9.6 mm-40 -56.19 -53.84 52.39 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.548 ' O ' ' CD1' ' A' ' 90' ' ' LEU . 18.3 mt -64.46 -12.7 46.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.532 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 1.9 t -94.97 -29.73 14.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 108.88 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 7.4 t0 -74.5 100.75 3.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.692 -0.63 . . . . 0.0 109.65 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.476 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.1 mm -80.44 -29.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -102.1 -18.56 15.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 4.8 m170 65.72 42.12 3.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.0 p30 -102.28 -3.74 26.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 95.12 25.87 13.52 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 5.1 mtp -152.56 161.25 42.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.245 . . . . 0.0 110.618 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.509 HD13 ' CG1' ' A' ' 36' ' ' VAL . 13.5 mt -119.78 102.12 8.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.667 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 5.1 p30 -71.57 167.47 19.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.56 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.7 ptt-85 -37.55 -46.04 0.8 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.0 111.854 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 80.7 m-20 -76.68 -37.21 56.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.075 -1.016 . . . . 0.0 110.665 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 44.9 mt-10 -71.85 -44.5 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CE2' HD12 ' A' ' 31' ' ' LEU . 11.6 t80 -60.51 -17.37 45.0 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -79.24 -45.79 19.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.511 HG13 ' CD1' ' A' ' 94' ' ' LEU . 46.5 t -61.4 -25.97 38.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.476 0.655 . . . . 0.0 109.747 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.55 -8.23 50.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 111.258 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.566 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.7 mmt -83.24 -47.74 11.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -75.14 -28.73 60.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 6.7 mt -66.93 -28.67 68.48 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.532 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 41.0 t -91.38 -23.94 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.686 -0.634 . . . . 0.0 110.393 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -29.78 17.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.897 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 79.6 m -84.82 -15.65 44.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.65 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.549 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -81.42 -10.24 59.55 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.907 -1.121 . . . . 0.0 108.211 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 4.0 mt -91.77 -48.51 6.76 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.356 0.598 . . . . 0.0 110.273 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -129.65 33.14 4.5 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.965 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 79' ' ' CYS . 3.7 tptt -150.86 -88.79 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.503 -1.373 . . . . 0.0 111.042 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -134.55 154.87 79.9 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 110.102 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.33 -159.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.139 1.6 . . . . 0.0 110.622 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.469 HG21 ' CG2' ' A' ' 53' ' ' VAL . 59.0 t -113.56 146.71 35.99 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.241 -0.912 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 43.8 Cg_endo -86.97 -168.46 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.632 1.333 . . . . 0.0 109.472 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.425 ' HG3' ' C ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -124.88 15.21 8.6 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.004 -1.06 . . . . 0.0 111.361 -179.138 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' LEU . 29.8 t -159.5 20.15 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.565 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.575 ' CD2' HD13 ' A' ' 94' ' ' LEU . 6.7 mt 58.98 123.94 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.731 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 42.4 Cg_endo -71.55 150.17 56.89 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.876 1.461 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.85 -0.39 8.34 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.052 1.554 . . . . 0.0 111.459 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -105.37 12.03 32.08 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.243 -0.911 . . . . 0.0 109.209 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -135.66 -7.04 2.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.685 -0.635 . . . . 0.0 110.196 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.503 HG11 ' HD2' ' A' ' 96' ' ' PRO . 11.2 t -90.41 133.22 33.43 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.825 -1.172 . . . . 0.0 110.572 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.503 ' HD2' HG11 ' A' ' 95' ' ' VAL . 41.0 Cg_endo -66.73 174.29 6.79 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.894 1.471 . . . . 0.0 110.569 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.476 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 47.1 Cg_endo -72.19 -14.04 28.54 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.023 1.538 . . . . 0.0 111.256 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.6 m -67.35 -23.15 65.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.026 -1.046 . . . . 0.0 110.088 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 12.42 29.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.476 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 110.588 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.534 ' O ' ' N ' ' B' ' 109' ' ' ASN . 1.3 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.322 0.582 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.437 ' OG1' ' C ' ' B' ' 107' ' ' SER . 0.1 OUTLIER 43.91 -89.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.487 -0.758 . . . . 0.0 111.007 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 107' ' ' SER . 6.0 t-20 48.38 82.38 0.24 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 109.333 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.54 ' HB2' ' CD ' ' A' ' 37' ' ' LYS . 50.6 Cg_endo -68.52 8.27 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.259 1.972 . . . . 0.0 112.573 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 2.0 m-85 -102.88 -67.49 0.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.545 -1.347 . . . . 0.0 108.577 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.5 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 2.0 mtt-85 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.121 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 N--CA 1.482 0.817 0 N-CA-C 110.391 -0.657 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.2 t90 -95.51 123.43 39.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.091 -1.005 . . . . 0.0 109.95 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.6 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . . . -41.63 -32.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 110.298 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.634 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 69.9 t -102.99 136.92 33.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 109.598 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mtmt -88.42 175.09 4.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 110.24 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.5 Cg_endo -70.21 -34.37 13.19 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.975 1.513 . . . . 0.0 109.745 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -77.08 -22.44 52.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.743 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 3.1 m-20 -82.93 -36.78 24.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.81 . . . . 0.0 109.132 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.551 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -80.5 -24.51 39.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.78 91.12 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.583 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.0 ptpt -74.71 -28.67 60.9 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.4 m-30 -70.58 -36.71 73.72 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -63.8 -20.48 65.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.71 -0.619 . . . . 0.0 110.15 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.63 -36.1 33.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.452 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 47.8 mt -78.43 -31.43 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.48 -32.53 68.37 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -87.49 -5.61 58.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.579 -0.7 . . . . 0.0 109.859 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -85.46 -8.49 58.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 0.0 109.085 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 25' ' ' SER . 7.2 mt -100.4 -16.87 17.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.627 -0.671 . . . . 0.0 109.316 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.5 t 88.74 89.03 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 121.358 0.599 . . . . 0.0 109.877 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.7 Cg_endo -73.33 151.37 48.33 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.552 1.817 . . . . 0.0 110.854 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 55.9 t -121.3 104.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.89 18.09 11.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.439 -0.788 . . . . 0.0 109.413 -178.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.85 34.16 6.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.18 137.82 32.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 112.017 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 7.9 mt -110.3 158.5 18.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 35' ' ' LYS . 8.2 p -104.07 143.79 32.43 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.602 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.76 -25.78 0.65 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -70.85 -25.24 62.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.571 -0.958 . . . . 0.0 110.314 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 35.1 mttm -88.56 -36.01 16.6 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 40' ' ' LEU . 81.2 t -77.22 -41.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.08 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.51 -51.65 6.48 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.518 -0.739 . . . . 0.0 111.026 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.9 Cg_endo -70.62 -34.27 12.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.369 1.194 . . . . 0.0 109.878 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.565 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.51 -32.56 53.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.653 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 23.7 mt -90.56 -29.34 17.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.587 -0.696 . . . . 0.0 109.977 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.489 HD12 ' HE2' ' A' ' 37' ' ' LYS . 33.5 mt -69.75 -9.55 54.93 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -90.65 -8.68 49.37 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.565 -0.71 . . . . 0.0 111.173 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.535 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 84.5 p -82.18 15.36 2.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -0.976 . . . . 0.0 110.652 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.18 14.03 3.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -0.99 . . . . 0.0 110.197 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' CB ' ' A' ' 80' ' ' ALA . 17.5 mt -98.16 157.89 33.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.977 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.0 Cg_endo -74.88 166.71 28.67 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 124.067 1.562 . . . . 0.0 109.228 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 47' ' ' VAL . 13.9 t -68.26 -6.97 6.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -30.0 58.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.876 -1.14 . . . . 0.0 109.143 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.551 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.5 mm -83.81 -40.06 15.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 10.2 mt -71.02 -30.6 66.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' B' ' 109' ' ' ASN . . . -72.18 -26.22 72.73 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 2.3 ttm-85 -100.12 -28.41 13.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.825 -0.809 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.541 ' CG2' HG23 ' A' ' 86' ' ' VAL . 10.3 t -74.18 -34.7 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.602 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.1 t-105 -66.74 -53.05 37.4 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.131 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.6 mt-10 -48.65 -58.36 4.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.547 ' HA ' ' CD1' ' A' ' 90' ' ' LEU . 2.7 mt -62.65 -13.09 27.83 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.069 -1.053 . . . . 0.0 108.773 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -91.81 -42.72 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.255 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' TRP . 11.6 t0 -66.04 78.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.492 -0.755 . . . . 0.0 110.395 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.488 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 42.8 mm -51.47 -27.72 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.41 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.496 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 2.4 m-20 -102.84 -20.18 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.29 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.496 ' CD2' ' C ' ' A' ' 60' ' ' ASP . 9.1 m-70 59.89 47.1 10.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 33.4 p-10 -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.063 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.455 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 86.45 28.9 26.02 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.521 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.1 mtt -150.24 161.44 42.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 111.09 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' CD1' HG13 ' A' ' 36' ' ' VAL . 7.6 mt -130.99 109.72 10.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.842 . . . . 0.0 110.072 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 1.8 m-20 -69.8 159.34 33.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.981 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.583 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -41.21 -42.19 2.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.503 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 57.8 t0 -82.4 -33.3 28.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.5 tt0 -69.11 -50.46 47.89 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.171 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.572 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 57.3 t80 -55.93 -22.84 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -67.17 -48.67 67.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.455 -0.778 . . . . 0.0 110.055 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.579 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 76.9 t -58.27 -24.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.528 -0.732 . . . . 0.0 110.132 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -84.86 -13.36 51.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.246 -0.909 . . . . 0.0 112.166 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 9.2 mmm -85.92 -36.07 20.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.545 -1.347 . . . . 0.0 110.732 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.634 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 5.0 p90 -79.08 -26.3 43.02 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.611 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.8 mt -71.72 -22.33 61.65 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.562 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 72.6 t -90.82 -32.89 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.639 -0.663 . . . . 0.0 110.142 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -78.36 -23.24 47.02 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.441 -0.787 . . . . 0.0 110.045 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -83.02 -13.79 55.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.639 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.567 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -87.49 -14.18 41.09 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.189 -0.944 . . . . 0.0 109.125 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 9.6 mt -92.35 -45.91 7.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.602 -0.686 . . . . 0.0 110.844 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.54 -11.17 9.96 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.505 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.487 ' HB2' ' CA ' ' A' ' 79' ' ' CYS . 8.8 mmtt -106.97 -88.14 0.47 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.424 -1.422 . . . . 0.0 111.488 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 7.4 mm-40 -145.42 167.77 13.61 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.862 . . . . 0.0 109.843 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 84' ' ' GLU . 37.3 Cg_endo -62.44 -176.69 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.843 1.444 . . . . 0.0 110.428 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.541 HG23 ' CG2' ' A' ' 53' ' ' VAL . 84.8 t -115.07 122.18 33.86 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 111.024 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.533 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 51.1 Cg_endo -81.55 -167.09 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.964 1.507 . . . . 0.0 109.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.541 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 14.7 mtp -120.04 18.66 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.02 . . . . 0.0 110.338 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.554 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 66.6 m -101.06 118.02 36.16 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.79 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.547 ' CD1' ' HA ' ' A' ' 56' ' ' LEU . 2.1 mt -100.72 75.57 0.13 Allowed Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.07 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.554 ' CD ' ' O ' ' A' ' 89' ' ' SER . 41.1 Cg_endo -66.65 175.86 4.83 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.594 1.313 . . . . 0.0 110.749 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.1 Cg_endo -70.52 -7.16 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 124.019 1.536 . . . . 0.0 111.04 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.33 -8.62 58.62 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.352 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.6 ' CD2' ' CB ' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -125.78 5.71 7.4 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.382 -0.824 . . . . 0.0 110.467 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 91' ' ' PRO . 87.4 t -103.26 122.16 46.2 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.099 -1.0 . . . . 0.0 111.466 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.525 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.0 Cg_endo -70.33 179.43 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.988 1.52 . . . . 0.0 109.217 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 50.3 Cg_endo -78.9 28.74 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.49 1.258 . . . . 0.0 111.657 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.35 -42.23 5.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.837 -1.165 . . . . 0.0 109.226 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -90.02 12.25 18.18 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.773 . . . . 0.0 110.352 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.468 ' O ' ' HB ' ' B' ' 108' ' ' THR . 1.3 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.249 0.547 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' B' ' 109' ' ' ASN . 11.8 m 55.94 110.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLY . 35.1 t-20 59.1 91.68 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.535 ' HD2' ' CE1' ' B' ' 111' ' ' PHE . 49.5 Cg_endo -69.54 3.04 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.32 1.695 . . . . 0.0 111.77 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.653 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -104.16 -62.92 1.25 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.776 -1.202 . . . . 0.0 108.903 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.168 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.487 1.119 0 CA-C-O 121.519 0.549 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.586 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.7 t90 -70.35 123.52 21.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.597 -0.689 . . . . 0.0 109.725 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.578 ' CB ' HD22 ' A' ' 94' ' ' LEU . . . -45.44 -26.36 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.293 -0.879 . . . . 0.0 110.207 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.593 HG22 ' CD2' ' A' ' 75' ' ' PHE . 76.4 t -102.7 137.97 28.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.45 -0.781 . . . . 0.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 5.5 mttt -110.71 176.04 1.67 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.411 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 39.6 Cg_endo -65.53 -38.13 26.66 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.94 1.495 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 12.4 pt-20 -67.94 -36.43 80.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.045 -1.035 . . . . 0.0 109.172 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -81.21 -37.8 28.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 10' ' ' LYS . 3.4 tttt -76.17 -17.05 59.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 11' ' ' PRO . . . -71.85 -40.87 68.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.598 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -75.69 -26.61 57.74 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -71.15 -34.32 70.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -21.67 64.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.662 -0.649 . . . . 0.0 110.265 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -80.6 -36.2 33.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.052 -1.03 . . . . 0.0 108.414 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 69.9 mt -76.94 -30.93 18.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.545 ' CE1' ' HG3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -73.85 -39.66 63.83 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t70 -86.45 2.57 47.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.558 -0.714 . . . . 0.0 110.096 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 3.1 m -89.53 -11.5 42.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.329 -0.857 . . . . 0.0 109.333 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 25' ' ' SER . 6.4 mt -99.83 -15.14 18.51 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.608 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 t 86.01 81.68 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.299 0 CA-C-O 121.439 0.638 . . . . 0.0 109.674 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.545 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 44.6 Cg_endo -71.06 152.57 62.66 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.87 1.984 . . . . 0.0 111.103 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.1 t -118.92 117.22 53.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER 63.78 13.06 7.17 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.579 -178.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.51 34.1 8.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 23.1 m-85 -135.36 138.36 43.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -1.11 . . . . 0.0 111.647 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.596 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.1 mt -109.49 137.57 47.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 34' ' ' ASP . 3.9 p -85.06 142.28 29.67 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.105 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.31 -25.81 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . 32.8 t70 -69.18 -24.28 64.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.384 -1.069 . . . . 0.0 110.326 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 9.6 mttm -92.53 -35.35 13.64 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.018 -1.051 . . . . 0.0 108.17 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.572 HG23 ' CE2' ' A' ' 70' ' ' PHE . 96.3 t -75.32 -41.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.566 0.698 . . . . 0.0 110.403 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.79 -54.92 6.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 111.035 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.12 -32.48 34.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.443 1.233 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 3.3 t -63.84 -33.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.661 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 26.1 mt -89.92 -27.25 19.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 110.461 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.438 HD12 ' HG3' ' A' ' 37' ' ' LYS . 45.3 mt -68.26 -15.04 63.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -90.76 -2.45 57.8 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.708 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.469 ' HB2' HD13 ' A' ' 81' ' ' LEU . 79.6 p -82.65 12.67 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.591 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 63.57 10.55 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.536 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 16.8 mt -100.46 159.11 30.59 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.391 -0.818 . . . . 0.0 110.486 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.1 Cg_endo -76.39 171.77 17.47 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.113 1.586 . . . . 0.0 109.415 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 4.5 t -71.92 -3.49 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.526 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.45 -30.87 42.34 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.156 -0.965 . . . . 0.0 109.097 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.559 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.8 mm -84.1 -39.6 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.586 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 12.8 mt -72.2 -26.44 62.05 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.548 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -74.53 -26.54 67.43 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.109 -1.997 . . . . 0.0 108.109 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 86' ' ' VAL . 1.5 ttm180 -100.7 -25.47 14.13 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.92 -0.753 . . . . 0.0 110.215 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 77' ' ' VAL . 13.6 t -74.27 -36.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.917 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.79 -48.17 67.06 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.15 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.3 mm-40 -52.55 -58.18 7.58 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 110.089 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 87' ' ' PRO . 3.5 mt -62.85 -17.57 61.64 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.481 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.523 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 30.1 t -86.08 -30.59 22.48 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.4 t0 -71.12 101.36 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.543 -0.723 . . . . 0.0 109.683 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.52 ' CG2' ' HE2' ' A' ' 99' ' ' LYS . 47.8 mm -75.63 -42.4 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.613 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 31.2 p30 -104.41 -4.69 22.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.062 -1.024 . . . . 0.0 111.044 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 38.0 m170 60.86 44.4 10.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.171 -0.955 . . . . 0.0 110.541 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 38.1 p30 -100.05 26.51 6.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.237 -0.914 . . . . 0.0 109.059 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 58.53 31.69 67.41 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.8 mtt -150.91 161.04 43.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -1.05 . . . . 0.0 110.357 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.579 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 16.0 mt -123.6 102.29 7.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -69.29 157.51 36.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 14.2 ptt180 -37.06 -39.39 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.676 . . . . 0.0 110.81 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . 17.8 m-20 -79.51 -35.0 40.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 109.928 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 14.5 mt-10 -75.4 -40.95 57.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 31' ' ' LEU . 27.0 t80 -62.62 -23.88 67.3 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.87 -44.79 63.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.465 -0.772 . . . . 0.0 110.13 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.439 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 85.7 t -64.28 -22.16 30.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.022 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.526 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -89.81 -5.66 56.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmt -87.94 -44.44 11.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.828 -1.17 . . . . 0.0 109.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CD2' HG22 ' A' ' 9' ' ' VAL . 2.3 p90 -75.55 -26.64 58.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 12.0 mt -67.53 -28.05 67.49 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.565 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 27.2 t -92.24 -60.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.411 0.624 . . . . 0.0 109.817 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -46.62 -27.33 1.12 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.536 -0.727 . . . . 0.0 111.391 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 56.9 m -81.61 -12.08 58.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 110.088 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.536 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -90.22 -12.53 37.78 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.392 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.4 mp -89.97 -43.47 10.53 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.516 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 3.3 mt-10 -73.52 -58.17 3.49 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.659 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 177.0 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.754 -0.591 . . . . 0.0 110.616 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 3.4 tt0 179.88 108.13 0.18 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.739 -1.226 . . . . 0.0 110.844 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.99 163.53 35.42 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.838 1.441 . . . . 0.0 110.163 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.5 t -113.3 119.25 42.49 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.532 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.556 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 50.6 Cg_endo -85.34 -168.99 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.924 1.486 . . . . 0.0 109.81 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.476 ' HE1' ' HG3' ' A' ' 52' ' ' ARG . 18.8 mtt -111.83 18.1 19.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.555 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 3.0 m -93.6 119.35 32.52 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.898 -1.121 . . . . 0.0 112.823 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.538 ' HG ' ' HA ' ' A' ' 56' ' ' LEU . 3.0 mt -101.02 75.4 0.13 Allowed Pre-proline 0 N--CA 1.489 1.518 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.846 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.555 ' CD ' ' O ' ' A' ' 89' ' ' SER . 39.6 Cg_endo -64.92 164.57 24.2 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.629 1.331 . . . . 0.0 110.021 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.449 ' O ' HG23 ' A' ' 95' ' ' VAL . 43.0 Cg_endo -71.08 -5.39 16.89 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.934 1.492 . . . . 0.0 110.699 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.465 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -82.47 9.58 8.92 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 109.055 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.578 HD22 ' CB ' ' A' ' 8' ' ' ALA . 39.5 mt -121.06 -21.14 6.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 110.748 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 92' ' ' PRO . 9.9 m -65.06 140.18 97.97 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 110.739 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.48 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 41.7 Cg_endo -69.55 175.53 7.8 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.073 1.565 . . . . 0.0 109.828 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 41.5 Cg_endo -68.26 -20.95 42.36 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.875 1.46 . . . . 0.0 110.867 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -29.43 68.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.048 -1.032 . . . . 0.0 109.907 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.52 ' HE2' ' CG2' ' A' ' 59' ' ' ILE . 11.0 mmmt -90.72 12.05 20.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.317 -0.864 . . . . 0.0 109.64 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 96' ' ' PRO . 40.5 mtt180 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.356 -0.84 . . . . 0.0 110.848 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.172 0.511 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.426 ' O ' ' C ' ' B' ' 109' ' ' ASN . 13.3 p -117.15 -43.74 2.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.13 -0.982 . . . . 0.0 110.356 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.7 t-20 -42.8 112.05 1.1 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.26 -0.9 . . . . 0.0 109.899 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.5 Cg_endo -70.99 1.08 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.939 1.494 . . . . 0.0 112.015 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -105.67 -59.79 1.72 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.658 -1.276 . . . . 0.0 109.21 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.456 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 N-CA-C 110.575 -0.587 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.577 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.8 t90 -92.58 126.81 37.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 110.08 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -48.26 -27.18 2.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.577 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 40.7 t -94.43 149.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.829 . . . . 0.0 110.312 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.552 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -104.24 170.22 6.35 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.511 -0.743 . . . . 0.0 109.731 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.15 -34.45 28.18 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.59 1.311 . . . . 0.0 109.926 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 2.1 pm0 -74.62 -25.67 59.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.917 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.507 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -81.37 -40.27 23.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 108.566 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -13.07 62.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.6 mtmt -84.54 -37.93 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 5.8 m-30 -64.22 -23.38 67.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.93 -23.66 26.88 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.816 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.2 34.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.523 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 23.7 mt -79.46 -32.04 14.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -72.79 -40.15 66.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 2.2 t70 -85.85 1.19 50.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.652 -0.655 . . . . 0.0 109.79 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.447 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -92.91 -4.94 51.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.086 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -107.32 -6.98 16.87 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 82.76 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.8 Cg_endo -73.07 149.94 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.08 1.569 . . . . 0.0 110.998 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 54.3 t -117.62 103.47 14.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.504 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 66.03 13.26 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.212 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 99.53 32.12 5.84 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 87.7 m-85 -143.09 153.91 43.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.271 . . . . 0.0 111.7 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.3 mt -119.78 137.15 54.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 17.7 p -80.8 142.58 33.58 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.051 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.566 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.66 -27.05 0.3 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -66.11 -27.28 67.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -1.023 . . . . 0.0 110.457 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 51.7 mttp -92.3 -33.24 14.7 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.041 -1.037 . . . . 0.0 108.299 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 40' ' ' LEU . 60.4 t -82.32 -45.07 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.7 tttt -43.96 -52.78 14.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.763 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.1 Cg_endo -65.51 -33.72 45.34 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.39 1.205 . . . . 0.0 109.48 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.533 HG22 HD12 ' A' ' 24' ' ' LEU . 2.1 t -64.56 -38.39 82.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.61 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 59.3 mt -81.98 -30.06 31.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 42.7 mt -73.43 -13.92 61.16 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -88.55 -8.97 53.87 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.929 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.549 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 4.3 p -80.07 9.46 5.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.254 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 67.34 12.93 9.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.529 HD12 ' CG2' ' A' ' 49' ' ' ILE . 17.0 mt -98.01 153.41 38.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 110.04 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.4 Cg_endo -75.01 171.84 17.54 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 123.994 1.523 . . . . 0.0 109.313 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.48 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.03 -6.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 109.467 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -77.53 -31.01 53.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.863 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.552 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.6 mm -85.32 -41.17 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 15.2 mt -73.71 -28.79 61.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.22 -23.61 74.78 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.2 ttm180 -101.06 -37.94 8.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.933 -0.745 . . . . 0.0 109.552 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.49 HG12 ' CG2' ' A' ' 77' ' ' VAL . 21.1 t -64.06 -39.79 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.631 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.566 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.6 t-105 -67.13 -51.38 54.72 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.463 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 56.1 mt-10 -53.24 -56.46 16.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.568 HD21 ' CA ' ' A' ' 90' ' ' LEU . 4.5 mt -61.33 -15.15 32.95 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.536 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 16.1 m -93.59 -33.97 13.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.522 -0.737 . . . . 0.0 109.527 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -67.72 69.1 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.452 -0.78 . . . . 0.0 110.056 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.483 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -50.56 -30.33 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -106.71 -15.3 14.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.878 . . . . 0.0 109.889 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 93.1 m-70 57.31 45.72 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.362 -0.836 . . . . 0.0 111.66 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.6 p-10 -107.21 28.91 7.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.403 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 66.25 25.93 72.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 12.8 mtp -151.06 161.37 42.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 110.199 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.522 ' CD1' HG12 ' A' ' 36' ' ' VAL . 8.6 mt -122.03 110.31 15.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.863 . . . . 0.0 109.798 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.58 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 6.3 t0 -68.71 163.96 22.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.561 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -49.27 -30.38 7.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.182 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -86.83 -33.56 19.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 42.4 mt-10 -75.59 -43.79 46.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.5 t80 -54.39 -34.0 60.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -59.21 -57.29 13.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.57 0.7 . . . . 0.0 110.253 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.526 ' CG2' HD23 ' A' ' 94' ' ' LEU . 44.9 t -52.23 -22.8 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -89.15 -10.22 48.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.3 mmm -89.41 -44.3 10.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.472 -1.393 . . . . 0.0 110.608 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.509 ' CE1' HD21 ' A' ' 94' ' ' LEU . 2.9 p90 -76.04 -19.4 58.67 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.466 ' HB3' HG23 ' A' ' 53' ' ' VAL . 6.2 mt -79.33 -25.5 42.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.549 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 17.6 t -91.11 -41.8 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.68 -25.67 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.423 -0.798 . . . . 0.0 110.266 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 1.2 m -80.1 -14.8 58.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.517 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -88.67 -10.09 49.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.143 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.567 HD21 ' N ' ' A' ' 81' ' ' LEU . 4.5 mt -90.51 -41.76 11.23 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 32.7 mm-40 -69.64 -53.25 19.6 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.611 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.6 ttmt 176.6 -26.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.186 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -67.49 116.83 41.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.189 -0.944 . . . . 0.0 111.457 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.89 177.93 7.06 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.806 1.424 . . . . 0.0 109.42 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 31.2 t -128.49 121.32 21.25 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.957 -1.089 . . . . 0.0 111.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.505 ' O ' HD13 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -85.53 166.64 10.44 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.86 1.453 . . . . 0.0 109.086 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.55 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 6.6 mtp -90.36 14.25 13.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.921 -1.112 . . . . 0.0 110.477 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 72.3 m -109.03 103.21 12.2 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.439 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.568 ' CA ' HD21 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -62.95 109.55 2.56 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.7 Cg_endo -66.08 147.28 84.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.818 1.43 . . . . 0.0 111.19 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.01 -7.27 21.07 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.321 1.695 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -84.32 -30.77 25.26 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.552 ' C ' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -93.14 -18.21 22.85 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.14 142.23 92.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 110.248 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 44.4 Cg_endo -72.12 163.83 37.54 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.915 1.481 . . . . 0.0 110.508 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 45.2 Cg_endo -72.46 -32.5 9.9 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.111 1.585 . . . . 0.0 111.089 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.8 m -64.2 -24.24 67.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.964 -1.085 . . . . 0.0 110.068 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.484 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -96.61 13.08 29.42 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.291 -0.88 . . . . 0.0 109.417 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.851 . . . . 0.0 110.355 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.237 0.542 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.08 -12.89 13.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 110.394 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' B' ' 111' ' ' PHE . 27.1 t-20 -137.82 120.6 11.19 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.479 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -76.41 12.57 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.488 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.61 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 9.8 m-85 -107.27 -61.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.798 -1.189 . . . . 0.0 109.08 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.056 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.482 0.845 0 N-CA-C 110.143 -0.753 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.575 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.5 t90 -52.54 124.45 13.64 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.991 -1.068 . . . . 0.0 109.237 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.586 ' CB ' HD21 ' A' ' 94' ' ' LEU . . . -40.14 -27.97 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.34 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.575 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 25.5 t -97.98 126.17 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 109.757 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.8 mttp -82.12 173.66 7.27 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 110.45 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.2 Cg_endo -68.31 -33.96 22.49 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.091 1.574 . . . . 0.0 109.387 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.01 -18.95 48.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.546 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.82 -43.19 15.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.91 61.59 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.09 61.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.47 -23.52 50.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 9.9 m-30 -74.98 -33.96 61.94 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.98 -22.27 63.16 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.734 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -78.23 -32.97 50.04 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.509 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 44.7 mt -81.55 -32.7 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' HB2' ' CG ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -73.36 -31.58 64.02 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.6 t0 -90.83 -3.22 57.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 71.6 p -87.84 -8.51 55.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.624 ' O ' ' CB ' ' A' ' 25' ' ' SER . 8.5 mt -98.81 -14.88 19.48 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.624 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 p 94.52 91.41 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.296 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.4 Cg_endo -72.73 147.27 44.63 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.194 1.628 . . . . 0.0 110.638 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 77.1 t -115.22 100.27 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 64.47 15.26 9.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 109.69 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.24 32.53 5.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 75.5 m-85 -145.63 148.75 33.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.17 . . . . 0.0 111.59 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 10.2 mt -115.0 159.03 21.26 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 35' ' ' LYS . 86.4 p -104.52 143.8 32.55 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.031 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.7 -25.32 0.86 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' SER . 1.6 t70 -71.67 -23.69 61.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.954 . . . . 0.0 110.354 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.3 mttp -92.36 -33.06 14.73 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.011 -1.055 . . . . 0.0 108.257 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.535 HG13 ' CD1' ' A' ' 40' ' ' LEU . 89.2 t -77.54 -38.42 26.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.296 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -42.54 -54.5 8.1 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -65.81 -32.62 45.88 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.622 1.327 . . . . 0.0 109.56 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.591 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.53 -31.97 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.654 ' CD1' ' CZ ' ' B' ' 111' ' ' PHE . 27.2 mt -92.91 -30.48 15.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.496 -0.753 . . . . 0.0 110.269 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 57.5 mt -72.39 -12.11 60.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -90.79 -9.63 45.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.417 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.52 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 92.2 p -81.32 11.0 4.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.363 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.59 14.75 9.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD11 ' CB ' ' A' ' 80' ' ' ALA . 14.4 mt -96.76 154.35 38.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.828 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.0 Cg_endo -75.38 169.26 22.81 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.939 1.494 . . . . 0.0 109.072 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.462 HG13 ' O ' ' B' ' 111' ' ' PHE . 2.1 t -69.87 -3.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.965 -1.085 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.63 -27.77 40.96 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.161 -0.962 . . . . 0.0 109.235 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.548 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.3 mm -87.81 -36.94 10.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 9.5 mt -76.23 -27.19 56.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -74.08 -25.84 70.19 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 87' ' ' PRO . 1.7 ttm-85 -101.19 -31.19 11.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.048 -0.678 . . . . 0.0 110.242 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' ILE . 13.1 t -70.5 -34.27 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.044 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.623 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 5.1 t-105 -68.17 -56.78 7.51 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.262 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 3.4 mm-40 -43.17 -64.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.35 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.599 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 4.6 mt -55.6 -20.01 12.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.952 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 57.8 m -91.61 -19.84 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.479 -0.763 . . . . 0.0 109.403 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.9 t0 -96.1 86.19 4.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.512 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -91.05 -13.93 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.63 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 11.1 m-20 -92.36 -12.65 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.457 ' N ' ' CD2' ' A' ' 61' ' ' HIS . 5.2 m170 56.8 47.11 18.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 110.648 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 21.9 p-10 -128.12 25.47 5.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.17 38.44 93.15 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.493 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 6.7 mtt -150.37 161.08 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -1.162 . . . . 0.0 111.981 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.596 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 13.9 mt -125.45 103.69 8.03 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.41 160.4 32.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.997 -1.065 . . . . 0.0 110.682 -179.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.437 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ptm180 -36.48 -44.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.774 -0.579 . . . . 0.0 111.392 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 t70 -79.53 -31.93 42.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.662 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.465 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 28.0 mt-10 -76.03 -45.38 34.69 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.079 -1.013 . . . . 0.0 109.134 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.6 t80 -58.19 -18.47 26.17 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.29 -45.82 37.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.444 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.78 -26.12 34.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 109.538 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.79 -5.61 55.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 111.193 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.596 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.2 mmt -84.43 -49.53 8.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.923 -1.111 . . . . 0.0 109.839 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.636 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.1 p90 -73.79 -28.26 61.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.593 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.1 mt -64.54 -28.23 69.5 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.527 ' CG2' ' CD2' ' A' ' 40' ' ' LEU . 45.8 t -91.25 -23.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.828 -0.545 . . . . 0.0 110.591 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.4 -23.22 23.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -0.972 . . . . 0.0 109.802 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.3 m -84.12 -12.85 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.537 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -87.86 -14.31 39.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 81' ' ' LEU . 1.7 mt -91.27 -39.93 11.79 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.853 0.835 . . . . 0.0 109.188 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 6.5 tp10 -68.15 -57.38 6.14 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.515 0.674 . . . . 0.0 109.462 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 177.14 -22.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 111.246 179.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' CYS . 4.0 mt-10 -70.86 118.18 62.84 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 110.845 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.99 165.38 32.76 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.808 1.425 . . . . 0.0 109.802 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.508 ' CG1' HG22 ' A' ' 53' ' ' VAL . 95.7 t -111.91 129.09 24.56 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.2 -0.938 . . . . 0.0 110.015 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.541 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 46.6 Cg_endo -90.16 -161.73 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.763 1.402 . . . . 0.0 109.642 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.531 ' HG2' ' NH1' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -130.19 3.08 4.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.49 -0.756 . . . . 0.0 109.566 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 67.7 m -105.7 102.21 11.68 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.597 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.599 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 4.7 mt -52.01 106.05 0.6 Allowed Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.61 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 40.6 Cg_endo -69.82 165.34 31.36 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.835 1.439 . . . . 0.0 110.298 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.78 -25.93 16.46 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.156 1.608 . . . . 0.0 111.332 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -84.96 6.3 25.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.952 -1.092 . . . . 0.0 109.689 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.636 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 4.5 mm? -117.45 -0.19 12.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 111.061 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 95' ' ' VAL . 32.8 m -110.94 138.02 21.03 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.06 -1.025 . . . . 0.0 111.534 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.477 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.5 Cg_endo -70.07 176.0 7.59 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.202 1.633 . . . . 0.0 109.594 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.0 Cg_endo -70.16 -11.06 29.63 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.548 1.288 . . . . 0.0 110.808 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 t -80.42 -12.5 59.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.035 -1.041 . . . . 0.0 109.64 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 34.7 tptt -89.55 -4.67 57.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.483 -0.761 . . . . 0.0 109.216 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 110.48 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.493 ' O ' ' N ' ' B' ' 109' ' ' ASN . 1.7 t . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.19 0.519 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.49 ' O ' ' O ' ' B' ' 109' ' ' ASN . 25.0 m 63.26 -64.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.513 -0.742 . . . . 0.0 110.994 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.533 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 0.9 OUTLIER 59.44 148.82 0.08 OUTLIER Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.193 -0.942 . . . . 0.0 109.067 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.648 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 41.7 Cg_endo -72.38 -2.42 11.69 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.168 1.088 . . . . 0.0 109.922 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.654 ' CZ ' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.5 -66.72 0.99 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.911 -1.118 . . . . 0.0 108.792 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.261 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 N--CA 1.484 0.942 0 N-CA-C 110.663 -0.553 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.573 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 -86.18 131.13 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.436 -0.79 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.581 ' CB ' HD22 ' A' ' 94' ' ' LEU . . . -47.74 -27.66 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 111.126 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 53.7 t -91.76 147.19 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 9.3 mttm -104.06 176.32 1.83 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.548 -0.72 . . . . 0.0 109.788 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.7 Cg_endo -67.89 -35.44 20.91 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.769 1.405 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.3 pt-20 -74.75 -29.08 61.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 35.3 m-20 -82.2 -33.14 29.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.296 -0.878 . . . . 0.0 109.07 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.461 ' HD3' ' O ' ' A' ' 14' ' ' LYS . 1.1 tmtt? -78.17 -13.21 59.95 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.199 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -79.29 -41.98 26.85 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.82 -26.2 61.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -73.32 -35.52 66.08 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.74 -23.56 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.831 -0.543 . . . . 0.0 109.765 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -79.14 -34.88 42.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.0 mt -79.35 -31.55 14.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.94 -36.71 59.26 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -90.4 3.98 52.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 0.0 109.609 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -91.9 -9.35 43.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 108.967 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.6 mt -104.8 -8.05 19.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 87.2 99.89 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.043 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 47.2 Cg_endo -70.68 146.72 55.25 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.453 1.765 . . . . 0.0 110.425 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.3 t -115.7 96.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.47 20.45 12.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 94.14 33.84 6.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 85.4 m-85 -150.24 145.69 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -1.191 . . . . 0.0 111.737 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.9 mt -112.8 149.22 33.36 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.518 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 24.8 p -99.22 144.86 27.86 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.182 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -40.96 -27.52 0.19 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.2 m-20 -65.38 -23.97 67.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -1.079 . . . . 0.0 110.407 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 25' ' ' SER . 69.8 mttt -99.22 -31.8 11.54 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.077 -1.014 . . . . 0.0 108.941 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.577 HG21 ' CE2' ' A' ' 70' ' ' PHE . 95.2 t -79.72 -42.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -42.0 -55.0 6.65 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.848 . . . . 0.0 110.868 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.84 -32.83 35.54 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.494 1.26 . . . . 0.0 109.866 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.489 ' CG2' HD22 ' A' ' 24' ' ' LEU . 3.6 t -65.22 -28.96 45.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 38.0 mt -92.95 -26.21 17.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.52 -0.737 . . . . 0.0 110.342 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 74.2 mt -73.5 -9.09 58.33 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.193 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.22 -4.13 57.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.944 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.576 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -84.65 10.38 11.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.1 -1.0 . . . . 0.0 110.283 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.9 OUTLIER 66.85 7.62 5.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 109.979 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 46' ' ' PRO . 13.9 mt -94.58 157.12 37.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.9 Cg_endo -77.0 176.4 10.18 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.079 1.568 . . . . 0.0 109.841 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.507 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.3 t -73.25 -4.44 5.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.14 -29.89 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.924 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.5 mm -86.37 -40.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 19.5 mt -76.3 -28.32 56.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -70.12 -25.16 75.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.535 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.3 ttm105 -101.46 -34.09 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.117 -0.637 . . . . 0.0 110.043 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 49' ' ' ILE . 24.5 t -67.37 -36.01 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.92 -1.113 . . . . 0.0 108.889 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.568 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.9 t-105 -66.82 -53.57 31.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.16 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 8.2 mt-10 -47.27 -58.04 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.126 -0.984 . . . . 0.0 110.396 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.3 mt -63.04 -12.66 27.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.049 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 47.0 m -94.97 -40.43 9.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 61.9 t0 -84.36 70.84 10.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 110.01 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.466 HG22 ' HE2' ' A' ' 99' ' ' LYS . 5.0 mt -61.04 -16.5 14.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 110.492 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 26.1 m-20 -91.98 -15.53 27.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.68 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 88.0 m-70 51.27 34.19 11.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.2 p-10 -103.03 4.68 37.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.993 . . . . 0.0 110.042 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.505 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 86.89 26.62 31.24 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.2 mmm -148.3 161.65 41.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.217 -1.167 . . . . 0.0 110.036 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 36' ' ' VAL . 12.1 mt -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.301 -0.874 . . . . 0.0 109.657 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.579 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 21.7 t0 -69.07 167.11 16.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.268 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 6.7 ptm180 -49.86 -39.23 38.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -35.49 38.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 109.448 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 57' ' ' SER . 40.3 mt-10 -72.56 -47.04 51.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 109.166 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.577 ' CE2' HG21 ' A' ' 36' ' ' VAL . 26.2 t80 -57.86 -26.79 62.55 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.491 -0.756 . . . . 0.0 109.028 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -68.47 -48.53 64.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.881 . . . . 0.0 110.115 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.443 ' O ' HD12 ' A' ' 76' ' ' LEU . 60.7 t -58.34 -22.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.688 -0.633 . . . . 0.0 109.847 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -88.5 -12.49 42.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.747 . . . . 0.0 111.96 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.7 mmm -85.6 -40.36 16.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.656 -1.277 . . . . 0.0 110.472 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.588 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 3.3 p90 -77.9 -25.19 48.34 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.788 -1.165 . . . . 0.0 107.894 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.504 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 4.6 mt -73.19 -20.13 60.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.544 0.688 . . . . 0.0 109.212 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.576 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 42.2 t -91.59 -49.82 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.849 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.565 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 3.4 m-85 -64.16 -41.07 97.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.471 -0.768 . . . . 0.0 110.711 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 59.9 m -80.67 -9.16 59.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.399 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 76' ' ' LEU . . . -92.97 -31.93 14.72 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.129 0.966 . . . . 0.0 109.136 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' CD2' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -90.33 -23.24 21.19 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.638 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 4.6 tp10 -70.11 -57.41 4.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.02 . . . . 0.0 109.855 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 22.4 ttmt -178.06 57.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.619 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 1.8 tt0 -165.87 139.5 3.59 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.021 -1.05 . . . . 0.0 110.726 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.41 ' HD2' ' HG3' ' A' ' 84' ' ' GLU . 51.1 Cg_endo -78.79 168.93 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.97 1.511 . . . . 0.0 110.458 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 80.0 t -121.09 126.01 26.77 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.477 ' O ' HD13 ' A' ' 56' ' ' LEU . 48.9 Cg_endo -85.16 152.96 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.846 1.446 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.535 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 24.8 mtm -88.13 17.58 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.515 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 38.9 m -113.41 99.9 8.13 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.836 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.586 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -57.31 106.93 0.76 Allowed Pre-proline 0 C--N 1.291 -1.96 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.649 178.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.573 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 43.2 Cg_endo -68.66 161.58 44.68 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.868 1.457 . . . . 0.0 110.148 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.95 -16.1 25.96 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.906 1.477 . . . . 0.0 110.965 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' C ' HD21 ' A' ' 94' ' ' LEU . . . -91.84 26.22 2.48 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 108.753 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.588 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -128.6 -31.35 2.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.625 -0.672 . . . . 0.0 110.903 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.3 m -81.52 142.95 50.5 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 110.642 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.7 168.93 18.67 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.191 1.627 . . . . 0.0 109.33 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 44.6 Cg_endo -71.01 56.39 1.92 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.655 1.345 . . . . 0.0 110.577 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.08 -47.24 0.27 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 99' ' ' LYS . 2.4 tmtm? -90.28 7.14 39.82 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.053 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.421 ' O ' ' OG1' ' B' ' 108' ' ' THR . 80.0 p . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.16 0.505 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.462 ' O ' ' HD3' ' B' ' 110' ' ' PRO . 29.8 m -165.66 -57.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 110.349 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.466 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 16.6 t-20 -51.98 106.93 0.72 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 110.067 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.566 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 51.2 Cg_endo -71.62 5.54 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.165 1.613 . . . . 0.0 112.01 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 6.9 m-85 -101.66 -62.83 1.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.658 -1.276 . . . . 0.0 109.167 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.362 179.685 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 N--CA 1.483 0.879 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.572 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -88.85 120.89 30.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.578 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.534 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -42.58 -28.06 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.97 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.7 t -97.42 152.6 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 110.045 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.0 mmmt -105.9 171.81 4.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.923 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.9 Cg_endo -67.61 -35.48 22.33 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.753 1.397 . . . . 0.0 109.46 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.21 -31.01 68.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -81.53 -33.72 31.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 10.9 tptp -74.76 -16.35 60.73 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.68 -38.65 47.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -78.52 -25.02 45.45 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.2 m-30 -75.33 -37.51 60.68 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 30.5 t70 -69.17 -18.58 63.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.653 -0.654 . . . . 0.0 109.655 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -83.08 -39.06 21.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 66.9 mt -75.14 -34.13 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -68.6 -41.17 79.96 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t70 -84.89 -0.64 54.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.587 -0.696 . . . . 0.0 109.905 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 36.7 t -86.49 -9.68 55.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.267 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.614 ' O ' ' CB ' ' A' ' 25' ' ' SER . 6.4 mt -100.75 -11.4 19.94 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.09 93.79 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 48.5 Cg_endo -74.25 151.06 43.07 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.385 1.729 . . . . 0.0 110.905 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -120.8 98.5 6.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 69.34 22.12 6.7 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.693 0.758 . . . . 0.0 109.207 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.85 37.43 7.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.559 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 71.9 m-85 -147.2 140.38 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -1.159 . . . . 0.0 111.766 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.6 mt -110.09 137.79 47.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.42 142.53 30.04 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.846 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.54 -25.87 0.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -70.01 -24.21 63.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.588 -0.948 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 39' ' ' VAL . 43.4 mttp -91.69 -35.12 14.36 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' CD1' ' A' ' 40' ' ' LEU . 90.8 t -79.68 -48.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.444 0.64 . . . . 0.0 110.296 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.6 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 9.0 tttp -38.94 -55.24 2.9 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.582 -0.699 . . . . 0.0 110.8 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.8 Cg_endo -66.18 -29.8 47.0 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.576 1.303 . . . . 0.0 110.025 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 24' ' ' LEU . 2.5 t -70.59 -31.74 47.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.522 -0.736 . . . . 0.0 109.07 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.64 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 32.9 mt -85.44 -28.63 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -0.822 . . . . 0.0 109.772 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 69.8 mt -69.63 -11.29 60.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.02 -5.01 57.09 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.556 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -81.97 14.52 2.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 110.144 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.73 15.34 1.56 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.812 -1.18 . . . . 0.0 109.847 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.572 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 14.0 mt -101.08 156.13 35.5 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.4 Cg_endo -73.61 160.74 43.54 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 123.803 1.422 . . . . 0.0 109.409 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 47' ' ' VAL . 38.2 t -63.26 -11.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.17 -0.957 . . . . 0.0 109.187 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -70.03 -29.73 66.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 108.815 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.547 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.1 mm -82.97 -42.47 17.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.961 0.886 . . . . 0.0 108.733 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.57 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 12.5 mt -71.72 -30.81 66.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.495 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -68.09 -25.05 74.59 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -101.82 -34.1 9.55 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.062 -0.669 . . . . 0.0 110.491 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.532 ' CG1' HG21 ' A' ' 77' ' ' VAL . 40.8 t -65.62 -38.13 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.156 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.4 t-105 -68.68 -50.73 48.73 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.462 -0.774 . . . . 0.0 110.412 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.0 mm-40 -51.04 -52.12 46.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.973 -1.079 . . . . 0.0 110.194 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.51 HD22 ' CA ' ' A' ' 90' ' ' LEU . 2.9 mt -64.69 -11.61 37.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.099 -1.0 . . . . 0.0 108.543 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.572 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 1.6 p -93.37 -46.7 7.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' CG ' ' HA ' ' A' ' 61' ' ' HIS . 3.5 t0 -59.56 78.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 110.308 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.514 HD13 HG22 ' A' ' 59' ' ' ILE . 43.8 mm -54.48 -27.1 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.24 -0.913 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 34.1 p30 -108.62 -13.66 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 85.1 m-70 58.63 47.33 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 10.9 p-10 -110.51 16.51 21.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.854 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 77.43 29.92 54.88 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.0 mtt -149.44 161.36 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -1.198 . . . . 0.0 110.636 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.537 ' CD2' ' OG ' ' A' ' 57' ' ' SER . 8.3 mt -127.84 107.0 9.49 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 5.0 t0 -69.58 162.61 27.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.583 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -46.63 -40.46 13.05 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.497 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 2.5 p30 -76.34 -42.04 46.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 109.856 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 30.8 mt-10 -66.27 -41.04 90.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.612 0.72 . . . . 0.0 109.059 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 47.1 t80 -63.49 -21.38 66.29 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 68' ' ' ASP . . . -71.93 -43.07 65.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.507 0.67 . . . . 0.0 109.689 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.29 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB1' ' CB ' ' A' ' 57' ' ' SER . . . -90.28 -2.13 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.483 -0.761 . . . . 0.0 111.176 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.56 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.8 mmt -88.39 -46.46 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 109.487 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.2 p90 -76.56 -19.1 58.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 53' ' ' VAL . 8.6 mt -77.13 -23.84 51.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.56 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 38.5 t -91.63 -46.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.654 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 1.4 m-85 -62.54 -28.89 70.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.536 -0.727 . . . . 0.0 111.514 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -82.26 -12.34 58.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.931 -1.106 . . . . 0.0 110.137 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.572 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -82.47 -19.62 38.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 0.8 OUTLIER -90.94 -42.32 10.64 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.733 0.778 . . . . 0.0 110.796 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 16.5 tp10 -68.88 -59.24 3.21 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.413 0.625 . . . . 0.0 110.214 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 176.06 47.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.479 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' CYS . 7.2 tp10 -151.02 110.28 3.06 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.737 -1.227 . . . . 0.0 110.856 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.06 164.23 32.79 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.871 1.458 . . . . 0.0 109.794 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 76.0 t -110.78 119.62 45.73 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.135 -0.978 . . . . 0.0 110.63 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.508 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.8 Cg_endo -82.78 175.01 9.1 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.968 1.51 . . . . 0.0 109.009 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.487 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 2.6 mtm -99.14 12.89 34.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.548 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 18.5 m -100.54 114.39 27.98 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.398 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -99.93 87.71 0.76 Allowed Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 89' ' ' SER . 37.9 Cg_endo -63.11 173.78 3.73 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.252 1.301 . . . . 0.0 111.425 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.8 Cg_endo -72.2 -14.62 28.67 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.27 1.669 . . . . 0.0 110.726 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -75.02 -9.91 58.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.222 -0.924 . . . . 0.0 108.902 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.534 HD23 ' CB ' ' A' ' 8' ' ' ALA . 3.7 mm? -99.85 -22.05 15.48 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.522 -0.736 . . . . 0.0 110.341 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.463 HG12 ' HG2' ' A' ' 99' ' ' LYS . 71.0 t -68.75 126.62 92.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.307 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.33 169.52 21.43 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.933 1.491 . . . . 0.0 110.265 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.44 -21.63 22.48 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.067 1.562 . . . . 0.0 110.148 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.64 -12.53 60.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.202 -0.936 . . . . 0.0 109.563 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' HG2' HG12 ' A' ' 95' ' ' VAL . 19.7 tptt -89.49 -4.84 57.77 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.356 -0.84 . . . . 0.0 109.126 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 179.369 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.403 ' C ' ' OG1' ' B' ' 108' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.261 0.553 . . . . 0.0 110.17 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.413 ' O ' ' C ' ' B' ' 109' ' ' ASN . 0.2 OUTLIER -161.1 -172.9 3.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 0.0 110.032 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.45 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 14.7 t-20 -44.13 107.41 0.6 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.162 -0.961 . . . . 0.0 109.945 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.567 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.0 Cg_endo -69.81 2.68 3.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.139 1.599 . . . . 0.0 111.913 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 2.4 m-85 -103.49 -54.89 2.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.703 -1.248 . . . . 0.0 109.371 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.319 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.485 0.976 0 N-CA-C 110.646 -0.559 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.474 ' CH2' ' HE2' ' A' ' 14' ' ' LYS . 11.2 t90 -88.54 128.95 35.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.903 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.587 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -49.13 -26.97 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 110.826 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.69 146.57 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.1 mttt -99.17 169.98 7.47 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.614 -0.679 . . . . 0.0 109.785 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -66.57 -35.12 30.73 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.609 1.321 . . . . 0.0 109.609 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.669 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.4 m-20 -79.61 -41.51 26.9 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' HE2' ' CH2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -66.36 -16.16 63.85 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.736 0.779 . . . . 0.0 108.908 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.1 -37.91 57.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 3.1 mtmt -81.67 -40.32 23.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.4 m-30 -63.29 -23.61 67.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.3 t70 -85.54 -24.77 27.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.582 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.96 -32.4 39.9 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.574 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.0 mt -79.08 -35.24 17.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -70.06 -39.65 75.55 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.5 t0 -87.49 1.24 54.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 110.073 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 6.7 t -89.36 -7.03 56.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.0 109.069 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.618 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.6 mt -107.26 -13.06 15.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.39 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.6 Cg_endo -73.6 151.34 46.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.322 1.696 . . . . 0.0 110.975 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 48.4 t -116.58 115.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.0 t30 56.77 17.9 3.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 108.816 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 91.73 37.63 6.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 73.3 m-85 -149.7 138.11 20.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.111 -1.229 . . . . 0.0 112.449 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.3 mt -104.79 145.29 30.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.498 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 52.7 p -95.89 145.58 25.27 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 110.087 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -41.01 -27.57 0.2 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 79.1 m-20 -64.04 -26.17 68.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.386 -1.067 . . . . 0.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 49.3 mttm -96.84 -32.03 12.3 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.125 -0.984 . . . . 0.0 108.659 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG22 ' CE2' ' A' ' 70' ' ' PHE . 98.9 t -79.6 -43.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.551 -0.718 . . . . 0.0 110.73 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 15.2 tttt -43.18 -51.11 14.24 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 110.725 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -67.04 -32.02 35.63 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.213 1.112 . . . . 0.0 109.6 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.591 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.9 t -68.23 -29.94 46.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.636 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 50.5 mt -92.0 -32.34 15.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.491 -0.755 . . . . 0.0 110.867 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.535 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 22.9 mt -70.55 -14.0 62.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.062 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -90.39 -3.25 57.83 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.642 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.508 ' CB ' HG11 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.44 17.23 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.962 . . . . 0.0 110.299 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.87 11.77 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.658 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.576 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 18.9 mt -100.82 153.18 37.88 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.9 Cg_endo -76.53 173.68 14.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.036 1.545 . . . . 0.0 109.522 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 111' ' ' PHE . 2.1 t -73.09 -3.86 4.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.91 -1.119 . . . . 0.0 109.383 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -78.24 -29.79 48.36 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.563 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 11.1 mm -85.84 -39.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 15.4 mt -75.19 -29.05 60.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -67.41 -26.12 73.62 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -101.16 -35.09 9.43 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.005 -0.703 . . . . 0.0 109.85 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.529 ' CG1' HG23 ' A' ' 77' ' ' VAL . 41.3 t -64.57 -39.66 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.081 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.6 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -65.74 -52.79 48.25 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.067 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mm-40 -56.0 -58.66 6.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 5.0 mt -56.14 -19.22 12.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.913 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.53 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 13.5 t -91.93 -35.67 13.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.577 0.703 . . . . 0.0 109.683 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.566 ' OD2' ' CE2' ' A' ' 54' ' ' TRP . 1.6 t0 -65.56 95.54 0.22 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 110.157 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.536 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 10.5 mm -67.7 -32.01 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.46 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 2.4 p30 -112.2 -13.67 13.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 110.818 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.562 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 18.1 m-70 62.52 44.55 6.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.907 . . . . 0.0 110.472 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 64' ' ' MET . 57.4 p30 -95.98 5.87 50.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.527 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 85.31 22.76 50.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.527 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 4.0 mmm -148.47 161.55 41.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -1.144 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.6 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 13.8 mt -122.14 106.07 10.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.162 -0.961 . . . . 0.0 109.996 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' CB ' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -71.41 160.08 33.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.025 . . . . 0.0 110.232 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 25.7 ptt180 -39.66 -37.63 0.53 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.575 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 12.2 m-20 -83.07 -29.92 28.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -75.89 -47.93 23.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 20.6 t80 -61.71 -16.11 46.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.13 -50.21 13.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.395 -0.816 . . . . 0.0 109.842 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.461 ' O ' HD11 ' A' ' 76' ' ' LEU . 58.8 t -58.02 -28.73 34.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.523 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.53 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.15 -4.73 57.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 111.254 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.588 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 11.8 mmt -84.01 -47.6 10.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.979 -1.076 . . . . 0.0 110.121 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.672 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 3.0 p90 -75.08 -28.89 60.49 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.1 mt -67.1 -22.7 65.8 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 40' ' ' LEU . 49.4 t -91.5 -44.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.749 -0.594 . . . . 0.0 109.773 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.457 ' HA ' HD11 ' A' ' 81' ' ' LEU . 2.0 m-85 -70.93 -25.43 62.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.508 -0.745 . . . . 0.0 110.873 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.554 ' CA ' ' HB3' ' A' ' 83' ' ' LYS . 17.1 m -82.38 -21.44 35.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.966 -1.084 . . . . 0.0 109.286 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.576 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -77.69 -11.1 59.84 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -91.13 -47.28 7.62 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.414 0.625 . . . . 0.0 110.568 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' A' ' 82' ' ' GLU . 2.8 tp10 -127.96 -6.79 5.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 111.772 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.554 ' HB3' ' CA ' ' A' ' 79' ' ' CYS . 0.7 OUTLIER -101.05 -90.82 0.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.446 -1.409 . . . . 0.0 111.405 -179.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.525 ' CG ' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -140.94 175.04 3.33 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.821 -1.174 . . . . 0.0 110.137 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.525 ' HD2' ' CG ' ' A' ' 84' ' ' GLU . 42.3 Cg_endo -69.1 -162.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.829 1.436 . . . . 0.0 110.465 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 53' ' ' VAL . 54.0 t -143.18 131.59 11.3 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.138 -0.976 . . . . 0.0 110.665 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.501 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.4 Cg_endo -89.45 -163.81 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.981 1.516 . . . . 0.0 109.51 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.467 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 -0.86 11.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.27 -0.894 . . . . 0.0 110.547 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.516 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.1 m -105.87 99.1 8.7 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.176 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -62.55 108.65 1.77 Allowed Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.536 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 38.2 Cg_endo -64.82 167.48 15.56 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.926 1.487 . . . . 0.0 111.443 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.15 -15.42 35.63 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.347 1.709 . . . . 0.0 111.502 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -87.17 5.35 38.37 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.999 -1.063 . . . . 0.0 109.553 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.672 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 3.9 mm? -123.13 1.84 9.2 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.274 -0.891 . . . . 0.0 110.834 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.468 HG21 HD13 ' A' ' 59' ' ' ILE . 7.9 p -124.81 135.98 27.39 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.071 -1.018 . . . . 0.0 110.699 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.68 168.93 21.33 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.026 1.54 . . . . 0.0 109.901 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 -5.57 17.31 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.791 1.416 . . . . 0.0 110.806 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.3 t -83.97 0.64 47.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.973 -1.079 . . . . 0.0 109.949 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.532 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -109.35 2.54 20.78 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.446 -0.783 . . . . 0.0 109.168 179.012 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 111.177 -179.519 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.239 0.542 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -81.85 80.89 8.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.48 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 23.2 t-20 -154.09 113.56 2.51 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.363 -0.836 . . . . 0.0 109.846 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.604 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.4 Cg_endo -72.35 1.39 6.17 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.843 1.443 . . . . 0.0 111.54 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 3.8 m-85 -101.19 -61.1 1.41 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.943 -1.098 . . . . 0.0 108.499 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.154 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.484 0.952 0 N-CA-C 109.929 -0.835 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.566 ' CH2' ' HG3' ' A' ' 14' ' ' LYS . 10.9 t90 -56.59 121.05 8.81 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.022 -1.049 . . . . 0.0 109.407 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.16 -25.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.505 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -96.31 146.98 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.951 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.8 mmtt -96.95 169.24 9.01 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.5 Cg_endo -69.95 -33.19 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.865 1.455 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.78 -27.38 31.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.496 -0.753 . . . . 0.0 109.548 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.59 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.1 m-20 -79.72 -30.46 40.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.566 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 2.9 tmtt? -81.9 -22.98 36.52 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.679 0.752 . . . . 0.0 109.112 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.56 85.46 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.9 -28.34 61.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -65.14 -36.14 83.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -22.39 64.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.673 -0.642 . . . . 0.0 109.847 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.69 -38.38 25.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 55.2 mt -76.09 -29.8 19.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' HB2' ' CD2' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -72.45 -39.36 67.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.495 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.8 t70 -87.19 2.09 51.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.306 0.574 . . . . 0.0 109.814 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -6.12 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.831 0.824 . . . . 0.0 109.178 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.607 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -107.07 -7.76 16.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.565 -0.709 . . . . 0.0 109.26 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.73 84.59 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.977 0 CA-C-O 121.269 0.556 . . . . 0.0 109.61 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 45.7 Cg_endo -74.58 150.4 40.3 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.536 1.808 . . . . 0.0 110.93 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.539 HG13 ' ND2' ' A' ' 28' ' ' ASN . 53.9 t -117.43 119.16 60.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.539 ' ND2' HG13 ' A' ' 27' ' ' VAL . 71.4 m-80 55.88 18.71 3.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.662 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.08 33.27 9.75 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 57.9 m-85 -137.73 137.25 38.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.854 -1.38 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.607 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.8 mt -108.5 138.22 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.458 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 20.8 p -86.0 144.37 27.64 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.177 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.603 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -45.64 -24.93 1.29 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 32' ' ' SER . 4.4 m-20 -70.95 -19.1 62.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.532 -0.981 . . . . 0.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 5.6 mttp -97.17 -34.97 10.93 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.579 HG23 ' CE1' ' A' ' 70' ' ' PHE . 98.0 t -77.35 -42.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.864 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.615 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.17 -53.98 6.17 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.576 -0.702 . . . . 0.0 110.729 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -68.39 -30.97 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.558 1.294 . . . . 0.0 110.078 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.496 ' CG2' HD13 ' A' ' 24' ' ' LEU . 2.6 t -66.38 -37.47 79.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.551 -0.718 . . . . 0.0 109.295 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 25.1 mt -83.01 -24.79 32.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.564 -0.71 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.11 -10.88 60.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.699 -0.801 . . . . 0.0 108.918 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -89.79 -7.12 55.12 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.523 -0.735 . . . . 0.0 110.224 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.467 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -78.07 7.82 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 0.0 110.284 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.91 10.78 7.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 109.358 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.578 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 16.1 mt -98.72 156.84 35.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.449 -0.782 . . . . 0.0 109.823 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.4 Cg_endo -75.98 172.1 16.9 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.121 1.59 . . . . 0.0 109.289 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.484 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.5 t -71.72 -5.03 5.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.967 -1.083 . . . . 0.0 108.951 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.34 -29.01 59.83 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.546 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.5 mm -87.4 -37.74 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.483 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 12.8 mt -79.39 -28.28 41.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.16 -24.99 75.6 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.533 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 6.7 ttm-85 -101.96 -33.78 9.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.109 -0.642 . . . . 0.0 110.014 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.522 ' CG2' HG23 ' A' ' 86' ' ' VAL . 8.7 t -70.9 -37.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.831 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.603 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.2 t-105 -63.64 -50.53 68.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.86 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.3 mt-10 -50.42 -55.1 17.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 109.925 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.3 mt -61.51 -15.34 37.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 108.934 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.55 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 3.0 t -94.52 -41.47 9.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.537 -0.727 . . . . 0.0 109.513 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 t70 -75.92 95.02 3.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.617 -0.677 . . . . 0.0 110.72 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 3.7 mt -93.13 -16.2 7.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.13 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.7 m-20 -89.81 -5.04 57.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 109.552 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.5 p80 41.3 47.37 2.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.658 . . . . 0.0 110.941 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 28.3 p30 -129.05 26.4 5.49 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.218 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 59.37 42.12 97.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 2.6 mmt -149.35 161.22 42.49 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.318 -1.107 . . . . 0.0 111.514 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.535 HD11 ' CZ3' ' A' ' 54' ' ' TRP . 43.3 mt -137.65 107.09 6.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.648 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.0 p30 -76.58 161.58 28.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 110.454 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -34.55 -46.89 0.3 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.735 -0.603 . . . . 0.0 111.584 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.454 ' O ' ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -78.01 -37.66 46.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.226 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 57' ' ' SER . 12.7 tt0 -66.91 -44.44 80.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.632 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.581 ' CD1' HD12 ' A' ' 31' ' ' LEU . 37.7 t80 -60.46 -21.89 62.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.656 -0.652 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -75.16 -37.98 61.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 109.813 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG11 ' CD2' ' A' ' 94' ' ' LEU . 38.0 t -66.46 -26.66 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.684 0.754 . . . . 0.0 109.733 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.506 ' HB1' ' CB ' ' A' ' 57' ' ' SER . . . -90.39 -7.21 53.78 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 110.767 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.557 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.3 mmt -88.01 -47.45 8.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.922 -1.111 . . . . 0.0 110.256 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.596 ' CE1' HD22 ' A' ' 94' ' ' LEU . 2.2 p90 -75.98 -19.51 58.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' HB3' ' CG1' ' A' ' 53' ' ' VAL . 5.2 mt -74.27 -25.19 59.46 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.547 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 37.2 t -90.59 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.417 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.2 m-85 -45.53 -24.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.692 -0.63 . . . . 0.0 111.273 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' GLU . 8.7 m -82.8 -18.84 39.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.964 -1.085 . . . . 0.0 110.009 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.578 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -86.43 -11.88 50.63 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.709 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.3 mp -90.51 -40.14 12.17 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.787 0.804 . . . . 0.0 108.871 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 51.5 mm-40 -69.63 -54.45 13.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.558 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 177.82 -22.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.92 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -83.74 116.87 66.81 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.783 -1.198 . . . . 0.0 111.431 -178.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.69 -168.51 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.791 1.416 . . . . 0.0 110.095 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 53' ' ' VAL . 48.9 t -134.85 124.11 16.46 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.052 -1.03 . . . . 0.0 111.274 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.52 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 50.1 Cg_endo -85.06 174.31 7.34 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.919 1.484 . . . . 0.0 109.514 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.525 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 2.0 mtp -96.16 12.19 31.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 0.0 110.432 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.499 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 15.1 m -109.34 102.9 11.77 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.881 -1.137 . . . . 0.0 110.779 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -63.48 109.24 2.35 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 89' ' ' SER . 37.6 Cg_endo -63.69 145.27 91.02 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.931 1.49 . . . . 0.0 111.819 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.08 -4.49 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.509 1.794 . . . . 0.0 110.884 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -94.05 -15.53 24.7 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.934 0.873 . . . . 0.0 108.653 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.596 HD22 ' CE1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -98.2 -15.32 19.92 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 99' ' ' LYS . 1.2 t -79.46 141.38 56.76 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.187 -0.946 . . . . 0.0 110.168 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 44.4 Cg_endo -71.74 171.95 15.44 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.11 1.584 . . . . 0.0 110.344 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.463 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 46.4 Cg_endo -73.65 0.39 8.24 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.94 1.495 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 p -90.93 -29.28 17.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.985 . . . . 0.0 109.843 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HB3' HG12 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -89.49 6.26 41.69 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.343 -0.848 . . . . 0.0 109.397 179.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 1.1 mtt180 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.316 -0.865 . . . . 0.0 110.52 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.42 ' C ' ' OG1' ' B' ' 108' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.177 0.513 . . . . 0.0 110.074 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.42 ' OG1' ' C ' ' B' ' 107' ' ' SER . 0.2 OUTLIER -162.41 169.78 19.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.5 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.432 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 25.1 t-20 -103.27 117.08 61.09 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 109.62 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.614 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.6 Cg_endo -74.17 7.59 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.866 1.456 . . . . 0.0 111.881 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 6.6 m-85 -107.14 -65.55 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.763 -1.21 . . . . 0.0 108.713 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.421 ' NH2' ' OE2' ' A' ' 55' ' ' GLU . 6.2 mtm180 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.289 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 N--CA 1.482 0.848 0 N-CA-C 109.927 -0.836 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.0 t90 -63.12 120.62 11.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 109.928 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.84 -26.16 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 43.9 t -101.19 151.03 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.237 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 31.5 mttt -111.67 169.37 6.4 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.324 -0.86 . . . . 0.0 109.792 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 37.5 Cg_endo -63.86 -35.26 57.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.616 1.324 . . . . 0.0 110.119 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -69.46 -30.03 67.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.387 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -82.35 -39.27 23.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' NZ ' ' OD1' ' A' ' 68' ' ' ASP . 14.8 tptm -72.28 -15.72 61.91 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.14 -39.65 54.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.03 -25.64 40.1 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.0 m-30 -72.27 -35.19 68.68 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.39 -20.23 62.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.837 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.89 -38.31 25.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.508 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 68.6 mt -76.2 -29.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -72.9 -36.68 67.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.5 t70 -90.45 0.86 57.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.728 -0.607 . . . . 0.0 110.186 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.0 t -88.77 -8.0 55.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.137 -0.977 . . . . 0.0 109.148 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.599 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.2 mt -106.76 -10.94 15.92 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 86.55 97.24 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.3 Cg_endo -74.02 149.69 42.09 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.214 1.639 . . . . 0.0 111.0 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 62.1 t -124.7 108.34 20.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 62.44 15.67 7.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.241 -179.035 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 92.51 38.04 5.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 81.5 m-85 -148.52 144.59 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 111.976 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.596 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.6 mt -112.14 131.13 55.63 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 1.6 m -80.23 147.04 31.4 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.582 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -44.94 -27.96 1.62 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 48.3 t0 -59.57 -25.37 64.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.89 . . . . 0.0 109.866 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 47.9 mttp -98.26 -36.42 10.03 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' CG1' ' CD1' ' A' ' 40' ' ' LEU . 95.1 t -77.17 -40.3 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.667 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -44.81 -50.51 24.97 Favored Pre-proline 0 N--CA 1.487 1.375 0 O-C-N 121.268 -0.895 . . . . 0.0 111.033 -178.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.2 Cg_endo -68.24 -33.25 24.83 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.089 1.047 . . . . 0.0 109.677 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.477 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.1 t -64.7 -35.94 76.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.612 -0.68 . . . . 0.0 109.705 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 17.8 mt -90.03 -30.67 17.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD11 ' CG ' ' A' ' 37' ' ' LYS . 53.8 mt -70.78 -10.69 60.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.874 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 1.2 t-20 -90.59 -9.94 45.21 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.444 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.477 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 83.5 p -80.58 11.25 3.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.871 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.04 11.21 4.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.944 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.538 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 13.3 mt -90.92 156.0 44.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.813 . . . . 0.0 109.663 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -76.62 169.28 22.11 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 O-C-N 123.907 1.478 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.552 HG13 ' CA ' ' B' ' 111' ' ' PHE . 42.1 t -70.6 -3.42 3.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.74 -32.97 35.46 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.57 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 14.3 mm -80.65 -42.42 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.65 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 14.3 mt -63.65 -32.03 73.38 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.075 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -72.25 -17.84 77.72 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -100.34 -31.28 11.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.843 -0.798 . . . . 0.0 110.138 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.56 ' CG1' HG21 ' A' ' 77' ' ' VAL . 32.3 t -75.87 -34.65 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.696 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.583 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 3.1 t-105 -70.82 -47.65 58.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.599 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' OE2' ' HB2' ' B' ' 109' ' ' ASN . 23.5 mm-40 -58.17 -57.25 13.69 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.019 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 5.8 mt -60.46 -16.53 37.34 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.354 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 73' ' ' ALA . 2.1 t -89.9 -34.52 16.04 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.661 0.743 . . . . 0.0 109.387 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.567 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -74.83 69.82 1.87 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.623 -0.673 . . . . 0.0 109.578 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 69' ' ' GLU . 42.2 mm -41.33 -32.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.493 -0.754 . . . . 0.0 110.406 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 3.0 p30 -108.38 -25.91 10.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 17.7 m-70 71.09 41.19 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 64' ' ' MET . 4.8 p-10 -90.69 -1.69 57.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 98.16 19.95 22.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtp -153.18 161.77 42.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -1.187 . . . . 0.0 110.341 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 36' ' ' VAL . 31.8 mt -118.73 107.79 14.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.099 -1.001 . . . . 0.0 110.662 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.76 165.07 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.04 . . . . 0.0 109.826 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -40.18 -43.53 1.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -78.44 -33.31 48.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.75 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 53.2 mt-10 -74.89 -42.95 56.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.45 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.553 ' CD2' HD12 ' A' ' 31' ' ' LEU . 36.7 t80 -63.12 -16.48 60.14 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.97 -44.36 22.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG13 ' CD1' ' A' ' 94' ' ' LEU . 42.4 t -61.73 -26.42 39.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.708 0.766 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -89.55 -7.84 54.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.76 . . . . 0.0 111.187 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.559 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.5 mmt -84.95 -48.11 9.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.924 -1.11 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 3.6 p90 -75.33 -21.25 58.55 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.501 ' HB3' HG23 ' A' ' 53' ' ' VAL . 5.6 mt -76.37 -19.41 58.2 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 ' CG1' ' A' ' 53' ' ' VAL . 32.8 t -91.96 -41.86 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.569 -0.707 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -72.01 -22.54 61.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.837 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -81.58 -15.26 55.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.979 -1.075 . . . . 0.0 109.24 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -88.94 -10.89 46.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.459 -0.775 . . . . 0.0 109.077 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 81' ' ' LEU . 1.9 mt -90.64 -43.13 10.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.787 . . . . 0.0 109.812 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 6.7 mm-40 -70.04 -53.33 18.0 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.834 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 177.76 -25.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.412 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 3.8 tm-20 -60.32 122.07 64.47 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.049 -1.032 . . . . 0.0 111.009 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -74.79 157.16 43.82 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.877 1.462 . . . . 0.0 109.652 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG23 ' HB1' ' A' ' 80' ' ' ALA . 89.7 t -112.64 121.58 38.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.926 -1.109 . . . . 0.0 110.893 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 45.2 Cg_endo -90.13 -174.4 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.973 1.512 . . . . 0.0 109.289 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.475 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -117.76 10.29 13.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.073 -1.017 . . . . 0.0 110.295 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 38.8 m -104.13 104.11 14.0 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.246 -0.981 . . . . 0.0 111.66 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 1.7 mt -53.09 106.63 0.69 Allowed Pre-proline 0 C--N 1.294 -1.825 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.803 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 40.8 Cg_endo -70.8 148.24 57.89 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.895 1.471 . . . . 0.0 110.689 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.2 -3.74 13.53 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.248 1.657 . . . . 0.0 111.196 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -92.17 -26.37 18.26 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.312 -0.868 . . . . 0.0 109.336 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -100.49 -18.09 16.84 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.788 0.804 . . . . 0.0 109.233 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.493 ' CG2' ' O ' ' A' ' 91' ' ' PRO . 88.3 t -68.5 138.2 91.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.947 -1.095 . . . . 0.0 110.689 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.73 166.18 30.4 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.123 1.591 . . . . 0.0 110.121 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.28 -14.25 25.54 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.008 1.531 . . . . 0.0 110.316 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -16.89 64.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.891 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.03 3.46 55.21 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 48.3 mtt-85 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 110.484 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.221 0.534 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 11.5 t -114.38 -10.95 12.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.312 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' B' ' 112' ' ' ARG . 1.9 t-20 -135.41 105.45 10.11 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 109.717 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.632 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.4 Cg_endo -71.49 -2.44 11.3 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.916 1.482 . . . . 0.0 111.028 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.65 ' CD2' ' HB3' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -116.16 -62.51 1.58 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.867 -1.146 . . . . 0.0 108.849 177.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.981 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.482 0.816 0 N-CA-C 110.456 -0.632 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.581 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 -59.79 129.81 43.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.282 -0.886 . . . . 0.0 109.84 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.566 ' CB ' HD12 ' A' ' 94' ' ' LEU . . . -35.72 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.648 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 99.5 t -97.9 130.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.548 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -86.62 -179.13 1.29 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.729 -178.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.81 -36.3 8.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.014 1.534 . . . . 0.0 110.058 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.27 -22.78 57.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 51.6 m-20 -81.41 -36.94 28.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.062 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' CE ' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -73.78 -16.76 61.15 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.318 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -40.83 38.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.541 -0.724 . . . . 0.0 109.303 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.582 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.08 -26.69 60.52 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.8 m-30 -74.65 -32.06 62.14 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.07 -18.24 61.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.504 -0.748 . . . . 0.0 109.868 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -82.54 -36.67 26.11 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.542 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 12.3 mt -78.01 -28.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.556 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -76.36 -38.29 56.02 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.8 t70 -90.26 3.89 52.26 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.704 -0.623 . . . . 0.0 109.792 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -93.23 -3.48 53.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 108.631 178.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.24 -3.42 13.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 79.83 95.45 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 Cg_endo -71.37 152.33 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.308 1.688 . . . . 0.0 110.76 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 94.1 t -120.1 97.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 109.106 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.537 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 68.68 10.58 7.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.2 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 66' ' ' ASP . . . 104.73 34.13 3.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 76.6 m-85 -150.89 149.88 30.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.468 -1.019 . . . . 0.0 111.886 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 18.1 mt -118.07 134.38 55.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -78.45 144.32 35.91 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.886 -1.125 . . . . 0.0 109.436 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -42.72 -28.33 0.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.0 m-20 -54.46 -25.14 23.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.44 -1.036 . . . . 0.0 109.506 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 1.1 mttp -104.38 -32.66 8.94 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.408 -0.807 . . . . 0.0 108.83 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.569 HG23 ' CE2' ' A' ' 70' ' ' PHE . 87.6 t -84.54 -44.76 17.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.683 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.6 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 15.4 tttt -43.99 -53.56 12.98 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 0.0 110.924 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.4 Cg_endo -67.19 -33.74 30.1 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.33 1.174 . . . . 0.0 109.467 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -63.38 -34.74 69.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.457 0.646 . . . . 0.0 109.389 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -85.92 -27.32 25.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 37' ' ' LYS . 58.0 mt -74.94 -10.89 59.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.225 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -89.56 -5.1 57.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.094 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.545 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.93 12.87 6.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.476 -0.765 . . . . 0.0 110.382 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 61.3 13.29 4.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.11 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.511 HD12 ' CB ' ' A' ' 80' ' ' ALA . 14.7 mt -97.91 154.53 37.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.663 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.61 172.34 16.4 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.071 1.564 . . . . 0.0 110.067 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.85 -6.04 6.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 109.072 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.63 -30.62 56.95 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.546 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.1 mm -88.02 -38.06 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 17.8 mt -77.17 -26.31 52.84 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.1 -27.38 72.09 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -101.47 -30.15 11.59 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 122.105 -0.644 . . . . 0.0 109.901 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 49' ' ' ILE . 22.3 t -71.25 -39.85 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.707 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 1.9 t-105 -64.27 -51.0 65.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.651 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.9 mm-40 -53.05 -57.54 10.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.322 -0.861 . . . . 0.0 109.847 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 13.8 mt -56.82 -21.07 26.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 108.94 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.506 ' CB ' HD21 ' A' ' 65' ' ' LEU . 69.7 m -89.48 -36.13 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 31.5 t0 -83.69 61.92 6.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.636 -0.665 . . . . 0.0 110.196 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.496 HG21 ' CD ' ' A' ' 99' ' ' LYS . 26.8 mt -59.5 -19.01 15.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.334 -0.853 . . . . 0.0 110.37 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 13.6 m-20 -91.74 -21.14 20.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.938 . . . . 0.0 109.637 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 2.2 m-70 61.27 33.74 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 110.745 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.43 -2.48 48.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.05 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 91.07 25.3 24.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.1 mtp -153.55 161.49 42.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.138 -1.213 . . . . 0.0 110.556 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 57' ' ' SER . 15.3 mt -117.84 110.84 18.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.324 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -70.99 172.39 9.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 110.562 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.556 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 3.5 ptp180 -51.15 -41.37 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.555 -0.715 . . . . 0.0 110.895 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.77 -36.31 37.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 57' ' ' SER . 45.8 mt-10 -72.13 -48.73 41.5 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.579 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 14.2 t80 -56.0 -26.27 47.91 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -67.75 -50.64 56.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 110.116 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.573 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 58.5 t -57.63 -22.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.744 . . . . 0.0 109.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.35 -5.34 56.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 111.425 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 3.5 mmm -89.98 -40.54 12.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.309 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.664 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.1 p90 -81.99 -22.77 36.38 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.848 -1.141 . . . . 0.0 108.339 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 4.4 mt -76.11 -23.33 54.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.545 ' CG1' ' OG ' ' A' ' 43' ' ' SER . 16.4 t -91.55 -47.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.533 -0.729 . . . . 0.0 109.722 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.57 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 m-85 -70.38 -35.29 73.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 110.417 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 75' ' ' PHE . 3.9 t -83.59 -8.6 59.28 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.511 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -92.18 -29.27 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.131 0.967 . . . . 0.0 109.208 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.57 ' CD2' ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -90.94 -24.71 20.08 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.759 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.529 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -72.45 -58.11 3.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 110.137 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.48 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -179.42 59.74 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.39 -0.819 . . . . 0.0 110.669 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -165.58 138.99 3.64 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 120.984 -1.072 . . . . 0.0 110.665 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 52.3 Cg_endo -79.84 170.46 16.75 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.898 1.473 . . . . 0.0 110.283 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.522 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 39.1 t -114.15 154.06 46.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 108.996 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.522 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 43.3 Cg_endo -86.13 -167.63 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.525 1.276 . . . . 0.0 109.877 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 mtt -122.25 11.12 10.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.02 -1.05 . . . . 0.0 111.541 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -168.0 23.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.677 -1.264 . . . . 0.0 111.609 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' CD2' ' CB ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER 56.34 122.26 0.01 OUTLIER Pre-proline 0 C--N 1.282 -2.354 0 O-C-N 121.941 -0.474 . . . . 0.0 111.666 178.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 41.0 Cg_endo -69.08 175.72 7.18 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.922 1.485 . . . . 0.0 109.807 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.7 Cg_endo -71.07 -22.32 26.32 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.657 1.346 . . . . 0.0 112.656 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -92.1 -4.27 54.57 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.569 -1.332 . . . . 0.0 110.813 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.664 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -107.78 11.76 27.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.1 -1.0 . . . . 0.0 110.194 -178.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 99' ' ' LYS . 8.2 t -121.6 142.43 35.74 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.981 . . . . 0.0 110.043 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' A' ' 100' ' ' ARG . 44.1 Cg_endo -71.52 173.74 12.01 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.923 1.486 . . . . 0.0 110.163 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.491 ' HA ' ' CD ' ' A' ' 100' ' ' ARG . 46.6 Cg_endo -71.55 -0.96 9.04 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.097 1.577 . . . . 0.0 111.175 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.9 p -84.77 -29.72 25.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.914 -1.116 . . . . 0.0 109.7 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HB3' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -97.62 15.78 22.42 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.461 -0.775 . . . . 0.0 109.007 179.079 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 111.213 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.254 0.549 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.06 148.92 51.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.402 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 60.01 92.04 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 110.176 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.496 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 46.0 Cg_endo -69.22 8.93 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.902 1.735 . . . . 0.0 112.344 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 13.5 m-85 -99.31 -49.74 4.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.505 -1.372 . . . . 0.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.939 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.482 0.832 0 N-CA-C 110.198 -0.731 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.554 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.7 t90 -70.17 125.75 27.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.061 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -42.22 -27.61 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 109.741 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.554 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -95.56 130.79 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.794 . . . . 0.0 109.327 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -88.77 172.4 7.6 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.335 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -34.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.988 1.52 . . . . 0.0 109.946 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -78.33 -28.85 47.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.291 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.505 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 9.1 m-20 -81.05 -33.86 33.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.61 -17.92 57.31 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.177 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -37.48 61.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -76.91 -23.16 52.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 12.3 m-30 -77.55 -34.75 53.71 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.73 -20.2 62.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.893 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.04 33.4 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.484 ' CG2' HG12 ' A' ' 39' ' ' VAL . 73.5 mt -79.23 -30.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -72.79 -36.12 67.52 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 t70 -91.21 -3.23 57.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.447 -0.783 . . . . 0.0 110.034 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.9 t -82.17 -14.67 55.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 108.765 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.644 ' O ' ' CB ' ' A' ' 25' ' ' SER . 8.4 mt -94.09 -53.8 3.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 m 140.87 97.18 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.11 150.4 42.74 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 O-C-N 123.97 1.51 . . . . 0.0 110.643 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 84.4 t -119.8 84.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.316 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 72.73 3.96 4.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.563 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 123.31 29.46 1.2 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -149.89 151.76 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.277 . . . . 0.0 112.326 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.589 HD11 ' CE2' ' A' ' 70' ' ' PHE . 9.4 mt -120.47 154.16 35.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -98.14 141.49 31.0 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 120.754 -1.217 . . . . 0.0 109.715 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.594 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.79 -27.89 0.2 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.7 m-20 -67.63 -24.78 65.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.424 -1.045 . . . . 0.0 110.481 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 66.6 mttm -90.24 -36.75 14.55 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.584 HG23 ' CE2' ' A' ' 70' ' ' PHE . 93.3 t -72.76 -39.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.252 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -42.8 -54.95 7.94 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 111.264 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.7 Cg_endo -65.69 -30.64 50.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.699 1.368 . . . . 0.0 110.005 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.486 HG23 HD11 ' A' ' 24' ' ' LEU . 2.5 t -69.01 -28.71 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.51 -0.744 . . . . 0.0 109.064 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 27.1 mt -94.78 -31.49 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 0.0 110.176 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.0 mt -70.3 -9.93 57.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 27.2 p-10 -90.9 -7.69 51.46 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.993 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.556 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 p -81.4 14.13 2.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.716 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.81 10.71 5.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD13 ' CB ' ' A' ' 80' ' ' ALA . 14.3 mt -98.22 157.9 33.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.926 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.572 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.66 170.42 20.26 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.063 1.559 . . . . 0.0 109.569 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.515 HG12 ' O ' ' B' ' 111' ' ' PHE . 2.0 t -71.3 -3.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.125 -0.985 . . . . 0.0 109.37 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -78.14 -32.17 50.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.572 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.6 mm -81.67 -40.81 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -71.09 -30.79 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.528 ' CA ' ' OD1' ' B' ' 109' ' ' ASN . . . -67.68 -24.97 74.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -100.68 -35.06 9.61 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.906 -0.761 . . . . 0.0 109.868 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG1' ' CG2' ' A' ' 77' ' ' VAL . 23.8 t -65.87 -34.39 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.829 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.594 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.07 -55.03 10.53 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.43 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 1.7 mt-10 -48.0 -57.1 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.09 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.617 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.6 mt -63.32 -14.62 51.79 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.938 . . . . 0.0 108.96 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.516 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 11.0 t -93.09 -35.14 13.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' TRP . 22.5 t0 -74.84 99.94 3.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.718 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 14.6 mm -86.91 -23.82 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.24 -12.83 31.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 2.6 m170 55.61 47.66 20.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -0.944 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 42.8 p-10 -125.64 17.64 8.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.923 -1.111 . . . . 0.0 110.197 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 74.07 32.99 57.88 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.491 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.6 mtp -150.76 161.33 42.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -1.229 . . . . 0.0 111.071 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.508 ' CD2' ' OG ' ' A' ' 57' ' ' SER . 19.6 mt -133.15 107.31 8.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.544 -0.723 . . . . 0.0 109.432 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.62 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 32.9 p30 -78.73 175.13 10.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.75 -1.219 . . . . 0.0 110.378 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.46 -50.62 3.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 112.17 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 5.1 p-10 -72.55 -46.82 52.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.151 -0.968 . . . . 0.0 110.444 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 52.2 mt-10 -62.02 -54.67 38.25 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.533 -0.73 . . . . 0.0 109.229 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.589 ' CE2' HD11 ' A' ' 31' ' ' LEU . 12.2 t80 -49.83 -30.0 9.02 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -61.45 -55.54 30.15 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.79 0.805 . . . . 0.0 110.005 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.525 ' CG1' HD11 ' A' ' 94' ' ' LEU . 92.0 t -51.07 -28.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.488 0.661 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.98 -6.87 58.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 0.0 112.411 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.59 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.1 mmm -90.37 -43.36 10.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.268 -1.52 . . . . 0.0 110.569 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 2.2 p90 -76.05 -22.3 55.85 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.156 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.491 ' HB3' HG21 ' A' ' 53' ' ' VAL . 6.3 mt -72.61 -30.1 64.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.562 ' CG2' ' CG1' ' A' ' 53' ' ' VAL . 37.5 t -91.07 -21.79 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.742 -0.599 . . . . 0.0 110.106 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.16 -27.69 21.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.543 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 5.4 m -83.48 -14.44 52.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -0.789 . . . . 0.0 109.418 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.537 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . -82.66 -12.59 57.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.53 ' CD2' HD12 ' A' ' 45' ' ' LEU . 8.3 mt -91.34 -47.05 7.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.734 -0.604 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.7 32.97 5.19 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.453 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -151.09 -89.54 0.06 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.653 -1.28 . . . . 0.0 111.261 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.568 ' CG ' ' HD2' ' A' ' 85' ' ' PRO . 7.5 tt0 -140.87 153.51 67.61 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.303 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 84' ' ' GLU . 36.9 Cg_endo -60.93 -162.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.575 1.302 . . . . 0.0 109.972 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.534 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 90.4 t -127.79 119.2 21.27 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.85 -1.157 . . . . 0.0 111.51 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.8 Cg_endo -81.67 154.5 17.95 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.978 1.515 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.506 ' HG3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -85.04 18.06 2.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.607 -1.308 . . . . 0.0 110.582 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.7 m -109.01 102.95 11.9 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.035 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.617 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -60.77 107.28 1.0 Allowed Pre-proline 0 C--N 1.291 -1.966 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.654 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.552 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 38.4 Cg_endo -65.49 149.51 87.73 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.873 1.459 . . . . 0.0 110.482 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -75.5 -10.38 20.39 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.226 1.645 . . . . 0.0 111.689 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.48 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -92.87 20.26 6.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 109.446 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.552 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -144.21 7.18 1.35 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.989 -178.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.539 ' CG1' HD22 ' A' ' 90' ' ' LEU . 11.2 m -109.48 152.29 42.66 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.016 -1.052 . . . . 0.0 111.293 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.482 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 41.7 Cg_endo -69.83 176.13 7.23 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.451 1.764 . . . . 0.0 110.099 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.484 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 42.4 Cg_endo -69.22 -17.08 40.2 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.674 1.355 . . . . 0.0 110.467 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.95 -16.68 61.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 109.367 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -90.37 2.17 55.85 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.456 -0.777 . . . . 0.0 109.715 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.346 -0.847 . . . . 0.0 109.999 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.303 0.573 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 48.0 p -87.79 83.0 7.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 110.31 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' CA ' ' A' ' 51' ' ' GLY . 5.9 t-20 -125.69 104.38 27.46 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.964 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.608 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -73.78 11.56 1.09 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.243 1.654 . . . . 0.0 112.386 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 2.7 m-85 -110.73 -73.58 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.54 -1.35 . . . . 0.0 108.405 178.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.185 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.483 0.875 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.567 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.5 t90 -73.48 124.53 26.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 109.831 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 94' ' ' LEU . . . -39.55 -29.25 0.05 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.747 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.567 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 29.5 t -88.62 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.309 -0.87 . . . . 0.0 109.349 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.85 174.35 4.62 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.101 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.3 Cg_endo -70.59 -33.72 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.921 1.485 . . . . 0.0 109.584 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.13 -19.97 58.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.2 m-20 -85.33 -43.87 13.32 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.05 -20.56 66.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.69 . . . . 0.0 109.161 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.56 49.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.51 -24.58 45.71 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -73.69 -36.02 65.24 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.42 -20.82 60.64 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.919 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -82.82 -36.86 25.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.471 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 19.6 mt -76.04 -31.57 21.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -67.77 -38.27 83.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 15.4 t70 -91.29 -3.79 56.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.793 -0.567 . . . . 0.0 110.097 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -78.63 -15.6 58.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 108.92 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 25' ' ' SER . 11.9 mt -96.14 -52.44 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.668 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.2 t 136.51 99.05 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.0 Cg_endo -72.47 145.23 42.12 Favored 'Trans proline' 0 C--N 1.297 -2.18 0 O-C-N 124.184 1.623 . . . . 0.0 111.01 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 10.7 t -118.07 111.46 34.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.534 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 48.15 23.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.382 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.14 34.52 5.61 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 78.9 m-85 -150.99 146.67 26.38 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.183 -1.186 . . . . 0.0 112.397 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 7.7 mt -111.73 148.85 32.58 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.471 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -91.04 142.92 27.25 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.735 -1.228 . . . . 0.0 110.3 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.591 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.52 -25.37 0.81 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.5 m-20 -71.99 -21.88 61.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.967 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 29.2 mttm -93.12 -36.23 12.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.541 ' CG1' HD13 ' A' ' 65' ' ' LEU . 64.1 t -79.01 -43.86 24.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.564 0.697 . . . . 0.0 109.863 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 15.7 tttt -41.01 -51.73 7.27 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.0 Cg_endo -67.61 -32.42 30.99 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.314 1.165 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 2.7 t -66.34 -31.91 55.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.561 -0.712 . . . . 0.0 109.089 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 33.9 mt -90.0 -29.85 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 110.075 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 58.8 mt -69.32 -15.36 63.31 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -90.72 -3.72 57.26 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.723 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 45' ' ' LEU . 83.8 p -81.37 12.56 3.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.816 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 2.9 ttmt 62.55 9.67 3.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.533 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 15.7 mt -100.55 153.22 37.86 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.6 Cg_endo -74.12 172.28 16.29 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.913 1.481 . . . . 0.0 109.734 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -70.2 -5.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.094 -1.004 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -78.11 -31.1 49.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 108.968 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.555 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.6 mm -85.17 -43.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 17.2 mt -70.24 -28.89 65.61 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.91 -25.99 74.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 8.8 ttm-85 -100.9 -31.06 11.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.876 -0.779 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 49' ' ' ILE . 7.4 t -69.82 -35.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.681 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.1 t-105 -69.08 -52.28 30.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.267 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 19.9 mm-40 -52.82 -54.27 36.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 110.111 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.6 mt -63.2 -13.26 35.37 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 108.612 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.542 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 3.9 m -96.18 -41.02 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.67 . . . . 0.0 110.601 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -69.54 82.3 0.41 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.239 -0.913 . . . . 0.0 110.615 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.529 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 33.4 mm -58.25 -21.7 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.144 -0.972 . . . . 0.0 108.939 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 1.9 m-20 -103.68 -9.91 18.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 0.0 109.818 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 29.8 p80 38.73 48.89 1.4 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.689 -0.632 . . . . 0.0 110.719 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 22.3 p-10 -117.01 12.26 14.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.325 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 88.11 28.76 22.15 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.8 mtt -150.75 161.59 42.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -1.21 . . . . 0.0 111.391 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.541 HD13 ' CG1' ' A' ' 36' ' ' VAL . 15.4 mt -135.73 110.41 8.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 1.1 t70 -72.94 172.64 10.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.547 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 4.2 ptm180 -51.24 -42.4 61.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 110.276 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 26.3 t0 -79.62 -35.2 39.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 7.9 tt0 -69.83 -52.38 25.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.723 0.773 . . . . 0.0 108.994 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.594 ' CD2' HD11 ' A' ' 31' ' ' LEU . 24.9 t80 -53.18 -26.59 17.79 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.94 -52.28 60.48 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.639 0.733 . . . . 0.0 109.917 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.517 HG11 ' CD1' ' A' ' 94' ' ' LEU . 89.9 t -54.22 -24.0 10.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -89.4 -7.71 54.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.293 -0.879 . . . . 0.0 112.129 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 mmm -90.22 -41.76 11.4 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.388 -1.445 . . . . 0.0 110.283 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.445 ' CE2' ' CD1' ' A' ' 94' ' ' LEU . 2.5 p90 -78.44 -19.42 53.2 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.355 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HB3' HG22 ' A' ' 53' ' ' VAL . 6.9 mt -76.08 -26.15 56.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.559 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 20.7 t -91.36 -57.23 4.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.68 -0.637 . . . . 0.0 109.557 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -53.15 -20.26 3.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.361 -0.837 . . . . 0.0 110.578 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' O ' ' O ' ' A' ' 84' ' ' GLU . 7.8 m -83.96 -16.7 43.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.089 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -89.01 -11.52 44.0 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.203 -0.935 . . . . 0.0 109.383 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.3 mp -89.92 -39.54 12.95 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.663 0.744 . . . . 0.0 109.387 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 2.8 mt-10 -72.94 -52.45 14.53 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.768 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 177.22 -25.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.527 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -72.37 112.5 15.05 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.03 . . . . 0.0 111.185 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 43.6 Cg_endo -70.66 164.68 34.56 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.791 1.416 . . . . 0.0 109.935 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.465 HG12 HG21 ' A' ' 53' ' ' VAL . 20.7 t -112.56 119.81 42.54 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.074 -1.016 . . . . 0.0 110.584 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.477 ' O ' HD13 ' A' ' 56' ' ' LEU . 47.9 Cg_endo -84.62 -162.44 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 109.448 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.454 ' O ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.09 0.23 12.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 46.5 m -108.11 102.7 11.83 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.434 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -66.79 108.63 2.55 Favored Pre-proline 0 C--N 1.287 -2.127 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.0 Cg_endo -64.46 151.15 86.64 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.803 1.423 . . . . 0.0 111.04 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.451 ' HA ' ' CG1' ' A' ' 95' ' ' VAL . 41.9 Cg_endo -68.63 -5.49 15.45 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.187 1.625 . . . . 0.0 111.09 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.19 -1.72 41.7 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 109.17 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.539 ' O ' ' CG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -147.25 36.57 0.91 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.683 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 92' ' ' PRO . 9.8 p -131.03 138.81 33.8 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 110.818 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.424 ' HD2' HG22 ' A' ' 95' ' ' VAL . 46.4 Cg_endo -73.05 165.79 31.79 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.074 1.565 . . . . 0.0 110.212 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 98' ' ' SER . 43.3 Cg_endo -70.48 -174.81 1.13 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.295 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 1.3 m 78.09 -41.21 0.32 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.579 -0.7 . . . . 0.0 110.214 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.23 5.69 40.39 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.961 -1.087 . . . . 0.0 108.637 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 109.716 179.548 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.245 0.545 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' B' ' 109' ' ' ASN . 8.9 m -79.23 106.38 11.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.253 -0.904 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.469 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 15.1 t-20 60.65 108.08 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.591 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.606 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -71.4 3.14 3.79 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.039 1.547 . . . . 0.0 111.573 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 8.4 m-85 -100.1 -45.83 5.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.862 -1.149 . . . . 0.0 109.561 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.219 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.933 0 N-CA-C 110.328 -0.682 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.572 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.6 t90 -51.61 124.62 12.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.605 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -39.88 -27.66 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 110.277 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 88.4 t -107.29 138.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.26 -178.03 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.895 . . . . 0.0 110.089 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.8 Cg_endo -71.16 -36.23 7.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.791 1.416 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.59 -24.51 60.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.992 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.568 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 2.8 m-20 -83.26 -40.26 19.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.336 -0.853 . . . . 0.0 109.015 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -74.62 -21.56 59.39 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -71.43 -38.12 71.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.747 . . . . 0.0 109.248 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.582 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -78.19 -29.34 48.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 12.4 m-30 -71.09 -37.71 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 29.1 t0 -69.61 -18.06 63.58 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.818 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.0 -36.67 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.448 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 mt -78.38 -34.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -67.85 -36.83 81.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.5 t70 -87.5 -3.08 59.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.738 -0.601 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 -8.02 58.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 109.409 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.615 ' O ' ' CB ' ' A' ' 25' ' ' SER . 7.2 mt -102.17 -15.61 16.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 87.99 88.94 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.0 Cg_endo -75.94 150.78 34.65 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.563 1.823 . . . . 0.0 110.495 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 41.8 t -116.12 110.47 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.8 OUTLIER 65.42 13.79 9.05 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -177.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 93.58 32.55 7.62 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 26.3 m-85 -138.03 136.12 36.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.285 . . . . 0.0 112.358 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.3 mt -107.06 151.0 25.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' ASP . 15.9 p -100.58 147.78 25.55 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.989 -1.069 . . . . 0.0 109.774 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.48 -25.05 0.73 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . 46.7 m-20 -67.5 -22.34 65.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.458 -1.025 . . . . 0.0 110.672 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HE3' ' O ' ' A' ' 24' ' ' LEU . 2.9 mtpp -101.63 -34.72 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.914 -1.116 . . . . 0.0 108.398 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG13 ' CD1' ' A' ' 40' ' ' LEU . 92.3 t -78.18 -36.09 20.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.499 0.666 . . . . 0.0 109.692 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 1.8 tttp -44.78 -53.84 14.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 110.706 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.52 -30.34 29.17 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.566 1.298 . . . . 0.0 110.144 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.596 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 3.5 t -64.92 -28.43 44.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.369 0.604 . . . . 0.0 109.799 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 21.3 mt -94.52 -30.45 14.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 56.6 mt -69.26 -10.01 55.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 108.591 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -87.92 -6.25 58.15 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.241 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.53 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -84.96 18.3 2.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 110.242 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 19.33 1.62 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.644 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.519 HD13 ' CB ' ' A' ' 80' ' ' ALA . 15.5 mt -100.51 155.3 36.53 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 109.9 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -75.11 162.48 36.78 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.019 1.536 . . . . 0.0 109.442 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 9.1 t -67.25 -6.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -74.86 -31.24 61.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.521 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.3 mm -81.45 -43.12 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.62 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 9.5 mt -68.68 -32.54 72.44 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.465 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -68.25 -23.88 74.82 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' CG ' ' CG ' ' A' ' 88' ' ' MET . 3.9 ttm180 -101.67 -32.42 10.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.07 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 57' ' ' SER . 7.6 t -70.43 -40.23 77.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.124 -1.031 . . . . 0.0 108.574 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.566 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.6 t-105 -63.66 -50.86 67.62 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.76 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 13.0 mt-10 -47.22 -56.87 5.89 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.904 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.622 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 1.7 mt -64.54 -13.25 51.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.99 . . . . 0.0 108.919 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -88.48 -40.78 13.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.8 t0 -80.04 95.25 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.312 0.577 . . . . 0.0 110.221 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.32 -13.09 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.928 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.469 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 11.7 m-20 -99.67 -13.13 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.179 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 6.8 m-70 55.57 47.47 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.494 -0.754 . . . . 0.0 110.546 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 19.5 p-10 -126.09 29.66 5.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.51 38.45 93.61 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtt -150.19 160.8 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 111.823 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.485 HD23 ' CB ' ' A' ' 69' ' ' GLU . 5.7 mt -129.81 108.12 9.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.641 -0.662 . . . . 0.0 109.512 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -69.46 158.04 35.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.858 -1.151 . . . . 0.0 109.448 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.578 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 14.1 ptt180 -41.5 -42.43 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -73.27 -43.88 60.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 12.4 mt-10 -64.79 -51.48 62.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.596 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 33.5 t80 -49.63 -28.64 6.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.0 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -65.84 -45.06 83.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 110.185 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.523 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 71.6 t -63.74 -20.34 26.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 110.179 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -89.86 -6.63 55.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.461 -0.775 . . . . 0.0 111.002 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 10.2 mmm -90.44 -44.93 9.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.548 -1.345 . . . . 0.0 110.318 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.565 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 1.5 p90 -75.32 -26.38 58.61 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.027 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.479 ' CD2' HG11 ' A' ' 86' ' ' VAL . 6.7 mt -67.56 -28.54 67.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 24.0 t -91.0 -59.9 2.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.531 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 2.5 m-85 -48.52 -23.07 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.772 -0.58 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 23.0 m -82.93 -20.41 35.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.861 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . -82.26 -12.37 58.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 3.3 mp -90.83 -46.02 8.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.415 -0.803 . . . . 0.0 110.17 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -69.32 -59.72 2.81 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.896 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 10.0 ttpt 176.57 48.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.694 -0.803 . . . . 0.0 111.523 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' CYS . 5.3 mm-40 -147.62 112.11 3.96 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.717 -1.239 . . . . 0.0 110.729 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.25 177.05 5.61 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.025 1.539 . . . . 0.0 109.985 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' A' ' 53' ' ' VAL . 33.0 t -124.44 125.86 25.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.958 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.471 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 53.1 Cg_endo -87.71 164.03 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.932 1.491 . . . . 0.0 109.961 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.534 ' CG ' ' CG ' ' A' ' 52' ' ' ARG . 17.0 mtt -93.83 16.68 13.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.969 -1.082 . . . . 0.0 110.465 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.6 m -110.47 104.59 13.35 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.549 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.69 107.9 1.25 Allowed Pre-proline 0 C--N 1.292 -1.907 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.325 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 89' ' ' SER . 42.8 Cg_endo -70.05 147.74 61.63 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.799 1.42 . . . . 0.0 108.948 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.65 -12.49 34.8 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.732 1.386 . . . . 0.0 110.299 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -87.61 17.1 4.87 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 108.798 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.605 ' CD1' ' CB ' ' A' ' 8' ' ' ALA . 1.3 tp -115.69 -5.74 12.14 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 110.213 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 99' ' ' LYS . 48.6 t -97.89 124.83 46.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 111.245 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.478 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 45.1 Cg_endo -77.81 175.19 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.052 1.554 . . . . 0.0 109.544 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 45.3 Cg_endo -72.11 -1.9 10.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.818 1.43 . . . . 0.0 110.384 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.8 t -81.02 -33.98 33.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.165 -0.959 . . . . 0.0 109.783 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' NZ ' ' OD2' ' A' ' 66' ' ' ASP . 8.4 mmpt? -89.31 10.6 21.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.336 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.9 ptt85 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 110.301 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 107' ' ' SER . 17.4 p . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.306 0.574 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.39 68.57 9.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.557 ' OD1' ' N ' ' B' ' 112' ' ' ARG . 11.6 t-20 -46.64 114.69 2.85 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.567 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.679 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.6 Cg_endo -73.73 -3.15 13.27 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.85 1.448 . . . . 0.0 111.042 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.679 ' CE1' ' HG2' ' B' ' 110' ' ' PRO . 0.1 OUTLIER -113.82 -65.92 1.14 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.851 -1.156 . . . . 0.0 108.705 177.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.602 ' CG ' ' O ' ' B' ' 111' ' ' PHE . 2.1 ptt-85 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.273 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 110.412 -0.649 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.512 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.6 t90 -52.55 123.39 10.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.34 -0.85 . . . . 0.0 109.585 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.545 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.64 -25.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.954 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.512 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 17.4 t -99.28 152.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.2 mttm -109.77 175.02 2.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.0 Cg_endo -68.35 -36.71 15.24 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.142 1.601 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -30.29 63.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.341 -0.849 . . . . 0.0 109.262 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -82.14 -38.8 24.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 12.6 tptp -70.84 -17.03 62.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.43 -40.98 49.15 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.93 -24.87 43.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.7 m-30 -73.45 -37.39 65.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -73.98 -20.29 60.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.925 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.51 -35.68 24.66 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.2 -0.938 . . . . 0.0 108.5 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.479 HG21 ' CE1' ' A' ' 70' ' ' PHE . 50.5 mt -77.22 -33.11 19.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -64.89 -37.87 89.06 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 t0 -90.53 -2.26 57.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 1.7 m -82.15 -9.93 59.35 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.309 -0.869 . . . . 0.0 108.948 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.625 ' O ' ' CB ' ' A' ' 25' ' ' SER . 13.1 mt -98.67 -53.89 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 150.62 84.33 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 55.8 Cg_endo -76.71 123.83 7.17 Favored 'Trans proline' 0 C--N 1.293 -2.357 0 O-C-N 124.307 1.688 . . . . 0.0 109.55 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN 0.251 2.2 p -119.48 121.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.723 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.026 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' ND2' ' CE2' ' A' ' 30' ' ' PHE . 10.0 t30 57.68 20.77 6.64 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 81.15 45.0 7.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.557 ' CE2' ' ND2' ' A' ' 28' ' ' ASN . 87.8 m-85 -151.87 158.79 43.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 112.452 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.603 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.7 mt -126.39 160.64 29.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' LYS . 1.4 p -106.88 146.78 30.57 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.682 -1.261 . . . . 0.0 110.532 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.597 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.65 -24.93 0.76 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.1 m-20 -75.85 -20.02 58.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.978 . . . . 0.0 110.618 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 11.7 mtmm -94.89 -35.2 12.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.976 -1.078 . . . . 0.0 108.141 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 HG22 ' CE2' ' A' ' 70' ' ' PHE . 96.8 t -78.01 -43.29 28.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.639 0.733 . . . . 0.0 109.764 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -40.83 -52.23 6.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 110.724 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.8 Cg_endo -67.03 -35.4 25.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.401 1.211 . . . . 0.0 109.65 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' CG2' HD21 ' A' ' 24' ' ' LEU . 2.2 t -61.5 -33.45 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.633 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 29.7 mt -88.97 -28.96 19.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.622 -0.674 . . . . 0.0 109.901 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.51 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 62.1 mt -71.95 -14.78 62.01 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -90.58 -3.74 57.35 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.118 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.511 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 37.7 m -81.75 11.44 4.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.2 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.14 11.72 4.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.707 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.539 HD12 ' CG2' ' A' ' 49' ' ' ILE . 16.2 mt -100.57 155.14 36.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.561 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.9 Cg_endo -75.27 170.13 21.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.046 1.551 . . . . 0.0 109.816 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.478 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -68.59 -7.3 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 120.952 -1.093 . . . . 0.0 109.045 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.34 -27.87 60.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.561 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.1 mm -88.38 -38.69 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.581 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 9.7 mt -77.28 -29.76 53.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.2 -25.66 75.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.549 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -102.22 -35.88 8.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.081 -0.658 . . . . 0.0 110.75 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.515 HG23 ' CG1' ' A' ' 86' ' ' VAL . 13.7 t -67.49 -37.72 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.819 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.597 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -64.11 -52.55 58.63 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.306 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 91.2 mt-10 -51.14 -58.79 5.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.388 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.597 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.2 mt -62.16 -13.98 32.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.98 . . . . 0.0 109.013 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.536 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 29.4 m -96.35 -26.73 15.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.717 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' TRP . 9.5 t0 -78.26 93.14 4.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' HG3' ' A' ' 69' ' ' GLU . 24.4 mm -73.12 -32.43 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 110.06 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 2.6 m-20 -95.62 -16.02 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.419 ' HA ' ' CG ' ' A' ' 58' ' ' ASP . 91.0 m-70 52.61 50.69 17.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.314 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 37.5 p-10 -125.0 36.87 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.5 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 58.19 33.01 68.47 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 6.6 mtt -150.54 160.66 43.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -1.091 . . . . 0.0 111.269 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.458 HD11 ' CG1' ' A' ' 36' ' ' VAL . 13.2 mt -132.28 110.49 10.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.222 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 10.7 t0 -70.13 167.62 17.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.946 -1.096 . . . . 0.0 110.372 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.3 ptm180 -45.61 -44.22 12.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.286 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.494 ' OD1' ' CZ2' ' A' ' 7' ' ' TRP . 11.7 t0 -78.19 -36.27 47.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.301 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -63.65 -52.47 60.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.938 0.875 . . . . 0.0 109.397 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.534 ' CD2' HD13 ' A' ' 31' ' ' LEU . 17.7 t80 -54.48 -20.37 7.53 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.533 0.682 . . . . 0.0 109.274 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -73.23 -46.27 51.2 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' CG2' HD22 ' A' ' 94' ' ' LEU . 23.7 t -59.94 -28.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.077 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.66 -4.67 57.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 5.6 mmt -87.43 -43.19 12.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.718 -1.239 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.468 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -77.77 -22.22 50.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.077 -1.014 . . . . 0.0 108.379 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.477 ' HB3' HG21 ' A' ' 53' ' ' VAL . 9.3 mt -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.566 HG23 ' CD2' ' A' ' 40' ' ' LEU . 41.3 t -91.7 -60.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.689 -0.632 . . . . 0.0 110.109 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.448 ' HA ' HD11 ' A' ' 81' ' ' LEU . 3.4 m-85 -55.97 -19.65 13.27 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.225 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 84' ' ' GLU . 7.5 m -83.25 -16.69 45.4 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.019 -1.051 . . . . 0.0 109.581 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.508 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -85.78 -15.22 42.76 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.454 -0.779 . . . . 0.0 109.557 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.2 mp -88.88 -40.34 13.17 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.643 0.735 . . . . 0.0 109.467 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 2.4 mm-40 -71.35 -51.77 22.42 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.933 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.1 OUTLIER 177.38 -24.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.856 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 79' ' ' CYS . 23.3 mm-40 -79.71 110.95 17.6 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.894 -1.128 . . . . 0.0 111.035 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 41.9 Cg_endo -68.75 -173.27 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.838 1.441 . . . . 0.0 109.969 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.515 ' CG1' HG23 ' A' ' 53' ' ' VAL . 96.5 t -128.44 109.61 19.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.975 . . . . 0.0 110.793 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.517 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 46.4 Cg_endo -76.31 -169.95 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.988 1.52 . . . . 0.0 109.564 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.549 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -112.8 20.87 16.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.514 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.513 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 74.8 m -114.0 101.62 9.42 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.102 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.597 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -69.95 109.34 4.58 Favored Pre-proline 0 C--N 1.29 -2.021 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 89' ' ' SER . 39.9 Cg_endo -65.34 146.18 85.17 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.01 1.532 . . . . 0.0 111.571 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.94 -5.99 18.2 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.323 1.697 . . . . 0.0 110.822 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -86.36 -22.91 26.41 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -94.65 -9.17 35.78 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.473 HG22 HD12 ' A' ' 90' ' ' LEU . 94.0 t -85.17 130.46 51.9 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 111.161 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.2 Cg_endo -72.39 177.82 6.9 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.972 1.512 . . . . 0.0 109.662 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 98' ' ' SER . 39.5 Cg_endo -65.87 -178.01 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.543 1.286 . . . . 0.0 110.113 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 75.44 -49.86 0.63 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.346 -0.846 . . . . 0.0 109.879 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 59' ' ' ILE . 4.8 ttmt -88.47 12.83 13.3 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 108.555 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.526 -0.734 . . . . 0.0 109.934 179.882 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.22 0.533 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.69 -46.16 5.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.147 -0.971 . . . . 0.0 110.344 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.43 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 7.6 t-20 52.32 93.02 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.181 -0.949 . . . . 0.0 110.297 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.486 ' HD2' ' CE1' ' B' ' 111' ' ' PHE . 48.5 Cg_endo -70.27 8.78 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.993 1.795 . . . . 0.0 112.176 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.633 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 15.3 m-85 -98.95 -45.04 6.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 109.854 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 N--CA 1.484 0.968 0 N-CA-C 110.686 -0.544 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.449 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 13.1 t90 -69.19 126.78 30.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.669 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -40.56 -28.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 62.8 t -94.02 165.45 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 12.6 mttt -119.55 172.65 4.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.3 Cg_endo -67.88 -35.46 20.93 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.005 1.529 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 6.4 pt-20 -72.64 -28.69 62.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.93 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.8 m-20 -81.17 -38.79 26.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 108.638 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppt? -68.56 -16.99 64.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -28.46 35.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -90.73 -35.62 14.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.7 m-30 -65.39 -28.56 69.35 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD2' ' HD2' ' A' ' 14' ' ' LYS . 9.6 m-20 -80.98 -24.09 38.27 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.662 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.37 -30.78 37.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.541 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 56.3 mt -80.78 -28.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -75.58 -35.8 60.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t70 -89.32 -3.06 58.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.758 -0.589 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -6.57 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.305 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.6 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.5 mt -106.5 -12.25 15.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 p 89.59 94.68 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.259 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -73.8 150.46 44.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.253 1.659 . . . . 0.0 110.871 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 71.9 t -123.9 110.27 25.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.3 t30 57.58 15.41 2.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.321 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.28 35.25 5.32 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 75.4 m-85 -150.56 143.2 24.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -1.205 . . . . 0.0 112.224 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.4 mt -109.56 134.46 51.89 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.489 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 1.7 m -78.37 142.56 37.57 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 118.939 -1.105 . . . . 0.0 109.942 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -43.48 -26.35 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 63.5 m-20 -67.55 -23.42 65.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 40.3 mttp -96.1 -33.18 12.18 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 40' ' ' LEU . 84.6 t -77.9 -38.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.641 0.734 . . . . 0.0 109.598 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.0 OUTLIER -43.15 -54.96 8.52 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.73 . . . . 0.0 111.137 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -67.79 -31.78 31.24 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.718 1.378 . . . . 0.0 109.926 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.578 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -64.27 -31.22 52.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.579 -0.701 . . . . 0.0 109.304 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CD1' ' CE2' ' B' ' 111' ' ' PHE . 22.2 mt -94.34 -34.92 12.62 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.597 -0.689 . . . . 0.0 109.974 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.4 mt -67.91 -14.45 62.97 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 19.8 t30 -90.73 -4.91 56.35 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.525 ' OG ' HG11 ' A' ' 77' ' ' VAL . 5.7 m -84.97 18.65 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 0.0 110.431 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.9 tptt 60.23 13.5 3.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.05 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 81' ' ' LEU . 12.7 mt -100.22 152.13 37.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.92 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.576 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.8 Cg_endo -76.61 170.06 20.63 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.017 1.535 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 3.4 t -71.03 -4.53 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.757 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.8 -33.78 45.97 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.818 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.576 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 14.5 mm -79.32 -42.07 23.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 108.825 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB3' ' CD2' ' B' ' 111' ' ' PHE . 12.9 mt -68.35 -29.46 68.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.28 -24.69 73.57 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.51 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 5.5 ttm-85 -100.81 -32.59 10.62 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.685 -0.891 . . . . 0.0 110.265 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.545 ' CG1' HG22 ' A' ' 77' ' ' VAL . 24.6 t -68.77 -36.37 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.821 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.581 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.7 t-105 -69.59 -52.32 27.15 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.344 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 84.1 mt-10 -50.96 -57.38 8.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.095 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 90' ' ' LEU . 3.1 mt -61.16 -14.36 24.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.128 -0.983 . . . . 0.0 108.834 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 15.5 t -97.0 -23.31 16.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.29 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 29.0 t0 -95.55 90.91 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.975 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.15 -15.45 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 110.164 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 8.0 m-20 -89.17 -17.25 29.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.479 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 11.8 m170 57.59 46.86 16.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.623 -0.673 . . . . 0.0 110.115 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 8.4 p30 -119.78 16.07 12.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.639 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.22 33.58 83.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 37.9 mtp -151.47 160.78 43.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.238 . . . . 0.0 110.635 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 12.6 mt -119.77 105.16 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.0 109.584 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.545 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -71.94 163.48 27.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.334 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -41.84 -39.84 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 111.108 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.466 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -79.71 -32.32 41.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.187 -0.946 . . . . 0.0 110.594 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' CG ' ' OD1' ' A' ' 66' ' ' ASP . 35.3 mt-10 -77.75 -39.24 44.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.108 -0.995 . . . . 0.0 109.021 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.579 ' CD2' HD11 ' A' ' 31' ' ' LEU . 20.9 t80 -62.35 -18.22 60.93 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 0.0 108.907 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.73 -44.34 28.09 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.797 0.808 . . . . 0.0 109.564 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.586 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 44.0 t -61.57 -30.43 48.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.607 0.717 . . . . 0.0 109.676 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 57' ' ' SER . . . -89.68 -2.81 58.38 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 110.82 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.5 mmt -83.62 -48.91 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.897 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.605 ' CE1' HD23 ' A' ' 94' ' ' LEU . 7.6 p90 -76.19 -23.74 54.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' HB3' HG22 ' A' ' 53' ' ' VAL . 5.7 mt -71.04 -24.45 62.35 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.545 HG22 ' CG1' ' A' ' 53' ' ' VAL . 45.7 t -91.68 -46.38 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.648 -0.658 . . . . 0.0 110.298 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -69.58 -26.42 64.45 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 110.865 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 16.1 t -81.43 -12.91 58.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.038 . . . . 0.0 109.385 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.53 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . -90.36 -10.54 43.63 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 109.023 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.591 ' N ' ' CD2' ' A' ' 81' ' ' LEU . 1.4 mt -90.87 -43.57 9.94 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.739 0.781 . . . . 0.0 109.708 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 1.4 tp10 -69.3 -57.16 5.68 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.628 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 175.17 79.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.369 179.617 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -172.67 119.24 0.41 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.694 -1.254 . . . . 0.0 110.958 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.32 158.01 49.05 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.704 1.37 . . . . 0.0 109.359 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.47 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 91.6 t -116.73 126.69 27.31 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 110.562 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.466 ' O ' HD13 ' A' ' 56' ' ' LEU . 49.5 Cg_endo -84.42 -170.51 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.994 1.523 . . . . 0.0 108.913 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.485 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -118.48 13.25 13.46 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.954 -1.091 . . . . 0.0 110.242 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.494 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 3.6 m -104.52 105.74 15.97 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.245 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.53 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -51.94 105.81 0.57 Allowed Pre-proline 0 N--CA 1.493 1.721 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.521 178.131 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.533 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.8 Cg_endo -69.75 147.2 62.4 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.791 1.416 . . . . 0.0 110.804 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.59 -5.57 17.42 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.775 1.65 . . . . 0.0 111.911 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -104.69 20.13 19.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.074 -1.016 . . . . 0.0 108.782 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.605 HD23 ' CE1' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -139.79 -0.92 1.67 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.456 0.646 . . . . 0.0 110.232 -178.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.47 129.24 77.89 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.615 -1.303 . . . . 0.0 110.529 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.481 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 48.6 Cg_endo -75.63 175.33 11.43 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.957 1.504 . . . . 0.0 110.001 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' SER . 42.6 Cg_endo -69.27 -178.94 2.38 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.799 1.421 . . . . 0.0 110.284 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 76.01 -43.83 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.464 -0.773 . . . . 0.0 110.019 -178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 51.2 tptt -87.75 8.5 25.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 110.345 179.823 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.244 0.545 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.412 ' O ' HG23 ' B' ' 108' ' ' THR . 14.8 t -96.55 128.1 43.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 110.454 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' B' ' 112' ' ' ARG . 2.5 t-20 -174.0 105.61 0.29 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.499 -0.751 . . . . 0.0 109.274 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.665 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 42.3 Cg_endo -70.5 -3.73 13.08 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.812 1.428 . . . . 0.0 110.514 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.665 ' CE1' ' HG2' ' B' ' 110' ' ' PRO . 0.1 OUTLIER -111.95 -60.99 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.598 ' CG ' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.358 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.493 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.261 0.553 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -42.98 -28.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.417 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.493 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 23.8 t -101.73 139.2 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.91 . . . . 0.0 110.708 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.03 -177.3 0.64 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.49 -0.756 . . . . 0.0 109.748 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 41.7 Cg_endo -71.66 -32.63 11.6 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.711 1.374 . . . . 0.0 110.249 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 13.0 mm-40 -77.36 -31.78 54.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 109.784 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -77.44 -35.19 54.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -82.21 -18.47 42.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.638 0.732 . . . . 0.0 109.112 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -70.08 -40.15 75.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.639 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -73.51 -32.01 64.02 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.639 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -66.22 -36.58 83.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.56 -20.98 63.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.663 -0.648 . . . . 0.0 110.155 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.01 -38.73 24.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.971 . . . . 0.0 108.511 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.69 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 42.7 mt -75.79 -29.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.735 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.97 -36.41 64.58 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t70 -89.97 1.48 56.23 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.977 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -92.4 -3.47 55.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.922 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.076 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -109.63 -4.58 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 84.99 89.97 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.3 Cg_endo -72.42 148.7 49.07 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 124.503 1.791 . . . . 0.0 110.864 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 68.7 t -121.03 104.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.1 t30 58.88 20.41 8.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.805 . . . . 0.0 110.001 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 94.27 37.1 5.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 87.1 m-85 -150.29 149.22 29.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.164 -1.198 . . . . 0.0 111.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.076 ' CD1' HD12 ' A' ' 24' ' ' LEU . 15.0 mt -122.54 130.48 53.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -77.29 148.14 35.87 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.55 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -46.66 -25.55 2.25 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 9.0 t0 -63.02 -20.75 65.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.567 -0.961 . . . . 0.0 109.685 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 27.9 mttp -104.42 -32.38 9.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.948 HG11 HD12 ' A' ' 65' ' ' LEU . 92.3 t -83.5 -46.29 18.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.175 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 8.0 tttt -41.68 -49.91 9.91 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -67.69 -31.97 31.42 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.341 1.179 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.671 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -68.4 -34.58 66.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.948 HD12 ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -86.3 -31.48 21.58 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.82 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.619 HD11 ' CG ' ' A' ' 37' ' ' LYS . 47.1 mt -71.02 -11.5 61.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.09 -10.36 53.07 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.169 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 1.012 ' O ' HD21 ' A' ' 81' ' ' LEU . 87.7 p -79.17 7.92 6.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 110.473 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.64 9.53 5.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.066 -1.021 . . . . 0.0 109.939 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.995 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.2 mt -93.17 157.26 39.25 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.5 Cg_endo -74.72 167.86 26.13 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.857 1.451 . . . . 0.0 109.635 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.478 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.51 -7.4 6.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.941 -1.099 . . . . 0.0 109.142 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.51 -29.87 61.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.897 HG13 HD22 ' A' ' 45' ' ' LEU . 8.7 mm -85.62 -39.1 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.925 0.869 . . . . 0.0 108.898 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.941 HD22 ' HB3' ' A' ' 40' ' ' LEU . 13.1 mt -79.52 -28.77 41.33 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.08 -26.83 71.49 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.741 ' O ' HD12 ' A' ' 56' ' ' LEU . 28.0 ttm180 -101.43 -31.19 11.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.113 -0.64 . . . . 0.0 110.501 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.861 HG11 HG23 ' A' ' 77' ' ' VAL . 18.7 t -70.63 -36.93 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 108.588 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CZ2' ' OD1' ' A' ' 58' ' ' ASP . 1.6 t-105 -63.44 -50.77 68.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.71 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.3 mm-40 -52.25 -57.7 8.91 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.11 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.4 mt -62.13 -19.28 62.87 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.141 -0.974 . . . . 0.0 108.646 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.879 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 7.5 t -85.9 -33.95 21.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -70.3 92.75 0.8 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 29.1 mm -75.31 -23.26 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 111.328 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -110.2 -9.54 14.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.884 -1.135 . . . . 0.0 110.948 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 3.9 m-70 59.59 44.8 14.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.109 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 19.2 p-10 -106.74 9.31 31.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 109.989 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 80.05 24.77 59.06 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.2 mtp -152.17 161.4 42.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.183 -1.187 . . . . 0.0 110.373 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.948 HD12 HG11 ' A' ' 36' ' ' VAL . 13.6 mt -116.84 103.12 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.723 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.599 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -69.26 173.23 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.067 -1.021 . . . . 0.0 110.021 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -50.07 -32.15 14.9 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.613 -0.679 . . . . 0.0 110.894 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 -30.38 20.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 36.2 mt-10 -79.16 -40.6 30.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 108.917 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.748 ' CD1' HD12 ' A' ' 31' ' ' LEU . 27.3 t80 -63.81 -24.45 67.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -70.17 -51.87 27.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.962 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.1 t -57.29 -25.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.547 -0.72 . . . . 0.0 110.359 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.879 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.07 -4.99 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 111.637 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmt -88.53 -44.16 10.88 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.862 -1.149 . . . . 0.0 110.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 4.5 p90 -77.71 -22.17 50.82 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.999 -1.081 . . . . 0.0 108.293 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 12.1 mt -74.63 -24.52 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.012 ' O ' HD12 ' A' ' 81' ' ' LEU . 49.3 t -91.62 -40.96 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.586 -0.696 . . . . 0.0 110.123 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -71.91 -22.52 61.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.648 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.3 m -83.2 -20.76 34.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.818 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.995 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -80.62 -12.82 59.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.332 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.012 HD21 ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.513 -0.742 . . . . 0.0 110.771 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.485 0.983 0 N-CA-C 110.588 -0.581 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.458 HG13 HD22 ' A' ' 76' ' ' LEU . 98.1 t -128.15 137.48 30.93 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 110.605 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.727 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.3 Cg_endo -84.41 175.43 7.2 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.869 1.457 . . . . 0.0 108.503 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.738 ' C ' HD21 ' A' ' 56' ' ' LEU . 9.9 mtm -108.48 18.21 21.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.74 -1.225 . . . . 0.0 110.49 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 56' ' ' LEU . 74.8 m . . . . . 0 C--N 1.295 -1.772 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.355 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.413 ' ND2' ' CD1' ' B' ' 111' ' ' PHE . 5.0 t-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.559 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -74.59 19.69 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.194 1.628 . . . . 0.0 112.35 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.948 ' CE2' HD12 ' A' ' 40' ' ' LEU . 24.5 m-85 -99.94 -61.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.511 -1.368 . . . . 0.0 108.69 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.416 ' HA ' HG11 ' A' ' 47' ' ' VAL . 27.1 mtm180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.222 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.609 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 16.0 t90 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.274 0.559 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.27 -27.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 42.0 t -96.6 145.3 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.55 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.4 mttm -112.52 -179.46 0.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.4 Cg_endo -67.56 -35.53 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.745 1.392 . . . . 0.0 110.199 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 6.2 pt-20 -71.21 -30.62 66.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 5.8 m-20 -83.63 -38.13 21.94 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.224 -0.923 . . . . 0.0 108.655 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 5.9 tptm -69.33 -17.65 63.73 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.74 -39.67 35.57 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.634 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.2 ptmm? -81.05 -22.85 38.98 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -76.93 -34.75 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.9 -19.63 60.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 0.0 110.31 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -83.6 -33.62 25.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.985 . . . . 0.0 108.451 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.736 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -78.07 -31.39 16.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.769 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -71.84 -38.95 70.06 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.704 0.764 . . . . 0.0 109.034 179.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.55 -6.49 54.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.512 -0.742 . . . . 0.0 109.878 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.2 t -78.76 -7.51 57.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 0.0 108.909 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.025 HD12 HD13 ' A' ' 31' ' ' LEU . 10.6 mt -101.77 -54.34 2.75 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 m 137.97 98.51 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.16 148.3 39.18 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 O-C-N 123.977 1.514 . . . . 0.0 110.499 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -120.08 98.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.627 -0.67 . . . . 0.0 109.31 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 24.1 t-20 60.37 14.86 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.726 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.458 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 107.03 32.88 3.38 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 84.9 m-85 -148.6 151.99 35.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.908 -1.348 . . . . 0.0 112.078 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.025 HD13 HD12 ' A' ' 24' ' ' LEU . 6.7 mt -120.31 143.18 48.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 33' ' ' GLY . 96.6 p -89.08 141.79 28.2 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.822 -1.174 . . . . 0.0 110.28 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.69 -25.96 0.99 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.0 t70 -65.83 -22.36 66.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.513 -0.993 . . . . 0.0 110.072 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB3' HD13 ' A' ' 24' ' ' LEU . 7.7 mttp -97.81 -35.91 10.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 98.1 t -77.77 -42.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.514 0.673 . . . . 0.0 110.011 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.48 -53.82 5.31 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 110.915 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.1 Cg_endo -68.67 -33.9 20.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.542 1.285 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.712 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.5 t -63.55 -31.75 54.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.031 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.981 ' HB3' HD22 ' A' ' 50' ' ' LEU . 33.0 mt -88.43 -26.58 22.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 110.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD11 ' HE2' ' A' ' 37' ' ' LYS . 51.9 mt -73.8 -11.23 60.32 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.175 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -90.31 -3.19 57.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 1.022 ' O ' HD21 ' A' ' 81' ' ' LEU . 91.9 p -84.34 13.98 4.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 110.09 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt 59.39 13.72 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.925 HD11 ' HB3' ' A' ' 80' ' ' ALA . 17.5 mt -100.16 156.87 34.78 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.905 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.6 Cg_endo -74.58 171.08 18.86 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.921 1.485 . . . . 0.0 109.868 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.561 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.4 -6.19 6.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.286 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.71 -31.15 59.54 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.879 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -83.12 -40.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 122.017 0.913 . . . . 0.0 108.556 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.981 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.1 mt -76.7 -26.94 55.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.729 0.776 . . . . 0.0 108.959 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.8 -29.08 65.81 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.857 ' O ' HD12 ' A' ' 56' ' ' LEU . 30.1 ttm180 -101.0 -28.3 12.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.886 -0.773 . . . . 0.0 109.934 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.928 HG11 HG23 ' A' ' 77' ' ' VAL . 19.4 t -72.49 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.43 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.558 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.3 t-105 -65.82 -51.46 58.75 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.814 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.2 mm-40 -50.82 -60.53 2.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.406 -0.809 . . . . 0.0 109.991 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -61.54 -15.93 43.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.498 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.028 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 9.2 t -92.24 -18.17 23.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.487 0.661 . . . . 0.0 109.235 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.1 t0 -90.83 82.11 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.514 -0.741 . . . . 0.0 110.322 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG12 ' HG2' ' A' ' 69' ' ' GLU . 12.1 mm -62.67 -24.12 34.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.604 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -104.24 -7.96 19.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 20.6 p80 38.35 51.92 1.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.567 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.2 p-10 -119.68 20.33 12.35 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.004 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.53 29.71 54.94 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.4 mtp -150.24 161.3 42.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -1.158 . . . . 0.0 111.087 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 14.0 mt -129.53 112.59 13.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 109.746 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 13.7 t0 -70.02 168.39 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.065 -1.022 . . . . 0.0 110.47 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.557 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -50.75 -41.08 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.872 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 46.4 t0 -81.01 -32.82 34.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HG2' HG12 ' A' ' 59' ' ' ILE . 2.3 mt-10 -71.96 -50.21 30.82 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.873 0.844 . . . . 0.0 109.257 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.922 ' CD2' HD12 ' A' ' 31' ' ' LEU . 29.3 t80 -53.57 -22.83 9.15 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -68.83 -52.87 25.38 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.852 0.834 . . . . 0.0 109.77 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.681 ' O ' HD12 ' A' ' 76' ' ' LEU . 49.0 t -52.64 -24.61 6.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 110.394 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.028 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.67 -11.48 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 0.0 112.499 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 mmm -86.77 -47.11 9.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.392 -1.442 . . . . 0.0 110.435 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.542 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 1.9 p90 -73.38 -21.75 60.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.691 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.2 mt -74.55 -24.95 59.01 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.928 HG23 HG11 ' A' ' 53' ' ' VAL . 59.8 t -90.96 -42.46 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -68.54 -19.09 64.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.619 -0.675 . . . . 0.0 110.21 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 16.1 m -84.65 -25.74 28.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -73.55 -17.44 61.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 108.698 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.022 HD21 ' O ' ' A' ' 43' ' ' SER . 1.1 mt . . . . . 0 C--N 1.305 -1.369 0 O-C-N 121.724 -0.61 . . . . 0.0 110.767 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.482 0.817 0 N-CA-C 110.244 -0.714 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.526 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 96.4 t -113.99 134.95 22.06 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.771 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.6 Cg_endo -84.69 -173.12 1.4 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.072 1.564 . . . . 0.0 109.02 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.776 ' C ' HD21 ' A' ' 56' ' ' LEU . 29.6 mtm -111.55 10.14 21.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 109.872 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.537 ' N ' HD21 ' A' ' 56' ' ' LEU . 19.6 m . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.887 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.506 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.5 t-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.803 0.335 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -72.94 2.39 5.48 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.078 1.568 . . . . 0.0 111.483 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.947 ' CE2' HD12 ' A' ' 40' ' ' LEU . 4.4 m-85 -101.2 -47.97 4.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.853 -1.155 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.514 ' HG2' ' HA3' ' A' ' 51' ' ' GLY . 1.2 mmm180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.275 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.599 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.9 t90 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.16 0.505 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -40.93 -28.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.451 -0.78 . . . . 0.0 110.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.599 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 85.4 t -113.31 135.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 110.152 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.542 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -93.77 -179.69 1.07 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.349 -0.844 . . . . 0.0 109.995 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.13 -35.27 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.927 1.488 . . . . 0.0 110.02 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.6 -33.52 58.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 15.0 m-20 -76.96 -34.66 57.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 68' ' ' ASP . 1.5 tttt -76.79 -20.16 56.75 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.7 71.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.627 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -70.13 -21.23 63.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -80.21 -29.29 38.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.38 -20.14 57.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.718 -0.614 . . . . 0.0 109.804 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -81.57 -32.69 32.02 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.831 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 63.8 mt -78.97 -33.0 15.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.821 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -67.78 -35.17 78.19 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -91.03 -5.44 55.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.461 -0.775 . . . . 0.0 110.324 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 87.3 p -78.95 -14.65 59.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 108.839 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.054 HD12 ' CD1' ' A' ' 31' ' ' LEU . 11.6 mt -92.96 -55.07 3.48 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 t 142.8 92.92 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.478 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.7 Cg_endo -74.87 148.99 36.67 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 O-C-N 124.198 1.631 . . . . 0.0 110.88 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -125.38 103.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 19.2 t-20 63.37 13.66 7.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.642 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 32.66 4.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.2 m-85 -146.5 148.79 32.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -1.166 . . . . 0.0 111.908 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.054 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.1 mt -113.83 158.51 20.93 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' LYS . 48.3 p -105.14 143.45 33.3 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.606 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.59 -25.1 0.49 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' SER . 61.4 t0 -71.32 -23.97 62.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.413 -1.051 . . . . 0.0 110.412 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 32' ' ' SER . 14.0 mttp -94.09 -35.61 12.48 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.071 -1.018 . . . . 0.0 108.417 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.917 HG11 HD12 ' A' ' 65' ' ' LEU . 87.5 t -78.16 -42.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.382 0.61 . . . . 0.0 110.384 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.572 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 14.8 tttt -40.03 -54.42 4.42 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 110.549 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -66.93 -33.85 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.406 1.214 . . . . 0.0 110.021 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.788 ' CG2' HD21 ' A' ' 24' ' ' LEU . 2.2 t -62.25 -35.2 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.818 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.009 ' HB3' HD22 ' A' ' 50' ' ' LEU . 30.3 mt -87.83 -30.02 20.52 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.705 -0.622 . . . . 0.0 110.063 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.516 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 67.2 mt -70.13 -13.95 62.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -91.36 -4.1 56.1 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.52 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -83.56 16.75 2.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.386 -0.821 . . . . 0.0 110.445 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.557 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.0 tttp 60.32 11.92 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.177 -0.952 . . . . 0.0 109.591 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.006 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.9 mt -99.19 153.39 37.81 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 110.566 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.0 Cg_endo -75.76 175.97 10.61 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 124.175 1.619 . . . . 0.0 109.271 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.6 t -73.27 -3.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.6 m-20 -81.68 -30.44 32.64 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.246 -0.909 . . . . 0.0 109.285 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.901 HG13 HD22 ' A' ' 45' ' ' LEU . 5.3 mm -88.0 -39.23 12.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.009 HD22 ' HB3' ' A' ' 40' ' ' LEU . 23.6 mt -74.78 -27.67 60.42 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -74.58 -21.8 78.19 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -99.99 -33.75 10.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.161 -0.611 . . . . 0.0 109.402 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 77' ' ' VAL . 18.6 t -69.22 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 4.4 t-105 -76.2 -55.38 5.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.557 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.8 mm-40 -52.02 -58.24 7.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.96 -1.088 . . . . 0.0 110.048 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.6 mt -59.29 -16.32 21.08 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.582 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.71 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.0 t -91.44 -40.25 11.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 109.713 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' TRP . 1.2 t0 -65.82 97.66 0.35 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.472 -0.767 . . . . 0.0 109.996 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.523 HG12 ' HG3' ' A' ' 69' ' ' GLU . 15.2 mm -72.22 -31.36 39.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.564 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 4.2 p30 -105.81 -9.64 17.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.801 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.564 ' CG ' ' C ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER 51.77 51.02 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.381 -0.825 . . . . 0.0 109.994 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 47.0 p-10 -111.09 20.83 17.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 75.11 32.81 55.73 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 10.6 mtp -150.69 161.34 42.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.248 . . . . 0.0 111.858 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.917 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 mt -132.27 99.73 4.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.606 -0.684 . . . . 0.0 109.293 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.2 p30 -71.49 160.41 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 110.468 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 10.1 ptt-85 -34.9 -44.21 0.21 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.756 -0.59 . . . . 0.0 111.31 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.8 m-20 -77.64 -35.08 52.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.701 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HG3' HG12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -70.13 -48.41 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.81 0.814 . . . . 0.0 109.22 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.831 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 25.3 t80 -61.04 -14.17 21.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -79.19 -47.28 16.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.527 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.845 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.9 t -59.01 -29.62 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.077 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.2 -2.37 58.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.63 -0.669 . . . . 0.0 111.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.615 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 10.0 mmt -88.08 -48.33 7.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.472 -1.392 . . . . 0.0 110.112 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -76.1 -24.18 54.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 72' ' ' VAL . 8.6 mt -70.8 -26.45 63.32 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.995 HG23 HG11 ' A' ' 53' ' ' VAL . 8.6 t -91.09 -23.61 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.728 -0.607 . . . . 0.0 109.998 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.45 -26.31 28.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.599 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.29 -17.67 48.52 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.549 -0.72 . . . . 0.0 109.675 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.006 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.39 -8.68 57.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.374 -0.828 . . . . 0.0 109.145 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.7 mt . . . . . 0 C--N 1.302 -1.458 0 CA-C-O 121.751 0.786 . . . . 0.0 108.959 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 N--CA 1.482 0.823 0 N-CA-C 110.063 -0.783 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG13 HD22 ' A' ' 76' ' ' LEU . 59.9 t -138.18 125.56 13.58 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.828 ' O ' HD11 ' A' ' 56' ' ' LEU . 53.2 Cg_endo -84.9 -175.95 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.926 1.488 . . . . 0.0 109.474 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.752 ' C ' HD21 ' A' ' 56' ' ' LEU . 28.4 mtp -110.73 12.36 22.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.474 ' N ' HD21 ' A' ' 56' ' ' LEU . 52.5 m . . . . . 0 C--N 1.299 -1.625 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.772 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 112' ' ' ARG . 10.6 t-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.01 0.434 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 52.2 Cg_endo -72.97 4.85 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.288 1.678 . . . . 0.0 111.686 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.955 ' CE2' HD12 ' A' ' 40' ' ' LEU . 4.1 m-85 -105.17 -69.42 0.82 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.793 -1.192 . . . . 0.0 109.007 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.515 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.566 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.251 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.609 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.4 t90 . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 121.287 0.565 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.07 -24.74 7.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 89.3 t -97.5 116.76 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.467 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.8 mttp -93.67 -177.81 0.75 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.496 -0.752 . . . . 0.0 109.633 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -67.63 -34.07 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.659 1.347 . . . . 0.0 110.048 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.43 -33.22 62.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.85 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.7 m-20 -81.55 -36.76 28.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.342 -0.849 . . . . 0.0 108.738 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.4 tttt -74.87 -15.17 60.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -76.93 -40.28 47.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.8 ptpt -75.34 -25.07 57.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -73.32 -36.02 66.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.83 -22.73 64.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.733 -0.604 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.24 -30.49 43.22 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.739 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 16.9 mt -82.8 -35.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.46 -36.59 68.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.556 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.5 t0 -87.03 -2.09 58.37 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.641 -0.662 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -86.48 -9.42 56.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 108.954 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.083 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.2 mt -102.96 -14.55 16.45 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.619 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.03 93.04 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -74.77 153.55 43.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.284 1.676 . . . . 0.0 111.068 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.1 t -120.92 105.86 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 65.04 12.64 8.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.218 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.71 33.83 5.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.575 ' CD1' ' OD1' ' A' ' 66' ' ' ASP . 76.9 m-85 -141.13 141.99 34.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.159 . . . . 0.0 111.882 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.083 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.8 mt -113.98 136.79 52.52 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 35' ' ' LYS . 3.3 p -83.5 146.01 28.61 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.77 -26.74 1.2 Allowed Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 33.4 t0 -66.41 -26.22 67.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.579 -0.954 . . . . 0.0 109.991 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 6.1 mttp -92.26 -33.26 14.72 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.838 HG21 HD12 ' A' ' 65' ' ' LEU . 86.4 t -80.96 -47.12 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.415 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 20.6 tttm -39.67 -51.58 5.12 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 0.0 110.917 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -68.8 -34.39 18.4 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.355 1.187 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.803 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -62.84 -32.67 56.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.017 ' HB3' HD22 ' A' ' 50' ' ' LEU . 36.9 mt -90.62 -27.64 18.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.573 -0.704 . . . . 0.0 110.081 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.487 HD11 ' HE2' ' A' ' 37' ' ' LYS . 55.9 mt -74.77 -11.29 60.12 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.035 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -90.38 -9.21 48.47 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 110.185 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.3 p -78.39 5.98 9.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.1 tttt 69.23 9.02 7.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.935 . . . . 0.0 110.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.911 HD22 HG13 ' A' ' 49' ' ' ILE . 18.5 mt -93.82 157.25 38.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -75.68 171.89 17.35 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.251 1.658 . . . . 0.0 109.285 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.8 t -70.73 -4.76 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 109.189 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.17 -29.53 54.52 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 108.78 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.911 HG13 HD22 ' A' ' 45' ' ' LEU . 6.5 mm -87.89 -36.71 9.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.866 0.841 . . . . 0.0 108.755 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.017 HD22 ' HB3' ' A' ' 40' ' ' LEU . 13.4 mt -79.33 -26.72 42.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -72.52 -23.14 78.43 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.789 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.6 ttm105 -100.83 -32.49 10.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.972 -0.722 . . . . 0.0 109.723 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.643 HG11 ' CG2' ' A' ' 77' ' ' VAL . 12.9 t -68.91 -38.97 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.205 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.596 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 4.0 t-105 -67.49 -48.01 68.36 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.359 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.8 mm-40 -59.53 -58.28 9.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.154 -0.966 . . . . 0.0 109.848 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.831 HD11 ' O ' ' A' ' 87' ' ' PRO . 5.6 mt -58.83 -17.39 23.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 108.483 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 10.2 t -88.25 -45.19 10.27 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.595 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -59.79 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.639 -0.663 . . . . 0.0 110.14 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.422 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 33.5 mm -67.98 -30.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 110.128 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.6 p30 -109.6 -15.67 14.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 6.1 m80 62.02 41.17 11.39 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.406 -0.809 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.1 p-10 -93.13 3.9 54.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.989 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 89.03 23.01 36.39 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.4 mtp -152.79 162.1 41.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -1.168 . . . . 0.0 110.454 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.838 HD12 HG21 ' A' ' 36' ' ' VAL . 46.0 mt -119.4 112.33 19.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.422 -0.799 . . . . 0.0 109.502 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 30' ' ' PHE . 2.0 m-20 -69.39 159.22 33.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.283 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 19.7 ptt180 -41.52 -42.25 2.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 109.988 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 9.9 t70 -81.64 -34.69 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 57' ' ' SER . 1.8 tt0 -69.35 -49.62 53.96 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.803 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 40.8 t80 -57.97 -19.8 33.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -70.56 -50.31 38.81 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.883 0.849 . . . . 0.0 109.587 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 76' ' ' LEU . 83.4 t -55.15 -24.87 15.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.458 0.647 . . . . 0.0 109.961 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -88.33 -10.46 49.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 111.972 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.566 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmm -84.58 -43.53 14.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.41 ' HB3' ' OH ' ' A' ' 17' ' ' TYR . 2.8 p90 -75.67 -22.88 56.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.645 -1.222 . . . . 0.0 107.751 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.0 mt -72.24 -22.16 61.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 73' ' ' ALA . 70.5 t -91.24 -44.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.765 -0.584 . . . . 0.0 109.513 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -65.14 -27.41 68.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.636 -0.665 . . . . 0.0 110.956 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -77.17 -20.47 55.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.99 -1.068 . . . . 0.0 108.722 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.856 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.48 -7.32 57.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.567 ' N ' HD23 ' A' ' 81' ' ' LEU . 3.2 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.399 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.484 0.941 0 N-CA-C 110.438 -0.639 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.467 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.8 t -132.32 127.41 20.79 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 110.753 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.831 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -83.16 -179.54 4.44 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.905 1.476 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.675 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.0 mtt -104.32 10.38 35.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.798 -1.189 . . . . 0.0 109.847 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.456 ' N ' HD21 ' A' ' 56' ' ' LEU . 68.3 m . . . . . 0 C--N 1.297 -1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 112.115 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.483 ' HA ' ' HD2' ' B' ' 110' ' ' PRO . 10.3 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.177 0.513 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.585 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 51.9 Cg_endo -71.01 6.16 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 121.887 1.725 . . . . 0.0 111.964 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.931 ' CE2' HD12 ' A' ' 40' ' ' LEU . 7.7 m-85 -99.88 -63.77 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.222 . . . . 0.0 108.992 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.4 t90 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.327 0.585 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.85 -27.75 3.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 0.0 109.935 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.4 t -92.14 122.64 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.483 ' HG2' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -80.33 176.01 4.22 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.192 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -70.08 -34.07 14.2 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.053 1.554 . . . . 0.0 109.788 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.2 pp20? -79.6 -22.59 43.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.421 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 m-20 -82.86 -38.49 22.89 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -14.93 61.18 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.34 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.472 -0.768 . . . . 0.0 109.024 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.8 ptpt -72.97 -26.14 61.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -71.81 -35.2 69.87 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.81 -23.05 60.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.654 -0.654 . . . . 0.0 109.869 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.25 -32.19 38.34 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.577 HG22 ' CE1' ' A' ' 70' ' ' PHE . 66.7 mt -81.31 -31.9 11.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.689 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.26 -37.03 66.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.5 t70 -88.76 -1.49 58.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.658 -0.652 . . . . 0.0 110.119 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -4.15 57.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.21 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.105 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.5 mt -108.84 -8.66 15.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 87.04 95.0 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -72.09 148.56 50.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.314 1.691 . . . . 0.0 110.838 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 73.8 t -119.76 100.36 9.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 63.77 16.55 9.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 97.11 34.01 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.2 m-85 -149.48 147.41 28.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -1.191 . . . . 0.0 111.776 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.105 ' CD1' HD12 ' A' ' 24' ' ' LEU . 14.8 mt -116.63 134.45 54.81 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 17.5 p -77.82 146.62 35.64 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.769 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.46 -27.19 1.18 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.3 m-20 -61.49 -25.42 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.869 . . . . 0.0 110.031 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 35.7 mttt -98.08 -32.19 11.74 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.111 -0.993 . . . . 0.0 108.338 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.972 HG11 HD12 ' A' ' 65' ' ' LEU . 97.9 t -83.54 -48.21 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.421 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 17.7 tttt -40.14 -53.56 5.02 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.49 -30.44 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.408 1.215 . . . . 0.0 109.703 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -68.81 -30.65 47.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.974 ' HB3' HD22 ' A' ' 50' ' ' LEU . 44.7 mt -88.79 -28.28 20.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.411 -0.806 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.76 -11.25 60.73 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.014 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -90.08 -5.46 56.53 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.568 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.523 ' CB ' HG13 ' A' ' 77' ' ' VAL . 5.8 p -83.21 13.28 4.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.108 -0.995 . . . . 0.0 110.673 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 63.43 8.98 3.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.923 . . . . 0.0 110.676 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.938 HD13 HG21 ' A' ' 49' ' ' ILE . 15.2 mt -94.67 157.76 36.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 0.0 109.582 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.7 Cg_endo -75.28 173.66 14.13 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 124.023 1.538 . . . . 0.0 109.243 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.0 t -74.45 -1.41 2.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.145 -0.972 . . . . 0.0 109.373 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -31.19 33.1 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.938 HG21 HD13 ' A' ' 45' ' ' LEU . 12.8 mm -83.02 -40.35 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.974 HD22 ' HB3' ' A' ' 40' ' ' LEU . 22.7 mt -73.84 -25.92 60.32 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -73.35 -25.28 73.31 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.86 -28.09 12.97 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.804 -0.821 . . . . 0.0 110.032 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.882 HG11 HG23 ' A' ' 77' ' ' VAL . 17.0 t -72.58 -39.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.78 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 2.4 t-105 -65.09 -50.97 64.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.576 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 9.6 mm-40 -56.19 -53.84 52.39 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.595 HD11 ' O ' ' A' ' 87' ' ' PRO . 18.3 mt -64.46 -12.7 46.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.67 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t -94.97 -29.73 14.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 108.88 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 7.4 t0 -74.5 100.75 3.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.692 -0.63 . . . . 0.0 109.65 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.486 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.1 mm -80.44 -29.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -102.1 -18.56 15.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 4.1 m-70 65.72 42.12 3.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.0 p30 -102.28 -3.74 26.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.461 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 95.12 25.87 13.52 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 5.1 mtp -152.56 161.25 42.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.245 . . . . 0.0 110.618 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.972 HD12 HG11 ' A' ' 36' ' ' VAL . 13.5 mt -119.78 102.12 8.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.667 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.618 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 5.1 p30 -71.57 167.47 19.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.56 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.7 ptt-85 -37.55 -46.04 0.8 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.0 111.854 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 80.7 m-20 -76.68 -37.21 56.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.075 -1.016 . . . . 0.0 110.665 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 44.9 mt-10 -71.85 -44.5 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.972 ' CD2' HD12 ' A' ' 31' ' ' LEU . 11.6 t80 -60.51 -17.37 45.0 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -79.24 -45.79 19.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.585 ' O ' HD12 ' A' ' 76' ' ' LEU . 46.5 t -61.4 -25.97 38.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.476 0.655 . . . . 0.0 109.747 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.67 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.55 -8.23 50.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 111.258 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.7 mmt -83.24 -47.74 11.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -75.14 -28.73 60.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 72' ' ' VAL . 6.7 mt -66.93 -28.67 68.48 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.882 HG23 HG11 ' A' ' 53' ' ' VAL . 41.0 t -91.38 -23.94 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.686 -0.634 . . . . 0.0 110.393 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -29.78 17.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.897 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.82 -15.65 44.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.65 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.665 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -81.42 -10.24 59.55 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.907 -1.121 . . . . 0.0 108.211 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 45' ' ' LEU . 4.0 mt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.356 0.598 . . . . 0.0 110.273 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.484 0.923 0 N-CA-C 110.622 -0.568 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 53' ' ' VAL . 59.0 t -113.56 146.71 35.99 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.241 -0.912 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.595 ' O ' HD11 ' A' ' 56' ' ' LEU . 43.8 Cg_endo -86.97 -168.46 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.632 1.333 . . . . 0.0 109.472 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.427 ' HG3' ' C ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -124.88 15.21 8.6 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.004 -1.06 . . . . 0.0 111.361 -179.138 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.495 1.801 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.565 -179.502 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.517 ' ND2' ' HG2' ' A' ' 55' ' ' GLU . 6.0 t-20 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.556 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 50.6 Cg_endo -68.52 8.27 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.259 1.972 . . . . 0.0 112.573 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.954 ' CE2' HD12 ' A' ' 40' ' ' LEU . 2.0 m-85 -102.88 -67.49 0.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.545 -1.347 . . . . 0.0 108.577 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.509 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 2.0 mtt-85 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.121 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.2 t90 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.336 0.589 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -41.63 -32.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 110.298 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.634 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 69.9 t -102.99 136.92 33.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 109.598 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.453 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mtmt -88.42 175.09 4.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 110.24 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.5 Cg_endo -70.21 -34.37 13.19 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.975 1.513 . . . . 0.0 109.745 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -77.08 -22.44 52.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.743 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 3.1 m-20 -82.93 -36.78 24.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.81 . . . . 0.0 109.132 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -80.5 -24.51 39.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -65.84 -39.78 91.12 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.0 ptpt -74.71 -28.67 60.9 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.4 m-30 -70.58 -36.71 73.72 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -63.8 -20.48 65.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.71 -0.619 . . . . 0.0 110.15 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.63 -36.1 33.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 47.8 mt -78.43 -31.43 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.814 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.48 -32.53 68.37 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -87.49 -5.61 58.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.579 -0.7 . . . . 0.0 109.859 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -85.46 -8.49 58.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 0.0 109.085 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.091 HD12 ' CD1' ' A' ' 31' ' ' LEU . 7.2 mt -100.4 -16.87 17.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.627 -0.671 . . . . 0.0 109.316 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.5 t 88.74 89.03 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 121.358 0.599 . . . . 0.0 109.877 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.7 Cg_endo -73.33 151.37 48.33 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.552 1.817 . . . . 0.0 110.854 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 55.9 t -121.3 104.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.89 18.09 11.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.439 -0.788 . . . . 0.0 109.413 -178.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.85 34.16 6.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.18 137.82 32.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 112.017 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.091 ' CD1' HD12 ' A' ' 24' ' ' LEU . 7.9 mt -110.3 158.5 18.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 35' ' ' LYS . 8.2 p -104.07 143.79 32.43 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.624 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.76 -25.78 0.65 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -70.85 -25.24 62.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.571 -0.958 . . . . 0.0 110.314 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB3' HD13 ' A' ' 24' ' ' LEU . 35.1 mttm -88.56 -36.01 16.6 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.915 HG12 ' CD1' ' A' ' 40' ' ' LEU . 81.2 t -77.22 -41.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.08 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.51 -51.65 6.48 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.518 -0.739 . . . . 0.0 111.026 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.9 Cg_endo -70.62 -34.27 12.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.369 1.194 . . . . 0.0 109.878 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.51 -32.56 53.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.934 HD12 ' CE2' ' B' ' 111' ' ' PHE . 23.7 mt -90.56 -29.34 17.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.587 -0.696 . . . . 0.0 109.977 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD11 ' HE2' ' A' ' 37' ' ' LYS . 33.5 mt -69.75 -9.55 54.93 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -90.65 -8.68 49.37 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.565 -0.71 . . . . 0.0 111.173 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.535 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 84.5 p -82.18 15.36 2.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -0.976 . . . . 0.0 110.652 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.18 14.03 3.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -0.99 . . . . 0.0 110.197 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.86 HD22 HG13 ' A' ' 49' ' ' ILE . 17.5 mt -98.16 157.89 33.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.977 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.0 Cg_endo -74.88 166.71 28.67 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 124.067 1.562 . . . . 0.0 109.228 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' B' ' 111' ' ' PHE . 13.9 t -68.26 -6.97 6.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -30.0 58.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.876 -1.14 . . . . 0.0 109.143 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.86 HG13 HD22 ' A' ' 45' ' ' LEU . 7.5 mm -83.81 -40.06 15.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -71.02 -30.6 66.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' B' ' 109' ' ' ASN . . . -72.18 -26.22 72.73 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.3 ttm-85 -100.12 -28.41 13.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.825 -0.809 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.825 HG11 ' CG2' ' A' ' 77' ' ' VAL . 10.3 t -74.18 -34.7 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.624 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.1 t-105 -66.74 -53.05 37.4 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.131 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.6 mt-10 -48.65 -58.36 4.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.941 HD21 ' C ' ' A' ' 88' ' ' MET . 2.7 mt -62.65 -13.09 27.83 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.069 -1.053 . . . . 0.0 108.773 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.688 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -91.81 -42.72 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.255 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' TRP . 11.6 t0 -66.04 78.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.492 -0.755 . . . . 0.0 110.395 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.509 HG12 ' HG3' ' A' ' 69' ' ' GLU . 42.8 mm -51.47 -27.72 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.41 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -102.84 -20.18 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.29 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.424 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . 5.7 m80 59.89 47.1 10.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 33.4 p-10 -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.063 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.463 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 86.45 28.9 26.02 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.1 mtt -150.24 161.44 42.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 111.09 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.651 HD13 ' HA ' ' A' ' 70' ' ' PHE . 7.6 mt -130.99 109.72 10.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.842 . . . . 0.0 110.072 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 1.8 m-20 -69.8 159.34 33.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.981 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -41.21 -42.19 2.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.503 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 57.8 t0 -82.4 -33.3 28.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.5 tt0 -69.11 -50.46 47.89 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.171 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.651 ' HA ' HD13 ' A' ' 65' ' ' LEU . 57.3 t80 -55.93 -22.84 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.17 -48.67 67.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.455 -0.778 . . . . 0.0 110.055 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.579 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 76.9 t -58.27 -24.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.528 -0.732 . . . . 0.0 110.132 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.688 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -84.86 -13.36 51.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.246 -0.909 . . . . 0.0 112.166 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.2 mmm -85.92 -36.07 20.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.545 -1.347 . . . . 0.0 110.732 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.634 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 5.0 p90 -79.08 -26.3 43.02 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.611 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.761 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.8 mt -71.72 -22.33 61.65 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.825 ' CG2' HG11 ' A' ' 53' ' ' VAL . 72.6 t -90.82 -32.89 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.639 -0.663 . . . . 0.0 110.142 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -78.36 -23.24 47.02 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.441 -0.787 . . . . 0.0 110.045 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -83.02 -13.79 55.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.639 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.686 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.49 -14.18 41.09 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.189 -0.944 . . . . 0.0 109.125 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.821 HD21 ' CD1' ' A' ' 45' ' ' LEU . 9.6 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.602 -0.686 . . . . 0.0 110.844 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.484 0.953 0 N-CA-C 110.428 -0.643 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.744 HG21 ' CG2' ' A' ' 53' ' ' VAL . 84.8 t -115.07 122.18 33.86 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 111.024 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.786 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.1 Cg_endo -81.55 -167.09 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.964 1.507 . . . . 0.0 109.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.941 ' C ' HD21 ' A' ' 56' ' ' LEU . 14.7 mtp -120.04 18.66 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.02 . . . . 0.0 110.338 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 56' ' ' LEU . 66.6 m . . . . . 0 C--N 1.295 -1.766 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.79 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLY . 35.1 t-20 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.911 0.386 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.522 ' HD2' ' CE1' ' B' ' 111' ' ' PHE . 49.5 Cg_endo -69.54 3.04 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.32 1.695 . . . . 0.0 111.77 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.934 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -104.16 -62.92 1.25 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.776 -1.202 . . . . 0.0 108.903 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.457 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.168 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.7 t90 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.191 0.52 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.44 -26.36 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.293 -0.879 . . . . 0.0 110.207 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.4 t -102.7 137.97 28.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.45 -0.781 . . . . 0.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.507 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 5.5 mttt -110.71 176.04 1.67 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.411 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.711 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 39.6 Cg_endo -65.53 -38.13 26.66 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.94 1.495 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 12.4 pt-20 -67.94 -36.43 80.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.045 -1.035 . . . . 0.0 109.172 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -81.21 -37.8 28.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -76.17 -17.05 59.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -71.85 -40.87 68.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -75.69 -26.61 57.74 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.624 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -71.15 -34.32 70.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -21.67 64.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.662 -0.649 . . . . 0.0 110.265 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.2 33.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.052 -1.03 . . . . 0.0 108.414 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.669 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 69.9 mt -76.94 -30.93 18.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.826 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.85 -39.66 63.83 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.546 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t70 -86.45 2.57 47.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.558 -0.714 . . . . 0.0 110.096 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -89.53 -11.5 42.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.329 -0.857 . . . . 0.0 109.333 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.106 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -99.83 -15.14 18.51 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.608 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 t 86.01 81.68 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.299 0 CA-C-O 121.439 0.638 . . . . 0.0 109.674 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 44.6 Cg_endo -71.06 152.57 62.66 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.87 1.984 . . . . 0.0 111.103 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.1 t -118.92 117.22 53.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER 63.78 13.06 7.17 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.579 -178.051 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.51 34.1 8.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 23.1 m-85 -135.36 138.36 43.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -1.11 . . . . 0.0 111.647 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.106 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.1 mt -109.49 137.57 47.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 34' ' ' ASP . 3.9 p -85.06 142.28 29.67 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.105 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.31 -25.81 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . 32.8 t70 -69.18 -24.28 64.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.384 -1.069 . . . . 0.0 110.326 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 9.6 mttm -92.53 -35.35 13.64 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.018 -1.051 . . . . 0.0 108.17 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.847 HG12 ' CD1' ' A' ' 40' ' ' LEU . 96.3 t -75.32 -41.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.566 0.698 . . . . 0.0 110.403 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.79 -54.92 6.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 111.035 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.12 -32.48 34.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.443 1.233 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.844 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.3 t -63.84 -33.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.023 ' HB3' HD22 ' A' ' 50' ' ' LEU . 26.1 mt -89.92 -27.25 19.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 110.461 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 45.3 mt -68.26 -15.04 63.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -90.76 -2.45 57.8 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.708 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.596 ' O ' HD21 ' A' ' 81' ' ' LEU . 79.6 p -82.65 12.67 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.591 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 63.57 10.55 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.042 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.8 mt -100.46 159.11 30.59 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.391 -0.818 . . . . 0.0 110.486 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.1 Cg_endo -76.39 171.77 17.47 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.113 1.586 . . . . 0.0 109.415 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' B' ' 111' ' ' PHE . 4.5 t -71.92 -3.49 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.526 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.45 -30.87 42.34 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.156 -0.965 . . . . 0.0 109.097 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.878 HG13 HD22 ' A' ' 45' ' ' LEU . 8.8 mm -84.1 -39.6 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.023 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.8 mt -72.2 -26.44 62.05 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.563 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -74.53 -26.54 67.43 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.109 -1.997 . . . . 0.0 108.109 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.781 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.5 ttm180 -100.7 -25.47 14.13 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.92 -0.753 . . . . 0.0 110.215 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.083 HG11 HG23 ' A' ' 77' ' ' VAL . 13.6 t -74.27 -36.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.917 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.614 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.79 -48.17 67.06 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.15 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.3 mm-40 -52.55 -58.18 7.58 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 110.089 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.929 HD21 ' C ' ' A' ' 88' ' ' MET . 3.5 mt -62.85 -17.57 61.64 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.481 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.893 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 30.1 t -86.08 -30.59 22.48 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.4 t0 -71.12 101.36 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.543 -0.723 . . . . 0.0 109.683 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.421 ' HB ' ' CD ' ' A' ' 69' ' ' GLU . 47.8 mm -75.63 -42.4 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.613 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 31.2 p30 -104.41 -4.69 22.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.062 -1.024 . . . . 0.0 111.044 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 2.0 m-70 60.86 44.4 10.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.171 -0.955 . . . . 0.0 110.541 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 38.1 p30 -100.05 26.51 6.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.237 -0.914 . . . . 0.0 109.059 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 58.53 31.69 67.41 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.8 mtt -150.91 161.04 43.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -1.05 . . . . 0.0 110.357 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.824 HD12 HG11 ' A' ' 36' ' ' VAL . 16.0 mt -123.6 102.29 7.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.538 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -69.29 157.51 36.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 66' ' ' ASP . 14.2 ptt180 -37.06 -39.39 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.676 . . . . 0.0 110.81 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' OD2' ' HG3' ' A' ' 67' ' ' ARG . 17.8 m-20 -79.51 -35.0 40.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 109.928 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 14.5 mt-10 -75.4 -40.95 57.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.963 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.0 t80 -62.62 -23.88 67.3 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.87 -44.79 63.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.465 -0.772 . . . . 0.0 110.13 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.64 ' O ' HD12 ' A' ' 76' ' ' LEU . 85.7 t -64.28 -22.16 30.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.022 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.81 -5.66 56.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmt -87.94 -44.44 11.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.828 -1.17 . . . . 0.0 109.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CD2' HG22 ' A' ' 9' ' ' VAL . 2.3 p90 -75.55 -26.64 58.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 72' ' ' VAL . 12.0 mt -67.53 -28.05 67.49 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.083 HG23 HG11 ' A' ' 53' ' ' VAL . 27.2 t -92.24 -60.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.411 0.624 . . . . 0.0 109.817 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.5 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.1 m-85 -46.62 -27.33 1.12 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.536 -0.727 . . . . 0.0 111.391 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 56.9 m -81.61 -12.08 58.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 110.088 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.042 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.22 -12.53 37.78 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.392 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.779 ' N ' HD12 ' A' ' 81' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.516 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.484 0.965 0 N-CA-C 110.163 -0.745 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.5 t -113.3 119.25 42.49 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.532 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.778 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.6 Cg_endo -85.34 -168.99 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.924 1.486 . . . . 0.0 109.81 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.929 ' C ' HD21 ' A' ' 56' ' ' LEU . 18.8 mtt -111.83 18.1 19.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.525 ' N ' HD21 ' A' ' 56' ' ' LEU . 3.0 m . . . . . 0 C--N 1.293 -1.87 0 C-N-CA 118.898 -1.121 . . . . 0.0 112.823 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.7 t-20 . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.601 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.5 Cg_endo -70.99 1.08 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.939 1.494 . . . . 0.0 112.015 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.949 ' CE2' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -105.67 -59.79 1.72 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.658 -1.276 . . . . 0.0 109.21 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.501 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.586 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.8 t90 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.351 0.596 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.26 -27.18 2.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 40.7 t -94.43 149.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.829 . . . . 0.0 110.312 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -104.24 170.22 6.35 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.511 -0.743 . . . . 0.0 109.731 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.15 -34.45 28.18 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.59 1.311 . . . . 0.0 109.926 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 2.1 pm0 -74.62 -25.67 59.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.917 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -81.37 -40.27 23.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 108.566 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -69.02 -13.07 62.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.6 mtmt -84.54 -37.93 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 5.8 m-30 -64.22 -23.38 67.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.93 -23.66 26.88 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.816 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.2 34.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.502 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 23.7 mt -79.46 -32.04 14.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.79 -40.15 66.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.2 t70 -85.85 1.19 50.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.652 -0.655 . . . . 0.0 109.79 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.451 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -92.91 -4.94 51.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.086 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.029 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -107.32 -6.98 16.87 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 82.76 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.8 Cg_endo -73.07 149.94 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.08 1.569 . . . . 0.0 110.998 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 54.3 t -117.62 103.47 14.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.5 OUTLIER 66.03 13.26 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.212 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 99.53 32.12 5.84 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 87.7 m-85 -143.09 153.91 43.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.271 . . . . 0.0 111.7 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.029 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -119.78 137.15 54.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 17.7 p -80.8 142.58 33.58 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.051 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.66 -27.05 0.3 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -66.11 -27.28 67.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -1.023 . . . . 0.0 110.457 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 51.7 mttp -92.3 -33.24 14.7 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.041 -1.037 . . . . 0.0 108.299 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 65' ' ' LEU . 60.4 t -82.32 -45.07 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.603 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.7 tttt -43.96 -52.78 14.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.763 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.1 Cg_endo -65.51 -33.72 45.34 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.39 1.205 . . . . 0.0 109.48 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -64.56 -38.39 82.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.042 ' HB3' HD22 ' A' ' 50' ' ' LEU . 59.3 mt -81.98 -30.06 31.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 38' ' ' PRO . 42.7 mt -73.43 -13.92 61.16 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -88.55 -8.97 53.87 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.929 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.549 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 4.3 p -80.07 9.46 5.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.254 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 67.34 12.93 9.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.139 HD11 ' HB3' ' A' ' 80' ' ' ALA . 17.0 mt -98.01 153.41 38.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 110.04 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.4 Cg_endo -75.01 171.84 17.54 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 123.994 1.523 . . . . 0.0 109.313 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.508 HG13 ' C ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.03 -6.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 109.467 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -77.53 -31.01 53.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.863 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.902 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -85.32 -41.17 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.042 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.2 mt -73.71 -28.79 61.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.22 -23.61 74.78 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.85 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.2 ttm180 -101.06 -37.94 8.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.933 -0.745 . . . . 0.0 109.552 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.005 HG11 HG23 ' A' ' 77' ' ' VAL . 21.1 t -64.06 -39.79 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.631 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.6 t-105 -67.13 -51.38 54.72 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.463 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 56.1 mt-10 -53.24 -56.46 16.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -61.33 -15.15 32.95 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.713 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 16.1 m -93.59 -33.97 13.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.522 -0.737 . . . . 0.0 109.527 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -67.72 69.1 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.452 -0.78 . . . . 0.0 110.056 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.488 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -50.56 -30.33 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -106.71 -15.3 14.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.878 . . . . 0.0 109.889 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 93.1 m-70 57.31 45.72 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.362 -0.836 . . . . 0.0 111.66 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.47 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.6 p-10 -107.21 28.91 7.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.403 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 66.25 25.93 72.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 12.8 mtp -151.06 161.37 42.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 110.199 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.021 HD12 HG11 ' A' ' 36' ' ' VAL . 8.6 mt -122.03 110.31 15.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.863 . . . . 0.0 109.798 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.58 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 6.3 t0 -68.71 163.96 22.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -49.27 -30.38 7.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.182 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 35.8 t0 -86.83 -33.56 19.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 42.4 mt-10 -75.59 -43.79 46.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.968 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.5 t80 -54.39 -34.0 60.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -59.21 -57.29 13.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.57 0.7 . . . . 0.0 110.253 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 76' ' ' LEU . 44.9 t -52.23 -22.8 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.15 -10.22 48.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.3 mmm -89.41 -44.3 10.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.472 -1.393 . . . . 0.0 110.608 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 2.9 p90 -76.04 -19.4 58.67 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.666 HD22 HG13 ' A' ' 86' ' ' VAL . 6.2 mt -79.33 -25.5 42.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.005 HG23 HG11 ' A' ' 53' ' ' VAL . 17.6 t -91.11 -41.8 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.68 -25.67 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.423 -0.798 . . . . 0.0 110.266 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.2 m -80.1 -14.8 58.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.139 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.67 -10.09 49.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.143 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.651 ' N ' HD23 ' A' ' 81' ' ' LEU . 4.5 mt . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.482 0.851 0 N-CA-C 109.42 -1.031 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.666 HG13 HD22 ' A' ' 76' ' ' LEU . 31.2 t -128.49 121.32 21.25 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.957 -1.089 . . . . 0.0 111.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.659 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -85.53 166.64 10.44 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.86 1.453 . . . . 0.0 109.086 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.821 ' C ' HD21 ' A' ' 56' ' ' LEU . 6.6 mtp -90.36 14.25 13.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.921 -1.112 . . . . 0.0 110.477 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.493 ' N ' HD21 ' A' ' 56' ' ' LEU . 72.3 m . . . . . 0 C--N 1.298 -1.673 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.439 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.488 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 27.1 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.709 0.29 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.597 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -76.41 12.57 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.488 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.969 ' CE2' HD12 ' A' ' 40' ' ' LEU . 9.8 m-85 -107.27 -61.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.798 -1.189 . . . . 0.0 109.08 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.056 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.5 t90 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -40.14 -27.97 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.34 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 25.5 t -97.98 126.17 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 109.757 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.8 mttp -82.12 173.66 7.27 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 110.45 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.2 Cg_endo -68.31 -33.96 22.49 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.091 1.574 . . . . 0.0 109.387 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.01 -18.95 48.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.546 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.82 -43.19 15.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.91 61.59 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.09 61.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.47 -23.52 50.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.621 ' CD2' ' HB2' ' A' ' 74' ' ' MET . 9.9 m-30 -74.98 -33.96 61.94 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 5.1 m-20 -69.98 -22.27 63.16 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.734 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -78.23 -32.97 50.04 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.684 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 44.7 mt -81.55 -32.7 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.792 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.36 -31.58 64.02 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.6 t0 -90.83 -3.22 57.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 71.6 p -87.84 -8.51 55.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 31' ' ' LEU . 8.5 mt -98.81 -14.88 19.48 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.624 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 p 94.52 91.41 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.296 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.4 Cg_endo -72.73 147.27 44.63 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.194 1.628 . . . . 0.0 110.638 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 77.1 t -115.22 100.27 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 64.47 15.26 9.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 109.69 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.24 32.53 5.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 75.5 m-85 -145.63 148.75 33.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.17 . . . . 0.0 111.59 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 24' ' ' LEU . 10.2 mt -115.0 159.03 21.26 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 35' ' ' LYS . 86.4 p -104.52 143.8 32.55 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.031 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.646 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.7 -25.32 0.86 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' SER . 1.6 t70 -71.67 -23.69 61.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.954 . . . . 0.0 110.354 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.3 mttp -92.36 -33.06 14.73 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.011 -1.055 . . . . 0.0 108.257 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.824 HG12 ' CD1' ' A' ' 40' ' ' LEU . 89.2 t -77.54 -38.42 26.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.296 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -42.54 -54.5 8.1 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -65.81 -32.62 45.88 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.622 1.327 . . . . 0.0 109.56 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.681 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.53 -31.97 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.978 ' HB3' HD22 ' A' ' 50' ' ' LEU . 27.2 mt -92.91 -30.48 15.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.496 -0.753 . . . . 0.0 110.269 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.443 HD11 ' HE3' ' A' ' 37' ' ' LYS . 57.5 mt -72.39 -12.11 60.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -90.79 -9.63 45.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.417 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.54 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 92.2 p -81.32 11.0 4.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.363 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.59 14.75 9.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.998 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.4 mt -96.76 154.35 38.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.828 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.0 Cg_endo -75.38 169.26 22.81 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.939 1.494 . . . . 0.0 109.072 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.535 HG13 ' C ' ' B' ' 111' ' ' PHE . 2.1 t -69.87 -3.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.965 -1.085 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.63 -27.77 40.96 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.161 -0.962 . . . . 0.0 109.235 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.908 HG13 HD22 ' A' ' 45' ' ' LEU . 7.3 mm -87.81 -36.94 10.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -76.23 -27.19 56.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -74.08 -25.84 70.19 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.655 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.7 ttm-85 -101.19 -31.19 11.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.048 -0.678 . . . . 0.0 110.242 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.711 HG11 HG23 ' A' ' 77' ' ' VAL . 13.1 t -70.5 -34.27 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.044 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.646 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 5.1 t-105 -68.17 -56.78 7.51 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.262 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 3.4 mm-40 -43.17 -64.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.35 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.864 HD21 ' C ' ' A' ' 88' ' ' MET . 4.6 mt -55.6 -20.01 12.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.952 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.87 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 57.8 m -91.61 -19.84 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.479 -0.763 . . . . 0.0 109.403 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.9 t0 -96.1 86.19 4.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.512 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -91.05 -13.93 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.63 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 11.1 m-20 -92.36 -12.65 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 56.8 47.11 18.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 110.648 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 21.9 p-10 -128.12 25.47 5.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.17 38.44 93.15 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.51 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 6.7 mtt -150.37 161.08 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -1.162 . . . . 0.0 111.981 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 HG21 ' A' ' 36' ' ' VAL . 13.9 mt -125.45 103.69 8.03 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.41 160.4 32.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.997 -1.065 . . . . 0.0 110.682 -179.025 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.437 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ptm180 -36.48 -44.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.774 -0.579 . . . . 0.0 111.392 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 t70 -79.53 -31.93 42.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.662 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.465 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 28.0 mt-10 -76.03 -45.38 34.69 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.079 -1.013 . . . . 0.0 109.134 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.768 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.6 t80 -58.19 -18.47 26.17 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.29 -45.82 37.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.444 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.562 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.7 t -59.78 -26.12 34.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 109.538 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.87 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.79 -5.61 55.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 111.193 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.621 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.2 mmt -84.43 -49.53 8.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.923 -1.111 . . . . 0.0 109.839 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.605 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.1 p90 -73.79 -28.26 61.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.605 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.1 mt -64.54 -28.23 69.5 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.829 HG21 ' CD2' ' A' ' 40' ' ' LEU . 45.8 t -91.25 -23.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.828 -0.545 . . . . 0.0 110.591 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.4 -23.22 23.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -0.972 . . . . 0.0 109.802 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.12 -12.85 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.998 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.86 -14.31 39.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.804 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.7 mt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.853 0.835 . . . . 0.0 109.188 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.48 0.729 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.665 HG11 HG23 ' A' ' 53' ' ' VAL . 95.7 t -111.91 129.09 24.56 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.2 -0.938 . . . . 0.0 110.015 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.6 Cg_endo -90.16 -161.73 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.763 1.402 . . . . 0.0 109.642 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.864 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -130.19 3.08 4.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.49 -0.756 . . . . 0.0 109.566 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.572 ' N ' HD21 ' A' ' 56' ' ' LEU . 67.7 m . . . . . 0 C--N 1.296 -1.723 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.597 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.823 HD21 ' N ' ' B' ' 109' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.662 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 41.7 Cg_endo -72.38 -2.42 11.69 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.168 1.088 . . . . 0.0 109.922 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.909 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.5 -66.72 0.99 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.911 -1.118 . . . . 0.0 108.792 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.455 ' HB2' ' HB2' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.261 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.271 0.558 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -47.74 -27.66 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 111.126 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 53.7 t -91.76 147.19 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 9.3 mttm -104.06 176.32 1.83 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.548 -0.72 . . . . 0.0 109.788 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.7 Cg_endo -67.89 -35.44 20.91 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.769 1.405 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.3 pt-20 -74.75 -29.08 61.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.519 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 35.3 m-20 -82.2 -33.14 29.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.296 -0.878 . . . . 0.0 109.07 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 14' ' ' LYS . 1.1 tmtt? -78.17 -13.21 59.95 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.199 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.29 -41.98 26.85 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.628 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.82 -26.2 61.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -73.32 -35.52 66.08 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.74 -23.56 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.831 -0.543 . . . . 0.0 109.765 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -79.14 -34.88 42.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.613 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 42.0 mt -79.35 -31.55 14.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.94 -36.71 59.26 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -90.4 3.98 52.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 0.0 109.609 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -91.9 -9.35 43.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 108.967 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.079 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -104.8 -8.05 19.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 87.2 99.89 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.043 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 47.2 Cg_endo -70.68 146.72 55.25 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.453 1.765 . . . . 0.0 110.425 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.3 t -115.7 96.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.47 20.45 12.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 94.14 33.84 6.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 85.4 m-85 -150.24 145.69 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -1.191 . . . . 0.0 111.737 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.079 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.9 mt -112.8 149.22 33.36 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.487 ' CA ' ' SD ' ' A' ' 64' ' ' MET . 24.8 p -99.22 144.86 27.86 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.182 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -40.96 -27.52 0.19 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.2 m-20 -65.38 -23.97 67.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -1.079 . . . . 0.0 110.407 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 69.8 mttt -99.22 -31.8 11.54 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.077 -1.014 . . . . 0.0 108.941 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.871 HG11 HD12 ' A' ' 65' ' ' LEU . 95.2 t -79.72 -42.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -42.0 -55.0 6.65 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.848 . . . . 0.0 110.868 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.84 -32.83 35.54 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.494 1.26 . . . . 0.0 109.866 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.6 t -65.22 -28.96 45.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.042 ' HB3' HD22 ' A' ' 50' ' ' LEU . 38.0 mt -92.95 -26.21 17.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.52 -0.737 . . . . 0.0 110.342 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 74.2 mt -73.5 -9.09 58.33 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.193 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.22 -4.13 57.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.944 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.576 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -84.65 10.38 11.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.1 -1.0 . . . . 0.0 110.283 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.9 OUTLIER 66.85 7.62 5.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 109.979 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.071 HD13 HG21 ' A' ' 49' ' ' ILE . 13.9 mt -94.58 157.12 37.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.9 Cg_endo -77.0 176.4 10.18 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.079 1.568 . . . . 0.0 109.841 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.524 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.3 t -73.25 -4.44 5.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.14 -29.89 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.924 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.071 HG21 HD13 ' A' ' 45' ' ' LEU . 8.5 mm -86.37 -40.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.042 HD22 ' HB3' ' A' ' 40' ' ' LEU . 19.5 mt -76.3 -28.32 56.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.49 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -70.12 -25.16 75.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.3 ttm105 -101.46 -34.09 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.117 -0.637 . . . . 0.0 110.043 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.776 HG11 HG23 ' A' ' 77' ' ' VAL . 24.5 t -67.37 -36.01 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.92 -1.113 . . . . 0.0 108.889 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.583 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.9 t-105 -66.82 -53.57 31.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.16 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 8.2 mt-10 -47.27 -58.04 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.126 -0.984 . . . . 0.0 110.396 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -63.04 -12.66 27.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.049 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.655 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 47.0 m -94.97 -40.43 9.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 61.9 t0 -84.36 70.84 10.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 110.01 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mt -61.04 -16.5 14.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 110.492 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 26.1 m-20 -91.98 -15.53 27.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.68 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 88.0 m-70 51.27 34.19 11.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.2 p-10 -103.03 4.68 37.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.993 . . . . 0.0 110.042 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.52 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 86.89 26.62 31.24 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.2 mmm -148.3 161.65 41.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.217 -1.167 . . . . 0.0 110.036 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.871 HD12 HG11 ' A' ' 36' ' ' VAL . 12.1 mt -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.301 -0.874 . . . . 0.0 109.657 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.579 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 21.7 t0 -69.07 167.11 16.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.268 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 6.7 ptm180 -49.86 -39.23 38.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -35.49 38.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 109.448 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 40.3 mt-10 -72.56 -47.04 51.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 109.166 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.918 ' CD2' HD12 ' A' ' 31' ' ' LEU . 26.2 t80 -57.86 -26.79 62.55 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.491 -0.756 . . . . 0.0 109.028 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -68.47 -48.53 64.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.881 . . . . 0.0 110.115 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 76' ' ' LEU . 60.7 t -58.34 -22.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.688 -0.633 . . . . 0.0 109.847 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -88.5 -12.49 42.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.747 . . . . 0.0 111.96 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.7 mmm -85.6 -40.36 16.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.656 -1.277 . . . . 0.0 110.472 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.3 p90 -77.9 -25.19 48.34 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.788 -1.165 . . . . 0.0 107.894 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 4.6 mt -73.19 -20.13 60.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.544 0.688 . . . . 0.0 109.212 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.776 HG23 HG11 ' A' ' 53' ' ' VAL . 42.2 t -91.59 -49.82 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.849 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.593 ' HA ' HD23 ' A' ' 81' ' ' LEU . 3.4 m-85 -64.16 -41.07 97.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.471 -0.768 . . . . 0.0 110.711 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 59.9 m -80.67 -9.16 59.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.399 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -92.97 -31.93 14.72 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.129 0.966 . . . . 0.0 109.136 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.596 ' N ' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.591 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.638 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 N--CA 1.482 0.849 0 N-CA-C 110.458 -0.632 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 80.0 t -121.09 126.01 26.77 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.649 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.9 Cg_endo -85.16 152.96 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.846 1.446 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.574 ' C ' HD21 ' A' ' 56' ' ' LEU . 24.8 mtm -88.13 17.58 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.475 ' N ' HD21 ' A' ' 56' ' ' LEU . 38.9 m . . . . . 0 C--N 1.294 -1.81 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.836 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 16.6 t-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.993 0.425 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 51.2 Cg_endo -71.62 5.54 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.165 1.613 . . . . 0.0 112.01 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.931 ' CE2' HD12 ' A' ' 40' ' ' LEU . 6.9 m-85 -101.66 -62.83 1.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.658 -1.276 . . . . 0.0 109.167 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.362 179.685 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.304 0.573 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.58 -28.06 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.97 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.7 t -97.42 152.6 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 110.045 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.511 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.0 mmmt -105.9 171.81 4.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.923 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.9 Cg_endo -67.61 -35.48 22.33 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.753 1.397 . . . . 0.0 109.46 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.21 -31.01 68.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -81.53 -33.72 31.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 10.9 tptp -74.76 -16.35 60.73 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.68 -38.65 47.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -78.52 -25.02 45.45 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.611 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.2 m-30 -75.33 -37.51 60.68 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 30.5 t70 -69.17 -18.58 63.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.653 -0.654 . . . . 0.0 109.655 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -83.08 -39.06 21.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.695 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.9 mt -75.14 -34.13 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.721 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -68.6 -41.17 79.96 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t70 -84.89 -0.64 54.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.587 -0.696 . . . . 0.0 109.905 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 36.7 t -86.49 -9.68 55.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.267 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.115 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -100.75 -11.4 19.94 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.09 93.79 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.538 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 48.5 Cg_endo -74.25 151.06 43.07 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.385 1.729 . . . . 0.0 110.905 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -120.8 98.5 6.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 69.34 22.12 6.7 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.693 0.758 . . . . 0.0 109.207 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.85 37.43 7.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.559 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 71.9 m-85 -147.2 140.38 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -1.159 . . . . 0.0 111.766 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.115 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.6 mt -110.09 137.79 47.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -84.42 142.53 30.04 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.846 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.54 -25.87 0.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -70.01 -24.21 63.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.588 -0.948 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.4 mttp -91.69 -35.12 14.36 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.95 HG11 HD12 ' A' ' 65' ' ' LEU . 90.8 t -79.68 -48.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.444 0.64 . . . . 0.0 110.296 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.61 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 9.0 tttp -38.94 -55.24 2.9 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.582 -0.699 . . . . 0.0 110.8 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.8 Cg_endo -66.18 -29.8 47.0 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.576 1.303 . . . . 0.0 110.025 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -70.59 -31.74 47.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.522 -0.736 . . . . 0.0 109.07 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.947 ' HB3' HD22 ' A' ' 50' ' ' LEU . 32.9 mt -85.44 -28.63 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -0.822 . . . . 0.0 109.772 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 38' ' ' PRO . 69.8 mt -69.63 -11.29 60.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.02 -5.01 57.09 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.769 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -81.97 14.52 2.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 110.144 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.73 15.34 1.56 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.812 -1.18 . . . . 0.0 109.847 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.035 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.0 mt -101.08 156.13 35.5 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.4 Cg_endo -73.61 160.74 43.54 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 123.803 1.422 . . . . 0.0 109.409 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' B' ' 111' ' ' PHE . 38.2 t -63.26 -11.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.17 -0.957 . . . . 0.0 109.187 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -70.03 -29.73 66.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 108.815 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 45' ' ' LEU . 7.1 mm -82.97 -42.47 17.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.961 0.886 . . . . 0.0 108.733 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.947 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.5 mt -71.72 -30.81 66.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.509 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -68.09 -25.05 74.59 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.871 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -101.82 -34.1 9.55 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.062 -0.669 . . . . 0.0 110.491 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.979 HG11 HG23 ' A' ' 77' ' ' VAL . 40.8 t -65.62 -38.13 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.156 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.4 t-105 -68.68 -50.73 48.73 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.462 -0.774 . . . . 0.0 110.412 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.0 mm-40 -51.04 -52.12 46.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.973 -1.079 . . . . 0.0 110.194 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.871 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.9 mt -64.69 -11.61 37.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.099 -1.0 . . . . 0.0 108.543 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.052 ' OG ' HD21 ' A' ' 65' ' ' LEU . 1.6 p -93.37 -46.7 7.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' CG ' ' HA ' ' A' ' 61' ' ' HIS . 3.5 t0 -59.56 78.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 110.308 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 57' ' ' SER . 43.8 mm -54.48 -27.1 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.24 -0.913 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 34.1 p30 -108.62 -13.66 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 85.1 m-70 58.63 47.33 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 10.9 p-10 -110.51 16.51 21.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.854 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 77.43 29.92 54.88 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.0 mtt -149.44 161.36 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -1.198 . . . . 0.0 110.636 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.052 HD21 ' OG ' ' A' ' 57' ' ' SER . 8.3 mt -127.84 107.0 9.49 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 5.0 t0 -69.58 162.61 27.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -46.63 -40.46 13.05 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.577 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 2.5 p30 -76.34 -42.04 46.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 109.856 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 30.8 mt-10 -66.27 -41.04 90.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.612 0.72 . . . . 0.0 109.059 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.756 ' CD2' HD12 ' A' ' 31' ' ' LEU . 47.1 t80 -63.49 -21.38 66.29 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -71.93 -43.07 65.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.507 0.67 . . . . 0.0 109.689 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.29 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.28 -2.13 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.483 -0.761 . . . . 0.0 111.176 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.586 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.8 mmt -88.39 -46.46 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 109.487 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 2.2 p90 -76.56 -19.1 58.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.635 HD22 HG13 ' A' ' 86' ' ' VAL . 8.6 mt -77.13 -23.84 51.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.979 HG23 HG11 ' A' ' 53' ' ' VAL . 38.5 t -91.63 -46.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.654 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 1.4 m-85 -62.54 -28.89 70.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.536 -0.727 . . . . 0.0 111.514 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -82.26 -12.34 58.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.931 -1.106 . . . . 0.0 110.137 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.035 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.47 -19.62 38.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.733 0.778 . . . . 0.0 110.796 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 109.794 -0.887 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.635 HG13 HD22 ' A' ' 76' ' ' LEU . 76.0 t -110.78 119.62 45.73 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.135 -0.978 . . . . 0.0 110.63 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.791 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -82.78 175.01 9.1 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.968 1.51 . . . . 0.0 109.009 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.6 mtm -99.14 12.89 34.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.55 ' N ' HD21 ' A' ' 56' ' ' LEU . 18.5 m . . . . . 0 C--N 1.296 -1.745 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.398 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.473 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 14.7 t-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.573 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.0 Cg_endo -69.81 2.68 3.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.139 1.599 . . . . 0.0 111.913 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.939 ' HB3' HG13 ' A' ' 47' ' ' VAL . 2.4 m-85 -103.49 -54.89 2.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.703 -1.248 . . . . 0.0 109.371 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.319 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CH2' ' HE2' ' A' ' 14' ' ' LYS . 11.2 t90 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.176 0.513 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.13 -26.97 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 110.826 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.69 146.57 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.1 mttt -99.17 169.98 7.47 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.614 -0.679 . . . . 0.0 109.785 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -66.57 -35.12 30.73 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.609 1.321 . . . . 0.0 109.609 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.669 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.4 m-20 -79.61 -41.51 26.9 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.36 -16.16 63.85 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.736 0.779 . . . . 0.0 108.908 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.1 -37.91 57.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 3.1 mtmt -81.67 -40.32 23.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.4 m-30 -63.29 -23.61 67.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.3 t70 -85.54 -24.77 27.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.582 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.96 -32.4 39.9 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.667 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.0 mt -79.08 -35.24 17.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.843 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -70.06 -39.65 75.55 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.5 t0 -87.49 1.24 54.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 110.073 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 6.7 t -89.36 -7.03 56.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.0 109.069 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.101 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.6 mt -107.26 -13.06 15.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.39 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.6 Cg_endo -73.6 151.34 46.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.322 1.696 . . . . 0.0 110.975 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 48.4 t -116.58 115.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.2 t-20 56.77 17.9 3.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 108.816 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 91.73 37.63 6.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 73.3 m-85 -149.7 138.11 20.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.111 -1.229 . . . . 0.0 112.449 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.101 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -104.79 145.29 30.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 52.7 p -95.89 145.58 25.27 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 110.087 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -41.01 -27.57 0.2 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 79.1 m-20 -64.04 -26.17 68.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.386 -1.067 . . . . 0.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 49.3 mttm -96.84 -32.03 12.3 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.125 -0.984 . . . . 0.0 108.659 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.893 HG12 ' CD1' ' A' ' 40' ' ' LEU . 98.9 t -79.6 -43.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.551 -0.718 . . . . 0.0 110.73 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.808 ' HG2' HD11 ' A' ' 41' ' ' LEU . 15.2 tttt -43.18 -51.11 14.24 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 110.725 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -67.04 -32.02 35.63 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.213 1.112 . . . . 0.0 109.6 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.896 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.9 t -68.23 -29.94 46.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.978 ' HB3' HD22 ' A' ' 50' ' ' LEU . 50.5 mt -92.0 -32.34 15.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.491 -0.755 . . . . 0.0 110.867 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.808 HD11 ' HG2' ' A' ' 37' ' ' LYS . 22.9 mt -70.55 -14.0 62.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.062 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -90.39 -3.25 57.83 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.642 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.715 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -84.44 17.23 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.962 . . . . 0.0 110.299 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB2' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER 61.87 11.77 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.658 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.078 HD11 ' HB3' ' A' ' 80' ' ' ALA . 18.9 mt -100.82 153.18 37.88 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.9 Cg_endo -76.53 173.68 14.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.036 1.545 . . . . 0.0 109.522 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.515 HG11 ' O ' ' B' ' 111' ' ' PHE . 2.1 t -73.09 -3.86 4.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.91 -1.119 . . . . 0.0 109.383 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -78.24 -29.79 48.36 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.894 HG13 HD22 ' A' ' 45' ' ' LEU . 11.1 mm -85.84 -39.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.4 mt -75.19 -29.05 60.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -67.41 -26.12 73.62 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.928 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -101.16 -35.09 9.43 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.005 -0.703 . . . . 0.0 109.85 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 HG23 ' A' ' 77' ' ' VAL . 41.3 t -64.57 -39.66 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.081 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.609 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -65.74 -52.79 48.25 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.067 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mm-40 -56.0 -58.66 6.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.965 HD21 ' C ' ' A' ' 88' ' ' MET . 5.0 mt -56.14 -19.22 12.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.913 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.98 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 13.5 t -91.93 -35.67 13.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.577 0.703 . . . . 0.0 109.683 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 1.6 t0 -65.56 95.54 0.22 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 110.157 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.536 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 10.5 mm -67.7 -32.01 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.46 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 2.4 p30 -112.2 -13.67 13.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 110.818 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 16.1 m80 62.52 44.55 6.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.907 . . . . 0.0 110.472 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 64' ' ' MET . 57.4 p30 -95.98 5.87 50.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.547 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 85.31 22.76 50.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.547 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 4.0 mmm -148.47 161.55 41.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -1.144 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.757 HD12 HG11 ' A' ' 36' ' ' VAL . 13.8 mt -122.14 106.07 10.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.162 -0.961 . . . . 0.0 109.996 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.585 ' CB ' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -71.41 160.08 33.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.025 . . . . 0.0 110.232 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 25.7 ptt180 -39.66 -37.63 0.53 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.575 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 12.2 m-20 -83.07 -29.92 28.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -75.89 -47.93 23.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.896 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 20.6 t80 -61.71 -16.11 46.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.13 -50.21 13.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.395 -0.816 . . . . 0.0 109.842 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.655 ' O ' HD12 ' A' ' 76' ' ' LEU . 58.8 t -58.02 -28.73 34.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.523 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.98 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.15 -4.73 57.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 111.254 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 11.8 mmt -84.01 -47.6 10.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.979 -1.076 . . . . 0.0 110.121 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -75.08 -28.89 60.49 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.1 mt -67.1 -22.7 65.8 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.936 ' O ' HD12 ' A' ' 81' ' ' LEU . 49.4 t -91.5 -44.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.749 -0.594 . . . . 0.0 109.773 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.93 -25.43 62.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.508 -0.745 . . . . 0.0 110.873 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 17.1 m -82.38 -21.44 35.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.966 -1.084 . . . . 0.0 109.286 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.078 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.69 -11.1 59.84 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 121.414 0.625 . . . . 0.0 110.568 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.485 1.001 0 N-CA-C 110.465 -0.629 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 54.0 t -143.18 131.59 11.3 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.138 -0.976 . . . . 0.0 110.665 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.869 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -89.45 -163.81 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.981 1.516 . . . . 0.0 109.51 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.965 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 -0.86 11.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.27 -0.894 . . . . 0.0 110.547 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.6 ' N ' HD21 ' A' ' 56' ' ' LEU . 4.1 m . . . . . 0 C--N 1.294 -1.827 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.176 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.504 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 23.2 t-20 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.609 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.4 Cg_endo -72.35 1.39 6.17 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.843 1.443 . . . . 0.0 111.54 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.902 ' CE2' HD12 ' A' ' 40' ' ' LEU . 3.8 m-85 -101.19 -61.1 1.41 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.943 -1.098 . . . . 0.0 108.499 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.154 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.578 ' CH2' ' HG3' ' A' ' 14' ' ' LYS . 10.9 t90 . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.16 -25.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.512 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -96.31 146.98 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.951 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.8 mmtt -96.95 169.24 9.01 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.5 Cg_endo -69.95 -33.19 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.865 1.455 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.78 -27.38 31.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.496 -0.753 . . . . 0.0 109.548 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.59 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.1 m-20 -79.72 -30.46 40.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.634 ' HG2' ' HB1' ' A' ' 71' ' ' ALA . 2.9 tmtt? -81.9 -22.98 36.52 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.679 0.752 . . . . 0.0 109.112 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.56 85.46 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.9 -28.34 61.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -65.14 -36.14 83.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -22.39 64.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.673 -0.642 . . . . 0.0 109.847 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.69 -38.38 25.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.682 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 55.2 mt -76.09 -29.8 19.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.798 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.45 -39.36 67.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.553 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.8 t70 -87.19 2.09 51.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.306 0.574 . . . . 0.0 109.814 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.509 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -91.75 -6.12 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.831 0.824 . . . . 0.0 109.178 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.016 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -107.07 -7.76 16.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.565 -0.709 . . . . 0.0 109.26 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.73 84.59 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.977 0 CA-C-O 121.269 0.556 . . . . 0.0 109.61 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 45.7 Cg_endo -74.58 150.4 40.3 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.536 1.808 . . . . 0.0 110.93 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 53.9 t -117.43 119.16 60.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 27' ' ' VAL . 36.0 m120 55.88 18.71 3.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.662 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.08 33.27 9.75 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 57.9 m-85 -137.73 137.25 38.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.854 -1.38 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.016 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.8 mt -108.5 138.22 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 33' ' ' GLY . 20.8 p -86.0 144.37 27.64 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.177 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.629 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -45.64 -24.93 1.29 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 32' ' ' SER . 4.4 m-20 -70.95 -19.1 62.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.532 -0.981 . . . . 0.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 5.6 mttp -97.17 -34.97 10.93 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 65' ' ' LEU . 98.0 t -77.35 -42.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.864 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.17 -53.98 6.17 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.576 -0.702 . . . . 0.0 110.729 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -68.39 -30.97 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.558 1.294 . . . . 0.0 110.078 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.511 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -66.38 -37.47 79.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.551 -0.718 . . . . 0.0 109.295 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.973 ' HB3' HD22 ' A' ' 50' ' ' LEU . 25.1 mt -83.01 -24.79 32.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.564 -0.71 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.11 -10.88 60.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.699 -0.801 . . . . 0.0 108.918 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -89.79 -7.12 55.12 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.523 -0.735 . . . . 0.0 110.224 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.572 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -78.07 7.82 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 0.0 110.284 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.91 10.78 7.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 109.358 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.053 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.1 mt -98.72 156.84 35.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.449 -0.782 . . . . 0.0 109.823 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.4 Cg_endo -75.98 172.1 16.9 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.121 1.59 . . . . 0.0 109.289 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.5 t -71.72 -5.03 5.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.967 -1.083 . . . . 0.0 108.951 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.34 -29.01 59.83 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.873 HG21 HD13 ' A' ' 45' ' ' LEU . 8.5 mm -87.4 -37.74 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.973 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.8 mt -79.39 -28.28 41.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.16 -24.99 75.6 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.864 ' O ' HD12 ' A' ' 56' ' ' LEU . 6.7 ttm-85 -101.96 -33.78 9.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.109 -0.642 . . . . 0.0 110.014 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.991 HG11 HG23 ' A' ' 77' ' ' VAL . 8.7 t -70.9 -37.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.831 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.629 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.2 t-105 -63.64 -50.53 68.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.86 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.3 mt-10 -50.42 -55.1 17.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 109.925 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.864 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.51 -15.34 37.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 108.934 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.954 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.0 t -94.52 -41.47 9.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.537 -0.727 . . . . 0.0 109.513 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 t70 -75.92 95.02 3.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.617 -0.677 . . . . 0.0 110.72 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 3.7 mt -93.13 -16.2 7.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.13 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.7 m-20 -89.81 -5.04 57.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 109.552 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.5 p80 41.3 47.37 2.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.658 . . . . 0.0 110.941 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 28.3 p30 -129.05 26.4 5.49 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.218 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 59.37 42.12 97.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 2.6 mmt -149.35 161.22 42.49 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.318 -1.107 . . . . 0.0 111.514 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.04 HD12 HG21 ' A' ' 36' ' ' VAL . 43.3 mt -137.65 107.09 6.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.648 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -76.58 161.58 28.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 110.454 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -34.55 -46.89 0.3 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.735 -0.603 . . . . 0.0 111.584 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -78.01 -37.66 46.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.226 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 57' ' ' SER . 12.7 tt0 -66.91 -44.44 80.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.632 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.973 ' CD1' HD12 ' A' ' 31' ' ' LEU . 37.7 t80 -60.46 -21.89 62.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.656 -0.652 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.634 ' HB1' ' HG2' ' A' ' 14' ' ' LYS . . . -75.16 -37.98 61.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 109.813 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 38.0 t -66.46 -26.66 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.684 0.754 . . . . 0.0 109.733 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.954 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.39 -7.21 53.78 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 110.767 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.584 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.3 mmt -88.01 -47.45 8.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.922 -1.111 . . . . 0.0 110.256 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 2.2 p90 -75.98 -19.51 58.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.883 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.2 mt -74.27 -25.19 59.46 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.991 HG23 HG11 ' A' ' 53' ' ' VAL . 37.2 t -90.59 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.457 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -45.53 -24.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.692 -0.63 . . . . 0.0 111.273 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.7 m -82.8 -18.84 39.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.964 -1.085 . . . . 0.0 110.009 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.053 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.43 -11.88 50.63 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.709 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.3 mp . . . . . 0 C--N 1.305 -1.362 0 CA-C-O 121.787 0.804 . . . . 0.0 108.871 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.485 1.029 0 N-CA-C 110.095 -0.771 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.732 HG13 HD22 ' A' ' 76' ' ' LEU . 48.9 t -134.85 124.11 16.46 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.052 -1.03 . . . . 0.0 111.274 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.8 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.1 Cg_endo -85.06 174.31 7.34 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.919 1.484 . . . . 0.0 109.514 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.803 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.0 mtp -96.16 12.19 31.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 0.0 110.432 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.577 ' N ' HD21 ' A' ' 56' ' ' LEU . 15.1 m . . . . . 0 C--N 1.296 -1.752 0 O-C-N 120.881 -1.137 . . . . 0.0 110.779 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.455 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 25.1 t-20 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.621 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.6 Cg_endo -74.17 7.59 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.866 1.456 . . . . 0.0 111.881 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.96 ' CE2' HD12 ' A' ' 40' ' ' LEU . 6.6 m-85 -107.14 -65.55 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.763 -1.21 . . . . 0.0 108.713 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.421 ' NH2' ' OE2' ' A' ' 55' ' ' GLU . 6.2 mtm180 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.289 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.659 ' HH2' ' HZ2' ' A' ' 14' ' ' LYS . 13.0 t90 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 121.217 0.532 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.84 -26.16 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 43.9 t -101.19 151.03 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.237 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 31.5 mttt -111.67 169.37 6.4 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.324 -0.86 . . . . 0.0 109.792 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 37.5 Cg_endo -63.86 -35.26 57.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.616 1.324 . . . . 0.0 110.119 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -69.46 -30.03 67.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.387 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -82.35 -39.27 23.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.659 ' HZ2' ' HH2' ' A' ' 7' ' ' TRP . 14.8 tptm -72.28 -15.72 61.91 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.14 -39.65 54.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.03 -25.64 40.1 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.0 m-30 -72.27 -35.19 68.68 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.39 -20.23 62.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.837 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -81.89 -38.31 25.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.647 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 68.6 mt -76.2 -29.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.887 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.9 -36.68 67.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.514 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.5 t70 -90.45 0.86 57.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.728 -0.607 . . . . 0.0 110.186 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 34.0 t -88.77 -8.0 55.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.137 -0.977 . . . . 0.0 109.148 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.084 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.2 mt -106.76 -10.94 15.92 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 86.55 97.24 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.3 Cg_endo -74.02 149.69 42.09 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.214 1.639 . . . . 0.0 111.0 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 62.1 t -124.7 108.34 20.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 62.44 15.67 7.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.241 -179.035 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 92.51 38.04 5.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 81.5 m-85 -148.52 144.59 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 111.976 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.084 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.6 mt -112.14 131.13 55.63 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 1.6 m -80.23 147.04 31.4 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.582 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -44.94 -27.96 1.62 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 48.3 t0 -59.57 -25.37 64.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.89 . . . . 0.0 109.866 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 47.9 mttp -98.26 -36.42 10.03 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.876 HG12 ' CD1' ' A' ' 40' ' ' LEU . 95.1 t -77.17 -40.3 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.667 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' CG ' HD11 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -44.81 -50.51 24.97 Favored Pre-proline 0 N--CA 1.487 1.375 0 O-C-N 121.268 -0.895 . . . . 0.0 111.033 -178.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.2 Cg_endo -68.24 -33.25 24.83 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.089 1.047 . . . . 0.0 109.677 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.619 HG21 ' HZ ' ' A' ' 70' ' ' PHE . 2.1 t -64.7 -35.94 76.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.612 -0.68 . . . . 0.0 109.705 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.039 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.8 mt -90.03 -30.67 17.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.619 HD11 ' CG ' ' A' ' 37' ' ' LYS . 53.8 mt -70.78 -10.69 60.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.874 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 1.2 t-20 -90.59 -9.94 45.21 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.444 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.559 ' HB2' HD11 ' A' ' 81' ' ' LEU . 83.5 p -80.58 11.25 3.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.871 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.04 11.21 4.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.944 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.125 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.3 mt -90.92 156.0 44.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.813 . . . . 0.0 109.663 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -76.62 169.28 22.11 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 O-C-N 123.907 1.478 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.561 HG13 ' CA ' ' B' ' 111' ' ' PHE . 42.1 t -70.6 -3.42 3.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.74 -32.97 35.46 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.793 HG21 HD13 ' A' ' 45' ' ' LEU . 14.3 mm -80.65 -42.42 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.039 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.3 mt -63.65 -32.03 73.38 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.075 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.569 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -72.25 -17.84 77.72 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.826 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.34 -31.28 11.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.843 -0.798 . . . . 0.0 110.138 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.91 HG11 HG23 ' A' ' 77' ' ' VAL . 32.3 t -75.87 -34.65 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.696 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.583 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 3.1 t-105 -70.82 -47.65 58.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.599 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' B' ' 109' ' ' ASN . 23.5 mm-40 -58.17 -57.25 13.69 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.019 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.8 mt -60.46 -16.53 37.34 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.354 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.758 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t -89.9 -34.52 16.04 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.661 0.743 . . . . 0.0 109.387 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.619 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -74.83 69.82 1.87 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.623 -0.673 . . . . 0.0 109.578 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.51 HG12 ' HG2' ' A' ' 69' ' ' GLU . 42.2 mm -41.33 -32.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.493 -0.754 . . . . 0.0 110.406 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 3.0 p30 -108.38 -25.91 10.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 7.1 m80 71.09 41.19 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.8 p-10 -90.69 -1.69 57.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 98.16 19.95 22.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.583 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtp -153.18 161.77 42.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -1.187 . . . . 0.0 110.341 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.76 HD12 HG21 ' A' ' 36' ' ' VAL . 31.8 mt -118.73 107.79 14.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.099 -1.001 . . . . 0.0 110.662 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.76 165.07 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.04 . . . . 0.0 109.826 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -40.18 -43.53 1.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -78.44 -33.31 48.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.75 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 59' ' ' ILE . 53.2 mt-10 -74.89 -42.95 56.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.45 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.95 ' CD2' HD12 ' A' ' 31' ' ' LEU . 36.7 t80 -63.12 -16.48 60.14 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -78.97 -44.36 22.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.653 ' O ' HD12 ' A' ' 76' ' ' LEU . 42.4 t -61.73 -26.42 39.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.708 0.766 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.758 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.55 -7.84 54.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.76 . . . . 0.0 111.187 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.576 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.5 mmt -84.95 -48.11 9.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.924 -1.11 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 3.6 p90 -75.33 -21.25 58.55 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.6 mt -76.37 -19.41 58.2 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.91 HG23 HG11 ' A' ' 53' ' ' VAL . 32.8 t -91.96 -41.86 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.569 -0.707 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 5.3 m-85 -72.01 -22.54 61.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.837 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -81.58 -15.26 55.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.979 -1.075 . . . . 0.0 109.24 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.125 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.94 -10.89 46.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.459 -0.775 . . . . 0.0 109.077 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.826 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.9 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.787 . . . . 0.0 109.812 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.483 0.9 0 N-CA-C 109.652 -0.941 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 52' ' ' ARG . 89.7 t -112.64 121.58 38.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.926 -1.109 . . . . 0.0 110.893 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.751 ' O ' HD11 ' A' ' 56' ' ' LEU . 45.2 Cg_endo -90.13 -174.4 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.973 1.512 . . . . 0.0 109.289 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.823 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.76 10.29 13.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.073 -1.017 . . . . 0.0 110.295 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.538 ' N ' HD21 ' A' ' 56' ' ' LEU . 38.8 m . . . . . 0 C--N 1.293 -1.852 0 C-N-CA 119.246 -0.981 . . . . 0.0 111.66 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.493 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 1.9 t-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.4 Cg_endo -71.49 -2.44 11.3 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.916 1.482 . . . . 0.0 111.028 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 1.005 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.16 -62.51 1.58 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.867 -1.146 . . . . 0.0 108.849 177.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.981 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.141 0.496 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -35.72 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.648 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 99.5 t -97.9 130.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -86.62 -179.13 1.29 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.729 -178.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.81 -36.3 8.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.014 1.534 . . . . 0.0 110.058 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.27 -22.78 57.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 51.6 m-20 -81.41 -36.94 28.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.062 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -73.78 -16.76 61.15 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.318 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -40.83 38.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.541 -0.724 . . . . 0.0 109.303 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.08 -26.69 60.52 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.8 m-30 -74.65 -32.06 62.14 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.07 -18.24 61.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.504 -0.748 . . . . 0.0 109.868 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -82.54 -36.67 26.11 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.561 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 12.3 mt -78.01 -28.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.36 -38.29 56.02 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.8 t70 -90.26 3.89 52.26 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.704 -0.623 . . . . 0.0 109.792 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -93.23 -3.48 53.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 108.631 178.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.022 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.24 -3.42 13.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 79.83 95.45 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 Cg_endo -71.37 152.33 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.308 1.688 . . . . 0.0 110.76 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.633 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 94.1 t -120.1 97.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 109.106 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.633 ' ND2' ' O ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER 68.68 10.58 7.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.2 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 104.73 34.13 3.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 76.6 m-85 -150.89 149.88 30.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.468 -1.019 . . . . 0.0 111.886 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.022 ' CD1' HD12 ' A' ' 24' ' ' LEU . 18.1 mt -118.07 134.38 55.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -78.45 144.32 35.91 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.886 -1.125 . . . . 0.0 109.436 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -42.72 -28.33 0.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.0 m-20 -54.46 -25.14 23.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.44 -1.036 . . . . 0.0 109.506 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 1.1 mttp -104.38 -32.66 8.94 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.408 -0.807 . . . . 0.0 108.83 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.061 HG11 HD12 ' A' ' 65' ' ' LEU . 87.6 t -84.54 -44.76 17.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.683 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 15.4 tttt -43.99 -53.56 12.98 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 0.0 110.924 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.4 Cg_endo -67.19 -33.74 30.1 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.33 1.174 . . . . 0.0 109.467 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -63.38 -34.74 69.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.457 0.646 . . . . 0.0 109.389 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.011 HD12 ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -85.92 -27.32 25.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 58.0 mt -74.94 -10.89 59.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.225 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -89.56 -5.1 57.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.094 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.545 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.93 12.87 6.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.476 -0.765 . . . . 0.0 110.382 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 61.3 13.29 4.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.11 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.891 HD22 HG13 ' A' ' 49' ' ' ILE . 14.7 mt -97.91 154.53 37.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.663 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.61 172.34 16.4 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.071 1.564 . . . . 0.0 110.067 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.85 -6.04 6.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 109.072 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.63 -30.62 56.95 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.891 HG13 HD22 ' A' ' 45' ' ' LEU . 7.1 mm -88.02 -38.06 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.005 HD22 ' HB3' ' A' ' 40' ' ' LEU . 17.8 mt -77.17 -26.31 52.84 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.1 -27.38 72.09 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.652 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -101.47 -30.15 11.59 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 122.105 -0.644 . . . . 0.0 109.901 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.041 HG11 HG23 ' A' ' 77' ' ' VAL . 22.3 t -71.25 -39.85 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.707 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 1.9 t-105 -64.27 -51.0 65.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.651 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.9 mm-40 -53.05 -57.54 10.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.322 -0.861 . . . . 0.0 109.847 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 52' ' ' ARG . 13.8 mt -56.82 -21.07 26.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 108.94 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.863 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 69.7 m -89.48 -36.13 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 31.5 t0 -83.69 61.92 6.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.636 -0.665 . . . . 0.0 110.196 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.8 mt -59.5 -19.01 15.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.334 -0.853 . . . . 0.0 110.37 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 13.6 m-20 -91.74 -21.14 20.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.938 . . . . 0.0 109.637 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 2.2 m-70 61.27 33.74 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 110.745 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.43 -2.48 48.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.05 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 91.07 25.3 24.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.1 mtp -153.55 161.49 42.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.138 -1.213 . . . . 0.0 110.556 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.061 HD12 HG11 ' A' ' 36' ' ' VAL . 15.3 mt -117.84 110.84 18.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.324 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -70.99 172.39 9.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 110.562 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.556 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 3.5 ptp180 -51.15 -41.37 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.555 -0.715 . . . . 0.0 110.895 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.77 -36.31 37.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 57' ' ' SER . 45.8 mt-10 -72.13 -48.73 41.5 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.958 ' CD2' HD12 ' A' ' 31' ' ' LEU . 14.2 t80 -56.0 -26.27 47.91 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.64 56.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 110.116 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.618 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 58.5 t -57.63 -22.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.744 . . . . 0.0 109.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.863 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.35 -5.34 56.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 111.425 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 3.5 mmm -89.98 -40.54 12.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.309 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.652 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 2.1 p90 -81.99 -22.77 36.38 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.848 -1.141 . . . . 0.0 108.339 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.703 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 4.4 mt -76.11 -23.33 54.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.041 HG23 HG11 ' A' ' 53' ' ' VAL . 16.4 t -91.55 -47.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.533 -0.729 . . . . 0.0 109.722 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.676 ' HA ' HD23 ' A' ' 81' ' ' LEU . 2.4 m-85 -70.38 -35.29 73.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 110.417 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 75' ' ' PHE . 3.9 t -83.59 -8.6 59.28 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -92.18 -29.27 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.131 0.967 . . . . 0.0 109.208 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.655 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.759 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 N--CA 1.481 0.762 0 N-CA-C 110.283 -0.699 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 87' ' ' PRO . 39.1 t -114.15 154.06 46.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 108.996 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.756 ' HD2' HG13 ' A' ' 86' ' ' VAL . 43.3 Cg_endo -86.13 -167.63 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.525 1.276 . . . . 0.0 109.877 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 mtt -122.25 11.12 10.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.02 -1.05 . . . . 0.0 111.541 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 120.677 -1.264 . . . . 0.0 111.609 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' B' ' 110' ' ' PRO . 6.7 t-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.982 0.42 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.513 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 46.0 Cg_endo -69.22 8.93 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.902 1.735 . . . . 0.0 112.344 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 1.011 ' CE2' HD12 ' A' ' 40' ' ' LEU . 13.5 m-85 -99.31 -49.74 4.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.505 -1.372 . . . . 0.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.939 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.562 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.7 t90 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.049 0.452 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.22 -27.61 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 109.741 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -95.56 130.79 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.794 . . . . 0.0 109.327 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -88.77 172.4 7.6 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.335 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -34.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.988 1.52 . . . . 0.0 109.946 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -78.33 -28.85 47.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.291 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.505 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 9.1 m-20 -81.05 -33.86 33.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.61 -17.92 57.31 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.177 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -37.48 61.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -76.91 -23.16 52.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 12.3 m-30 -77.55 -34.75 53.71 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.73 -20.2 62.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.893 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.04 33.4 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' CE1' ' A' ' 70' ' ' PHE . 73.5 mt -79.23 -30.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.725 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.79 -36.12 67.52 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 t70 -91.21 -3.23 57.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.447 -0.783 . . . . 0.0 110.034 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.9 t -82.17 -14.67 55.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 108.765 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.079 HD12 HD13 ' A' ' 31' ' ' LEU . 8.4 mt -94.09 -53.8 3.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 m 140.87 97.18 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.11 150.4 42.74 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 O-C-N 123.97 1.51 . . . . 0.0 110.643 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.639 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 84.4 t -119.8 84.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.316 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' ND2' ' O ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER 72.73 3.96 4.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.563 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 123.31 29.46 1.2 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -149.89 151.76 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.277 . . . . 0.0 112.326 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.079 HD13 HD12 ' A' ' 24' ' ' LEU . 9.4 mt -120.47 154.16 35.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -98.14 141.49 31.0 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 120.754 -1.217 . . . . 0.0 109.715 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.615 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.79 -27.89 0.2 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.7 m-20 -67.63 -24.78 65.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.424 -1.045 . . . . 0.0 110.481 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 66.6 mttm -90.24 -36.75 14.55 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.916 HG12 ' CD1' ' A' ' 40' ' ' LEU . 93.3 t -72.76 -39.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.252 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -42.8 -54.95 7.94 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 111.264 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.7 Cg_endo -65.69 -30.64 50.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.699 1.368 . . . . 0.0 110.005 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.82 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.5 t -69.01 -28.71 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.51 -0.744 . . . . 0.0 109.064 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.956 ' HB3' HD22 ' A' ' 50' ' ' LEU . 27.1 mt -94.78 -31.49 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 0.0 110.176 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 37' ' ' LYS . 23.0 mt -70.3 -9.93 57.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 27.2 p-10 -90.9 -7.69 51.46 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.993 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.579 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 p -81.4 14.13 2.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.716 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.81 10.71 5.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.027 HD13 HG21 ' A' ' 49' ' ' ILE . 14.3 mt -98.22 157.9 33.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.926 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.66 170.42 20.26 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.063 1.559 . . . . 0.0 109.569 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.56 HG13 ' C ' ' B' ' 111' ' ' PHE . 2.0 t -71.3 -3.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.125 -0.985 . . . . 0.0 109.37 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -78.14 -32.17 50.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.027 HG21 HD13 ' A' ' 45' ' ' LEU . 9.6 mm -81.67 -40.81 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.956 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -71.09 -30.79 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.68 -24.97 74.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.789 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -100.68 -35.06 9.61 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.906 -0.761 . . . . 0.0 109.868 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.09 HG11 ' CG2' ' A' ' 77' ' ' VAL . 23.8 t -65.87 -34.39 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.829 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.615 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.07 -55.03 10.53 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.43 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 1.7 mt-10 -48.0 -57.1 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.09 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.6 mt -63.32 -14.62 51.79 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.938 . . . . 0.0 108.96 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.905 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 11.0 t -93.09 -35.14 13.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 22.5 t0 -74.84 99.94 3.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.718 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.537 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 14.6 mm -86.91 -23.82 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.24 -12.83 31.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 55.61 47.66 20.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -0.944 . . . . 0.0 110.204 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -125.64 17.64 8.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.923 -1.111 . . . . 0.0 110.197 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 74.07 32.99 57.88 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.6 mtp -150.76 161.33 42.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -1.229 . . . . 0.0 111.071 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.771 HD12 HG21 ' A' ' 36' ' ' VAL . 19.6 mt -133.15 107.31 8.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.544 -0.723 . . . . 0.0 109.432 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.636 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 32.9 p30 -78.73 175.13 10.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.75 -1.219 . . . . 0.0 110.378 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.46 -50.62 3.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 112.17 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.769 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 5.1 p-10 -72.55 -46.82 52.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.151 -0.968 . . . . 0.0 110.444 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.537 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 52.2 mt-10 -62.02 -54.67 38.25 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.533 -0.73 . . . . 0.0 109.229 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.994 ' CD2' HD12 ' A' ' 31' ' ' LEU . 12.2 t80 -49.83 -30.0 9.02 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -61.45 -55.54 30.15 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.79 0.805 . . . . 0.0 110.005 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.418 ' HA ' ' HE2' ' A' ' 75' ' ' PHE . 92.0 t -51.07 -28.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.488 0.661 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.905 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.98 -6.87 58.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 0.0 112.411 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.59 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.1 mmm -90.37 -43.36 10.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.268 -1.52 . . . . 0.0 110.569 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 2.2 p90 -76.05 -22.3 55.85 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.156 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 86' ' ' VAL . 6.3 mt -72.61 -30.1 64.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.09 ' CG2' HG11 ' A' ' 53' ' ' VAL . 37.5 t -91.07 -21.79 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.742 -0.599 . . . . 0.0 110.106 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.16 -27.69 21.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.543 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 5.4 m -83.48 -14.44 52.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -0.789 . . . . 0.0 109.418 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.683 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.66 -12.59 57.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' A' ' 45' ' ' LEU . 8.3 mt . . . . . 0 N--CA 1.487 1.423 0 O-C-N 121.734 -0.604 . . . . 0.0 110.482 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.483 0.857 0 N-CA-C 109.972 -0.818 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.538 HG13 HD22 ' A' ' 76' ' ' LEU . 90.4 t -127.79 119.2 21.27 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.85 -1.157 . . . . 0.0 111.51 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.756 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -81.67 154.5 17.95 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.978 1.515 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.524 ' HG3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -85.04 18.06 2.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.607 -1.308 . . . . 0.0 110.582 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.416 ' N ' HD21 ' A' ' 56' ' ' LEU . 4.7 m . . . . . 0 C--N 1.289 -2.029 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.035 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' CA ' ' A' ' 51' ' ' GLY . 5.9 t-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.936 0.398 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.611 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -73.78 11.56 1.09 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.243 1.654 . . . . 0.0 112.386 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.914 ' CE2' HD12 ' A' ' 40' ' ' LEU . 2.7 m-85 -110.73 -73.58 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.54 -1.35 . . . . 0.0 108.405 178.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.412 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.575 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.5 t90 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -39.55 -29.25 0.05 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.747 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.575 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 29.5 t -88.62 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.309 -0.87 . . . . 0.0 109.349 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.562 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.85 174.35 4.62 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.101 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.3 Cg_endo -70.59 -33.72 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.921 1.485 . . . . 0.0 109.584 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.13 -19.97 58.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.2 m-20 -85.33 -43.87 13.32 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.05 -20.56 66.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.69 . . . . 0.0 109.161 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.56 49.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.51 -24.58 45.71 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.682 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -73.69 -36.02 65.24 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.42 -20.82 60.64 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.919 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -82.82 -36.86 25.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.645 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 19.6 mt -76.04 -31.57 21.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -67.77 -38.27 83.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 15.4 t70 -91.29 -3.79 56.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.793 -0.567 . . . . 0.0 110.097 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -78.63 -15.6 58.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 108.92 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.1 HD12 ' CD1' ' A' ' 31' ' ' LEU . 11.9 mt -96.14 -52.44 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.668 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.2 t 136.51 99.05 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.0 Cg_endo -72.47 145.23 42.12 Favored 'Trans proline' 0 C--N 1.297 -2.18 0 O-C-N 124.184 1.623 . . . . 0.0 111.01 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 10.7 t -118.07 111.46 34.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 48.15 23.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.382 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.14 34.52 5.61 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 78.9 m-85 -150.99 146.67 26.38 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.183 -1.186 . . . . 0.0 112.397 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.1 ' CD1' HD12 ' A' ' 24' ' ' LEU . 7.7 mt -111.73 148.85 32.58 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.486 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -91.04 142.92 27.25 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.735 -1.228 . . . . 0.0 110.3 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.611 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.52 -25.37 0.81 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.5 m-20 -71.99 -21.88 61.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.967 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 29.2 mttm -93.12 -36.23 12.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.882 HG11 HD12 ' A' ' 65' ' ' LEU . 64.1 t -79.01 -43.86 24.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.564 0.697 . . . . 0.0 109.863 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 15.7 tttt -41.01 -51.73 7.27 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.0 Cg_endo -67.61 -32.42 30.99 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.314 1.165 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -66.34 -31.91 55.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.561 -0.712 . . . . 0.0 109.089 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.951 ' HB3' HD22 ' A' ' 50' ' ' LEU . 33.9 mt -90.0 -29.85 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 110.075 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 37' ' ' LYS . 58.8 mt -69.32 -15.36 63.31 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -90.72 -3.72 57.26 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.723 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.582 ' O ' HD21 ' A' ' 81' ' ' LEU . 83.8 p -81.37 12.56 3.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.816 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 2.9 ttmt 62.55 9.67 3.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.05 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.7 mt -100.55 153.22 37.86 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.6 Cg_endo -74.12 172.28 16.29 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.913 1.481 . . . . 0.0 109.734 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -70.2 -5.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.094 -1.004 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -78.11 -31.1 49.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 108.968 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.837 HG13 HD22 ' A' ' 45' ' ' LEU . 7.6 mm -85.17 -43.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.951 HD22 ' HB3' ' A' ' 40' ' ' LEU . 17.2 mt -70.24 -28.89 65.61 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.91 -25.99 74.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 1.013 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.8 ttm-85 -100.9 -31.06 11.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.876 -0.779 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.045 HG11 HG23 ' A' ' 77' ' ' VAL . 7.4 t -69.82 -35.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.681 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.611 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.1 t-105 -69.08 -52.28 30.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.267 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 19.9 mm-40 -52.82 -54.27 36.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 110.111 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.013 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.6 mt -63.2 -13.26 35.37 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 108.612 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.651 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.9 m -96.18 -41.02 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.67 . . . . 0.0 110.601 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -69.54 82.3 0.41 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.239 -0.913 . . . . 0.0 110.615 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.529 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 33.4 mm -58.25 -21.7 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.144 -0.972 . . . . 0.0 108.939 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 1.9 m-20 -103.68 -9.91 18.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 0.0 109.818 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 29.8 p80 38.73 48.89 1.4 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.689 -0.632 . . . . 0.0 110.719 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 22.3 p-10 -117.01 12.26 14.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.325 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 88.11 28.76 22.15 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.8 mtt -150.75 161.59 42.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -1.21 . . . . 0.0 111.391 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.882 HD12 HG11 ' A' ' 36' ' ' VAL . 15.4 mt -135.73 110.41 8.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 1.1 t70 -72.94 172.64 10.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.514 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 4.2 ptm180 -51.24 -42.4 61.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 110.276 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 26.3 t0 -79.62 -35.2 39.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 7.9 tt0 -69.83 -52.38 25.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.723 0.773 . . . . 0.0 108.994 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.955 ' CD2' HD12 ' A' ' 31' ' ' LEU . 24.9 t80 -53.18 -26.59 17.79 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -63.94 -52.28 60.48 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.639 0.733 . . . . 0.0 109.917 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.401 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 89.9 t -54.22 -24.0 10.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.4 -7.71 54.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.293 -0.879 . . . . 0.0 112.129 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 mmm -90.22 -41.76 11.4 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.388 -1.445 . . . . 0.0 110.283 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.432 ' O ' ' SG ' ' A' ' 79' ' ' CYS . 2.5 p90 -78.44 -19.42 53.2 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.355 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 HG13 ' A' ' 86' ' ' VAL . 6.9 mt -76.08 -26.15 56.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.045 HG23 HG11 ' A' ' 53' ' ' VAL . 20.7 t -91.36 -57.23 4.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.68 -0.637 . . . . 0.0 109.557 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.415 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.7 m-85 -53.15 -20.26 3.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.361 -0.837 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 7.8 m -83.96 -16.7 43.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.089 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.05 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.01 -11.52 44.0 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.203 -0.935 . . . . 0.0 109.383 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.582 HD21 ' O ' ' A' ' 43' ' ' SER . 6.3 mp . . . . . 0 C--N 1.304 -1.412 0 CA-C-O 121.663 0.744 . . . . 0.0 109.387 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 N--CA 1.482 0.805 0 N-CA-C 109.935 -0.833 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.591 HG11 HG23 ' A' ' 53' ' ' VAL . 20.7 t -112.56 119.81 42.54 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.074 -1.016 . . . . 0.0 110.584 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.9 Cg_endo -84.62 -162.44 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 109.448 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.814 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.09 0.23 12.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 C--N 1.293 -1.88 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.434 -178.472 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.496 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 15.1 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.91 0.386 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -71.4 3.14 3.79 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.039 1.547 . . . . 0.0 111.573 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.95 ' CE2' HD12 ' A' ' 40' ' ' LEU . 8.4 m-85 -100.1 -45.83 5.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.862 -1.149 . . . . 0.0 109.561 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.219 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.6 t90 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.333 0.587 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -39.88 -27.66 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 110.277 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 13' ' ' ASP . 88.4 t -107.29 138.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.26 -178.03 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.895 . . . . 0.0 110.089 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.8 Cg_endo -71.16 -36.23 7.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.791 1.416 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.59 -24.51 60.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.992 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB3' HG13 ' A' ' 9' ' ' VAL . 2.8 m-20 -83.26 -40.26 19.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.336 -0.853 . . . . 0.0 109.015 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -74.62 -21.56 59.39 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.12 71.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.747 . . . . 0.0 109.248 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -78.19 -29.34 48.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 12.4 m-30 -71.09 -37.71 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 29.1 t0 -69.61 -18.06 63.58 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.818 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.0 -36.67 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.676 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 mt -78.38 -34.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.783 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -67.85 -36.83 81.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.557 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.5 t70 -87.5 -3.08 59.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.738 -0.601 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 -8.02 58.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 109.409 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.105 HD12 ' CD1' ' A' ' 31' ' ' LEU . 7.2 mt -102.17 -15.61 16.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 87.99 88.94 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.0 Cg_endo -75.94 150.78 34.65 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.563 1.823 . . . . 0.0 110.495 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 41.8 t -116.12 110.47 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.8 OUTLIER 65.42 13.79 9.05 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -177.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 93.58 32.55 7.62 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 26.3 m-85 -138.03 136.12 36.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.285 . . . . 0.0 112.358 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.105 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -107.06 151.0 25.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' ASP . 15.9 p -100.58 147.78 25.55 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.989 -1.069 . . . . 0.0 109.774 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.48 -25.05 0.73 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . 46.7 m-20 -67.5 -22.34 65.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.458 -1.025 . . . . 0.0 110.672 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 24' ' ' LEU . 2.9 mtpp -101.63 -34.72 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.914 -1.116 . . . . 0.0 108.398 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.888 HG11 HD12 ' A' ' 65' ' ' LEU . 92.3 t -78.18 -36.09 20.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.499 0.666 . . . . 0.0 109.692 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.663 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 1.8 tttp -44.78 -53.84 14.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 110.706 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.52 -30.34 29.17 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.566 1.298 . . . . 0.0 110.144 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.756 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.5 t -64.92 -28.43 44.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.369 0.604 . . . . 0.0 109.799 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.984 HD12 ' CE2' ' B' ' 111' ' ' PHE . 21.3 mt -94.52 -30.45 14.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 ' HG3' ' A' ' 37' ' ' LYS . 56.6 mt -69.26 -10.01 55.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 108.591 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -87.92 -6.25 58.15 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.241 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.631 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -84.96 18.3 2.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 110.242 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 19.33 1.62 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.644 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.067 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.5 mt -100.51 155.3 36.53 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 109.9 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -75.11 162.48 36.78 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.019 1.536 . . . . 0.0 109.442 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.68 HG12 ' OXT' ' B' ' 112' ' ' ARG . 9.1 t -67.25 -6.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -74.86 -31.24 61.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.794 HG13 HD22 ' A' ' 45' ' ' LEU . 7.3 mm -81.45 -43.12 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.847 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -68.68 -32.54 72.44 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.465 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.576 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -68.25 -23.88 74.82 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.817 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.9 ttm180 -101.67 -32.42 10.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.07 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.942 HG11 HG23 ' A' ' 77' ' ' VAL . 7.6 t -70.43 -40.23 77.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.124 -1.031 . . . . 0.0 108.574 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.581 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.6 t-105 -63.66 -50.86 67.62 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.76 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.495 ' HG3' ' ND2' ' B' ' 109' ' ' ASN . 13.0 mt-10 -47.22 -56.87 5.89 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.904 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 52' ' ' ARG . 1.7 mt -64.54 -13.25 51.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.99 . . . . 0.0 108.919 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.942 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -88.48 -40.78 13.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.8 t0 -80.04 95.25 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.312 0.577 . . . . 0.0 110.221 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.32 -13.09 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.928 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.469 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 11.7 m-20 -99.67 -13.13 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.179 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 3.3 m80 55.57 47.47 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.494 -0.754 . . . . 0.0 110.546 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 19.5 p-10 -126.09 29.66 5.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.51 38.45 93.61 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtt -150.19 160.8 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 111.823 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.888 HD12 HG11 ' A' ' 36' ' ' VAL . 5.7 mt -129.81 108.12 9.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.641 -0.662 . . . . 0.0 109.512 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.529 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -69.46 158.04 35.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.858 -1.151 . . . . 0.0 109.448 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 14.1 ptt180 -41.5 -42.43 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.589 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -73.27 -43.88 60.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 12.4 mt-10 -64.79 -51.48 62.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.81 ' CD2' HD12 ' A' ' 31' ' ' LEU . 33.5 t80 -49.63 -28.64 6.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.0 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -65.84 -45.06 83.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 110.185 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.568 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 71.6 t -63.74 -20.34 26.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 110.179 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.942 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -89.86 -6.63 55.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.461 -0.775 . . . . 0.0 111.002 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 10.2 mmm -90.44 -44.93 9.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.548 -1.345 . . . . 0.0 110.318 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.568 ' CE2' ' HA ' ' A' ' 72' ' ' VAL . 1.5 p90 -75.32 -26.38 58.61 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.027 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.819 HD22 HG13 ' A' ' 86' ' ' VAL . 6.7 mt -67.56 -28.54 67.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.942 HG23 HG11 ' A' ' 53' ' ' VAL . 24.0 t -91.0 -59.9 2.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.77 ' HA ' HD13 ' A' ' 81' ' ' LEU . 2.5 m-85 -48.52 -23.07 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.772 -0.58 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 23.0 m -82.93 -20.41 35.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.861 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.067 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.26 -12.37 58.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 77' ' ' VAL . 3.3 mp . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.415 -0.803 . . . . 0.0 110.17 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 N--CA 1.484 0.959 0 N-CA-C 109.985 -0.814 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.819 HG13 HD22 ' A' ' 76' ' ' LEU . 33.0 t -124.44 125.86 25.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.958 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.677 ' O ' HD11 ' A' ' 56' ' ' LEU . 53.1 Cg_endo -87.71 164.03 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.932 1.491 . . . . 0.0 109.961 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.547 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 17.0 mtt -93.83 16.68 13.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.969 -1.082 . . . . 0.0 110.465 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.292 -1.911 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.549 -178.413 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.576 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 11.6 t-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.692 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.6 Cg_endo -73.73 -3.15 13.27 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.85 1.448 . . . . 0.0 111.042 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.984 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.82 -65.92 1.14 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.851 -1.156 . . . . 0.0 108.705 177.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.68 ' OXT' HG12 ' A' ' 47' ' ' VAL . 2.1 ptt-85 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.273 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.6 t90 . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.64 -25.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.954 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 17.4 t -99.28 152.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.2 mttm -109.77 175.02 2.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.0 Cg_endo -68.35 -36.71 15.24 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.142 1.601 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -30.29 63.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.341 -0.849 . . . . 0.0 109.262 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -82.14 -38.8 24.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 12.6 tptp -70.84 -17.03 62.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.43 -40.98 49.15 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.93 -24.87 43.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.597 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.7 m-30 -73.45 -37.39 65.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -73.98 -20.29 60.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.925 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.51 -35.68 24.66 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.2 -0.938 . . . . 0.0 108.5 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.566 HG22 ' CE1' ' A' ' 70' ' ' PHE . 50.5 mt -77.22 -33.11 19.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.725 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -64.89 -37.87 89.06 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.545 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 t0 -90.53 -2.26 57.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 1.7 m -82.15 -9.93 59.35 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.309 -0.869 . . . . 0.0 108.948 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.128 HD12 ' CD1' ' A' ' 31' ' ' LEU . 13.1 mt -98.67 -53.89 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 150.62 84.33 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 55.8 Cg_endo -76.71 123.83 7.17 Favored 'Trans proline' 0 C--N 1.293 -2.357 0 O-C-N 124.307 1.688 . . . . 0.0 109.55 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 28' ' ' ASN 0.251 2.2 p -119.48 121.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.723 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.026 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 6.0 t-20 57.68 20.77 6.64 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 81.15 45.0 7.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 28' ' ' ASN . 87.8 m-85 -151.87 158.79 43.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 112.452 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.128 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.7 mt -126.39 160.64 29.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' LYS . 1.4 p -106.88 146.78 30.57 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.682 -1.261 . . . . 0.0 110.532 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.618 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.65 -24.93 0.76 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.1 m-20 -75.85 -20.02 58.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.978 . . . . 0.0 110.618 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HD2' HD22 ' A' ' 31' ' ' LEU . 11.7 mtmm -94.89 -35.2 12.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.976 -1.078 . . . . 0.0 108.141 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.786 HG12 ' CD1' ' A' ' 40' ' ' LEU . 96.8 t -78.01 -43.29 28.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.639 0.733 . . . . 0.0 109.764 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -40.83 -52.23 6.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 110.724 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.8 Cg_endo -67.03 -35.4 25.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.401 1.211 . . . . 0.0 109.65 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.58 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.5 -33.45 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.98 ' HB3' HD22 ' A' ' 50' ' ' LEU . 29.7 mt -88.97 -28.96 19.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.622 -0.674 . . . . 0.0 109.901 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.533 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 62.1 mt -71.95 -14.78 62.01 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -90.58 -3.74 57.35 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.118 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.647 ' O ' HD21 ' A' ' 81' ' ' LEU . 37.7 m -81.75 11.44 4.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.2 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.14 11.72 4.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.707 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.2 mt -100.57 155.14 36.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.9 Cg_endo -75.27 170.13 21.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.046 1.551 . . . . 0.0 109.816 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.576 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -68.59 -7.3 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 120.952 -1.093 . . . . 0.0 109.045 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.34 -27.87 60.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.927 HG21 HD13 ' A' ' 45' ' ' LEU . 10.1 mm -88.38 -38.69 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.98 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.7 mt -77.28 -29.76 53.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.2 -25.66 75.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.746 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -102.22 -35.88 8.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.081 -0.658 . . . . 0.0 110.75 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 77' ' ' VAL . 13.7 t -67.49 -37.72 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.819 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.618 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -64.11 -52.55 58.63 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.306 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 91.2 mt-10 -51.14 -58.79 5.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.388 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.812 HD21 ' C ' ' A' ' 88' ' ' MET . 3.2 mt -62.16 -13.98 32.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.98 . . . . 0.0 109.013 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.909 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 29.4 m -96.35 -26.73 15.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.717 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' TRP . 9.5 t0 -78.26 93.14 4.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.508 HG12 ' HG3' ' A' ' 69' ' ' GLU . 24.4 mm -73.12 -32.43 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 110.06 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 2.6 m-20 -95.62 -16.02 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 58' ' ' ASP . 91.0 m-70 52.61 50.69 17.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.314 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 37.5 p-10 -125.0 36.87 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.5 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 58.19 33.01 68.47 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 6.6 mtt -150.54 160.66 43.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -1.091 . . . . 0.0 111.269 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.767 HD12 HG11 ' A' ' 36' ' ' VAL . 13.2 mt -132.28 110.49 10.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.222 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 10.7 t0 -70.13 167.62 17.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.946 -1.096 . . . . 0.0 110.372 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.3 ptm180 -45.61 -44.22 12.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.286 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.614 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 11.7 t0 -78.19 -36.27 47.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.301 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -63.65 -52.47 60.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.938 0.875 . . . . 0.0 109.397 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.867 ' CD2' HD12 ' A' ' 31' ' ' LEU . 17.7 t80 -54.48 -20.37 7.53 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.533 0.682 . . . . 0.0 109.274 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -73.23 -46.27 51.2 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 72' ' ' VAL . 23.7 t -59.94 -28.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.077 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.909 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -89.66 -4.67 57.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 5.6 mmt -87.43 -43.19 12.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.718 -1.239 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.476 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -77.77 -22.22 50.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.077 -1.014 . . . . 0.0 108.379 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.608 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.3 mt -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 53' ' ' VAL . 41.3 t -91.7 -60.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.689 -0.632 . . . . 0.0 110.109 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.478 ' HA ' HD13 ' A' ' 81' ' ' LEU . 3.4 m-85 -55.97 -19.65 13.27 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.225 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 7.5 m -83.25 -16.69 45.4 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.019 -1.051 . . . . 0.0 109.581 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.982 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.78 -15.22 42.76 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.454 -0.779 . . . . 0.0 109.557 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.647 HD21 ' O ' ' A' ' 43' ' ' SER . 6.2 mp . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 121.643 0.735 . . . . 0.0 109.467 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.484 0.931 0 N-CA-C 109.969 -0.82 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.629 HG11 ' CG2' ' A' ' 53' ' ' VAL . 96.5 t -128.44 109.61 19.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.975 . . . . 0.0 110.793 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.657 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.4 Cg_endo -76.31 -169.95 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.988 1.52 . . . . 0.0 109.564 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -112.8 20.87 16.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.514 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.51 ' N ' HD21 ' A' ' 56' ' ' LEU . 74.8 m . . . . . 0 C--N 1.29 -2.0 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.102 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.451 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 7.6 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.029 0.442 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.509 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -70.27 8.78 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.993 1.795 . . . . 0.0 112.176 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.923 ' CE2' HD12 ' A' ' 40' ' ' LEU . 15.3 m-85 -98.95 -45.04 6.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 109.854 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.459 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 13.1 t90 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -40.56 -28.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 10' ' ' LYS . 62.8 t -94.02 165.45 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 12.6 mttt -119.55 172.65 4.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.3 Cg_endo -67.88 -35.46 20.93 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.005 1.529 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 6.4 pt-20 -72.64 -28.69 62.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.93 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.8 m-20 -81.17 -38.79 26.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 108.638 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppt? -68.56 -16.99 64.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -28.46 35.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -90.73 -35.62 14.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.7 m-30 -65.39 -28.56 69.35 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 14' ' ' LYS . 9.6 m-20 -80.98 -24.09 38.27 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.662 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.37 -30.78 37.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.718 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 56.3 mt -80.78 -28.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.642 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.58 -35.8 60.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.521 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t70 -89.32 -3.06 58.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.758 -0.589 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -6.57 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.305 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.118 HD12 HD13 ' A' ' 31' ' ' LEU . 4.5 mt -106.5 -12.25 15.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 p 89.59 94.68 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.259 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -73.8 150.46 44.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.253 1.659 . . . . 0.0 110.871 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 71.9 t -123.9 110.27 25.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.3 t30 57.58 15.41 2.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.321 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.28 35.25 5.32 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 75.4 m-85 -150.56 143.2 24.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -1.205 . . . . 0.0 112.224 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.118 HD13 HD12 ' A' ' 24' ' ' LEU . 12.4 mt -109.56 134.46 51.89 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 1.7 m -78.37 142.56 37.57 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 118.939 -1.105 . . . . 0.0 109.942 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.529 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -43.48 -26.35 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 63.5 m-20 -67.55 -23.42 65.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 40.3 mttp -96.1 -33.18 12.18 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.841 HG12 ' CD1' ' A' ' 40' ' ' LEU . 84.6 t -77.9 -38.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.641 0.734 . . . . 0.0 109.598 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.0 OUTLIER -43.15 -54.96 8.52 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.73 . . . . 0.0 111.137 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -67.79 -31.78 31.24 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.718 1.378 . . . . 0.0 109.926 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -64.27 -31.22 52.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.579 -0.701 . . . . 0.0 109.304 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.979 HD12 ' CE2' ' B' ' 111' ' ' PHE . 22.2 mt -94.34 -34.92 12.62 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.597 -0.689 . . . . 0.0 109.974 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.4 mt -67.91 -14.45 62.97 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 19.8 t30 -90.73 -4.91 56.35 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.47 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 5.7 m -84.97 18.65 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 0.0 110.431 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.9 tptt 60.23 13.5 3.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.05 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.051 HD11 ' HB3' ' A' ' 80' ' ' ALA . 12.7 mt -100.22 152.13 37.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.92 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.572 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.8 Cg_endo -76.61 170.06 20.63 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.017 1.535 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 3.4 t -71.03 -4.53 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.757 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.8 -33.78 45.97 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.818 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.897 HG13 HD22 ' A' ' 45' ' ' LEU . 14.5 mm -79.32 -42.07 23.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 108.825 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.9 mt -68.35 -29.46 68.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.57 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.28 -24.69 73.57 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 1.011 ' O ' HD12 ' A' ' 56' ' ' LEU . 5.5 ttm-85 -100.81 -32.59 10.62 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.685 -0.891 . . . . 0.0 110.265 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.801 HG11 HG23 ' A' ' 77' ' ' VAL . 24.6 t -68.77 -36.37 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.821 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.6 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.7 t-105 -69.59 -52.32 27.15 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.344 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 84.1 mt-10 -50.96 -57.38 8.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.095 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.011 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.1 mt -61.16 -14.36 24.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.128 -0.983 . . . . 0.0 108.834 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.934 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 15.5 t -97.0 -23.31 16.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.29 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 29.0 t0 -95.55 90.91 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.975 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.15 -15.45 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 110.164 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 8.0 m-20 -89.17 -17.25 29.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.479 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 3.0 m80 57.59 46.86 16.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.623 -0.673 . . . . 0.0 110.115 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 8.4 p30 -119.78 16.07 12.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.639 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.22 33.58 83.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 37.9 mtp -151.47 160.78 43.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.238 . . . . 0.0 110.635 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.835 HD12 HG11 ' A' ' 36' ' ' VAL . 12.6 mt -119.77 105.16 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.0 109.584 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.567 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -71.94 163.48 27.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.334 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -41.84 -39.84 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 111.108 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -79.71 -32.32 41.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.187 -0.946 . . . . 0.0 110.594 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' CG ' ' OD1' ' A' ' 66' ' ' ASP . 35.3 mt-10 -77.75 -39.24 44.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.108 -0.995 . . . . 0.0 109.021 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.895 ' CD2' HD12 ' A' ' 31' ' ' LEU . 20.9 t80 -62.35 -18.22 60.93 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 0.0 108.907 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.73 -44.34 28.09 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.797 0.808 . . . . 0.0 109.564 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.586 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 44.0 t -61.57 -30.43 48.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.607 0.717 . . . . 0.0 109.676 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.934 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.68 -2.81 58.38 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 110.82 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.622 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.5 mmt -83.62 -48.91 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.897 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 7.6 p90 -76.19 -23.74 54.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.7 mt -71.04 -24.45 62.35 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.801 HG23 HG11 ' A' ' 53' ' ' VAL . 45.7 t -91.68 -46.38 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.648 -0.658 . . . . 0.0 110.298 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.401 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 2.7 m-85 -69.58 -26.42 64.45 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 110.865 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 16.1 t -81.43 -12.91 58.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.038 . . . . 0.0 109.385 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.051 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.36 -10.54 43.63 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 109.023 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.4 mt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.739 0.781 . . . . 0.0 109.708 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 N--CA 1.479 0.639 0 N-CA-C 109.359 -1.054 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 91.6 t -116.73 126.69 27.31 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 110.562 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.696 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.5 Cg_endo -84.42 -170.51 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.994 1.523 . . . . 0.0 108.913 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.777 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.48 13.25 13.46 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.954 -1.091 . . . . 0.0 110.242 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.618 ' N ' HD21 ' A' ' 56' ' ' LEU . 3.6 m . . . . . 0 C--N 1.292 -1.921 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.245 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 2.5 t-20 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.677 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 42.3 Cg_endo -70.5 -3.73 13.08 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.812 1.428 . . . . 0.0 110.514 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.979 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -111.95 -60.99 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.598 ' CG ' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.358 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.485 0.993 0 N-CA-C 110.56 -0.592 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.493 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -88.3 123.34 32.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.935 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.796 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -42.98 -28.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.417 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.493 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 23.8 t -101.73 139.2 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.91 . . . . 0.0 110.708 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.03 -177.3 0.64 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.49 -0.756 . . . . 0.0 109.748 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 41.7 Cg_endo -71.66 -32.63 11.6 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.711 1.374 . . . . 0.0 110.249 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 13.0 mm-40 -77.36 -31.78 54.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 109.784 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -77.44 -35.19 54.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -82.21 -18.47 42.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.638 0.732 . . . . 0.0 109.112 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -70.08 -40.15 75.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.639 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -73.51 -32.01 64.02 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.639 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -66.22 -36.58 83.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.56 -20.98 63.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.663 -0.648 . . . . 0.0 110.155 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.01 -38.73 24.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.971 . . . . 0.0 108.511 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.69 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 42.7 mt -75.79 -29.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.735 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.97 -36.41 64.58 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t70 -89.97 1.48 56.23 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.977 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -92.4 -3.47 55.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.922 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.076 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -109.63 -4.58 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 84.99 89.97 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.3 Cg_endo -72.42 148.7 49.07 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 124.503 1.791 . . . . 0.0 110.864 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 68.7 t -121.03 104.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.1 t30 58.88 20.41 8.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.805 . . . . 0.0 110.001 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 94.27 37.1 5.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 87.1 m-85 -150.29 149.22 29.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.164 -1.198 . . . . 0.0 111.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.076 ' CD1' HD12 ' A' ' 24' ' ' LEU . 15.0 mt -122.54 130.48 53.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -77.29 148.14 35.87 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.55 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -46.66 -25.55 2.25 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 9.0 t0 -63.02 -20.75 65.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.567 -0.961 . . . . 0.0 109.685 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 27.9 mttp -104.42 -32.38 9.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.948 HG11 HD12 ' A' ' 65' ' ' LEU . 92.3 t -83.5 -46.29 18.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.175 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' CG ' HD11 ' A' ' 41' ' ' LEU . 8.0 tttt -41.68 -49.91 9.91 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -67.69 -31.97 31.42 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.341 1.179 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.671 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -68.4 -34.58 66.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.948 HD12 ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -86.3 -31.48 21.58 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.82 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD11 ' CG ' ' A' ' 37' ' ' LYS . 47.1 mt -71.02 -11.5 61.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.09 -10.36 53.07 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.169 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 1.012 ' O ' HD21 ' A' ' 81' ' ' LEU . 87.7 p -79.17 7.92 6.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 110.473 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.64 9.53 5.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.066 -1.021 . . . . 0.0 109.939 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.995 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.2 mt -93.17 157.26 39.25 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.5 Cg_endo -74.72 167.86 26.13 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.857 1.451 . . . . 0.0 109.635 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.478 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.51 -7.4 6.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.941 -1.099 . . . . 0.0 109.142 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.51 -29.87 61.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.897 HG13 HD22 ' A' ' 45' ' ' LEU . 8.7 mm -85.62 -39.1 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.925 0.869 . . . . 0.0 108.898 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.941 HD22 ' HB3' ' A' ' 40' ' ' LEU . 13.1 mt -79.52 -28.77 41.33 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.08 -26.83 71.49 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.741 ' O ' HD12 ' A' ' 56' ' ' LEU . 28.0 ttm180 -101.43 -31.19 11.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.113 -0.64 . . . . 0.0 110.501 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.861 HG11 HG23 ' A' ' 77' ' ' VAL . 18.7 t -70.63 -36.93 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 108.588 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CZ2' ' OD1' ' A' ' 58' ' ' ASP . 1.6 t-105 -63.44 -50.77 68.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.71 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.3 mm-40 -52.25 -57.7 8.91 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.11 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.4 mt -62.13 -19.28 62.87 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.141 -0.974 . . . . 0.0 108.646 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.879 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 7.5 t -85.9 -33.95 21.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -70.3 92.75 0.8 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 29.1 mm -75.31 -23.26 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 111.328 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -110.2 -9.54 14.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.884 -1.135 . . . . 0.0 110.948 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 3.9 m-70 59.59 44.8 14.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.109 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 19.2 p-10 -106.74 9.31 31.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 109.989 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 80.05 24.77 59.06 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.2 mtp -152.17 161.4 42.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.183 -1.187 . . . . 0.0 110.373 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.948 HD12 HG11 ' A' ' 36' ' ' VAL . 13.6 mt -116.84 103.12 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.723 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.599 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -69.26 173.23 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.067 -1.021 . . . . 0.0 110.021 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -50.07 -32.15 14.9 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.613 -0.679 . . . . 0.0 110.894 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 -30.38 20.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 36.2 mt-10 -79.16 -40.6 30.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 108.917 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.748 ' CD1' HD12 ' A' ' 31' ' ' LEU . 27.3 t80 -63.81 -24.45 67.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -70.17 -51.87 27.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.962 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.1 t -57.29 -25.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.547 -0.72 . . . . 0.0 110.359 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.879 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.07 -4.99 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 111.637 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmt -88.53 -44.16 10.88 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.862 -1.149 . . . . 0.0 110.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.79 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 4.5 p90 -77.71 -22.17 50.82 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.999 -1.081 . . . . 0.0 108.293 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 12.1 mt -74.63 -24.52 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.012 ' O ' HD12 ' A' ' 81' ' ' LEU . 49.3 t -91.62 -40.96 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.586 -0.696 . . . . 0.0 110.123 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -71.91 -22.52 61.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.648 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 14.3 m -83.2 -20.76 34.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.818 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.995 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -80.62 -12.82 59.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.332 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.012 HD21 ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -91.2 -41.13 11.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.513 -0.742 . . . . 0.0 110.771 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 4.0 tt0 -125.66 -9.15 6.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 111.768 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -110.47 -90.01 0.48 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.543 -1.348 . . . . 0.0 111.612 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.0 mt-10 -146.08 172.75 4.91 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.673 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 42.3 Cg_endo -67.65 -169.29 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.057 1.556 . . . . 0.0 110.588 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.458 HG13 HD22 ' A' ' 76' ' ' LEU . 98.1 t -128.15 137.48 30.93 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 110.605 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.727 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.3 Cg_endo -84.41 175.43 7.2 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.869 1.457 . . . . 0.0 108.503 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.738 ' C ' HD21 ' A' ' 56' ' ' LEU . 9.9 mtm -108.48 18.21 21.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.74 -1.225 . . . . 0.0 110.49 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 56' ' ' LEU . 74.8 m -112.88 99.51 7.94 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.355 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.719 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -47.16 104.97 0.44 Allowed Pre-proline 0 C--N 1.293 -1.863 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.494 178.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 43.5 Cg_endo -71.52 148.95 54.96 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.984 1.518 . . . . 0.0 110.54 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.45 -15.0 34.45 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.056 1.556 . . . . 0.0 110.554 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.612 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -84.57 -3.29 58.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.796 HD13 ' HB3' ' A' ' 8' ' ' ALA . 3.9 mm? -105.67 -8.58 17.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.338 -0.851 . . . . 0.0 110.086 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 99' ' ' LYS . 35.6 t -74.03 130.01 83.68 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.623 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.462 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.4 Cg_endo -71.41 174.78 10.35 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.9 1.474 . . . . 0.0 110.059 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.515 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 44.2 Cg_endo -71.91 -21.4 24.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.902 1.475 . . . . 0.0 110.842 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t -66.56 -15.77 63.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.879 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HB3' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -97.34 8.52 44.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.89 . . . . 0.0 109.578 179.179 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.183 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.259 0.552 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' B' ' 109' ' ' ASN . 3.2 t -174.4 -166.24 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.226 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.413 ' ND2' ' CD1' ' B' ' 111' ' ' PHE . 5.0 t-20 46.57 88.84 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.903 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.559 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -74.59 19.69 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.194 1.628 . . . . 0.0 112.35 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.948 ' CE2' HD12 ' A' ' 40' ' ' LEU . 24.5 m-85 -99.94 -61.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.511 -1.368 . . . . 0.0 108.69 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.416 ' HA ' HG11 ' A' ' 47' ' ' VAL . 27.1 mtm180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.222 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 110.491 -0.619 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.609 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 16.0 t90 -80.2 126.15 30.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.933 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -43.27 -27.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 42.0 t -96.6 145.3 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.55 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.4 mttm -112.52 -179.46 0.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.4 Cg_endo -67.56 -35.53 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.745 1.392 . . . . 0.0 110.199 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 6.2 pt-20 -71.21 -30.62 66.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 5.8 m-20 -83.63 -38.13 21.94 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.224 -0.923 . . . . 0.0 108.655 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 5.9 tptm -69.33 -17.65 63.73 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.74 -39.67 35.57 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.634 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.2 ptmm? -81.05 -22.85 38.98 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -76.93 -34.75 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.9 -19.63 60.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 0.0 110.31 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -83.6 -33.62 25.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.985 . . . . 0.0 108.451 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.736 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -78.07 -31.39 16.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.769 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -71.84 -38.95 70.06 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.704 0.764 . . . . 0.0 109.034 179.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.55 -6.49 54.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.512 -0.742 . . . . 0.0 109.878 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.2 t -78.76 -7.51 57.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 0.0 108.909 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.025 HD12 HD13 ' A' ' 31' ' ' LEU . 10.6 mt -101.77 -54.34 2.75 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 m 137.97 98.51 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.16 148.3 39.18 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 O-C-N 123.977 1.514 . . . . 0.0 110.499 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -120.08 98.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.627 -0.67 . . . . 0.0 109.31 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 24.1 t-20 60.37 14.86 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.726 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.458 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 107.03 32.88 3.38 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 84.9 m-85 -148.6 151.99 35.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.908 -1.348 . . . . 0.0 112.078 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.025 HD13 HD12 ' A' ' 24' ' ' LEU . 6.7 mt -120.31 143.18 48.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 33' ' ' GLY . 96.6 p -89.08 141.79 28.2 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.822 -1.174 . . . . 0.0 110.28 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.69 -25.96 0.99 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.0 t70 -65.83 -22.36 66.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.513 -0.993 . . . . 0.0 110.072 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB3' HD13 ' A' ' 24' ' ' LEU . 7.7 mttp -97.81 -35.91 10.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 98.1 t -77.77 -42.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.514 0.673 . . . . 0.0 110.011 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.48 -53.82 5.31 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 110.915 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.1 Cg_endo -68.67 -33.9 20.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.542 1.285 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.712 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.5 t -63.55 -31.75 54.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.031 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.981 ' HB3' HD22 ' A' ' 50' ' ' LEU . 33.0 mt -88.43 -26.58 22.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 110.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD11 ' HE2' ' A' ' 37' ' ' LYS . 51.9 mt -73.8 -11.23 60.32 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.175 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -90.31 -3.19 57.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 1.022 ' O ' HD21 ' A' ' 81' ' ' LEU . 91.9 p -84.34 13.98 4.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 110.09 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt 59.39 13.72 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.925 HD11 ' HB3' ' A' ' 80' ' ' ALA . 17.5 mt -100.16 156.87 34.78 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.905 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.6 Cg_endo -74.58 171.08 18.86 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.921 1.485 . . . . 0.0 109.868 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.561 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.4 -6.19 6.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.286 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.71 -31.15 59.54 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.879 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -83.12 -40.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 122.017 0.913 . . . . 0.0 108.556 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.981 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.1 mt -76.7 -26.94 55.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.729 0.776 . . . . 0.0 108.959 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.8 -29.08 65.81 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.857 ' O ' HD12 ' A' ' 56' ' ' LEU . 30.1 ttm180 -101.0 -28.3 12.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.886 -0.773 . . . . 0.0 109.934 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.928 HG11 HG23 ' A' ' 77' ' ' VAL . 19.4 t -72.49 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.43 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.558 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.3 t-105 -65.82 -51.46 58.75 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.814 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.2 mm-40 -50.82 -60.53 2.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.406 -0.809 . . . . 0.0 109.991 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -61.54 -15.93 43.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.498 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.028 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 9.2 t -92.24 -18.17 23.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.487 0.661 . . . . 0.0 109.235 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.1 t0 -90.83 82.11 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.514 -0.741 . . . . 0.0 110.322 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG12 ' HG2' ' A' ' 69' ' ' GLU . 12.1 mm -62.67 -24.12 34.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.604 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -104.24 -7.96 19.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 20.6 p80 38.35 51.92 1.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.567 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.2 p-10 -119.68 20.33 12.35 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.004 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.53 29.71 54.94 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.4 mtp -150.24 161.3 42.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -1.158 . . . . 0.0 111.087 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 14.0 mt -129.53 112.59 13.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 109.746 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 13.7 t0 -70.02 168.39 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.065 -1.022 . . . . 0.0 110.47 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.557 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -50.75 -41.08 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.872 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 46.4 t0 -81.01 -32.82 34.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HG2' HG12 ' A' ' 59' ' ' ILE . 2.3 mt-10 -71.96 -50.21 30.82 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.873 0.844 . . . . 0.0 109.257 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.922 ' CD2' HD12 ' A' ' 31' ' ' LEU . 29.3 t80 -53.57 -22.83 9.15 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -68.83 -52.87 25.38 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.852 0.834 . . . . 0.0 109.77 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.115 HG13 HD21 ' A' ' 94' ' ' LEU . 49.0 t -52.64 -24.61 6.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 110.394 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.028 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.67 -11.48 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 0.0 112.499 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 mmm -86.77 -47.11 9.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.392 -1.442 . . . . 0.0 110.435 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.542 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 1.9 p90 -73.38 -21.75 60.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.691 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.2 mt -74.55 -24.95 59.01 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.928 HG23 HG11 ' A' ' 53' ' ' VAL . 59.8 t -90.96 -42.46 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -68.54 -19.09 64.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.619 -0.675 . . . . 0.0 110.21 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 16.1 m -84.65 -25.74 28.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -73.55 -17.44 61.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 108.698 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.022 HD21 ' O ' ' A' ' 43' ' ' SER . 1.1 mt -91.93 -41.21 10.71 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.724 -0.61 . . . . 0.0 110.767 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -121.49 -10.9 8.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.84 . . . . 0.0 111.778 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 79' ' ' CYS . 7.9 tttp -106.01 -85.11 0.5 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.553 -1.342 . . . . 0.0 110.932 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 2.8 mt-10 -161.8 179.6 1.26 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.94 -1.1 . . . . 0.0 109.947 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 39.7 Cg_endo -66.51 170.64 11.97 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.668 1.352 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.526 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 96.4 t -113.99 134.95 22.06 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.771 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.6 Cg_endo -84.69 -173.12 1.4 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.072 1.564 . . . . 0.0 109.02 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.776 ' C ' HD21 ' A' ' 56' ' ' LEU . 29.6 mtm -111.55 10.14 21.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 109.872 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.537 ' N ' HD21 ' A' ' 56' ' ' LEU . 19.6 m -108.12 101.19 10.44 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.887 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.921 HD22 HG22 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -50.69 106.46 0.65 Allowed Pre-proline 0 C--N 1.292 -1.893 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.512 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.757 ' O ' HG23 ' A' ' 95' ' ' VAL . 41.6 Cg_endo -70.99 152.76 63.21 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.791 1.416 . . . . 0.0 110.728 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.62 -9.94 24.58 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.285 1.676 . . . . 0.0 111.397 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -84.73 -27.79 26.73 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 109.025 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.115 HD21 HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.94 -12.09 17.75 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.849 0.833 . . . . 0.0 108.972 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.921 HG22 HD22 ' A' ' 90' ' ' LEU . 47.8 t -87.38 137.21 32.62 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.924 -1.11 . . . . 0.0 110.781 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.498 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 46.1 Cg_endo -72.11 175.67 9.54 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.128 1.594 . . . . 0.0 109.985 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.59 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 41.6 Cg_endo -67.86 179.9 2.46 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.84 1.442 . . . . 0.0 110.529 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER 70.25 -53.91 0.63 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.311 -0.868 . . . . 0.0 110.08 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 100' ' ' ARG . 2.3 tptt -88.59 16.12 7.08 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 108.652 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.59 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 41.5 mmm-85 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.627 -0.671 . . . . 0.0 110.465 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.337 0.589 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 17.1 m -97.15 -27.43 14.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.506 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.5 t-20 -112.53 110.78 52.5 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -72.94 2.39 5.48 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.078 1.568 . . . . 0.0 111.483 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.947 ' CE2' HD12 ' A' ' 40' ' ' LEU . 4.4 m-85 -101.2 -47.97 4.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.853 -1.155 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.514 ' HG2' ' HA3' ' A' ' 51' ' ' GLY . 1.2 mmm180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.275 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 110.304 -0.691 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.599 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.9 t90 -52.42 134.39 34.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 109.668 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.719 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -40.93 -28.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.451 -0.78 . . . . 0.0 110.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.599 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 85.4 t -113.31 135.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 110.152 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.542 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -93.77 -179.69 1.07 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.349 -0.844 . . . . 0.0 109.995 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.13 -35.27 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.927 1.488 . . . . 0.0 110.02 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.6 -33.52 58.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 15.0 m-20 -76.96 -34.66 57.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 68' ' ' ASP . 1.5 tttt -76.79 -20.16 56.75 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.7 71.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.627 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -70.13 -21.23 63.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -80.21 -29.29 38.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.38 -20.14 57.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.718 -0.614 . . . . 0.0 109.804 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -81.57 -32.69 32.02 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.831 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 63.8 mt -78.97 -33.0 15.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.821 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -67.78 -35.17 78.19 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -91.03 -5.44 55.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.461 -0.775 . . . . 0.0 110.324 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 87.3 p -78.95 -14.65 59.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 108.839 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.054 HD12 ' CD1' ' A' ' 31' ' ' LEU . 11.6 mt -92.96 -55.07 3.48 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 t 142.8 92.92 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.478 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.7 Cg_endo -74.87 148.99 36.67 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 O-C-N 124.198 1.631 . . . . 0.0 110.88 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -125.38 103.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 19.2 t-20 63.37 13.66 7.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.642 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 32.66 4.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.2 m-85 -146.5 148.79 32.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -1.166 . . . . 0.0 111.908 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.054 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.1 mt -113.83 158.51 20.93 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' LYS . 48.3 p -105.14 143.45 33.3 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.606 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.59 -25.1 0.49 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' SER . 61.4 t0 -71.32 -23.97 62.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.413 -1.051 . . . . 0.0 110.412 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 32' ' ' SER . 14.0 mttp -94.09 -35.61 12.48 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.071 -1.018 . . . . 0.0 108.417 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.917 HG11 HD12 ' A' ' 65' ' ' LEU . 87.5 t -78.16 -42.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.382 0.61 . . . . 0.0 110.384 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.572 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 14.8 tttt -40.03 -54.42 4.42 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 110.549 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -66.93 -33.85 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.406 1.214 . . . . 0.0 110.021 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.788 ' CG2' HD21 ' A' ' 24' ' ' LEU . 2.2 t -62.25 -35.2 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.818 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.009 ' HB3' HD22 ' A' ' 50' ' ' LEU . 30.3 mt -87.83 -30.02 20.52 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.705 -0.622 . . . . 0.0 110.063 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.516 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 67.2 mt -70.13 -13.95 62.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -91.36 -4.1 56.1 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.52 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -83.56 16.75 2.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.386 -0.821 . . . . 0.0 110.445 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.557 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.0 tttp 60.32 11.92 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.177 -0.952 . . . . 0.0 109.591 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.006 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.9 mt -99.19 153.39 37.81 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 110.566 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.0 Cg_endo -75.76 175.97 10.61 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 124.175 1.619 . . . . 0.0 109.271 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.6 t -73.27 -3.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.6 m-20 -81.68 -30.44 32.64 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.246 -0.909 . . . . 0.0 109.285 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.901 HG13 HD22 ' A' ' 45' ' ' LEU . 5.3 mm -88.0 -39.23 12.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.009 HD22 ' HB3' ' A' ' 40' ' ' LEU . 23.6 mt -74.78 -27.67 60.42 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -74.58 -21.8 78.19 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -99.99 -33.75 10.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.161 -0.611 . . . . 0.0 109.402 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 77' ' ' VAL . 18.6 t -69.22 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 4.4 t-105 -76.2 -55.38 5.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.557 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.8 mm-40 -52.02 -58.24 7.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.96 -1.088 . . . . 0.0 110.048 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.6 mt -59.29 -16.32 21.08 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.582 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.71 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.0 t -91.44 -40.25 11.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 109.713 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' TRP . 1.2 t0 -65.82 97.66 0.35 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.472 -0.767 . . . . 0.0 109.996 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.818 HG21 ' HD2' ' A' ' 99' ' ' LYS . 15.2 mm -72.22 -31.36 39.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.564 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 4.2 p30 -105.81 -9.64 17.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.801 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.777 ' HB3' HG21 ' B' ' 108' ' ' THR . 0.0 OUTLIER 51.77 51.02 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.381 -0.825 . . . . 0.0 109.994 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 47.0 p-10 -111.09 20.83 17.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 75.11 32.81 55.73 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 10.6 mtp -150.69 161.34 42.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.248 . . . . 0.0 111.858 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.917 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 mt -132.27 99.73 4.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.606 -0.684 . . . . 0.0 109.293 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.2 p30 -71.49 160.41 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 110.468 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 10.1 ptt-85 -34.9 -44.21 0.21 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.756 -0.59 . . . . 0.0 111.31 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.8 m-20 -77.64 -35.08 52.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.701 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HG3' HG12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -70.13 -48.41 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.81 0.814 . . . . 0.0 109.22 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.831 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 25.3 t80 -61.04 -14.17 21.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -79.19 -47.28 16.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.527 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.024 HG13 HD12 ' A' ' 94' ' ' LEU . 59.9 t -59.01 -29.62 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.077 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.2 -2.37 58.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.63 -0.669 . . . . 0.0 111.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.615 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 10.0 mmt -88.08 -48.33 7.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.472 -1.392 . . . . 0.0 110.112 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.043 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.0 p90 -76.1 -24.18 54.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 72' ' ' VAL . 8.6 mt -70.8 -26.45 63.32 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.995 HG23 HG11 ' A' ' 53' ' ' VAL . 8.6 t -91.09 -23.61 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.728 -0.607 . . . . 0.0 109.998 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.45 -26.31 28.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.599 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.1 m -81.29 -17.67 48.52 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.549 -0.72 . . . . 0.0 109.675 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.006 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.39 -8.68 57.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.374 -0.828 . . . . 0.0 109.145 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.7 mt -90.33 -45.02 9.3 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.751 0.786 . . . . 0.0 108.959 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -71.49 -52.22 19.51 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.725 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 179.32 -30.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.255 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 79' ' ' CYS . 4.4 mt-10 -65.48 110.33 4.24 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.174 -0.954 . . . . 0.0 111.074 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 44.0 Cg_endo -71.7 -170.92 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.832 1.438 . . . . 0.0 110.063 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG13 HD22 ' A' ' 76' ' ' LEU . 59.9 t -138.18 125.56 13.58 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.828 ' O ' HD11 ' A' ' 56' ' ' LEU . 53.2 Cg_endo -84.9 -175.95 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.926 1.488 . . . . 0.0 109.474 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.752 ' C ' HD21 ' A' ' 56' ' ' LEU . 28.4 mtp -110.73 12.36 22.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.474 ' N ' HD21 ' A' ' 56' ' ' LEU . 52.5 m -110.3 101.51 10.24 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.772 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -53.41 106.89 0.72 Allowed Pre-proline 0 C--N 1.29 -2.008 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.924 178.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.998 ' HG2' HD23 ' A' ' 94' ' ' LEU . 46.9 Cg_endo -69.93 170.27 17.18 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.912 1.48 . . . . 0.0 109.909 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.58 -21.68 14.56 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.913 1.48 . . . . 0.0 111.272 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -82.24 4.96 21.52 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.078 -1.014 . . . . 0.0 109.249 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.043 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 2.1 mm? -114.29 9.72 17.03 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.423 -0.798 . . . . 0.0 110.944 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -124.13 107.99 30.14 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 0.0 110.831 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.82 168.49 24.7 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.976 1.514 . . . . 0.0 109.612 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 98' ' ' SER . 43.7 Cg_endo -71.03 175.13 9.59 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.755 1.397 . . . . 0.0 110.151 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 2.0 t 80.07 -33.6 0.13 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.828 -0.545 . . . . 0.0 110.121 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.818 ' HD2' HG21 ' A' ' 59' ' ' ILE . 8.6 mmtt -88.73 0.7 56.21 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.023 -1.048 . . . . 0.0 108.632 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.04 179.722 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' B' ' 108' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.269 0.557 . . . . 0.0 110.199 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.777 HG21 ' HB3' ' A' ' 61' ' ' HIS . 8.4 t -73.22 69.07 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.068 -1.02 . . . . 0.0 109.863 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 112' ' ' ARG . 10.6 t-20 -151.62 100.51 2.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.432 -0.793 . . . . 0.0 110.106 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 52.2 Cg_endo -72.97 4.85 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.288 1.678 . . . . 0.0 111.686 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.955 ' CE2' HD12 ' A' ' 40' ' ' LEU . 4.1 m-85 -105.17 -69.42 0.82 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.793 -1.192 . . . . 0.0 109.007 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.515 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.566 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.251 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 1.187 ' N ' ' HB3' ' B' ' 110' ' ' PRO 2.129 0.0 OUTLIER . . . . . 1 N--CA 28.865 1611.611 1 N-CA-C 11.458 -38.709 . . . . 0.0 11.458 . . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.65 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.4 t90 -89.53 121.03 31.35 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 109.919 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -52.07 -24.74 7.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 89.3 t -97.5 116.76 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.467 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.8 mttp -93.67 -177.81 0.75 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.496 -0.752 . . . . 0.0 109.633 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -67.63 -34.07 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.659 1.347 . . . . 0.0 110.048 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.43 -33.22 62.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.85 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.7 m-20 -81.55 -36.76 28.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.342 -0.849 . . . . 0.0 108.738 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.4 tttt -74.87 -15.17 60.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -76.93 -40.28 47.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.8 ptpt -75.34 -25.07 57.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -73.32 -36.02 66.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.83 -22.73 64.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.733 -0.604 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.24 -30.49 43.22 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.739 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 16.9 mt -82.8 -35.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.46 -36.59 68.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.556 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.5 t0 -87.03 -2.09 58.37 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.641 -0.662 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -86.48 -9.42 56.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 108.954 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.083 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.2 mt -102.96 -14.55 16.45 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.619 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.03 93.04 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -74.77 153.55 43.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.284 1.676 . . . . 0.0 111.068 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.1 t -120.92 105.86 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.512 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 65.04 12.64 8.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.218 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.71 33.83 5.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.575 ' CD1' ' OD1' ' A' ' 66' ' ' ASP . 76.9 m-85 -141.13 141.99 34.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.159 . . . . 0.0 111.882 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.083 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.8 mt -113.98 136.79 52.52 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 35' ' ' LYS . 3.3 p -83.5 146.01 28.61 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.77 -26.74 1.2 Allowed Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 33.4 t0 -66.41 -26.22 67.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.579 -0.954 . . . . 0.0 109.991 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 6.1 mttp -92.26 -33.26 14.72 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.838 HG21 HD12 ' A' ' 65' ' ' LEU . 86.4 t -80.96 -47.12 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.415 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 20.6 tttm -39.67 -51.58 5.12 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 0.0 110.917 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -68.8 -34.39 18.4 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.355 1.187 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.803 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -62.84 -32.67 56.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.017 ' HB3' HD22 ' A' ' 50' ' ' LEU . 36.9 mt -90.62 -27.64 18.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.573 -0.704 . . . . 0.0 110.081 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.487 HD11 ' HE2' ' A' ' 37' ' ' LYS . 55.9 mt -74.77 -11.29 60.12 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.035 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -90.38 -9.21 48.47 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 110.185 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.3 p -78.39 5.98 9.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.1 tttt 69.23 9.02 7.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.935 . . . . 0.0 110.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.911 HD22 HG13 ' A' ' 49' ' ' ILE . 18.5 mt -93.82 157.25 38.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -75.68 171.89 17.35 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.251 1.658 . . . . 0.0 109.285 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.8 t -70.73 -4.76 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 109.189 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.17 -29.53 54.52 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 108.78 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.911 HG13 HD22 ' A' ' 45' ' ' LEU . 6.5 mm -87.89 -36.71 9.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.866 0.841 . . . . 0.0 108.755 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.017 HD22 ' HB3' ' A' ' 40' ' ' LEU . 13.4 mt -79.33 -26.72 42.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -72.52 -23.14 78.43 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.789 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.6 ttm105 -100.83 -32.49 10.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.972 -0.722 . . . . 0.0 109.723 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.643 HG11 ' CG2' ' A' ' 77' ' ' VAL . 12.9 t -68.91 -38.97 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.205 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.596 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 4.0 t-105 -67.49 -48.01 68.36 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.359 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.8 mm-40 -59.53 -58.28 9.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.154 -0.966 . . . . 0.0 109.848 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.96 ' O ' HD21 ' A' ' 90' ' ' LEU . 5.6 mt -58.83 -17.39 23.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 108.483 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 10.2 t -88.25 -45.19 10.27 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.595 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -59.79 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.639 -0.663 . . . . 0.0 110.14 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.422 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 33.5 mm -67.98 -30.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 110.128 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.6 p30 -109.6 -15.67 14.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 6.1 m80 62.02 41.17 11.39 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.406 -0.809 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.1 p-10 -93.13 3.9 54.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.989 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 89.03 23.01 36.39 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.4 mtp -152.79 162.1 41.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -1.168 . . . . 0.0 110.454 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.838 HD12 HG21 ' A' ' 36' ' ' VAL . 46.0 mt -119.4 112.33 19.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.422 -0.799 . . . . 0.0 109.502 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 30' ' ' PHE . 2.0 m-20 -69.39 159.22 33.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.283 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 19.7 ptt180 -41.52 -42.25 2.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 109.988 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 9.9 t70 -81.64 -34.69 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 57' ' ' SER . 1.8 tt0 -69.35 -49.62 53.96 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.803 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 40.8 t80 -57.97 -19.8 33.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -70.56 -50.31 38.81 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.883 0.849 . . . . 0.0 109.587 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.056 HG13 HD21 ' A' ' 94' ' ' LEU . 83.4 t -55.15 -24.87 15.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.458 0.647 . . . . 0.0 109.961 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -88.33 -10.46 49.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 111.972 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.566 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmm -84.58 -43.53 14.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.41 ' HB3' ' OH ' ' A' ' 17' ' ' TYR . 2.8 p90 -75.67 -22.88 56.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.645 -1.222 . . . . 0.0 107.751 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.0 mt -72.24 -22.16 61.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 73' ' ' ALA . 70.5 t -91.24 -44.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.765 -0.584 . . . . 0.0 109.513 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -65.14 -27.41 68.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.636 -0.665 . . . . 0.0 110.956 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.0 OUTLIER -77.17 -20.47 55.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.99 -1.068 . . . . 0.0 108.722 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.856 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.48 -7.32 57.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 81' ' ' LEU . 3.2 mt -90.99 -39.8 12.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.399 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 1.8 mt-10 -69.17 -52.55 26.88 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.362 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER 176.26 -24.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.606 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -80.88 112.79 35.15 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.982 -1.073 . . . . 0.0 110.847 -178.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 40.9 Cg_endo -67.53 -162.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.958 1.504 . . . . 0.0 110.438 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.467 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.8 t -132.32 127.41 20.79 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 110.753 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.831 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -83.16 -179.54 4.44 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.905 1.476 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.675 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.0 mtt -104.32 10.38 35.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.798 -1.189 . . . . 0.0 109.847 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.456 ' N ' HD21 ' A' ' 56' ' ' LEU . 68.3 m -108.73 104.14 13.36 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 112.115 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.96 HD21 ' O ' ' A' ' 56' ' ' LEU . 4.1 mt -44.97 106.08 0.51 Allowed Pre-proline 0 C--N 1.293 -1.858 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.927 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 40.3 Cg_endo -68.06 145.55 67.67 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.75 1.395 . . . . 0.0 110.998 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 95' ' ' VAL . 44.0 Cg_endo -69.57 -7.97 22.39 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.228 1.646 . . . . 0.0 110.826 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.79 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -97.95 24.39 7.03 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.056 HD21 HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -154.11 -35.08 0.1 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.499 0.666 . . . . 0.0 109.649 -178.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.851 ' N ' HD13 ' A' ' 94' ' ' LEU . 2.8 p -74.9 135.7 73.98 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.265 -0.897 . . . . 0.0 110.41 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.32 157.2 45.83 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.015 1.534 . . . . 0.0 110.48 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.43 -2.17 10.85 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.172 1.617 . . . . 0.0 110.654 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.54 -19.28 62.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.133 -0.98 . . . . 0.0 109.806 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -96.93 10.9 37.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 109.49 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.311 -0.868 . . . . 0.0 110.259 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' B' ' 108' ' ' THR . 3.0 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' B' ' 107' ' ' SER . 39.7 p 43.97 -163.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.424 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.483 ' HA ' ' HD2' ' B' ' 110' ' ' PRO . 10.3 t-20 62.35 96.98 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 110.118 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 1.187 ' HB3' ' N ' ' A' ' 6' ' ' PRO . 51.9 Cg_endo -71.01 6.16 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 121.887 1.725 . . . . 0.0 111.964 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.931 ' CE2' HD12 ' A' ' 40' ' ' LEU . 7.7 m-85 -99.88 -63.77 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.222 . . . . 0.0 108.992 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.481 0.785 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.839 ' HE1' HD22 ' A' ' 94' ' ' LEU . 12.4 t90 -98.81 124.95 44.03 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.158 -0.964 . . . . 0.0 110.26 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -48.85 -27.75 3.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 0.0 109.935 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.4 t -92.14 122.64 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.483 ' HG2' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -80.33 176.01 4.22 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.192 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -70.08 -34.07 14.2 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.053 1.554 . . . . 0.0 109.788 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.2 pp20? -79.6 -22.59 43.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.421 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 m-20 -82.86 -38.49 22.89 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -14.93 61.18 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.34 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.472 -0.768 . . . . 0.0 109.024 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.8 ptpt -72.97 -26.14 61.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -71.81 -35.2 69.87 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.81 -23.05 60.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.654 -0.654 . . . . 0.0 109.869 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.25 -32.19 38.34 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.577 HG22 ' CE1' ' A' ' 70' ' ' PHE . 66.7 mt -81.31 -31.9 11.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.689 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.26 -37.03 66.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.5 t70 -88.76 -1.49 58.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.658 -0.652 . . . . 0.0 110.119 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -4.15 57.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.21 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.105 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.5 mt -108.84 -8.66 15.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 87.04 95.0 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -72.09 148.56 50.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.314 1.691 . . . . 0.0 110.838 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 73.8 t -119.76 100.36 9.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 63.77 16.55 9.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 97.11 34.01 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.2 m-85 -149.48 147.41 28.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -1.191 . . . . 0.0 111.776 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.105 ' CD1' HD12 ' A' ' 24' ' ' LEU . 14.8 mt -116.63 134.45 54.81 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 17.5 p -77.82 146.62 35.64 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.769 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.46 -27.19 1.18 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.3 m-20 -61.49 -25.42 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.869 . . . . 0.0 110.031 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 35.7 mttt -98.08 -32.19 11.74 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.111 -0.993 . . . . 0.0 108.338 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.972 HG11 HD12 ' A' ' 65' ' ' LEU . 97.9 t -83.54 -48.21 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.421 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 17.7 tttt -40.14 -53.56 5.02 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.49 -30.44 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.408 1.215 . . . . 0.0 109.703 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -68.81 -30.65 47.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.974 ' HB3' HD22 ' A' ' 50' ' ' LEU . 44.7 mt -88.79 -28.28 20.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.411 -0.806 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.76 -11.25 60.73 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.014 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -90.08 -5.46 56.53 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.568 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.523 ' CB ' HG13 ' A' ' 77' ' ' VAL . 5.8 p -83.21 13.28 4.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.108 -0.995 . . . . 0.0 110.673 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 63.43 8.98 3.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.923 . . . . 0.0 110.676 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.938 HD13 HG21 ' A' ' 49' ' ' ILE . 15.2 mt -94.67 157.76 36.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 0.0 109.582 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.7 Cg_endo -75.28 173.66 14.13 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 124.023 1.538 . . . . 0.0 109.243 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.0 t -74.45 -1.41 2.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.145 -0.972 . . . . 0.0 109.373 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -31.19 33.1 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.938 HG21 HD13 ' A' ' 45' ' ' LEU . 12.8 mm -83.02 -40.35 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.974 HD22 ' HB3' ' A' ' 40' ' ' LEU . 22.7 mt -73.84 -25.92 60.32 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -73.35 -25.28 73.31 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.86 -28.09 12.97 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.804 -0.821 . . . . 0.0 110.032 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.882 HG11 HG23 ' A' ' 77' ' ' VAL . 17.0 t -72.58 -39.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.78 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 2.4 t-105 -65.09 -50.97 64.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.576 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 9.6 mm-40 -56.19 -53.84 52.39 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.892 ' O ' HD11 ' A' ' 90' ' ' LEU . 18.3 mt -64.46 -12.7 46.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.67 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t -94.97 -29.73 14.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 108.88 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 7.4 t0 -74.5 100.75 3.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.692 -0.63 . . . . 0.0 109.65 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.486 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.1 mm -80.44 -29.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -102.1 -18.56 15.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 4.1 m-70 65.72 42.12 3.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.0 p30 -102.28 -3.74 26.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.461 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 95.12 25.87 13.52 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 5.1 mtp -152.56 161.25 42.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.245 . . . . 0.0 110.618 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.972 HD12 HG11 ' A' ' 36' ' ' VAL . 13.5 mt -119.78 102.12 8.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.667 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.618 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 5.1 p30 -71.57 167.47 19.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.56 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.7 ptt-85 -37.55 -46.04 0.8 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.0 111.854 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 80.7 m-20 -76.68 -37.21 56.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.075 -1.016 . . . . 0.0 110.665 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 44.9 mt-10 -71.85 -44.5 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.972 ' CD2' HD12 ' A' ' 31' ' ' LEU . 11.6 t80 -60.51 -17.37 45.0 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -79.24 -45.79 19.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.879 ' CG1' HD11 ' A' ' 94' ' ' LEU . 46.5 t -61.4 -25.97 38.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.476 0.655 . . . . 0.0 109.747 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.67 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.55 -8.23 50.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 111.258 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.7 mmt -83.24 -47.74 11.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -75.14 -28.73 60.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 72' ' ' VAL . 6.7 mt -66.93 -28.67 68.48 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.882 HG23 HG11 ' A' ' 53' ' ' VAL . 41.0 t -91.38 -23.94 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.686 -0.634 . . . . 0.0 110.393 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -29.78 17.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.897 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 79.6 m -84.82 -15.65 44.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.65 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.665 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -81.42 -10.24 59.55 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.907 -1.121 . . . . 0.0 108.211 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 45' ' ' LEU . 4.0 mt -91.77 -48.51 6.76 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.356 0.598 . . . . 0.0 110.273 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 81' ' ' LEU . 3.3 mm-40 -129.65 33.14 4.5 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.965 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 79' ' ' CYS . 3.7 tptt -150.86 -88.79 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.503 -1.373 . . . . 0.0 111.042 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -134.55 154.87 79.9 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 110.102 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.33 -159.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.139 1.6 . . . . 0.0 110.622 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 53' ' ' VAL . 59.0 t -113.56 146.71 35.99 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.241 -0.912 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.595 ' O ' HD11 ' A' ' 56' ' ' LEU . 43.8 Cg_endo -86.97 -168.46 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.632 1.333 . . . . 0.0 109.472 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.427 ' HG3' ' C ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -124.88 15.21 8.6 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.004 -1.06 . . . . 0.0 111.361 -179.138 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 29.8 t -159.5 20.15 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.565 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.945 HD22 HD12 ' A' ' 94' ' ' LEU . 6.7 mt 58.98 123.94 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.731 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.701 ' O ' HG23 ' A' ' 95' ' ' VAL . 42.4 Cg_endo -71.55 150.17 56.89 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.876 1.461 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.85 -0.39 8.34 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.052 1.554 . . . . 0.0 111.459 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -105.37 12.03 32.08 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.243 -0.911 . . . . 0.0 109.209 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.945 HD12 HD22 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -135.66 -7.04 2.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.685 -0.635 . . . . 0.0 110.196 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 91' ' ' PRO . 11.2 t -90.41 133.22 33.43 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.825 -1.172 . . . . 0.0 110.572 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.468 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 41.0 Cg_endo -66.73 174.29 6.79 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.894 1.471 . . . . 0.0 110.569 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 47.1 Cg_endo -72.19 -14.04 28.54 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.023 1.538 . . . . 0.0 111.256 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.6 m -67.35 -23.15 65.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.026 -1.046 . . . . 0.0 110.088 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 12.42 29.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.476 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.572 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 110.588 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.534 ' O ' ' N ' ' B' ' 109' ' ' ASN . 1.3 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.322 0.582 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.437 ' OG1' ' C ' ' B' ' 107' ' ' SER . 0.1 OUTLIER 43.91 -89.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.487 -0.758 . . . . 0.0 111.007 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 107' ' ' SER . 6.0 t-20 48.38 82.38 0.24 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 109.333 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.556 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 50.6 Cg_endo -68.52 8.27 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.259 1.972 . . . . 0.0 112.573 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.954 ' CE2' HD12 ' A' ' 40' ' ' LEU . 2.0 m-85 -102.88 -67.49 0.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.545 -1.347 . . . . 0.0 108.577 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.509 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 2.0 mtt-85 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.121 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 N--CA 1.482 0.817 0 N-CA-C 110.391 -0.657 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.2 t90 -95.51 123.43 39.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.091 -1.005 . . . . 0.0 109.95 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -41.63 -32.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 110.298 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.634 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 69.9 t -102.99 136.92 33.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 109.598 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.453 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mtmt -88.42 175.09 4.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 110.24 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.5 Cg_endo -70.21 -34.37 13.19 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.975 1.513 . . . . 0.0 109.745 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -77.08 -22.44 52.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.743 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 3.1 m-20 -82.93 -36.78 24.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.81 . . . . 0.0 109.132 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -80.5 -24.51 39.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -65.84 -39.78 91.12 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.0 ptpt -74.71 -28.67 60.9 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.4 m-30 -70.58 -36.71 73.72 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -63.8 -20.48 65.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.71 -0.619 . . . . 0.0 110.15 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.63 -36.1 33.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 47.8 mt -78.43 -31.43 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.814 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.48 -32.53 68.37 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -87.49 -5.61 58.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.579 -0.7 . . . . 0.0 109.859 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -85.46 -8.49 58.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 0.0 109.085 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.091 HD12 ' CD1' ' A' ' 31' ' ' LEU . 7.2 mt -100.4 -16.87 17.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.627 -0.671 . . . . 0.0 109.316 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.5 t 88.74 89.03 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 121.358 0.599 . . . . 0.0 109.877 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.7 Cg_endo -73.33 151.37 48.33 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.552 1.817 . . . . 0.0 110.854 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 55.9 t -121.3 104.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.89 18.09 11.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.439 -0.788 . . . . 0.0 109.413 -178.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.85 34.16 6.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.18 137.82 32.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 112.017 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.091 ' CD1' HD12 ' A' ' 24' ' ' LEU . 7.9 mt -110.3 158.5 18.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 35' ' ' LYS . 8.2 p -104.07 143.79 32.43 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.624 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.76 -25.78 0.65 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -70.85 -25.24 62.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.571 -0.958 . . . . 0.0 110.314 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB3' HD13 ' A' ' 24' ' ' LEU . 35.1 mttm -88.56 -36.01 16.6 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.915 HG12 ' CD1' ' A' ' 40' ' ' LEU . 81.2 t -77.22 -41.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.08 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.51 -51.65 6.48 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.518 -0.739 . . . . 0.0 111.026 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.9 Cg_endo -70.62 -34.27 12.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.369 1.194 . . . . 0.0 109.878 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.51 -32.56 53.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.934 HD12 ' CE2' ' B' ' 111' ' ' PHE . 23.7 mt -90.56 -29.34 17.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.587 -0.696 . . . . 0.0 109.977 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD11 ' HE2' ' A' ' 37' ' ' LYS . 33.5 mt -69.75 -9.55 54.93 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -90.65 -8.68 49.37 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.565 -0.71 . . . . 0.0 111.173 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.535 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 84.5 p -82.18 15.36 2.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -0.976 . . . . 0.0 110.652 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.18 14.03 3.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -0.99 . . . . 0.0 110.197 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.86 HD22 HG13 ' A' ' 49' ' ' ILE . 17.5 mt -98.16 157.89 33.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.977 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.0 Cg_endo -74.88 166.71 28.67 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 124.067 1.562 . . . . 0.0 109.228 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' B' ' 111' ' ' PHE . 13.9 t -68.26 -6.97 6.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -30.0 58.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.876 -1.14 . . . . 0.0 109.143 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.86 HG13 HD22 ' A' ' 45' ' ' LEU . 7.5 mm -83.81 -40.06 15.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -71.02 -30.6 66.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' B' ' 109' ' ' ASN . . . -72.18 -26.22 72.73 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.3 ttm-85 -100.12 -28.41 13.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.825 -0.809 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.825 HG11 ' CG2' ' A' ' 77' ' ' VAL . 10.3 t -74.18 -34.7 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.624 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.1 t-105 -66.74 -53.05 37.4 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.131 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.6 mt-10 -48.65 -58.36 4.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.941 HD21 ' C ' ' A' ' 88' ' ' MET . 2.7 mt -62.65 -13.09 27.83 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.069 -1.053 . . . . 0.0 108.773 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.688 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -91.81 -42.72 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.255 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' TRP . 11.6 t0 -66.04 78.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.492 -0.755 . . . . 0.0 110.395 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.509 HG12 ' HG3' ' A' ' 69' ' ' GLU . 42.8 mm -51.47 -27.72 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.41 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.496 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 2.4 m-20 -102.84 -20.18 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.29 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.496 ' CD2' ' C ' ' A' ' 60' ' ' ASP . 9.1 m-70 59.89 47.1 10.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 33.4 p-10 -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.063 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 86.45 28.9 26.02 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.1 mtt -150.24 161.44 42.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 111.09 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.651 HD13 ' HA ' ' A' ' 70' ' ' PHE . 7.6 mt -130.99 109.72 10.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.842 . . . . 0.0 110.072 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 1.8 m-20 -69.8 159.34 33.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.981 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -41.21 -42.19 2.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.503 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 57.8 t0 -82.4 -33.3 28.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.5 tt0 -69.11 -50.46 47.89 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.171 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.651 ' HA ' HD13 ' A' ' 65' ' ' LEU . 57.3 t80 -55.93 -22.84 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.17 -48.67 67.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.455 -0.778 . . . . 0.0 110.055 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.579 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 76.9 t -58.27 -24.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.528 -0.732 . . . . 0.0 110.132 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.688 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -84.86 -13.36 51.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.246 -0.909 . . . . 0.0 112.166 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.2 mmm -85.92 -36.07 20.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.545 -1.347 . . . . 0.0 110.732 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.634 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 5.0 p90 -79.08 -26.3 43.02 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.611 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.761 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.8 mt -71.72 -22.33 61.65 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.825 ' CG2' HG11 ' A' ' 53' ' ' VAL . 72.6 t -90.82 -32.89 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.639 -0.663 . . . . 0.0 110.142 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -78.36 -23.24 47.02 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.441 -0.787 . . . . 0.0 110.045 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -83.02 -13.79 55.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.639 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.686 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.49 -14.18 41.09 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.189 -0.944 . . . . 0.0 109.125 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.821 HD21 ' CD1' ' A' ' 45' ' ' LEU . 9.6 mt -92.35 -45.91 7.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.602 -0.686 . . . . 0.0 110.844 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.54 -11.17 9.96 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.505 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 8.8 mmtt -106.97 -88.14 0.47 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.424 -1.422 . . . . 0.0 111.488 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 79' ' ' CYS . 7.4 mm-40 -145.42 167.77 13.61 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.862 . . . . 0.0 109.843 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 84' ' ' GLU . 37.3 Cg_endo -62.44 -176.69 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.843 1.444 . . . . 0.0 110.428 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.744 HG21 ' CG2' ' A' ' 53' ' ' VAL . 84.8 t -115.07 122.18 33.86 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 111.024 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.786 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.1 Cg_endo -81.55 -167.09 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.964 1.507 . . . . 0.0 109.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.941 ' C ' HD21 ' A' ' 56' ' ' LEU . 14.7 mtp -120.04 18.66 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.02 . . . . 0.0 110.338 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 56' ' ' LEU . 66.6 m -101.06 118.02 36.16 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.79 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 56' ' ' LEU . 2.1 mt -100.72 75.57 0.13 Allowed Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.07 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.718 ' HG2' HD12 ' A' ' 94' ' ' LEU . 41.1 Cg_endo -66.65 175.86 4.83 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.594 1.313 . . . . 0.0 110.749 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.1 Cg_endo -70.52 -7.16 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 124.019 1.536 . . . . 0.0 111.04 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.33 -8.62 58.62 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.352 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -125.78 5.71 7.4 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.382 -0.824 . . . . 0.0 110.467 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 91' ' ' PRO . 87.4 t -103.26 122.16 46.2 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.099 -1.0 . . . . 0.0 111.466 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.551 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.0 Cg_endo -70.33 179.43 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.988 1.52 . . . . 0.0 109.217 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 50.3 Cg_endo -78.9 28.74 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.49 1.258 . . . . 0.0 111.657 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.35 -42.23 5.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.837 -1.165 . . . . 0.0 109.226 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 59' ' ' ILE . 1.7 tttp -90.02 12.25 18.18 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.773 . . . . 0.0 110.352 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' B' ' 108' ' ' THR . 1.3 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.249 0.547 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.482 ' O ' ' HB3' ' B' ' 109' ' ' ASN . 11.8 m 55.94 110.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLY . 35.1 t-20 59.1 91.68 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.522 ' HD2' ' CE1' ' B' ' 111' ' ' PHE . 49.5 Cg_endo -69.54 3.04 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.32 1.695 . . . . 0.0 111.77 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.934 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -104.16 -62.92 1.25 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.776 -1.202 . . . . 0.0 108.903 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.457 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.168 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.487 1.119 0 CA-C-O 121.519 0.549 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.7 t90 -70.35 123.52 21.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.597 -0.689 . . . . 0.0 109.725 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.674 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -45.44 -26.36 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.293 -0.879 . . . . 0.0 110.207 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.4 t -102.7 137.97 28.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.45 -0.781 . . . . 0.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.507 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 5.5 mttt -110.71 176.04 1.67 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.411 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.711 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 39.6 Cg_endo -65.53 -38.13 26.66 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.94 1.495 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 12.4 pt-20 -67.94 -36.43 80.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.045 -1.035 . . . . 0.0 109.172 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -81.21 -37.8 28.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -76.17 -17.05 59.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -71.85 -40.87 68.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -75.69 -26.61 57.74 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.624 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -71.15 -34.32 70.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -21.67 64.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.662 -0.649 . . . . 0.0 110.265 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.2 33.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.052 -1.03 . . . . 0.0 108.414 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.669 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 69.9 mt -76.94 -30.93 18.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.826 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.85 -39.66 63.83 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.546 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t70 -86.45 2.57 47.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.558 -0.714 . . . . 0.0 110.096 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -89.53 -11.5 42.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.329 -0.857 . . . . 0.0 109.333 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.106 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -99.83 -15.14 18.51 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.608 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 t 86.01 81.68 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.299 0 CA-C-O 121.439 0.638 . . . . 0.0 109.674 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 44.6 Cg_endo -71.06 152.57 62.66 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.87 1.984 . . . . 0.0 111.103 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.1 t -118.92 117.22 53.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER 63.78 13.06 7.17 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.579 -178.051 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.51 34.1 8.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 23.1 m-85 -135.36 138.36 43.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -1.11 . . . . 0.0 111.647 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.106 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.1 mt -109.49 137.57 47.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 34' ' ' ASP . 3.9 p -85.06 142.28 29.67 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.105 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.31 -25.81 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . 32.8 t70 -69.18 -24.28 64.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.384 -1.069 . . . . 0.0 110.326 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 9.6 mttm -92.53 -35.35 13.64 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.018 -1.051 . . . . 0.0 108.17 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.847 HG12 ' CD1' ' A' ' 40' ' ' LEU . 96.3 t -75.32 -41.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.566 0.698 . . . . 0.0 110.403 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.79 -54.92 6.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 111.035 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.12 -32.48 34.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.443 1.233 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.844 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.3 t -63.84 -33.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.023 ' HB3' HD22 ' A' ' 50' ' ' LEU . 26.1 mt -89.92 -27.25 19.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 110.461 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 45.3 mt -68.26 -15.04 63.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -90.76 -2.45 57.8 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.708 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.596 ' O ' HD21 ' A' ' 81' ' ' LEU . 79.6 p -82.65 12.67 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.591 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 63.57 10.55 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.042 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.8 mt -100.46 159.11 30.59 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.391 -0.818 . . . . 0.0 110.486 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.1 Cg_endo -76.39 171.77 17.47 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.113 1.586 . . . . 0.0 109.415 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' B' ' 111' ' ' PHE . 4.5 t -71.92 -3.49 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.526 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.45 -30.87 42.34 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.156 -0.965 . . . . 0.0 109.097 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.878 HG13 HD22 ' A' ' 45' ' ' LEU . 8.8 mm -84.1 -39.6 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.023 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.8 mt -72.2 -26.44 62.05 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.563 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -74.53 -26.54 67.43 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.109 -1.997 . . . . 0.0 108.109 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.781 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.5 ttm180 -100.7 -25.47 14.13 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.92 -0.753 . . . . 0.0 110.215 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.083 HG11 HG23 ' A' ' 77' ' ' VAL . 13.6 t -74.27 -36.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.917 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.614 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.79 -48.17 67.06 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.15 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.3 mm-40 -52.55 -58.18 7.58 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 110.089 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.929 HD21 ' C ' ' A' ' 88' ' ' MET . 3.5 mt -62.85 -17.57 61.64 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.481 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.893 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 30.1 t -86.08 -30.59 22.48 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.4 t0 -71.12 101.36 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.543 -0.723 . . . . 0.0 109.683 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.593 HG23 ' HE2' ' A' ' 99' ' ' LYS . 47.8 mm -75.63 -42.4 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.613 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 31.2 p30 -104.41 -4.69 22.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.062 -1.024 . . . . 0.0 111.044 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 2.0 m-70 60.86 44.4 10.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.171 -0.955 . . . . 0.0 110.541 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 38.1 p30 -100.05 26.51 6.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.237 -0.914 . . . . 0.0 109.059 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 58.53 31.69 67.41 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.8 mtt -150.91 161.04 43.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -1.05 . . . . 0.0 110.357 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.824 HD12 HG11 ' A' ' 36' ' ' VAL . 16.0 mt -123.6 102.29 7.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -69.29 157.51 36.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 66' ' ' ASP . 14.2 ptt180 -37.06 -39.39 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.676 . . . . 0.0 110.81 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . 17.8 m-20 -79.51 -35.0 40.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 109.928 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 14.5 mt-10 -75.4 -40.95 57.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.963 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.0 t80 -62.62 -23.88 67.3 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.87 -44.79 63.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.465 -0.772 . . . . 0.0 110.13 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.64 ' O ' HD12 ' A' ' 76' ' ' LEU . 85.7 t -64.28 -22.16 30.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.022 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.81 -5.66 56.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmt -87.94 -44.44 11.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.828 -1.17 . . . . 0.0 109.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CD2' HG22 ' A' ' 9' ' ' VAL . 2.3 p90 -75.55 -26.64 58.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 72' ' ' VAL . 12.0 mt -67.53 -28.05 67.49 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.083 HG23 HG11 ' A' ' 53' ' ' VAL . 27.2 t -92.24 -60.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.411 0.624 . . . . 0.0 109.817 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.5 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.1 m-85 -46.62 -27.33 1.12 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.536 -0.727 . . . . 0.0 111.391 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 56.9 m -81.61 -12.08 58.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 110.088 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.042 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.22 -12.53 37.78 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.392 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.779 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.4 mp -89.97 -43.47 10.53 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.516 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 3.3 mt-10 -73.52 -58.17 3.49 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.659 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 177.0 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.754 -0.591 . . . . 0.0 110.616 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 3.4 tt0 179.88 108.13 0.18 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.739 -1.226 . . . . 0.0 110.844 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 41.7 Cg_endo -67.99 163.53 35.42 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.838 1.441 . . . . 0.0 110.163 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.5 t -113.3 119.25 42.49 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.532 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.778 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.6 Cg_endo -85.34 -168.99 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.924 1.486 . . . . 0.0 109.81 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.929 ' C ' HD21 ' A' ' 56' ' ' LEU . 18.8 mtt -111.83 18.1 19.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.555 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 3.0 m -93.6 119.35 32.52 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.898 -1.121 . . . . 0.0 112.823 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.867 HD21 ' O ' ' A' ' 56' ' ' LEU . 3.0 mt -101.02 75.4 0.13 Allowed Pre-proline 0 N--CA 1.489 1.518 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.846 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.555 ' CD ' ' O ' ' A' ' 89' ' ' SER . 39.6 Cg_endo -64.92 164.57 24.2 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.629 1.331 . . . . 0.0 110.021 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.596 ' O ' HG22 ' A' ' 95' ' ' VAL . 43.0 Cg_endo -71.08 -5.39 16.89 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.934 1.492 . . . . 0.0 110.699 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.448 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -82.47 9.58 8.92 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 109.055 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.674 HD23 ' HB3' ' A' ' 8' ' ' ALA . 39.5 mt -121.06 -21.14 6.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 110.748 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 92' ' ' PRO . 9.9 m -65.06 140.18 97.97 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 110.739 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 41.7 Cg_endo -69.55 175.53 7.8 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.073 1.565 . . . . 0.0 109.828 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 41.5 Cg_endo -68.26 -20.95 42.36 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.875 1.46 . . . . 0.0 110.867 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -29.43 68.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.048 -1.032 . . . . 0.0 109.907 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.593 ' HE2' HG23 ' A' ' 59' ' ' ILE . 11.0 mmmt -90.72 12.05 20.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.317 -0.864 . . . . 0.0 109.64 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 96' ' ' PRO . 40.5 mtt180 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.356 -0.84 . . . . 0.0 110.848 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.172 0.511 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.426 ' O ' ' C ' ' B' ' 109' ' ' ASN . 13.3 p -117.15 -43.74 2.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.13 -0.982 . . . . 0.0 110.356 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.7 t-20 -42.8 112.05 1.1 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.26 -0.9 . . . . 0.0 109.899 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.601 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.5 Cg_endo -70.99 1.08 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.939 1.494 . . . . 0.0 112.015 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.949 ' CE2' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -105.67 -59.79 1.72 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.658 -1.276 . . . . 0.0 109.21 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.501 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 N-CA-C 110.575 -0.587 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.801 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.8 t90 -92.58 126.81 37.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 110.08 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -48.26 -27.18 2.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 40.7 t -94.43 149.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.829 . . . . 0.0 110.312 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -104.24 170.22 6.35 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.511 -0.743 . . . . 0.0 109.731 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.15 -34.45 28.18 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.59 1.311 . . . . 0.0 109.926 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 2.1 pm0 -74.62 -25.67 59.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.917 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -81.37 -40.27 23.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 108.566 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -69.02 -13.07 62.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.6 mtmt -84.54 -37.93 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 5.8 m-30 -64.22 -23.38 67.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.93 -23.66 26.88 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.816 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.2 34.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.502 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 23.7 mt -79.46 -32.04 14.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.79 -40.15 66.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.2 t70 -85.85 1.19 50.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.652 -0.655 . . . . 0.0 109.79 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.451 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -92.91 -4.94 51.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.086 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.029 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -107.32 -6.98 16.87 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 82.76 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.8 Cg_endo -73.07 149.94 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.08 1.569 . . . . 0.0 110.998 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 54.3 t -117.62 103.47 14.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.5 OUTLIER 66.03 13.26 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.212 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 99.53 32.12 5.84 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 87.7 m-85 -143.09 153.91 43.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.271 . . . . 0.0 111.7 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.029 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -119.78 137.15 54.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 17.7 p -80.8 142.58 33.58 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.051 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.66 -27.05 0.3 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -66.11 -27.28 67.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -1.023 . . . . 0.0 110.457 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 51.7 mttp -92.3 -33.24 14.7 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.041 -1.037 . . . . 0.0 108.299 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 65' ' ' LEU . 60.4 t -82.32 -45.07 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.603 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.7 tttt -43.96 -52.78 14.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.763 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.1 Cg_endo -65.51 -33.72 45.34 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.39 1.205 . . . . 0.0 109.48 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -64.56 -38.39 82.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.042 ' HB3' HD22 ' A' ' 50' ' ' LEU . 59.3 mt -81.98 -30.06 31.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 38' ' ' PRO . 42.7 mt -73.43 -13.92 61.16 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -88.55 -8.97 53.87 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.929 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.549 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 4.3 p -80.07 9.46 5.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.254 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 67.34 12.93 9.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.139 HD11 ' HB3' ' A' ' 80' ' ' ALA . 17.0 mt -98.01 153.41 38.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 110.04 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.4 Cg_endo -75.01 171.84 17.54 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 123.994 1.523 . . . . 0.0 109.313 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.508 HG13 ' C ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.03 -6.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 109.467 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -77.53 -31.01 53.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.863 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.902 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -85.32 -41.17 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.042 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.2 mt -73.71 -28.79 61.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.22 -23.61 74.78 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.85 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.2 ttm180 -101.06 -37.94 8.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.933 -0.745 . . . . 0.0 109.552 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.005 HG11 HG23 ' A' ' 77' ' ' VAL . 21.1 t -64.06 -39.79 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.631 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.6 t-105 -67.13 -51.38 54.72 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.463 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 56.1 mt-10 -53.24 -56.46 16.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -61.33 -15.15 32.95 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.713 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 16.1 m -93.59 -33.97 13.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.522 -0.737 . . . . 0.0 109.527 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -67.72 69.1 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.452 -0.78 . . . . 0.0 110.056 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.795 HG23 ' HE2' ' A' ' 99' ' ' LYS . 34.2 mm -50.56 -30.33 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -106.71 -15.3 14.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.878 . . . . 0.0 109.889 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 93.1 m-70 57.31 45.72 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.362 -0.836 . . . . 0.0 111.66 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.47 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.6 p-10 -107.21 28.91 7.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.403 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 66.25 25.93 72.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 12.8 mtp -151.06 161.37 42.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 110.199 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.021 HD12 HG11 ' A' ' 36' ' ' VAL . 8.6 mt -122.03 110.31 15.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.863 . . . . 0.0 109.798 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.58 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 6.3 t0 -68.71 163.96 22.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -49.27 -30.38 7.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.182 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 35.8 t0 -86.83 -33.56 19.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 42.4 mt-10 -75.59 -43.79 46.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.968 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.5 t80 -54.39 -34.0 60.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -59.21 -57.29 13.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.57 0.7 . . . . 0.0 110.253 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.027 HG22 HD21 ' A' ' 94' ' ' LEU . 44.9 t -52.23 -22.8 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.15 -10.22 48.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.3 mmm -89.41 -44.3 10.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.472 -1.393 . . . . 0.0 110.608 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 2.9 p90 -76.04 -19.4 58.67 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.666 HD22 HG13 ' A' ' 86' ' ' VAL . 6.2 mt -79.33 -25.5 42.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.005 HG23 HG11 ' A' ' 53' ' ' VAL . 17.6 t -91.11 -41.8 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.68 -25.67 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.423 -0.798 . . . . 0.0 110.266 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 1.2 m -80.1 -14.8 58.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.139 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.67 -10.09 49.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.143 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 81' ' ' LEU . 4.5 mt -90.51 -41.76 11.23 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 32.7 mm-40 -69.64 -53.25 19.6 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.611 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.6 ttmt 176.6 -26.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.186 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -67.49 116.83 41.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.189 -0.944 . . . . 0.0 111.457 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.89 177.93 7.06 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.806 1.424 . . . . 0.0 109.42 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.666 HG13 HD22 ' A' ' 76' ' ' LEU . 31.2 t -128.49 121.32 21.25 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.957 -1.089 . . . . 0.0 111.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.659 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -85.53 166.64 10.44 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.86 1.453 . . . . 0.0 109.086 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.821 ' C ' HD21 ' A' ' 56' ' ' LEU . 6.6 mtp -90.36 14.25 13.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.921 -1.112 . . . . 0.0 110.477 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.493 ' N ' HD21 ' A' ' 56' ' ' LEU . 72.3 m -109.03 103.21 12.2 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.439 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.692 ' CD1' HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -62.95 109.55 2.56 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 38.7 Cg_endo -66.08 147.28 84.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.818 1.43 . . . . 0.0 111.19 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.01 -7.27 21.07 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.321 1.695 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -84.32 -30.77 25.26 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -93.14 -18.21 22.85 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.538 HG22 ' HD2' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -69.14 142.23 92.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 110.248 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HD2' HG22 ' A' ' 95' ' ' VAL . 44.4 Cg_endo -72.12 163.83 37.54 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.915 1.481 . . . . 0.0 110.508 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 45.2 Cg_endo -72.46 -32.5 9.9 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.111 1.585 . . . . 0.0 111.089 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.8 m -64.2 -24.24 67.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.964 -1.085 . . . . 0.0 110.068 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.795 ' HE2' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -96.61 13.08 29.42 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.291 -0.88 . . . . 0.0 109.417 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.851 . . . . 0.0 110.355 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.237 0.542 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.08 -12.89 13.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 110.394 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.488 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 27.1 t-20 -137.82 120.6 11.19 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.479 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.597 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -76.41 12.57 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.488 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.969 ' CE2' HD12 ' A' ' 40' ' ' LEU . 9.8 m-85 -107.27 -61.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.798 -1.189 . . . . 0.0 109.08 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.056 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.482 0.845 0 N-CA-C 110.143 -0.753 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.5 t90 -52.54 124.45 13.64 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.991 -1.068 . . . . 0.0 109.237 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.75 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -40.14 -27.97 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.34 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 25.5 t -97.98 126.17 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 109.757 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.8 mttp -82.12 173.66 7.27 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 110.45 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.2 Cg_endo -68.31 -33.96 22.49 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.091 1.574 . . . . 0.0 109.387 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.01 -18.95 48.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.546 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.82 -43.19 15.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.91 61.59 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.09 61.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.47 -23.52 50.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.621 ' CD2' ' HB2' ' A' ' 74' ' ' MET . 9.9 m-30 -74.98 -33.96 61.94 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 5.1 m-20 -69.98 -22.27 63.16 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.734 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -78.23 -32.97 50.04 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.684 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 44.7 mt -81.55 -32.7 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.792 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.36 -31.58 64.02 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.6 t0 -90.83 -3.22 57.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 71.6 p -87.84 -8.51 55.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 31' ' ' LEU . 8.5 mt -98.81 -14.88 19.48 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.624 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 p 94.52 91.41 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.296 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.4 Cg_endo -72.73 147.27 44.63 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.194 1.628 . . . . 0.0 110.638 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 77.1 t -115.22 100.27 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 64.47 15.26 9.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 109.69 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.24 32.53 5.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 75.5 m-85 -145.63 148.75 33.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.17 . . . . 0.0 111.59 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 24' ' ' LEU . 10.2 mt -115.0 159.03 21.26 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 35' ' ' LYS . 86.4 p -104.52 143.8 32.55 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.031 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.646 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.7 -25.32 0.86 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' SER . 1.6 t70 -71.67 -23.69 61.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.954 . . . . 0.0 110.354 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.3 mttp -92.36 -33.06 14.73 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.011 -1.055 . . . . 0.0 108.257 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG12 ' CD1' ' A' ' 40' ' ' LEU . 89.2 t -77.54 -38.42 26.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.296 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -42.54 -54.5 8.1 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -65.81 -32.62 45.88 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.622 1.327 . . . . 0.0 109.56 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.53 -31.97 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.978 ' HB3' HD22 ' A' ' 50' ' ' LEU . 27.2 mt -92.91 -30.48 15.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.496 -0.753 . . . . 0.0 110.269 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.443 HD11 ' HE3' ' A' ' 37' ' ' LYS . 57.5 mt -72.39 -12.11 60.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -90.79 -9.63 45.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.417 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.54 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 92.2 p -81.32 11.0 4.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.363 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.59 14.75 9.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.998 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.4 mt -96.76 154.35 38.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.828 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.0 Cg_endo -75.38 169.26 22.81 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.939 1.494 . . . . 0.0 109.072 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.535 HG13 ' C ' ' B' ' 111' ' ' PHE . 2.1 t -69.87 -3.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.965 -1.085 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.63 -27.77 40.96 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.161 -0.962 . . . . 0.0 109.235 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.908 HG13 HD22 ' A' ' 45' ' ' LEU . 7.3 mm -87.81 -36.94 10.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -76.23 -27.19 56.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -74.08 -25.84 70.19 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.655 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.7 ttm-85 -101.19 -31.19 11.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.048 -0.678 . . . . 0.0 110.242 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.711 HG11 HG23 ' A' ' 77' ' ' VAL . 13.1 t -70.5 -34.27 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.044 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.646 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 5.1 t-105 -68.17 -56.78 7.51 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.262 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 3.4 mm-40 -43.17 -64.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.35 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.864 HD21 ' C ' ' A' ' 88' ' ' MET . 4.6 mt -55.6 -20.01 12.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.952 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.87 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 57.8 m -91.61 -19.84 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.479 -0.763 . . . . 0.0 109.403 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.9 t0 -96.1 86.19 4.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.512 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -91.05 -13.93 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.63 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 11.1 m-20 -92.36 -12.65 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 56.8 47.11 18.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 110.648 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 21.9 p-10 -128.12 25.47 5.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.17 38.44 93.15 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.51 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 6.7 mtt -150.37 161.08 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -1.162 . . . . 0.0 111.981 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 HG21 ' A' ' 36' ' ' VAL . 13.9 mt -125.45 103.69 8.03 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.41 160.4 32.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.997 -1.065 . . . . 0.0 110.682 -179.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.437 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ptm180 -36.48 -44.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.774 -0.579 . . . . 0.0 111.392 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 t70 -79.53 -31.93 42.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.662 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.465 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 28.0 mt-10 -76.03 -45.38 34.69 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.079 -1.013 . . . . 0.0 109.134 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.768 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.6 t80 -58.19 -18.47 26.17 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.29 -45.82 37.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.444 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.562 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.7 t -59.78 -26.12 34.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 109.538 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.87 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.79 -5.61 55.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 111.193 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.621 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.2 mmt -84.43 -49.53 8.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.923 -1.111 . . . . 0.0 109.839 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.1 p90 -73.79 -28.26 61.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.605 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.1 mt -64.54 -28.23 69.5 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.829 HG21 ' CD2' ' A' ' 40' ' ' LEU . 45.8 t -91.25 -23.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.828 -0.545 . . . . 0.0 110.591 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.4 -23.22 23.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -0.972 . . . . 0.0 109.802 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.3 m -84.12 -12.85 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.998 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.86 -14.31 39.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.804 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.7 mt -91.27 -39.93 11.79 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.853 0.835 . . . . 0.0 109.188 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 6.5 tp10 -68.15 -57.38 6.14 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.515 0.674 . . . . 0.0 109.462 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 177.14 -22.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 111.246 179.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' CYS . 4.0 mt-10 -70.86 118.18 62.84 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 110.845 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.99 165.38 32.76 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.808 1.425 . . . . 0.0 109.802 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.665 HG11 HG23 ' A' ' 53' ' ' VAL . 95.7 t -111.91 129.09 24.56 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.2 -0.938 . . . . 0.0 110.015 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.6 Cg_endo -90.16 -161.73 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.763 1.402 . . . . 0.0 109.642 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.864 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -130.19 3.08 4.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.49 -0.756 . . . . 0.0 109.566 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.572 ' N ' HD21 ' A' ' 56' ' ' LEU . 67.7 m -105.7 102.21 11.68 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.597 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 56' ' ' LEU . 4.7 mt -52.01 106.05 0.6 Allowed Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.61 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.6 Cg_endo -69.82 165.34 31.36 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.835 1.439 . . . . 0.0 110.298 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.78 -25.93 16.46 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.156 1.608 . . . . 0.0 111.332 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.7 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -84.96 6.3 25.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.952 -1.092 . . . . 0.0 109.689 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.75 HD13 ' HB3' ' A' ' 8' ' ' ALA . 4.5 mm? -117.45 -0.19 12.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 111.061 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.94 138.02 21.03 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.06 -1.025 . . . . 0.0 111.534 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.494 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.5 Cg_endo -70.07 176.0 7.59 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.202 1.633 . . . . 0.0 109.594 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.0 Cg_endo -70.16 -11.06 29.63 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.548 1.288 . . . . 0.0 110.808 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 t -80.42 -12.5 59.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.035 -1.041 . . . . 0.0 109.64 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 34.7 tptt -89.55 -4.67 57.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.483 -0.761 . . . . 0.0 109.216 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 110.48 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.531 ' O ' ' N ' ' B' ' 109' ' ' ASN . 1.7 t . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.19 0.519 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' B' ' 107' ' ' SER . 25.0 m 63.26 -64.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.513 -0.742 . . . . 0.0 110.994 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.533 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 0.9 OUTLIER 59.44 148.82 0.08 OUTLIER Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.193 -0.942 . . . . 0.0 109.067 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.662 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 41.7 Cg_endo -72.38 -2.42 11.69 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.168 1.088 . . . . 0.0 109.922 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.909 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.5 -66.72 0.99 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.911 -1.118 . . . . 0.0 108.792 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.455 ' HB2' ' HB2' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.261 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 N--CA 1.484 0.942 0 N-CA-C 110.663 -0.553 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 -86.18 131.13 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.436 -0.79 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.74 -27.66 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 111.126 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 53.7 t -91.76 147.19 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 9.3 mttm -104.06 176.32 1.83 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.548 -0.72 . . . . 0.0 109.788 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.7 Cg_endo -67.89 -35.44 20.91 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.769 1.405 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.3 pt-20 -74.75 -29.08 61.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 35.3 m-20 -82.2 -33.14 29.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.296 -0.878 . . . . 0.0 109.07 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 14' ' ' LYS . 1.1 tmtt? -78.17 -13.21 59.95 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.199 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.29 -41.98 26.85 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.628 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.82 -26.2 61.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -73.32 -35.52 66.08 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.74 -23.56 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.831 -0.543 . . . . 0.0 109.765 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -79.14 -34.88 42.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.613 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 42.0 mt -79.35 -31.55 14.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.94 -36.71 59.26 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -90.4 3.98 52.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 0.0 109.609 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -91.9 -9.35 43.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 108.967 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.079 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -104.8 -8.05 19.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 87.2 99.89 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.043 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 47.2 Cg_endo -70.68 146.72 55.25 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.453 1.765 . . . . 0.0 110.425 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.3 t -115.7 96.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.47 20.45 12.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 94.14 33.84 6.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 85.4 m-85 -150.24 145.69 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -1.191 . . . . 0.0 111.737 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.079 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.9 mt -112.8 149.22 33.36 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.487 ' CA ' ' SD ' ' A' ' 64' ' ' MET . 24.8 p -99.22 144.86 27.86 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.182 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -40.96 -27.52 0.19 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.2 m-20 -65.38 -23.97 67.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -1.079 . . . . 0.0 110.407 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 69.8 mttt -99.22 -31.8 11.54 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.077 -1.014 . . . . 0.0 108.941 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.871 HG11 HD12 ' A' ' 65' ' ' LEU . 95.2 t -79.72 -42.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -42.0 -55.0 6.65 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.848 . . . . 0.0 110.868 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.84 -32.83 35.54 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.494 1.26 . . . . 0.0 109.866 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.6 t -65.22 -28.96 45.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.042 ' HB3' HD22 ' A' ' 50' ' ' LEU . 38.0 mt -92.95 -26.21 17.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.52 -0.737 . . . . 0.0 110.342 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 74.2 mt -73.5 -9.09 58.33 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.193 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.22 -4.13 57.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.944 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.576 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -84.65 10.38 11.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.1 -1.0 . . . . 0.0 110.283 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.9 OUTLIER 66.85 7.62 5.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 109.979 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.071 HD13 HG21 ' A' ' 49' ' ' ILE . 13.9 mt -94.58 157.12 37.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.9 Cg_endo -77.0 176.4 10.18 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.079 1.568 . . . . 0.0 109.841 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.524 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.3 t -73.25 -4.44 5.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.14 -29.89 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.924 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.071 HG21 HD13 ' A' ' 45' ' ' LEU . 8.5 mm -86.37 -40.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.042 HD22 ' HB3' ' A' ' 40' ' ' LEU . 19.5 mt -76.3 -28.32 56.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.49 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -70.12 -25.16 75.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.3 ttm105 -101.46 -34.09 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.117 -0.637 . . . . 0.0 110.043 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.776 HG11 HG23 ' A' ' 77' ' ' VAL . 24.5 t -67.37 -36.01 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.92 -1.113 . . . . 0.0 108.889 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.583 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.9 t-105 -66.82 -53.57 31.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.16 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 8.2 mt-10 -47.27 -58.04 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.126 -0.984 . . . . 0.0 110.396 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -63.04 -12.66 27.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.049 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.655 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 47.0 m -94.97 -40.43 9.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 61.9 t0 -84.36 70.84 10.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 110.01 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.636 HG23 ' HE2' ' A' ' 99' ' ' LYS . 5.0 mt -61.04 -16.5 14.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 110.492 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 26.1 m-20 -91.98 -15.53 27.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.68 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 88.0 m-70 51.27 34.19 11.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.2 p-10 -103.03 4.68 37.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.993 . . . . 0.0 110.042 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 86.89 26.62 31.24 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.2 mmm -148.3 161.65 41.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.217 -1.167 . . . . 0.0 110.036 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.871 HD12 HG11 ' A' ' 36' ' ' VAL . 12.1 mt -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.301 -0.874 . . . . 0.0 109.657 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.579 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 21.7 t0 -69.07 167.11 16.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.268 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 6.7 ptm180 -49.86 -39.23 38.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -35.49 38.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 109.448 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 40.3 mt-10 -72.56 -47.04 51.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 109.166 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.918 ' CD2' HD12 ' A' ' 31' ' ' LEU . 26.2 t80 -57.86 -26.79 62.55 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.491 -0.756 . . . . 0.0 109.028 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -68.47 -48.53 64.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.881 . . . . 0.0 110.115 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.98 HG13 HD12 ' A' ' 94' ' ' LEU . 60.7 t -58.34 -22.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.688 -0.633 . . . . 0.0 109.847 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -88.5 -12.49 42.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.747 . . . . 0.0 111.96 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.7 mmm -85.6 -40.36 16.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.656 -1.277 . . . . 0.0 110.472 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.105 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.3 p90 -77.9 -25.19 48.34 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.788 -1.165 . . . . 0.0 107.894 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 4.6 mt -73.19 -20.13 60.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.544 0.688 . . . . 0.0 109.212 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.776 HG23 HG11 ' A' ' 53' ' ' VAL . 42.2 t -91.59 -49.82 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.849 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.593 ' HA ' HD23 ' A' ' 81' ' ' LEU . 3.4 m-85 -64.16 -41.07 97.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.471 -0.768 . . . . 0.0 110.711 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 59.9 m -80.67 -9.16 59.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.399 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -92.97 -31.93 14.72 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.129 0.966 . . . . 0.0 109.136 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.596 ' N ' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -90.33 -23.24 21.19 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.638 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.488 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 4.6 tp10 -70.11 -57.41 4.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.02 . . . . 0.0 109.855 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 22.4 ttmt -178.06 57.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.619 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 1.8 tt0 -165.87 139.5 3.59 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.021 -1.05 . . . . 0.0 110.726 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HD2' ' HG3' ' A' ' 84' ' ' GLU . 51.1 Cg_endo -78.79 168.93 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.97 1.511 . . . . 0.0 110.458 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 80.0 t -121.09 126.01 26.77 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.649 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.9 Cg_endo -85.16 152.96 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.846 1.446 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.574 ' C ' HD21 ' A' ' 56' ' ' LEU . 24.8 mtm -88.13 17.58 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 38.9 m -113.41 99.9 8.13 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.836 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.745 HD11 ' O ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -57.31 106.93 0.76 Allowed Pre-proline 0 C--N 1.291 -1.96 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.649 178.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.023 ' HG2' HD23 ' A' ' 94' ' ' LEU . 43.2 Cg_endo -68.66 161.58 44.68 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.868 1.457 . . . . 0.0 110.148 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.95 -16.1 25.96 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.906 1.477 . . . . 0.0 110.965 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.583 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -91.84 26.22 2.48 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 108.753 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.105 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -128.6 -31.35 2.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.625 -0.672 . . . . 0.0 110.903 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 95' ' ' VAL . 18.3 m -81.52 142.95 50.5 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 110.642 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.7 168.93 18.67 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.191 1.627 . . . . 0.0 109.33 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 44.6 Cg_endo -71.01 56.39 1.92 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.655 1.345 . . . . 0.0 110.577 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.08 -47.24 0.27 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.636 ' HE2' HG23 ' A' ' 59' ' ' ILE . 2.4 tmtm? -90.28 7.14 39.82 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.053 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.0 p . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.16 0.505 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' B' ' 110' ' ' PRO . 29.8 m -165.66 -57.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 110.349 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 16.6 t-20 -51.98 106.93 0.72 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 110.067 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 51.2 Cg_endo -71.62 5.54 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.165 1.613 . . . . 0.0 112.01 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.931 ' CE2' HD12 ' A' ' 40' ' ' LEU . 6.9 m-85 -101.66 -62.83 1.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.658 -1.276 . . . . 0.0 109.167 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.362 179.685 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 N--CA 1.483 0.879 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -88.85 120.89 30.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.578 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.572 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -42.58 -28.06 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.97 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.7 t -97.42 152.6 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 110.045 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.0 mmmt -105.9 171.81 4.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.923 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.9 Cg_endo -67.61 -35.48 22.33 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.753 1.397 . . . . 0.0 109.46 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.21 -31.01 68.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -81.53 -33.72 31.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 10.9 tptp -74.76 -16.35 60.73 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.68 -38.65 47.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -78.52 -25.02 45.45 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.611 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.2 m-30 -75.33 -37.51 60.68 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 30.5 t70 -69.17 -18.58 63.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.653 -0.654 . . . . 0.0 109.655 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -83.08 -39.06 21.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.695 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.9 mt -75.14 -34.13 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.721 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -68.6 -41.17 79.96 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t70 -84.89 -0.64 54.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.587 -0.696 . . . . 0.0 109.905 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 36.7 t -86.49 -9.68 55.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.267 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.115 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -100.75 -11.4 19.94 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.09 93.79 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.538 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 48.5 Cg_endo -74.25 151.06 43.07 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.385 1.729 . . . . 0.0 110.905 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -120.8 98.5 6.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 69.34 22.12 6.7 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.693 0.758 . . . . 0.0 109.207 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.85 37.43 7.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.559 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 71.9 m-85 -147.2 140.38 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -1.159 . . . . 0.0 111.766 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.115 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.6 mt -110.09 137.79 47.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -84.42 142.53 30.04 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.846 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.54 -25.87 0.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -70.01 -24.21 63.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.588 -0.948 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.4 mttp -91.69 -35.12 14.36 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.95 HG11 HD12 ' A' ' 65' ' ' LEU . 90.8 t -79.68 -48.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.444 0.64 . . . . 0.0 110.296 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.61 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 9.0 tttp -38.94 -55.24 2.9 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.582 -0.699 . . . . 0.0 110.8 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.8 Cg_endo -66.18 -29.8 47.0 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.576 1.303 . . . . 0.0 110.025 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -70.59 -31.74 47.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.522 -0.736 . . . . 0.0 109.07 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.947 ' HB3' HD22 ' A' ' 50' ' ' LEU . 32.9 mt -85.44 -28.63 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -0.822 . . . . 0.0 109.772 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 38' ' ' PRO . 69.8 mt -69.63 -11.29 60.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.02 -5.01 57.09 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.769 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -81.97 14.52 2.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 110.144 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.73 15.34 1.56 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.812 -1.18 . . . . 0.0 109.847 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.035 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.0 mt -101.08 156.13 35.5 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.4 Cg_endo -73.61 160.74 43.54 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 123.803 1.422 . . . . 0.0 109.409 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' B' ' 111' ' ' PHE . 38.2 t -63.26 -11.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.17 -0.957 . . . . 0.0 109.187 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -70.03 -29.73 66.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 108.815 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 45' ' ' LEU . 7.1 mm -82.97 -42.47 17.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.961 0.886 . . . . 0.0 108.733 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.947 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.5 mt -71.72 -30.81 66.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.509 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -68.09 -25.05 74.59 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.871 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -101.82 -34.1 9.55 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.062 -0.669 . . . . 0.0 110.491 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.979 HG11 HG23 ' A' ' 77' ' ' VAL . 40.8 t -65.62 -38.13 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.156 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.4 t-105 -68.68 -50.73 48.73 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.462 -0.774 . . . . 0.0 110.412 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.0 mm-40 -51.04 -52.12 46.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.973 -1.079 . . . . 0.0 110.194 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.871 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.9 mt -64.69 -11.61 37.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.099 -1.0 . . . . 0.0 108.543 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.052 ' OG ' HD21 ' A' ' 65' ' ' LEU . 1.6 p -93.37 -46.7 7.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' CG ' ' HA ' ' A' ' 61' ' ' HIS . 3.5 t0 -59.56 78.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 110.308 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 57' ' ' SER . 43.8 mm -54.48 -27.1 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.24 -0.913 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 34.1 p30 -108.62 -13.66 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 85.1 m-70 58.63 47.33 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 10.9 p-10 -110.51 16.51 21.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.854 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 77.43 29.92 54.88 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.0 mtt -149.44 161.36 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -1.198 . . . . 0.0 110.636 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.052 HD21 ' OG ' ' A' ' 57' ' ' SER . 8.3 mt -127.84 107.0 9.49 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 5.0 t0 -69.58 162.61 27.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -46.63 -40.46 13.05 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.577 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 2.5 p30 -76.34 -42.04 46.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 109.856 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 30.8 mt-10 -66.27 -41.04 90.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.612 0.72 . . . . 0.0 109.059 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.756 ' CD2' HD12 ' A' ' 31' ' ' LEU . 47.1 t80 -63.49 -21.38 66.29 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -71.93 -43.07 65.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.507 0.67 . . . . 0.0 109.689 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.787 HG13 HD12 ' A' ' 94' ' ' LEU . 59.1 t -62.29 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.715 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.28 -2.13 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.483 -0.761 . . . . 0.0 111.176 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.586 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.8 mmt -88.39 -46.46 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 109.487 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.859 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.2 p90 -76.56 -19.1 58.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.635 HD22 HG13 ' A' ' 86' ' ' VAL . 8.6 mt -77.13 -23.84 51.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.979 HG23 HG11 ' A' ' 53' ' ' VAL . 38.5 t -91.63 -46.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.654 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 1.4 m-85 -62.54 -28.89 70.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.536 -0.727 . . . . 0.0 111.514 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -82.26 -12.34 58.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.931 -1.106 . . . . 0.0 110.137 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.035 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.47 -19.62 38.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER -90.94 -42.32 10.64 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.733 0.778 . . . . 0.0 110.796 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 16.5 tp10 -68.88 -59.24 3.21 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.413 0.625 . . . . 0.0 110.214 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 176.06 47.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.479 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' CYS . 7.2 tp10 -151.02 110.28 3.06 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.737 -1.227 . . . . 0.0 110.856 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 41.1 Cg_endo -68.06 164.23 32.79 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.871 1.458 . . . . 0.0 109.794 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.635 HG13 HD22 ' A' ' 76' ' ' LEU . 76.0 t -110.78 119.62 45.73 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.135 -0.978 . . . . 0.0 110.63 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.791 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -82.78 175.01 9.1 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.968 1.51 . . . . 0.0 109.009 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.6 mtm -99.14 12.89 34.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.593 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 18.5 m -100.54 114.39 27.98 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.398 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.758 ' C ' HD12 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -99.93 87.71 0.76 Allowed Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 89' ' ' SER . 37.9 Cg_endo -63.11 173.78 3.73 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.252 1.301 . . . . 0.0 111.425 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.8 Cg_endo -72.2 -14.62 28.67 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.27 1.669 . . . . 0.0 110.726 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -75.02 -9.91 58.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.222 -0.924 . . . . 0.0 108.902 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.859 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.7 mm? -99.85 -22.05 15.48 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.522 -0.736 . . . . 0.0 110.341 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.662 HG13 ' HG2' ' A' ' 99' ' ' LYS . 71.0 t -68.75 126.62 92.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.307 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.33 169.52 21.43 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.933 1.491 . . . . 0.0 110.265 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.44 -21.63 22.48 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.067 1.562 . . . . 0.0 110.148 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.64 -12.53 60.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.202 -0.936 . . . . 0.0 109.563 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.662 ' HG2' HG13 ' A' ' 95' ' ' VAL . 19.7 tptt -89.49 -4.84 57.77 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.356 -0.84 . . . . 0.0 109.126 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 179.369 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.403 ' C ' ' OG1' ' B' ' 108' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.261 0.553 . . . . 0.0 110.17 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.413 ' O ' ' C ' ' B' ' 109' ' ' ASN . 0.2 OUTLIER -161.1 -172.9 3.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 0.0 110.032 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.473 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 14.7 t-20 -44.13 107.41 0.6 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.162 -0.961 . . . . 0.0 109.945 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.573 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.0 Cg_endo -69.81 2.68 3.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.139 1.599 . . . . 0.0 111.913 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.939 ' HB3' HG13 ' A' ' 47' ' ' VAL . 2.4 m-85 -103.49 -54.89 2.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.703 -1.248 . . . . 0.0 109.371 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.319 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.485 0.976 0 N-CA-C 110.646 -0.559 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CH2' ' HE2' ' A' ' 14' ' ' LYS . 11.2 t90 -88.54 128.95 35.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.903 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.846 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -49.13 -26.97 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 110.826 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.69 146.57 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.1 mttt -99.17 169.98 7.47 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.614 -0.679 . . . . 0.0 109.785 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -66.57 -35.12 30.73 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.609 1.321 . . . . 0.0 109.609 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.669 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.4 m-20 -79.61 -41.51 26.9 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.36 -16.16 63.85 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.736 0.779 . . . . 0.0 108.908 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.1 -37.91 57.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 3.1 mtmt -81.67 -40.32 23.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.4 m-30 -63.29 -23.61 67.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.3 t70 -85.54 -24.77 27.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.582 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.96 -32.4 39.9 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.667 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.0 mt -79.08 -35.24 17.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.843 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -70.06 -39.65 75.55 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.5 t0 -87.49 1.24 54.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 110.073 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 6.7 t -89.36 -7.03 56.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.0 109.069 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.101 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.6 mt -107.26 -13.06 15.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.39 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.6 Cg_endo -73.6 151.34 46.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.322 1.696 . . . . 0.0 110.975 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 48.4 t -116.58 115.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.2 t-20 56.77 17.9 3.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 108.816 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 91.73 37.63 6.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 73.3 m-85 -149.7 138.11 20.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.111 -1.229 . . . . 0.0 112.449 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.101 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -104.79 145.29 30.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 52.7 p -95.89 145.58 25.27 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 110.087 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -41.01 -27.57 0.2 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 79.1 m-20 -64.04 -26.17 68.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.386 -1.067 . . . . 0.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 49.3 mttm -96.84 -32.03 12.3 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.125 -0.984 . . . . 0.0 108.659 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.893 HG12 ' CD1' ' A' ' 40' ' ' LEU . 98.9 t -79.6 -43.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.551 -0.718 . . . . 0.0 110.73 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.808 ' HG2' HD11 ' A' ' 41' ' ' LEU . 15.2 tttt -43.18 -51.11 14.24 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 110.725 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -67.04 -32.02 35.63 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.213 1.112 . . . . 0.0 109.6 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.896 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.9 t -68.23 -29.94 46.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.978 ' HB3' HD22 ' A' ' 50' ' ' LEU . 50.5 mt -92.0 -32.34 15.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.491 -0.755 . . . . 0.0 110.867 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.808 HD11 ' HG2' ' A' ' 37' ' ' LYS . 22.9 mt -70.55 -14.0 62.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.062 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -90.39 -3.25 57.83 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.642 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.715 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -84.44 17.23 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.962 . . . . 0.0 110.299 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB2' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER 61.87 11.77 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.658 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.078 HD11 ' HB3' ' A' ' 80' ' ' ALA . 18.9 mt -100.82 153.18 37.88 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.9 Cg_endo -76.53 173.68 14.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.036 1.545 . . . . 0.0 109.522 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.515 HG11 ' O ' ' B' ' 111' ' ' PHE . 2.1 t -73.09 -3.86 4.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.91 -1.119 . . . . 0.0 109.383 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -78.24 -29.79 48.36 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.894 HG13 HD22 ' A' ' 45' ' ' LEU . 11.1 mm -85.84 -39.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.4 mt -75.19 -29.05 60.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -67.41 -26.12 73.62 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.928 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -101.16 -35.09 9.43 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.005 -0.703 . . . . 0.0 109.85 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 HG23 ' A' ' 77' ' ' VAL . 41.3 t -64.57 -39.66 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.081 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.609 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -65.74 -52.79 48.25 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.067 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mm-40 -56.0 -58.66 6.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.965 HD21 ' C ' ' A' ' 88' ' ' MET . 5.0 mt -56.14 -19.22 12.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.913 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.98 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 13.5 t -91.93 -35.67 13.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.577 0.703 . . . . 0.0 109.683 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 1.6 t0 -65.56 95.54 0.22 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 110.157 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.013 HG23 ' HG3' ' A' ' 99' ' ' LYS . 10.5 mm -67.7 -32.01 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.46 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 2.4 p30 -112.2 -13.67 13.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 110.818 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 16.1 m80 62.52 44.55 6.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.907 . . . . 0.0 110.472 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 64' ' ' MET . 57.4 p30 -95.98 5.87 50.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.547 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 85.31 22.76 50.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.547 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 4.0 mmm -148.47 161.55 41.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -1.144 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.757 HD12 HG11 ' A' ' 36' ' ' VAL . 13.8 mt -122.14 106.07 10.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.162 -0.961 . . . . 0.0 109.996 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' CB ' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -71.41 160.08 33.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.025 . . . . 0.0 110.232 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 25.7 ptt180 -39.66 -37.63 0.53 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.575 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 12.2 m-20 -83.07 -29.92 28.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -75.89 -47.93 23.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.896 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 20.6 t80 -61.71 -16.11 46.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.13 -50.21 13.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.395 -0.816 . . . . 0.0 109.842 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.655 ' O ' HD12 ' A' ' 76' ' ' LEU . 58.8 t -58.02 -28.73 34.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.523 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.98 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.15 -4.73 57.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 111.254 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 11.8 mmt -84.01 -47.6 10.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.979 -1.076 . . . . 0.0 110.121 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.672 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 3.0 p90 -75.08 -28.89 60.49 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.1 mt -67.1 -22.7 65.8 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.936 ' O ' HD12 ' A' ' 81' ' ' LEU . 49.4 t -91.5 -44.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.749 -0.594 . . . . 0.0 109.773 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.93 -25.43 62.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.508 -0.745 . . . . 0.0 110.873 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.575 ' CA ' ' HB3' ' A' ' 83' ' ' LYS . 17.1 m -82.38 -21.44 35.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.966 -1.084 . . . . 0.0 109.286 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.078 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.69 -11.1 59.84 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -91.13 -47.28 7.62 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.414 0.625 . . . . 0.0 110.568 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' A' ' 82' ' ' GLU . 2.8 tp10 -127.96 -6.79 5.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 111.772 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.575 ' HB3' ' CA ' ' A' ' 79' ' ' CYS . 0.7 OUTLIER -101.05 -90.82 0.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.446 -1.409 . . . . 0.0 111.405 -179.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.544 ' CG ' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -140.94 175.04 3.33 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.821 -1.174 . . . . 0.0 110.137 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 84' ' ' GLU . 42.3 Cg_endo -69.1 -162.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.829 1.436 . . . . 0.0 110.465 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 54.0 t -143.18 131.59 11.3 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.138 -0.976 . . . . 0.0 110.665 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.869 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -89.45 -163.81 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.981 1.516 . . . . 0.0 109.51 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.965 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 -0.86 11.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.27 -0.894 . . . . 0.0 110.547 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.6 ' N ' HD21 ' A' ' 56' ' ' LEU . 4.1 m -105.87 99.1 8.7 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.176 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.747 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -62.55 108.65 1.77 Allowed Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 1.006 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.2 Cg_endo -64.82 167.48 15.56 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.926 1.487 . . . . 0.0 111.443 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.15 -15.42 35.63 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.347 1.709 . . . . 0.0 111.502 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.804 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -87.17 5.35 38.37 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.999 -1.063 . . . . 0.0 109.553 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.006 HD23 ' HG2' ' A' ' 91' ' ' PRO . 3.9 mm? -123.13 1.84 9.2 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.274 -0.891 . . . . 0.0 110.834 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.655 ' HB ' HD11 ' A' ' 90' ' ' LEU . 7.9 p -124.81 135.98 27.39 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.071 -1.018 . . . . 0.0 110.699 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.68 168.93 21.33 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.026 1.54 . . . . 0.0 109.901 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 -5.57 17.31 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.791 1.416 . . . . 0.0 110.806 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.3 t -83.97 0.64 47.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.973 -1.079 . . . . 0.0 109.949 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 1.013 ' HG3' HG23 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -109.35 2.54 20.78 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.446 -0.783 . . . . 0.0 109.168 179.012 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 111.177 -179.519 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.239 0.542 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -81.85 80.89 8.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.504 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 23.2 t-20 -154.09 113.56 2.51 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.363 -0.836 . . . . 0.0 109.846 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.609 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.4 Cg_endo -72.35 1.39 6.17 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.843 1.443 . . . . 0.0 111.54 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.902 ' CE2' HD12 ' A' ' 40' ' ' LEU . 3.8 m-85 -101.19 -61.1 1.41 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.943 -1.098 . . . . 0.0 108.499 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.154 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.484 0.952 0 N-CA-C 109.929 -0.835 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.835 ' HE1' HD22 ' A' ' 94' ' ' LEU . 10.9 t90 -56.59 121.05 8.81 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.022 -1.049 . . . . 0.0 109.407 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.16 -25.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.512 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -96.31 146.98 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.951 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.8 mmtt -96.95 169.24 9.01 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.5 Cg_endo -69.95 -33.19 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.865 1.455 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.78 -27.38 31.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.496 -0.753 . . . . 0.0 109.548 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.59 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.1 m-20 -79.72 -30.46 40.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.634 ' HG2' ' HB1' ' A' ' 71' ' ' ALA . 2.9 tmtt? -81.9 -22.98 36.52 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.679 0.752 . . . . 0.0 109.112 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.56 85.46 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.9 -28.34 61.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -65.14 -36.14 83.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -22.39 64.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.673 -0.642 . . . . 0.0 109.847 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.69 -38.38 25.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.682 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 55.2 mt -76.09 -29.8 19.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.798 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.45 -39.36 67.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.553 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.8 t70 -87.19 2.09 51.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.306 0.574 . . . . 0.0 109.814 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.509 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -91.75 -6.12 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.831 0.824 . . . . 0.0 109.178 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.016 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -107.07 -7.76 16.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.565 -0.709 . . . . 0.0 109.26 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.73 84.59 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.977 0 CA-C-O 121.269 0.556 . . . . 0.0 109.61 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 45.7 Cg_endo -74.58 150.4 40.3 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.536 1.808 . . . . 0.0 110.93 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 53.9 t -117.43 119.16 60.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 27' ' ' VAL . 36.0 m120 55.88 18.71 3.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.662 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.08 33.27 9.75 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 57.9 m-85 -137.73 137.25 38.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.854 -1.38 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.016 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.8 mt -108.5 138.22 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 33' ' ' GLY . 20.8 p -86.0 144.37 27.64 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.177 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.629 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -45.64 -24.93 1.29 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 32' ' ' SER . 4.4 m-20 -70.95 -19.1 62.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.532 -0.981 . . . . 0.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 5.6 mttp -97.17 -34.97 10.93 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 65' ' ' LEU . 98.0 t -77.35 -42.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.864 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.17 -53.98 6.17 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.576 -0.702 . . . . 0.0 110.729 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -68.39 -30.97 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.558 1.294 . . . . 0.0 110.078 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.511 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -66.38 -37.47 79.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.551 -0.718 . . . . 0.0 109.295 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.973 ' HB3' HD22 ' A' ' 50' ' ' LEU . 25.1 mt -83.01 -24.79 32.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.564 -0.71 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.11 -10.88 60.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.699 -0.801 . . . . 0.0 108.918 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -89.79 -7.12 55.12 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.523 -0.735 . . . . 0.0 110.224 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.572 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -78.07 7.82 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 0.0 110.284 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.91 10.78 7.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 109.358 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.053 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.1 mt -98.72 156.84 35.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.449 -0.782 . . . . 0.0 109.823 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.4 Cg_endo -75.98 172.1 16.9 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.121 1.59 . . . . 0.0 109.289 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.5 t -71.72 -5.03 5.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.967 -1.083 . . . . 0.0 108.951 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.34 -29.01 59.83 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.873 HG21 HD13 ' A' ' 45' ' ' LEU . 8.5 mm -87.4 -37.74 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.973 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.8 mt -79.39 -28.28 41.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.16 -24.99 75.6 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.864 ' O ' HD12 ' A' ' 56' ' ' LEU . 6.7 ttm-85 -101.96 -33.78 9.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.109 -0.642 . . . . 0.0 110.014 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.991 HG11 HG23 ' A' ' 77' ' ' VAL . 8.7 t -70.9 -37.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.831 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.629 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.2 t-105 -63.64 -50.53 68.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.86 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.3 mt-10 -50.42 -55.1 17.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 109.925 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.864 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.51 -15.34 37.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 108.934 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.954 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.0 t -94.52 -41.47 9.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.537 -0.727 . . . . 0.0 109.513 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 t70 -75.92 95.02 3.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.617 -0.677 . . . . 0.0 110.72 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 3.7 mt -93.13 -16.2 7.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.13 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.7 m-20 -89.81 -5.04 57.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 109.552 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.5 p80 41.3 47.37 2.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.658 . . . . 0.0 110.941 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 28.3 p30 -129.05 26.4 5.49 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.218 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 59.37 42.12 97.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 2.6 mmt -149.35 161.22 42.49 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.318 -1.107 . . . . 0.0 111.514 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.04 HD12 HG21 ' A' ' 36' ' ' VAL . 43.3 mt -137.65 107.09 6.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.648 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -76.58 161.58 28.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 110.454 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -34.55 -46.89 0.3 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.735 -0.603 . . . . 0.0 111.584 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -78.01 -37.66 46.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.226 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 57' ' ' SER . 12.7 tt0 -66.91 -44.44 80.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.632 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.973 ' CD1' HD12 ' A' ' 31' ' ' LEU . 37.7 t80 -60.46 -21.89 62.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.656 -0.652 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.634 ' HB1' ' HG2' ' A' ' 14' ' ' LYS . . . -75.16 -37.98 61.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 109.813 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.927 ' CG1' HD11 ' A' ' 94' ' ' LEU . 38.0 t -66.46 -26.66 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.684 0.754 . . . . 0.0 109.733 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.954 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.39 -7.21 53.78 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 110.767 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.584 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.3 mmt -88.01 -47.45 8.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.922 -1.111 . . . . 0.0 110.256 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 2.2 p90 -75.98 -19.51 58.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.883 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.2 mt -74.27 -25.19 59.46 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.991 HG23 HG11 ' A' ' 53' ' ' VAL . 37.2 t -90.59 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.457 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -45.53 -24.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.692 -0.63 . . . . 0.0 111.273 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' GLU . 8.7 m -82.8 -18.84 39.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.964 -1.085 . . . . 0.0 110.009 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.053 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.43 -11.88 50.63 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.709 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.3 mp -90.51 -40.14 12.17 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.787 0.804 . . . . 0.0 108.871 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 51.5 mm-40 -69.63 -54.45 13.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.558 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 177.82 -22.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.92 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -83.74 116.87 66.81 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.783 -1.198 . . . . 0.0 111.431 -178.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.69 -168.51 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.791 1.416 . . . . 0.0 110.095 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.732 HG13 HD22 ' A' ' 76' ' ' LEU . 48.9 t -134.85 124.11 16.46 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.052 -1.03 . . . . 0.0 111.274 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.8 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.1 Cg_endo -85.06 174.31 7.34 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.919 1.484 . . . . 0.0 109.514 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.803 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.0 mtp -96.16 12.19 31.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 0.0 110.432 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.577 ' N ' HD21 ' A' ' 56' ' ' LEU . 15.1 m -109.34 102.9 11.77 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.881 -1.137 . . . . 0.0 110.779 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.887 ' CD1' HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -63.48 109.24 2.35 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 37.6 Cg_endo -63.69 145.27 91.02 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.931 1.49 . . . . 0.0 111.819 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.08 -4.49 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.509 1.794 . . . . 0.0 110.884 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -94.05 -15.53 24.7 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.934 0.873 . . . . 0.0 108.653 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.962 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -98.2 -15.32 19.92 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.854 HG23 HD11 ' A' ' 90' ' ' LEU . 1.2 t -79.46 141.38 56.76 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.187 -0.946 . . . . 0.0 110.168 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 44.4 Cg_endo -71.74 171.95 15.44 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.11 1.584 . . . . 0.0 110.344 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 46.4 Cg_endo -73.65 0.39 8.24 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.94 1.495 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 p -90.93 -29.28 17.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.985 . . . . 0.0 109.843 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HD3' HG21 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -89.49 6.26 41.69 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.343 -0.848 . . . . 0.0 109.397 179.162 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 1.1 mtt180 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.316 -0.865 . . . . 0.0 110.52 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.42 ' C ' ' OG1' ' B' ' 108' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.177 0.513 . . . . 0.0 110.074 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.42 ' OG1' ' C ' ' B' ' 107' ' ' SER . 0.2 OUTLIER -162.41 169.78 19.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.5 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.455 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 25.1 t-20 -103.27 117.08 61.09 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 109.62 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.621 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.6 Cg_endo -74.17 7.59 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.866 1.456 . . . . 0.0 111.881 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.96 ' CE2' HD12 ' A' ' 40' ' ' LEU . 6.6 m-85 -107.14 -65.55 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.763 -1.21 . . . . 0.0 108.713 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.421 ' NH2' ' OE2' ' A' ' 55' ' ' GLU . 6.2 mtm180 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.289 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 N--CA 1.482 0.848 0 N-CA-C 109.927 -0.836 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.707 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.0 t90 -63.12 120.62 11.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 109.928 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.545 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.84 -26.16 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 43.9 t -101.19 151.03 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.237 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 31.5 mttt -111.67 169.37 6.4 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.324 -0.86 . . . . 0.0 109.792 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 37.5 Cg_endo -63.86 -35.26 57.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.616 1.324 . . . . 0.0 110.119 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -69.46 -30.03 67.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.387 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -82.35 -39.27 23.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.659 ' HZ2' ' HH2' ' A' ' 7' ' ' TRP . 14.8 tptm -72.28 -15.72 61.91 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.14 -39.65 54.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.03 -25.64 40.1 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.0 m-30 -72.27 -35.19 68.68 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.39 -20.23 62.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.837 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -81.89 -38.31 25.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.647 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 68.6 mt -76.2 -29.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.887 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.9 -36.68 67.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.514 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.5 t70 -90.45 0.86 57.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.728 -0.607 . . . . 0.0 110.186 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 34.0 t -88.77 -8.0 55.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.137 -0.977 . . . . 0.0 109.148 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.084 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.2 mt -106.76 -10.94 15.92 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 86.55 97.24 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.3 Cg_endo -74.02 149.69 42.09 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.214 1.639 . . . . 0.0 111.0 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 62.1 t -124.7 108.34 20.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 62.44 15.67 7.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.241 -179.035 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 92.51 38.04 5.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 81.5 m-85 -148.52 144.59 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 111.976 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.084 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.6 mt -112.14 131.13 55.63 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 1.6 m -80.23 147.04 31.4 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.582 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -44.94 -27.96 1.62 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 48.3 t0 -59.57 -25.37 64.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.89 . . . . 0.0 109.866 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 47.9 mttp -98.26 -36.42 10.03 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.876 HG12 ' CD1' ' A' ' 40' ' ' LEU . 95.1 t -77.17 -40.3 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.667 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' CG ' HD11 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -44.81 -50.51 24.97 Favored Pre-proline 0 N--CA 1.487 1.375 0 O-C-N 121.268 -0.895 . . . . 0.0 111.033 -178.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.2 Cg_endo -68.24 -33.25 24.83 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.089 1.047 . . . . 0.0 109.677 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.619 HG21 ' HZ ' ' A' ' 70' ' ' PHE . 2.1 t -64.7 -35.94 76.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.612 -0.68 . . . . 0.0 109.705 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.039 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.8 mt -90.03 -30.67 17.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD11 ' CG ' ' A' ' 37' ' ' LYS . 53.8 mt -70.78 -10.69 60.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.874 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 1.2 t-20 -90.59 -9.94 45.21 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.444 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.559 ' HB2' HD11 ' A' ' 81' ' ' LEU . 83.5 p -80.58 11.25 3.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.871 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.04 11.21 4.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.944 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.125 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.3 mt -90.92 156.0 44.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.813 . . . . 0.0 109.663 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -76.62 169.28 22.11 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 O-C-N 123.907 1.478 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.561 HG13 ' CA ' ' B' ' 111' ' ' PHE . 42.1 t -70.6 -3.42 3.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.74 -32.97 35.46 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.793 HG21 HD13 ' A' ' 45' ' ' LEU . 14.3 mm -80.65 -42.42 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.039 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.3 mt -63.65 -32.03 73.38 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.075 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.569 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -72.25 -17.84 77.72 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.826 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.34 -31.28 11.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.843 -0.798 . . . . 0.0 110.138 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.91 HG11 HG23 ' A' ' 77' ' ' VAL . 32.3 t -75.87 -34.65 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.696 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.583 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 3.1 t-105 -70.82 -47.65 58.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.599 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' B' ' 109' ' ' ASN . 23.5 mm-40 -58.17 -57.25 13.69 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.019 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.8 mt -60.46 -16.53 37.34 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.354 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.758 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t -89.9 -34.52 16.04 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.661 0.743 . . . . 0.0 109.387 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.619 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -74.83 69.82 1.87 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.623 -0.673 . . . . 0.0 109.578 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.51 HG12 ' HG2' ' A' ' 69' ' ' GLU . 42.2 mm -41.33 -32.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.493 -0.754 . . . . 0.0 110.406 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 3.0 p30 -108.38 -25.91 10.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 7.1 m80 71.09 41.19 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.8 p-10 -90.69 -1.69 57.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 98.16 19.95 22.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.583 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtp -153.18 161.77 42.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -1.187 . . . . 0.0 110.341 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.76 HD12 HG21 ' A' ' 36' ' ' VAL . 31.8 mt -118.73 107.79 14.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.099 -1.001 . . . . 0.0 110.662 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.76 165.07 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.04 . . . . 0.0 109.826 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -40.18 -43.53 1.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -78.44 -33.31 48.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.75 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 59' ' ' ILE . 53.2 mt-10 -74.89 -42.95 56.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.45 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.95 ' CD2' HD12 ' A' ' 31' ' ' LEU . 36.7 t80 -63.12 -16.48 60.14 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -78.97 -44.36 22.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.008 HG13 HD21 ' A' ' 94' ' ' LEU . 42.4 t -61.73 -26.42 39.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.708 0.766 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.758 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.55 -7.84 54.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.76 . . . . 0.0 111.187 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.576 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.5 mmt -84.95 -48.11 9.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.924 -1.11 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 3.6 p90 -75.33 -21.25 58.55 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.6 mt -76.37 -19.41 58.2 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.91 HG23 HG11 ' A' ' 53' ' ' VAL . 32.8 t -91.96 -41.86 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.569 -0.707 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 5.3 m-85 -72.01 -22.54 61.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.837 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -81.58 -15.26 55.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.979 -1.075 . . . . 0.0 109.24 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.125 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.94 -10.89 46.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.459 -0.775 . . . . 0.0 109.077 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.9 mt -90.64 -43.13 10.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.787 . . . . 0.0 109.812 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 6.7 mm-40 -70.04 -53.33 18.0 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.834 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 177.76 -25.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.412 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 3.8 tm-20 -60.32 122.07 64.47 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.049 -1.032 . . . . 0.0 111.009 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -74.79 157.16 43.82 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.877 1.462 . . . . 0.0 109.652 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 52' ' ' ARG . 89.7 t -112.64 121.58 38.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.926 -1.109 . . . . 0.0 110.893 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.751 ' O ' HD11 ' A' ' 56' ' ' LEU . 45.2 Cg_endo -90.13 -174.4 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.973 1.512 . . . . 0.0 109.289 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.823 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.76 10.29 13.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.073 -1.017 . . . . 0.0 110.295 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.538 ' N ' HD21 ' A' ' 56' ' ' LEU . 38.8 m -104.13 104.11 14.0 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.246 -0.981 . . . . 0.0 111.66 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.592 HD23 HD12 ' A' ' 94' ' ' LEU . 1.7 mt -53.09 106.63 0.69 Allowed Pre-proline 0 C--N 1.294 -1.825 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.803 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.959 ' O ' HG23 ' A' ' 95' ' ' VAL . 40.8 Cg_endo -70.8 148.24 57.89 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.895 1.471 . . . . 0.0 110.689 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.2 -3.74 13.53 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.248 1.657 . . . . 0.0 111.196 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -92.17 -26.37 18.26 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.312 -0.868 . . . . 0.0 109.336 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.008 HD21 HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -100.49 -18.09 16.84 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.788 0.804 . . . . 0.0 109.233 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.959 HG23 ' O ' ' A' ' 91' ' ' PRO . 88.3 t -68.5 138.2 91.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.947 -1.095 . . . . 0.0 110.689 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.73 166.18 30.4 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.123 1.591 . . . . 0.0 110.121 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.28 -14.25 25.54 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.008 1.531 . . . . 0.0 110.316 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -16.89 64.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.891 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.03 3.46 55.21 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 48.3 mtt-85 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 110.484 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.221 0.534 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 11.5 t -114.38 -10.95 12.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.312 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.493 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 1.9 t-20 -135.41 105.45 10.11 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 109.717 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.4 Cg_endo -71.49 -2.44 11.3 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.916 1.482 . . . . 0.0 111.028 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 1.005 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.16 -62.51 1.58 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.867 -1.146 . . . . 0.0 108.849 177.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.981 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.482 0.816 0 N-CA-C 110.456 -0.632 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 -59.79 129.81 43.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.282 -0.886 . . . . 0.0 109.84 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.884 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -35.72 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.648 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 99.5 t -97.9 130.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -86.62 -179.13 1.29 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.729 -178.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.81 -36.3 8.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.014 1.534 . . . . 0.0 110.058 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.27 -22.78 57.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 51.6 m-20 -81.41 -36.94 28.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.062 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -73.78 -16.76 61.15 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.318 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -40.83 38.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.541 -0.724 . . . . 0.0 109.303 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.08 -26.69 60.52 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.8 m-30 -74.65 -32.06 62.14 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.07 -18.24 61.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.504 -0.748 . . . . 0.0 109.868 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -82.54 -36.67 26.11 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.561 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 12.3 mt -78.01 -28.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.36 -38.29 56.02 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.8 t70 -90.26 3.89 52.26 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.704 -0.623 . . . . 0.0 109.792 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -93.23 -3.48 53.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 108.631 178.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.022 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.24 -3.42 13.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 79.83 95.45 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 Cg_endo -71.37 152.33 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.308 1.688 . . . . 0.0 110.76 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.633 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 94.1 t -120.1 97.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 109.106 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.633 ' ND2' ' O ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER 68.68 10.58 7.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.2 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 104.73 34.13 3.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 76.6 m-85 -150.89 149.88 30.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.468 -1.019 . . . . 0.0 111.886 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.022 ' CD1' HD12 ' A' ' 24' ' ' LEU . 18.1 mt -118.07 134.38 55.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -78.45 144.32 35.91 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.886 -1.125 . . . . 0.0 109.436 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -42.72 -28.33 0.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.0 m-20 -54.46 -25.14 23.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.44 -1.036 . . . . 0.0 109.506 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 1.1 mttp -104.38 -32.66 8.94 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.408 -0.807 . . . . 0.0 108.83 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.061 HG11 HD12 ' A' ' 65' ' ' LEU . 87.6 t -84.54 -44.76 17.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.683 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 15.4 tttt -43.99 -53.56 12.98 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 0.0 110.924 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.4 Cg_endo -67.19 -33.74 30.1 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.33 1.174 . . . . 0.0 109.467 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -63.38 -34.74 69.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.457 0.646 . . . . 0.0 109.389 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.011 HD12 ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -85.92 -27.32 25.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 58.0 mt -74.94 -10.89 59.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.225 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -89.56 -5.1 57.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.094 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.545 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.93 12.87 6.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.476 -0.765 . . . . 0.0 110.382 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 61.3 13.29 4.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.11 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.891 HD22 HG13 ' A' ' 49' ' ' ILE . 14.7 mt -97.91 154.53 37.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.663 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.61 172.34 16.4 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.071 1.564 . . . . 0.0 110.067 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.85 -6.04 6.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 109.072 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.63 -30.62 56.95 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.891 HG13 HD22 ' A' ' 45' ' ' LEU . 7.1 mm -88.02 -38.06 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.005 HD22 ' HB3' ' A' ' 40' ' ' LEU . 17.8 mt -77.17 -26.31 52.84 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.1 -27.38 72.09 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.652 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -101.47 -30.15 11.59 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 122.105 -0.644 . . . . 0.0 109.901 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.041 HG11 HG23 ' A' ' 77' ' ' VAL . 22.3 t -71.25 -39.85 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.707 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 1.9 t-105 -64.27 -51.0 65.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.651 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.9 mm-40 -53.05 -57.54 10.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.322 -0.861 . . . . 0.0 109.847 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 90' ' ' LEU . 13.8 mt -56.82 -21.07 26.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 108.94 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.863 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 69.7 m -89.48 -36.13 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 31.5 t0 -83.69 61.92 6.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.636 -0.665 . . . . 0.0 110.196 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.791 HG23 ' HD2' ' A' ' 99' ' ' LYS . 26.8 mt -59.5 -19.01 15.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.334 -0.853 . . . . 0.0 110.37 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 13.6 m-20 -91.74 -21.14 20.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.938 . . . . 0.0 109.637 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 2.2 m-70 61.27 33.74 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 110.745 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.43 -2.48 48.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.05 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 91.07 25.3 24.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.1 mtp -153.55 161.49 42.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.138 -1.213 . . . . 0.0 110.556 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.061 HD12 HG11 ' A' ' 36' ' ' VAL . 15.3 mt -117.84 110.84 18.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.324 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -70.99 172.39 9.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 110.562 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.556 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 3.5 ptp180 -51.15 -41.37 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.555 -0.715 . . . . 0.0 110.895 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.77 -36.31 37.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 57' ' ' SER . 45.8 mt-10 -72.13 -48.73 41.5 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.958 ' CD2' HD12 ' A' ' 31' ' ' LEU . 14.2 t80 -56.0 -26.27 47.91 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.64 56.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 110.116 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.618 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 58.5 t -57.63 -22.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.744 . . . . 0.0 109.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.863 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.35 -5.34 56.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 111.425 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 3.5 mmm -89.98 -40.54 12.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.309 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.002 ' CZ ' HD12 ' A' ' 94' ' ' LEU . 2.1 p90 -81.99 -22.77 36.38 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.848 -1.141 . . . . 0.0 108.339 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.703 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 4.4 mt -76.11 -23.33 54.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.041 HG23 HG11 ' A' ' 53' ' ' VAL . 16.4 t -91.55 -47.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.533 -0.729 . . . . 0.0 109.722 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.676 ' HA ' HD23 ' A' ' 81' ' ' LEU . 2.4 m-85 -70.38 -35.29 73.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 110.417 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 75' ' ' PHE . 3.9 t -83.59 -8.6 59.28 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 49' ' ' ILE . . . -92.18 -29.27 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.131 0.967 . . . . 0.0 109.208 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -90.94 -24.71 20.08 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.759 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -72.45 -58.11 3.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 110.137 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.48 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -179.42 59.74 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.39 -0.819 . . . . 0.0 110.669 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -165.58 138.99 3.64 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 120.984 -1.072 . . . . 0.0 110.665 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 52.3 Cg_endo -79.84 170.46 16.75 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.898 1.473 . . . . 0.0 110.283 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 87' ' ' PRO . 39.1 t -114.15 154.06 46.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 108.996 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.756 ' HD2' HG13 ' A' ' 86' ' ' VAL . 43.3 Cg_endo -86.13 -167.63 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.525 1.276 . . . . 0.0 109.877 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 mtt -122.25 11.12 10.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.02 -1.05 . . . . 0.0 111.541 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -168.0 23.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.677 -1.264 . . . . 0.0 111.609 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.71 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER 56.34 122.26 0.01 OUTLIER Pre-proline 0 C--N 1.282 -2.354 0 O-C-N 121.941 -0.474 . . . . 0.0 111.666 178.276 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.639 ' HG2' HD23 ' A' ' 94' ' ' LEU . 41.0 Cg_endo -69.08 175.72 7.18 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.922 1.485 . . . . 0.0 109.807 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.7 Cg_endo -71.07 -22.32 26.32 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.657 1.346 . . . . 0.0 112.656 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.645 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -92.1 -4.27 54.57 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.569 -1.332 . . . . 0.0 110.813 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.002 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -107.78 11.76 27.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.1 -1.0 . . . . 0.0 110.194 -178.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 99' ' ' LYS . 8.2 t -121.6 142.43 35.74 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.981 . . . . 0.0 110.043 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 100' ' ' ARG . 44.1 Cg_endo -71.52 173.74 12.01 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.923 1.486 . . . . 0.0 110.163 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HA ' ' CD ' ' A' ' 100' ' ' ARG . 46.6 Cg_endo -71.55 -0.96 9.04 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.097 1.577 . . . . 0.0 111.175 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.9 p -84.77 -29.72 25.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.914 -1.116 . . . . 0.0 109.7 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.791 ' HD2' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -97.62 15.78 22.42 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.461 -0.775 . . . . 0.0 109.007 179.079 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' CD ' ' HA ' ' A' ' 97' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 111.213 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.254 0.549 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.06 148.92 51.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.402 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' B' ' 110' ' ' PRO . 6.7 t-20 60.01 92.04 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 110.176 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.513 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 46.0 Cg_endo -69.22 8.93 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.902 1.735 . . . . 0.0 112.344 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 1.011 ' CE2' HD12 ' A' ' 40' ' ' LEU . 13.5 m-85 -99.31 -49.74 4.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.505 -1.372 . . . . 0.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.939 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.482 0.832 0 N-CA-C 110.198 -0.731 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.562 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.7 t90 -70.17 125.75 27.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.061 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -42.22 -27.61 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 109.741 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -95.56 130.79 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.794 . . . . 0.0 109.327 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -88.77 172.4 7.6 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.335 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -34.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.988 1.52 . . . . 0.0 109.946 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -78.33 -28.85 47.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.291 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.505 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 9.1 m-20 -81.05 -33.86 33.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.61 -17.92 57.31 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.177 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -37.48 61.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -76.91 -23.16 52.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 12.3 m-30 -77.55 -34.75 53.71 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.73 -20.2 62.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.893 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.04 33.4 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' CE1' ' A' ' 70' ' ' PHE . 73.5 mt -79.23 -30.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.725 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.79 -36.12 67.52 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 t70 -91.21 -3.23 57.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.447 -0.783 . . . . 0.0 110.034 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.9 t -82.17 -14.67 55.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 108.765 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.079 HD12 HD13 ' A' ' 31' ' ' LEU . 8.4 mt -94.09 -53.8 3.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 m 140.87 97.18 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.11 150.4 42.74 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 O-C-N 123.97 1.51 . . . . 0.0 110.643 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.639 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 84.4 t -119.8 84.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.316 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' ND2' ' O ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER 72.73 3.96 4.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.563 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 123.31 29.46 1.2 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -149.89 151.76 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.277 . . . . 0.0 112.326 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.079 HD13 HD12 ' A' ' 24' ' ' LEU . 9.4 mt -120.47 154.16 35.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -98.14 141.49 31.0 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 120.754 -1.217 . . . . 0.0 109.715 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.615 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.79 -27.89 0.2 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.7 m-20 -67.63 -24.78 65.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.424 -1.045 . . . . 0.0 110.481 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 66.6 mttm -90.24 -36.75 14.55 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.916 HG12 ' CD1' ' A' ' 40' ' ' LEU . 93.3 t -72.76 -39.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.252 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -42.8 -54.95 7.94 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 111.264 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.7 Cg_endo -65.69 -30.64 50.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.699 1.368 . . . . 0.0 110.005 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.82 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.5 t -69.01 -28.71 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.51 -0.744 . . . . 0.0 109.064 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.956 ' HB3' HD22 ' A' ' 50' ' ' LEU . 27.1 mt -94.78 -31.49 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 0.0 110.176 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 37' ' ' LYS . 23.0 mt -70.3 -9.93 57.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 27.2 p-10 -90.9 -7.69 51.46 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.993 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.579 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 p -81.4 14.13 2.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.716 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.81 10.71 5.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.027 HD13 HG21 ' A' ' 49' ' ' ILE . 14.3 mt -98.22 157.9 33.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.926 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.66 170.42 20.26 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.063 1.559 . . . . 0.0 109.569 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.56 HG13 ' C ' ' B' ' 111' ' ' PHE . 2.0 t -71.3 -3.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.125 -0.985 . . . . 0.0 109.37 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -78.14 -32.17 50.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.027 HG21 HD13 ' A' ' 45' ' ' LEU . 9.6 mm -81.67 -40.81 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.956 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -71.09 -30.79 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.68 -24.97 74.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.789 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -100.68 -35.06 9.61 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.906 -0.761 . . . . 0.0 109.868 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.09 HG11 ' CG2' ' A' ' 77' ' ' VAL . 23.8 t -65.87 -34.39 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.829 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.615 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.07 -55.03 10.53 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.43 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 1.7 mt-10 -48.0 -57.1 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.09 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.6 mt -63.32 -14.62 51.79 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.938 . . . . 0.0 108.96 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.905 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 11.0 t -93.09 -35.14 13.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 22.5 t0 -74.84 99.94 3.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.718 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.537 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 14.6 mm -86.91 -23.82 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.24 -12.83 31.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 55.61 47.66 20.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -0.944 . . . . 0.0 110.204 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -125.64 17.64 8.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.923 -1.111 . . . . 0.0 110.197 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 74.07 32.99 57.88 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.6 mtp -150.76 161.33 42.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -1.229 . . . . 0.0 111.071 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.771 HD12 HG21 ' A' ' 36' ' ' VAL . 19.6 mt -133.15 107.31 8.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.544 -0.723 . . . . 0.0 109.432 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.636 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 32.9 p30 -78.73 175.13 10.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.75 -1.219 . . . . 0.0 110.378 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.46 -50.62 3.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 112.17 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.769 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 5.1 p-10 -72.55 -46.82 52.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.151 -0.968 . . . . 0.0 110.444 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.537 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 52.2 mt-10 -62.02 -54.67 38.25 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.533 -0.73 . . . . 0.0 109.229 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.994 ' CD2' HD12 ' A' ' 31' ' ' LEU . 12.2 t80 -49.83 -30.0 9.02 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -61.45 -55.54 30.15 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.79 0.805 . . . . 0.0 110.005 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.005 ' CG1' HD11 ' A' ' 94' ' ' LEU . 92.0 t -51.07 -28.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.488 0.661 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.905 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.98 -6.87 58.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 0.0 112.411 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.59 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.1 mmm -90.37 -43.36 10.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.268 -1.52 . . . . 0.0 110.569 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.753 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 2.2 p90 -76.05 -22.3 55.85 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.156 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 86' ' ' VAL . 6.3 mt -72.61 -30.1 64.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.09 ' CG2' HG11 ' A' ' 53' ' ' VAL . 37.5 t -91.07 -21.79 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.742 -0.599 . . . . 0.0 110.106 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.16 -27.69 21.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.543 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 5.4 m -83.48 -14.44 52.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -0.789 . . . . 0.0 109.418 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.683 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.66 -12.59 57.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' A' ' 45' ' ' LEU . 8.3 mt -91.34 -47.05 7.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.734 -0.604 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.7 32.97 5.19 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.453 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -151.09 -89.54 0.06 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.653 -1.28 . . . . 0.0 111.261 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.557 ' CG ' ' HD2' ' A' ' 85' ' ' PRO . 7.5 tt0 -140.87 153.51 67.61 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.303 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.557 ' HD2' ' CG ' ' A' ' 84' ' ' GLU . 36.9 Cg_endo -60.93 -162.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.575 1.302 . . . . 0.0 109.972 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.538 HG13 HD22 ' A' ' 76' ' ' LEU . 90.4 t -127.79 119.2 21.27 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.85 -1.157 . . . . 0.0 111.51 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.756 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -81.67 154.5 17.95 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.978 1.515 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.524 ' HG3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -85.04 18.06 2.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.607 -1.308 . . . . 0.0 110.582 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.522 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.7 m -109.01 102.95 11.9 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.035 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.633 HD22 ' CG1' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -60.77 107.28 1.0 Allowed Pre-proline 0 C--N 1.291 -1.966 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.654 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.762 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.4 Cg_endo -65.49 149.51 87.73 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.873 1.459 . . . . 0.0 110.482 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -75.5 -10.38 20.39 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.226 1.645 . . . . 0.0 111.689 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -92.87 20.26 6.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 109.446 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.005 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -144.21 7.18 1.35 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.989 -178.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.633 ' CG1' HD22 ' A' ' 90' ' ' LEU . 11.2 m -109.48 152.29 42.66 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.016 -1.052 . . . . 0.0 111.293 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 41.7 Cg_endo -69.83 176.13 7.23 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.451 1.764 . . . . 0.0 110.099 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 42.4 Cg_endo -69.22 -17.08 40.2 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.674 1.355 . . . . 0.0 110.467 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.95 -16.68 61.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 109.367 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -90.37 2.17 55.85 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.456 -0.777 . . . . 0.0 109.715 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.56 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.346 -0.847 . . . . 0.0 109.999 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.303 0.573 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 48.0 p -87.79 83.0 7.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 110.31 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' CA ' ' A' ' 51' ' ' GLY . 5.9 t-20 -125.69 104.38 27.46 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.964 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.611 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -73.78 11.56 1.09 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.243 1.654 . . . . 0.0 112.386 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.914 ' CE2' HD12 ' A' ' 40' ' ' LEU . 2.7 m-85 -110.73 -73.58 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.54 -1.35 . . . . 0.0 108.405 178.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.412 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.483 0.875 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.575 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.5 t90 -73.48 124.53 26.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 109.831 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -39.55 -29.25 0.05 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.747 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.575 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 29.5 t -88.62 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.309 -0.87 . . . . 0.0 109.349 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.562 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.85 174.35 4.62 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.101 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.3 Cg_endo -70.59 -33.72 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.921 1.485 . . . . 0.0 109.584 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.13 -19.97 58.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.2 m-20 -85.33 -43.87 13.32 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.05 -20.56 66.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.69 . . . . 0.0 109.161 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.56 49.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.51 -24.58 45.71 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.682 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -73.69 -36.02 65.24 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.42 -20.82 60.64 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.919 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -82.82 -36.86 25.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.645 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 19.6 mt -76.04 -31.57 21.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -67.77 -38.27 83.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 15.4 t70 -91.29 -3.79 56.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.793 -0.567 . . . . 0.0 110.097 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -78.63 -15.6 58.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 108.92 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.1 HD12 ' CD1' ' A' ' 31' ' ' LEU . 11.9 mt -96.14 -52.44 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.668 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.2 t 136.51 99.05 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.0 Cg_endo -72.47 145.23 42.12 Favored 'Trans proline' 0 C--N 1.297 -2.18 0 O-C-N 124.184 1.623 . . . . 0.0 111.01 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 10.7 t -118.07 111.46 34.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.534 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 48.15 23.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.382 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.14 34.52 5.61 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 78.9 m-85 -150.99 146.67 26.38 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.183 -1.186 . . . . 0.0 112.397 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.1 ' CD1' HD12 ' A' ' 24' ' ' LEU . 7.7 mt -111.73 148.85 32.58 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.486 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -91.04 142.92 27.25 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.735 -1.228 . . . . 0.0 110.3 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.52 -25.37 0.81 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.5 m-20 -71.99 -21.88 61.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.967 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 29.2 mttm -93.12 -36.23 12.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.882 HG11 HD12 ' A' ' 65' ' ' LEU . 64.1 t -79.01 -43.86 24.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.564 0.697 . . . . 0.0 109.863 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 15.7 tttt -41.01 -51.73 7.27 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.0 Cg_endo -67.61 -32.42 30.99 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.314 1.165 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -66.34 -31.91 55.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.561 -0.712 . . . . 0.0 109.089 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.951 ' HB3' HD22 ' A' ' 50' ' ' LEU . 33.9 mt -90.0 -29.85 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 110.075 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 37' ' ' LYS . 58.8 mt -69.32 -15.36 63.31 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -90.72 -3.72 57.26 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.723 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.582 ' O ' HD21 ' A' ' 81' ' ' LEU . 83.8 p -81.37 12.56 3.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.816 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 2.9 ttmt 62.55 9.67 3.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.05 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.7 mt -100.55 153.22 37.86 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.6 Cg_endo -74.12 172.28 16.29 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.913 1.481 . . . . 0.0 109.734 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -70.2 -5.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.094 -1.004 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -78.11 -31.1 49.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 108.968 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.837 HG13 HD22 ' A' ' 45' ' ' LEU . 7.6 mm -85.17 -43.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.951 HD22 ' HB3' ' A' ' 40' ' ' LEU . 17.2 mt -70.24 -28.89 65.61 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.91 -25.99 74.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 1.013 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.8 ttm-85 -100.9 -31.06 11.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.876 -0.779 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.045 HG11 HG23 ' A' ' 77' ' ' VAL . 7.4 t -69.82 -35.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.681 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.611 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.1 t-105 -69.08 -52.28 30.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.267 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 19.9 mm-40 -52.82 -54.27 36.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 110.111 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.013 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.6 mt -63.2 -13.26 35.37 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 108.612 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.651 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.9 m -96.18 -41.02 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.67 . . . . 0.0 110.601 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -69.54 82.3 0.41 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.239 -0.913 . . . . 0.0 110.615 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.529 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 33.4 mm -58.25 -21.7 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.144 -0.972 . . . . 0.0 108.939 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 1.9 m-20 -103.68 -9.91 18.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 0.0 109.818 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 29.8 p80 38.73 48.89 1.4 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.689 -0.632 . . . . 0.0 110.719 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 22.3 p-10 -117.01 12.26 14.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.325 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 88.11 28.76 22.15 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.8 mtt -150.75 161.59 42.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -1.21 . . . . 0.0 111.391 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.882 HD12 HG11 ' A' ' 36' ' ' VAL . 15.4 mt -135.73 110.41 8.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 1.1 t70 -72.94 172.64 10.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.514 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 4.2 ptm180 -51.24 -42.4 61.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 110.276 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 26.3 t0 -79.62 -35.2 39.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 7.9 tt0 -69.83 -52.38 25.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.723 0.773 . . . . 0.0 108.994 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.955 ' CD2' HD12 ' A' ' 31' ' ' LEU . 24.9 t80 -53.18 -26.59 17.79 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -63.94 -52.28 60.48 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.639 0.733 . . . . 0.0 109.917 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.002 HG13 HD11 ' A' ' 94' ' ' LEU . 89.9 t -54.22 -24.0 10.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.4 -7.71 54.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.293 -0.879 . . . . 0.0 112.129 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 mmm -90.22 -41.76 11.4 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.388 -1.445 . . . . 0.0 110.283 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.9 ' CE2' HD13 ' A' ' 94' ' ' LEU . 2.5 p90 -78.44 -19.42 53.2 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.355 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 HG13 ' A' ' 86' ' ' VAL . 6.9 mt -76.08 -26.15 56.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.045 HG23 HG11 ' A' ' 53' ' ' VAL . 20.7 t -91.36 -57.23 4.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.68 -0.637 . . . . 0.0 109.557 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.416 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 1.7 m-85 -53.15 -20.26 3.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.361 -0.837 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 7.8 m -83.96 -16.7 43.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.089 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.05 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.01 -11.52 44.0 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.203 -0.935 . . . . 0.0 109.383 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.582 HD21 ' O ' ' A' ' 43' ' ' SER . 6.3 mp -89.92 -39.54 12.95 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.663 0.744 . . . . 0.0 109.387 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 2.8 mt-10 -72.94 -52.45 14.53 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.768 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 177.22 -25.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.527 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -72.37 112.5 15.05 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.03 . . . . 0.0 111.185 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 43.6 Cg_endo -70.66 164.68 34.56 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.791 1.416 . . . . 0.0 109.935 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.591 HG11 HG23 ' A' ' 53' ' ' VAL . 20.7 t -112.56 119.81 42.54 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.074 -1.016 . . . . 0.0 110.584 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.9 Cg_endo -84.62 -162.44 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 109.448 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.814 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.09 0.23 12.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 46.5 m -108.11 102.7 11.83 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.434 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.688 HD11 ' HB ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -66.79 108.63 2.55 Favored Pre-proline 0 C--N 1.287 -2.127 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.868 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.0 Cg_endo -64.46 151.15 86.64 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.803 1.423 . . . . 0.0 111.04 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HA ' HG12 ' A' ' 95' ' ' VAL . 41.9 Cg_endo -68.63 -5.49 15.45 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.187 1.625 . . . . 0.0 111.09 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.19 -1.72 41.7 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 109.17 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.002 HD11 HG13 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -147.25 36.57 0.91 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.683 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.688 ' HB ' HD11 ' A' ' 90' ' ' LEU . 9.8 p -131.03 138.81 33.8 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 110.818 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.05 165.79 31.79 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.074 1.565 . . . . 0.0 110.212 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 98' ' ' SER . 43.3 Cg_endo -70.48 -174.81 1.13 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.295 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 1.3 m 78.09 -41.21 0.32 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.579 -0.7 . . . . 0.0 110.214 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.23 5.69 40.39 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.961 -1.087 . . . . 0.0 108.637 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 109.716 179.548 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.245 0.545 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' B' ' 109' ' ' ASN . 8.9 m -79.23 106.38 11.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.253 -0.904 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.496 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 15.1 t-20 60.65 108.08 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.591 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -71.4 3.14 3.79 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.039 1.547 . . . . 0.0 111.573 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.95 ' CE2' HD12 ' A' ' 40' ' ' LEU . 8.4 m-85 -100.1 -45.83 5.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.862 -1.149 . . . . 0.0 109.561 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.219 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.933 0 N-CA-C 110.328 -0.682 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.6 t90 -51.61 124.62 12.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.91 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . -39.88 -27.66 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 110.277 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 13' ' ' ASP . 88.4 t -107.29 138.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.26 -178.03 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.895 . . . . 0.0 110.089 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.8 Cg_endo -71.16 -36.23 7.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.791 1.416 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.59 -24.51 60.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.992 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB3' HG13 ' A' ' 9' ' ' VAL . 2.8 m-20 -83.26 -40.26 19.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.336 -0.853 . . . . 0.0 109.015 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -74.62 -21.56 59.39 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.12 71.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.747 . . . . 0.0 109.248 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -78.19 -29.34 48.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 12.4 m-30 -71.09 -37.71 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 29.1 t0 -69.61 -18.06 63.58 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.818 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.0 -36.67 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.676 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 mt -78.38 -34.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.783 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -67.85 -36.83 81.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.557 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.5 t70 -87.5 -3.08 59.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.738 -0.601 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 -8.02 58.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 109.409 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.105 HD12 ' CD1' ' A' ' 31' ' ' LEU . 7.2 mt -102.17 -15.61 16.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 87.99 88.94 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.0 Cg_endo -75.94 150.78 34.65 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.563 1.823 . . . . 0.0 110.495 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 41.8 t -116.12 110.47 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.8 OUTLIER 65.42 13.79 9.05 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -177.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 93.58 32.55 7.62 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 26.3 m-85 -138.03 136.12 36.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.285 . . . . 0.0 112.358 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.105 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -107.06 151.0 25.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' ASP . 15.9 p -100.58 147.78 25.55 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.989 -1.069 . . . . 0.0 109.774 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.48 -25.05 0.73 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . 46.7 m-20 -67.5 -22.34 65.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.458 -1.025 . . . . 0.0 110.672 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 24' ' ' LEU . 2.9 mtpp -101.63 -34.72 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.914 -1.116 . . . . 0.0 108.398 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.888 HG11 HD12 ' A' ' 65' ' ' LEU . 92.3 t -78.18 -36.09 20.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.499 0.666 . . . . 0.0 109.692 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.663 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 1.8 tttp -44.78 -53.84 14.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 110.706 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.52 -30.34 29.17 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.566 1.298 . . . . 0.0 110.144 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.756 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.5 t -64.92 -28.43 44.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.369 0.604 . . . . 0.0 109.799 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.984 HD12 ' CE2' ' B' ' 111' ' ' PHE . 21.3 mt -94.52 -30.45 14.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 ' HG3' ' A' ' 37' ' ' LYS . 56.6 mt -69.26 -10.01 55.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 108.591 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -87.92 -6.25 58.15 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.241 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.631 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -84.96 18.3 2.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 110.242 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 19.33 1.62 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.644 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.067 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.5 mt -100.51 155.3 36.53 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 109.9 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -75.11 162.48 36.78 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.019 1.536 . . . . 0.0 109.442 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.68 HG12 ' OXT' ' B' ' 112' ' ' ARG . 9.1 t -67.25 -6.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -74.86 -31.24 61.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.794 HG13 HD22 ' A' ' 45' ' ' LEU . 7.3 mm -81.45 -43.12 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.847 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -68.68 -32.54 72.44 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.465 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.576 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -68.25 -23.88 74.82 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.817 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.9 ttm180 -101.67 -32.42 10.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.07 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.942 HG11 HG23 ' A' ' 77' ' ' VAL . 7.6 t -70.43 -40.23 77.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.124 -1.031 . . . . 0.0 108.574 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.581 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.6 t-105 -63.66 -50.86 67.62 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.76 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.495 ' HG3' ' ND2' ' B' ' 109' ' ' ASN . 13.0 mt-10 -47.22 -56.87 5.89 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.904 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 52' ' ' ARG . 1.7 mt -64.54 -13.25 51.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.99 . . . . 0.0 108.919 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.942 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -88.48 -40.78 13.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.8 t0 -80.04 95.25 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.312 0.577 . . . . 0.0 110.221 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.32 -13.09 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.928 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.469 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 11.7 m-20 -99.67 -13.13 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.179 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 3.3 m80 55.57 47.47 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.494 -0.754 . . . . 0.0 110.546 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 19.5 p-10 -126.09 29.66 5.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.51 38.45 93.61 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtt -150.19 160.8 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 111.823 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.888 HD12 HG11 ' A' ' 36' ' ' VAL . 5.7 mt -129.81 108.12 9.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.641 -0.662 . . . . 0.0 109.512 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.529 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -69.46 158.04 35.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.858 -1.151 . . . . 0.0 109.448 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 14.1 ptt180 -41.5 -42.43 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.589 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -73.27 -43.88 60.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 12.4 mt-10 -64.79 -51.48 62.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.81 ' CD2' HD12 ' A' ' 31' ' ' LEU . 33.5 t80 -49.63 -28.64 6.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.0 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -65.84 -45.06 83.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 110.185 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.841 HG13 ' HG ' ' A' ' 94' ' ' LEU . 71.6 t -63.74 -20.34 26.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 110.179 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.942 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -89.86 -6.63 55.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.461 -0.775 . . . . 0.0 111.002 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 10.2 mmm -90.44 -44.93 9.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.548 -1.345 . . . . 0.0 110.318 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.891 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.5 p90 -75.32 -26.38 58.61 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.027 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.819 HD22 HG13 ' A' ' 86' ' ' VAL . 6.7 mt -67.56 -28.54 67.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.942 HG23 HG11 ' A' ' 53' ' ' VAL . 24.0 t -91.0 -59.9 2.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.77 ' HA ' HD13 ' A' ' 81' ' ' LEU . 2.5 m-85 -48.52 -23.07 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.772 -0.58 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 23.0 m -82.93 -20.41 35.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.861 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.067 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.26 -12.37 58.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 77' ' ' VAL . 3.3 mp -90.83 -46.02 8.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.415 -0.803 . . . . 0.0 110.17 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -69.32 -59.72 2.81 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.896 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 10.0 ttpt 176.57 48.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.694 -0.803 . . . . 0.0 111.523 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' CYS . 5.3 mm-40 -147.62 112.11 3.96 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.717 -1.239 . . . . 0.0 110.729 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 42.2 Cg_endo -69.25 177.05 5.61 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.025 1.539 . . . . 0.0 109.985 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.819 HG13 HD22 ' A' ' 76' ' ' LEU . 33.0 t -124.44 125.86 25.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.958 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.677 ' O ' HD11 ' A' ' 56' ' ' LEU . 53.1 Cg_endo -87.71 164.03 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.932 1.491 . . . . 0.0 109.961 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.547 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 17.0 mtt -93.83 16.68 13.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.969 -1.082 . . . . 0.0 110.465 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.6 m -110.47 104.59 13.35 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.549 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.69 107.9 1.25 Allowed Pre-proline 0 C--N 1.292 -1.907 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.325 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.746 ' HD2' HD22 ' A' ' 94' ' ' LEU . 42.8 Cg_endo -70.05 147.74 61.63 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.799 1.42 . . . . 0.0 108.948 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.65 -12.49 34.8 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.732 1.386 . . . . 0.0 110.299 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -87.61 17.1 4.87 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 108.798 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.91 HD12 ' HB3' ' A' ' 8' ' ' ALA . 1.3 tp -115.69 -5.74 12.14 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 110.213 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 99' ' ' LYS . 48.6 t -97.89 124.83 46.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 111.245 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 45.1 Cg_endo -77.81 175.19 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.052 1.554 . . . . 0.0 109.544 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 45.3 Cg_endo -72.11 -1.9 10.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.818 1.43 . . . . 0.0 110.384 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.8 t -81.02 -33.98 33.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.165 -0.959 . . . . 0.0 109.783 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' NZ ' ' OD2' ' A' ' 66' ' ' ASP . 8.4 mmpt? -89.31 10.6 21.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.336 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 28.9 ptt85 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 110.301 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.306 0.574 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.39 68.57 9.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.576 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 11.6 t-20 -46.64 114.69 2.85 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.567 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.692 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.6 Cg_endo -73.73 -3.15 13.27 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.85 1.448 . . . . 0.0 111.042 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.984 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.82 -65.92 1.14 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.851 -1.156 . . . . 0.0 108.705 177.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.68 ' OXT' HG12 ' A' ' 47' ' ' VAL . 2.1 ptt-85 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.273 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 110.412 -0.649 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.725 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.6 t90 -52.55 123.39 10.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.34 -0.85 . . . . 0.0 109.585 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.55 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.64 -25.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.954 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 17.4 t -99.28 152.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.2 mttm -109.77 175.02 2.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.0 Cg_endo -68.35 -36.71 15.24 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.142 1.601 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -30.29 63.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.341 -0.849 . . . . 0.0 109.262 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -82.14 -38.8 24.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 12.6 tptp -70.84 -17.03 62.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.43 -40.98 49.15 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.93 -24.87 43.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.597 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.7 m-30 -73.45 -37.39 65.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -73.98 -20.29 60.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.925 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.51 -35.68 24.66 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.2 -0.938 . . . . 0.0 108.5 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.566 HG22 ' CE1' ' A' ' 70' ' ' PHE . 50.5 mt -77.22 -33.11 19.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.725 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -64.89 -37.87 89.06 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.545 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 t0 -90.53 -2.26 57.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 1.7 m -82.15 -9.93 59.35 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.309 -0.869 . . . . 0.0 108.948 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.128 HD12 ' CD1' ' A' ' 31' ' ' LEU . 13.1 mt -98.67 -53.89 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 150.62 84.33 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 55.8 Cg_endo -76.71 123.83 7.17 Favored 'Trans proline' 0 C--N 1.293 -2.357 0 O-C-N 124.307 1.688 . . . . 0.0 109.55 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 28' ' ' ASN 0.251 2.2 p -119.48 121.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.723 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.026 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 6.0 t-20 57.68 20.77 6.64 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 81.15 45.0 7.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 28' ' ' ASN . 87.8 m-85 -151.87 158.79 43.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 112.452 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.128 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.7 mt -126.39 160.64 29.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' LYS . 1.4 p -106.88 146.78 30.57 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.682 -1.261 . . . . 0.0 110.532 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.618 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.65 -24.93 0.76 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.1 m-20 -75.85 -20.02 58.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.978 . . . . 0.0 110.618 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HD2' HD22 ' A' ' 31' ' ' LEU . 11.7 mtmm -94.89 -35.2 12.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.976 -1.078 . . . . 0.0 108.141 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.786 HG12 ' CD1' ' A' ' 40' ' ' LEU . 96.8 t -78.01 -43.29 28.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.639 0.733 . . . . 0.0 109.764 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -40.83 -52.23 6.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 110.724 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.8 Cg_endo -67.03 -35.4 25.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.401 1.211 . . . . 0.0 109.65 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.58 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.5 -33.45 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.98 ' HB3' HD22 ' A' ' 50' ' ' LEU . 29.7 mt -88.97 -28.96 19.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.622 -0.674 . . . . 0.0 109.901 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.533 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 62.1 mt -71.95 -14.78 62.01 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -90.58 -3.74 57.35 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.118 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.647 ' O ' HD21 ' A' ' 81' ' ' LEU . 37.7 m -81.75 11.44 4.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.2 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.14 11.72 4.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.707 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.2 mt -100.57 155.14 36.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.9 Cg_endo -75.27 170.13 21.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.046 1.551 . . . . 0.0 109.816 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.576 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -68.59 -7.3 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 120.952 -1.093 . . . . 0.0 109.045 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.34 -27.87 60.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.927 HG21 HD13 ' A' ' 45' ' ' LEU . 10.1 mm -88.38 -38.69 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.98 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.7 mt -77.28 -29.76 53.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.2 -25.66 75.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.746 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -102.22 -35.88 8.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.081 -0.658 . . . . 0.0 110.75 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 77' ' ' VAL . 13.7 t -67.49 -37.72 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.819 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.618 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -64.11 -52.55 58.63 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.306 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 91.2 mt-10 -51.14 -58.79 5.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.388 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.812 HD21 ' C ' ' A' ' 88' ' ' MET . 3.2 mt -62.16 -13.98 32.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.98 . . . . 0.0 109.013 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.909 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 29.4 m -96.35 -26.73 15.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.717 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' TRP . 9.5 t0 -78.26 93.14 4.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.699 HG23 ' HD2' ' A' ' 99' ' ' LYS . 24.4 mm -73.12 -32.43 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 110.06 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 2.6 m-20 -95.62 -16.02 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 58' ' ' ASP . 91.0 m-70 52.61 50.69 17.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.314 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 37.5 p-10 -125.0 36.87 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.5 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 58.19 33.01 68.47 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 6.6 mtt -150.54 160.66 43.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -1.091 . . . . 0.0 111.269 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.767 HD12 HG11 ' A' ' 36' ' ' VAL . 13.2 mt -132.28 110.49 10.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.222 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 10.7 t0 -70.13 167.62 17.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.946 -1.096 . . . . 0.0 110.372 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.3 ptm180 -45.61 -44.22 12.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.286 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.614 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 11.7 t0 -78.19 -36.27 47.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.301 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -63.65 -52.47 60.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.938 0.875 . . . . 0.0 109.397 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.867 ' CD2' HD12 ' A' ' 31' ' ' LEU . 17.7 t80 -54.48 -20.37 7.53 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.533 0.682 . . . . 0.0 109.274 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -73.23 -46.27 51.2 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.953 HG22 HD21 ' A' ' 94' ' ' LEU . 23.7 t -59.94 -28.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.077 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.909 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -89.66 -4.67 57.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 5.6 mmt -87.43 -43.19 12.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.718 -1.239 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.476 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -77.77 -22.22 50.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.077 -1.014 . . . . 0.0 108.379 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.608 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.3 mt -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 53' ' ' VAL . 41.3 t -91.7 -60.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.689 -0.632 . . . . 0.0 110.109 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.478 ' HA ' HD13 ' A' ' 81' ' ' LEU . 3.4 m-85 -55.97 -19.65 13.27 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.225 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 84' ' ' GLU . 7.5 m -83.25 -16.69 45.4 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.019 -1.051 . . . . 0.0 109.581 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.982 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.78 -15.22 42.76 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.454 -0.779 . . . . 0.0 109.557 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.647 HD21 ' O ' ' A' ' 43' ' ' SER . 6.2 mp -88.88 -40.34 13.17 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.643 0.735 . . . . 0.0 109.467 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 2.4 mm-40 -71.35 -51.77 22.42 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.933 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.1 OUTLIER 177.38 -24.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.856 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 79' ' ' CYS . 23.3 mm-40 -79.71 110.95 17.6 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.894 -1.128 . . . . 0.0 111.035 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 41.9 Cg_endo -68.75 -173.27 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.838 1.441 . . . . 0.0 109.969 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.629 HG11 ' CG2' ' A' ' 53' ' ' VAL . 96.5 t -128.44 109.61 19.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.975 . . . . 0.0 110.793 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.657 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.4 Cg_endo -76.31 -169.95 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.988 1.52 . . . . 0.0 109.564 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -112.8 20.87 16.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.514 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 74.8 m -114.0 101.62 9.42 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.102 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 1.009 ' CD1' HD12 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -69.95 109.34 4.58 Favored Pre-proline 0 C--N 1.29 -2.021 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 95' ' ' VAL . 39.9 Cg_endo -65.34 146.18 85.17 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.01 1.532 . . . . 0.0 111.571 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.94 -5.99 18.2 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.323 1.697 . . . . 0.0 110.822 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -86.36 -22.91 26.41 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.009 HD12 ' CD1' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -94.65 -9.17 35.78 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.706 ' CG2' HD11 ' A' ' 90' ' ' LEU . 94.0 t -85.17 130.46 51.9 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 111.161 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.531 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.2 Cg_endo -72.39 177.82 6.9 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.972 1.512 . . . . 0.0 109.662 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 98' ' ' SER . 39.5 Cg_endo -65.87 -178.01 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.543 1.286 . . . . 0.0 110.113 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 75.44 -49.86 0.63 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.346 -0.846 . . . . 0.0 109.879 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.699 ' HD2' HG23 ' A' ' 59' ' ' ILE . 4.8 ttmt -88.47 12.83 13.3 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 108.555 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.526 -0.734 . . . . 0.0 109.934 179.882 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.22 0.533 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.69 -46.16 5.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.147 -0.971 . . . . 0.0 110.344 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.451 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 7.6 t-20 52.32 93.02 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.181 -0.949 . . . . 0.0 110.297 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.509 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -70.27 8.78 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.993 1.795 . . . . 0.0 112.176 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.923 ' CE2' HD12 ' A' ' 40' ' ' LEU . 15.3 m-85 -98.95 -45.04 6.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 109.854 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 N--CA 1.484 0.968 0 N-CA-C 110.686 -0.544 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.842 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.1 t90 -69.19 126.78 30.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.669 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.56 -28.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 10' ' ' LYS . 62.8 t -94.02 165.45 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 12.6 mttt -119.55 172.65 4.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.3 Cg_endo -67.88 -35.46 20.93 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.005 1.529 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 6.4 pt-20 -72.64 -28.69 62.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.93 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.8 m-20 -81.17 -38.79 26.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 108.638 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppt? -68.56 -16.99 64.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -28.46 35.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -90.73 -35.62 14.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.7 m-30 -65.39 -28.56 69.35 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 14' ' ' LYS . 9.6 m-20 -80.98 -24.09 38.27 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.662 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.37 -30.78 37.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.718 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 56.3 mt -80.78 -28.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.642 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.58 -35.8 60.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.521 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t70 -89.32 -3.06 58.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.758 -0.589 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -6.57 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.305 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.118 HD12 HD13 ' A' ' 31' ' ' LEU . 4.5 mt -106.5 -12.25 15.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 p 89.59 94.68 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.259 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -73.8 150.46 44.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.253 1.659 . . . . 0.0 110.871 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 71.9 t -123.9 110.27 25.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.3 t30 57.58 15.41 2.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.321 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.28 35.25 5.32 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 75.4 m-85 -150.56 143.2 24.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -1.205 . . . . 0.0 112.224 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.118 HD13 HD12 ' A' ' 24' ' ' LEU . 12.4 mt -109.56 134.46 51.89 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 1.7 m -78.37 142.56 37.57 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 118.939 -1.105 . . . . 0.0 109.942 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -43.48 -26.35 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 63.5 m-20 -67.55 -23.42 65.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 40.3 mttp -96.1 -33.18 12.18 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.841 HG12 ' CD1' ' A' ' 40' ' ' LEU . 84.6 t -77.9 -38.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.641 0.734 . . . . 0.0 109.598 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.0 OUTLIER -43.15 -54.96 8.52 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.73 . . . . 0.0 111.137 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -67.79 -31.78 31.24 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.718 1.378 . . . . 0.0 109.926 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -64.27 -31.22 52.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.579 -0.701 . . . . 0.0 109.304 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.979 HD12 ' CE2' ' B' ' 111' ' ' PHE . 22.2 mt -94.34 -34.92 12.62 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.597 -0.689 . . . . 0.0 109.974 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.4 mt -67.91 -14.45 62.97 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 19.8 t30 -90.73 -4.91 56.35 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.47 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 5.7 m -84.97 18.65 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 0.0 110.431 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.9 tptt 60.23 13.5 3.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.05 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.051 HD11 ' HB3' ' A' ' 80' ' ' ALA . 12.7 mt -100.22 152.13 37.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.92 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.572 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.8 Cg_endo -76.61 170.06 20.63 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.017 1.535 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 3.4 t -71.03 -4.53 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.757 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.8 -33.78 45.97 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.818 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.897 HG13 HD22 ' A' ' 45' ' ' LEU . 14.5 mm -79.32 -42.07 23.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 108.825 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.9 mt -68.35 -29.46 68.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.57 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.28 -24.69 73.57 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 1.011 ' O ' HD12 ' A' ' 56' ' ' LEU . 5.5 ttm-85 -100.81 -32.59 10.62 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.685 -0.891 . . . . 0.0 110.265 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.801 HG11 HG23 ' A' ' 77' ' ' VAL . 24.6 t -68.77 -36.37 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.821 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.6 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.7 t-105 -69.59 -52.32 27.15 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.344 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 84.1 mt-10 -50.96 -57.38 8.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.095 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.011 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.1 mt -61.16 -14.36 24.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.128 -0.983 . . . . 0.0 108.834 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.934 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 15.5 t -97.0 -23.31 16.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.29 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 29.0 t0 -95.55 90.91 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.975 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.15 -15.45 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 110.164 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 8.0 m-20 -89.17 -17.25 29.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.479 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 3.0 m80 57.59 46.86 16.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.623 -0.673 . . . . 0.0 110.115 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 8.4 p30 -119.78 16.07 12.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.639 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.22 33.58 83.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 37.9 mtp -151.47 160.78 43.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.238 . . . . 0.0 110.635 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.835 HD12 HG11 ' A' ' 36' ' ' VAL . 12.6 mt -119.77 105.16 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.0 109.584 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.567 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -71.94 163.48 27.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.334 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -41.84 -39.84 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 111.108 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -79.71 -32.32 41.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.187 -0.946 . . . . 0.0 110.594 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' CG ' ' OD1' ' A' ' 66' ' ' ASP . 35.3 mt-10 -77.75 -39.24 44.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.108 -0.995 . . . . 0.0 109.021 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.895 ' CD2' HD12 ' A' ' 31' ' ' LEU . 20.9 t80 -62.35 -18.22 60.93 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 0.0 108.907 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.73 -44.34 28.09 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.797 0.808 . . . . 0.0 109.564 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.976 ' CG1' HD11 ' A' ' 94' ' ' LEU . 44.0 t -61.57 -30.43 48.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.607 0.717 . . . . 0.0 109.676 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.934 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.68 -2.81 58.38 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 110.82 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.622 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.5 mmt -83.62 -48.91 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.897 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 7.6 p90 -76.19 -23.74 54.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.7 mt -71.04 -24.45 62.35 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.801 HG23 HG11 ' A' ' 53' ' ' VAL . 45.7 t -91.68 -46.38 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.648 -0.658 . . . . 0.0 110.298 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.401 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 2.7 m-85 -69.58 -26.42 64.45 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 110.865 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 16.1 t -81.43 -12.91 58.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.038 . . . . 0.0 109.385 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.051 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.36 -10.54 43.63 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 109.023 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.4 mt -90.87 -43.57 9.94 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.739 0.781 . . . . 0.0 109.708 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 1.4 tp10 -69.3 -57.16 5.68 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.628 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 175.17 79.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.369 179.617 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -172.67 119.24 0.41 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.694 -1.254 . . . . 0.0 110.958 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.32 158.01 49.05 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.704 1.37 . . . . 0.0 109.359 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 91.6 t -116.73 126.69 27.31 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 110.562 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.696 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.5 Cg_endo -84.42 -170.51 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.994 1.523 . . . . 0.0 108.913 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.777 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.48 13.25 13.46 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.954 -1.091 . . . . 0.0 110.242 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.618 ' N ' HD21 ' A' ' 56' ' ' LEU . 3.6 m -104.52 105.74 15.97 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.245 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.615 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -51.94 105.81 0.57 Allowed Pre-proline 0 N--CA 1.493 1.721 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.521 178.131 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.8 Cg_endo -69.75 147.2 62.4 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.791 1.416 . . . . 0.0 110.804 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.59 -5.57 17.42 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.775 1.65 . . . . 0.0 111.911 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -104.69 20.13 19.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.074 -1.016 . . . . 0.0 108.782 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.976 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -139.79 -0.92 1.67 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.456 0.646 . . . . 0.0 110.232 -178.345 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.47 129.24 77.89 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.615 -1.303 . . . . 0.0 110.529 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 48.6 Cg_endo -75.63 175.33 11.43 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.957 1.504 . . . . 0.0 110.001 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' SER . 42.6 Cg_endo -69.27 -178.94 2.38 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.799 1.421 . . . . 0.0 110.284 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 76.01 -43.83 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.464 -0.773 . . . . 0.0 110.019 -178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 51.2 tptt -87.75 8.5 25.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 110.345 179.823 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.244 0.545 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.517 HG23 ' O ' ' B' ' 108' ' ' THR . 14.8 t -96.55 128.1 43.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 110.454 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 2.5 t-20 -174.0 105.61 0.29 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.499 -0.751 . . . . 0.0 109.274 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.677 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 42.3 Cg_endo -70.5 -3.73 13.08 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.812 1.428 . . . . 0.0 110.514 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.979 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -111.95 -60.99 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.598 ' CG ' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.358 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.493 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.261 0.553 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -42.98 -28.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.417 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.493 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 23.8 t -101.73 139.2 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.91 . . . . 0.0 110.708 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.03 -177.3 0.64 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.49 -0.756 . . . . 0.0 109.748 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 41.7 Cg_endo -71.66 -32.63 11.6 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.711 1.374 . . . . 0.0 110.249 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 13.0 mm-40 -77.36 -31.78 54.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 109.784 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -77.44 -35.19 54.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -82.21 -18.47 42.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.638 0.732 . . . . 0.0 109.112 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -70.08 -40.15 75.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.639 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -73.51 -32.01 64.02 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.639 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -66.22 -36.58 83.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.56 -20.98 63.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.663 -0.648 . . . . 0.0 110.155 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.01 -38.73 24.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.971 . . . . 0.0 108.511 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.69 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 42.7 mt -75.79 -29.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.735 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.97 -36.41 64.58 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t70 -89.97 1.48 56.23 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.977 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -92.4 -3.47 55.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.922 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.076 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -109.63 -4.58 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 84.99 89.97 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.3 Cg_endo -72.42 148.7 49.07 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 124.503 1.791 . . . . 0.0 110.864 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 68.7 t -121.03 104.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.1 t30 58.88 20.41 8.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.805 . . . . 0.0 110.001 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 94.27 37.1 5.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 87.1 m-85 -150.29 149.22 29.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.164 -1.198 . . . . 0.0 111.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.076 ' CD1' HD12 ' A' ' 24' ' ' LEU . 15.0 mt -122.54 130.48 53.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -77.29 148.14 35.87 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.55 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -46.66 -25.55 2.25 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 9.0 t0 -63.02 -20.75 65.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.567 -0.961 . . . . 0.0 109.685 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 27.9 mttp -104.42 -32.38 9.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.948 HG11 HD12 ' A' ' 65' ' ' LEU . 92.3 t -83.5 -46.29 18.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.175 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 8.0 tttt -41.68 -49.91 9.91 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -67.69 -31.97 31.42 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.341 1.179 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.671 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -68.4 -34.58 66.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.948 HD12 ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -86.3 -31.48 21.58 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.82 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.619 HD11 ' CG ' ' A' ' 37' ' ' LYS . 47.1 mt -71.02 -11.5 61.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.09 -10.36 53.07 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.169 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 1.012 ' O ' HD21 ' A' ' 81' ' ' LEU . 87.7 p -79.17 7.92 6.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 110.473 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.64 9.53 5.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.066 -1.021 . . . . 0.0 109.939 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.995 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.2 mt -93.17 157.26 39.25 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.5 Cg_endo -74.72 167.86 26.13 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.857 1.451 . . . . 0.0 109.635 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.478 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.51 -7.4 6.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.941 -1.099 . . . . 0.0 109.142 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.51 -29.87 61.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.897 HG13 HD22 ' A' ' 45' ' ' LEU . 8.7 mm -85.62 -39.1 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.925 0.869 . . . . 0.0 108.898 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.941 HD22 ' HB3' ' A' ' 40' ' ' LEU . 13.1 mt -79.52 -28.77 41.33 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.08 -26.83 71.49 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.741 ' O ' HD12 ' A' ' 56' ' ' LEU . 28.0 ttm180 -101.43 -31.19 11.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.113 -0.64 . . . . 0.0 110.501 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.861 HG11 HG23 ' A' ' 77' ' ' VAL . 18.7 t -70.63 -36.93 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 108.588 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CZ2' ' OD1' ' A' ' 58' ' ' ASP . 1.6 t-105 -63.44 -50.77 68.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.71 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.3 mm-40 -52.25 -57.7 8.91 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.11 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.4 mt -62.13 -19.28 62.87 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.141 -0.974 . . . . 0.0 108.646 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.879 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 7.5 t -85.9 -33.95 21.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -70.3 92.75 0.8 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 29.1 mm -75.31 -23.26 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 111.328 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -110.2 -9.54 14.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.884 -1.135 . . . . 0.0 110.948 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 50.7 m170 59.59 44.8 14.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.109 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 19.2 p-10 -106.74 9.31 31.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 109.989 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 80.05 24.77 59.06 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.2 mtp -152.17 161.4 42.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.183 -1.187 . . . . 0.0 110.373 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.948 HD12 HG11 ' A' ' 36' ' ' VAL . 13.6 mt -116.84 103.12 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.723 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.599 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -69.26 173.23 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.067 -1.021 . . . . 0.0 110.021 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -50.07 -32.15 14.9 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.613 -0.679 . . . . 0.0 110.894 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 -30.38 20.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 36.2 mt-10 -79.16 -40.6 30.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 108.917 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.748 ' CD1' HD12 ' A' ' 31' ' ' LEU . 27.3 t80 -63.81 -24.45 67.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -70.17 -51.87 27.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.962 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.1 t -57.29 -25.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.547 -0.72 . . . . 0.0 110.359 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.879 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.07 -4.99 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 111.637 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmt -88.53 -44.16 10.88 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.862 -1.149 . . . . 0.0 110.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 4.5 p90 -77.71 -22.17 50.82 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.999 -1.081 . . . . 0.0 108.293 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 12.1 mt -74.63 -24.52 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.012 ' O ' HD12 ' A' ' 81' ' ' LEU . 49.3 t -91.62 -40.96 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.586 -0.696 . . . . 0.0 110.123 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -71.91 -22.52 61.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.648 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.3 m -83.2 -20.76 34.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.818 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.995 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -80.62 -12.82 59.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.332 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.012 HD21 ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.513 -0.742 . . . . 0.0 110.771 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.485 0.983 0 N-CA-C 110.588 -0.581 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.458 HG13 HD22 ' A' ' 76' ' ' LEU . 98.1 t -128.15 137.48 30.93 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 110.605 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.727 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.3 Cg_endo -84.41 175.43 7.2 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.869 1.457 . . . . 0.0 108.503 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.738 ' C ' HD21 ' A' ' 56' ' ' LEU . 9.9 mtm -108.48 18.21 21.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.74 -1.225 . . . . 0.0 110.49 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 56' ' ' LEU . 74.8 m . . . . . 0 C--N 1.295 -1.772 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.355 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.413 ' ND2' ' CD1' ' B' ' 111' ' ' PHE . 5.0 t-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.559 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -74.59 19.69 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.194 1.628 . . . . 0.0 112.35 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.948 ' CE2' HD12 ' A' ' 40' ' ' LEU . 24.5 m-85 -99.94 -61.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.511 -1.368 . . . . 0.0 108.69 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.416 ' HA ' HG11 ' A' ' 47' ' ' VAL . 27.1 mtm180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.222 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.609 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 16.0 t90 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.274 0.559 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.27 -27.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 42.0 t -96.6 145.3 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.55 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.4 mttm -112.52 -179.46 0.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.4 Cg_endo -67.56 -35.53 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.745 1.392 . . . . 0.0 110.199 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 6.2 pt-20 -71.21 -30.62 66.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 5.8 m-20 -83.63 -38.13 21.94 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.224 -0.923 . . . . 0.0 108.655 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 5.9 tptm -69.33 -17.65 63.73 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.74 -39.67 35.57 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.634 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.2 ptmm? -81.05 -22.85 38.98 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -76.93 -34.75 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.9 -19.63 60.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 0.0 110.31 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -83.6 -33.62 25.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.985 . . . . 0.0 108.451 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.736 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -78.07 -31.39 16.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.769 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -71.84 -38.95 70.06 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.704 0.764 . . . . 0.0 109.034 179.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.55 -6.49 54.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.512 -0.742 . . . . 0.0 109.878 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.2 t -78.76 -7.51 57.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 0.0 108.909 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.025 HD12 HD13 ' A' ' 31' ' ' LEU . 10.6 mt -101.77 -54.34 2.75 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 m 137.97 98.51 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.16 148.3 39.18 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 O-C-N 123.977 1.514 . . . . 0.0 110.499 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -120.08 98.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.627 -0.67 . . . . 0.0 109.31 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 3.8 t30 60.37 14.86 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.726 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.458 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 107.03 32.88 3.38 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 84.9 m-85 -148.6 151.99 35.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.908 -1.348 . . . . 0.0 112.078 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.025 HD13 HD12 ' A' ' 24' ' ' LEU . 6.7 mt -120.31 143.18 48.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 33' ' ' GLY . 96.6 p -89.08 141.79 28.2 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.822 -1.174 . . . . 0.0 110.28 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.69 -25.96 0.99 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.0 t70 -65.83 -22.36 66.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.513 -0.993 . . . . 0.0 110.072 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB3' HD13 ' A' ' 24' ' ' LEU . 7.7 mttp -97.81 -35.91 10.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 98.1 t -77.77 -42.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.514 0.673 . . . . 0.0 110.011 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.48 -53.82 5.31 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 110.915 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.1 Cg_endo -68.67 -33.9 20.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.542 1.285 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.712 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.5 t -63.55 -31.75 54.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.031 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.981 ' HB3' HD22 ' A' ' 50' ' ' LEU . 33.0 mt -88.43 -26.58 22.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 110.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD11 ' HE2' ' A' ' 37' ' ' LYS . 51.9 mt -73.8 -11.23 60.32 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.175 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -90.31 -3.19 57.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 1.022 ' O ' HD21 ' A' ' 81' ' ' LEU . 91.9 p -84.34 13.98 4.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 110.09 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt 59.39 13.72 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.925 HD11 ' HB3' ' A' ' 80' ' ' ALA . 17.5 mt -100.16 156.87 34.78 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.905 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.6 Cg_endo -74.58 171.08 18.86 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.921 1.485 . . . . 0.0 109.868 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.561 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.4 -6.19 6.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.286 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.71 -31.15 59.54 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.879 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -83.12 -40.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 122.017 0.913 . . . . 0.0 108.556 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.981 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.1 mt -76.7 -26.94 55.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.729 0.776 . . . . 0.0 108.959 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.8 -29.08 65.81 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.857 ' O ' HD12 ' A' ' 56' ' ' LEU . 30.1 ttm180 -101.0 -28.3 12.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.886 -0.773 . . . . 0.0 109.934 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.928 HG11 HG23 ' A' ' 77' ' ' VAL . 19.4 t -72.49 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.43 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.558 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.3 t-105 -65.82 -51.46 58.75 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.814 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.2 mm-40 -50.82 -60.53 2.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.406 -0.809 . . . . 0.0 109.991 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -61.54 -15.93 43.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.498 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.028 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 9.2 t -92.24 -18.17 23.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.487 0.661 . . . . 0.0 109.235 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.1 t0 -90.83 82.11 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.514 -0.741 . . . . 0.0 110.322 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG12 ' HG2' ' A' ' 69' ' ' GLU . 12.1 mm -62.67 -24.12 34.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.604 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -104.24 -7.96 19.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 20.6 p80 38.35 51.92 1.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.567 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.2 p-10 -119.68 20.33 12.35 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.004 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.53 29.71 54.94 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.4 mtp -150.24 161.3 42.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -1.158 . . . . 0.0 111.087 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 14.0 mt -129.53 112.59 13.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 109.746 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 13.7 t0 -70.02 168.39 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.065 -1.022 . . . . 0.0 110.47 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.557 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -50.75 -41.08 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.872 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 46.4 t0 -81.01 -32.82 34.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HG2' HG12 ' A' ' 59' ' ' ILE . 2.3 mt-10 -71.96 -50.21 30.82 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.873 0.844 . . . . 0.0 109.257 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.922 ' CD2' HD12 ' A' ' 31' ' ' LEU . 29.3 t80 -53.57 -22.83 9.15 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -68.83 -52.87 25.38 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.852 0.834 . . . . 0.0 109.77 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.681 ' O ' HD12 ' A' ' 76' ' ' LEU . 49.0 t -52.64 -24.61 6.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 110.394 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.028 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.67 -11.48 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 0.0 112.499 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 mmm -86.77 -47.11 9.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.392 -1.442 . . . . 0.0 110.435 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.542 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 1.9 p90 -73.38 -21.75 60.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.691 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.2 mt -74.55 -24.95 59.01 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.928 HG23 HG11 ' A' ' 53' ' ' VAL . 59.8 t -90.96 -42.46 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -68.54 -19.09 64.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.619 -0.675 . . . . 0.0 110.21 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 16.1 m -84.65 -25.74 28.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -73.55 -17.44 61.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 108.698 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.022 HD21 ' O ' ' A' ' 43' ' ' SER . 1.1 mt . . . . . 0 C--N 1.305 -1.369 0 O-C-N 121.724 -0.61 . . . . 0.0 110.767 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.482 0.817 0 N-CA-C 110.244 -0.714 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.526 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 96.4 t -113.99 134.95 22.06 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.771 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.6 Cg_endo -84.69 -173.12 1.4 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.072 1.564 . . . . 0.0 109.02 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.776 ' C ' HD21 ' A' ' 56' ' ' LEU . 29.6 mtm -111.55 10.14 21.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 109.872 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.537 ' N ' HD21 ' A' ' 56' ' ' LEU . 19.6 m . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.887 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.506 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.5 t-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.803 0.335 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -72.94 2.39 5.48 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.078 1.568 . . . . 0.0 111.483 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.947 ' CE2' HD12 ' A' ' 40' ' ' LEU . 4.4 m-85 -101.2 -47.97 4.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.853 -1.155 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.514 ' HG2' ' HA3' ' A' ' 51' ' ' GLY . 1.2 mmm180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.275 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.599 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.9 t90 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.16 0.505 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -40.93 -28.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.451 -0.78 . . . . 0.0 110.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.599 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 85.4 t -113.31 135.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 110.152 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.542 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -93.77 -179.69 1.07 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.349 -0.844 . . . . 0.0 109.995 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.13 -35.27 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.927 1.488 . . . . 0.0 110.02 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.6 -33.52 58.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 15.0 m-20 -76.96 -34.66 57.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 68' ' ' ASP . 1.5 tttt -76.79 -20.16 56.75 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.7 71.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.627 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -70.13 -21.23 63.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -80.21 -29.29 38.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.38 -20.14 57.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.718 -0.614 . . . . 0.0 109.804 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -81.57 -32.69 32.02 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.831 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 63.8 mt -78.97 -33.0 15.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.821 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -67.78 -35.17 78.19 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -91.03 -5.44 55.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.461 -0.775 . . . . 0.0 110.324 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 87.3 p -78.95 -14.65 59.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 108.839 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.054 HD12 ' CD1' ' A' ' 31' ' ' LEU . 11.6 mt -92.96 -55.07 3.48 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 t 142.8 92.92 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.478 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.7 Cg_endo -74.87 148.99 36.67 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 O-C-N 124.198 1.631 . . . . 0.0 110.88 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -125.38 103.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.5 t30 63.37 13.66 7.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.642 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 32.66 4.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.2 m-85 -146.5 148.79 32.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -1.166 . . . . 0.0 111.908 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.054 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.1 mt -113.83 158.51 20.93 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' LYS . 48.3 p -105.14 143.45 33.3 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.606 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.59 -25.1 0.49 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' SER . 61.4 t0 -71.32 -23.97 62.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.413 -1.051 . . . . 0.0 110.412 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 32' ' ' SER . 14.0 mttp -94.09 -35.61 12.48 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.071 -1.018 . . . . 0.0 108.417 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.917 HG11 HD12 ' A' ' 65' ' ' LEU . 87.5 t -78.16 -42.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.382 0.61 . . . . 0.0 110.384 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.572 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 14.8 tttt -40.03 -54.42 4.42 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 110.549 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -66.93 -33.85 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.406 1.214 . . . . 0.0 110.021 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.788 ' CG2' HD21 ' A' ' 24' ' ' LEU . 2.2 t -62.25 -35.2 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.818 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.009 ' HB3' HD22 ' A' ' 50' ' ' LEU . 30.3 mt -87.83 -30.02 20.52 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.705 -0.622 . . . . 0.0 110.063 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.516 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 67.2 mt -70.13 -13.95 62.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -91.36 -4.1 56.1 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.52 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -83.56 16.75 2.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.386 -0.821 . . . . 0.0 110.445 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.557 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.0 tttp 60.32 11.92 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.177 -0.952 . . . . 0.0 109.591 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.006 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.9 mt -99.19 153.39 37.81 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 110.566 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.0 Cg_endo -75.76 175.97 10.61 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 124.175 1.619 . . . . 0.0 109.271 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.6 t -73.27 -3.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.6 m-20 -81.68 -30.44 32.64 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.246 -0.909 . . . . 0.0 109.285 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.901 HG13 HD22 ' A' ' 45' ' ' LEU . 5.3 mm -88.0 -39.23 12.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.009 HD22 ' HB3' ' A' ' 40' ' ' LEU . 23.6 mt -74.78 -27.67 60.42 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -74.58 -21.8 78.19 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -99.99 -33.75 10.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.161 -0.611 . . . . 0.0 109.402 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 77' ' ' VAL . 18.6 t -69.22 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 4.4 t-105 -76.2 -55.38 5.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.557 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.8 mm-40 -52.02 -58.24 7.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.96 -1.088 . . . . 0.0 110.048 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.6 mt -59.29 -16.32 21.08 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.582 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.71 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.0 t -91.44 -40.25 11.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 109.713 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' TRP . 1.2 t0 -65.82 97.66 0.35 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.472 -0.767 . . . . 0.0 109.996 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.523 HG12 ' HG3' ' A' ' 69' ' ' GLU . 15.2 mm -72.22 -31.36 39.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.564 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 4.2 p30 -105.81 -9.64 17.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.801 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.564 ' CG ' ' C ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER 51.77 51.02 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.381 -0.825 . . . . 0.0 109.994 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 47.0 p-10 -111.09 20.83 17.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 75.11 32.81 55.73 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 10.6 mtp -150.69 161.34 42.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.248 . . . . 0.0 111.858 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.917 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 mt -132.27 99.73 4.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.606 -0.684 . . . . 0.0 109.293 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.2 p30 -71.49 160.41 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 110.468 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 10.1 ptt-85 -34.9 -44.21 0.21 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.756 -0.59 . . . . 0.0 111.31 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.8 m-20 -77.64 -35.08 52.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.701 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HG3' HG12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -70.13 -48.41 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.81 0.814 . . . . 0.0 109.22 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.831 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 25.3 t80 -61.04 -14.17 21.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -79.19 -47.28 16.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.527 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.845 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.9 t -59.01 -29.62 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.077 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.2 -2.37 58.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.63 -0.669 . . . . 0.0 111.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.615 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 10.0 mmt -88.08 -48.33 7.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.472 -1.392 . . . . 0.0 110.112 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -76.1 -24.18 54.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 72' ' ' VAL . 8.6 mt -70.8 -26.45 63.32 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.995 HG23 HG11 ' A' ' 53' ' ' VAL . 8.6 t -91.09 -23.61 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.728 -0.607 . . . . 0.0 109.998 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.45 -26.31 28.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.599 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.29 -17.67 48.52 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.549 -0.72 . . . . 0.0 109.675 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.006 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.39 -8.68 57.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.374 -0.828 . . . . 0.0 109.145 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.7 mt . . . . . 0 C--N 1.302 -1.458 0 CA-C-O 121.751 0.786 . . . . 0.0 108.959 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 N--CA 1.482 0.823 0 N-CA-C 110.063 -0.783 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG13 HD22 ' A' ' 76' ' ' LEU . 59.9 t -138.18 125.56 13.58 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.828 ' O ' HD11 ' A' ' 56' ' ' LEU . 53.2 Cg_endo -84.9 -175.95 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.926 1.488 . . . . 0.0 109.474 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.752 ' C ' HD21 ' A' ' 56' ' ' LEU . 28.4 mtp -110.73 12.36 22.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.474 ' N ' HD21 ' A' ' 56' ' ' LEU . 52.5 m . . . . . 0 C--N 1.299 -1.625 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.772 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 112' ' ' ARG . 10.6 t-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.01 0.434 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 52.2 Cg_endo -72.97 4.85 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.288 1.678 . . . . 0.0 111.686 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.955 ' CE2' HD12 ' A' ' 40' ' ' LEU . 4.1 m-85 -105.17 -69.42 0.82 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.793 -1.192 . . . . 0.0 109.007 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.515 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.566 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.251 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.609 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.4 t90 . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 121.287 0.565 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.07 -24.74 7.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 89.3 t -97.5 116.76 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.467 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.8 mttp -93.67 -177.81 0.75 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.496 -0.752 . . . . 0.0 109.633 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -67.63 -34.07 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.659 1.347 . . . . 0.0 110.048 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.43 -33.22 62.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.85 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.7 m-20 -81.55 -36.76 28.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.342 -0.849 . . . . 0.0 108.738 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.4 tttt -74.87 -15.17 60.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -76.93 -40.28 47.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.8 ptpt -75.34 -25.07 57.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -73.32 -36.02 66.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.83 -22.73 64.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.733 -0.604 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.24 -30.49 43.22 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.739 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 16.9 mt -82.8 -35.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.46 -36.59 68.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.556 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.5 t0 -87.03 -2.09 58.37 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.641 -0.662 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -86.48 -9.42 56.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 108.954 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.083 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.2 mt -102.96 -14.55 16.45 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.619 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.03 93.04 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -74.77 153.55 43.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.284 1.676 . . . . 0.0 111.068 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.1 t -120.92 105.86 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 65.04 12.64 8.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.218 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.71 33.83 5.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.575 ' CD1' ' OD1' ' A' ' 66' ' ' ASP . 76.9 m-85 -141.13 141.99 34.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.159 . . . . 0.0 111.882 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.083 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.8 mt -113.98 136.79 52.52 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 35' ' ' LYS . 3.3 p -83.5 146.01 28.61 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.77 -26.74 1.2 Allowed Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 33.4 t0 -66.41 -26.22 67.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.579 -0.954 . . . . 0.0 109.991 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 6.1 mttp -92.26 -33.26 14.72 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.838 HG21 HD12 ' A' ' 65' ' ' LEU . 86.4 t -80.96 -47.12 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.415 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 20.6 tttm -39.67 -51.58 5.12 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 0.0 110.917 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -68.8 -34.39 18.4 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.355 1.187 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.803 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -62.84 -32.67 56.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.017 ' HB3' HD22 ' A' ' 50' ' ' LEU . 36.9 mt -90.62 -27.64 18.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.573 -0.704 . . . . 0.0 110.081 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.487 HD11 ' HE2' ' A' ' 37' ' ' LYS . 55.9 mt -74.77 -11.29 60.12 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.035 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -90.38 -9.21 48.47 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 110.185 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.3 p -78.39 5.98 9.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.1 tttt 69.23 9.02 7.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.935 . . . . 0.0 110.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.911 HD22 HG13 ' A' ' 49' ' ' ILE . 18.5 mt -93.82 157.25 38.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -75.68 171.89 17.35 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.251 1.658 . . . . 0.0 109.285 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.8 t -70.73 -4.76 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 109.189 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.17 -29.53 54.52 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 108.78 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.911 HG13 HD22 ' A' ' 45' ' ' LEU . 6.5 mm -87.89 -36.71 9.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.866 0.841 . . . . 0.0 108.755 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.017 HD22 ' HB3' ' A' ' 40' ' ' LEU . 13.4 mt -79.33 -26.72 42.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -72.52 -23.14 78.43 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.789 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.6 ttm105 -100.83 -32.49 10.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.972 -0.722 . . . . 0.0 109.723 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.643 HG11 ' CG2' ' A' ' 77' ' ' VAL . 12.9 t -68.91 -38.97 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.205 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.596 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 4.0 t-105 -67.49 -48.01 68.36 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.359 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.8 mm-40 -59.53 -58.28 9.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.154 -0.966 . . . . 0.0 109.848 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.831 HD11 ' O ' ' A' ' 87' ' ' PRO . 5.6 mt -58.83 -17.39 23.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 108.483 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 10.2 t -88.25 -45.19 10.27 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.583 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -59.79 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.639 -0.663 . . . . 0.0 110.14 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.422 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 33.5 mm -67.98 -30.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 110.128 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.6 p30 -109.6 -15.67 14.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 9.9 m-70 62.02 41.17 11.39 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.406 -0.809 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.1 p-10 -93.13 3.9 54.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.989 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 89.03 23.01 36.39 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.4 mtp -152.79 162.1 41.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -1.168 . . . . 0.0 110.454 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.838 HD12 HG21 ' A' ' 36' ' ' VAL . 46.0 mt -119.4 112.33 19.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.422 -0.799 . . . . 0.0 109.502 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 30' ' ' PHE . 2.0 m-20 -69.39 159.22 33.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.283 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 19.7 ptt180 -41.52 -42.25 2.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 109.988 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 9.9 t70 -81.64 -34.69 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 57' ' ' SER . 1.8 tt0 -69.35 -49.62 53.96 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.803 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 40.8 t80 -57.97 -19.8 33.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -70.56 -50.31 38.81 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.883 0.849 . . . . 0.0 109.587 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 76' ' ' LEU . 83.4 t -55.15 -24.87 15.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.458 0.647 . . . . 0.0 109.961 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -88.33 -10.46 49.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 111.972 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.566 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmm -84.58 -43.53 14.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.41 ' HB3' ' OH ' ' A' ' 17' ' ' TYR . 2.8 p90 -75.67 -22.88 56.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.645 -1.222 . . . . 0.0 107.751 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.0 mt -72.24 -22.16 61.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 73' ' ' ALA . 70.5 t -91.24 -44.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.765 -0.584 . . . . 0.0 109.513 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -65.14 -27.41 68.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.636 -0.665 . . . . 0.0 110.956 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -77.17 -20.47 55.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.99 -1.068 . . . . 0.0 108.722 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.856 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.48 -7.32 57.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.567 ' N ' HD23 ' A' ' 81' ' ' LEU . 3.2 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.399 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.484 0.941 0 N-CA-C 110.438 -0.639 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.467 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.8 t -132.32 127.41 20.79 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 110.753 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.831 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -83.16 -179.54 4.44 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.905 1.476 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.675 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.0 mtt -104.32 10.38 35.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.798 -1.189 . . . . 0.0 109.847 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.456 ' N ' HD21 ' A' ' 56' ' ' LEU . 68.3 m . . . . . 0 C--N 1.297 -1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 112.115 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.483 ' HA ' ' HD2' ' B' ' 110' ' ' PRO . 10.3 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.177 0.513 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.585 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 51.9 Cg_endo -71.01 6.16 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 121.887 1.725 . . . . 0.0 111.964 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.931 ' CE2' HD12 ' A' ' 40' ' ' LEU . 7.7 m-85 -99.88 -63.77 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.222 . . . . 0.0 108.992 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.549 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.4 t90 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.327 0.585 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.85 -27.75 3.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 0.0 109.935 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.4 t -92.14 122.64 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.483 ' HG2' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -80.33 176.01 4.22 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.192 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -70.08 -34.07 14.2 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.053 1.554 . . . . 0.0 109.788 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.2 pp20? -79.6 -22.59 43.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.421 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 m-20 -82.86 -38.49 22.89 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -14.93 61.18 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.34 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.472 -0.768 . . . . 0.0 109.024 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.8 ptpt -72.97 -26.14 61.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -71.81 -35.2 69.87 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.81 -23.05 60.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.654 -0.654 . . . . 0.0 109.869 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.25 -32.19 38.34 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.577 HG22 ' CE1' ' A' ' 70' ' ' PHE . 66.7 mt -81.31 -31.9 11.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.689 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.26 -37.03 66.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.5 t70 -88.76 -1.49 58.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.658 -0.652 . . . . 0.0 110.119 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -4.15 57.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.21 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.105 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.5 mt -108.84 -8.66 15.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 87.04 95.0 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -72.09 148.56 50.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.314 1.691 . . . . 0.0 110.838 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 73.8 t -119.76 100.36 9.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 63.77 16.55 9.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 97.11 34.01 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.2 m-85 -149.48 147.41 28.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -1.191 . . . . 0.0 111.776 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.105 ' CD1' HD12 ' A' ' 24' ' ' LEU . 14.8 mt -116.63 134.45 54.81 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 17.5 p -77.82 146.62 35.64 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.769 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.46 -27.19 1.18 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.3 m-20 -61.49 -25.42 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.869 . . . . 0.0 110.031 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 35.7 mttt -98.08 -32.19 11.74 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.111 -0.993 . . . . 0.0 108.338 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.972 HG11 HD12 ' A' ' 65' ' ' LEU . 97.9 t -83.54 -48.21 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.421 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 17.7 tttt -40.14 -53.56 5.02 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.49 -30.44 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.408 1.215 . . . . 0.0 109.703 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -68.81 -30.65 47.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.974 ' HB3' HD22 ' A' ' 50' ' ' LEU . 44.7 mt -88.79 -28.28 20.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.411 -0.806 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.76 -11.25 60.73 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.014 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -90.08 -5.46 56.53 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.568 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.523 ' CB ' HG13 ' A' ' 77' ' ' VAL . 5.8 p -83.21 13.28 4.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.108 -0.995 . . . . 0.0 110.673 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 63.43 8.98 3.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.923 . . . . 0.0 110.676 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.938 HD13 HG21 ' A' ' 49' ' ' ILE . 15.2 mt -94.67 157.76 36.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 0.0 109.582 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.7 Cg_endo -75.28 173.66 14.13 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 124.023 1.538 . . . . 0.0 109.243 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.0 t -74.45 -1.41 2.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.145 -0.972 . . . . 0.0 109.373 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -31.19 33.1 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.938 HG21 HD13 ' A' ' 45' ' ' LEU . 12.8 mm -83.02 -40.35 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.974 HD22 ' HB3' ' A' ' 40' ' ' LEU . 22.7 mt -73.84 -25.92 60.32 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -73.35 -25.28 73.31 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.86 -28.09 12.97 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.804 -0.821 . . . . 0.0 110.032 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.882 HG11 HG23 ' A' ' 77' ' ' VAL . 17.0 t -72.58 -39.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.78 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 2.4 t-105 -65.09 -50.97 64.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.576 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 9.6 mm-40 -56.19 -53.84 52.39 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.595 HD11 ' O ' ' A' ' 87' ' ' PRO . 18.3 mt -64.46 -12.7 46.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.67 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t -94.97 -29.73 14.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 108.88 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 7.4 t0 -74.5 100.75 3.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.692 -0.63 . . . . 0.0 109.65 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.486 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.1 mm -80.44 -29.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -102.1 -18.56 15.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 4.8 m170 65.72 42.12 3.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.0 p30 -102.28 -3.74 26.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.461 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 95.12 25.87 13.52 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 5.1 mtp -152.56 161.25 42.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.245 . . . . 0.0 110.618 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.972 HD12 HG11 ' A' ' 36' ' ' VAL . 13.5 mt -119.78 102.12 8.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.667 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.618 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 5.1 p30 -71.57 167.47 19.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.56 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.7 ptt-85 -37.55 -46.04 0.8 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.0 111.854 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 80.7 m-20 -76.68 -37.21 56.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.075 -1.016 . . . . 0.0 110.665 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 44.9 mt-10 -71.85 -44.5 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.972 ' CD2' HD12 ' A' ' 31' ' ' LEU . 11.6 t80 -60.51 -17.37 45.0 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -79.24 -45.79 19.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.585 ' O ' HD12 ' A' ' 76' ' ' LEU . 46.5 t -61.4 -25.97 38.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.476 0.655 . . . . 0.0 109.747 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.67 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.55 -8.23 50.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 111.258 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.7 mmt -83.24 -47.74 11.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -75.14 -28.73 60.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 72' ' ' VAL . 6.7 mt -66.93 -28.67 68.48 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.882 HG23 HG11 ' A' ' 53' ' ' VAL . 41.0 t -91.38 -23.94 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.686 -0.634 . . . . 0.0 110.393 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -29.78 17.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.897 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.82 -15.65 44.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.65 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.665 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -81.42 -10.24 59.55 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.907 -1.121 . . . . 0.0 108.211 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 45' ' ' LEU . 4.0 mt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.356 0.598 . . . . 0.0 110.273 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.484 0.923 0 N-CA-C 110.622 -0.568 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 53' ' ' VAL . 59.0 t -113.56 146.71 35.99 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.241 -0.912 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.595 ' O ' HD11 ' A' ' 56' ' ' LEU . 43.8 Cg_endo -86.97 -168.46 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.632 1.333 . . . . 0.0 109.472 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.427 ' HG3' ' C ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -124.88 15.21 8.6 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.004 -1.06 . . . . 0.0 111.361 -179.138 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.495 1.801 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.565 -179.502 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.517 ' ND2' ' HG2' ' A' ' 55' ' ' GLU . 6.0 t-20 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.556 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 50.6 Cg_endo -68.52 8.27 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.259 1.972 . . . . 0.0 112.573 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.954 ' CE2' HD12 ' A' ' 40' ' ' LEU . 2.0 m-85 -102.88 -67.49 0.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.545 -1.347 . . . . 0.0 108.577 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.509 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 2.0 mtt-85 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.121 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.2 t90 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.336 0.589 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -41.63 -32.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 110.298 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.634 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 69.9 t -102.99 136.92 33.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 109.598 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.453 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mtmt -88.42 175.09 4.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 110.24 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.5 Cg_endo -70.21 -34.37 13.19 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.975 1.513 . . . . 0.0 109.745 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -77.08 -22.44 52.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.743 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 3.1 m-20 -82.93 -36.78 24.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.81 . . . . 0.0 109.132 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -80.5 -24.51 39.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -65.84 -39.78 91.12 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.0 ptpt -74.71 -28.67 60.9 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.4 m-30 -70.58 -36.71 73.72 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -63.8 -20.48 65.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.71 -0.619 . . . . 0.0 110.15 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.63 -36.1 33.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 47.8 mt -78.43 -31.43 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.814 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.48 -32.53 68.37 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -87.49 -5.61 58.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.579 -0.7 . . . . 0.0 109.859 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -85.46 -8.49 58.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 0.0 109.085 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.091 HD12 ' CD1' ' A' ' 31' ' ' LEU . 7.2 mt -100.4 -16.87 17.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.627 -0.671 . . . . 0.0 109.316 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.5 t 88.74 89.03 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 121.358 0.599 . . . . 0.0 109.877 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.7 Cg_endo -73.33 151.37 48.33 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.552 1.817 . . . . 0.0 110.854 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 55.9 t -121.3 104.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.89 18.09 11.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.439 -0.788 . . . . 0.0 109.413 -178.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.85 34.16 6.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.18 137.82 32.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 112.017 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.091 ' CD1' HD12 ' A' ' 24' ' ' LEU . 7.9 mt -110.3 158.5 18.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 35' ' ' LYS . 8.2 p -104.07 143.79 32.43 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.624 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.76 -25.78 0.65 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -70.85 -25.24 62.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.571 -0.958 . . . . 0.0 110.314 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB3' HD13 ' A' ' 24' ' ' LEU . 35.1 mttm -88.56 -36.01 16.6 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.915 HG12 ' CD1' ' A' ' 40' ' ' LEU . 81.2 t -77.22 -41.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.08 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.51 -51.65 6.48 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.518 -0.739 . . . . 0.0 111.026 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.9 Cg_endo -70.62 -34.27 12.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.369 1.194 . . . . 0.0 109.878 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.51 -32.56 53.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.934 HD12 ' CE2' ' B' ' 111' ' ' PHE . 23.7 mt -90.56 -29.34 17.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.587 -0.696 . . . . 0.0 109.977 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD11 ' HE2' ' A' ' 37' ' ' LYS . 33.5 mt -69.75 -9.55 54.93 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -90.65 -8.68 49.37 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.565 -0.71 . . . . 0.0 111.173 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.535 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 84.5 p -82.18 15.36 2.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -0.976 . . . . 0.0 110.652 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.18 14.03 3.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -0.99 . . . . 0.0 110.197 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.86 HD22 HG13 ' A' ' 49' ' ' ILE . 17.5 mt -98.16 157.89 33.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.977 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.0 Cg_endo -74.88 166.71 28.67 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 124.067 1.562 . . . . 0.0 109.228 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' B' ' 111' ' ' PHE . 13.9 t -68.26 -6.97 6.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -30.0 58.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.876 -1.14 . . . . 0.0 109.143 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.86 HG13 HD22 ' A' ' 45' ' ' LEU . 7.5 mm -83.81 -40.06 15.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -71.02 -30.6 66.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' B' ' 109' ' ' ASN . . . -72.18 -26.22 72.73 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.3 ttm-85 -100.12 -28.41 13.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.825 -0.809 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.825 HG11 ' CG2' ' A' ' 77' ' ' VAL . 10.3 t -74.18 -34.7 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.624 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.1 t-105 -66.74 -53.05 37.4 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.131 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.6 mt-10 -48.65 -58.36 4.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.941 HD21 ' C ' ' A' ' 88' ' ' MET . 2.7 mt -62.65 -13.09 27.83 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.069 -1.053 . . . . 0.0 108.773 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.688 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -91.81 -42.72 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.255 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' TRP . 11.6 t0 -66.04 78.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.492 -0.755 . . . . 0.0 110.395 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.509 HG12 ' HG3' ' A' ' 69' ' ' GLU . 42.8 mm -51.47 -27.72 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.41 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.496 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 2.4 m-20 -102.84 -20.18 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.29 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.496 ' CD2' ' C ' ' A' ' 60' ' ' ASP . 9.1 m-70 59.89 47.1 10.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 33.4 p-10 -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.063 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.463 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 86.45 28.9 26.02 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.1 mtt -150.24 161.44 42.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 111.09 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.651 HD13 ' HA ' ' A' ' 70' ' ' PHE . 7.6 mt -130.99 109.72 10.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.842 . . . . 0.0 110.072 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 1.8 m-20 -69.8 159.34 33.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.981 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -41.21 -42.19 2.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.503 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 57.8 t0 -82.4 -33.3 28.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.5 tt0 -69.11 -50.46 47.89 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.171 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.651 ' HA ' HD13 ' A' ' 65' ' ' LEU . 57.3 t80 -55.93 -22.84 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.17 -48.67 67.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.455 -0.778 . . . . 0.0 110.055 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.579 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 76.9 t -58.27 -24.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.528 -0.732 . . . . 0.0 110.132 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.688 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -84.86 -13.36 51.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.246 -0.909 . . . . 0.0 112.166 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.2 mmm -85.92 -36.07 20.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.545 -1.347 . . . . 0.0 110.732 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.634 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 5.0 p90 -79.08 -26.3 43.02 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.611 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.761 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.8 mt -71.72 -22.33 61.65 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.825 ' CG2' HG11 ' A' ' 53' ' ' VAL . 72.6 t -90.82 -32.89 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.639 -0.663 . . . . 0.0 110.142 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -78.36 -23.24 47.02 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.441 -0.787 . . . . 0.0 110.045 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -83.02 -13.79 55.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.639 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.686 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.49 -14.18 41.09 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.189 -0.944 . . . . 0.0 109.125 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.821 HD21 ' CD1' ' A' ' 45' ' ' LEU . 9.6 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.602 -0.686 . . . . 0.0 110.844 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.484 0.953 0 N-CA-C 110.428 -0.643 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.744 HG21 ' CG2' ' A' ' 53' ' ' VAL . 84.8 t -115.07 122.18 33.86 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 111.024 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.786 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.1 Cg_endo -81.55 -167.09 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.964 1.507 . . . . 0.0 109.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.941 ' C ' HD21 ' A' ' 56' ' ' LEU . 14.7 mtp -120.04 18.66 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.02 . . . . 0.0 110.338 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 56' ' ' LEU . 66.6 m . . . . . 0 C--N 1.295 -1.766 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.79 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLY . 35.1 t-20 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.911 0.386 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.522 ' HD2' ' CE1' ' B' ' 111' ' ' PHE . 49.5 Cg_endo -69.54 3.04 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.32 1.695 . . . . 0.0 111.77 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.934 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -104.16 -62.92 1.25 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.776 -1.202 . . . . 0.0 108.903 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.457 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.168 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.7 t90 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.191 0.52 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.44 -26.36 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.293 -0.879 . . . . 0.0 110.207 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.4 t -102.7 137.97 28.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.45 -0.781 . . . . 0.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.507 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 5.5 mttt -110.71 176.04 1.67 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.411 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.711 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 39.6 Cg_endo -65.53 -38.13 26.66 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.94 1.495 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 12.4 pt-20 -67.94 -36.43 80.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.045 -1.035 . . . . 0.0 109.172 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -81.21 -37.8 28.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -76.17 -17.05 59.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -71.85 -40.87 68.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -75.69 -26.61 57.74 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.624 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -71.15 -34.32 70.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -21.67 64.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.662 -0.649 . . . . 0.0 110.265 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.2 33.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.052 -1.03 . . . . 0.0 108.414 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.669 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 69.9 mt -76.94 -30.93 18.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.826 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.85 -39.66 63.83 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.546 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t70 -86.45 2.57 47.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.558 -0.714 . . . . 0.0 110.096 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -89.53 -11.5 42.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.329 -0.857 . . . . 0.0 109.333 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.106 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -99.83 -15.14 18.51 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.608 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 t 86.01 81.68 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.299 0 CA-C-O 121.439 0.638 . . . . 0.0 109.674 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 44.6 Cg_endo -71.06 152.57 62.66 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.87 1.984 . . . . 0.0 111.103 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.1 t -118.92 117.22 53.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER 63.78 13.06 7.17 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.579 -178.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.51 34.1 8.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 23.1 m-85 -135.36 138.36 43.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -1.11 . . . . 0.0 111.647 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.106 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.1 mt -109.49 137.57 47.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 34' ' ' ASP . 3.9 p -85.06 142.28 29.67 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.105 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.31 -25.81 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . 32.8 t70 -69.18 -24.28 64.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.384 -1.069 . . . . 0.0 110.326 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 9.6 mttm -92.53 -35.35 13.64 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.018 -1.051 . . . . 0.0 108.17 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.847 HG12 ' CD1' ' A' ' 40' ' ' LEU . 96.3 t -75.32 -41.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.566 0.698 . . . . 0.0 110.403 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.79 -54.92 6.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 111.035 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.12 -32.48 34.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.443 1.233 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.844 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.3 t -63.84 -33.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.023 ' HB3' HD22 ' A' ' 50' ' ' LEU . 26.1 mt -89.92 -27.25 19.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 110.461 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 45.3 mt -68.26 -15.04 63.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -90.76 -2.45 57.8 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.708 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.596 ' O ' HD21 ' A' ' 81' ' ' LEU . 79.6 p -82.65 12.67 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.591 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 63.57 10.55 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.042 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.8 mt -100.46 159.11 30.59 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.391 -0.818 . . . . 0.0 110.486 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.1 Cg_endo -76.39 171.77 17.47 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.113 1.586 . . . . 0.0 109.415 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' B' ' 111' ' ' PHE . 4.5 t -71.92 -3.49 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.526 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.45 -30.87 42.34 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.156 -0.965 . . . . 0.0 109.097 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.878 HG13 HD22 ' A' ' 45' ' ' LEU . 8.8 mm -84.1 -39.6 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.023 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.8 mt -72.2 -26.44 62.05 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.563 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -74.53 -26.54 67.43 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.109 -1.997 . . . . 0.0 108.109 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.781 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.5 ttm180 -100.7 -25.47 14.13 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.92 -0.753 . . . . 0.0 110.215 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.083 HG11 HG23 ' A' ' 77' ' ' VAL . 13.6 t -74.27 -36.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.917 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.614 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.79 -48.17 67.06 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.15 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.3 mm-40 -52.55 -58.18 7.58 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 110.089 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.929 HD21 ' C ' ' A' ' 88' ' ' MET . 3.5 mt -62.85 -17.57 61.64 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.481 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.893 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 30.1 t -86.08 -30.59 22.48 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.4 t0 -71.12 101.36 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.543 -0.723 . . . . 0.0 109.683 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.421 ' HB ' ' CD ' ' A' ' 69' ' ' GLU . 47.8 mm -75.63 -42.4 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.613 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 31.2 p30 -104.41 -4.69 22.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.062 -1.024 . . . . 0.0 111.044 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 38.0 m170 60.86 44.4 10.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.171 -0.955 . . . . 0.0 110.541 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 38.1 p30 -100.05 26.51 6.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.237 -0.914 . . . . 0.0 109.059 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 58.53 31.69 67.41 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.8 mtt -150.91 161.04 43.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -1.05 . . . . 0.0 110.357 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.824 HD12 HG11 ' A' ' 36' ' ' VAL . 16.0 mt -123.6 102.29 7.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.538 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -69.29 157.51 36.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 66' ' ' ASP . 14.2 ptt180 -37.06 -39.39 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.676 . . . . 0.0 110.81 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' OD2' ' HG3' ' A' ' 67' ' ' ARG . 17.8 m-20 -79.51 -35.0 40.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 109.928 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 14.5 mt-10 -75.4 -40.95 57.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.963 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.0 t80 -62.62 -23.88 67.3 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.87 -44.79 63.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.465 -0.772 . . . . 0.0 110.13 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.64 ' O ' HD12 ' A' ' 76' ' ' LEU . 85.7 t -64.28 -22.16 30.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.022 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.81 -5.66 56.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmt -87.94 -44.44 11.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.828 -1.17 . . . . 0.0 109.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CD2' HG22 ' A' ' 9' ' ' VAL . 2.3 p90 -75.55 -26.64 58.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 72' ' ' VAL . 12.0 mt -67.53 -28.05 67.49 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.083 HG23 HG11 ' A' ' 53' ' ' VAL . 27.2 t -92.24 -60.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.411 0.624 . . . . 0.0 109.817 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.5 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.1 m-85 -46.62 -27.33 1.12 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.536 -0.727 . . . . 0.0 111.391 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 56.9 m -81.61 -12.08 58.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 110.088 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.042 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.22 -12.53 37.78 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.392 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.779 ' N ' HD12 ' A' ' 81' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.516 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.484 0.965 0 N-CA-C 110.163 -0.745 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.5 t -113.3 119.25 42.49 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.532 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.778 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.6 Cg_endo -85.34 -168.99 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.924 1.486 . . . . 0.0 109.81 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.929 ' C ' HD21 ' A' ' 56' ' ' LEU . 18.8 mtt -111.83 18.1 19.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.525 ' N ' HD21 ' A' ' 56' ' ' LEU . 3.0 m . . . . . 0 C--N 1.293 -1.87 0 C-N-CA 118.898 -1.121 . . . . 0.0 112.823 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.7 t-20 . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.601 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.5 Cg_endo -70.99 1.08 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.939 1.494 . . . . 0.0 112.015 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.949 ' CE2' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -105.67 -59.79 1.72 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.658 -1.276 . . . . 0.0 109.21 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.501 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.586 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.8 t90 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.351 0.596 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.26 -27.18 2.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 40.7 t -94.43 149.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.829 . . . . 0.0 110.312 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -104.24 170.22 6.35 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.511 -0.743 . . . . 0.0 109.731 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.15 -34.45 28.18 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.59 1.311 . . . . 0.0 109.926 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 2.1 pm0 -74.62 -25.67 59.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.917 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -81.37 -40.27 23.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 108.566 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -69.02 -13.07 62.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.6 mtmt -84.54 -37.93 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 5.8 m-30 -64.22 -23.38 67.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.93 -23.66 26.88 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.816 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.2 34.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.502 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 23.7 mt -79.46 -32.04 14.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.79 -40.15 66.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.2 t70 -85.85 1.19 50.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.652 -0.655 . . . . 0.0 109.79 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.451 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -92.91 -4.94 51.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.086 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.029 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -107.32 -6.98 16.87 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 82.76 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.8 Cg_endo -73.07 149.94 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.08 1.569 . . . . 0.0 110.998 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 54.3 t -117.62 103.47 14.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.5 OUTLIER 66.03 13.26 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.212 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 99.53 32.12 5.84 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 87.7 m-85 -143.09 153.91 43.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.271 . . . . 0.0 111.7 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.029 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -119.78 137.15 54.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 17.7 p -80.8 142.58 33.58 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.051 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.66 -27.05 0.3 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -66.11 -27.28 67.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -1.023 . . . . 0.0 110.457 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 51.7 mttp -92.3 -33.24 14.7 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.041 -1.037 . . . . 0.0 108.299 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 65' ' ' LEU . 60.4 t -82.32 -45.07 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.603 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.7 tttt -43.96 -52.78 14.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.763 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.1 Cg_endo -65.51 -33.72 45.34 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.39 1.205 . . . . 0.0 109.48 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -64.56 -38.39 82.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.042 ' HB3' HD22 ' A' ' 50' ' ' LEU . 59.3 mt -81.98 -30.06 31.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 38' ' ' PRO . 42.7 mt -73.43 -13.92 61.16 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -88.55 -8.97 53.87 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.929 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.549 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 4.3 p -80.07 9.46 5.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.254 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 67.34 12.93 9.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.139 HD11 ' HB3' ' A' ' 80' ' ' ALA . 17.0 mt -98.01 153.41 38.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 110.04 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.4 Cg_endo -75.01 171.84 17.54 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 123.994 1.523 . . . . 0.0 109.313 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.508 HG13 ' C ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.03 -6.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 109.467 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -77.53 -31.01 53.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.863 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.902 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -85.32 -41.17 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.042 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.2 mt -73.71 -28.79 61.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.22 -23.61 74.78 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.85 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.2 ttm180 -101.06 -37.94 8.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.933 -0.745 . . . . 0.0 109.552 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.005 HG11 HG23 ' A' ' 77' ' ' VAL . 21.1 t -64.06 -39.79 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.631 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.6 t-105 -67.13 -51.38 54.72 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.463 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 56.1 mt-10 -53.24 -56.46 16.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -61.33 -15.15 32.95 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.713 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 16.1 m -93.59 -33.97 13.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.522 -0.737 . . . . 0.0 109.527 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -67.72 69.1 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.452 -0.78 . . . . 0.0 110.056 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.488 ' HB ' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -50.56 -30.33 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -106.71 -15.3 14.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.878 . . . . 0.0 109.889 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 93.1 m-70 57.31 45.72 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.362 -0.836 . . . . 0.0 111.66 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.47 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.6 p-10 -107.21 28.91 7.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.403 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 66.25 25.93 72.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 12.8 mtp -151.06 161.37 42.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 110.199 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.021 HD12 HG11 ' A' ' 36' ' ' VAL . 8.6 mt -122.03 110.31 15.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.863 . . . . 0.0 109.798 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.58 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 6.3 t0 -68.71 163.96 22.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -49.27 -30.38 7.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.182 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 35.8 t0 -86.83 -33.56 19.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 42.4 mt-10 -75.59 -43.79 46.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.968 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.5 t80 -54.39 -34.0 60.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -59.21 -57.29 13.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.57 0.7 . . . . 0.0 110.253 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 76' ' ' LEU . 44.9 t -52.23 -22.8 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.15 -10.22 48.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.3 mmm -89.41 -44.3 10.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.472 -1.393 . . . . 0.0 110.608 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 2.9 p90 -76.04 -19.4 58.67 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.666 HD22 HG13 ' A' ' 86' ' ' VAL . 6.2 mt -79.33 -25.5 42.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.005 HG23 HG11 ' A' ' 53' ' ' VAL . 17.6 t -91.11 -41.8 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.68 -25.67 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.423 -0.798 . . . . 0.0 110.266 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.2 m -80.1 -14.8 58.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.139 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.67 -10.09 49.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.143 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.651 ' N ' HD23 ' A' ' 81' ' ' LEU . 4.5 mt . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.482 0.851 0 N-CA-C 109.42 -1.031 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.666 HG13 HD22 ' A' ' 76' ' ' LEU . 31.2 t -128.49 121.32 21.25 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.957 -1.089 . . . . 0.0 111.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.659 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -85.53 166.64 10.44 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.86 1.453 . . . . 0.0 109.086 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.821 ' C ' HD21 ' A' ' 56' ' ' LEU . 6.6 mtp -90.36 14.25 13.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.921 -1.112 . . . . 0.0 110.477 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.493 ' N ' HD21 ' A' ' 56' ' ' LEU . 72.3 m . . . . . 0 C--N 1.298 -1.673 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.439 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.488 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 27.1 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.709 0.29 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.597 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -76.41 12.57 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.488 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.969 ' CE2' HD12 ' A' ' 40' ' ' LEU . 9.8 m-85 -107.27 -61.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.798 -1.189 . . . . 0.0 109.08 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.056 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.5 t90 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -40.14 -27.97 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.34 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 25.5 t -97.98 126.17 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 109.757 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.8 mttp -82.12 173.66 7.27 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 110.45 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.2 Cg_endo -68.31 -33.96 22.49 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.091 1.574 . . . . 0.0 109.387 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.01 -18.95 48.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.546 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.82 -43.19 15.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.91 61.59 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.09 61.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.47 -23.52 50.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.621 ' CD2' ' HB2' ' A' ' 74' ' ' MET . 9.9 m-30 -74.98 -33.96 61.94 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 5.1 m-20 -69.98 -22.27 63.16 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.734 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -78.23 -32.97 50.04 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.684 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 44.7 mt -81.55 -32.7 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.792 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.36 -31.58 64.02 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.6 t0 -90.83 -3.22 57.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 71.6 p -87.84 -8.51 55.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 31' ' ' LEU . 8.5 mt -98.81 -14.88 19.48 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.624 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 p 94.52 91.41 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.296 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.4 Cg_endo -72.73 147.27 44.63 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.194 1.628 . . . . 0.0 110.638 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 77.1 t -115.22 100.27 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 64.47 15.26 9.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 109.69 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.24 32.53 5.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 75.5 m-85 -145.63 148.75 33.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.17 . . . . 0.0 111.59 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 24' ' ' LEU . 10.2 mt -115.0 159.03 21.26 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 35' ' ' LYS . 86.4 p -104.52 143.8 32.55 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.031 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.646 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.7 -25.32 0.86 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' SER . 1.6 t70 -71.67 -23.69 61.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.954 . . . . 0.0 110.354 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.3 mttp -92.36 -33.06 14.73 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.011 -1.055 . . . . 0.0 108.257 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.824 HG12 ' CD1' ' A' ' 40' ' ' LEU . 89.2 t -77.54 -38.42 26.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.296 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -42.54 -54.5 8.1 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -65.81 -32.62 45.88 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.622 1.327 . . . . 0.0 109.56 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.681 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.53 -31.97 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.978 ' HB3' HD22 ' A' ' 50' ' ' LEU . 27.2 mt -92.91 -30.48 15.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.496 -0.753 . . . . 0.0 110.269 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.443 HD11 ' HE3' ' A' ' 37' ' ' LYS . 57.5 mt -72.39 -12.11 60.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -90.79 -9.63 45.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.417 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.54 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 92.2 p -81.32 11.0 4.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.363 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.59 14.75 9.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.998 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.4 mt -96.76 154.35 38.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.828 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.0 Cg_endo -75.38 169.26 22.81 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.939 1.494 . . . . 0.0 109.072 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.535 HG13 ' C ' ' B' ' 111' ' ' PHE . 2.1 t -69.87 -3.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.965 -1.085 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.63 -27.77 40.96 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.161 -0.962 . . . . 0.0 109.235 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.908 HG13 HD22 ' A' ' 45' ' ' LEU . 7.3 mm -87.81 -36.94 10.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -76.23 -27.19 56.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -74.08 -25.84 70.19 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.655 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.7 ttm-85 -101.19 -31.19 11.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.048 -0.678 . . . . 0.0 110.242 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.711 HG11 HG23 ' A' ' 77' ' ' VAL . 13.1 t -70.5 -34.27 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.044 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.646 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 5.1 t-105 -68.17 -56.78 7.51 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.262 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 3.4 mm-40 -43.17 -64.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.35 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.864 HD21 ' C ' ' A' ' 88' ' ' MET . 4.6 mt -55.6 -20.01 12.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.952 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.87 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 57.8 m -91.61 -19.84 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.479 -0.763 . . . . 0.0 109.403 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.9 t0 -96.1 86.19 4.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.512 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -91.05 -13.93 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.63 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 11.1 m-20 -92.36 -12.65 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 5.2 m170 56.8 47.11 18.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 110.648 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 21.9 p-10 -128.12 25.47 5.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.17 38.44 93.15 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.51 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 6.7 mtt -150.37 161.08 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -1.162 . . . . 0.0 111.981 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 HG21 ' A' ' 36' ' ' VAL . 13.9 mt -125.45 103.69 8.03 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.41 160.4 32.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.997 -1.065 . . . . 0.0 110.682 -179.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.437 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ptm180 -36.48 -44.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.774 -0.579 . . . . 0.0 111.392 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 t70 -79.53 -31.93 42.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.662 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.465 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 28.0 mt-10 -76.03 -45.38 34.69 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.079 -1.013 . . . . 0.0 109.134 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.768 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.6 t80 -58.19 -18.47 26.17 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.29 -45.82 37.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.444 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.562 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.7 t -59.78 -26.12 34.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 109.538 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.87 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.79 -5.61 55.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 111.193 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.621 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.2 mmt -84.43 -49.53 8.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.923 -1.111 . . . . 0.0 109.839 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.605 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.1 p90 -73.79 -28.26 61.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.605 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.1 mt -64.54 -28.23 69.5 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.829 HG21 ' CD2' ' A' ' 40' ' ' LEU . 45.8 t -91.25 -23.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.828 -0.545 . . . . 0.0 110.591 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.4 -23.22 23.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -0.972 . . . . 0.0 109.802 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.12 -12.85 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.998 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.86 -14.31 39.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.804 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.7 mt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.853 0.835 . . . . 0.0 109.188 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.48 0.729 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.665 HG11 HG23 ' A' ' 53' ' ' VAL . 95.7 t -111.91 129.09 24.56 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.2 -0.938 . . . . 0.0 110.015 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.6 Cg_endo -90.16 -161.73 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.763 1.402 . . . . 0.0 109.642 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.864 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -130.19 3.08 4.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.49 -0.756 . . . . 0.0 109.566 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.572 ' N ' HD21 ' A' ' 56' ' ' LEU . 67.7 m . . . . . 0 C--N 1.296 -1.723 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.597 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.533 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.662 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 41.7 Cg_endo -72.38 -2.42 11.69 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.168 1.088 . . . . 0.0 109.922 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.909 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.5 -66.72 0.99 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.911 -1.118 . . . . 0.0 108.792 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.455 ' HB2' ' HB2' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.261 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.271 0.558 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -47.74 -27.66 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 111.126 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 53.7 t -91.76 147.19 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 9.3 mttm -104.06 176.32 1.83 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.548 -0.72 . . . . 0.0 109.788 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.7 Cg_endo -67.89 -35.44 20.91 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.769 1.405 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.3 pt-20 -74.75 -29.08 61.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.519 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 35.3 m-20 -82.2 -33.14 29.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.296 -0.878 . . . . 0.0 109.07 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 14' ' ' LYS . 1.1 tmtt? -78.17 -13.21 59.95 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.199 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.29 -41.98 26.85 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.628 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.82 -26.2 61.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -73.32 -35.52 66.08 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.74 -23.56 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.831 -0.543 . . . . 0.0 109.765 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -79.14 -34.88 42.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.613 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 42.0 mt -79.35 -31.55 14.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.94 -36.71 59.26 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -90.4 3.98 52.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 0.0 109.609 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -91.9 -9.35 43.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 108.967 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.079 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -104.8 -8.05 19.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 87.2 99.89 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.043 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 47.2 Cg_endo -70.68 146.72 55.25 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.453 1.765 . . . . 0.0 110.425 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.3 t -115.7 96.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.47 20.45 12.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 94.14 33.84 6.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 85.4 m-85 -150.24 145.69 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -1.191 . . . . 0.0 111.737 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.079 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.9 mt -112.8 149.22 33.36 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.487 ' CA ' ' SD ' ' A' ' 64' ' ' MET . 24.8 p -99.22 144.86 27.86 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.182 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -40.96 -27.52 0.19 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.2 m-20 -65.38 -23.97 67.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -1.079 . . . . 0.0 110.407 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 69.8 mttt -99.22 -31.8 11.54 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.077 -1.014 . . . . 0.0 108.941 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.871 HG11 HD12 ' A' ' 65' ' ' LEU . 95.2 t -79.72 -42.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -42.0 -55.0 6.65 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.848 . . . . 0.0 110.868 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.84 -32.83 35.54 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.494 1.26 . . . . 0.0 109.866 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.6 t -65.22 -28.96 45.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.042 ' HB3' HD22 ' A' ' 50' ' ' LEU . 38.0 mt -92.95 -26.21 17.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.52 -0.737 . . . . 0.0 110.342 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 74.2 mt -73.5 -9.09 58.33 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.193 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.22 -4.13 57.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.944 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.576 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -84.65 10.38 11.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.1 -1.0 . . . . 0.0 110.283 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.9 OUTLIER 66.85 7.62 5.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 109.979 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.071 HD13 HG21 ' A' ' 49' ' ' ILE . 13.9 mt -94.58 157.12 37.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.9 Cg_endo -77.0 176.4 10.18 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.079 1.568 . . . . 0.0 109.841 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.524 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.3 t -73.25 -4.44 5.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.14 -29.89 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.924 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.071 HG21 HD13 ' A' ' 45' ' ' LEU . 8.5 mm -86.37 -40.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.042 HD22 ' HB3' ' A' ' 40' ' ' LEU . 19.5 mt -76.3 -28.32 56.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.49 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -70.12 -25.16 75.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.3 ttm105 -101.46 -34.09 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.117 -0.637 . . . . 0.0 110.043 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.776 HG11 HG23 ' A' ' 77' ' ' VAL . 24.5 t -67.37 -36.01 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.92 -1.113 . . . . 0.0 108.889 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.583 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.9 t-105 -66.82 -53.57 31.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.16 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 8.2 mt-10 -47.27 -58.04 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.126 -0.984 . . . . 0.0 110.396 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -63.04 -12.66 27.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.049 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.655 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 47.0 m -94.97 -40.43 9.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 61.9 t0 -84.36 70.84 10.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 110.01 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mt -61.04 -16.5 14.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 110.492 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 26.1 m-20 -91.98 -15.53 27.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.68 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 88.0 m-70 51.27 34.19 11.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.2 p-10 -103.03 4.68 37.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.993 . . . . 0.0 110.042 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.52 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 86.89 26.62 31.24 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.2 mmm -148.3 161.65 41.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.217 -1.167 . . . . 0.0 110.036 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.871 HD12 HG11 ' A' ' 36' ' ' VAL . 12.1 mt -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.301 -0.874 . . . . 0.0 109.657 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.579 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 21.7 t0 -69.07 167.11 16.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.268 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 6.7 ptm180 -49.86 -39.23 38.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -35.49 38.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 109.448 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 40.3 mt-10 -72.56 -47.04 51.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 109.166 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.918 ' CD2' HD12 ' A' ' 31' ' ' LEU . 26.2 t80 -57.86 -26.79 62.55 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.491 -0.756 . . . . 0.0 109.028 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -68.47 -48.53 64.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.881 . . . . 0.0 110.115 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 76' ' ' LEU . 60.7 t -58.34 -22.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.688 -0.633 . . . . 0.0 109.847 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -88.5 -12.49 42.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.747 . . . . 0.0 111.96 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.7 mmm -85.6 -40.36 16.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.656 -1.277 . . . . 0.0 110.472 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.3 p90 -77.9 -25.19 48.34 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.788 -1.165 . . . . 0.0 107.894 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 4.6 mt -73.19 -20.13 60.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.544 0.688 . . . . 0.0 109.212 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.776 HG23 HG11 ' A' ' 53' ' ' VAL . 42.2 t -91.59 -49.82 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.849 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.593 ' HA ' HD23 ' A' ' 81' ' ' LEU . 3.4 m-85 -64.16 -41.07 97.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.471 -0.768 . . . . 0.0 110.711 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 59.9 m -80.67 -9.16 59.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.399 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -92.97 -31.93 14.72 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.129 0.966 . . . . 0.0 109.136 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.596 ' N ' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.591 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.638 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 N--CA 1.482 0.849 0 N-CA-C 110.458 -0.632 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 80.0 t -121.09 126.01 26.77 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.649 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.9 Cg_endo -85.16 152.96 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.846 1.446 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.574 ' C ' HD21 ' A' ' 56' ' ' LEU . 24.8 mtm -88.13 17.58 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.475 ' N ' HD21 ' A' ' 56' ' ' LEU . 38.9 m . . . . . 0 C--N 1.294 -1.81 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.836 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 16.6 t-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.993 0.425 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 51.2 Cg_endo -71.62 5.54 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.165 1.613 . . . . 0.0 112.01 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.931 ' CE2' HD12 ' A' ' 40' ' ' LEU . 6.9 m-85 -101.66 -62.83 1.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.658 -1.276 . . . . 0.0 109.167 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.362 179.685 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.304 0.573 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.58 -28.06 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.97 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.7 t -97.42 152.6 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 110.045 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.511 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.0 mmmt -105.9 171.81 4.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.923 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.9 Cg_endo -67.61 -35.48 22.33 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.753 1.397 . . . . 0.0 109.46 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.21 -31.01 68.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -81.53 -33.72 31.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 10.9 tptp -74.76 -16.35 60.73 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.68 -38.65 47.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -78.52 -25.02 45.45 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.611 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.2 m-30 -75.33 -37.51 60.68 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 30.5 t70 -69.17 -18.58 63.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.653 -0.654 . . . . 0.0 109.655 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -83.08 -39.06 21.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.695 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.9 mt -75.14 -34.13 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.721 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -68.6 -41.17 79.96 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t70 -84.89 -0.64 54.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.587 -0.696 . . . . 0.0 109.905 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 36.7 t -86.49 -9.68 55.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.267 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.115 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -100.75 -11.4 19.94 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.09 93.79 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.538 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 48.5 Cg_endo -74.25 151.06 43.07 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.385 1.729 . . . . 0.0 110.905 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -120.8 98.5 6.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 69.34 22.12 6.7 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.693 0.758 . . . . 0.0 109.207 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.85 37.43 7.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.559 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 71.9 m-85 -147.2 140.38 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -1.159 . . . . 0.0 111.766 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.115 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.6 mt -110.09 137.79 47.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -84.42 142.53 30.04 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.846 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.54 -25.87 0.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -70.01 -24.21 63.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.588 -0.948 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.4 mttp -91.69 -35.12 14.36 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.95 HG11 HD12 ' A' ' 65' ' ' LEU . 90.8 t -79.68 -48.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.444 0.64 . . . . 0.0 110.296 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.61 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 9.0 tttp -38.94 -55.24 2.9 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.582 -0.699 . . . . 0.0 110.8 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.8 Cg_endo -66.18 -29.8 47.0 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.576 1.303 . . . . 0.0 110.025 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -70.59 -31.74 47.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.522 -0.736 . . . . 0.0 109.07 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.947 ' HB3' HD22 ' A' ' 50' ' ' LEU . 32.9 mt -85.44 -28.63 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -0.822 . . . . 0.0 109.772 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 38' ' ' PRO . 69.8 mt -69.63 -11.29 60.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.02 -5.01 57.09 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.769 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -81.97 14.52 2.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 110.144 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.73 15.34 1.56 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.812 -1.18 . . . . 0.0 109.847 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.035 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.0 mt -101.08 156.13 35.5 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.4 Cg_endo -73.61 160.74 43.54 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 123.803 1.422 . . . . 0.0 109.409 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' B' ' 111' ' ' PHE . 38.2 t -63.26 -11.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.17 -0.957 . . . . 0.0 109.187 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -70.03 -29.73 66.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 108.815 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 45' ' ' LEU . 7.1 mm -82.97 -42.47 17.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.961 0.886 . . . . 0.0 108.733 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.947 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.5 mt -71.72 -30.81 66.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.509 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -68.09 -25.05 74.59 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.871 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -101.82 -34.1 9.55 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.062 -0.669 . . . . 0.0 110.491 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.979 HG11 HG23 ' A' ' 77' ' ' VAL . 40.8 t -65.62 -38.13 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.156 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.4 t-105 -68.68 -50.73 48.73 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.462 -0.774 . . . . 0.0 110.412 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.0 mm-40 -51.04 -52.12 46.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.973 -1.079 . . . . 0.0 110.194 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.871 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.9 mt -64.69 -11.61 37.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.099 -1.0 . . . . 0.0 108.543 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.052 ' OG ' HD21 ' A' ' 65' ' ' LEU . 1.6 p -93.37 -46.7 7.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' CG ' ' HA ' ' A' ' 61' ' ' HIS . 3.5 t0 -59.56 78.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 110.308 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 57' ' ' SER . 43.8 mm -54.48 -27.1 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.24 -0.913 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 34.1 p30 -108.62 -13.66 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 85.1 m-70 58.63 47.33 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 10.9 p-10 -110.51 16.51 21.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.854 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 77.43 29.92 54.88 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.0 mtt -149.44 161.36 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -1.198 . . . . 0.0 110.636 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.052 HD21 ' OG ' ' A' ' 57' ' ' SER . 8.3 mt -127.84 107.0 9.49 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 5.0 t0 -69.58 162.61 27.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -46.63 -40.46 13.05 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.577 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 2.5 p30 -76.34 -42.04 46.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 109.856 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 30.8 mt-10 -66.27 -41.04 90.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.612 0.72 . . . . 0.0 109.059 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.756 ' CD2' HD12 ' A' ' 31' ' ' LEU . 47.1 t80 -63.49 -21.38 66.29 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -71.93 -43.07 65.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.507 0.67 . . . . 0.0 109.689 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.29 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.715 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.28 -2.13 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.483 -0.761 . . . . 0.0 111.176 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.586 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.8 mmt -88.39 -46.46 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 109.487 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 2.2 p90 -76.56 -19.1 58.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.635 HD22 HG13 ' A' ' 86' ' ' VAL . 8.6 mt -77.13 -23.84 51.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.979 HG23 HG11 ' A' ' 53' ' ' VAL . 38.5 t -91.63 -46.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.654 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 1.4 m-85 -62.54 -28.89 70.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.536 -0.727 . . . . 0.0 111.514 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -82.26 -12.34 58.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.931 -1.106 . . . . 0.0 110.137 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.035 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.47 -19.62 38.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.733 0.778 . . . . 0.0 110.796 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 109.794 -0.887 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.635 HG13 HD22 ' A' ' 76' ' ' LEU . 76.0 t -110.78 119.62 45.73 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.135 -0.978 . . . . 0.0 110.63 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.791 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -82.78 175.01 9.1 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.968 1.51 . . . . 0.0 109.009 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.6 mtm -99.14 12.89 34.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.55 ' N ' HD21 ' A' ' 56' ' ' LEU . 18.5 m . . . . . 0 C--N 1.296 -1.745 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.398 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.473 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 14.7 t-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.573 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.0 Cg_endo -69.81 2.68 3.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.139 1.599 . . . . 0.0 111.913 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.939 ' HB3' HG13 ' A' ' 47' ' ' VAL . 2.4 m-85 -103.49 -54.89 2.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.703 -1.248 . . . . 0.0 109.371 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.319 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CH2' ' HE2' ' A' ' 14' ' ' LYS . 11.2 t90 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.176 0.513 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.13 -26.97 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 110.826 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.69 146.57 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.1 mttt -99.17 169.98 7.47 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.614 -0.679 . . . . 0.0 109.785 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -66.57 -35.12 30.73 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.609 1.321 . . . . 0.0 109.609 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.669 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.4 m-20 -79.61 -41.51 26.9 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.36 -16.16 63.85 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.736 0.779 . . . . 0.0 108.908 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.1 -37.91 57.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 3.1 mtmt -81.67 -40.32 23.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.4 m-30 -63.29 -23.61 67.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.3 t70 -85.54 -24.77 27.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.582 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.96 -32.4 39.9 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.667 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.0 mt -79.08 -35.24 17.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.843 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -70.06 -39.65 75.55 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.5 t0 -87.49 1.24 54.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 110.073 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 6.7 t -89.36 -7.03 56.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.0 109.069 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.101 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.6 mt -107.26 -13.06 15.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.39 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.6 Cg_endo -73.6 151.34 46.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.322 1.696 . . . . 0.0 110.975 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 48.4 t -116.58 115.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.0 t30 56.77 17.9 3.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 108.816 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 91.73 37.63 6.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 73.3 m-85 -149.7 138.11 20.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.111 -1.229 . . . . 0.0 112.449 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.101 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -104.79 145.29 30.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 52.7 p -95.89 145.58 25.27 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 110.087 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -41.01 -27.57 0.2 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 79.1 m-20 -64.04 -26.17 68.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.386 -1.067 . . . . 0.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 49.3 mttm -96.84 -32.03 12.3 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.125 -0.984 . . . . 0.0 108.659 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.893 HG12 ' CD1' ' A' ' 40' ' ' LEU . 98.9 t -79.6 -43.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.551 -0.718 . . . . 0.0 110.73 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.808 ' HG2' HD11 ' A' ' 41' ' ' LEU . 15.2 tttt -43.18 -51.11 14.24 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 110.725 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -67.04 -32.02 35.63 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.213 1.112 . . . . 0.0 109.6 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.896 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.9 t -68.23 -29.94 46.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.978 ' HB3' HD22 ' A' ' 50' ' ' LEU . 50.5 mt -92.0 -32.34 15.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.491 -0.755 . . . . 0.0 110.867 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.808 HD11 ' HG2' ' A' ' 37' ' ' LYS . 22.9 mt -70.55 -14.0 62.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.062 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -90.39 -3.25 57.83 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.642 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.715 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -84.44 17.23 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.962 . . . . 0.0 110.299 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB2' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER 61.87 11.77 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.658 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.078 HD11 ' HB3' ' A' ' 80' ' ' ALA . 18.9 mt -100.82 153.18 37.88 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.9 Cg_endo -76.53 173.68 14.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.036 1.545 . . . . 0.0 109.522 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.515 HG11 ' O ' ' B' ' 111' ' ' PHE . 2.1 t -73.09 -3.86 4.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.91 -1.119 . . . . 0.0 109.383 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -78.24 -29.79 48.36 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.894 HG13 HD22 ' A' ' 45' ' ' LEU . 11.1 mm -85.84 -39.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.4 mt -75.19 -29.05 60.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -67.41 -26.12 73.62 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.928 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -101.16 -35.09 9.43 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.005 -0.703 . . . . 0.0 109.85 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 HG23 ' A' ' 77' ' ' VAL . 41.3 t -64.57 -39.66 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.081 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.609 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -65.74 -52.79 48.25 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.067 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mm-40 -56.0 -58.66 6.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.965 HD21 ' C ' ' A' ' 88' ' ' MET . 5.0 mt -56.14 -19.22 12.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.913 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.98 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 13.5 t -91.93 -35.67 13.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.577 0.703 . . . . 0.0 109.683 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.566 ' OD2' ' CE2' ' A' ' 54' ' ' TRP . 1.6 t0 -65.56 95.54 0.22 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 110.157 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.536 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 10.5 mm -67.7 -32.01 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.46 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 2.4 p30 -112.2 -13.67 13.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 110.818 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.562 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 18.1 m-70 62.52 44.55 6.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.907 . . . . 0.0 110.472 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 64' ' ' MET . 57.4 p30 -95.98 5.87 50.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.547 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 85.31 22.76 50.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.547 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 4.0 mmm -148.47 161.55 41.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -1.144 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.757 HD12 HG11 ' A' ' 36' ' ' VAL . 13.8 mt -122.14 106.07 10.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.162 -0.961 . . . . 0.0 109.996 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.585 ' CB ' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -71.41 160.08 33.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.025 . . . . 0.0 110.232 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 25.7 ptt180 -39.66 -37.63 0.53 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.575 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 12.2 m-20 -83.07 -29.92 28.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -75.89 -47.93 23.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.896 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 20.6 t80 -61.71 -16.11 46.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.13 -50.21 13.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.395 -0.816 . . . . 0.0 109.842 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.655 ' O ' HD12 ' A' ' 76' ' ' LEU . 58.8 t -58.02 -28.73 34.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.523 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.98 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.15 -4.73 57.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 111.254 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 11.8 mmt -84.01 -47.6 10.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.979 -1.076 . . . . 0.0 110.121 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -75.08 -28.89 60.49 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.1 mt -67.1 -22.7 65.8 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.936 ' O ' HD12 ' A' ' 81' ' ' LEU . 49.4 t -91.5 -44.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.749 -0.594 . . . . 0.0 109.773 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.93 -25.43 62.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.508 -0.745 . . . . 0.0 110.873 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 17.1 m -82.38 -21.44 35.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.966 -1.084 . . . . 0.0 109.286 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.078 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.69 -11.1 59.84 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 121.414 0.625 . . . . 0.0 110.568 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.485 1.001 0 N-CA-C 110.465 -0.629 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 54.0 t -143.18 131.59 11.3 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.138 -0.976 . . . . 0.0 110.665 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.869 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -89.45 -163.81 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.981 1.516 . . . . 0.0 109.51 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.965 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 -0.86 11.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.27 -0.894 . . . . 0.0 110.547 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.6 ' N ' HD21 ' A' ' 56' ' ' LEU . 4.1 m . . . . . 0 C--N 1.294 -1.827 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.176 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.504 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 23.2 t-20 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.609 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.4 Cg_endo -72.35 1.39 6.17 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.843 1.443 . . . . 0.0 111.54 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.902 ' CE2' HD12 ' A' ' 40' ' ' LEU . 3.8 m-85 -101.19 -61.1 1.41 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.943 -1.098 . . . . 0.0 108.499 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.154 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.578 ' CH2' ' HG3' ' A' ' 14' ' ' LYS . 10.9 t90 . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.16 -25.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.512 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -96.31 146.98 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.951 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.8 mmtt -96.95 169.24 9.01 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.5 Cg_endo -69.95 -33.19 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.865 1.455 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.78 -27.38 31.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.496 -0.753 . . . . 0.0 109.548 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.59 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.1 m-20 -79.72 -30.46 40.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.634 ' HG2' ' HB1' ' A' ' 71' ' ' ALA . 2.9 tmtt? -81.9 -22.98 36.52 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.679 0.752 . . . . 0.0 109.112 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.56 85.46 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.9 -28.34 61.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -65.14 -36.14 83.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -22.39 64.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.673 -0.642 . . . . 0.0 109.847 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.69 -38.38 25.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.682 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 55.2 mt -76.09 -29.8 19.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.798 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.45 -39.36 67.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.553 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.8 t70 -87.19 2.09 51.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.306 0.574 . . . . 0.0 109.814 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.509 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -91.75 -6.12 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.831 0.824 . . . . 0.0 109.178 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.016 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -107.07 -7.76 16.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.565 -0.709 . . . . 0.0 109.26 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.73 84.59 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.977 0 CA-C-O 121.269 0.556 . . . . 0.0 109.61 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 45.7 Cg_endo -74.58 150.4 40.3 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.536 1.808 . . . . 0.0 110.93 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.82 HG12 HD22 ' A' ' 28' ' ' ASN . 53.9 t -117.43 119.16 60.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.82 HD22 HG12 ' A' ' 27' ' ' VAL . 71.4 m-80 55.88 18.71 3.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.662 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.08 33.27 9.75 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 57.9 m-85 -137.73 137.25 38.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.854 -1.38 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.016 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.8 mt -108.5 138.22 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 33' ' ' GLY . 20.8 p -86.0 144.37 27.64 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.177 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.629 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -45.64 -24.93 1.29 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 32' ' ' SER . 4.4 m-20 -70.95 -19.1 62.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.532 -0.981 . . . . 0.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 5.6 mttp -97.17 -34.97 10.93 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 65' ' ' LEU . 98.0 t -77.35 -42.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.864 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.17 -53.98 6.17 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.576 -0.702 . . . . 0.0 110.729 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -68.39 -30.97 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.558 1.294 . . . . 0.0 110.078 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.511 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -66.38 -37.47 79.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.551 -0.718 . . . . 0.0 109.295 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.973 ' HB3' HD22 ' A' ' 50' ' ' LEU . 25.1 mt -83.01 -24.79 32.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.564 -0.71 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.11 -10.88 60.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.699 -0.801 . . . . 0.0 108.918 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -89.79 -7.12 55.12 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.523 -0.735 . . . . 0.0 110.224 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.572 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -78.07 7.82 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 0.0 110.284 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.91 10.78 7.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 109.358 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.053 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.1 mt -98.72 156.84 35.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.449 -0.782 . . . . 0.0 109.823 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.4 Cg_endo -75.98 172.1 16.9 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.121 1.59 . . . . 0.0 109.289 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.5 t -71.72 -5.03 5.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.967 -1.083 . . . . 0.0 108.951 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.34 -29.01 59.83 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.873 HG21 HD13 ' A' ' 45' ' ' LEU . 8.5 mm -87.4 -37.74 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.973 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.8 mt -79.39 -28.28 41.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.16 -24.99 75.6 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.864 ' O ' HD12 ' A' ' 56' ' ' LEU . 6.7 ttm-85 -101.96 -33.78 9.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.109 -0.642 . . . . 0.0 110.014 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.991 HG11 HG23 ' A' ' 77' ' ' VAL . 8.7 t -70.9 -37.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.831 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.629 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.2 t-105 -63.64 -50.53 68.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.86 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.3 mt-10 -50.42 -55.1 17.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 109.925 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.864 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.51 -15.34 37.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 108.934 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.954 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.0 t -94.52 -41.47 9.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.537 -0.727 . . . . 0.0 109.513 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 t70 -75.92 95.02 3.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.617 -0.677 . . . . 0.0 110.72 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 3.7 mt -93.13 -16.2 7.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.13 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.7 m-20 -89.81 -5.04 57.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 109.552 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.5 p80 41.3 47.37 2.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.658 . . . . 0.0 110.941 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 28.3 p30 -129.05 26.4 5.49 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.218 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 59.37 42.12 97.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 2.6 mmt -149.35 161.22 42.49 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.318 -1.107 . . . . 0.0 111.514 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.04 HD12 HG21 ' A' ' 36' ' ' VAL . 43.3 mt -137.65 107.09 6.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.648 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -76.58 161.58 28.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 110.454 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -34.55 -46.89 0.3 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.735 -0.603 . . . . 0.0 111.584 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -78.01 -37.66 46.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.226 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 57' ' ' SER . 12.7 tt0 -66.91 -44.44 80.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.632 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.973 ' CD1' HD12 ' A' ' 31' ' ' LEU . 37.7 t80 -60.46 -21.89 62.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.656 -0.652 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.634 ' HB1' ' HG2' ' A' ' 14' ' ' LYS . . . -75.16 -37.98 61.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 109.813 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 38.0 t -66.46 -26.66 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.684 0.754 . . . . 0.0 109.733 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.954 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.39 -7.21 53.78 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 110.767 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.584 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.3 mmt -88.01 -47.45 8.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.922 -1.111 . . . . 0.0 110.256 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 2.2 p90 -75.98 -19.51 58.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.883 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.2 mt -74.27 -25.19 59.46 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.991 HG23 HG11 ' A' ' 53' ' ' VAL . 37.2 t -90.59 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.457 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -45.53 -24.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.692 -0.63 . . . . 0.0 111.273 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.7 m -82.8 -18.84 39.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.964 -1.085 . . . . 0.0 110.009 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.053 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.43 -11.88 50.63 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.709 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.3 mp . . . . . 0 C--N 1.305 -1.362 0 CA-C-O 121.787 0.804 . . . . 0.0 108.871 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.485 1.029 0 N-CA-C 110.095 -0.771 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.732 HG13 HD22 ' A' ' 76' ' ' LEU . 48.9 t -134.85 124.11 16.46 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.052 -1.03 . . . . 0.0 111.274 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.8 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.1 Cg_endo -85.06 174.31 7.34 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.919 1.484 . . . . 0.0 109.514 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.803 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.0 mtp -96.16 12.19 31.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 0.0 110.432 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.577 ' N ' HD21 ' A' ' 56' ' ' LEU . 15.1 m . . . . . 0 C--N 1.296 -1.752 0 O-C-N 120.881 -1.137 . . . . 0.0 110.779 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.455 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 25.1 t-20 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.621 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.6 Cg_endo -74.17 7.59 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.866 1.456 . . . . 0.0 111.881 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.96 ' CE2' HD12 ' A' ' 40' ' ' LEU . 6.6 m-85 -107.14 -65.55 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.763 -1.21 . . . . 0.0 108.713 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.421 ' NH2' ' OE2' ' A' ' 55' ' ' GLU . 6.2 mtm180 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.289 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.659 ' HH2' ' HZ2' ' A' ' 14' ' ' LYS . 13.0 t90 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 121.217 0.532 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.84 -26.16 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 43.9 t -101.19 151.03 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.237 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 31.5 mttt -111.67 169.37 6.4 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.324 -0.86 . . . . 0.0 109.792 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 37.5 Cg_endo -63.86 -35.26 57.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.616 1.324 . . . . 0.0 110.119 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -69.46 -30.03 67.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.387 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -82.35 -39.27 23.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.659 ' HZ2' ' HH2' ' A' ' 7' ' ' TRP . 14.8 tptm -72.28 -15.72 61.91 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.14 -39.65 54.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.03 -25.64 40.1 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.0 m-30 -72.27 -35.19 68.68 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.39 -20.23 62.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.837 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -81.89 -38.31 25.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.647 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 68.6 mt -76.2 -29.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.887 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.9 -36.68 67.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.514 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.5 t70 -90.45 0.86 57.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.728 -0.607 . . . . 0.0 110.186 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 34.0 t -88.77 -8.0 55.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.137 -0.977 . . . . 0.0 109.148 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.084 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.2 mt -106.76 -10.94 15.92 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 86.55 97.24 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.3 Cg_endo -74.02 149.69 42.09 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.214 1.639 . . . . 0.0 111.0 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 62.1 t -124.7 108.34 20.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 62.44 15.67 7.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.241 -179.035 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 92.51 38.04 5.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 81.5 m-85 -148.52 144.59 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 111.976 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.084 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.6 mt -112.14 131.13 55.63 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 1.6 m -80.23 147.04 31.4 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.582 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -44.94 -27.96 1.62 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 48.3 t0 -59.57 -25.37 64.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.89 . . . . 0.0 109.866 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 47.9 mttp -98.26 -36.42 10.03 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.876 HG12 ' CD1' ' A' ' 40' ' ' LEU . 95.1 t -77.17 -40.3 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.667 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' CG ' HD11 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -44.81 -50.51 24.97 Favored Pre-proline 0 N--CA 1.487 1.375 0 O-C-N 121.268 -0.895 . . . . 0.0 111.033 -178.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.2 Cg_endo -68.24 -33.25 24.83 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.089 1.047 . . . . 0.0 109.677 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.619 HG21 ' HZ ' ' A' ' 70' ' ' PHE . 2.1 t -64.7 -35.94 76.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.612 -0.68 . . . . 0.0 109.705 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.039 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.8 mt -90.03 -30.67 17.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.619 HD11 ' CG ' ' A' ' 37' ' ' LYS . 53.8 mt -70.78 -10.69 60.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.874 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 1.2 t-20 -90.59 -9.94 45.21 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.444 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.559 ' HB2' HD11 ' A' ' 81' ' ' LEU . 83.5 p -80.58 11.25 3.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.871 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.04 11.21 4.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.944 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.125 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.3 mt -90.92 156.0 44.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.813 . . . . 0.0 109.663 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -76.62 169.28 22.11 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 O-C-N 123.907 1.478 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.561 HG13 ' CA ' ' B' ' 111' ' ' PHE . 42.1 t -70.6 -3.42 3.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.74 -32.97 35.46 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.793 HG21 HD13 ' A' ' 45' ' ' LEU . 14.3 mm -80.65 -42.42 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.039 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.3 mt -63.65 -32.03 73.38 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.075 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.569 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -72.25 -17.84 77.72 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.826 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.34 -31.28 11.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.843 -0.798 . . . . 0.0 110.138 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.91 HG11 HG23 ' A' ' 77' ' ' VAL . 32.3 t -75.87 -34.65 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.696 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.583 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 3.1 t-105 -70.82 -47.65 58.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.599 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' B' ' 109' ' ' ASN . 23.5 mm-40 -58.17 -57.25 13.69 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.019 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.8 mt -60.46 -16.53 37.34 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.354 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.758 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t -89.9 -34.52 16.04 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.661 0.743 . . . . 0.0 109.387 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.567 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -74.83 69.82 1.87 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.623 -0.673 . . . . 0.0 109.578 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.51 HG12 ' HG2' ' A' ' 69' ' ' GLU . 42.2 mm -41.33 -32.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.493 -0.754 . . . . 0.0 110.406 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 3.0 p30 -108.38 -25.91 10.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 17.7 m-70 71.09 41.19 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.8 p-10 -90.69 -1.69 57.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 98.16 19.95 22.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.583 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtp -153.18 161.77 42.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -1.187 . . . . 0.0 110.341 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.76 HD12 HG21 ' A' ' 36' ' ' VAL . 31.8 mt -118.73 107.79 14.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.099 -1.001 . . . . 0.0 110.662 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.76 165.07 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.04 . . . . 0.0 109.826 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -40.18 -43.53 1.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -78.44 -33.31 48.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.75 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 59' ' ' ILE . 53.2 mt-10 -74.89 -42.95 56.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.45 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.95 ' CD2' HD12 ' A' ' 31' ' ' LEU . 36.7 t80 -63.12 -16.48 60.14 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -78.97 -44.36 22.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.653 ' O ' HD12 ' A' ' 76' ' ' LEU . 42.4 t -61.73 -26.42 39.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.708 0.766 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.758 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.55 -7.84 54.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.76 . . . . 0.0 111.187 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.576 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.5 mmt -84.95 -48.11 9.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.924 -1.11 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 3.6 p90 -75.33 -21.25 58.55 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.6 mt -76.37 -19.41 58.2 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.91 HG23 HG11 ' A' ' 53' ' ' VAL . 32.8 t -91.96 -41.86 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.569 -0.707 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 5.3 m-85 -72.01 -22.54 61.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.837 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -81.58 -15.26 55.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.979 -1.075 . . . . 0.0 109.24 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.125 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.94 -10.89 46.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.459 -0.775 . . . . 0.0 109.077 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.826 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.9 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.787 . . . . 0.0 109.812 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.483 0.9 0 N-CA-C 109.652 -0.941 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 52' ' ' ARG . 89.7 t -112.64 121.58 38.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.926 -1.109 . . . . 0.0 110.893 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.751 ' O ' HD11 ' A' ' 56' ' ' LEU . 45.2 Cg_endo -90.13 -174.4 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.973 1.512 . . . . 0.0 109.289 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.823 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.76 10.29 13.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.073 -1.017 . . . . 0.0 110.295 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.538 ' N ' HD21 ' A' ' 56' ' ' LEU . 38.8 m . . . . . 0 C--N 1.293 -1.852 0 C-N-CA 119.246 -0.981 . . . . 0.0 111.66 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.493 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 1.9 t-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.4 Cg_endo -71.49 -2.44 11.3 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.916 1.482 . . . . 0.0 111.028 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 1.005 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.16 -62.51 1.58 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.867 -1.146 . . . . 0.0 108.849 177.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.981 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.141 0.496 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -35.72 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.648 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 99.5 t -97.9 130.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -86.62 -179.13 1.29 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.729 -178.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.81 -36.3 8.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.014 1.534 . . . . 0.0 110.058 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.27 -22.78 57.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 51.6 m-20 -81.41 -36.94 28.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.062 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -73.78 -16.76 61.15 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.318 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -40.83 38.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.541 -0.724 . . . . 0.0 109.303 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.08 -26.69 60.52 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.8 m-30 -74.65 -32.06 62.14 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.07 -18.24 61.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.504 -0.748 . . . . 0.0 109.868 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -82.54 -36.67 26.11 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.561 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 12.3 mt -78.01 -28.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.36 -38.29 56.02 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.8 t70 -90.26 3.89 52.26 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.704 -0.623 . . . . 0.0 109.792 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -93.23 -3.48 53.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 108.631 178.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.022 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.24 -3.42 13.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 79.83 95.45 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 Cg_endo -71.37 152.33 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.308 1.688 . . . . 0.0 110.76 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 94.1 t -120.1 97.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 109.106 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 68.68 10.58 7.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.2 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 104.73 34.13 3.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 76.6 m-85 -150.89 149.88 30.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.468 -1.019 . . . . 0.0 111.886 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.022 ' CD1' HD12 ' A' ' 24' ' ' LEU . 18.1 mt -118.07 134.38 55.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -78.45 144.32 35.91 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.886 -1.125 . . . . 0.0 109.436 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -42.72 -28.33 0.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.0 m-20 -54.46 -25.14 23.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.44 -1.036 . . . . 0.0 109.506 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 1.1 mttp -104.38 -32.66 8.94 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.408 -0.807 . . . . 0.0 108.83 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.061 HG11 HD12 ' A' ' 65' ' ' LEU . 87.6 t -84.54 -44.76 17.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.683 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 15.4 tttt -43.99 -53.56 12.98 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 0.0 110.924 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.4 Cg_endo -67.19 -33.74 30.1 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.33 1.174 . . . . 0.0 109.467 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -63.38 -34.74 69.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.457 0.646 . . . . 0.0 109.389 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.011 HD12 ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -85.92 -27.32 25.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 58.0 mt -74.94 -10.89 59.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.225 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -89.56 -5.1 57.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.094 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.545 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.93 12.87 6.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.476 -0.765 . . . . 0.0 110.382 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 61.3 13.29 4.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.11 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.891 HD22 HG13 ' A' ' 49' ' ' ILE . 14.7 mt -97.91 154.53 37.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.663 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.61 172.34 16.4 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.071 1.564 . . . . 0.0 110.067 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.85 -6.04 6.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 109.072 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.63 -30.62 56.95 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.891 HG13 HD22 ' A' ' 45' ' ' LEU . 7.1 mm -88.02 -38.06 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.005 HD22 ' HB3' ' A' ' 40' ' ' LEU . 17.8 mt -77.17 -26.31 52.84 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.1 -27.38 72.09 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.652 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -101.47 -30.15 11.59 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 122.105 -0.644 . . . . 0.0 109.901 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.041 HG11 HG23 ' A' ' 77' ' ' VAL . 22.3 t -71.25 -39.85 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.707 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 1.9 t-105 -64.27 -51.0 65.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.651 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.9 mm-40 -53.05 -57.54 10.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.322 -0.861 . . . . 0.0 109.847 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 52' ' ' ARG . 13.8 mt -56.82 -21.07 26.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 108.94 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.863 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 69.7 m -89.48 -36.13 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 31.5 t0 -83.69 61.92 6.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.636 -0.665 . . . . 0.0 110.196 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.8 mt -59.5 -19.01 15.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.334 -0.853 . . . . 0.0 110.37 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 13.6 m-20 -91.74 -21.14 20.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.938 . . . . 0.0 109.637 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 2.2 m-70 61.27 33.74 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 110.745 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.43 -2.48 48.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.05 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 91.07 25.3 24.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.1 mtp -153.55 161.49 42.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.138 -1.213 . . . . 0.0 110.556 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.061 HD12 HG11 ' A' ' 36' ' ' VAL . 15.3 mt -117.84 110.84 18.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.324 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -70.99 172.39 9.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 110.562 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.556 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 3.5 ptp180 -51.15 -41.37 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.555 -0.715 . . . . 0.0 110.895 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.77 -36.31 37.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 57' ' ' SER . 45.8 mt-10 -72.13 -48.73 41.5 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.958 ' CD2' HD12 ' A' ' 31' ' ' LEU . 14.2 t80 -56.0 -26.27 47.91 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.64 56.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 110.116 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.618 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 58.5 t -57.63 -22.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.744 . . . . 0.0 109.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.863 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.35 -5.34 56.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 111.425 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 3.5 mmm -89.98 -40.54 12.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.309 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.652 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 2.1 p90 -81.99 -22.77 36.38 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.848 -1.141 . . . . 0.0 108.339 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.703 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 4.4 mt -76.11 -23.33 54.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.041 HG23 HG11 ' A' ' 53' ' ' VAL . 16.4 t -91.55 -47.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.533 -0.729 . . . . 0.0 109.722 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.676 ' HA ' HD23 ' A' ' 81' ' ' LEU . 2.4 m-85 -70.38 -35.29 73.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 110.417 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 75' ' ' PHE . 3.9 t -83.59 -8.6 59.28 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -92.18 -29.27 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.131 0.967 . . . . 0.0 109.208 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.655 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.759 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 N--CA 1.481 0.762 0 N-CA-C 110.283 -0.699 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 87' ' ' PRO . 39.1 t -114.15 154.06 46.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 108.996 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.756 ' HD2' HG13 ' A' ' 86' ' ' VAL . 43.3 Cg_endo -86.13 -167.63 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.525 1.276 . . . . 0.0 109.877 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 mtt -122.25 11.12 10.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.02 -1.05 . . . . 0.0 111.541 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 120.677 -1.264 . . . . 0.0 111.609 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' B' ' 110' ' ' PRO . 6.7 t-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.982 0.42 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.513 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 46.0 Cg_endo -69.22 8.93 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.902 1.735 . . . . 0.0 112.344 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 1.011 ' CE2' HD12 ' A' ' 40' ' ' LEU . 13.5 m-85 -99.31 -49.74 4.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.505 -1.372 . . . . 0.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.939 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.562 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.7 t90 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.049 0.452 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.22 -27.61 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 109.741 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -95.56 130.79 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.794 . . . . 0.0 109.327 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -88.77 172.4 7.6 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.335 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -34.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.988 1.52 . . . . 0.0 109.946 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -78.33 -28.85 47.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.291 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.505 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 9.1 m-20 -81.05 -33.86 33.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.61 -17.92 57.31 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.177 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -37.48 61.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -76.91 -23.16 52.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 12.3 m-30 -77.55 -34.75 53.71 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.73 -20.2 62.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.893 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.04 33.4 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' CE1' ' A' ' 70' ' ' PHE . 73.5 mt -79.23 -30.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.725 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.79 -36.12 67.52 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 t70 -91.21 -3.23 57.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.447 -0.783 . . . . 0.0 110.034 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.9 t -82.17 -14.67 55.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 108.765 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.079 HD12 HD13 ' A' ' 31' ' ' LEU . 8.4 mt -94.09 -53.8 3.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 m 140.87 97.18 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.11 150.4 42.74 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 O-C-N 123.97 1.51 . . . . 0.0 110.643 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 84.4 t -119.8 84.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.316 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 72.73 3.96 4.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.563 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 123.31 29.46 1.2 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -149.89 151.76 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.277 . . . . 0.0 112.326 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.079 HD13 HD12 ' A' ' 24' ' ' LEU . 9.4 mt -120.47 154.16 35.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -98.14 141.49 31.0 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 120.754 -1.217 . . . . 0.0 109.715 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.615 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.79 -27.89 0.2 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.7 m-20 -67.63 -24.78 65.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.424 -1.045 . . . . 0.0 110.481 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 66.6 mttm -90.24 -36.75 14.55 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.916 HG12 ' CD1' ' A' ' 40' ' ' LEU . 93.3 t -72.76 -39.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.252 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -42.8 -54.95 7.94 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 111.264 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.7 Cg_endo -65.69 -30.64 50.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.699 1.368 . . . . 0.0 110.005 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.82 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.5 t -69.01 -28.71 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.51 -0.744 . . . . 0.0 109.064 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.956 ' HB3' HD22 ' A' ' 50' ' ' LEU . 27.1 mt -94.78 -31.49 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 0.0 110.176 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 37' ' ' LYS . 23.0 mt -70.3 -9.93 57.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 27.2 p-10 -90.9 -7.69 51.46 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.993 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.579 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 p -81.4 14.13 2.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.716 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.81 10.71 5.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.027 HD13 HG21 ' A' ' 49' ' ' ILE . 14.3 mt -98.22 157.9 33.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.926 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.66 170.42 20.26 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.063 1.559 . . . . 0.0 109.569 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.56 HG13 ' C ' ' B' ' 111' ' ' PHE . 2.0 t -71.3 -3.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.125 -0.985 . . . . 0.0 109.37 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -78.14 -32.17 50.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.027 HG21 HD13 ' A' ' 45' ' ' LEU . 9.6 mm -81.67 -40.81 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.956 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -71.09 -30.79 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.68 -24.97 74.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.789 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -100.68 -35.06 9.61 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.906 -0.761 . . . . 0.0 109.868 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.09 HG11 ' CG2' ' A' ' 77' ' ' VAL . 23.8 t -65.87 -34.39 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.829 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.615 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.07 -55.03 10.53 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.43 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 1.7 mt-10 -48.0 -57.1 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.09 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.6 mt -63.32 -14.62 51.79 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.938 . . . . 0.0 108.96 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.905 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 11.0 t -93.09 -35.14 13.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 22.5 t0 -74.84 99.94 3.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.718 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.537 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 14.6 mm -86.91 -23.82 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.24 -12.83 31.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 2.6 m170 55.61 47.66 20.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -0.944 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -125.64 17.64 8.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.923 -1.111 . . . . 0.0 110.197 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 74.07 32.99 57.88 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.6 mtp -150.76 161.33 42.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -1.229 . . . . 0.0 111.071 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.771 HD12 HG21 ' A' ' 36' ' ' VAL . 19.6 mt -133.15 107.31 8.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.544 -0.723 . . . . 0.0 109.432 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.636 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 32.9 p30 -78.73 175.13 10.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.75 -1.219 . . . . 0.0 110.378 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.46 -50.62 3.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 112.17 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.769 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 5.1 p-10 -72.55 -46.82 52.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.151 -0.968 . . . . 0.0 110.444 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.537 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 52.2 mt-10 -62.02 -54.67 38.25 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.533 -0.73 . . . . 0.0 109.229 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.994 ' CD2' HD12 ' A' ' 31' ' ' LEU . 12.2 t80 -49.83 -30.0 9.02 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -61.45 -55.54 30.15 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.79 0.805 . . . . 0.0 110.005 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.418 ' HA ' ' HE2' ' A' ' 75' ' ' PHE . 92.0 t -51.07 -28.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.488 0.661 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.905 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.98 -6.87 58.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 0.0 112.411 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.59 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.1 mmm -90.37 -43.36 10.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.268 -1.52 . . . . 0.0 110.569 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 2.2 p90 -76.05 -22.3 55.85 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.156 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 86' ' ' VAL . 6.3 mt -72.61 -30.1 64.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.09 ' CG2' HG11 ' A' ' 53' ' ' VAL . 37.5 t -91.07 -21.79 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.742 -0.599 . . . . 0.0 110.106 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.16 -27.69 21.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.543 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 5.4 m -83.48 -14.44 52.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -0.789 . . . . 0.0 109.418 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.683 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.66 -12.59 57.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' A' ' 45' ' ' LEU . 8.3 mt . . . . . 0 N--CA 1.487 1.423 0 O-C-N 121.734 -0.604 . . . . 0.0 110.482 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.483 0.857 0 N-CA-C 109.972 -0.818 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.538 HG13 HD22 ' A' ' 76' ' ' LEU . 90.4 t -127.79 119.2 21.27 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.85 -1.157 . . . . 0.0 111.51 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.756 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -81.67 154.5 17.95 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.978 1.515 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.524 ' HG3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -85.04 18.06 2.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.607 -1.308 . . . . 0.0 110.582 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.416 ' N ' HD21 ' A' ' 56' ' ' LEU . 4.7 m . . . . . 0 C--N 1.289 -2.029 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.035 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' CA ' ' A' ' 51' ' ' GLY . 5.9 t-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.936 0.398 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.611 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -73.78 11.56 1.09 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.243 1.654 . . . . 0.0 112.386 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.914 ' CE2' HD12 ' A' ' 40' ' ' LEU . 2.7 m-85 -110.73 -73.58 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.54 -1.35 . . . . 0.0 108.405 178.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.412 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.575 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.5 t90 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -39.55 -29.25 0.05 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.747 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.575 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 29.5 t -88.62 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.309 -0.87 . . . . 0.0 109.349 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.562 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.85 174.35 4.62 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.101 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.3 Cg_endo -70.59 -33.72 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.921 1.485 . . . . 0.0 109.584 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.13 -19.97 58.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.2 m-20 -85.33 -43.87 13.32 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.05 -20.56 66.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.69 . . . . 0.0 109.161 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.56 49.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.51 -24.58 45.71 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -73.69 -36.02 65.24 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.42 -20.82 60.64 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.919 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -82.82 -36.86 25.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.645 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 19.6 mt -76.04 -31.57 21.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -67.77 -38.27 83.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 15.4 t70 -91.29 -3.79 56.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.793 -0.567 . . . . 0.0 110.097 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -78.63 -15.6 58.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 108.92 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.1 HD12 ' CD1' ' A' ' 31' ' ' LEU . 11.9 mt -96.14 -52.44 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.668 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.2 t 136.51 99.05 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.0 Cg_endo -72.47 145.23 42.12 Favored 'Trans proline' 0 C--N 1.297 -2.18 0 O-C-N 124.184 1.623 . . . . 0.0 111.01 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 10.7 t -118.07 111.46 34.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 48.15 23.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.382 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.14 34.52 5.61 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 78.9 m-85 -150.99 146.67 26.38 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.183 -1.186 . . . . 0.0 112.397 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.1 ' CD1' HD12 ' A' ' 24' ' ' LEU . 7.7 mt -111.73 148.85 32.58 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.486 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -91.04 142.92 27.25 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.735 -1.228 . . . . 0.0 110.3 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.611 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.52 -25.37 0.81 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.5 m-20 -71.99 -21.88 61.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.967 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 29.2 mttm -93.12 -36.23 12.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.882 HG11 HD12 ' A' ' 65' ' ' LEU . 64.1 t -79.01 -43.86 24.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.564 0.697 . . . . 0.0 109.863 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 15.7 tttt -41.01 -51.73 7.27 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.0 Cg_endo -67.61 -32.42 30.99 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.314 1.165 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -66.34 -31.91 55.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.561 -0.712 . . . . 0.0 109.089 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.951 ' HB3' HD22 ' A' ' 50' ' ' LEU . 33.9 mt -90.0 -29.85 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 110.075 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 37' ' ' LYS . 58.8 mt -69.32 -15.36 63.31 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -90.72 -3.72 57.26 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.723 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.582 ' O ' HD21 ' A' ' 81' ' ' LEU . 83.8 p -81.37 12.56 3.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.816 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 2.9 ttmt 62.55 9.67 3.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.05 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.7 mt -100.55 153.22 37.86 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.6 Cg_endo -74.12 172.28 16.29 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.913 1.481 . . . . 0.0 109.734 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -70.2 -5.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.094 -1.004 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -78.11 -31.1 49.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 108.968 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.837 HG13 HD22 ' A' ' 45' ' ' LEU . 7.6 mm -85.17 -43.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.951 HD22 ' HB3' ' A' ' 40' ' ' LEU . 17.2 mt -70.24 -28.89 65.61 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.91 -25.99 74.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 1.013 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.8 ttm-85 -100.9 -31.06 11.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.876 -0.779 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.045 HG11 HG23 ' A' ' 77' ' ' VAL . 7.4 t -69.82 -35.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.681 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.611 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.1 t-105 -69.08 -52.28 30.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.267 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 19.9 mm-40 -52.82 -54.27 36.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 110.111 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.013 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.6 mt -63.2 -13.26 35.37 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 108.612 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.651 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.9 m -96.18 -41.02 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.67 . . . . 0.0 110.601 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -69.54 82.3 0.41 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.239 -0.913 . . . . 0.0 110.615 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.529 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 33.4 mm -58.25 -21.7 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.144 -0.972 . . . . 0.0 108.939 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 1.9 m-20 -103.68 -9.91 18.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 0.0 109.818 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 29.8 p80 38.73 48.89 1.4 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.689 -0.632 . . . . 0.0 110.719 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 22.3 p-10 -117.01 12.26 14.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.325 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 88.11 28.76 22.15 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.8 mtt -150.75 161.59 42.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -1.21 . . . . 0.0 111.391 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.882 HD12 HG11 ' A' ' 36' ' ' VAL . 15.4 mt -135.73 110.41 8.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 1.1 t70 -72.94 172.64 10.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.514 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 4.2 ptm180 -51.24 -42.4 61.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 110.276 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 26.3 t0 -79.62 -35.2 39.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 7.9 tt0 -69.83 -52.38 25.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.723 0.773 . . . . 0.0 108.994 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.955 ' CD2' HD12 ' A' ' 31' ' ' LEU . 24.9 t80 -53.18 -26.59 17.79 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -63.94 -52.28 60.48 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.639 0.733 . . . . 0.0 109.917 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.401 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 89.9 t -54.22 -24.0 10.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.4 -7.71 54.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.293 -0.879 . . . . 0.0 112.129 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 mmm -90.22 -41.76 11.4 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.388 -1.445 . . . . 0.0 110.283 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.432 ' O ' ' SG ' ' A' ' 79' ' ' CYS . 2.5 p90 -78.44 -19.42 53.2 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.355 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 HG13 ' A' ' 86' ' ' VAL . 6.9 mt -76.08 -26.15 56.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.045 HG23 HG11 ' A' ' 53' ' ' VAL . 20.7 t -91.36 -57.23 4.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.68 -0.637 . . . . 0.0 109.557 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.415 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.7 m-85 -53.15 -20.26 3.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.361 -0.837 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 7.8 m -83.96 -16.7 43.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.089 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.05 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.01 -11.52 44.0 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.203 -0.935 . . . . 0.0 109.383 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.582 HD21 ' O ' ' A' ' 43' ' ' SER . 6.3 mp . . . . . 0 C--N 1.304 -1.412 0 CA-C-O 121.663 0.744 . . . . 0.0 109.387 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 N--CA 1.482 0.805 0 N-CA-C 109.935 -0.833 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.591 HG11 HG23 ' A' ' 53' ' ' VAL . 20.7 t -112.56 119.81 42.54 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.074 -1.016 . . . . 0.0 110.584 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.9 Cg_endo -84.62 -162.44 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 109.448 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.814 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.09 0.23 12.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 C--N 1.293 -1.88 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.434 -178.472 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.496 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 15.1 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.91 0.386 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -71.4 3.14 3.79 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.039 1.547 . . . . 0.0 111.573 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.95 ' CE2' HD12 ' A' ' 40' ' ' LEU . 8.4 m-85 -100.1 -45.83 5.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.862 -1.149 . . . . 0.0 109.561 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.219 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.6 t90 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.333 0.587 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -39.88 -27.66 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 110.277 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 13' ' ' ASP . 88.4 t -107.29 138.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.26 -178.03 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.895 . . . . 0.0 110.089 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.8 Cg_endo -71.16 -36.23 7.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.791 1.416 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.59 -24.51 60.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.992 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB3' HG13 ' A' ' 9' ' ' VAL . 2.8 m-20 -83.26 -40.26 19.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.336 -0.853 . . . . 0.0 109.015 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -74.62 -21.56 59.39 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.12 71.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.747 . . . . 0.0 109.248 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -78.19 -29.34 48.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 12.4 m-30 -71.09 -37.71 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 29.1 t0 -69.61 -18.06 63.58 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.818 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.0 -36.67 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.676 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 mt -78.38 -34.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.783 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -67.85 -36.83 81.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.557 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.5 t70 -87.5 -3.08 59.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.738 -0.601 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 -8.02 58.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 109.409 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.105 HD12 ' CD1' ' A' ' 31' ' ' LEU . 7.2 mt -102.17 -15.61 16.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 87.99 88.94 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.0 Cg_endo -75.94 150.78 34.65 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.563 1.823 . . . . 0.0 110.495 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 41.8 t -116.12 110.47 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.8 OUTLIER 65.42 13.79 9.05 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -177.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 93.58 32.55 7.62 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 26.3 m-85 -138.03 136.12 36.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.285 . . . . 0.0 112.358 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.105 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -107.06 151.0 25.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' ASP . 15.9 p -100.58 147.78 25.55 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.989 -1.069 . . . . 0.0 109.774 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.48 -25.05 0.73 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . 46.7 m-20 -67.5 -22.34 65.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.458 -1.025 . . . . 0.0 110.672 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 24' ' ' LEU . 2.9 mtpp -101.63 -34.72 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.914 -1.116 . . . . 0.0 108.398 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.888 HG11 HD12 ' A' ' 65' ' ' LEU . 92.3 t -78.18 -36.09 20.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.499 0.666 . . . . 0.0 109.692 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.663 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 1.8 tttp -44.78 -53.84 14.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 110.706 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.52 -30.34 29.17 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.566 1.298 . . . . 0.0 110.144 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.756 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.5 t -64.92 -28.43 44.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.369 0.604 . . . . 0.0 109.799 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.984 HD12 ' CE2' ' B' ' 111' ' ' PHE . 21.3 mt -94.52 -30.45 14.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 ' HG3' ' A' ' 37' ' ' LYS . 56.6 mt -69.26 -10.01 55.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 108.591 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -87.92 -6.25 58.15 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.241 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.631 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -84.96 18.3 2.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 110.242 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 19.33 1.62 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.644 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.067 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.5 mt -100.51 155.3 36.53 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 109.9 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -75.11 162.48 36.78 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.019 1.536 . . . . 0.0 109.442 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.68 HG12 ' OXT' ' B' ' 112' ' ' ARG . 9.1 t -67.25 -6.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -74.86 -31.24 61.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.794 HG13 HD22 ' A' ' 45' ' ' LEU . 7.3 mm -81.45 -43.12 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.847 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -68.68 -32.54 72.44 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.465 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.576 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -68.25 -23.88 74.82 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.817 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.9 ttm180 -101.67 -32.42 10.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.07 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.942 HG11 HG23 ' A' ' 77' ' ' VAL . 7.6 t -70.43 -40.23 77.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.124 -1.031 . . . . 0.0 108.574 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.581 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.6 t-105 -63.66 -50.86 67.62 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.76 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.495 ' HG3' ' ND2' ' B' ' 109' ' ' ASN . 13.0 mt-10 -47.22 -56.87 5.89 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.904 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 52' ' ' ARG . 1.7 mt -64.54 -13.25 51.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.99 . . . . 0.0 108.919 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.942 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -88.48 -40.78 13.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.8 t0 -80.04 95.25 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.312 0.577 . . . . 0.0 110.221 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.32 -13.09 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.928 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.469 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 11.7 m-20 -99.67 -13.13 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.179 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 6.8 m-70 55.57 47.47 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.494 -0.754 . . . . 0.0 110.546 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 19.5 p-10 -126.09 29.66 5.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.51 38.45 93.61 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtt -150.19 160.8 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 111.823 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.888 HD12 HG11 ' A' ' 36' ' ' VAL . 5.7 mt -129.81 108.12 9.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.641 -0.662 . . . . 0.0 109.512 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.529 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -69.46 158.04 35.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.858 -1.151 . . . . 0.0 109.448 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 14.1 ptt180 -41.5 -42.43 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.589 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -73.27 -43.88 60.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 12.4 mt-10 -64.79 -51.48 62.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.81 ' CD2' HD12 ' A' ' 31' ' ' LEU . 33.5 t80 -49.63 -28.64 6.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.0 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -65.84 -45.06 83.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 110.185 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.568 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 71.6 t -63.74 -20.34 26.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 110.179 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.942 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -89.86 -6.63 55.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.461 -0.775 . . . . 0.0 111.002 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 10.2 mmm -90.44 -44.93 9.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.548 -1.345 . . . . 0.0 110.318 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.568 ' CE2' ' HA ' ' A' ' 72' ' ' VAL . 1.5 p90 -75.32 -26.38 58.61 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.027 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.819 HD22 HG13 ' A' ' 86' ' ' VAL . 6.7 mt -67.56 -28.54 67.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.942 HG23 HG11 ' A' ' 53' ' ' VAL . 24.0 t -91.0 -59.9 2.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.77 ' HA ' HD13 ' A' ' 81' ' ' LEU . 2.5 m-85 -48.52 -23.07 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.772 -0.58 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 23.0 m -82.93 -20.41 35.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.861 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.067 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.26 -12.37 58.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 77' ' ' VAL . 3.3 mp . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.415 -0.803 . . . . 0.0 110.17 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 N--CA 1.484 0.959 0 N-CA-C 109.985 -0.814 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.819 HG13 HD22 ' A' ' 76' ' ' LEU . 33.0 t -124.44 125.86 25.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.958 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.677 ' O ' HD11 ' A' ' 56' ' ' LEU . 53.1 Cg_endo -87.71 164.03 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.932 1.491 . . . . 0.0 109.961 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.547 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 17.0 mtt -93.83 16.68 13.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.969 -1.082 . . . . 0.0 110.465 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.292 -1.911 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.549 -178.413 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.576 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 11.6 t-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.692 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.6 Cg_endo -73.73 -3.15 13.27 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.85 1.448 . . . . 0.0 111.042 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.984 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.82 -65.92 1.14 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.851 -1.156 . . . . 0.0 108.705 177.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.68 ' OXT' HG12 ' A' ' 47' ' ' VAL . 2.1 ptt-85 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.273 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.6 t90 . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -42.64 -25.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.954 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 17.4 t -99.28 152.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.2 mttm -109.77 175.02 2.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.0 Cg_endo -68.35 -36.71 15.24 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.142 1.601 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -30.29 63.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.341 -0.849 . . . . 0.0 109.262 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -82.14 -38.8 24.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 12.6 tptp -70.84 -17.03 62.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.43 -40.98 49.15 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.93 -24.87 43.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.7 m-30 -73.45 -37.39 65.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -73.98 -20.29 60.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.925 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.51 -35.68 24.66 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.2 -0.938 . . . . 0.0 108.5 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.566 HG22 ' CE1' ' A' ' 70' ' ' PHE . 50.5 mt -77.22 -33.11 19.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.725 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -64.89 -37.87 89.06 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.545 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 t0 -90.53 -2.26 57.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 1.7 m -82.15 -9.93 59.35 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.309 -0.869 . . . . 0.0 108.948 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.128 HD12 ' CD1' ' A' ' 31' ' ' LEU . 13.1 mt -98.67 -53.89 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 150.62 84.33 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 55.8 Cg_endo -76.71 123.83 7.17 Favored 'Trans proline' 0 C--N 1.293 -2.357 0 O-C-N 124.307 1.688 . . . . 0.0 109.55 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 28' ' ' ASN 0.251 2.2 p -119.48 121.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.723 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.026 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' ND2' ' CE2' ' A' ' 30' ' ' PHE . 10.0 t30 57.68 20.77 6.64 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 81.15 45.0 7.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.557 ' CE2' ' ND2' ' A' ' 28' ' ' ASN . 87.8 m-85 -151.87 158.79 43.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 112.452 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.128 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.7 mt -126.39 160.64 29.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' LYS . 1.4 p -106.88 146.78 30.57 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.682 -1.261 . . . . 0.0 110.532 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.618 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.65 -24.93 0.76 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.1 m-20 -75.85 -20.02 58.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.978 . . . . 0.0 110.618 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HD2' HD22 ' A' ' 31' ' ' LEU . 11.7 mtmm -94.89 -35.2 12.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.976 -1.078 . . . . 0.0 108.141 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.786 HG12 ' CD1' ' A' ' 40' ' ' LEU . 96.8 t -78.01 -43.29 28.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.639 0.733 . . . . 0.0 109.764 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -40.83 -52.23 6.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 110.724 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.8 Cg_endo -67.03 -35.4 25.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.401 1.211 . . . . 0.0 109.65 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.58 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.5 -33.45 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.98 ' HB3' HD22 ' A' ' 50' ' ' LEU . 29.7 mt -88.97 -28.96 19.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.622 -0.674 . . . . 0.0 109.901 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.533 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 62.1 mt -71.95 -14.78 62.01 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -90.58 -3.74 57.35 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.118 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.647 ' O ' HD21 ' A' ' 81' ' ' LEU . 37.7 m -81.75 11.44 4.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.2 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.14 11.72 4.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.707 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.2 mt -100.57 155.14 36.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.9 Cg_endo -75.27 170.13 21.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.046 1.551 . . . . 0.0 109.816 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.576 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -68.59 -7.3 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 120.952 -1.093 . . . . 0.0 109.045 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.34 -27.87 60.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.927 HG21 HD13 ' A' ' 45' ' ' LEU . 10.1 mm -88.38 -38.69 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.98 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.7 mt -77.28 -29.76 53.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.2 -25.66 75.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.746 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -102.22 -35.88 8.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.081 -0.658 . . . . 0.0 110.75 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 77' ' ' VAL . 13.7 t -67.49 -37.72 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.819 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.618 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -64.11 -52.55 58.63 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.306 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 91.2 mt-10 -51.14 -58.79 5.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.388 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.812 HD21 ' C ' ' A' ' 88' ' ' MET . 3.2 mt -62.16 -13.98 32.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.98 . . . . 0.0 109.013 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.909 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 29.4 m -96.35 -26.73 15.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.717 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' TRP . 9.5 t0 -78.26 93.14 4.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.508 HG12 ' HG3' ' A' ' 69' ' ' GLU . 24.4 mm -73.12 -32.43 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 110.06 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 2.6 m-20 -95.62 -16.02 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 58' ' ' ASP . 91.0 m-70 52.61 50.69 17.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.314 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 37.5 p-10 -125.0 36.87 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.5 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 58.19 33.01 68.47 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 6.6 mtt -150.54 160.66 43.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -1.091 . . . . 0.0 111.269 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.767 HD12 HG11 ' A' ' 36' ' ' VAL . 13.2 mt -132.28 110.49 10.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.222 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 10.7 t0 -70.13 167.62 17.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.946 -1.096 . . . . 0.0 110.372 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.3 ptm180 -45.61 -44.22 12.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.286 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.614 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 11.7 t0 -78.19 -36.27 47.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.301 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -63.65 -52.47 60.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.938 0.875 . . . . 0.0 109.397 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.867 ' CD2' HD12 ' A' ' 31' ' ' LEU . 17.7 t80 -54.48 -20.37 7.53 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.533 0.682 . . . . 0.0 109.274 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -73.23 -46.27 51.2 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 72' ' ' VAL . 23.7 t -59.94 -28.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.077 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.909 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -89.66 -4.67 57.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 5.6 mmt -87.43 -43.19 12.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.718 -1.239 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.476 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -77.77 -22.22 50.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.077 -1.014 . . . . 0.0 108.379 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.608 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.3 mt -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 53' ' ' VAL . 41.3 t -91.7 -60.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.689 -0.632 . . . . 0.0 110.109 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.478 ' HA ' HD13 ' A' ' 81' ' ' LEU . 3.4 m-85 -55.97 -19.65 13.27 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.225 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 7.5 m -83.25 -16.69 45.4 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.019 -1.051 . . . . 0.0 109.581 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.982 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.78 -15.22 42.76 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.454 -0.779 . . . . 0.0 109.557 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.647 HD21 ' O ' ' A' ' 43' ' ' SER . 6.2 mp . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 121.643 0.735 . . . . 0.0 109.467 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.484 0.931 0 N-CA-C 109.969 -0.82 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.629 HG11 ' CG2' ' A' ' 53' ' ' VAL . 96.5 t -128.44 109.61 19.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.975 . . . . 0.0 110.793 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.657 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.4 Cg_endo -76.31 -169.95 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.988 1.52 . . . . 0.0 109.564 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -112.8 20.87 16.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.514 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.51 ' N ' HD21 ' A' ' 56' ' ' LEU . 74.8 m . . . . . 0 C--N 1.29 -2.0 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.102 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.451 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 7.6 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.029 0.442 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.509 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -70.27 8.78 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.993 1.795 . . . . 0.0 112.176 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.923 ' CE2' HD12 ' A' ' 40' ' ' LEU . 15.3 m-85 -98.95 -45.04 6.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 109.854 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.459 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 13.1 t90 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 7' ' ' TRP . . . -40.56 -28.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 10' ' ' LYS . 62.8 t -94.02 165.45 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 12.6 mttt -119.55 172.65 4.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.3 Cg_endo -67.88 -35.46 20.93 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.005 1.529 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 6.4 pt-20 -72.64 -28.69 62.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.93 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.8 m-20 -81.17 -38.79 26.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 108.638 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppt? -68.56 -16.99 64.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -28.46 35.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -90.73 -35.62 14.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.7 m-30 -65.39 -28.56 69.35 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 14' ' ' LYS . 9.6 m-20 -80.98 -24.09 38.27 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.662 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.37 -30.78 37.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.718 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 56.3 mt -80.78 -28.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.642 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.58 -35.8 60.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.521 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t70 -89.32 -3.06 58.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.758 -0.589 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -6.57 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.305 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.118 HD12 HD13 ' A' ' 31' ' ' LEU . 4.5 mt -106.5 -12.25 15.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 p 89.59 94.68 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.259 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -73.8 150.46 44.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.253 1.659 . . . . 0.0 110.871 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 71.9 t -123.9 110.27 25.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.3 t30 57.58 15.41 2.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.321 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.28 35.25 5.32 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 75.4 m-85 -150.56 143.2 24.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -1.205 . . . . 0.0 112.224 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.118 HD13 HD12 ' A' ' 24' ' ' LEU . 12.4 mt -109.56 134.46 51.89 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 1.7 m -78.37 142.56 37.57 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 118.939 -1.105 . . . . 0.0 109.942 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.529 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -43.48 -26.35 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 63.5 m-20 -67.55 -23.42 65.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 40.3 mttp -96.1 -33.18 12.18 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.841 HG12 ' CD1' ' A' ' 40' ' ' LEU . 84.6 t -77.9 -38.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.641 0.734 . . . . 0.0 109.598 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.0 OUTLIER -43.15 -54.96 8.52 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.73 . . . . 0.0 111.137 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -67.79 -31.78 31.24 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.718 1.378 . . . . 0.0 109.926 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -64.27 -31.22 52.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.579 -0.701 . . . . 0.0 109.304 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.979 HD12 ' CE2' ' B' ' 111' ' ' PHE . 22.2 mt -94.34 -34.92 12.62 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.597 -0.689 . . . . 0.0 109.974 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.4 mt -67.91 -14.45 62.97 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 19.8 t30 -90.73 -4.91 56.35 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.47 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 5.7 m -84.97 18.65 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 0.0 110.431 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.9 tptt 60.23 13.5 3.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.05 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.051 HD11 ' HB3' ' A' ' 80' ' ' ALA . 12.7 mt -100.22 152.13 37.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.92 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.572 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.8 Cg_endo -76.61 170.06 20.63 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.017 1.535 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 3.4 t -71.03 -4.53 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.757 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.8 -33.78 45.97 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.818 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.897 HG13 HD22 ' A' ' 45' ' ' LEU . 14.5 mm -79.32 -42.07 23.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 108.825 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.9 mt -68.35 -29.46 68.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.57 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.28 -24.69 73.57 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 1.011 ' O ' HD12 ' A' ' 56' ' ' LEU . 5.5 ttm-85 -100.81 -32.59 10.62 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.685 -0.891 . . . . 0.0 110.265 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.801 HG11 HG23 ' A' ' 77' ' ' VAL . 24.6 t -68.77 -36.37 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.821 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.6 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.7 t-105 -69.59 -52.32 27.15 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.344 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 84.1 mt-10 -50.96 -57.38 8.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.095 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.011 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.1 mt -61.16 -14.36 24.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.128 -0.983 . . . . 0.0 108.834 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.934 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 15.5 t -97.0 -23.31 16.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.29 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 29.0 t0 -95.55 90.91 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.975 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.15 -15.45 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 110.164 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 8.0 m-20 -89.17 -17.25 29.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.479 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 11.8 m170 57.59 46.86 16.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.623 -0.673 . . . . 0.0 110.115 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 8.4 p30 -119.78 16.07 12.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.639 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.22 33.58 83.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 37.9 mtp -151.47 160.78 43.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.238 . . . . 0.0 110.635 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.835 HD12 HG11 ' A' ' 36' ' ' VAL . 12.6 mt -119.77 105.16 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.0 109.584 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.567 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -71.94 163.48 27.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.334 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -41.84 -39.84 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 111.108 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -79.71 -32.32 41.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.187 -0.946 . . . . 0.0 110.594 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' CG ' ' OD1' ' A' ' 66' ' ' ASP . 35.3 mt-10 -77.75 -39.24 44.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.108 -0.995 . . . . 0.0 109.021 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.895 ' CD2' HD12 ' A' ' 31' ' ' LEU . 20.9 t80 -62.35 -18.22 60.93 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 0.0 108.907 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.73 -44.34 28.09 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.797 0.808 . . . . 0.0 109.564 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.586 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 44.0 t -61.57 -30.43 48.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.607 0.717 . . . . 0.0 109.676 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.934 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.68 -2.81 58.38 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 110.82 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.622 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.5 mmt -83.62 -48.91 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.897 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 7.6 p90 -76.19 -23.74 54.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.7 mt -71.04 -24.45 62.35 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.801 HG23 HG11 ' A' ' 53' ' ' VAL . 45.7 t -91.68 -46.38 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.648 -0.658 . . . . 0.0 110.298 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.401 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 2.7 m-85 -69.58 -26.42 64.45 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 110.865 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 16.1 t -81.43 -12.91 58.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.038 . . . . 0.0 109.385 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.051 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.36 -10.54 43.63 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 109.023 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.4 mt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.739 0.781 . . . . 0.0 109.708 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 N--CA 1.479 0.639 0 N-CA-C 109.359 -1.054 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 91.6 t -116.73 126.69 27.31 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 110.562 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.696 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.5 Cg_endo -84.42 -170.51 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.994 1.523 . . . . 0.0 108.913 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.777 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.48 13.25 13.46 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.954 -1.091 . . . . 0.0 110.242 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.618 ' N ' HD21 ' A' ' 56' ' ' LEU . 3.6 m . . . . . 0 C--N 1.292 -1.921 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.245 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 2.5 t-20 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.677 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 42.3 Cg_endo -70.5 -3.73 13.08 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.812 1.428 . . . . 0.0 110.514 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.979 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -111.95 -60.99 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.598 ' CG ' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.358 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.485 0.993 0 N-CA-C 110.56 -0.592 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.493 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -88.3 123.34 32.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.935 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.796 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -42.98 -28.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.417 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.493 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 23.8 t -101.73 139.2 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.91 . . . . 0.0 110.708 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.03 -177.3 0.64 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.49 -0.756 . . . . 0.0 109.748 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 41.7 Cg_endo -71.66 -32.63 11.6 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.711 1.374 . . . . 0.0 110.249 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 13.0 mm-40 -77.36 -31.78 54.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.521 -0.737 . . . . 0.0 109.784 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -77.44 -35.19 54.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -82.21 -18.47 42.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.638 0.732 . . . . 0.0 109.112 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -70.08 -40.15 75.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.639 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -73.51 -32.01 64.02 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.639 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -66.22 -36.58 83.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.56 -20.98 63.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.663 -0.648 . . . . 0.0 110.155 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.01 -38.73 24.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.971 . . . . 0.0 108.511 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.69 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 42.7 mt -75.79 -29.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.735 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.97 -36.41 64.58 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t70 -89.97 1.48 56.23 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.977 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -92.4 -3.47 55.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.922 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.076 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -109.63 -4.58 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 84.99 89.97 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.3 Cg_endo -72.42 148.7 49.07 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 124.503 1.791 . . . . 0.0 110.864 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 68.7 t -121.03 104.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.1 t30 58.88 20.41 8.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.805 . . . . 0.0 110.001 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 94.27 37.1 5.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 87.1 m-85 -150.29 149.22 29.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.164 -1.198 . . . . 0.0 111.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.076 ' CD1' HD12 ' A' ' 24' ' ' LEU . 15.0 mt -122.54 130.48 53.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -77.29 148.14 35.87 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.55 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -46.66 -25.55 2.25 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 9.0 t0 -63.02 -20.75 65.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.567 -0.961 . . . . 0.0 109.685 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 27.9 mttp -104.42 -32.38 9.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.948 HG11 HD12 ' A' ' 65' ' ' LEU . 92.3 t -83.5 -46.29 18.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.175 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' CG ' HD11 ' A' ' 41' ' ' LEU . 8.0 tttt -41.68 -49.91 9.91 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -67.69 -31.97 31.42 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.341 1.179 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.671 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -68.4 -34.58 66.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.948 HD12 ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -86.3 -31.48 21.58 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.82 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD11 ' CG ' ' A' ' 37' ' ' LYS . 47.1 mt -71.02 -11.5 61.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.762 . . . . 0.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.09 -10.36 53.07 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.169 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 1.012 ' O ' HD21 ' A' ' 81' ' ' LEU . 87.7 p -79.17 7.92 6.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 110.473 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.64 9.53 5.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.066 -1.021 . . . . 0.0 109.939 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.995 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.2 mt -93.17 157.26 39.25 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.5 Cg_endo -74.72 167.86 26.13 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.857 1.451 . . . . 0.0 109.635 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.478 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.51 -7.4 6.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.941 -1.099 . . . . 0.0 109.142 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.51 -29.87 61.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.897 HG13 HD22 ' A' ' 45' ' ' LEU . 8.7 mm -85.62 -39.1 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.925 0.869 . . . . 0.0 108.898 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.941 HD22 ' HB3' ' A' ' 40' ' ' LEU . 13.1 mt -79.52 -28.77 41.33 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.08 -26.83 71.49 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.741 ' O ' HD12 ' A' ' 56' ' ' LEU . 28.0 ttm180 -101.43 -31.19 11.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.113 -0.64 . . . . 0.0 110.501 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.861 HG11 HG23 ' A' ' 77' ' ' VAL . 18.7 t -70.63 -36.93 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 108.588 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CZ2' ' OD1' ' A' ' 58' ' ' ASP . 1.6 t-105 -63.44 -50.77 68.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.71 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.3 mm-40 -52.25 -57.7 8.91 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.11 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.4 mt -62.13 -19.28 62.87 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.141 -0.974 . . . . 0.0 108.646 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.879 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 7.5 t -85.9 -33.95 21.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -70.3 92.75 0.8 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.51 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 29.1 mm -75.31 -23.26 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.063 -1.023 . . . . 0.0 111.328 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -110.2 -9.54 14.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.884 -1.135 . . . . 0.0 110.948 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 50.7 m170 59.59 44.8 14.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.109 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 19.2 p-10 -106.74 9.31 31.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 109.989 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 80.05 24.77 59.06 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 3.2 mtp -152.17 161.4 42.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.183 -1.187 . . . . 0.0 110.373 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.948 HD12 HG11 ' A' ' 36' ' ' VAL . 13.6 mt -116.84 103.12 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.723 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.599 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -69.26 173.23 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.067 -1.021 . . . . 0.0 110.021 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' N ' ' CG ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -50.07 -32.15 14.9 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.613 -0.679 . . . . 0.0 110.894 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 -30.38 20.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 36.2 mt-10 -79.16 -40.6 30.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 108.917 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.748 ' CD1' HD12 ' A' ' 31' ' ' LEU . 27.3 t80 -63.81 -24.45 67.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -70.17 -51.87 27.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.962 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.1 t -57.29 -25.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.547 -0.72 . . . . 0.0 110.359 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.879 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.07 -4.99 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 111.637 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.7 mmt -88.53 -44.16 10.88 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.862 -1.149 . . . . 0.0 110.361 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.79 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 4.5 p90 -77.71 -22.17 50.82 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.999 -1.081 . . . . 0.0 108.293 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 12.1 mt -74.63 -24.52 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.012 ' O ' HD12 ' A' ' 81' ' ' LEU . 49.3 t -91.62 -40.96 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.586 -0.696 . . . . 0.0 110.123 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -71.91 -22.52 61.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.648 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 14.3 m -83.2 -20.76 34.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.818 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.995 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -80.62 -12.82 59.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.332 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.012 HD21 ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -91.2 -41.13 11.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.513 -0.742 . . . . 0.0 110.771 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 4.0 tt0 -125.66 -9.15 6.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 111.768 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -110.47 -90.01 0.48 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.543 -1.348 . . . . 0.0 111.612 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.0 mt-10 -146.08 172.75 4.91 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.673 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 42.3 Cg_endo -67.65 -169.29 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.057 1.556 . . . . 0.0 110.588 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.458 HG13 HD22 ' A' ' 76' ' ' LEU . 98.1 t -128.15 137.48 30.93 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 110.605 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.727 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.3 Cg_endo -84.41 175.43 7.2 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.869 1.457 . . . . 0.0 108.503 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.738 ' C ' HD21 ' A' ' 56' ' ' LEU . 9.9 mtm -108.48 18.21 21.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.74 -1.225 . . . . 0.0 110.49 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 56' ' ' LEU . 74.8 m -112.88 99.51 7.94 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.355 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.719 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -47.16 104.97 0.44 Allowed Pre-proline 0 C--N 1.293 -1.863 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.494 178.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 43.5 Cg_endo -71.52 148.95 54.96 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.984 1.518 . . . . 0.0 110.54 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.45 -15.0 34.45 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.056 1.556 . . . . 0.0 110.554 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.612 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -84.57 -3.29 58.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.796 HD13 ' HB3' ' A' ' 8' ' ' ALA . 3.9 mm? -105.67 -8.58 17.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.338 -0.851 . . . . 0.0 110.086 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 99' ' ' LYS . 35.6 t -74.03 130.01 83.68 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.623 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.462 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.4 Cg_endo -71.41 174.78 10.35 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.9 1.474 . . . . 0.0 110.059 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.515 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 44.2 Cg_endo -71.91 -21.4 24.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.902 1.475 . . . . 0.0 110.842 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t -66.56 -15.77 63.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.879 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HB3' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -97.34 8.52 44.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.89 . . . . 0.0 109.578 179.179 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.183 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.259 0.552 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' B' ' 109' ' ' ASN . 3.2 t -174.4 -166.24 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.226 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.413 ' ND2' ' CD1' ' B' ' 111' ' ' PHE . 5.0 t-20 46.57 88.84 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.903 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.559 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -74.59 19.69 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.194 1.628 . . . . 0.0 112.35 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.948 ' CE2' HD12 ' A' ' 40' ' ' LEU . 24.5 m-85 -99.94 -61.46 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.511 -1.368 . . . . 0.0 108.69 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.416 ' HA ' HG11 ' A' ' 47' ' ' VAL . 27.1 mtm180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.222 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 110.491 -0.619 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.609 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 16.0 t90 -80.2 126.15 30.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.933 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -43.27 -27.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 110.424 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 42.0 t -96.6 145.3 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.55 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.4 mttm -112.52 -179.46 0.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.4 Cg_endo -67.56 -35.53 22.46 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.745 1.392 . . . . 0.0 110.199 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 6.2 pt-20 -71.21 -30.62 66.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.593 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 5.8 m-20 -83.63 -38.13 21.94 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.224 -0.923 . . . . 0.0 108.655 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 5.9 tptm -69.33 -17.65 63.73 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.74 -39.67 35.57 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.634 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 6.2 ptmm? -81.05 -22.85 38.98 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.8 m-30 -76.93 -34.75 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.9 -19.63 60.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 0.0 110.31 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -83.6 -33.62 25.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.985 . . . . 0.0 108.451 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.736 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -78.07 -31.39 16.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.769 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -71.84 -38.95 70.06 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.704 0.764 . . . . 0.0 109.034 179.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.55 -6.49 54.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.512 -0.742 . . . . 0.0 109.878 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.2 t -78.76 -7.51 57.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.292 -0.88 . . . . 0.0 108.909 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.025 HD12 HD13 ' A' ' 31' ' ' LEU . 10.6 mt -101.77 -54.34 2.75 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 m 137.97 98.51 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.16 148.3 39.18 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 O-C-N 123.977 1.514 . . . . 0.0 110.499 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 60.2 t -120.08 98.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.627 -0.67 . . . . 0.0 109.31 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 3.8 t30 60.37 14.86 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.726 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.458 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 107.03 32.88 3.38 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 84.9 m-85 -148.6 151.99 35.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.908 -1.348 . . . . 0.0 112.078 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.025 HD13 HD12 ' A' ' 24' ' ' LEU . 6.7 mt -120.31 143.18 48.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 33' ' ' GLY . 96.6 p -89.08 141.79 28.2 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.822 -1.174 . . . . 0.0 110.28 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.69 -25.96 0.99 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' SER . 4.0 t70 -65.83 -22.36 66.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.513 -0.993 . . . . 0.0 110.072 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB3' HD13 ' A' ' 24' ' ' LEU . 7.7 mttp -97.81 -35.91 10.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 98.1 t -77.77 -42.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.514 0.673 . . . . 0.0 110.011 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.48 -53.82 5.31 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 110.915 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.1 Cg_endo -68.67 -33.9 20.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.542 1.285 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.712 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.5 t -63.55 -31.75 54.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.031 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.981 ' HB3' HD22 ' A' ' 50' ' ' LEU . 33.0 mt -88.43 -26.58 22.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 110.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD11 ' HE2' ' A' ' 37' ' ' LYS . 51.9 mt -73.8 -11.23 60.32 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.175 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -90.31 -3.19 57.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.373 -0.829 . . . . 0.0 110.503 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 1.022 ' O ' HD21 ' A' ' 81' ' ' LEU . 91.9 p -84.34 13.98 4.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 110.09 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt 59.39 13.72 3.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.925 HD11 ' HB3' ' A' ' 80' ' ' ALA . 17.5 mt -100.16 156.87 34.78 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.905 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.6 Cg_endo -74.58 171.08 18.86 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.921 1.485 . . . . 0.0 109.868 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.561 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.4 -6.19 6.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 109.286 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.71 -31.15 59.54 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.879 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -83.12 -40.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 122.017 0.913 . . . . 0.0 108.556 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.981 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.1 mt -76.7 -26.94 55.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.729 0.776 . . . . 0.0 108.959 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.8 -29.08 65.81 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.857 ' O ' HD12 ' A' ' 56' ' ' LEU . 30.1 ttm180 -101.0 -28.3 12.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.886 -0.773 . . . . 0.0 109.934 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.928 HG11 HG23 ' A' ' 77' ' ' VAL . 19.4 t -72.49 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.43 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.558 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.3 t-105 -65.82 -51.46 58.75 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.814 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.2 mm-40 -50.82 -60.53 2.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.406 -0.809 . . . . 0.0 109.991 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -61.54 -15.93 43.06 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.498 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.028 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 9.2 t -92.24 -18.17 23.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.487 0.661 . . . . 0.0 109.235 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.1 t0 -90.83 82.11 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.514 -0.741 . . . . 0.0 110.322 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG12 ' HG2' ' A' ' 69' ' ' GLU . 12.1 mm -62.67 -24.12 34.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.604 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -104.24 -7.96 19.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 20.6 p80 38.35 51.92 1.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.567 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.2 p-10 -119.68 20.33 12.35 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.428 -0.795 . . . . 0.0 109.004 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.53 29.71 54.94 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.4 mtp -150.24 161.3 42.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -1.158 . . . . 0.0 111.087 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 14.0 mt -129.53 112.59 13.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 109.746 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 13.7 t0 -70.02 168.39 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.065 -1.022 . . . . 0.0 110.47 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.557 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -50.75 -41.08 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.872 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 46.4 t0 -81.01 -32.82 34.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HG2' HG12 ' A' ' 59' ' ' ILE . 2.3 mt-10 -71.96 -50.21 30.82 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.873 0.844 . . . . 0.0 109.257 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.922 ' CD2' HD12 ' A' ' 31' ' ' LEU . 29.3 t80 -53.57 -22.83 9.15 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -68.83 -52.87 25.38 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.852 0.834 . . . . 0.0 109.77 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.115 HG13 HD21 ' A' ' 94' ' ' LEU . 49.0 t -52.64 -24.61 6.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 110.394 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.028 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -89.67 -11.48 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 0.0 112.499 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 mmm -86.77 -47.11 9.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.392 -1.442 . . . . 0.0 110.435 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.542 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 1.9 p90 -73.38 -21.75 60.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.691 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.2 mt -74.55 -24.95 59.01 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.928 HG23 HG11 ' A' ' 53' ' ' VAL . 59.8 t -90.96 -42.46 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -68.54 -19.09 64.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.619 -0.675 . . . . 0.0 110.21 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 16.1 m -84.65 -25.74 28.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -73.55 -17.44 61.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 108.698 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.022 HD21 ' O ' ' A' ' 43' ' ' SER . 1.1 mt -91.93 -41.21 10.71 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.724 -0.61 . . . . 0.0 110.767 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -121.49 -10.9 8.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.84 . . . . 0.0 111.778 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 79' ' ' CYS . 7.9 tttp -106.01 -85.11 0.5 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.553 -1.342 . . . . 0.0 110.932 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 2.8 mt-10 -161.8 179.6 1.26 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.94 -1.1 . . . . 0.0 109.947 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 39.7 Cg_endo -66.51 170.64 11.97 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.668 1.352 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.526 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 96.4 t -113.99 134.95 22.06 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.771 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.6 Cg_endo -84.69 -173.12 1.4 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.072 1.564 . . . . 0.0 109.02 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.776 ' C ' HD21 ' A' ' 56' ' ' LEU . 29.6 mtm -111.55 10.14 21.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 109.872 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.537 ' N ' HD21 ' A' ' 56' ' ' LEU . 19.6 m -108.12 101.19 10.44 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.887 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.921 HD22 HG22 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -50.69 106.46 0.65 Allowed Pre-proline 0 C--N 1.292 -1.893 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.512 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.757 ' O ' HG23 ' A' ' 95' ' ' VAL . 41.6 Cg_endo -70.99 152.76 63.21 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.791 1.416 . . . . 0.0 110.728 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.62 -9.94 24.58 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.285 1.676 . . . . 0.0 111.397 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -84.73 -27.79 26.73 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 109.025 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.115 HD21 HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.94 -12.09 17.75 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.849 0.833 . . . . 0.0 108.972 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.921 HG22 HD22 ' A' ' 90' ' ' LEU . 47.8 t -87.38 137.21 32.62 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.924 -1.11 . . . . 0.0 110.781 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.498 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 46.1 Cg_endo -72.11 175.67 9.54 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.128 1.594 . . . . 0.0 109.985 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.59 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 41.6 Cg_endo -67.86 179.9 2.46 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.84 1.442 . . . . 0.0 110.529 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER 70.25 -53.91 0.63 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.311 -0.868 . . . . 0.0 110.08 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 100' ' ' ARG . 2.3 tptt -88.59 16.12 7.08 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 108.652 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.59 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 41.5 mmm-85 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.627 -0.671 . . . . 0.0 110.465 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.337 0.589 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 17.1 m -97.15 -27.43 14.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.506 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.5 t-20 -112.53 110.78 52.5 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -72.94 2.39 5.48 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.078 1.568 . . . . 0.0 111.483 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.947 ' CE2' HD12 ' A' ' 40' ' ' LEU . 4.4 m-85 -101.2 -47.97 4.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.853 -1.155 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.514 ' HG2' ' HA3' ' A' ' 51' ' ' GLY . 1.2 mmm180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.275 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 110.304 -0.691 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.599 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.9 t90 -52.42 134.39 34.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 109.668 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.719 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -40.93 -28.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.451 -0.78 . . . . 0.0 110.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.599 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 85.4 t -113.31 135.21 53.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 110.152 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.542 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -93.77 -179.69 1.07 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.349 -0.844 . . . . 0.0 109.995 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.13 -35.27 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.927 1.488 . . . . 0.0 110.02 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.6 -33.52 58.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.515 -0.741 . . . . 0.0 109.376 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 15.0 m-20 -76.96 -34.66 57.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 68' ' ' ASP . 1.5 tttt -76.79 -20.16 56.75 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.7 71.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.627 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -70.13 -21.23 63.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.7 m-30 -80.21 -29.29 38.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.38 -20.14 57.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.718 -0.614 . . . . 0.0 109.804 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -81.57 -32.69 32.02 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.831 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 63.8 mt -78.97 -33.0 15.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.821 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -67.78 -35.17 78.19 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -91.03 -5.44 55.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.461 -0.775 . . . . 0.0 110.324 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 87.3 p -78.95 -14.65 59.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 108.839 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.054 HD12 ' CD1' ' A' ' 31' ' ' LEU . 11.6 mt -92.96 -55.07 3.48 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 t 142.8 92.92 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.478 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.7 Cg_endo -74.87 148.99 36.67 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 O-C-N 124.198 1.631 . . . . 0.0 110.88 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -125.38 103.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.5 t30 63.37 13.66 7.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.642 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 32.66 4.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.2 m-85 -146.5 148.79 32.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -1.166 . . . . 0.0 111.908 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.054 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.1 mt -113.83 158.51 20.93 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' LYS . 48.3 p -105.14 143.45 33.3 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.606 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.59 -25.1 0.49 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' SER . 61.4 t0 -71.32 -23.97 62.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.413 -1.051 . . . . 0.0 110.412 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 32' ' ' SER . 14.0 mttp -94.09 -35.61 12.48 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.071 -1.018 . . . . 0.0 108.417 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.917 HG11 HD12 ' A' ' 65' ' ' LEU . 87.5 t -78.16 -42.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.382 0.61 . . . . 0.0 110.384 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.572 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 14.8 tttt -40.03 -54.42 4.42 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 110.549 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.7 Cg_endo -66.93 -33.85 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.406 1.214 . . . . 0.0 110.021 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.788 ' CG2' HD21 ' A' ' 24' ' ' LEU . 2.2 t -62.25 -35.2 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.818 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.009 ' HB3' HD22 ' A' ' 50' ' ' LEU . 30.3 mt -87.83 -30.02 20.52 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.705 -0.622 . . . . 0.0 110.063 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.516 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 67.2 mt -70.13 -13.95 62.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -91.36 -4.1 56.1 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.52 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -83.56 16.75 2.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.386 -0.821 . . . . 0.0 110.445 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.557 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.0 tttp 60.32 11.92 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.177 -0.952 . . . . 0.0 109.591 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.006 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.9 mt -99.19 153.39 37.81 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 110.566 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.0 Cg_endo -75.76 175.97 10.61 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 124.175 1.619 . . . . 0.0 109.271 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.6 t -73.27 -3.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.6 m-20 -81.68 -30.44 32.64 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.246 -0.909 . . . . 0.0 109.285 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.901 HG13 HD22 ' A' ' 45' ' ' LEU . 5.3 mm -88.0 -39.23 12.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.009 HD22 ' HB3' ' A' ' 40' ' ' LEU . 23.6 mt -74.78 -27.67 60.42 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -74.58 -21.8 78.19 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -99.99 -33.75 10.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.161 -0.611 . . . . 0.0 109.402 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 77' ' ' VAL . 18.6 t -69.22 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 4.4 t-105 -76.2 -55.38 5.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.557 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.8 mm-40 -52.02 -58.24 7.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.96 -1.088 . . . . 0.0 110.048 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.6 mt -59.29 -16.32 21.08 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.582 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.71 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.0 t -91.44 -40.25 11.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 109.713 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' TRP . 1.2 t0 -65.82 97.66 0.35 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.472 -0.767 . . . . 0.0 109.996 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.818 HG21 ' HD2' ' A' ' 99' ' ' LYS . 15.2 mm -72.22 -31.36 39.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.564 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 4.2 p30 -105.81 -9.64 17.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.801 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.777 ' HB3' HG21 ' B' ' 108' ' ' THR . 0.0 OUTLIER 51.77 51.02 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.381 -0.825 . . . . 0.0 109.994 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 47.0 p-10 -111.09 20.83 17.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 75.11 32.81 55.73 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 10.6 mtp -150.69 161.34 42.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.248 . . . . 0.0 111.858 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.917 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 mt -132.27 99.73 4.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.606 -0.684 . . . . 0.0 109.293 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.605 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.2 p30 -71.49 160.41 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 110.468 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 10.1 ptt-85 -34.9 -44.21 0.21 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.756 -0.59 . . . . 0.0 111.31 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 1.8 m-20 -77.64 -35.08 52.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.701 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HG3' HG12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -70.13 -48.41 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.81 0.814 . . . . 0.0 109.22 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.831 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 25.3 t80 -61.04 -14.17 21.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -79.19 -47.28 16.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.527 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.024 HG13 HD12 ' A' ' 94' ' ' LEU . 59.9 t -59.01 -29.62 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.077 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.2 -2.37 58.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.63 -0.669 . . . . 0.0 111.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.615 ' HB3' ' CD1' ' A' ' 17' ' ' TYR . 10.0 mmt -88.08 -48.33 7.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.472 -1.392 . . . . 0.0 110.112 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.043 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.0 p90 -76.1 -24.18 54.99 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 72' ' ' VAL . 8.6 mt -70.8 -26.45 63.32 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.995 HG23 HG11 ' A' ' 53' ' ' VAL . 8.6 t -91.09 -23.61 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.728 -0.607 . . . . 0.0 109.998 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.45 -26.31 28.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.599 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.1 m -81.29 -17.67 48.52 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.549 -0.72 . . . . 0.0 109.675 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.006 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.39 -8.68 57.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.374 -0.828 . . . . 0.0 109.145 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.7 mt -90.33 -45.02 9.3 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.751 0.786 . . . . 0.0 108.959 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -71.49 -52.22 19.51 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.725 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 179.32 -30.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.255 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 79' ' ' CYS . 4.4 mt-10 -65.48 110.33 4.24 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.174 -0.954 . . . . 0.0 111.074 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 44.0 Cg_endo -71.7 -170.92 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.832 1.438 . . . . 0.0 110.063 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG13 HD22 ' A' ' 76' ' ' LEU . 59.9 t -138.18 125.56 13.58 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.017 -1.052 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.828 ' O ' HD11 ' A' ' 56' ' ' LEU . 53.2 Cg_endo -84.9 -175.95 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.926 1.488 . . . . 0.0 109.474 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.752 ' C ' HD21 ' A' ' 56' ' ' LEU . 28.4 mtp -110.73 12.36 22.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.967 -1.083 . . . . 0.0 110.168 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.474 ' N ' HD21 ' A' ' 56' ' ' LEU . 52.5 m -110.3 101.51 10.24 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.772 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -53.41 106.89 0.72 Allowed Pre-proline 0 C--N 1.29 -2.008 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.924 178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.998 ' HG2' HD23 ' A' ' 94' ' ' LEU . 46.9 Cg_endo -69.93 170.27 17.18 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.912 1.48 . . . . 0.0 109.909 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.58 -21.68 14.56 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.913 1.48 . . . . 0.0 111.272 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -82.24 4.96 21.52 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.078 -1.014 . . . . 0.0 109.249 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.043 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 2.1 mm? -114.29 9.72 17.03 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.423 -0.798 . . . . 0.0 110.944 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -124.13 107.99 30.14 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 0.0 110.831 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.82 168.49 24.7 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.976 1.514 . . . . 0.0 109.612 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 98' ' ' SER . 43.7 Cg_endo -71.03 175.13 9.59 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.755 1.397 . . . . 0.0 110.151 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 2.0 t 80.07 -33.6 0.13 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.828 -0.545 . . . . 0.0 110.121 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.818 ' HD2' HG21 ' A' ' 59' ' ' ILE . 8.6 mmtt -88.73 0.7 56.21 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.023 -1.048 . . . . 0.0 108.632 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.04 179.722 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' B' ' 108' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.269 0.557 . . . . 0.0 110.199 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.777 HG21 ' HB3' ' A' ' 61' ' ' HIS . 8.4 t -73.22 69.07 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.068 -1.02 . . . . 0.0 109.863 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 112' ' ' ARG . 10.6 t-20 -151.62 100.51 2.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.432 -0.793 . . . . 0.0 110.106 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 52.2 Cg_endo -72.97 4.85 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.288 1.678 . . . . 0.0 111.686 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.955 ' CE2' HD12 ' A' ' 40' ' ' LEU . 4.1 m-85 -105.17 -69.42 0.82 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.793 -1.192 . . . . 0.0 109.007 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.515 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.566 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.251 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 1.187 ' N ' ' HB3' ' B' ' 110' ' ' PRO 2.129 0.0 OUTLIER . . . . . 1 N--CA 28.865 1611.611 1 N-CA-C 11.458 -38.709 . . . . 0.0 11.458 . . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.65 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.4 t90 -89.53 121.03 31.35 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 109.919 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -52.07 -24.74 7.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 89.3 t -97.5 116.76 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.467 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.8 mttp -93.67 -177.81 0.75 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.496 -0.752 . . . . 0.0 109.633 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -67.63 -34.07 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.659 1.347 . . . . 0.0 110.048 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.43 -33.22 62.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.85 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.7 m-20 -81.55 -36.76 28.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.342 -0.849 . . . . 0.0 108.738 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.4 tttt -74.87 -15.17 60.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -76.93 -40.28 47.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.8 ptpt -75.34 -25.07 57.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.5 m-30 -73.32 -36.02 66.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.83 -22.73 64.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.733 -0.604 . . . . 0.0 109.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.24 -30.49 43.22 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.739 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 16.9 mt -82.8 -35.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.46 -36.59 68.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.556 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.5 t0 -87.03 -2.09 58.37 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.641 -0.662 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -86.48 -9.42 56.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 108.954 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.083 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.2 mt -102.96 -14.55 16.45 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.619 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.03 93.04 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -74.77 153.55 43.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.284 1.676 . . . . 0.0 111.068 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.1 t -120.92 105.86 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.512 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 65.04 12.64 8.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.218 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.71 33.83 5.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.575 ' CD1' ' OD1' ' A' ' 66' ' ' ASP . 76.9 m-85 -141.13 141.99 34.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.159 . . . . 0.0 111.882 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.083 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.8 mt -113.98 136.79 52.52 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 35' ' ' LYS . 3.3 p -83.5 146.01 28.61 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.585 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.77 -26.74 1.2 Allowed Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 33.4 t0 -66.41 -26.22 67.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.579 -0.954 . . . . 0.0 109.991 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 6.1 mttp -92.26 -33.26 14.72 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.838 HG21 HD12 ' A' ' 65' ' ' LEU . 86.4 t -80.96 -47.12 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.415 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 20.6 tttm -39.67 -51.58 5.12 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 0.0 110.917 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -68.8 -34.39 18.4 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.355 1.187 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.803 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -62.84 -32.67 56.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.017 ' HB3' HD22 ' A' ' 50' ' ' LEU . 36.9 mt -90.62 -27.64 18.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.573 -0.704 . . . . 0.0 110.081 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.487 HD11 ' HE2' ' A' ' 37' ' ' LYS . 55.9 mt -74.77 -11.29 60.12 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.781 . . . . 0.0 109.035 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -90.38 -9.21 48.47 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 110.185 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 1.3 p -78.39 5.98 9.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.1 tttt 69.23 9.02 7.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.935 . . . . 0.0 110.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.911 HD22 HG13 ' A' ' 49' ' ' ILE . 18.5 mt -93.82 157.25 38.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -75.68 171.89 17.35 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.251 1.658 . . . . 0.0 109.285 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.8 t -70.73 -4.76 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 109.189 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.17 -29.53 54.52 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 108.78 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.911 HG13 HD22 ' A' ' 45' ' ' LEU . 6.5 mm -87.89 -36.71 9.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.866 0.841 . . . . 0.0 108.755 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.017 HD22 ' HB3' ' A' ' 40' ' ' LEU . 13.4 mt -79.33 -26.72 42.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -72.52 -23.14 78.43 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.789 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.6 ttm105 -100.83 -32.49 10.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.972 -0.722 . . . . 0.0 109.723 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.643 HG11 ' CG2' ' A' ' 77' ' ' VAL . 12.9 t -68.91 -38.97 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.205 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.596 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 4.0 t-105 -67.49 -48.01 68.36 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.359 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.8 mm-40 -59.53 -58.28 9.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.154 -0.966 . . . . 0.0 109.848 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.96 ' O ' HD21 ' A' ' 90' ' ' LEU . 5.6 mt -58.83 -17.39 23.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 108.483 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 10.2 t -88.25 -45.19 10.27 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.583 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -59.79 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.639 -0.663 . . . . 0.0 110.14 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.422 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 33.5 mm -67.98 -30.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 110.128 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.6 p30 -109.6 -15.67 14.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 9.9 m-70 62.02 41.17 11.39 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.406 -0.809 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 14.1 p-10 -93.13 3.9 54.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.989 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 89.03 23.01 36.39 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.4 mtp -152.79 162.1 41.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.214 -1.168 . . . . 0.0 110.454 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.838 HD12 HG21 ' A' ' 36' ' ' VAL . 46.0 mt -119.4 112.33 19.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.422 -0.799 . . . . 0.0 109.502 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.575 ' OD1' ' CD1' ' A' ' 30' ' ' PHE . 2.0 m-20 -69.39 159.22 33.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.283 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 19.7 ptt180 -41.52 -42.25 2.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 109.988 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 9.9 t70 -81.64 -34.69 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 57' ' ' SER . 1.8 tt0 -69.35 -49.62 53.96 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.803 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 40.8 t80 -57.97 -19.8 33.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -70.56 -50.31 38.81 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.883 0.849 . . . . 0.0 109.587 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.056 HG13 HD21 ' A' ' 94' ' ' LEU . 83.4 t -55.15 -24.87 15.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.458 0.647 . . . . 0.0 109.961 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -88.33 -10.46 49.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 111.972 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.566 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmm -84.58 -43.53 14.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.41 ' HB3' ' OH ' ' A' ' 17' ' ' TYR . 2.8 p90 -75.67 -22.88 56.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.645 -1.222 . . . . 0.0 107.751 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.0 mt -72.24 -22.16 61.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 73' ' ' ALA . 70.5 t -91.24 -44.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.765 -0.584 . . . . 0.0 109.513 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -65.14 -27.41 68.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.636 -0.665 . . . . 0.0 110.956 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.0 OUTLIER -77.17 -20.47 55.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.99 -1.068 . . . . 0.0 108.722 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.856 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.48 -7.32 57.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 81' ' ' LEU . 3.2 mt -90.99 -39.8 12.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.399 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 1.8 mt-10 -69.17 -52.55 26.88 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.362 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER 176.26 -24.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.606 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -80.88 112.79 35.15 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.982 -1.073 . . . . 0.0 110.847 -178.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 40.9 Cg_endo -67.53 -162.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.958 1.504 . . . . 0.0 110.438 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.467 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.8 t -132.32 127.41 20.79 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 110.753 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.831 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -83.16 -179.54 4.44 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.905 1.476 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.675 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.0 mtt -104.32 10.38 35.52 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.798 -1.189 . . . . 0.0 109.847 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.456 ' N ' HD21 ' A' ' 56' ' ' LEU . 68.3 m -108.73 104.14 13.36 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 112.115 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.96 HD21 ' O ' ' A' ' 56' ' ' LEU . 4.1 mt -44.97 106.08 0.51 Allowed Pre-proline 0 C--N 1.293 -1.858 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.927 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 40.3 Cg_endo -68.06 145.55 67.67 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.75 1.395 . . . . 0.0 110.998 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 95' ' ' VAL . 44.0 Cg_endo -69.57 -7.97 22.39 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.228 1.646 . . . . 0.0 110.826 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.79 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -97.95 24.39 7.03 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.056 HD21 HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -154.11 -35.08 0.1 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.499 0.666 . . . . 0.0 109.649 -178.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.851 ' N ' HD13 ' A' ' 94' ' ' LEU . 2.8 p -74.9 135.7 73.98 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.265 -0.897 . . . . 0.0 110.41 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.32 157.2 45.83 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.015 1.534 . . . . 0.0 110.48 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.43 -2.17 10.85 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.172 1.617 . . . . 0.0 110.654 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.54 -19.28 62.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.133 -0.98 . . . . 0.0 109.806 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -96.93 10.9 37.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 109.49 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.311 -0.868 . . . . 0.0 110.259 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' B' ' 108' ' ' THR . 3.0 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' B' ' 107' ' ' SER . 39.7 p 43.97 -163.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.424 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.483 ' HA ' ' HD2' ' B' ' 110' ' ' PRO . 10.3 t-20 62.35 96.98 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 110.118 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 1.187 ' HB3' ' N ' ' A' ' 6' ' ' PRO . 51.9 Cg_endo -71.01 6.16 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 121.887 1.725 . . . . 0.0 111.964 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.931 ' CE2' HD12 ' A' ' 40' ' ' LEU . 7.7 m-85 -99.88 -63.77 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.222 . . . . 0.0 108.992 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.481 0.785 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.839 ' HE1' HD22 ' A' ' 94' ' ' LEU . 12.4 t90 -98.81 124.95 44.03 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.158 -0.964 . . . . 0.0 110.26 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -48.85 -27.75 3.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 0.0 109.935 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.4 t -92.14 122.64 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.483 ' HG2' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -80.33 176.01 4.22 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.192 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 10' ' ' LYS . 41.3 Cg_endo -70.08 -34.07 14.2 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.053 1.554 . . . . 0.0 109.788 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.2 pp20? -79.6 -22.59 43.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.421 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 m-20 -82.86 -38.49 22.89 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -14.93 61.18 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.34 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.472 -0.768 . . . . 0.0 109.024 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.8 ptpt -72.97 -26.14 61.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -71.81 -35.2 69.87 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.81 -23.05 60.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.654 -0.654 . . . . 0.0 109.869 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.25 -32.19 38.34 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.577 HG22 ' CE1' ' A' ' 70' ' ' PHE . 66.7 mt -81.31 -31.9 11.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.689 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.26 -37.03 66.45 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.5 t70 -88.76 -1.49 58.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.658 -0.652 . . . . 0.0 110.119 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -4.15 57.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.21 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.105 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.5 mt -108.84 -8.66 15.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.5 m 87.04 95.0 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.9 Cg_endo -72.09 148.56 50.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.314 1.691 . . . . 0.0 110.838 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 73.8 t -119.76 100.36 9.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 63.77 16.55 9.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 97.11 34.01 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.2 m-85 -149.48 147.41 28.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -1.191 . . . . 0.0 111.776 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.105 ' CD1' HD12 ' A' ' 24' ' ' LEU . 14.8 mt -116.63 134.45 54.81 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 17.5 p -77.82 146.62 35.64 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.769 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -44.46 -27.19 1.18 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.3 m-20 -61.49 -25.42 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.724 -0.869 . . . . 0.0 110.031 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 35.7 mttt -98.08 -32.19 11.74 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.111 -0.993 . . . . 0.0 108.338 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.972 HG11 HD12 ' A' ' 65' ' ' LEU . 97.9 t -83.54 -48.21 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.421 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 17.7 tttt -40.14 -53.56 5.02 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.49 -30.44 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.408 1.215 . . . . 0.0 109.703 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -68.81 -30.65 47.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.974 ' HB3' HD22 ' A' ' 50' ' ' LEU . 44.7 mt -88.79 -28.28 20.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.411 -0.806 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.76 -11.25 60.73 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.014 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -90.08 -5.46 56.53 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.568 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.523 ' CB ' HG13 ' A' ' 77' ' ' VAL . 5.8 p -83.21 13.28 4.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.108 -0.995 . . . . 0.0 110.673 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 63.43 8.98 3.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.923 . . . . 0.0 110.676 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.938 HD13 HG21 ' A' ' 49' ' ' ILE . 15.2 mt -94.67 157.76 36.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 0.0 109.582 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.7 Cg_endo -75.28 173.66 14.13 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 124.023 1.538 . . . . 0.0 109.243 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.0 t -74.45 -1.41 2.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.145 -0.972 . . . . 0.0 109.373 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -31.19 33.1 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.938 HG21 HD13 ' A' ' 45' ' ' LEU . 12.8 mm -83.02 -40.35 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.974 HD22 ' HB3' ' A' ' 40' ' ' LEU . 22.7 mt -73.84 -25.92 60.32 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -73.35 -25.28 73.31 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.86 -28.09 12.97 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.804 -0.821 . . . . 0.0 110.032 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.882 HG11 HG23 ' A' ' 77' ' ' VAL . 17.0 t -72.58 -39.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.78 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 2.4 t-105 -65.09 -50.97 64.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.576 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 9.6 mm-40 -56.19 -53.84 52.39 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.892 ' O ' HD11 ' A' ' 90' ' ' LEU . 18.3 mt -64.46 -12.7 46.31 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.67 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t -94.97 -29.73 14.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 108.88 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 7.4 t0 -74.5 100.75 3.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.692 -0.63 . . . . 0.0 109.65 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.486 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.1 mm -80.44 -29.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -102.1 -18.56 15.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 4.8 m170 65.72 42.12 3.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 109.817 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.0 p30 -102.28 -3.74 26.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.461 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 95.12 25.87 13.52 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 5.1 mtp -152.56 161.25 42.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.245 . . . . 0.0 110.618 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.972 HD12 HG11 ' A' ' 36' ' ' VAL . 13.5 mt -119.78 102.12 8.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.362 -0.836 . . . . 0.0 109.667 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.618 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 5.1 p30 -71.57 167.47 19.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.56 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.7 ptt-85 -37.55 -46.04 0.8 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.0 111.854 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 80.7 m-20 -76.68 -37.21 56.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.075 -1.016 . . . . 0.0 110.665 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 44.9 mt-10 -71.85 -44.5 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.972 ' CD2' HD12 ' A' ' 31' ' ' LEU . 11.6 t80 -60.51 -17.37 45.0 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -79.24 -45.79 19.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.879 ' CG1' HD11 ' A' ' 94' ' ' LEU . 46.5 t -61.4 -25.97 38.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.476 0.655 . . . . 0.0 109.747 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.67 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.55 -8.23 50.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 111.258 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.7 mmt -83.24 -47.74 11.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.0 p90 -75.14 -28.73 60.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 72' ' ' VAL . 6.7 mt -66.93 -28.67 68.48 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.882 HG23 HG11 ' A' ' 53' ' ' VAL . 41.0 t -91.38 -23.94 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.686 -0.634 . . . . 0.0 110.393 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -29.78 17.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.897 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 79.6 m -84.82 -15.65 44.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.65 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.665 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -81.42 -10.24 59.55 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.907 -1.121 . . . . 0.0 108.211 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 45' ' ' LEU . 4.0 mt -91.77 -48.51 6.76 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.356 0.598 . . . . 0.0 110.273 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 81' ' ' LEU . 3.3 mm-40 -129.65 33.14 4.5 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.965 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 79' ' ' CYS . 3.7 tptt -150.86 -88.79 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.503 -1.373 . . . . 0.0 111.042 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -134.55 154.87 79.9 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 110.102 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.33 -159.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.139 1.6 . . . . 0.0 110.622 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 53' ' ' VAL . 59.0 t -113.56 146.71 35.99 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.241 -0.912 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.595 ' O ' HD11 ' A' ' 56' ' ' LEU . 43.8 Cg_endo -86.97 -168.46 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.632 1.333 . . . . 0.0 109.472 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.427 ' HG3' ' C ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -124.88 15.21 8.6 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.004 -1.06 . . . . 0.0 111.361 -179.138 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 29.8 t -159.5 20.15 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.565 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.945 HD22 HD12 ' A' ' 94' ' ' LEU . 6.7 mt 58.98 123.94 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.731 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.701 ' O ' HG23 ' A' ' 95' ' ' VAL . 42.4 Cg_endo -71.55 150.17 56.89 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.876 1.461 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.85 -0.39 8.34 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.052 1.554 . . . . 0.0 111.459 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -105.37 12.03 32.08 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.243 -0.911 . . . . 0.0 109.209 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.945 HD12 HD22 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -135.66 -7.04 2.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.685 -0.635 . . . . 0.0 110.196 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 91' ' ' PRO . 11.2 t -90.41 133.22 33.43 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.825 -1.172 . . . . 0.0 110.572 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.468 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 41.0 Cg_endo -66.73 174.29 6.79 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.894 1.471 . . . . 0.0 110.569 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 47.1 Cg_endo -72.19 -14.04 28.54 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.023 1.538 . . . . 0.0 111.256 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.6 m -67.35 -23.15 65.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.026 -1.046 . . . . 0.0 110.088 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 12.42 29.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.476 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.572 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 110.588 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.534 ' O ' ' N ' ' B' ' 109' ' ' ASN . 1.3 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.322 0.582 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.437 ' OG1' ' C ' ' B' ' 107' ' ' SER . 0.1 OUTLIER 43.91 -89.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.487 -0.758 . . . . 0.0 111.007 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 107' ' ' SER . 6.0 t-20 48.38 82.38 0.24 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 109.333 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.556 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 50.6 Cg_endo -68.52 8.27 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.259 1.972 . . . . 0.0 112.573 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.954 ' CE2' HD12 ' A' ' 40' ' ' LEU . 2.0 m-85 -102.88 -67.49 0.88 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.545 -1.347 . . . . 0.0 108.577 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.509 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 2.0 mtt-85 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.121 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 N--CA 1.482 0.817 0 N-CA-C 110.391 -0.657 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.2 t90 -95.51 123.43 39.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.091 -1.005 . . . . 0.0 109.95 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -41.63 -32.01 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 110.298 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.634 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 69.9 t -102.99 136.92 33.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 109.598 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.453 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mtmt -88.42 175.09 4.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 110.24 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.5 Cg_endo -70.21 -34.37 13.19 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.975 1.513 . . . . 0.0 109.745 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -77.08 -22.44 52.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.743 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 3.1 m-20 -82.93 -36.78 24.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.81 . . . . 0.0 109.132 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -80.5 -24.51 39.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -65.84 -39.78 91.12 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.0 ptpt -74.71 -28.67 60.9 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.4 m-30 -70.58 -36.71 73.72 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -63.8 -20.48 65.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.71 -0.619 . . . . 0.0 110.15 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.63 -36.1 33.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 47.8 mt -78.43 -31.43 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.814 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.48 -32.53 68.37 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.7 OUTLIER -87.49 -5.61 58.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.579 -0.7 . . . . 0.0 109.859 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -85.46 -8.49 58.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 0.0 109.085 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.091 HD12 ' CD1' ' A' ' 31' ' ' LEU . 7.2 mt -100.4 -16.87 17.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.627 -0.671 . . . . 0.0 109.316 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.5 t 88.74 89.03 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 121.358 0.599 . . . . 0.0 109.877 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.7 Cg_endo -73.33 151.37 48.33 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.552 1.817 . . . . 0.0 110.854 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 55.9 t -121.3 104.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.89 18.09 11.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.439 -0.788 . . . . 0.0 109.413 -178.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.85 34.16 6.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -141.18 137.82 32.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 112.017 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.091 ' CD1' HD12 ' A' ' 24' ' ' LEU . 7.9 mt -110.3 158.5 18.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 35' ' ' LYS . 8.2 p -104.07 143.79 32.43 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.624 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.76 -25.78 0.65 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -70.85 -25.24 62.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.571 -0.958 . . . . 0.0 110.314 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB3' HD13 ' A' ' 24' ' ' LEU . 35.1 mttm -88.56 -36.01 16.6 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.915 HG12 ' CD1' ' A' ' 40' ' ' LEU . 81.2 t -77.22 -41.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.08 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 6.4 tttm -40.51 -51.65 6.48 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.518 -0.739 . . . . 0.0 111.026 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.9 Cg_endo -70.62 -34.27 12.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.369 1.194 . . . . 0.0 109.878 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.51 -32.56 53.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.934 HD12 ' CE2' ' B' ' 111' ' ' PHE . 23.7 mt -90.56 -29.34 17.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.587 -0.696 . . . . 0.0 109.977 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD11 ' HE2' ' A' ' 37' ' ' LYS . 33.5 mt -69.75 -9.55 54.93 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -90.65 -8.68 49.37 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.565 -0.71 . . . . 0.0 111.173 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.535 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 84.5 p -82.18 15.36 2.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -0.976 . . . . 0.0 110.652 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.18 14.03 3.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -0.99 . . . . 0.0 110.197 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.86 HD22 HG13 ' A' ' 49' ' ' ILE . 17.5 mt -98.16 157.89 33.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.977 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.0 Cg_endo -74.88 166.71 28.67 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 124.067 1.562 . . . . 0.0 109.228 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' B' ' 111' ' ' PHE . 13.9 t -68.26 -6.97 6.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 109.273 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -30.0 58.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.876 -1.14 . . . . 0.0 109.143 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.86 HG13 HD22 ' A' ' 45' ' ' LEU . 7.5 mm -83.81 -40.06 15.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -71.02 -30.6 66.86 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' B' ' 109' ' ' ASN . . . -72.18 -26.22 72.73 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.3 ttm-85 -100.12 -28.41 13.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.825 -0.809 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.825 HG11 ' CG2' ' A' ' 77' ' ' VAL . 10.3 t -74.18 -34.7 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.624 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.1 t-105 -66.74 -53.05 37.4 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.131 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.6 mt-10 -48.65 -58.36 4.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 110.394 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.941 HD21 ' C ' ' A' ' 88' ' ' MET . 2.7 mt -62.65 -13.09 27.83 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.069 -1.053 . . . . 0.0 108.773 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.688 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -91.81 -42.72 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.255 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' TRP . 11.6 t0 -66.04 78.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.492 -0.755 . . . . 0.0 110.395 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.509 HG12 ' HG3' ' A' ' 69' ' ' GLU . 42.8 mm -51.47 -27.72 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.41 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.496 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 2.4 m-20 -102.84 -20.18 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.29 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.496 ' CD2' ' C ' ' A' ' 60' ' ' ASP . 9.1 m-70 59.89 47.1 10.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 33.4 p-10 -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.063 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 86.45 28.9 26.02 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.1 mtt -150.24 161.44 42.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 111.09 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.651 HD13 ' HA ' ' A' ' 70' ' ' PHE . 7.6 mt -130.99 109.72 10.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.842 . . . . 0.0 110.072 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 1.8 m-20 -69.8 159.34 33.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.981 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -41.21 -42.19 2.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.503 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 57.8 t0 -82.4 -33.3 28.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 57' ' ' SER . 4.5 tt0 -69.11 -50.46 47.89 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.171 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.651 ' HA ' HD13 ' A' ' 65' ' ' LEU . 57.3 t80 -55.93 -22.84 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.17 -48.67 67.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.455 -0.778 . . . . 0.0 110.055 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.579 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 76.9 t -58.27 -24.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.528 -0.732 . . . . 0.0 110.132 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.688 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -84.86 -13.36 51.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.246 -0.909 . . . . 0.0 112.166 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.2 mmm -85.92 -36.07 20.12 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.545 -1.347 . . . . 0.0 110.732 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.634 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 5.0 p90 -79.08 -26.3 43.02 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.611 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.761 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.8 mt -71.72 -22.33 61.65 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.825 ' CG2' HG11 ' A' ' 53' ' ' VAL . 72.6 t -90.82 -32.89 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.639 -0.663 . . . . 0.0 110.142 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -78.36 -23.24 47.02 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.441 -0.787 . . . . 0.0 110.045 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -83.02 -13.79 55.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.639 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.686 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.49 -14.18 41.09 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.189 -0.944 . . . . 0.0 109.125 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.821 HD21 ' CD1' ' A' ' 45' ' ' LEU . 9.6 mt -92.35 -45.91 7.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.602 -0.686 . . . . 0.0 110.844 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.54 -11.17 9.96 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.505 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 8.8 mmtt -106.97 -88.14 0.47 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.424 -1.422 . . . . 0.0 111.488 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 79' ' ' CYS . 7.4 mm-40 -145.42 167.77 13.61 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.862 . . . . 0.0 109.843 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 84' ' ' GLU . 37.3 Cg_endo -62.44 -176.69 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.843 1.444 . . . . 0.0 110.428 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.744 HG21 ' CG2' ' A' ' 53' ' ' VAL . 84.8 t -115.07 122.18 33.86 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 111.024 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.786 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.1 Cg_endo -81.55 -167.09 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.964 1.507 . . . . 0.0 109.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.941 ' C ' HD21 ' A' ' 56' ' ' LEU . 14.7 mtp -120.04 18.66 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.02 . . . . 0.0 110.338 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 56' ' ' LEU . 66.6 m -101.06 118.02 36.16 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.79 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 56' ' ' LEU . 2.1 mt -100.72 75.57 0.13 Allowed Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.07 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.718 ' HG2' HD12 ' A' ' 94' ' ' LEU . 41.1 Cg_endo -66.65 175.86 4.83 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.594 1.313 . . . . 0.0 110.749 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.1 Cg_endo -70.52 -7.16 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 124.019 1.536 . . . . 0.0 111.04 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.33 -8.62 58.62 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.352 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -125.78 5.71 7.4 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.382 -0.824 . . . . 0.0 110.467 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 91' ' ' PRO . 87.4 t -103.26 122.16 46.2 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.099 -1.0 . . . . 0.0 111.466 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.551 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 43.0 Cg_endo -70.33 179.43 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.988 1.52 . . . . 0.0 109.217 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 50.3 Cg_endo -78.9 28.74 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.49 1.258 . . . . 0.0 111.657 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.35 -42.23 5.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.837 -1.165 . . . . 0.0 109.226 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 59' ' ' ILE . 1.7 tttp -90.02 12.25 18.18 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.773 . . . . 0.0 110.352 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' B' ' 108' ' ' THR . 1.3 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.249 0.547 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.482 ' O ' ' HB3' ' B' ' 109' ' ' ASN . 11.8 m 55.94 110.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLY . 35.1 t-20 59.1 91.68 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.522 ' HD2' ' CE1' ' B' ' 111' ' ' PHE . 49.5 Cg_endo -69.54 3.04 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.32 1.695 . . . . 0.0 111.77 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.934 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -104.16 -62.92 1.25 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.776 -1.202 . . . . 0.0 108.903 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.457 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.168 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.487 1.119 0 CA-C-O 121.519 0.549 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.7 t90 -70.35 123.52 21.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.597 -0.689 . . . . 0.0 109.725 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.674 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -45.44 -26.36 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.293 -0.879 . . . . 0.0 110.207 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.4 t -102.7 137.97 28.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.45 -0.781 . . . . 0.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.507 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 5.5 mttt -110.71 176.04 1.67 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.411 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.711 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 39.6 Cg_endo -65.53 -38.13 26.66 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.94 1.495 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 12.4 pt-20 -67.94 -36.43 80.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.045 -1.035 . . . . 0.0 109.172 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -81.21 -37.8 28.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -76.17 -17.05 59.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -71.85 -40.87 68.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.9 ptpt -75.69 -26.61 57.74 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.624 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -71.15 -34.32 70.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -21.67 64.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.662 -0.649 . . . . 0.0 110.265 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.2 33.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.052 -1.03 . . . . 0.0 108.414 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.669 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 69.9 mt -76.94 -30.93 18.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.826 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.85 -39.66 63.83 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.546 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t70 -86.45 2.57 47.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.558 -0.714 . . . . 0.0 110.096 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -89.53 -11.5 42.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.329 -0.857 . . . . 0.0 109.333 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.106 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -99.83 -15.14 18.51 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.608 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 t 86.01 81.68 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.299 0 CA-C-O 121.439 0.638 . . . . 0.0 109.674 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 44.6 Cg_endo -71.06 152.57 62.66 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.87 1.984 . . . . 0.0 111.103 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.1 t -118.92 117.22 53.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER 63.78 13.06 7.17 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.579 -178.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 90.51 34.1 8.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 23.1 m-85 -135.36 138.36 43.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -1.11 . . . . 0.0 111.647 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.106 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.1 mt -109.49 137.57 47.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 34' ' ' ASP . 3.9 p -85.06 142.28 29.67 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.105 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.31 -25.81 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . 32.8 t70 -69.18 -24.28 64.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.384 -1.069 . . . . 0.0 110.326 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 9.6 mttm -92.53 -35.35 13.64 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.018 -1.051 . . . . 0.0 108.17 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.847 HG12 ' CD1' ' A' ' 40' ' ' LEU . 96.3 t -75.32 -41.06 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.566 0.698 . . . . 0.0 110.403 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.79 -54.92 6.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 111.035 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.9 Cg_endo -67.12 -32.48 34.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.443 1.233 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.844 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.3 t -63.84 -33.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.023 ' HB3' HD22 ' A' ' 50' ' ' LEU . 26.1 mt -89.92 -27.25 19.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 110.461 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 45.3 mt -68.26 -15.04 63.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -90.76 -2.45 57.8 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.708 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.596 ' O ' HD21 ' A' ' 81' ' ' LEU . 79.6 p -82.65 12.67 4.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.591 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 63.57 10.55 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.042 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.8 mt -100.46 159.11 30.59 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.391 -0.818 . . . . 0.0 110.486 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.1 Cg_endo -76.39 171.77 17.47 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.113 1.586 . . . . 0.0 109.415 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' B' ' 111' ' ' PHE . 4.5 t -71.92 -3.49 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.526 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.45 -30.87 42.34 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.156 -0.965 . . . . 0.0 109.097 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.878 HG13 HD22 ' A' ' 45' ' ' LEU . 8.8 mm -84.1 -39.6 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.023 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.8 mt -72.2 -26.44 62.05 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.563 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -74.53 -26.54 67.43 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.109 -1.997 . . . . 0.0 108.109 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.781 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.5 ttm180 -100.7 -25.47 14.13 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.92 -0.753 . . . . 0.0 110.215 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.083 HG11 HG23 ' A' ' 77' ' ' VAL . 13.6 t -74.27 -36.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.917 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.614 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.79 -48.17 67.06 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.15 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.3 mm-40 -52.55 -58.18 7.58 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 110.089 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.929 HD21 ' C ' ' A' ' 88' ' ' MET . 3.5 mt -62.85 -17.57 61.64 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.481 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.893 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 30.1 t -86.08 -30.59 22.48 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.4 t0 -71.12 101.36 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.543 -0.723 . . . . 0.0 109.683 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.593 HG23 ' HE2' ' A' ' 99' ' ' LYS . 47.8 mm -75.63 -42.4 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.613 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 31.2 p30 -104.41 -4.69 22.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.062 -1.024 . . . . 0.0 111.044 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 38.0 m170 60.86 44.4 10.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.171 -0.955 . . . . 0.0 110.541 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 38.1 p30 -100.05 26.51 6.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.237 -0.914 . . . . 0.0 109.059 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 58.53 31.69 67.41 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.8 mtt -150.91 161.04 43.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -1.05 . . . . 0.0 110.357 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.824 HD12 HG11 ' A' ' 36' ' ' VAL . 16.0 mt -123.6 102.29 7.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.6 OUTLIER -69.29 157.51 36.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 66' ' ' ASP . 14.2 ptt180 -37.06 -39.39 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.618 -0.676 . . . . 0.0 110.81 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . 17.8 m-20 -79.51 -35.0 40.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 109.928 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 14.5 mt-10 -75.4 -40.95 57.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.963 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.0 t80 -62.62 -23.88 67.3 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.87 -44.79 63.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.465 -0.772 . . . . 0.0 110.13 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.64 ' O ' HD12 ' A' ' 76' ' ' LEU . 85.7 t -64.28 -22.16 30.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.022 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.81 -5.66 56.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.602 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mmt -87.94 -44.44 11.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.828 -1.17 . . . . 0.0 109.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CD2' HG22 ' A' ' 9' ' ' VAL . 2.3 p90 -75.55 -26.64 58.16 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 72' ' ' VAL . 12.0 mt -67.53 -28.05 67.49 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.083 HG23 HG11 ' A' ' 53' ' ' VAL . 27.2 t -92.24 -60.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.411 0.624 . . . . 0.0 109.817 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.5 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.1 m-85 -46.62 -27.33 1.12 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.536 -0.727 . . . . 0.0 111.391 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 56.9 m -81.61 -12.08 58.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 110.088 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.042 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.22 -12.53 37.78 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.392 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.779 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.4 mp -89.97 -43.47 10.53 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.516 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 3.3 mt-10 -73.52 -58.17 3.49 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.659 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 177.0 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.754 -0.591 . . . . 0.0 110.616 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 3.4 tt0 179.88 108.13 0.18 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.739 -1.226 . . . . 0.0 110.844 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 41.7 Cg_endo -67.99 163.53 35.42 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.838 1.441 . . . . 0.0 110.163 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 70.5 t -113.3 119.25 42.49 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.532 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.778 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.6 Cg_endo -85.34 -168.99 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.924 1.486 . . . . 0.0 109.81 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.929 ' C ' HD21 ' A' ' 56' ' ' LEU . 18.8 mtt -111.83 18.1 19.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.555 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 3.0 m -93.6 119.35 32.52 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.898 -1.121 . . . . 0.0 112.823 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.867 HD21 ' O ' ' A' ' 56' ' ' LEU . 3.0 mt -101.02 75.4 0.13 Allowed Pre-proline 0 N--CA 1.489 1.518 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.846 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.555 ' CD ' ' O ' ' A' ' 89' ' ' SER . 39.6 Cg_endo -64.92 164.57 24.2 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.629 1.331 . . . . 0.0 110.021 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.596 ' O ' HG22 ' A' ' 95' ' ' VAL . 43.0 Cg_endo -71.08 -5.39 16.89 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.934 1.492 . . . . 0.0 110.699 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.448 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -82.47 9.58 8.92 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 109.055 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.674 HD23 ' HB3' ' A' ' 8' ' ' ALA . 39.5 mt -121.06 -21.14 6.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 110.748 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 92' ' ' PRO . 9.9 m -65.06 140.18 97.97 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 110.739 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 41.7 Cg_endo -69.55 175.53 7.8 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.073 1.565 . . . . 0.0 109.828 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 41.5 Cg_endo -68.26 -20.95 42.36 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.875 1.46 . . . . 0.0 110.867 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -29.43 68.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.048 -1.032 . . . . 0.0 109.907 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.593 ' HE2' HG23 ' A' ' 59' ' ' ILE . 11.0 mmmt -90.72 12.05 20.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.317 -0.864 . . . . 0.0 109.64 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 96' ' ' PRO . 40.5 mtt180 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.356 -0.84 . . . . 0.0 110.848 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.172 0.511 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.426 ' O ' ' C ' ' B' ' 109' ' ' ASN . 13.3 p -117.15 -43.74 2.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.13 -0.982 . . . . 0.0 110.356 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 18.7 t-20 -42.8 112.05 1.1 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.26 -0.9 . . . . 0.0 109.899 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.601 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.5 Cg_endo -70.99 1.08 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.939 1.494 . . . . 0.0 112.015 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.949 ' CE2' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -105.67 -59.79 1.72 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.658 -1.276 . . . . 0.0 109.21 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.501 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 N-CA-C 110.575 -0.587 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.801 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.8 t90 -92.58 126.81 37.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 110.08 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -48.26 -27.18 2.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 40.7 t -94.43 149.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.829 . . . . 0.0 110.312 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -104.24 170.22 6.35 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.511 -0.743 . . . . 0.0 109.731 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.15 -34.45 28.18 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.59 1.311 . . . . 0.0 109.926 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 2.1 pm0 -74.62 -25.67 59.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.917 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -81.37 -40.27 23.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 108.566 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG3' ' CH2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -69.02 -13.07 62.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 2.6 mtmt -84.54 -37.93 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 5.8 m-30 -64.22 -23.38 67.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.93 -23.66 26.88 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.816 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.2 34.27 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.502 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 23.7 mt -79.46 -32.04 14.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.79 -40.15 66.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.2 t70 -85.85 1.19 50.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.652 -0.655 . . . . 0.0 109.79 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.451 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -92.91 -4.94 51.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.086 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.029 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -107.32 -6.98 16.87 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 82.76 92.1 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.8 Cg_endo -73.07 149.94 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.08 1.569 . . . . 0.0 110.998 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 54.3 t -117.62 103.47 14.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.5 OUTLIER 66.03 13.26 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.212 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 99.53 32.12 5.84 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 87.7 m-85 -143.09 153.91 43.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.271 . . . . 0.0 111.7 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.029 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -119.78 137.15 54.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 17.7 p -80.8 142.58 33.58 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.051 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.66 -27.05 0.3 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -66.11 -27.28 67.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -1.023 . . . . 0.0 110.457 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 51.7 mttp -92.3 -33.24 14.7 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.041 -1.037 . . . . 0.0 108.299 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 65' ' ' LEU . 60.4 t -82.32 -45.07 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.603 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.7 tttt -43.96 -52.78 14.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.763 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.1 Cg_endo -65.51 -33.72 45.34 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.39 1.205 . . . . 0.0 109.48 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -64.56 -38.39 82.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.042 ' HB3' HD22 ' A' ' 50' ' ' LEU . 59.3 mt -81.98 -30.06 31.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 38' ' ' PRO . 42.7 mt -73.43 -13.92 61.16 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -88.55 -8.97 53.87 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.929 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.549 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 4.3 p -80.07 9.46 5.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.254 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 67.34 12.93 9.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.039 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.139 HD11 ' HB3' ' A' ' 80' ' ' ALA . 17.0 mt -98.01 153.41 38.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 110.04 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.4 Cg_endo -75.01 171.84 17.54 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 123.994 1.523 . . . . 0.0 109.313 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.508 HG13 ' C ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.03 -6.04 6.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 109.467 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -77.53 -31.01 53.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.863 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.902 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -85.32 -41.17 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.042 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.2 mt -73.71 -28.79 61.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.22 -23.61 74.78 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.85 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.2 ttm180 -101.06 -37.94 8.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.933 -0.745 . . . . 0.0 109.552 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.005 HG11 HG23 ' A' ' 77' ' ' VAL . 21.1 t -64.06 -39.79 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.631 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.6 t-105 -67.13 -51.38 54.72 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.463 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 56.1 mt-10 -53.24 -56.46 16.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -61.33 -15.15 32.95 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.713 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 16.1 m -93.59 -33.97 13.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.522 -0.737 . . . . 0.0 109.527 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -67.72 69.1 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.452 -0.78 . . . . 0.0 110.056 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.795 HG23 ' HE2' ' A' ' 99' ' ' LYS . 34.2 mm -50.56 -30.33 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -106.71 -15.3 14.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.878 . . . . 0.0 109.889 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 93.1 m-70 57.31 45.72 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.362 -0.836 . . . . 0.0 111.66 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.47 ' HB3' ' OD2' ' A' ' 60' ' ' ASP . 5.6 p-10 -107.21 28.91 7.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.832 -1.167 . . . . 0.0 109.403 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 66.25 25.93 72.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 12.8 mtp -151.06 161.37 42.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 110.199 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.021 HD12 HG11 ' A' ' 36' ' ' VAL . 8.6 mt -122.03 110.31 15.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.863 . . . . 0.0 109.798 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.58 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 6.3 t0 -68.71 163.96 22.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -49.27 -30.38 7.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.182 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 35.8 t0 -86.83 -33.56 19.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 42.4 mt-10 -75.59 -43.79 46.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.968 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.5 t80 -54.39 -34.0 60.36 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -59.21 -57.29 13.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.57 0.7 . . . . 0.0 110.253 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.027 HG22 HD21 ' A' ' 94' ' ' LEU . 44.9 t -52.23 -22.8 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.15 -10.22 48.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 9.3 mmm -89.41 -44.3 10.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.472 -1.393 . . . . 0.0 110.608 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 2.9 p90 -76.04 -19.4 58.67 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.666 HD22 HG13 ' A' ' 86' ' ' VAL . 6.2 mt -79.33 -25.5 42.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.005 HG23 HG11 ' A' ' 53' ' ' VAL . 17.6 t -91.11 -41.8 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.68 -25.67 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.423 -0.798 . . . . 0.0 110.266 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 1.2 m -80.1 -14.8 58.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.139 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.67 -10.09 49.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.493 -0.754 . . . . 0.0 109.143 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 81' ' ' LEU . 4.5 mt -90.51 -41.76 11.23 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 32.7 mm-40 -69.64 -53.25 19.6 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.611 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.6 ttmt 176.6 -26.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.186 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -67.49 116.83 41.21 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.189 -0.944 . . . . 0.0 111.457 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.89 177.93 7.06 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.806 1.424 . . . . 0.0 109.42 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.666 HG13 HD22 ' A' ' 76' ' ' LEU . 31.2 t -128.49 121.32 21.25 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.957 -1.089 . . . . 0.0 111.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.659 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.5 Cg_endo -85.53 166.64 10.44 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.86 1.453 . . . . 0.0 109.086 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.821 ' C ' HD21 ' A' ' 56' ' ' LEU . 6.6 mtp -90.36 14.25 13.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.921 -1.112 . . . . 0.0 110.477 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.493 ' N ' HD21 ' A' ' 56' ' ' LEU . 72.3 m -109.03 103.21 12.2 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.439 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.692 ' CD1' HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -62.95 109.55 2.56 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 38.7 Cg_endo -66.08 147.28 84.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.818 1.43 . . . . 0.0 111.19 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.01 -7.27 21.07 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.321 1.695 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -84.32 -30.77 25.26 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -93.14 -18.21 22.85 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.538 HG22 ' HD2' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -69.14 142.23 92.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 110.248 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HD2' HG22 ' A' ' 95' ' ' VAL . 44.4 Cg_endo -72.12 163.83 37.54 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.915 1.481 . . . . 0.0 110.508 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 45.2 Cg_endo -72.46 -32.5 9.9 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.111 1.585 . . . . 0.0 111.089 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.8 m -64.2 -24.24 67.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.964 -1.085 . . . . 0.0 110.068 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.795 ' HE2' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -96.61 13.08 29.42 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.291 -0.88 . . . . 0.0 109.417 179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.851 . . . . 0.0 110.355 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.237 0.542 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.08 -12.89 13.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 110.394 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.488 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 27.1 t-20 -137.82 120.6 11.19 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.479 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.597 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -76.41 12.57 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.488 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.969 ' CE2' HD12 ' A' ' 40' ' ' LEU . 9.8 m-85 -107.27 -61.22 1.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.798 -1.189 . . . . 0.0 109.08 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.056 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.482 0.845 0 N-CA-C 110.143 -0.753 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.585 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.5 t90 -52.54 124.45 13.64 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.991 -1.068 . . . . 0.0 109.237 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.75 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -40.14 -27.97 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.34 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 25.5 t -97.98 126.17 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 109.757 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.8 mttp -82.12 173.66 7.27 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 110.45 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.2 Cg_endo -68.31 -33.96 22.49 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.091 1.574 . . . . 0.0 109.387 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.01 -18.95 48.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.546 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -83.82 -43.19 15.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.91 61.59 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.09 61.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.47 -23.52 50.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.621 ' CD2' ' HB2' ' A' ' 74' ' ' MET . 9.9 m-30 -74.98 -33.96 61.94 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 5.1 m-20 -69.98 -22.27 63.16 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.734 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -78.23 -32.97 50.04 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.684 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 44.7 mt -81.55 -32.7 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.792 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.36 -31.58 64.02 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.6 t0 -90.83 -3.22 57.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 71.6 p -87.84 -8.51 55.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 31' ' ' LEU . 8.5 mt -98.81 -14.88 19.48 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.624 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 p 94.52 91.41 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.296 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 49.4 Cg_endo -72.73 147.27 44.63 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.194 1.628 . . . . 0.0 110.638 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 77.1 t -115.22 100.27 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 64.47 15.26 9.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 109.69 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.24 32.53 5.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 75.5 m-85 -145.63 148.75 33.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.17 . . . . 0.0 111.59 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 24' ' ' LEU . 10.2 mt -115.0 159.03 21.26 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 35' ' ' LYS . 86.4 p -104.52 143.8 32.55 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.031 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.646 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.7 -25.32 0.86 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' SER . 1.6 t70 -71.67 -23.69 61.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.578 -0.954 . . . . 0.0 110.354 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.3 mttp -92.36 -33.06 14.73 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.011 -1.055 . . . . 0.0 108.257 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG12 ' CD1' ' A' ' 40' ' ' LEU . 89.2 t -77.54 -38.42 26.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.296 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 ttpt -42.54 -54.5 8.1 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -65.81 -32.62 45.88 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.622 1.327 . . . . 0.0 109.56 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.53 -31.97 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.978 ' HB3' HD22 ' A' ' 50' ' ' LEU . 27.2 mt -92.91 -30.48 15.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.496 -0.753 . . . . 0.0 110.269 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.443 HD11 ' HE3' ' A' ' 37' ' ' LYS . 57.5 mt -72.39 -12.11 60.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -90.79 -9.63 45.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.417 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.54 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 92.2 p -81.32 11.0 4.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.363 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.59 14.75 9.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.998 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.4 mt -96.76 154.35 38.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.828 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.0 Cg_endo -75.38 169.26 22.81 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.939 1.494 . . . . 0.0 109.072 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.535 HG13 ' C ' ' B' ' 111' ' ' PHE . 2.1 t -69.87 -3.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.965 -1.085 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.63 -27.77 40.96 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.161 -0.962 . . . . 0.0 109.235 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.908 HG13 HD22 ' A' ' 45' ' ' LEU . 7.3 mm -87.81 -36.94 10.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -76.23 -27.19 56.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -74.08 -25.84 70.19 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.655 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.7 ttm-85 -101.19 -31.19 11.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.048 -0.678 . . . . 0.0 110.242 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.711 HG11 HG23 ' A' ' 77' ' ' VAL . 13.1 t -70.5 -34.27 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.044 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.646 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 5.1 t-105 -68.17 -56.78 7.51 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.262 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 3.4 mm-40 -43.17 -64.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.35 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.864 HD21 ' C ' ' A' ' 88' ' ' MET . 4.6 mt -55.6 -20.01 12.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.952 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.87 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 57.8 m -91.61 -19.84 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.479 -0.763 . . . . 0.0 109.403 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.9 t0 -96.1 86.19 4.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.512 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -91.05 -13.93 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.63 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 11.1 m-20 -92.36 -12.65 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.457 ' N ' ' CD2' ' A' ' 61' ' ' HIS . 5.2 m170 56.8 47.11 18.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.501 -0.749 . . . . 0.0 110.648 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 21.9 p-10 -128.12 25.47 5.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.695 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.17 38.44 93.15 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.51 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 6.7 mtt -150.37 161.08 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -1.162 . . . . 0.0 111.981 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD12 HG21 ' A' ' 36' ' ' VAL . 13.9 mt -125.45 103.69 8.03 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.41 160.4 32.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.997 -1.065 . . . . 0.0 110.682 -179.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.437 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ptm180 -36.48 -44.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.774 -0.579 . . . . 0.0 111.392 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.4 t70 -79.53 -31.93 42.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.662 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.465 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 28.0 mt-10 -76.03 -45.38 34.69 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.079 -1.013 . . . . 0.0 109.134 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.768 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.6 t80 -58.19 -18.47 26.17 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.29 -45.82 37.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.444 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.562 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.7 t -59.78 -26.12 34.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 109.538 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.87 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.79 -5.61 55.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.527 -0.733 . . . . 0.0 111.193 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.621 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.2 mmt -84.43 -49.53 8.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.923 -1.111 . . . . 0.0 109.839 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.1 p90 -73.79 -28.26 61.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.605 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.1 mt -64.54 -28.23 69.5 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.829 HG21 ' CD2' ' A' ' 40' ' ' LEU . 45.8 t -91.25 -23.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.828 -0.545 . . . . 0.0 110.591 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -88.4 -23.22 23.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -0.972 . . . . 0.0 109.802 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.3 m -84.12 -12.85 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.998 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.86 -14.31 39.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.804 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.7 mt -91.27 -39.93 11.79 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.853 0.835 . . . . 0.0 109.188 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 6.5 tp10 -68.15 -57.38 6.14 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.515 0.674 . . . . 0.0 109.462 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 177.14 -22.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 111.246 179.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' CYS . 4.0 mt-10 -70.86 118.18 62.84 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 110.845 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.99 165.38 32.76 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.808 1.425 . . . . 0.0 109.802 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.665 HG11 HG23 ' A' ' 53' ' ' VAL . 95.7 t -111.91 129.09 24.56 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.2 -0.938 . . . . 0.0 110.015 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.6 Cg_endo -90.16 -161.73 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.763 1.402 . . . . 0.0 109.642 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.864 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -130.19 3.08 4.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.49 -0.756 . . . . 0.0 109.566 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.572 ' N ' HD21 ' A' ' 56' ' ' LEU . 67.7 m -105.7 102.21 11.68 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.597 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 56' ' ' LEU . 4.7 mt -52.01 106.05 0.6 Allowed Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.61 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' HG2' HD23 ' A' ' 94' ' ' LEU . 40.6 Cg_endo -69.82 165.34 31.36 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.835 1.439 . . . . 0.0 110.298 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.78 -25.93 16.46 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.156 1.608 . . . . 0.0 111.332 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.7 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -84.96 6.3 25.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.952 -1.092 . . . . 0.0 109.689 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.75 HD13 ' HB3' ' A' ' 8' ' ' ALA . 4.5 mm? -117.45 -0.19 12.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 111.061 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.94 138.02 21.03 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.06 -1.025 . . . . 0.0 111.534 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.494 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.5 Cg_endo -70.07 176.0 7.59 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.202 1.633 . . . . 0.0 109.594 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.0 Cg_endo -70.16 -11.06 29.63 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.548 1.288 . . . . 0.0 110.808 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 t -80.42 -12.5 59.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.035 -1.041 . . . . 0.0 109.64 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 34.7 tptt -89.55 -4.67 57.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.483 -0.761 . . . . 0.0 109.216 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 110.48 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.531 ' O ' ' N ' ' B' ' 109' ' ' ASN . 1.7 t . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.19 0.519 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' B' ' 107' ' ' SER . 25.0 m 63.26 -64.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.513 -0.742 . . . . 0.0 110.994 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.533 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 0.9 OUTLIER 59.44 148.82 0.08 OUTLIER Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.193 -0.942 . . . . 0.0 109.067 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.662 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 41.7 Cg_endo -72.38 -2.42 11.69 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.168 1.088 . . . . 0.0 109.922 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.909 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.5 -66.72 0.99 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.911 -1.118 . . . . 0.0 108.792 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.455 ' HB2' ' HB2' ' B' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.261 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 N--CA 1.484 0.942 0 N-CA-C 110.663 -0.553 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.1 t90 -86.18 131.13 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.436 -0.79 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -47.74 -27.66 2.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 111.126 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 53.7 t -91.76 147.19 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 9.3 mttm -104.06 176.32 1.83 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.548 -0.72 . . . . 0.0 109.788 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.7 Cg_endo -67.89 -35.44 20.91 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.769 1.405 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 10.3 pt-20 -74.75 -29.08 61.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 35.3 m-20 -82.2 -33.14 29.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.296 -0.878 . . . . 0.0 109.07 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 14' ' ' LYS . 1.1 tmtt? -78.17 -13.21 59.95 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.199 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.29 -41.98 26.85 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.628 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -72.82 -26.2 61.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -73.32 -35.52 66.08 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.74 -23.56 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.831 -0.543 . . . . 0.0 109.765 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 23' ' ' SER . . . -79.14 -34.88 42.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.613 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 42.0 mt -79.35 -31.55 14.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.94 -36.71 59.26 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.6 t70 -90.4 3.98 52.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 0.0 109.609 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -91.9 -9.35 43.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 108.967 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.079 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -104.8 -8.05 19.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 87.2 99.89 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.043 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 47.2 Cg_endo -70.68 146.72 55.25 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.453 1.765 . . . . 0.0 110.425 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 98.3 t -115.7 96.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.9 OUTLIER 64.47 20.45 12.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 94.14 33.84 6.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 85.4 m-85 -150.24 145.69 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -1.191 . . . . 0.0 111.737 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.079 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.9 mt -112.8 149.22 33.36 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.487 ' CA ' ' SD ' ' A' ' 64' ' ' MET . 24.8 p -99.22 144.86 27.86 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.182 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -40.96 -27.52 0.19 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.2 m-20 -65.38 -23.97 67.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -1.079 . . . . 0.0 110.407 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 69.8 mttt -99.22 -31.8 11.54 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.077 -1.014 . . . . 0.0 108.941 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.871 HG11 HD12 ' A' ' 65' ' ' LEU . 95.2 t -79.72 -42.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -42.0 -55.0 6.65 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.848 . . . . 0.0 110.868 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -66.84 -32.83 35.54 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.494 1.26 . . . . 0.0 109.866 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.6 t -65.22 -28.96 45.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.042 ' HB3' HD22 ' A' ' 50' ' ' LEU . 38.0 mt -92.95 -26.21 17.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.52 -0.737 . . . . 0.0 110.342 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 74.2 mt -73.5 -9.09 58.33 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.193 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.22 -4.13 57.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.944 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.576 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -84.65 10.38 11.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.1 -1.0 . . . . 0.0 110.283 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.9 OUTLIER 66.85 7.62 5.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.927 . . . . 0.0 109.979 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.071 HD13 HG21 ' A' ' 49' ' ' ILE . 13.9 mt -94.58 157.12 37.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.9 Cg_endo -77.0 176.4 10.18 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.079 1.568 . . . . 0.0 109.841 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.524 HG13 ' C ' ' B' ' 111' ' ' PHE . 1.3 t -73.25 -4.44 5.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.14 -29.89 48.98 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.924 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.071 HG21 HD13 ' A' ' 45' ' ' LEU . 8.5 mm -86.37 -40.39 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.042 HD22 ' HB3' ' A' ' 40' ' ' LEU . 19.5 mt -76.3 -28.32 56.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.49 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -70.12 -25.16 75.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.3 ttm105 -101.46 -34.09 9.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.117 -0.637 . . . . 0.0 110.043 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.776 HG11 HG23 ' A' ' 77' ' ' VAL . 24.5 t -67.37 -36.01 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.92 -1.113 . . . . 0.0 108.889 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.583 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.9 t-105 -66.82 -53.57 31.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.16 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.496 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 8.2 mt-10 -47.27 -58.04 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.126 -0.984 . . . . 0.0 110.396 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -63.04 -12.66 27.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.049 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.655 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 47.0 m -94.97 -40.43 9.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 61.9 t0 -84.36 70.84 10.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 110.01 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.636 HG23 ' HE2' ' A' ' 99' ' ' LYS . 5.0 mt -61.04 -16.5 14.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.548 -0.72 . . . . 0.0 110.492 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD2' ' OE1' ' A' ' 69' ' ' GLU . 26.1 m-20 -91.98 -15.53 27.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.68 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 88.0 m-70 51.27 34.19 11.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.2 p-10 -103.03 4.68 37.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.993 . . . . 0.0 110.042 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 86.89 26.62 31.24 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.2 mmm -148.3 161.65 41.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.217 -1.167 . . . . 0.0 110.036 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.871 HD12 HG11 ' A' ' 36' ' ' VAL . 12.1 mt -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.301 -0.874 . . . . 0.0 109.657 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.579 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 21.7 t0 -69.07 167.11 16.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.268 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 6.7 ptm180 -49.86 -39.23 38.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -35.49 38.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 109.448 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 40.3 mt-10 -72.56 -47.04 51.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 109.166 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.918 ' CD2' HD12 ' A' ' 31' ' ' LEU . 26.2 t80 -57.86 -26.79 62.55 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.491 -0.756 . . . . 0.0 109.028 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -68.47 -48.53 64.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.881 . . . . 0.0 110.115 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.98 HG13 HD12 ' A' ' 94' ' ' LEU . 60.7 t -58.34 -22.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.688 -0.633 . . . . 0.0 109.847 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -88.5 -12.49 42.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.747 . . . . 0.0 111.96 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.7 mmm -85.6 -40.36 16.33 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.656 -1.277 . . . . 0.0 110.472 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.105 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.3 p90 -77.9 -25.19 48.34 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.788 -1.165 . . . . 0.0 107.894 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 4.6 mt -73.19 -20.13 60.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.544 0.688 . . . . 0.0 109.212 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.776 HG23 HG11 ' A' ' 53' ' ' VAL . 42.2 t -91.59 -49.82 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.849 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.593 ' HA ' HD23 ' A' ' 81' ' ' LEU . 3.4 m-85 -64.16 -41.07 97.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.471 -0.768 . . . . 0.0 110.711 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 59.9 m -80.67 -9.16 59.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.399 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -92.97 -31.93 14.72 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.129 0.966 . . . . 0.0 109.136 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.596 ' N ' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -90.33 -23.24 21.19 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.638 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.488 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 4.6 tp10 -70.11 -57.41 4.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.02 . . . . 0.0 109.855 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 22.4 ttmt -178.06 57.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.619 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 1.8 tt0 -165.87 139.5 3.59 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.021 -1.05 . . . . 0.0 110.726 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HD2' ' HG3' ' A' ' 84' ' ' GLU . 51.1 Cg_endo -78.79 168.93 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.97 1.511 . . . . 0.0 110.458 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 80.0 t -121.09 126.01 26.77 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.649 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.9 Cg_endo -85.16 152.96 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.846 1.446 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.574 ' C ' HD21 ' A' ' 56' ' ' LEU . 24.8 mtm -88.13 17.58 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 38.9 m -113.41 99.9 8.13 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.836 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.745 HD11 ' O ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -57.31 106.93 0.76 Allowed Pre-proline 0 C--N 1.291 -1.96 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.649 178.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.023 ' HG2' HD23 ' A' ' 94' ' ' LEU . 43.2 Cg_endo -68.66 161.58 44.68 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.868 1.457 . . . . 0.0 110.148 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.95 -16.1 25.96 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.906 1.477 . . . . 0.0 110.965 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.583 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -91.84 26.22 2.48 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 108.753 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.105 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -128.6 -31.35 2.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.625 -0.672 . . . . 0.0 110.903 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 95' ' ' VAL . 18.3 m -81.52 142.95 50.5 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 110.642 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.7 168.93 18.67 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.191 1.627 . . . . 0.0 109.33 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 44.6 Cg_endo -71.01 56.39 1.92 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.655 1.345 . . . . 0.0 110.577 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.08 -47.24 0.27 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.636 ' HE2' HG23 ' A' ' 59' ' ' ILE . 2.4 tmtm? -90.28 7.14 39.82 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.053 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.0 p . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.16 0.505 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' B' ' 110' ' ' PRO . 29.8 m -165.66 -57.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 110.349 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 16.6 t-20 -51.98 106.93 0.72 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 110.067 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 51.2 Cg_endo -71.62 5.54 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.165 1.613 . . . . 0.0 112.01 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.931 ' CE2' HD12 ' A' ' 40' ' ' LEU . 6.9 m-85 -101.66 -62.83 1.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.658 -1.276 . . . . 0.0 109.167 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.362 179.685 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 N--CA 1.483 0.879 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -88.85 120.89 30.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.578 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.572 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -42.58 -28.06 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 109.97 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 76.7 t -97.42 152.6 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.879 . . . . 0.0 110.045 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 3.0 mmmt -105.9 171.81 4.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.923 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.9 Cg_endo -67.61 -35.48 22.33 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.753 1.397 . . . . 0.0 109.46 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.21 -31.01 68.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -81.53 -33.72 31.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 10.9 tptp -74.76 -16.35 60.73 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.68 -38.65 47.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -78.52 -25.02 45.45 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.611 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.2 m-30 -75.33 -37.51 60.68 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 30.5 t70 -69.17 -18.58 63.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.653 -0.654 . . . . 0.0 109.655 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -83.08 -39.06 21.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.695 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.9 mt -75.14 -34.13 30.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.721 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -68.6 -41.17 79.96 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t70 -84.89 -0.64 54.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.587 -0.696 . . . . 0.0 109.905 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 36.7 t -86.49 -9.68 55.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.267 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.115 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -100.75 -11.4 19.94 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.09 93.79 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.538 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 48.5 Cg_endo -74.25 151.06 43.07 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.385 1.729 . . . . 0.0 110.905 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 61.3 t -120.8 98.5 6.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 69.34 22.12 6.7 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.693 0.758 . . . . 0.0 109.207 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.85 37.43 7.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.559 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 71.9 m-85 -147.2 140.38 25.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -1.159 . . . . 0.0 111.766 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.115 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.6 mt -110.09 137.79 47.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -84.42 142.53 30.04 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.846 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.54 -25.87 0.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -70.01 -24.21 63.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.588 -0.948 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.4 mttp -91.69 -35.12 14.36 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.95 HG11 HD12 ' A' ' 65' ' ' LEU . 90.8 t -79.68 -48.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.444 0.64 . . . . 0.0 110.296 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.61 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 9.0 tttp -38.94 -55.24 2.9 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.582 -0.699 . . . . 0.0 110.8 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.8 Cg_endo -66.18 -29.8 47.0 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.576 1.303 . . . . 0.0 110.025 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -70.59 -31.74 47.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.522 -0.736 . . . . 0.0 109.07 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.947 ' HB3' HD22 ' A' ' 50' ' ' LEU . 32.9 mt -85.44 -28.63 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -0.822 . . . . 0.0 109.772 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 38' ' ' PRO . 69.8 mt -69.63 -11.29 60.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.02 -5.01 57.09 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.769 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -81.97 14.52 2.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 110.144 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.73 15.34 1.56 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.812 -1.18 . . . . 0.0 109.847 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.035 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.0 mt -101.08 156.13 35.5 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.4 Cg_endo -73.61 160.74 43.54 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 123.803 1.422 . . . . 0.0 109.409 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' B' ' 111' ' ' PHE . 38.2 t -63.26 -11.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.17 -0.957 . . . . 0.0 109.187 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -70.03 -29.73 66.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 108.815 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 45' ' ' LEU . 7.1 mm -82.97 -42.47 17.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.961 0.886 . . . . 0.0 108.733 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.947 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.5 mt -71.72 -30.81 66.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.509 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -68.09 -25.05 74.59 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.871 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -101.82 -34.1 9.55 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.062 -0.669 . . . . 0.0 110.491 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.979 HG11 HG23 ' A' ' 77' ' ' VAL . 40.8 t -65.62 -38.13 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.156 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.4 t-105 -68.68 -50.73 48.73 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.462 -0.774 . . . . 0.0 110.412 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 2.0 mm-40 -51.04 -52.12 46.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.973 -1.079 . . . . 0.0 110.194 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.871 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.9 mt -64.69 -11.61 37.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.099 -1.0 . . . . 0.0 108.543 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.052 ' OG ' HD21 ' A' ' 65' ' ' LEU . 1.6 p -93.37 -46.7 7.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' CG ' ' HA ' ' A' ' 61' ' ' HIS . 3.5 t0 -59.56 78.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 110.308 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 57' ' ' SER . 43.8 mm -54.48 -27.1 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.24 -0.913 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 34.1 p30 -108.62 -13.66 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 85.1 m-70 58.63 47.33 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 10.9 p-10 -110.51 16.51 21.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.228 -0.92 . . . . 0.0 109.854 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 77.43 29.92 54.88 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.0 mtt -149.44 161.36 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -1.198 . . . . 0.0 110.636 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.052 HD21 ' OG ' ' A' ' 57' ' ' SER . 8.3 mt -127.84 107.0 9.49 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.395 -0.816 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 5.0 t0 -69.58 162.61 27.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -46.63 -40.46 13.05 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.298 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.577 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 2.5 p30 -76.34 -42.04 46.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 109.856 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 30.8 mt-10 -66.27 -41.04 90.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.612 0.72 . . . . 0.0 109.059 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.756 ' CD2' HD12 ' A' ' 31' ' ' LEU . 47.1 t80 -63.49 -21.38 66.29 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -71.93 -43.07 65.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.507 0.67 . . . . 0.0 109.689 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.787 HG13 HD12 ' A' ' 94' ' ' LEU . 59.1 t -62.29 -27.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.715 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.28 -2.13 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.483 -0.761 . . . . 0.0 111.176 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.586 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.8 mmt -88.39 -46.46 9.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 109.487 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.859 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.2 p90 -76.56 -19.1 58.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.635 HD22 HG13 ' A' ' 86' ' ' VAL . 8.6 mt -77.13 -23.84 51.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.979 HG23 HG11 ' A' ' 53' ' ' VAL . 38.5 t -91.63 -46.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.654 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 1.4 m-85 -62.54 -28.89 70.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.536 -0.727 . . . . 0.0 111.514 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -82.26 -12.34 58.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.931 -1.106 . . . . 0.0 110.137 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.035 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.47 -19.62 38.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER -90.94 -42.32 10.64 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.733 0.778 . . . . 0.0 110.796 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 16.5 tp10 -68.88 -59.24 3.21 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.413 0.625 . . . . 0.0 110.214 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 176.06 47.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.479 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' CYS . 7.2 tp10 -151.02 110.28 3.06 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.737 -1.227 . . . . 0.0 110.856 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 41.1 Cg_endo -68.06 164.23 32.79 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.871 1.458 . . . . 0.0 109.794 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.635 HG13 HD22 ' A' ' 76' ' ' LEU . 76.0 t -110.78 119.62 45.73 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.135 -0.978 . . . . 0.0 110.63 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.791 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -82.78 175.01 9.1 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.968 1.51 . . . . 0.0 109.009 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.6 mtm -99.14 12.89 34.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.593 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 18.5 m -100.54 114.39 27.98 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.398 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.758 ' C ' HD12 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -99.93 87.71 0.76 Allowed Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 89' ' ' SER . 37.9 Cg_endo -63.11 173.78 3.73 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.252 1.301 . . . . 0.0 111.425 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.8 Cg_endo -72.2 -14.62 28.67 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.27 1.669 . . . . 0.0 110.726 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -75.02 -9.91 58.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.222 -0.924 . . . . 0.0 108.902 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.859 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.7 mm? -99.85 -22.05 15.48 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.522 -0.736 . . . . 0.0 110.341 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.662 HG13 ' HG2' ' A' ' 99' ' ' LYS . 71.0 t -68.75 126.62 92.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.307 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.33 169.52 21.43 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.933 1.491 . . . . 0.0 110.265 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.44 -21.63 22.48 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.067 1.562 . . . . 0.0 110.148 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.64 -12.53 60.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.202 -0.936 . . . . 0.0 109.563 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.662 ' HG2' HG13 ' A' ' 95' ' ' VAL . 19.7 tptt -89.49 -4.84 57.77 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.356 -0.84 . . . . 0.0 109.126 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 179.369 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.403 ' C ' ' OG1' ' B' ' 108' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.261 0.553 . . . . 0.0 110.17 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.413 ' O ' ' C ' ' B' ' 109' ' ' ASN . 0.2 OUTLIER -161.1 -172.9 3.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 0.0 110.032 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.473 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 14.7 t-20 -44.13 107.41 0.6 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.162 -0.961 . . . . 0.0 109.945 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.573 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 44.0 Cg_endo -69.81 2.68 3.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.139 1.599 . . . . 0.0 111.913 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.939 ' HB3' HG13 ' A' ' 47' ' ' VAL . 2.4 m-85 -103.49 -54.89 2.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.703 -1.248 . . . . 0.0 109.371 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.319 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.485 0.976 0 N-CA-C 110.646 -0.559 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CH2' ' HE2' ' A' ' 14' ' ' LYS . 11.2 t90 -88.54 128.95 35.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.903 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.846 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -49.13 -26.97 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 110.826 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.69 146.57 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 18.1 mttt -99.17 169.98 7.47 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.614 -0.679 . . . . 0.0 109.785 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.4 Cg_endo -66.57 -35.12 30.73 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.609 1.321 . . . . 0.0 109.609 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.669 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 1.4 m-20 -79.61 -41.51 26.9 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.36 -16.16 63.85 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.736 0.779 . . . . 0.0 108.908 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.1 -37.91 57.57 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 3.1 mtmt -81.67 -40.32 23.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.4 m-30 -63.29 -23.61 67.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 4.3 t70 -85.54 -24.77 27.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.582 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -79.96 -32.4 39.9 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.667 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 66.0 mt -79.08 -35.24 17.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.843 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -70.06 -39.65 75.55 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 6.5 t0 -87.49 1.24 54.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 110.073 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 6.7 t -89.36 -7.03 56.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.0 109.069 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.101 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.6 mt -107.26 -13.06 15.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.39 91.56 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.6 Cg_endo -73.6 151.34 46.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.322 1.696 . . . . 0.0 110.975 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 48.4 t -116.58 115.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.0 t30 56.77 17.9 3.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 108.816 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 91.73 37.63 6.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CE1' ' CB ' ' A' ' 66' ' ' ASP . 73.3 m-85 -149.7 138.11 20.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.111 -1.229 . . . . 0.0 112.449 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.101 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -104.79 145.29 30.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' ASP . 52.7 p -95.89 145.58 25.27 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 110.087 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -41.01 -27.57 0.2 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' SER . 79.1 m-20 -64.04 -26.17 68.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.386 -1.067 . . . . 0.0 110.282 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 49.3 mttm -96.84 -32.03 12.3 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.125 -0.984 . . . . 0.0 108.659 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.893 HG12 ' CD1' ' A' ' 40' ' ' LEU . 98.9 t -79.6 -43.41 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.551 -0.718 . . . . 0.0 110.73 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.808 ' HG2' HD11 ' A' ' 41' ' ' LEU . 15.2 tttt -43.18 -51.11 14.24 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 110.725 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.6 Cg_endo -67.04 -32.02 35.63 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.213 1.112 . . . . 0.0 109.6 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.896 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.9 t -68.23 -29.94 46.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.978 ' HB3' HD22 ' A' ' 50' ' ' LEU . 50.5 mt -92.0 -32.34 15.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.491 -0.755 . . . . 0.0 110.867 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.808 HD11 ' HG2' ' A' ' 37' ' ' LYS . 22.9 mt -70.55 -14.0 62.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.062 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -90.39 -3.25 57.83 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.642 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.715 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -84.44 17.23 2.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.962 . . . . 0.0 110.299 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB2' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER 61.87 11.77 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.658 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.078 HD11 ' HB3' ' A' ' 80' ' ' ALA . 18.9 mt -100.82 153.18 37.88 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.9 Cg_endo -76.53 173.68 14.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.036 1.545 . . . . 0.0 109.522 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.515 HG11 ' O ' ' B' ' 111' ' ' PHE . 2.1 t -73.09 -3.86 4.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.91 -1.119 . . . . 0.0 109.383 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -78.24 -29.79 48.36 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.894 HG13 HD22 ' A' ' 45' ' ' LEU . 11.1 mm -85.84 -39.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.4 mt -75.19 -29.05 60.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -67.41 -26.12 73.62 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.928 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -101.16 -35.09 9.43 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.005 -0.703 . . . . 0.0 109.85 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 HG23 ' A' ' 77' ' ' VAL . 41.3 t -64.57 -39.66 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.081 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.609 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -65.74 -52.79 48.25 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.067 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mm-40 -56.0 -58.66 6.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.662 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.965 HD21 ' C ' ' A' ' 88' ' ' MET . 5.0 mt -56.14 -19.22 12.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.913 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.98 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 13.5 t -91.93 -35.67 13.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.577 0.703 . . . . 0.0 109.683 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.566 ' OD2' ' CE2' ' A' ' 54' ' ' TRP . 1.6 t0 -65.56 95.54 0.22 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 110.157 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.013 HG23 ' HG3' ' A' ' 99' ' ' LYS . 10.5 mm -67.7 -32.01 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.46 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 2.4 p30 -112.2 -13.67 13.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 110.818 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.562 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 18.1 m-70 62.52 44.55 6.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.907 . . . . 0.0 110.472 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 64' ' ' MET . 57.4 p30 -95.98 5.87 50.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.547 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 85.31 22.76 50.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.547 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 4.0 mmm -148.47 161.55 41.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.255 -1.144 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.757 HD12 HG11 ' A' ' 36' ' ' VAL . 13.8 mt -122.14 106.07 10.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.162 -0.961 . . . . 0.0 109.996 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' CB ' ' CE1' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -71.41 160.08 33.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.025 . . . . 0.0 110.232 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 25.7 ptt180 -39.66 -37.63 0.53 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.74 . . . . 0.0 110.575 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 12.2 m-20 -83.07 -29.92 28.41 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -75.89 -47.93 23.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.896 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 20.6 t80 -61.71 -16.11 46.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.13 -50.21 13.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.395 -0.816 . . . . 0.0 109.842 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.655 ' O ' HD12 ' A' ' 76' ' ' LEU . 58.8 t -58.02 -28.73 34.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.523 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.98 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.15 -4.73 57.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 111.254 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 11.8 mmt -84.01 -47.6 10.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.979 -1.076 . . . . 0.0 110.121 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.672 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 3.0 p90 -75.08 -28.89 60.49 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.1 mt -67.1 -22.7 65.8 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.936 ' O ' HD12 ' A' ' 81' ' ' LEU . 49.4 t -91.5 -44.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.749 -0.594 . . . . 0.0 109.773 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.93 -25.43 62.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.508 -0.745 . . . . 0.0 110.873 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.575 ' CA ' ' HB3' ' A' ' 83' ' ' LYS . 17.1 m -82.38 -21.44 35.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.966 -1.084 . . . . 0.0 109.286 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.078 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.69 -11.1 59.84 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -91.13 -47.28 7.62 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.414 0.625 . . . . 0.0 110.568 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' A' ' 82' ' ' GLU . 2.8 tp10 -127.96 -6.79 5.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 111.772 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.575 ' HB3' ' CA ' ' A' ' 79' ' ' CYS . 0.7 OUTLIER -101.05 -90.82 0.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.446 -1.409 . . . . 0.0 111.405 -179.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.544 ' CG ' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -140.94 175.04 3.33 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.821 -1.174 . . . . 0.0 110.137 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 84' ' ' GLU . 42.3 Cg_endo -69.1 -162.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.829 1.436 . . . . 0.0 110.465 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 54.0 t -143.18 131.59 11.3 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.138 -0.976 . . . . 0.0 110.665 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.869 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.4 Cg_endo -89.45 -163.81 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.981 1.516 . . . . 0.0 109.51 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.965 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 -0.86 11.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.27 -0.894 . . . . 0.0 110.547 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.6 ' N ' HD21 ' A' ' 56' ' ' LEU . 4.1 m -105.87 99.1 8.7 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.176 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.747 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -62.55 108.65 1.77 Allowed Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 1.006 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.2 Cg_endo -64.82 167.48 15.56 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.926 1.487 . . . . 0.0 111.443 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.15 -15.42 35.63 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.347 1.709 . . . . 0.0 111.502 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.804 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -87.17 5.35 38.37 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.999 -1.063 . . . . 0.0 109.553 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.006 HD23 ' HG2' ' A' ' 91' ' ' PRO . 3.9 mm? -123.13 1.84 9.2 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.274 -0.891 . . . . 0.0 110.834 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.655 ' HB ' HD11 ' A' ' 90' ' ' LEU . 7.9 p -124.81 135.98 27.39 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.071 -1.018 . . . . 0.0 110.699 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.68 168.93 21.33 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.026 1.54 . . . . 0.0 109.901 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 -5.57 17.31 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.791 1.416 . . . . 0.0 110.806 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.3 t -83.97 0.64 47.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.973 -1.079 . . . . 0.0 109.949 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 1.013 ' HG3' HG23 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -109.35 2.54 20.78 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.446 -0.783 . . . . 0.0 109.168 179.012 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 111.177 -179.519 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.239 0.542 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -81.85 80.89 8.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.504 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 23.2 t-20 -154.09 113.56 2.51 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.363 -0.836 . . . . 0.0 109.846 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.609 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 50.4 Cg_endo -72.35 1.39 6.17 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.843 1.443 . . . . 0.0 111.54 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.902 ' CE2' HD12 ' A' ' 40' ' ' LEU . 3.8 m-85 -101.19 -61.1 1.41 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.943 -1.098 . . . . 0.0 108.499 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.154 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.484 0.952 0 N-CA-C 109.929 -0.835 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.835 ' HE1' HD22 ' A' ' 94' ' ' LEU . 10.9 t90 -56.59 121.05 8.81 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.022 -1.049 . . . . 0.0 109.407 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.16 -25.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.512 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 12.3 t -96.31 146.98 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.951 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 5.8 mmtt -96.95 169.24 9.01 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.5 Cg_endo -69.95 -33.19 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.865 1.455 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.78 -27.38 31.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.496 -0.753 . . . . 0.0 109.548 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.59 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.1 m-20 -79.72 -30.46 40.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.634 ' HG2' ' HB1' ' A' ' 71' ' ' ALA . 2.9 tmtt? -81.9 -22.98 36.52 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.679 0.752 . . . . 0.0 109.112 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.56 85.46 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.9 -28.34 61.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.8 m-30 -65.14 -36.14 83.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -22.39 64.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.673 -0.642 . . . . 0.0 109.847 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.69 -38.38 25.91 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.682 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 55.2 mt -76.09 -29.8 19.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.798 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.45 -39.36 67.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.553 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.8 t70 -87.19 2.09 51.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.306 0.574 . . . . 0.0 109.814 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.509 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -91.75 -6.12 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.831 0.824 . . . . 0.0 109.178 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.016 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -107.07 -7.76 16.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.565 -0.709 . . . . 0.0 109.26 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 81.73 84.59 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.977 0 CA-C-O 121.269 0.556 . . . . 0.0 109.61 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 45.7 Cg_endo -74.58 150.4 40.3 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.536 1.808 . . . . 0.0 110.93 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.82 HG12 HD22 ' A' ' 28' ' ' ASN . 53.9 t -117.43 119.16 60.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.82 HD22 HG12 ' A' ' 27' ' ' VAL . 71.4 m-80 55.88 18.71 3.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.662 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.08 33.27 9.75 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 57.9 m-85 -137.73 137.25 38.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.854 -1.38 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.016 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.8 mt -108.5 138.22 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 33' ' ' GLY . 20.8 p -86.0 144.37 27.64 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.177 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.629 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -45.64 -24.93 1.29 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 32' ' ' SER . 4.4 m-20 -70.95 -19.1 62.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.532 -0.981 . . . . 0.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 5.6 mttp -97.17 -34.97 10.93 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 65' ' ' LEU . 98.0 t -77.35 -42.47 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.864 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -41.17 -53.98 6.17 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.576 -0.702 . . . . 0.0 110.729 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -68.39 -30.97 28.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.558 1.294 . . . . 0.0 110.078 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.511 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -66.38 -37.47 79.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.551 -0.718 . . . . 0.0 109.295 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.973 ' HB3' HD22 ' A' ' 50' ' ' LEU . 25.1 mt -83.01 -24.79 32.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.564 -0.71 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.11 -10.88 60.25 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.699 -0.801 . . . . 0.0 108.918 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -89.79 -7.12 55.12 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.523 -0.735 . . . . 0.0 110.224 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.572 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -78.07 7.82 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 0.0 110.284 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 65.91 10.78 7.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 109.358 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.053 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.1 mt -98.72 156.84 35.17 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.449 -0.782 . . . . 0.0 109.823 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.4 Cg_endo -75.98 172.1 16.9 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.121 1.59 . . . . 0.0 109.289 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG11 ' O ' ' B' ' 111' ' ' PHE . 1.5 t -71.72 -5.03 5.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.967 -1.083 . . . . 0.0 108.951 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.34 -29.01 59.83 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.873 HG21 HD13 ' A' ' 45' ' ' LEU . 8.5 mm -87.4 -37.74 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.973 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.8 mt -79.39 -28.28 41.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.16 -24.99 75.6 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.864 ' O ' HD12 ' A' ' 56' ' ' LEU . 6.7 ttm-85 -101.96 -33.78 9.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.109 -0.642 . . . . 0.0 110.014 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.991 HG11 HG23 ' A' ' 77' ' ' VAL . 8.7 t -70.9 -37.22 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.831 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.629 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.2 t-105 -63.64 -50.53 68.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.86 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.3 mt-10 -50.42 -55.1 17.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 109.925 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.864 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.51 -15.34 37.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 108.934 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.954 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.0 t -94.52 -41.47 9.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.537 -0.727 . . . . 0.0 109.513 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 5.5 t70 -75.92 95.02 3.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.617 -0.677 . . . . 0.0 110.72 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.494 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 3.7 mt -93.13 -16.2 7.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.13 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.7 m-20 -89.81 -5.04 57.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 109.552 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 34.5 p80 41.3 47.37 2.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.658 . . . . 0.0 110.941 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 28.3 p30 -129.05 26.4 5.49 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.218 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 59.37 42.12 97.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 2.6 mmt -149.35 161.22 42.49 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.318 -1.107 . . . . 0.0 111.514 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.04 HD12 HG21 ' A' ' 36' ' ' VAL . 43.3 mt -137.65 107.09 6.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.648 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 2.0 p30 -76.58 161.58 28.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 110.454 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -34.55 -46.89 0.3 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.735 -0.603 . . . . 0.0 111.584 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -78.01 -37.66 46.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.226 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 57' ' ' SER . 12.7 tt0 -66.91 -44.44 80.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.632 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.973 ' CD1' HD12 ' A' ' 31' ' ' LEU . 37.7 t80 -60.46 -21.89 62.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.656 -0.652 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.634 ' HB1' ' HG2' ' A' ' 14' ' ' LYS . . . -75.16 -37.98 61.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 109.813 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.927 ' CG1' HD11 ' A' ' 94' ' ' LEU . 38.0 t -66.46 -26.66 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.684 0.754 . . . . 0.0 109.733 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.954 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.39 -7.21 53.78 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 110.767 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.584 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.3 mmt -88.01 -47.45 8.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.922 -1.111 . . . . 0.0 110.256 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.47 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 2.2 p90 -75.98 -19.51 58.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.883 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.2 mt -74.27 -25.19 59.46 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.991 HG23 HG11 ' A' ' 53' ' ' VAL . 37.2 t -90.59 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.457 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.2 m-85 -45.53 -24.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.692 -0.63 . . . . 0.0 111.273 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' GLU . 8.7 m -82.8 -18.84 39.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.964 -1.085 . . . . 0.0 110.009 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.053 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.43 -11.88 50.63 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.709 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.3 mp -90.51 -40.14 12.17 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.787 0.804 . . . . 0.0 108.871 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 51.5 mm-40 -69.63 -54.45 13.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.558 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 177.82 -22.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.92 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -83.74 116.87 66.81 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.783 -1.198 . . . . 0.0 111.431 -178.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.69 -168.51 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.791 1.416 . . . . 0.0 110.095 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.732 HG13 HD22 ' A' ' 76' ' ' LEU . 48.9 t -134.85 124.11 16.46 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.052 -1.03 . . . . 0.0 111.274 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.8 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.1 Cg_endo -85.06 174.31 7.34 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.919 1.484 . . . . 0.0 109.514 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.803 ' C ' HD21 ' A' ' 56' ' ' LEU . 2.0 mtp -96.16 12.19 31.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 0.0 110.432 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.577 ' N ' HD21 ' A' ' 56' ' ' LEU . 15.1 m -109.34 102.9 11.77 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.881 -1.137 . . . . 0.0 110.779 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.887 ' CD1' HD12 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -63.48 109.24 2.35 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 37.6 Cg_endo -63.69 145.27 91.02 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.931 1.49 . . . . 0.0 111.819 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.08 -4.49 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.509 1.794 . . . . 0.0 110.884 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -94.05 -15.53 24.7 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.934 0.873 . . . . 0.0 108.653 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.962 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -98.2 -15.32 19.92 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.854 HG23 HD11 ' A' ' 90' ' ' LEU . 1.2 t -79.46 141.38 56.76 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.187 -0.946 . . . . 0.0 110.168 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 44.4 Cg_endo -71.74 171.95 15.44 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.11 1.584 . . . . 0.0 110.344 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 46.4 Cg_endo -73.65 0.39 8.24 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.94 1.495 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 p -90.93 -29.28 17.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.985 . . . . 0.0 109.843 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HD3' HG21 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -89.49 6.26 41.69 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.343 -0.848 . . . . 0.0 109.397 179.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 1.1 mtt180 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.316 -0.865 . . . . 0.0 110.52 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.42 ' C ' ' OG1' ' B' ' 108' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.177 0.513 . . . . 0.0 110.074 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.42 ' OG1' ' C ' ' B' ' 107' ' ' SER . 0.2 OUTLIER -162.41 169.78 19.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.5 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.455 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 25.1 t-20 -103.27 117.08 61.09 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 109.62 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.621 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.6 Cg_endo -74.17 7.59 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.866 1.456 . . . . 0.0 111.881 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.96 ' CE2' HD12 ' A' ' 40' ' ' LEU . 6.6 m-85 -107.14 -65.55 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.763 -1.21 . . . . 0.0 108.713 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.421 ' NH2' ' OE2' ' A' ' 55' ' ' GLU . 6.2 mtm180 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.289 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 N--CA 1.482 0.848 0 N-CA-C 109.927 -0.836 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.707 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.0 t90 -63.12 120.62 11.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 109.928 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.545 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.84 -26.16 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 43.9 t -101.19 151.03 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.237 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 31.5 mttt -111.67 169.37 6.4 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.324 -0.86 . . . . 0.0 109.792 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 37.5 Cg_endo -63.86 -35.26 57.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.616 1.324 . . . . 0.0 110.119 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -69.46 -30.03 67.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.387 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -82.35 -39.27 23.02 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.659 ' HZ2' ' HH2' ' A' ' 7' ' ' TRP . 14.8 tptm -72.28 -15.72 61.91 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.14 -39.65 54.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -80.03 -25.64 40.1 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.0 m-30 -72.27 -35.19 68.68 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.39 -20.23 62.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.837 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -81.89 -38.31 25.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.647 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 68.6 mt -76.2 -29.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.887 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.9 -36.68 67.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.514 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.5 t70 -90.45 0.86 57.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.728 -0.607 . . . . 0.0 110.186 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 34.0 t -88.77 -8.0 55.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.137 -0.977 . . . . 0.0 109.148 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.084 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.2 mt -106.76 -10.94 15.92 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.6 p 86.55 97.24 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.3 Cg_endo -74.02 149.69 42.09 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.214 1.639 . . . . 0.0 111.0 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 62.1 t -124.7 108.34 20.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 62.44 15.67 7.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.241 -179.035 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . 92.51 38.04 5.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 81.5 m-85 -148.52 144.59 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 111.976 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.084 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.6 mt -112.14 131.13 55.63 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 33' ' ' GLY . 1.6 m -80.23 147.04 31.4 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.582 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -44.94 -27.96 1.62 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' N ' ' C ' ' A' ' 32' ' ' SER . 48.3 t0 -59.57 -25.37 64.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.89 . . . . 0.0 109.866 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 47.9 mttp -98.26 -36.42 10.03 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.876 HG12 ' CD1' ' A' ' 40' ' ' LEU . 95.1 t -77.17 -40.3 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.667 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' CG ' HD11 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -44.81 -50.51 24.97 Favored Pre-proline 0 N--CA 1.487 1.375 0 O-C-N 121.268 -0.895 . . . . 0.0 111.033 -178.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.2 Cg_endo -68.24 -33.25 24.83 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.089 1.047 . . . . 0.0 109.677 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.619 HG21 ' HZ ' ' A' ' 70' ' ' PHE . 2.1 t -64.7 -35.94 76.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.612 -0.68 . . . . 0.0 109.705 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.039 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.8 mt -90.03 -30.67 17.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 110.341 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD11 ' CG ' ' A' ' 37' ' ' LYS . 53.8 mt -70.78 -10.69 60.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.874 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 1.2 t-20 -90.59 -9.94 45.21 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.444 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.559 ' HB2' HD11 ' A' ' 81' ' ' LEU . 83.5 p -80.58 11.25 3.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.871 . . . . 0.0 110.588 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.04 11.21 4.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.944 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.125 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.3 mt -90.92 156.0 44.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.813 . . . . 0.0 109.663 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -76.62 169.28 22.11 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 O-C-N 123.907 1.478 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.561 HG13 ' CA ' ' B' ' 111' ' ' PHE . 42.1 t -70.6 -3.42 3.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.74 -32.97 35.46 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.327 -0.858 . . . . 0.0 108.823 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.793 HG21 HD13 ' A' ' 45' ' ' LEU . 14.3 mm -80.65 -42.42 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.039 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.3 mt -63.65 -32.03 73.38 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.075 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.569 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -72.25 -17.84 77.72 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.826 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.34 -31.28 11.41 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.843 -0.798 . . . . 0.0 110.138 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.91 HG11 HG23 ' A' ' 77' ' ' VAL . 32.3 t -75.87 -34.65 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.696 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.583 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 3.1 t-105 -70.82 -47.65 58.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.599 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' B' ' 109' ' ' ASN . 23.5 mm-40 -58.17 -57.25 13.69 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.019 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.8 mt -60.46 -16.53 37.34 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.354 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.758 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.1 t -89.9 -34.52 16.04 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.661 0.743 . . . . 0.0 109.387 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.567 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -74.83 69.82 1.87 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.623 -0.673 . . . . 0.0 109.578 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.51 HG12 ' HG2' ' A' ' 69' ' ' GLU . 42.2 mm -41.33 -32.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.493 -0.754 . . . . 0.0 110.406 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 3.0 p30 -108.38 -25.91 10.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 17.7 m-70 71.09 41.19 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.8 p-10 -90.69 -1.69 57.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 98.16 19.95 22.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.583 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtp -153.18 161.77 42.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -1.187 . . . . 0.0 110.341 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.76 HD12 HG21 ' A' ' 36' ' ' VAL . 31.8 mt -118.73 107.79 14.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.099 -1.001 . . . . 0.0 110.662 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -71.76 165.07 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.04 . . . . 0.0 109.826 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -40.18 -43.53 1.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -78.44 -33.31 48.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.75 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 59' ' ' ILE . 53.2 mt-10 -74.89 -42.95 56.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.45 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.95 ' CD2' HD12 ' A' ' 31' ' ' LEU . 36.7 t80 -63.12 -16.48 60.14 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -78.97 -44.36 22.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.008 HG13 HD21 ' A' ' 94' ' ' LEU . 42.4 t -61.73 -26.42 39.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.708 0.766 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.758 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.55 -7.84 54.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.76 . . . . 0.0 111.187 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.576 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 4.5 mmt -84.95 -48.11 9.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.924 -1.11 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 3.6 p90 -75.33 -21.25 58.55 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.6 mt -76.37 -19.41 58.2 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.91 HG23 HG11 ' A' ' 53' ' ' VAL . 32.8 t -91.96 -41.86 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.569 -0.707 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 5.3 m-85 -72.01 -22.54 61.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.837 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -81.58 -15.26 55.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.979 -1.075 . . . . 0.0 109.24 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.125 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.94 -10.89 46.09 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.459 -0.775 . . . . 0.0 109.077 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.9 mt -90.64 -43.13 10.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.787 . . . . 0.0 109.812 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 6.7 mm-40 -70.04 -53.33 18.0 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.834 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 177.76 -25.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.412 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 3.8 tm-20 -60.32 122.07 64.47 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.049 -1.032 . . . . 0.0 111.009 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -74.79 157.16 43.82 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.877 1.462 . . . . 0.0 109.652 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 52' ' ' ARG . 89.7 t -112.64 121.58 38.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.926 -1.109 . . . . 0.0 110.893 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.751 ' O ' HD11 ' A' ' 56' ' ' LEU . 45.2 Cg_endo -90.13 -174.4 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.973 1.512 . . . . 0.0 109.289 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.823 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.76 10.29 13.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.073 -1.017 . . . . 0.0 110.295 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.538 ' N ' HD21 ' A' ' 56' ' ' LEU . 38.8 m -104.13 104.11 14.0 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.246 -0.981 . . . . 0.0 111.66 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.592 HD23 HD12 ' A' ' 94' ' ' LEU . 1.7 mt -53.09 106.63 0.69 Allowed Pre-proline 0 C--N 1.294 -1.825 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.803 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.959 ' O ' HG23 ' A' ' 95' ' ' VAL . 40.8 Cg_endo -70.8 148.24 57.89 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.895 1.471 . . . . 0.0 110.689 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.2 -3.74 13.53 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.248 1.657 . . . . 0.0 111.196 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -92.17 -26.37 18.26 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.312 -0.868 . . . . 0.0 109.336 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.008 HD21 HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -100.49 -18.09 16.84 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.788 0.804 . . . . 0.0 109.233 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.959 HG23 ' O ' ' A' ' 91' ' ' PRO . 88.3 t -68.5 138.2 91.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.947 -1.095 . . . . 0.0 110.689 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.73 166.18 30.4 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.123 1.591 . . . . 0.0 110.121 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.28 -14.25 25.54 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.008 1.531 . . . . 0.0 110.316 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -16.89 64.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.891 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.03 3.46 55.21 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 48.3 mtt-85 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 110.484 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.221 0.534 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 11.5 t -114.38 -10.95 12.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.312 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.493 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 1.9 t-20 -135.41 105.45 10.11 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 109.717 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.4 Cg_endo -71.49 -2.44 11.3 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.916 1.482 . . . . 0.0 111.028 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 1.005 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.16 -62.51 1.58 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.867 -1.146 . . . . 0.0 108.849 177.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 111' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.981 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.482 0.816 0 N-CA-C 110.456 -0.632 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.3 t90 -59.79 129.81 43.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.282 -0.886 . . . . 0.0 109.84 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.884 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -35.72 -31.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.648 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 99.5 t -97.9 130.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -86.62 -179.13 1.29 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.729 -178.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 43.1 Cg_endo -70.81 -36.3 8.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.014 1.534 . . . . 0.0 110.058 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.27 -22.78 57.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 51.6 m-20 -81.41 -36.94 28.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.062 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -73.78 -16.76 61.15 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.318 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -40.83 38.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.541 -0.724 . . . . 0.0 109.303 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.08 -26.69 60.52 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 11.8 m-30 -74.65 -32.06 62.14 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.07 -18.24 61.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.504 -0.748 . . . . 0.0 109.868 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -82.54 -36.67 26.11 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.561 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 12.3 mt -78.01 -28.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.36 -38.29 56.02 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.8 t70 -90.26 3.89 52.26 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.704 -0.623 . . . . 0.0 109.792 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -93.23 -3.48 53.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 108.631 178.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.022 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -114.24 -3.42 13.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.1 m 79.83 95.45 0.04 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 Cg_endo -71.37 152.33 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.308 1.688 . . . . 0.0 110.76 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 94.1 t -120.1 97.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 109.106 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.537 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 68.68 10.58 7.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.2 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 104.73 34.13 3.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 76.6 m-85 -150.89 149.88 30.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.468 -1.019 . . . . 0.0 111.886 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.022 ' CD1' HD12 ' A' ' 24' ' ' LEU . 18.1 mt -118.07 134.38 55.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -78.45 144.32 35.91 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.886 -1.125 . . . . 0.0 109.436 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -42.72 -28.33 0.64 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.0 m-20 -54.46 -25.14 23.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.44 -1.036 . . . . 0.0 109.506 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 1.1 mttp -104.38 -32.66 8.94 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.408 -0.807 . . . . 0.0 108.83 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.061 HG11 HD12 ' A' ' 65' ' ' LEU . 87.6 t -84.54 -44.76 17.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.683 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 15.4 tttt -43.99 -53.56 12.98 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 0.0 110.924 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.4 Cg_endo -67.19 -33.74 30.1 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.33 1.174 . . . . 0.0 109.467 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.1 t -63.38 -34.74 69.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.457 0.646 . . . . 0.0 109.389 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.011 HD12 ' CE2' ' B' ' 111' ' ' PHE . 49.7 mt -85.92 -27.32 25.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 58.0 mt -74.94 -10.89 59.92 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.225 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -89.56 -5.1 57.52 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.094 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.545 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.93 12.87 6.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.476 -0.765 . . . . 0.0 110.382 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 61.3 13.29 4.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.11 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.891 HD22 HG13 ' A' ' 49' ' ' ILE . 14.7 mt -97.91 154.53 37.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.663 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.61 172.34 16.4 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.071 1.564 . . . . 0.0 110.067 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -70.85 -6.04 6.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 109.072 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.63 -30.62 56.95 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.891 HG13 HD22 ' A' ' 45' ' ' LEU . 7.1 mm -88.02 -38.06 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.005 HD22 ' HB3' ' A' ' 40' ' ' LEU . 17.8 mt -77.17 -26.31 52.84 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.1 -27.38 72.09 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.652 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -101.47 -30.15 11.59 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 122.105 -0.644 . . . . 0.0 109.901 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.041 HG11 HG23 ' A' ' 77' ' ' VAL . 22.3 t -71.25 -39.85 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.707 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CB ' ' CE1' ' B' ' 111' ' ' PHE . 1.9 t-105 -64.27 -51.0 65.71 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.651 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.9 mm-40 -53.05 -57.54 10.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.322 -0.861 . . . . 0.0 109.847 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 90' ' ' LEU . 13.8 mt -56.82 -21.07 26.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 108.94 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.863 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 69.7 m -89.48 -36.13 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 31.5 t0 -83.69 61.92 6.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.636 -0.665 . . . . 0.0 110.196 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.791 HG23 ' HD2' ' A' ' 99' ' ' LYS . 26.8 mt -59.5 -19.01 15.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.334 -0.853 . . . . 0.0 110.37 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 13.6 m-20 -91.74 -21.14 20.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.938 . . . . 0.0 109.637 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 2.2 m-70 61.27 33.74 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 110.745 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.43 -2.48 48.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.05 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 91.07 25.3 24.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 4.1 mtp -153.55 161.49 42.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.138 -1.213 . . . . 0.0 110.556 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.061 HD12 HG11 ' A' ' 36' ' ' VAL . 15.3 mt -117.84 110.84 18.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.324 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -70.99 172.39 9.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 110.562 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.556 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 3.5 ptp180 -51.15 -41.37 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.555 -0.715 . . . . 0.0 110.895 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.77 -36.31 37.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 57' ' ' SER . 45.8 mt-10 -72.13 -48.73 41.5 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.958 ' CD2' HD12 ' A' ' 31' ' ' LEU . 14.2 t80 -56.0 -26.27 47.91 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.64 56.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 110.116 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.618 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 58.5 t -57.63 -22.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.744 . . . . 0.0 109.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.863 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.35 -5.34 56.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 111.425 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 3.5 mmm -89.98 -40.54 12.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.606 -1.309 . . . . 0.0 110.309 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.002 ' CZ ' HD12 ' A' ' 94' ' ' LEU . 2.1 p90 -81.99 -22.77 36.38 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.848 -1.141 . . . . 0.0 108.339 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.703 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 4.4 mt -76.11 -23.33 54.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.041 HG23 HG11 ' A' ' 53' ' ' VAL . 16.4 t -91.55 -47.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.533 -0.729 . . . . 0.0 109.722 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.676 ' HA ' HD23 ' A' ' 81' ' ' LEU . 2.4 m-85 -70.38 -35.29 73.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 110.417 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 75' ' ' PHE . 3.9 t -83.59 -8.6 59.28 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 49' ' ' ILE . . . -92.18 -29.27 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.131 0.967 . . . . 0.0 109.208 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 78' ' ' TYR . 0.5 OUTLIER -90.94 -24.71 20.08 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.759 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -72.45 -58.11 3.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 110.137 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.48 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -179.42 59.74 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.39 -0.819 . . . . 0.0 110.669 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -165.58 138.99 3.64 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 120.984 -1.072 . . . . 0.0 110.665 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 52.3 Cg_endo -79.84 170.46 16.75 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.898 1.473 . . . . 0.0 110.283 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 87' ' ' PRO . 39.1 t -114.15 154.06 46.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 108.996 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.756 ' HD2' HG13 ' A' ' 86' ' ' VAL . 43.3 Cg_endo -86.13 -167.63 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.525 1.276 . . . . 0.0 109.877 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 mtt -122.25 11.12 10.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.02 -1.05 . . . . 0.0 111.541 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -168.0 23.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.677 -1.264 . . . . 0.0 111.609 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.71 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER 56.34 122.26 0.01 OUTLIER Pre-proline 0 C--N 1.282 -2.354 0 O-C-N 121.941 -0.474 . . . . 0.0 111.666 178.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.639 ' HG2' HD23 ' A' ' 94' ' ' LEU . 41.0 Cg_endo -69.08 175.72 7.18 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.922 1.485 . . . . 0.0 109.807 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 44.7 Cg_endo -71.07 -22.32 26.32 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.657 1.346 . . . . 0.0 112.656 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.645 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -92.1 -4.27 54.57 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.569 -1.332 . . . . 0.0 110.813 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.002 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -107.78 11.76 27.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.1 -1.0 . . . . 0.0 110.194 -178.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 99' ' ' LYS . 8.2 t -121.6 142.43 35.74 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.981 . . . . 0.0 110.043 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 100' ' ' ARG . 44.1 Cg_endo -71.52 173.74 12.01 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.923 1.486 . . . . 0.0 110.163 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HA ' ' CD ' ' A' ' 100' ' ' ARG . 46.6 Cg_endo -71.55 -0.96 9.04 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.097 1.577 . . . . 0.0 111.175 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.9 p -84.77 -29.72 25.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.914 -1.116 . . . . 0.0 109.7 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.791 ' HD2' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -97.62 15.78 22.42 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.461 -0.775 . . . . 0.0 109.007 179.079 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' CD ' ' HA ' ' A' ' 97' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 111.213 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.254 0.549 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.06 148.92 51.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.402 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' B' ' 110' ' ' PRO . 6.7 t-20 60.01 92.04 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 110.176 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.513 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 46.0 Cg_endo -69.22 8.93 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.902 1.735 . . . . 0.0 112.344 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 1.011 ' CE2' HD12 ' A' ' 40' ' ' LEU . 13.5 m-85 -99.31 -49.74 4.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.505 -1.372 . . . . 0.0 110.211 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.939 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.482 0.832 0 N-CA-C 110.198 -0.731 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.562 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.7 t90 -70.17 125.75 27.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.061 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -42.22 -27.61 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 109.741 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 10.0 t -95.56 130.79 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.429 -0.794 . . . . 0.0 109.327 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -88.77 172.4 7.6 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.102 -0.999 . . . . 0.0 110.335 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -34.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.988 1.52 . . . . 0.0 109.946 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -78.33 -28.85 47.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.291 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.505 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 9.1 m-20 -81.05 -33.86 33.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.61 -17.92 57.31 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.515 -0.741 . . . . 0.0 109.177 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -37.48 61.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -76.91 -23.16 52.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 12.3 m-30 -77.55 -34.75 53.71 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.73 -20.2 62.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.893 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.04 33.4 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' CE1' ' A' ' 70' ' ' PHE . 73.5 mt -79.23 -30.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.725 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.79 -36.12 67.52 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 t70 -91.21 -3.23 57.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.447 -0.783 . . . . 0.0 110.034 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.9 t -82.17 -14.67 55.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 108.765 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.079 HD12 HD13 ' A' ' 31' ' ' LEU . 8.4 mt -94.09 -53.8 3.83 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.644 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.2 m 140.87 97.18 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -74.11 150.4 42.74 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 O-C-N 123.97 1.51 . . . . 0.0 110.643 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 84.4 t -119.8 84.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.316 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 72.73 3.96 4.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.563 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 123.31 29.46 1.2 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -149.89 151.76 33.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.277 . . . . 0.0 112.326 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.079 HD13 HD12 ' A' ' 24' ' ' LEU . 9.4 mt -120.47 154.16 35.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -98.14 141.49 31.0 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 120.754 -1.217 . . . . 0.0 109.715 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.615 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.79 -27.89 0.2 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.7 m-20 -67.63 -24.78 65.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.424 -1.045 . . . . 0.0 110.481 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 66.6 mttm -90.24 -36.75 14.55 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.916 HG12 ' CD1' ' A' ' 40' ' ' LEU . 93.3 t -72.76 -39.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.252 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -42.8 -54.95 7.94 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 111.264 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.7 Cg_endo -65.69 -30.64 50.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.699 1.368 . . . . 0.0 110.005 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.82 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.5 t -69.01 -28.71 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.51 -0.744 . . . . 0.0 109.064 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.956 ' HB3' HD22 ' A' ' 50' ' ' LEU . 27.1 mt -94.78 -31.49 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.401 -0.812 . . . . 0.0 110.176 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 37' ' ' LYS . 23.0 mt -70.3 -9.93 57.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 27.2 p-10 -90.9 -7.69 51.46 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.993 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.579 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 p -81.4 14.13 2.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.716 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.81 10.71 5.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.027 HD13 HG21 ' A' ' 49' ' ' ILE . 14.3 mt -98.22 157.9 33.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.926 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.66 170.42 20.26 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.063 1.559 . . . . 0.0 109.569 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.56 HG13 ' C ' ' B' ' 111' ' ' PHE . 2.0 t -71.3 -3.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.125 -0.985 . . . . 0.0 109.37 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -78.14 -32.17 50.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.027 HG21 HD13 ' A' ' 45' ' ' LEU . 9.6 mm -81.67 -40.81 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.956 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -71.09 -30.79 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.68 -24.97 74.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.789 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -100.68 -35.06 9.61 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.906 -0.761 . . . . 0.0 109.868 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.09 HG11 ' CG2' ' A' ' 77' ' ' VAL . 23.8 t -65.87 -34.39 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.829 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.615 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.07 -55.03 10.53 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.43 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 1.7 mt-10 -48.0 -57.1 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.09 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.6 mt -63.32 -14.62 51.79 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.938 . . . . 0.0 108.96 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.905 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 11.0 t -93.09 -35.14 13.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 22.5 t0 -74.84 99.94 3.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.718 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.537 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 14.6 mm -86.91 -23.82 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.24 -12.83 31.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 2.6 m170 55.61 47.66 20.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -0.944 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -125.64 17.64 8.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.923 -1.111 . . . . 0.0 110.197 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 74.07 32.99 57.88 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 21.6 mtp -150.76 161.33 42.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -1.229 . . . . 0.0 111.071 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.771 HD12 HG21 ' A' ' 36' ' ' VAL . 19.6 mt -133.15 107.31 8.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.544 -0.723 . . . . 0.0 109.432 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.636 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 32.9 p30 -78.73 175.13 10.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.75 -1.219 . . . . 0.0 110.378 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -41.46 -50.62 3.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 112.17 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.769 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 5.1 p-10 -72.55 -46.82 52.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.151 -0.968 . . . . 0.0 110.444 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.537 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 52.2 mt-10 -62.02 -54.67 38.25 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.533 -0.73 . . . . 0.0 109.229 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.994 ' CD2' HD12 ' A' ' 31' ' ' LEU . 12.2 t80 -49.83 -30.0 9.02 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -61.45 -55.54 30.15 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.79 0.805 . . . . 0.0 110.005 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.005 ' CG1' HD11 ' A' ' 94' ' ' LEU . 92.0 t -51.07 -28.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.488 0.661 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.905 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -86.98 -6.87 58.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 0.0 112.411 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.59 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 9.1 mmm -90.37 -43.36 10.37 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.268 -1.52 . . . . 0.0 110.569 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.753 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 2.2 p90 -76.05 -22.3 55.85 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.156 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 86' ' ' VAL . 6.3 mt -72.61 -30.1 64.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.09 ' CG2' HG11 ' A' ' 53' ' ' VAL . 37.5 t -91.07 -21.79 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.742 -0.599 . . . . 0.0 110.106 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.16 -27.69 21.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.543 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 5.4 m -83.48 -14.44 52.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -0.789 . . . . 0.0 109.418 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.683 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.66 -12.59 57.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' A' ' 45' ' ' LEU . 8.3 mt -91.34 -47.05 7.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.734 -0.604 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.7 32.97 5.19 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.453 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -151.09 -89.54 0.06 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.653 -1.28 . . . . 0.0 111.261 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.557 ' CG ' ' HD2' ' A' ' 85' ' ' PRO . 7.5 tt0 -140.87 153.51 67.61 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.303 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.557 ' HD2' ' CG ' ' A' ' 84' ' ' GLU . 36.9 Cg_endo -60.93 -162.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.575 1.302 . . . . 0.0 109.972 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.538 HG13 HD22 ' A' ' 76' ' ' LEU . 90.4 t -127.79 119.2 21.27 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.85 -1.157 . . . . 0.0 111.51 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.756 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.8 Cg_endo -81.67 154.5 17.95 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.978 1.515 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.524 ' HG3' ' CG ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -85.04 18.06 2.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.607 -1.308 . . . . 0.0 110.582 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.522 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.7 m -109.01 102.95 11.9 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.035 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.633 HD22 ' CG1' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -60.77 107.28 1.0 Allowed Pre-proline 0 C--N 1.291 -1.966 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.654 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.762 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.4 Cg_endo -65.49 149.51 87.73 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.873 1.459 . . . . 0.0 110.482 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -75.5 -10.38 20.39 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.226 1.645 . . . . 0.0 111.689 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -92.87 20.26 6.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 109.446 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.005 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -144.21 7.18 1.35 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.989 -178.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.633 ' CG1' HD22 ' A' ' 90' ' ' LEU . 11.2 m -109.48 152.29 42.66 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.016 -1.052 . . . . 0.0 111.293 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 41.7 Cg_endo -69.83 176.13 7.23 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.451 1.764 . . . . 0.0 110.099 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 42.4 Cg_endo -69.22 -17.08 40.2 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.674 1.355 . . . . 0.0 110.467 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.95 -16.68 61.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 109.367 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -90.37 2.17 55.85 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.456 -0.777 . . . . 0.0 109.715 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.56 ' HG3' ' HA ' ' A' ' 97' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.346 -0.847 . . . . 0.0 109.999 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.303 0.573 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 48.0 p -87.79 83.0 7.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 110.31 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' CA ' ' A' ' 51' ' ' GLY . 5.9 t-20 -125.69 104.38 27.46 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.964 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.611 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -73.78 11.56 1.09 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.243 1.654 . . . . 0.0 112.386 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.914 ' CE2' HD12 ' A' ' 40' ' ' LEU . 2.7 m-85 -110.73 -73.58 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.54 -1.35 . . . . 0.0 108.405 178.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.412 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.483 0.875 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.575 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.5 t90 -73.48 124.53 26.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 109.831 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -39.55 -29.25 0.05 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.747 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.575 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 29.5 t -88.62 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.309 -0.87 . . . . 0.0 109.349 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.562 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.85 174.35 4.62 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.101 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.3 Cg_endo -70.59 -33.72 12.98 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.921 1.485 . . . . 0.0 109.584 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.13 -19.97 58.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.2 m-20 -85.33 -43.87 13.32 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.05 -20.56 66.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.69 . . . . 0.0 109.161 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.56 49.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.51 -24.58 45.71 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -73.69 -36.02 65.24 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.42 -20.82 60.64 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.919 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -82.82 -36.86 25.16 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.645 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 19.6 mt -76.04 -31.57 21.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -67.77 -38.27 83.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 15.4 t70 -91.29 -3.79 56.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.793 -0.567 . . . . 0.0 110.097 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -78.63 -15.6 58.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 108.92 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.1 HD12 ' CD1' ' A' ' 31' ' ' LEU . 11.9 mt -96.14 -52.44 4.02 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.668 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.2 t 136.51 99.05 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.0 Cg_endo -72.47 145.23 42.12 Favored 'Trans proline' 0 C--N 1.297 -2.18 0 O-C-N 124.184 1.623 . . . . 0.0 111.01 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 10.7 t -118.07 111.46 34.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.534 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 48.15 23.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.382 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.14 34.52 5.61 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 78.9 m-85 -150.99 146.67 26.38 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.183 -1.186 . . . . 0.0 112.397 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.1 ' CD1' HD12 ' A' ' 24' ' ' LEU . 7.7 mt -111.73 148.85 32.58 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.486 ' OG ' ' HE2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -91.04 142.92 27.25 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.735 -1.228 . . . . 0.0 110.3 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.52 -25.37 0.81 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.5 m-20 -71.99 -21.88 61.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.967 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 29.2 mttm -93.12 -36.23 12.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.882 HG11 HD12 ' A' ' 65' ' ' LEU . 64.1 t -79.01 -43.86 24.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.564 0.697 . . . . 0.0 109.863 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 15.7 tttt -41.01 -51.73 7.27 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.0 Cg_endo -67.61 -32.42 30.99 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.314 1.165 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -66.34 -31.91 55.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.561 -0.712 . . . . 0.0 109.089 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.951 ' HB3' HD22 ' A' ' 50' ' ' LEU . 33.9 mt -90.0 -29.85 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.355 -0.84 . . . . 0.0 110.075 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 37' ' ' LYS . 58.8 mt -69.32 -15.36 63.31 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -90.72 -3.72 57.26 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.723 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.582 ' O ' HD21 ' A' ' 81' ' ' LEU . 83.8 p -81.37 12.56 3.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.816 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 2.9 ttmt 62.55 9.67 3.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.05 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.7 mt -100.55 153.22 37.86 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.6 Cg_endo -74.12 172.28 16.29 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.913 1.481 . . . . 0.0 109.734 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -70.2 -5.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.094 -1.004 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -78.11 -31.1 49.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 108.968 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.837 HG13 HD22 ' A' ' 45' ' ' LEU . 7.6 mm -85.17 -43.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.951 HD22 ' HB3' ' A' ' 40' ' ' LEU . 17.2 mt -70.24 -28.89 65.61 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.91 -25.99 74.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 1.013 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.8 ttm-85 -100.9 -31.06 11.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.876 -0.779 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.045 HG11 HG23 ' A' ' 77' ' ' VAL . 7.4 t -69.82 -35.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.681 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.611 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.1 t-105 -69.08 -52.28 30.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.267 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 19.9 mm-40 -52.82 -54.27 36.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 110.111 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.013 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.6 mt -63.2 -13.26 35.37 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 108.612 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.651 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.9 m -96.18 -41.02 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.67 . . . . 0.0 110.601 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.58 ' OD1' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -69.54 82.3 0.41 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.239 -0.913 . . . . 0.0 110.615 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.529 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 33.4 mm -58.25 -21.7 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.144 -0.972 . . . . 0.0 108.939 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 1.9 m-20 -103.68 -9.91 18.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 0.0 109.818 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 29.8 p80 38.73 48.89 1.4 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.689 -0.632 . . . . 0.0 110.719 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 22.3 p-10 -117.01 12.26 14.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.325 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 88.11 28.76 22.15 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 9.8 mtt -150.75 161.59 42.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -1.21 . . . . 0.0 111.391 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.882 HD12 HG11 ' A' ' 36' ' ' VAL . 15.4 mt -135.73 110.41 8.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 1.1 t70 -72.94 172.64 10.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.514 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 4.2 ptm180 -51.24 -42.4 61.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 110.276 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 26.3 t0 -79.62 -35.2 39.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 7.9 tt0 -69.83 -52.38 25.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.723 0.773 . . . . 0.0 108.994 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.955 ' CD2' HD12 ' A' ' 31' ' ' LEU . 24.9 t80 -53.18 -26.59 17.79 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -63.94 -52.28 60.48 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.639 0.733 . . . . 0.0 109.917 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.002 HG13 HD11 ' A' ' 94' ' ' LEU . 89.9 t -54.22 -24.0 10.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.4 -7.71 54.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.293 -0.879 . . . . 0.0 112.129 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 mmm -90.22 -41.76 11.4 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.388 -1.445 . . . . 0.0 110.283 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.9 ' CE2' HD13 ' A' ' 94' ' ' LEU . 2.5 p90 -78.44 -19.42 53.2 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.355 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 HG13 ' A' ' 86' ' ' VAL . 6.9 mt -76.08 -26.15 56.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.045 HG23 HG11 ' A' ' 53' ' ' VAL . 20.7 t -91.36 -57.23 4.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.68 -0.637 . . . . 0.0 109.557 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.416 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 1.7 m-85 -53.15 -20.26 3.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.361 -0.837 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 7.8 m -83.96 -16.7 43.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.089 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.05 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.01 -11.52 44.0 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.203 -0.935 . . . . 0.0 109.383 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.582 HD21 ' O ' ' A' ' 43' ' ' SER . 6.3 mp -89.92 -39.54 12.95 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.663 0.744 . . . . 0.0 109.387 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 2.8 mt-10 -72.94 -52.45 14.53 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.768 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 177.22 -25.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.527 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -72.37 112.5 15.05 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.03 . . . . 0.0 111.185 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 43.6 Cg_endo -70.66 164.68 34.56 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.791 1.416 . . . . 0.0 109.935 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.591 HG11 HG23 ' A' ' 53' ' ' VAL . 20.7 t -112.56 119.81 42.54 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.074 -1.016 . . . . 0.0 110.584 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.9 Cg_endo -84.62 -162.44 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 109.448 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.814 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -117.09 0.23 12.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 46.5 m -108.11 102.7 11.83 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.434 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.688 HD11 ' HB ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -66.79 108.63 2.55 Favored Pre-proline 0 C--N 1.287 -2.127 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.868 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.0 Cg_endo -64.46 151.15 86.64 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.803 1.423 . . . . 0.0 111.04 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HA ' HG12 ' A' ' 95' ' ' VAL . 41.9 Cg_endo -68.63 -5.49 15.45 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.187 1.625 . . . . 0.0 111.09 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.19 -1.72 41.7 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 109.17 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.002 HD11 HG13 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -147.25 36.57 0.91 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.683 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.688 ' HB ' HD11 ' A' ' 90' ' ' LEU . 9.8 p -131.03 138.81 33.8 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 110.818 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.05 165.79 31.79 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.074 1.565 . . . . 0.0 110.212 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 98' ' ' SER . 43.3 Cg_endo -70.48 -174.81 1.13 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.295 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 1.3 m 78.09 -41.21 0.32 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.579 -0.7 . . . . 0.0 110.214 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.23 5.69 40.39 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.961 -1.087 . . . . 0.0 108.637 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 109.716 179.548 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.245 0.545 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' B' ' 109' ' ' ASN . 8.9 m -79.23 106.38 11.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.253 -0.904 . . . . 0.0 110.312 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.496 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 15.1 t-20 60.65 108.08 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.591 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 48.2 Cg_endo -71.4 3.14 3.79 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.039 1.547 . . . . 0.0 111.573 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.95 ' CE2' HD12 ' A' ' 40' ' ' LEU . 8.4 m-85 -100.1 -45.83 5.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.862 -1.149 . . . . 0.0 109.561 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.219 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.933 0 N-CA-C 110.328 -0.682 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 15.6 t90 -51.61 124.62 12.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.91 ' HB3' HD12 ' A' ' 94' ' ' LEU . . . -39.88 -27.66 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 110.277 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 13' ' ' ASP . 88.4 t -107.29 138.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.558 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -90.26 -178.03 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.895 . . . . 0.0 110.089 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.8 Cg_endo -71.16 -36.23 7.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.791 1.416 . . . . 0.0 109.814 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.59 -24.51 60.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.992 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB3' HG13 ' A' ' 9' ' ' VAL . 2.8 m-20 -83.26 -40.26 19.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.336 -0.853 . . . . 0.0 109.015 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -74.62 -21.56 59.39 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.12 71.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.506 -0.747 . . . . 0.0 109.248 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -78.19 -29.34 48.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 12.4 m-30 -71.09 -37.71 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 29.1 t0 -69.61 -18.06 63.58 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.818 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.0 -36.67 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.676 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 mt -78.38 -34.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.783 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -67.85 -36.83 81.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.557 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.5 t70 -87.5 -3.08 59.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.738 -0.601 . . . . 0.0 110.122 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 -8.02 58.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 109.409 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.105 HD12 ' CD1' ' A' ' 31' ' ' LEU . 7.2 mt -102.17 -15.61 16.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m 87.99 88.94 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.0 Cg_endo -75.94 150.78 34.65 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.563 1.823 . . . . 0.0 110.495 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 41.8 t -116.12 110.47 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.8 OUTLIER 65.42 13.79 9.05 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -177.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 93.58 32.55 7.62 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 26.3 m-85 -138.03 136.12 36.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.285 . . . . 0.0 112.358 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.105 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.3 mt -107.06 151.0 25.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' ASP . 15.9 p -100.58 147.78 25.55 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.989 -1.069 . . . . 0.0 109.774 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.48 -25.05 0.73 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . 46.7 m-20 -67.5 -22.34 65.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.458 -1.025 . . . . 0.0 110.672 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 24' ' ' LEU . 2.9 mtpp -101.63 -34.72 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.914 -1.116 . . . . 0.0 108.398 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.888 HG11 HD12 ' A' ' 65' ' ' LEU . 92.3 t -78.18 -36.09 20.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.499 0.666 . . . . 0.0 109.692 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.663 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 1.8 tttp -44.78 -53.84 14.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 110.706 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.52 -30.34 29.17 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.566 1.298 . . . . 0.0 110.144 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.756 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 3.5 t -64.92 -28.43 44.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.369 0.604 . . . . 0.0 109.799 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.984 HD12 ' CE2' ' B' ' 111' ' ' PHE . 21.3 mt -94.52 -30.45 14.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 ' HG3' ' A' ' 37' ' ' LYS . 56.6 mt -69.26 -10.01 55.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 108.591 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -87.92 -6.25 58.15 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.241 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.631 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -84.96 18.3 2.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 110.242 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.45 19.33 1.62 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.644 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.067 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.5 mt -100.51 155.3 36.53 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 109.9 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.2 Cg_endo -75.11 162.48 36.78 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.019 1.536 . . . . 0.0 109.442 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.68 HG12 ' OXT' ' B' ' 112' ' ' ARG . 9.1 t -67.25 -6.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.948 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -74.86 -31.24 61.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.794 HG13 HD22 ' A' ' 45' ' ' LEU . 7.3 mm -81.45 -43.12 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.847 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.5 mt -68.68 -32.54 72.44 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.465 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.576 ' HA2' ' OD1' ' B' ' 109' ' ' ASN . . . -68.25 -23.88 74.82 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.817 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.9 ttm180 -101.67 -32.42 10.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.07 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.942 HG11 HG23 ' A' ' 77' ' ' VAL . 7.6 t -70.43 -40.23 77.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.124 -1.031 . . . . 0.0 108.574 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.581 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.6 t-105 -63.66 -50.86 67.62 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.76 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.495 ' HG3' ' ND2' ' B' ' 109' ' ' ASN . 13.0 mt-10 -47.22 -56.87 5.89 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.904 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 52' ' ' ARG . 1.7 mt -64.54 -13.25 51.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.99 . . . . 0.0 108.919 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.942 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -88.48 -40.78 13.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.8 t0 -80.04 95.25 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.312 0.577 . . . . 0.0 110.221 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.32 -13.09 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.928 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.469 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 11.7 m-20 -99.67 -13.13 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.179 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 6.8 m-70 55.57 47.47 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.494 -0.754 . . . . 0.0 110.546 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 19.5 p-10 -126.09 29.66 5.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.622 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 59.51 38.45 93.61 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.3 mtt -150.19 160.8 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -1.152 . . . . 0.0 111.823 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.888 HD12 HG11 ' A' ' 36' ' ' VAL . 5.7 mt -129.81 108.12 9.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.641 -0.662 . . . . 0.0 109.512 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.529 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -69.46 158.04 35.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.858 -1.151 . . . . 0.0 109.448 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 14.1 ptt180 -41.5 -42.43 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.589 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -73.27 -43.88 60.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 12.4 mt-10 -64.79 -51.48 62.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.81 ' CD2' HD12 ' A' ' 31' ' ' LEU . 33.5 t80 -49.63 -28.64 6.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.0 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -65.84 -45.06 83.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 110.185 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.841 HG13 ' HG ' ' A' ' 94' ' ' LEU . 71.6 t -63.74 -20.34 26.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 110.179 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.942 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -89.86 -6.63 55.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.461 -0.775 . . . . 0.0 111.002 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 10.2 mmm -90.44 -44.93 9.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.548 -1.345 . . . . 0.0 110.318 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.891 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 1.5 p90 -75.32 -26.38 58.61 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.027 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.819 HD22 HG13 ' A' ' 86' ' ' VAL . 6.7 mt -67.56 -28.54 67.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.942 HG23 HG11 ' A' ' 53' ' ' VAL . 24.0 t -91.0 -59.9 2.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.77 ' HA ' HD13 ' A' ' 81' ' ' LEU . 2.5 m-85 -48.52 -23.07 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.772 -0.58 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 23.0 m -82.93 -20.41 35.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.861 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.067 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.26 -12.37 58.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.337 -0.852 . . . . 0.0 109.548 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 77' ' ' VAL . 3.3 mp -90.83 -46.02 8.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.415 -0.803 . . . . 0.0 110.17 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -69.32 -59.72 2.81 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.896 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 10.0 ttpt 176.57 48.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.694 -0.803 . . . . 0.0 111.523 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' CYS . 5.3 mm-40 -147.62 112.11 3.96 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.717 -1.239 . . . . 0.0 110.729 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 42.2 Cg_endo -69.25 177.05 5.61 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.025 1.539 . . . . 0.0 109.985 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.819 HG13 HD22 ' A' ' 76' ' ' LEU . 33.0 t -124.44 125.86 25.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.958 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.677 ' O ' HD11 ' A' ' 56' ' ' LEU . 53.1 Cg_endo -87.71 164.03 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.932 1.491 . . . . 0.0 109.961 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.547 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 17.0 mtt -93.83 16.68 13.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.969 -1.082 . . . . 0.0 110.465 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.6 m -110.47 104.59 13.35 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.549 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.69 107.9 1.25 Allowed Pre-proline 0 C--N 1.292 -1.907 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.325 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.746 ' HD2' HD22 ' A' ' 94' ' ' LEU . 42.8 Cg_endo -70.05 147.74 61.63 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.799 1.42 . . . . 0.0 108.948 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.65 -12.49 34.8 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.732 1.386 . . . . 0.0 110.299 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -87.61 17.1 4.87 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 108.798 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.91 HD12 ' HB3' ' A' ' 8' ' ' ALA . 1.3 tp -115.69 -5.74 12.14 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 110.213 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 99' ' ' LYS . 48.6 t -97.89 124.83 46.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 111.245 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 45.1 Cg_endo -77.81 175.19 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.052 1.554 . . . . 0.0 109.544 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 45.3 Cg_endo -72.11 -1.9 10.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.818 1.43 . . . . 0.0 110.384 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.8 t -81.02 -33.98 33.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.165 -0.959 . . . . 0.0 109.783 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' NZ ' ' OD2' ' A' ' 66' ' ' ASP . 8.4 mmpt? -89.31 10.6 21.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.336 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 28.9 ptt85 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 110.301 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.306 0.574 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.39 68.57 9.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.576 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 11.6 t-20 -46.64 114.69 2.85 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.567 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.692 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 43.6 Cg_endo -73.73 -3.15 13.27 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.85 1.448 . . . . 0.0 111.042 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.984 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.82 -65.92 1.14 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.851 -1.156 . . . . 0.0 108.705 177.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.68 ' OXT' HG12 ' A' ' 47' ' ' VAL . 2.1 ptt-85 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.273 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 110.412 -0.649 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.725 ' HE1' HD22 ' A' ' 94' ' ' LEU . 11.6 t90 -52.55 123.39 10.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.34 -0.85 . . . . 0.0 109.585 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.55 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.64 -25.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.954 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 17.4 t -99.28 152.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 2.2 mttm -109.77 175.02 2.09 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.0 Cg_endo -68.35 -36.71 15.24 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.142 1.601 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -30.29 63.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.341 -0.849 . . . . 0.0 109.262 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -82.14 -38.8 24.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 12.6 tptp -70.84 -17.03 62.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.43 -40.98 49.15 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.93 -24.87 43.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.7 m-30 -73.45 -37.39 65.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -73.98 -20.29 60.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.925 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.51 -35.68 24.66 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.2 -0.938 . . . . 0.0 108.5 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.566 HG22 ' CE1' ' A' ' 70' ' ' PHE . 50.5 mt -77.22 -33.11 19.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.725 ' O ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -64.89 -37.87 89.06 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.545 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 t0 -90.53 -2.26 57.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 20' ' ' ILE . 1.7 m -82.15 -9.93 59.35 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.309 -0.869 . . . . 0.0 108.948 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.128 HD12 ' CD1' ' A' ' 31' ' ' LEU . 13.1 mt -98.67 -53.89 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER 150.62 84.33 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.271 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 55.8 Cg_endo -76.71 123.83 7.17 Favored 'Trans proline' 0 C--N 1.293 -2.357 0 O-C-N 124.307 1.688 . . . . 0.0 109.55 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 28' ' ' ASN 0.251 2.2 p -119.48 121.33 66.12 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.723 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.026 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' ND2' ' CE2' ' A' ' 30' ' ' PHE . 10.0 t30 57.68 20.77 6.64 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 81.15 45.0 7.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.557 ' CE2' ' ND2' ' A' ' 28' ' ' ASN . 87.8 m-85 -151.87 158.79 43.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 112.452 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.128 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.7 mt -126.39 160.64 29.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' LYS . 1.4 p -106.88 146.78 30.57 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 120.682 -1.261 . . . . 0.0 110.532 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.618 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.65 -24.93 0.76 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' SER . 10.1 m-20 -75.85 -20.02 58.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.538 -0.978 . . . . 0.0 110.618 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HD2' HD22 ' A' ' 31' ' ' LEU . 11.7 mtmm -94.89 -35.2 12.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.976 -1.078 . . . . 0.0 108.141 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.786 HG12 ' CD1' ' A' ' 40' ' ' LEU . 96.8 t -78.01 -43.29 28.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.639 0.733 . . . . 0.0 109.764 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 2.5 tttt -40.83 -52.23 6.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.614 -0.679 . . . . 0.0 110.724 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.8 Cg_endo -67.03 -35.4 25.73 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.401 1.211 . . . . 0.0 109.65 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.58 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.5 -33.45 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.98 ' HB3' HD22 ' A' ' 50' ' ' LEU . 29.7 mt -88.97 -28.96 19.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.622 -0.674 . . . . 0.0 109.901 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.533 ' CD1' ' HG3' ' A' ' 37' ' ' LYS . 62.1 mt -71.95 -14.78 62.01 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -90.58 -3.74 57.35 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.118 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.647 ' O ' HD21 ' A' ' 81' ' ' LEU . 37.7 m -81.75 11.44 4.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.2 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.14 11.72 4.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.707 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.2 mt -100.57 155.14 36.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.9 Cg_endo -75.27 170.13 21.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.046 1.551 . . . . 0.0 109.816 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.576 HG11 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -68.59 -7.3 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 120.952 -1.093 . . . . 0.0 109.045 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.34 -27.87 60.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.927 HG21 HD13 ' A' ' 45' ' ' LEU . 10.1 mm -88.38 -38.69 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.98 HD22 ' HB3' ' A' ' 40' ' ' LEU . 9.7 mt -77.28 -29.76 53.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.2 -25.66 75.27 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.746 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -102.22 -35.88 8.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.081 -0.658 . . . . 0.0 110.75 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 77' ' ' VAL . 13.7 t -67.49 -37.72 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.819 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.618 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -64.11 -52.55 58.63 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.306 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 91.2 mt-10 -51.14 -58.79 5.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.388 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.812 HD21 ' C ' ' A' ' 88' ' ' MET . 3.2 mt -62.16 -13.98 32.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.131 -0.98 . . . . 0.0 109.013 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.909 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 29.4 m -96.35 -26.73 15.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.717 . . . . 0.0 110.131 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' TRP . 9.5 t0 -78.26 93.14 4.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.555 -0.715 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.699 HG23 ' HD2' ' A' ' 99' ' ' LYS . 24.4 mm -73.12 -32.43 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 110.06 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.518 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 2.6 m-20 -95.62 -16.02 22.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 58' ' ' ASP . 91.0 m-70 52.61 50.69 17.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.314 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 37.5 p-10 -125.0 36.87 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.5 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 58.19 33.01 68.47 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 6.6 mtt -150.54 160.66 43.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -1.091 . . . . 0.0 111.269 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.767 HD12 HG11 ' A' ' 36' ' ' VAL . 13.2 mt -132.28 110.49 10.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.222 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 10.7 t0 -70.13 167.62 17.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.946 -1.096 . . . . 0.0 110.372 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.3 ptm180 -45.61 -44.22 12.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.501 -0.749 . . . . 0.0 110.286 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.614 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 11.7 t0 -78.19 -36.27 47.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.301 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 60' ' ' ASP . 0.4 OUTLIER -63.65 -52.47 60.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.938 0.875 . . . . 0.0 109.397 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.867 ' CD2' HD12 ' A' ' 31' ' ' LEU . 17.7 t80 -54.48 -20.37 7.53 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.533 0.682 . . . . 0.0 109.274 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -73.23 -46.27 51.2 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.953 HG22 HD21 ' A' ' 94' ' ' LEU . 23.7 t -59.94 -28.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.077 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.909 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -89.66 -4.67 57.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 5.6 mmt -87.43 -43.19 12.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.718 -1.239 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.476 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -77.77 -22.22 50.53 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.077 -1.014 . . . . 0.0 108.379 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.608 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.3 mt -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 53' ' ' VAL . 41.3 t -91.7 -60.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.689 -0.632 . . . . 0.0 110.109 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.478 ' HA ' HD13 ' A' ' 81' ' ' LEU . 3.4 m-85 -55.97 -19.65 13.27 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.225 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 84' ' ' GLU . 7.5 m -83.25 -16.69 45.4 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.019 -1.051 . . . . 0.0 109.581 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.982 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -85.78 -15.22 42.76 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.454 -0.779 . . . . 0.0 109.557 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.647 HD21 ' O ' ' A' ' 43' ' ' SER . 6.2 mp -88.88 -40.34 13.17 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.643 0.735 . . . . 0.0 109.467 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 2.4 mm-40 -71.35 -51.77 22.42 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.933 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.1 OUTLIER 177.38 -24.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.856 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 79' ' ' CYS . 23.3 mm-40 -79.71 110.95 17.6 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.894 -1.128 . . . . 0.0 111.035 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 41.9 Cg_endo -68.75 -173.27 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.838 1.441 . . . . 0.0 109.969 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.629 HG11 ' CG2' ' A' ' 53' ' ' VAL . 96.5 t -128.44 109.61 19.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.975 . . . . 0.0 110.793 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.657 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.4 Cg_endo -76.31 -169.95 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.988 1.52 . . . . 0.0 109.564 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -112.8 20.87 16.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.514 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 74.8 m -114.0 101.62 9.42 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.102 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 1.009 ' CD1' HD12 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -69.95 109.34 4.58 Favored Pre-proline 0 C--N 1.29 -2.021 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 95' ' ' VAL . 39.9 Cg_endo -65.34 146.18 85.17 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.01 1.532 . . . . 0.0 111.571 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.94 -5.99 18.2 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.323 1.697 . . . . 0.0 110.822 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -86.36 -22.91 26.41 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.009 HD12 ' CD1' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -94.65 -9.17 35.78 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.706 ' CG2' HD11 ' A' ' 90' ' ' LEU . 94.0 t -85.17 130.46 51.9 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 111.161 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.531 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.2 Cg_endo -72.39 177.82 6.9 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.972 1.512 . . . . 0.0 109.662 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 98' ' ' SER . 39.5 Cg_endo -65.87 -178.01 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.543 1.286 . . . . 0.0 110.113 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 75.44 -49.86 0.63 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.346 -0.846 . . . . 0.0 109.879 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.699 ' HD2' HG23 ' A' ' 59' ' ' ILE . 4.8 ttmt -88.47 12.83 13.3 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 108.555 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.526 -0.734 . . . . 0.0 109.934 179.882 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.22 0.533 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.69 -46.16 5.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.147 -0.971 . . . . 0.0 110.344 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.451 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 7.6 t-20 52.32 93.02 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.181 -0.949 . . . . 0.0 110.297 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.509 ' HG3' ' HA3' ' A' ' 33' ' ' GLY . 48.5 Cg_endo -70.27 8.78 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.993 1.795 . . . . 0.0 112.176 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.923 ' CE2' HD12 ' A' ' 40' ' ' LEU . 15.3 m-85 -98.95 -45.04 6.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.762 -1.211 . . . . 0.0 109.854 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 N--CA 1.484 0.968 0 N-CA-C 110.686 -0.544 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.842 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.1 t90 -69.19 126.78 30.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.669 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 93' ' ' ALA . . . -40.56 -28.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 10' ' ' LYS . 62.8 t -94.02 165.45 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 12.6 mttt -119.55 172.65 4.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 40.3 Cg_endo -67.88 -35.46 20.93 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.005 1.529 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 6.4 pt-20 -72.64 -28.69 62.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.93 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 76.8 m-20 -81.17 -38.79 26.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 0.0 108.638 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppt? -68.56 -16.99 64.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -28.46 35.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -90.73 -35.62 14.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.7 m-30 -65.39 -28.56 69.35 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 14' ' ' LYS . 9.6 m-20 -80.98 -24.09 38.27 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.662 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.37 -30.78 37.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.718 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 56.3 mt -80.78 -28.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.642 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.58 -35.8 60.5 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.521 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t70 -89.32 -3.06 58.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.758 -0.589 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -6.57 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.305 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.118 HD12 HD13 ' A' ' 31' ' ' LEU . 4.5 mt -106.5 -12.25 15.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.2 p 89.59 94.68 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.259 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.9 Cg_endo -73.8 150.46 44.47 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.253 1.659 . . . . 0.0 110.871 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 71.9 t -123.9 110.27 25.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.3 t30 57.58 15.41 2.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.321 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 97.28 35.25 5.32 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 75.4 m-85 -150.56 143.2 24.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -1.205 . . . . 0.0 112.224 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.118 HD13 HD12 ' A' ' 24' ' ' LEU . 12.4 mt -109.56 134.46 51.89 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 1.7 m -78.37 142.56 37.57 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 118.939 -1.105 . . . . 0.0 109.942 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' HA3' ' HG3' ' B' ' 110' ' ' PRO . . . -43.48 -26.35 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' SER . 63.5 m-20 -67.55 -23.42 65.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 40.3 mttp -96.1 -33.18 12.18 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.841 HG12 ' CD1' ' A' ' 40' ' ' LEU . 84.6 t -77.9 -38.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.641 0.734 . . . . 0.0 109.598 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HA ' ' CE2' ' B' ' 111' ' ' PHE . 0.0 OUTLIER -43.15 -54.96 8.52 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.533 -0.73 . . . . 0.0 111.137 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -67.79 -31.78 31.24 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.718 1.378 . . . . 0.0 109.926 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -64.27 -31.22 52.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.579 -0.701 . . . . 0.0 109.304 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.979 HD12 ' CE2' ' B' ' 111' ' ' PHE . 22.2 mt -94.34 -34.92 12.62 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.597 -0.689 . . . . 0.0 109.974 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.4 mt -67.91 -14.45 62.97 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 19.8 t30 -90.73 -4.91 56.35 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.081 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.47 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 5.7 m -84.97 18.65 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.419 -0.801 . . . . 0.0 110.431 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.9 tptt 60.23 13.5 3.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 110.05 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.051 HD11 ' HB3' ' A' ' 80' ' ' ALA . 12.7 mt -100.22 152.13 37.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.92 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.572 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.8 Cg_endo -76.61 170.06 20.63 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.017 1.535 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 3.4 t -71.03 -4.53 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.757 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.8 -33.78 45.97 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.818 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.897 HG13 HD22 ' A' ' 45' ' ' LEU . 14.5 mm -79.32 -42.07 23.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 108.825 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 40' ' ' LEU . 12.9 mt -68.35 -29.46 68.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.57 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -67.28 -24.69 73.57 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 1.011 ' O ' HD12 ' A' ' 56' ' ' LEU . 5.5 ttm-85 -100.81 -32.59 10.62 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.685 -0.891 . . . . 0.0 110.265 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.801 HG11 HG23 ' A' ' 77' ' ' VAL . 24.6 t -68.77 -36.37 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.821 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.6 ' HB2' ' CE1' ' B' ' 111' ' ' PHE . 2.7 t-105 -69.59 -52.32 27.15 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.344 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 84.1 mt-10 -50.96 -57.38 8.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.095 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.011 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.1 mt -61.16 -14.36 24.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.128 -0.983 . . . . 0.0 108.834 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.934 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 15.5 t -97.0 -23.31 16.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.29 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' TRP . 29.0 t0 -95.55 90.91 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.975 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.15 -15.45 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 110.164 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 8.0 m-20 -89.17 -17.25 29.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.479 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 11.8 m170 57.59 46.86 16.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.623 -0.673 . . . . 0.0 110.115 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 8.4 p30 -119.78 16.07 12.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.639 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.22 33.58 83.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 37.9 mtp -151.47 160.78 43.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.238 . . . . 0.0 110.635 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.835 HD12 HG11 ' A' ' 36' ' ' VAL . 12.6 mt -119.77 105.16 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.0 109.584 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.567 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -71.94 163.48 27.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.334 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -41.84 -39.84 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 111.108 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -79.71 -32.32 41.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.187 -0.946 . . . . 0.0 110.594 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' CG ' ' OD1' ' A' ' 66' ' ' ASP . 35.3 mt-10 -77.75 -39.24 44.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.108 -0.995 . . . . 0.0 109.021 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.895 ' CD2' HD12 ' A' ' 31' ' ' LEU . 20.9 t80 -62.35 -18.22 60.93 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 0.0 108.907 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -77.73 -44.34 28.09 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.797 0.808 . . . . 0.0 109.564 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.976 ' CG1' HD11 ' A' ' 94' ' ' LEU . 44.0 t -61.57 -30.43 48.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.607 0.717 . . . . 0.0 109.676 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.934 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.68 -2.81 58.38 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 110.82 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.622 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 6.5 mmt -83.62 -48.91 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.031 -1.043 . . . . 0.0 109.897 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 7.6 p90 -76.19 -23.74 54.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.7 mt -71.04 -24.45 62.35 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.801 HG23 HG11 ' A' ' 53' ' ' VAL . 45.7 t -91.68 -46.38 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.648 -0.658 . . . . 0.0 110.298 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.401 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 2.7 m-85 -69.58 -26.42 64.45 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 110.865 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 16.1 t -81.43 -12.91 58.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.038 . . . . 0.0 109.385 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.051 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.36 -10.54 43.63 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 109.023 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.4 mt -90.87 -43.57 9.94 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.739 0.781 . . . . 0.0 109.708 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 1.4 tp10 -69.3 -57.16 5.68 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.628 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 175.17 79.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.369 179.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -172.67 119.24 0.41 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.694 -1.254 . . . . 0.0 110.958 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.32 158.01 49.05 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.704 1.37 . . . . 0.0 109.359 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 91.6 t -116.73 126.69 27.31 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 110.562 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.696 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.5 Cg_endo -84.42 -170.51 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.994 1.523 . . . . 0.0 108.913 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.777 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.48 13.25 13.46 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.954 -1.091 . . . . 0.0 110.242 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.618 ' N ' HD21 ' A' ' 56' ' ' LEU . 3.6 m -104.52 105.74 15.97 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.245 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.615 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -51.94 105.81 0.57 Allowed Pre-proline 0 N--CA 1.493 1.721 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.521 178.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.8 Cg_endo -69.75 147.2 62.4 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.791 1.416 . . . . 0.0 110.804 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.59 -5.57 17.42 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.775 1.65 . . . . 0.0 111.911 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -104.69 20.13 19.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.074 -1.016 . . . . 0.0 108.782 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.976 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -139.79 -0.92 1.67 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.456 0.646 . . . . 0.0 110.232 -178.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.47 129.24 77.89 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.615 -1.303 . . . . 0.0 110.529 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 48.6 Cg_endo -75.63 175.33 11.43 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.957 1.504 . . . . 0.0 110.001 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' SER . 42.6 Cg_endo -69.27 -178.94 2.38 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.799 1.421 . . . . 0.0 110.284 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 76.01 -43.83 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.464 -0.773 . . . . 0.0 110.019 -178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 51.2 tptt -87.75 8.5 25.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 110.345 179.823 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.244 0.545 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.517 HG23 ' O ' ' B' ' 108' ' ' THR . 14.8 t -96.55 128.1 43.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 110.454 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 2.5 t-20 -174.0 105.61 0.29 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.499 -0.751 . . . . 0.0 109.274 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.677 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 42.3 Cg_endo -70.5 -3.73 13.08 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.812 1.428 . . . . 0.0 110.514 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.979 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -111.95 -60.99 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.598 ' CG ' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.358 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_